Citrus Sinensis ID: 003971
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 782 | 2.2.26 [Sep-21-2011] | |||||||
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.329 | 0.314 | 0.477 | 1e-70 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.326 | 0.273 | 0.471 | 1e-70 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.363 | 0.310 | 0.383 | 9e-56 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.338 | 0.353 | 0.414 | 3e-55 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.320 | 0.390 | 0.409 | 2e-54 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.320 | 0.363 | 0.406 | 1e-52 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.322 | 0.155 | 0.391 | 8e-51 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.320 | 0.152 | 0.390 | 1e-49 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.318 | 0.193 | 0.373 | 3e-49 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.320 | 0.151 | 0.358 | 9e-48 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 268 bits (686), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 126/264 (47%), Positives = 181/264 (68%), Gaps = 6/264 (2%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILS 576
++ +I + +L + ++G G FG V R W+G+DVA+K+ +EQD AE + +F E++I+
Sbjct: 542 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMK 601
Query: 577 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
RLRHPN++LF+GA T+PP LS++TEY+ GSLY L+H SG +++L RR+L M D+ +G
Sbjct: 602 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 661
Query: 637 LMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694
+ +H IVHRDLKS N LV+K +TVK+CDFGLSR+ + + S+AGTPEWMAPE
Sbjct: 662 MNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 721
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 751
++R+EP EK D++S GVI+WEL TL +PW + P +VV AV + RLEIP +
Sbjct: 722 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 781
Query: 752 RLIADCWA-EPQERPSCEEILSRL 774
+I CW EP +RPS I+ L
Sbjct: 782 AIIEGCWTNEPWKRPSFATIMDLL 805
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (684), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 124/263 (47%), Positives = 180/263 (68%), Gaps = 8/263 (3%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 577
E I +++L + R+G+G +GEV+ W+GT+VA+K FL+QD + + +F +E+ I+ R
Sbjct: 661 ECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRR 720
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
LRHPNV+ FLGA T+PP LS++TE++ GSLY ++H K + RR++KM D+ G+
Sbjct: 721 LRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRP--KSHIDERRRIKMALDVAMGM 778
Query: 638 MCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
C+H IVHRDLK+ N LV+ +W VK+ DFGLSR+ ++ + S+AGTPEWMAPE+
Sbjct: 779 NCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 838
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 752
+RNEP EKCD++S GVI+WEL TL PW G+ P +VV AV + RLEIP + +GR
Sbjct: 839 LRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVGR 898
Query: 753 LIADCW-AEPQERPSCEEILSRL 774
+I +CW +P RPS ++ L
Sbjct: 899 IILECWQTDPNLRPSFAQLTEVL 921
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 219 bits (557), Expect = 9e-56, Method: Compositional matrix adjust.
Identities = 118/308 (38%), Positives = 183/308 (59%), Gaps = 24/308 (7%)
Query: 472 SPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTR 531
SP++Y + G+ S V+E P Q + + + I FSEL + ++
Sbjct: 624 SPNQYNNQGNILKNSG-------------SVVEPPSQQQQ---YFSDIEISFSELKISSK 667
Query: 532 VGIGFFGEVFRGIWNGTDVAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 590
+G G FG V++G+W G+ VAIK + + +D+ + +E+F E++ILSRLRHPN++L + AC
Sbjct: 668 LGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRLRHPNIVLLMAAC 727
Query: 591 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 650
T PP L ITEY+ GSLY +H +K K++ + K+ I +G+ +H ++HRD+
Sbjct: 728 TAPPNLCFITEYLPGGSLYDALH--SKKIKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDI 785
Query: 651 KSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSL 710
KS N L+++H VKICDFGLS++ + S + S G+P WM+PEL+ E +TEK D+++
Sbjct: 786 KSLNLLLDEHMNVKICDFGLSKLKSKS-TEMTKSIGSPIWMSPELLMGEDYTEKVDVYAF 844
Query: 711 GVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPS 766
G+I+WEL T P+ G+ ++ AV + R IP L LI CW +P +RPS
Sbjct: 845 GIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPS 904
Query: 767 CEEILSRL 774
EIL+ L
Sbjct: 905 FTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 217 bits (553), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 117/282 (41%), Positives = 166/282 (58%), Gaps = 17/282 (6%)
Query: 505 SPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN 564
SP+ + +E ID SE+ V R+G G EVF G W G VAIK + L E+
Sbjct: 470 SPLLKTDYKTLFEIKPIDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIK---KAKLLNED 526
Query: 565 MEDFCNEI----SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK 620
EDF NE+ +I+S+LRHPN+ FLG C PP + ++ EYM LGSLY ++H
Sbjct: 527 DEDFLNELAQEATIMSQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILH--DPSIS 584
Query: 621 LSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678
L W R M DI +G+ +H ++HRDLKS N LV++H+ VKI DFGLS
Sbjct: 585 LDWPRMKSMALDIAKGMNYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHL 644
Query: 679 MRDS--SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV 736
+ + + GTP W APE++RN+P+TEK D+FS +++WE+ T P++G+ ++V +V
Sbjct: 645 DKKTAMTPVGTPCWTAPEVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISV 704
Query: 737 ANEGSRLEIP---EGPLGRLIADCWAE-PQERPSCEEILSRL 774
R +P P RLI +CW+E PQ+RPS +EI+ RL
Sbjct: 705 GQHKLRPIVPPQVSAPFTRLITECWSEDPQQRPSFQEIVKRL 746
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 214 bits (546), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 107/261 (40%), Positives = 165/261 (63%), Gaps = 10/261 (3%)
Query: 520 NIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 579
+ID ++ +G R+G G +GEV+ G W G+ VA+K ++ +++F EI+++ LR
Sbjct: 368 DIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 427
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
HPNVI FLG+C PP + + TEYM GSLY ++H Q +L W +KM+ D +G++
Sbjct: 428 HPNVIQFLGSCLIPPDICICTEYMPRGSLYSILH--DQALQLQWSLLIKMMIDAAKGVIY 485
Query: 640 IHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 697
+H I+HRDLKS N LV+++W VK+ DFGLS I + ++ GTP W +PE++R
Sbjct: 486 LHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPCWTSPEVLR 543
Query: 698 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE-GP--LGRLI 754
++ +TEK D++S G+I+WE T P+ G+ P +V++AV EG R +P+ GP +L+
Sbjct: 544 SQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLL 603
Query: 755 ADCWAE-PQERPSCEEILSRL 774
DC E P RP+ E+ L RL
Sbjct: 604 IDCLNENPSHRPTMEQCLERL 624
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 208 bits (529), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 106/261 (40%), Positives = 164/261 (62%), Gaps = 10/261 (3%)
Query: 520 NIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 579
+ID ++ +G R+G G FGEV+ G W G+ VA+K ++ +++F EI+++ LR
Sbjct: 385 DIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 444
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
HPNVI FLG+C P + + TEYM GSLY ++H +K K+SW +M+ D +G++
Sbjct: 445 HPNVIQFLGSCLISPDICICTEYMPRGSLYSILH--NEKIKISWSLVKRMMIDAAKGIIY 502
Query: 640 IHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 697
+H I+HRDLKS N LV+++W VK+ DFGLS I + ++ GTP W +PE++R
Sbjct: 503 LHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPCWTSPEVLR 560
Query: 698 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE-GP--LGRLI 754
++ +TEK D++S G+I+WE T P+ G+ P +V++AV EG R P+ GP +L+
Sbjct: 561 SQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLL 620
Query: 755 ADCWAE-PQERPSCEEILSRL 774
DC E P +RP+ E+ L L
Sbjct: 621 KDCLNENPSQRPTMEQCLEIL 641
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 202 bits (514), Expect = 8e-51, Method: Compositional matrix adjust.
Identities = 103/263 (39%), Positives = 159/263 (60%), Gaps = 11/263 (4%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 578
W I++ E+++G ++G+G +G VF G W G DVA+K F++Q L+ + +F E++ LS L
Sbjct: 1357 WIINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAFLSEL 1416
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
+H N++ F+GAC K P + ++TEYM +G+L + L K+++ KLK+L G+
Sbjct: 1417 KHSNIVTFIGACIKKPNICIVTEYMRMGNLRDV--LKNPDIKITFANKLKLLYGAAMGID 1474
Query: 639 CIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
+H IVHRD+K AN LV++H+ VKI DFG +RI D+ + GTP W APE+I
Sbjct: 1475 YLHSSNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDNTTM--TRCGTPCWTAPEVI 1532
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 753
R E + EK D+FS GV+MWE+ T P+ +V + EG R IP +L
Sbjct: 1533 RGEKYCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDIL-EGGRPIIPSDCPHEFAKL 1591
Query: 754 IADCW-AEPQERPSCEEILSRLL 775
I CW A+ +RP+ E++ +L+
Sbjct: 1592 IKKCWHAKAHKRPTMTEVVQQLM 1614
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 198 bits (504), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 103/264 (39%), Positives = 164/264 (62%), Gaps = 13/264 (4%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 578
W I++ ++ +G ++G+G +G V G W +VA+K F++Q + + M +F EI+ LS+L
Sbjct: 1387 WIINYDDIQIGKQIGVGSYGIVNMGKWKNINVAVKKFVKQKIDEKQMLEFRAEIAFLSQL 1446
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
RHP++IL +GAC K P + ++TE+M GSL ++I + K W+ K+KML G+
Sbjct: 1447 RHPHIILMIGACLKRPNICIVTEFMGNGSLRNVI----KTTKPEWKLKIKMLYQTALGIG 1502
Query: 639 CIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
+H I+HRD+K +N LV+ VKI DFG +RI ++ + + GTP W APE+I
Sbjct: 1503 YLHNSDPIIIHRDIKPSNILVDDSMNVKIADFGFARIKEENSVM--TRCGTPCWTAPEII 1560
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLG--RL 753
R E +TEK D+FS G++MWE+ T P+ G +V + EG+R +IP + P+ +L
Sbjct: 1561 RGEKYTEKVDVFSFGIVMWEVLTCKEPFSGCNFMKVSMDIL-EGARPQIPSDCPIDFTKL 1619
Query: 754 IADCW-AEPQERPSCEEILSRLLD 776
+ CW A+P +RPS E+++ L D
Sbjct: 1620 MKQCWHAKPDKRPSMEDVIMGLND 1643
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 3e-49, Method: Compositional matrix adjust.
Identities = 97/260 (37%), Positives = 157/260 (60%), Gaps = 11/260 (4%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 577
EW + SE+ +G R+G G +G+VFRG W GT+VA+K+ ++ + + D E+ +L +
Sbjct: 843 EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCK 902
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
LRHPN++LF+GACT+P ++TEY+ GSL ++ L + ++ W +L++ D RG+
Sbjct: 903 LRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANI--LLDESIEMDWGLRLQLGFDCARGM 960
Query: 638 MCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
+H I+HRDLK+ N LV+ W VK+ DFGL+ + + + + + GT W+APE+
Sbjct: 961 TYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTFAK--TMCGTTGWVAPEV 1018
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGR 752
+ E +TEK D++S +++WEL T P+ G +VV ++ + G RL +P
Sbjct: 1019 LAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSI-DRGERLPMPAWCPPKYAA 1077
Query: 753 LIADCW-AEPQERPSCEEIL 771
L+ CW +P RPS EIL
Sbjct: 1078 LMNRCWETDPTHRPSFPEIL 1097
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 192 bits (488), Expect = 9e-48, Method: Compositional matrix adjust.
Identities = 94/262 (35%), Positives = 158/262 (60%), Gaps = 11/262 (4%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 578
W I++ E+ +G ++G+G +G V+RG W DVAIK F++Q + ++ EI+ L +L
Sbjct: 1392 WVINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAFLKKL 1451
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
HPN+I +GA K P + ++TEYM G+L + KL W +K+K+L +I +G+
Sbjct: 1452 HHPNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTC--TPKLEWHQKIKILVNIAKGIS 1509
Query: 639 CIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
+H I+HRD+K +N L++++W VKI DFG +RI ++ + + GTP W APE+I
Sbjct: 1510 YLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAIM--TRCGTPCWTAPEII 1567
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 753
RN+ + EK D+FS G++MWE+ T P+ G ++ + E R +IP+ +L
Sbjct: 1568 RNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITMDIL-EDVRPKIPQDCPEEFAKL 1626
Query: 754 IADCW-AEPQERPSCEEILSRL 774
+ CW A+ +RP+ ++++ L
Sbjct: 1627 MRKCWHAKSTKRPTMDDVIIVL 1648
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 782 | ||||||
| 255575293 | 810 | protein kinase, putative [Ricinus commun | 0.987 | 0.953 | 0.810 | 0.0 | |
| 224131388 | 822 | predicted protein [Populus trichocarpa] | 0.998 | 0.950 | 0.795 | 0.0 | |
| 225446619 | 817 | PREDICTED: uncharacterized protein LOC10 | 0.992 | 0.949 | 0.783 | 0.0 | |
| 356543914 | 813 | PREDICTED: uncharacterized protein LOC10 | 0.993 | 0.955 | 0.779 | 0.0 | |
| 356549852 | 813 | PREDICTED: uncharacterized protein LOC10 | 0.993 | 0.955 | 0.773 | 0.0 | |
| 356543916 | 791 | PREDICTED: uncharacterized protein LOC10 | 0.968 | 0.957 | 0.761 | 0.0 | |
| 356543086 | 816 | PREDICTED: uncharacterized protein LOC10 | 0.994 | 0.953 | 0.764 | 0.0 | |
| 356517339 | 812 | PREDICTED: uncharacterized protein LOC10 | 0.984 | 0.948 | 0.745 | 0.0 | |
| 357474617 | 803 | Tyrosine-protein kinase ABL2 [Medicago t | 0.971 | 0.946 | 0.746 | 0.0 | |
| 356517341 | 768 | PREDICTED: uncharacterized protein LOC10 | 0.934 | 0.951 | 0.737 | 0.0 |
| >gi|255575293|ref|XP_002528550.1| protein kinase, putative [Ricinus communis] gi|223532052|gb|EEF33862.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1335 bits (3455), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 665/820 (81%), Positives = 715/820 (87%), Gaps = 48/820 (5%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETRDD G AEQG NA WW+ DFIE F SVSL SQE++LSNKESPRN+E+D LSSQTA
Sbjct: 1 MEETRDDVGPAEQGPSNALWWSSDFIEKFESVSLLSQEDSLSNKESPRNYEEDNLSSQTA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQILWSTGMLSE IPNGFYSV+P+KRLKELFDSIPT D+LHALG EG +ADII VD+KKD
Sbjct: 61 SQILWSTGMLSERIPNGFYSVVPEKRLKELFDSIPTFDDLHALGAEGFKADIIFVDAKKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETS--HMFET 178
KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLV+D YKRP+VESPAKAALEETS HMFE
Sbjct: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVSDVYKRPNVESPAKAALEETSHVHMFEN 180
Query: 179 RGVQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLN 238
RG+QLLGQI+HGSCRPRAILFKVLADTVGLESRLMVGLPNDGT+EC DS+KHMSVIVVLN
Sbjct: 181 RGIQLLGQIKHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTVECADSFKHMSVIVVLN 240
Query: 239 SVELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVD 298
SVELLVDLMRFPGQLIPR+T+AIFM+HISAAGESDSAENDSCDSPLEPNSPLYG SERVD
Sbjct: 241 SVELLVDLMRFPGQLIPRTTRAIFMTHISAAGESDSAENDSCDSPLEPNSPLYGFSERVD 300
Query: 299 PDSSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKL----SEPNIATTFWRRSR 354
PDS+EKDES Q RKLE N+SGP+LRNMMLR A S+DRKL SEPNIATTFWRRSR
Sbjct: 301 PDSAEKDESLQFHRKLE--GNVSGPALRNMMLRSATSIDRKLSLSHSEPNIATTFWRRSR 358
Query: 355 RKVIAEQRTASS--------------------------------RSEGASTSEARRIRRR 382
+KVIAEQRTASS RS GAS SE RRIRRR
Sbjct: 359 KKVIAEQRTASSSPEHPSFRARGRSMLSGDRHSIRDYADDEAAPRSVGASASETRRIRRR 418
Query: 383 SISITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGT 442
SIS+TPEIGDDIVRAVRAMNE+LKQNRLL+ER + DN +D +N SN L
Sbjct: 419 SISMTPEIGDDIVRAVRAMNESLKQNRLLRERDD--------KDNGTDFQRNVSNLDLDG 470
Query: 443 HDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKV 502
HD+ISGGRSALY L RD +NSQKAISLPSSPH+Y SH S+R G SG+ N E VSTWNKV
Sbjct: 471 HDDISGGRSALYTLQRDHINSQKAISLPSSPHQYRSHISDRRGPSGHAVNDELVSTWNKV 530
Query: 503 LESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 562
LESPMF NKPLL ++EWNIDF+ELTVGTRVGIGFFGEVFRG+WNGTDVAIKVFLEQDLTA
Sbjct: 531 LESPMFNNKPLLPFQEWNIDFTELTVGTRVGIGFFGEVFRGVWNGTDVAIKVFLEQDLTA 590
Query: 563 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 622
ENMEDFCNEISILSRLRHPNVILFLGAC KPP LSM+TEYME+GSLY+LIHLSGQKK+LS
Sbjct: 591 ENMEDFCNEISILSRLRHPNVILFLGACMKPPHLSMVTEYMEMGSLYYLIHLSGQKKRLS 650
Query: 623 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682
WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI+T++P+RDS
Sbjct: 651 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIMTETPIRDS 710
Query: 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 742
SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV PERVVYAVANE SR
Sbjct: 711 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVPPERVVYAVANERSR 770
Query: 743 LEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 782
L+IPEGPLGRLI+DCW EP ERPSCEEIL+RLLDCEYSLC
Sbjct: 771 LDIPEGPLGRLISDCWGEPHERPSCEEILARLLDCEYSLC 810
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224131388|ref|XP_002321072.1| predicted protein [Populus trichocarpa] gi|222861845|gb|EEE99387.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1313 bits (3398), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 655/823 (79%), Positives = 714/823 (86%), Gaps = 42/823 (5%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETRDD+G AEQG N+ WW DFIE F SVSL SQE+TL NKES +N+E+DGLSSQTA
Sbjct: 1 MEETRDDSGPAEQGPSNSVWWGSDFIEKFESVSLLSQEDTLRNKESHKNYEEDGLSSQTA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQ+LWSTGMLSE IPNGFYSVIPDKRLKELF +IPT+DELH+LG EG +ADIILVD+KKD
Sbjct: 61 SQVLWSTGMLSEQIPNGFYSVIPDKRLKELFVNIPTLDELHSLGAEGCKADIILVDAKKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
KKLSMLKQLIV LVKGLNSNPAAMIKKIAGLVADFYKRP+VESPAKAALEE SHM E RG
Sbjct: 121 KKLSMLKQLIVPLVKGLNSNPAAMIKKIAGLVADFYKRPNVESPAKAALEEASHMLENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSV 240
VQLLGQIRHGSCRPRAI FKVLAD+VGLESRL+VGLPNDG +ECVDSYKHMSVIV+LNSV
Sbjct: 181 VQLLGQIRHGSCRPRAIFFKVLADSVGLESRLVVGLPNDGIVECVDSYKHMSVIVMLNSV 240
Query: 241 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 300
ELLVDLMR PGQL+PRST+AIFM+HISAAGESDSAENDSCDSPLEPNSP+YG +ERVDPD
Sbjct: 241 ELLVDLMRSPGQLMPRSTRAIFMTHISAAGESDSAENDSCDSPLEPNSPMYGFAERVDPD 300
Query: 301 SSEKDE-SFQVQRKLETPANISGPSLRNMMLRPAASLDRKLS----EPNIATTFWRRSRR 355
S+EKDE S QV RKLE +N+ GPSLRNMMLR A S+DRKLS EPNIATTFWRRSR+
Sbjct: 301 SAEKDEGSLQVHRKLEASSNVLGPSLRNMMLRSATSIDRKLSLSHSEPNIATTFWRRSRK 360
Query: 356 KVIAEQRTASS----------------------------------RSEGASTSEARRIRR 381
KVIAEQRTASS RSEGAS SEARR+RR
Sbjct: 361 KVIAEQRTASSSPEHPSFRGRGRSMLSGDRHSIRHYADDVAISSHRSEGASMSEARRMRR 420
Query: 382 RSISITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRS--SNDNTSDLPKNASNFH 439
RSIS+TPEIGDDIVRAVRAMNETLKQNRLL E+G+DR FT + DN +DL KN SNF
Sbjct: 421 RSISMTPEIGDDIVRAVRAMNETLKQNRLLMEQGDDRLFTNNLGDKDNGTDLQKNVSNFS 480
Query: 440 LGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTW 499
L DEISGGRSALY L R+++NSQKAISLPSSPHEY S SER G SG++A+ + VSTW
Sbjct: 481 LDGRDEISGGRSALYTLERNRINSQKAISLPSSPHEYRSQTSERSGPSGFVADDQLVSTW 540
Query: 500 NKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQD 559
NKVLESP+F N P L ++EW+IDFSELTVGTRVGIGFFGEVFRGIWNGT+VA+KVFLEQD
Sbjct: 541 NKVLESPLFHNNPPLPFQEWHIDFSELTVGTRVGIGFFGEVFRGIWNGTEVAVKVFLEQD 600
Query: 560 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKK 619
LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYME+GSLY+LIH SGQ K
Sbjct: 601 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMEMGSLYYLIHSSGQ-K 659
Query: 620 KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679
KLSWRR+LKMLRDICRGLMCIHRMKIVHRDLKSANCLVN H T+KICDFGLSR++TD P+
Sbjct: 660 KLSWRRRLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNNHKTIKICDFGLSRVMTDIPI 719
Query: 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 739
RDSSSAGTPEWMAPELIRNEP TEKCDIFSLGVIMWELCTL+RPWEGV P+RVV AVANE
Sbjct: 720 RDSSSAGTPEWMAPELIRNEPVTEKCDIFSLGVIMWELCTLSRPWEGVPPKRVVDAVANE 779
Query: 740 GSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 782
GSRLEIPEGPLGRLI+DCWAEP RPSC EIL+RLLDCEY+ C
Sbjct: 780 GSRLEIPEGPLGRLISDCWAEPDLRPSCGEILTRLLDCEYTSC 822
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225446619|ref|XP_002280724.1| PREDICTED: uncharacterized protein LOC100255804 [Vitis vinifera] gi|302143427|emb|CBI21988.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1290 bits (3338), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 645/823 (78%), Positives = 705/823 (85%), Gaps = 47/823 (5%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETRDDAG AEQG P TWW DFIE FGSVSL SQEE LSNK S N EQD LSSQTA
Sbjct: 1 MEETRDDAGPAEQGSPVTTWWPSDFIERFGSVSLVSQEEILSNKNSNSNTEQDELSSQTA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQILWSTGMLSEPIPNGFYSVIPDK+LKE+FD IPT+DEL+ALG EG RADIILVD+ +D
Sbjct: 61 SQILWSTGMLSEPIPNGFYSVIPDKKLKEIFDDIPTLDELYALGSEGVRADIILVDAVRD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVE-SPAKAALEETSHMFETR 179
KKLSMLKQLIVALVKGLNSNPAA+IKKIAGLV+DFYKRP++E SPAKAALEETSH+ E R
Sbjct: 121 KKLSMLKQLIVALVKGLNSNPAAVIKKIAGLVSDFYKRPNLELSPAKAALEETSHVSENR 180
Query: 180 GVQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNS 239
QLLGQI+HGSCRPRAILFKVLADTVGLESRLMVGLPNDG + CVDSYKHMSVIV+LNS
Sbjct: 181 VAQLLGQIKHGSCRPRAILFKVLADTVGLESRLMVGLPNDGAIGCVDSYKHMSVIVMLNS 240
Query: 240 VELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDP 299
ELLVDLMRFPGQLIPRST+AIFM+HISAAGESDSAENDSCDSPLEPNSPLYG S+RVDP
Sbjct: 241 GELLVDLMRFPGQLIPRSTRAIFMTHISAAGESDSAENDSCDSPLEPNSPLYGFSDRVDP 300
Query: 300 DSSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLS----EPNIATTFWRRSRR 355
DS+EKDE Q QR+LE +N+SGPSLRN+MLR S+DRKLS EPNIATTFWRRSRR
Sbjct: 301 DSTEKDEGLQFQRRLEASSNVSGPSLRNVMLRSTPSIDRKLSLSHSEPNIATTFWRRSRR 360
Query: 356 KVIAEQRTASS----------------------------------RSEGASTSEARRIRR 381
KVIAEQRTASS RS+GASTS + R
Sbjct: 361 KVIAEQRTASSSPEHPSFRARGRSMLSGDRKSFRDYADDIAASSYRSDGASTSTSETRRI 420
Query: 382 RSISIT--PEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFH 439
R SI+ PEIGDDIVRAVRAMNETLK NRL++++G+DR F SSN D+ KN S+FH
Sbjct: 421 RRRSISITPEIGDDIVRAVRAMNETLKANRLMRDQGDDRAF--SSN---PDIQKNVSDFH 475
Query: 440 LGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTW 499
L H EIS G S++Y L R+Q++SQKAISLPSSPHE+ S S R G+S + N E VS W
Sbjct: 476 LDGHGEISHGSSSMYTLPREQISSQKAISLPSSPHEFRSQTSGRSGTSD-IVNDEMVSIW 534
Query: 500 NKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQD 559
N+VLE PMF +KPLL ++EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQD
Sbjct: 535 NRVLEKPMFHSKPLLPFQEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQD 594
Query: 560 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKK 619
LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME+GSLY+LIHLSGQKK
Sbjct: 595 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEIGSLYYLIHLSGQKK 654
Query: 620 KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679
KLSWRR++KMLRDICRGLMCIHRMKIVHRD+KSANCLVNKHWTVKICDFGLSR++TD+P+
Sbjct: 655 KLSWRRRIKMLRDICRGLMCIHRMKIVHRDIKSANCLVNKHWTVKICDFGLSRVMTDTPL 714
Query: 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 739
RDSSSAGTPEWMAPELIRNEPFTEKCDIFS G+IMWELCTLNRPWEGV PERVVYAVA+E
Sbjct: 715 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSFGMIMWELCTLNRPWEGVPPERVVYAVAHE 774
Query: 740 GSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 782
GSRL+IPEGPLG LIADCWAEP +RPSCE+ILSRL DCEY+LC
Sbjct: 775 GSRLDIPEGPLGMLIADCWAEPHQRPSCEDILSRLQDCEYTLC 817
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543914|ref|XP_003540403.1| PREDICTED: uncharacterized protein LOC100803469 isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1283 bits (3321), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 638/818 (77%), Positives = 702/818 (85%), Gaps = 41/818 (5%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETR+DAG AEQG N +WW DF+E FGSVSLGSQ+E LSNKESPR+F++D LSSQ A
Sbjct: 1 MEETREDAGPAEQGPSNVSWWPSDFVEKFGSVSLGSQDEILSNKESPRHFDKDVLSSQKA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQ LW G+LSEPIPNGFYSVIP+ RLKELFDSIPT+DELHALGGEG +ADIILVDS+KD
Sbjct: 61 SQTLWRIGVLSEPIPNGFYSVIPETRLKELFDSIPTLDELHALGGEGFKADIILVDSEKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
KKLSMLK+LI+ALV+GLNSNPAA+IKKIAGLV+DFYK P+VESPAKAAL+E+SHMFE RG
Sbjct: 121 KKLSMLKKLIMALVRGLNSNPAAIIKKIAGLVSDFYKCPNVESPAKAALDESSHMFENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSV 240
VQ+LGQI+HGSCRPRAILFKVLADTVGLESRLMVGLPNDG +EC DSYKHMSVIVVLNSV
Sbjct: 181 VQMLGQIKHGSCRPRAILFKVLADTVGLESRLMVGLPNDGAIECQDSYKHMSVIVVLNSV 240
Query: 241 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 300
E+LVDLMRFPGQL+PRSTKA+FM+HIS AGESDSAENDSCDSPLEPNSPL+GVSER+DP+
Sbjct: 241 EMLVDLMRFPGQLLPRSTKAVFMTHIS-AGESDSAENDSCDSPLEPNSPLFGVSERLDPN 299
Query: 301 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSEPNIATTFWRRSRRKVIAE 360
S+EK+E+ Q R+ E +N+SG SLRN+MLR +SL SEPNIAT F RRSRRKVIAE
Sbjct: 300 SAEKEENLQFHRRFEASSNVSGLSLRNVMLRSNSSLSLSHSEPNIATAFGRRSRRKVIAE 359
Query: 361 QRTASS-------RSEGASTSEARRIRRRSIS---------------------------I 386
QRTASS R+ G S R R + I
Sbjct: 360 QRTASSSPEHPSFRARGRSMLSGDRTTFRDFADDQATSSYRSDNTSSSEARRIRRRSISI 419
Query: 387 TPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSD--LPKNASNFHLGTHD 444
TPEIGDDIVRAVRAMNETLKQNRLL+ERG+D F S N+++SD L KN SNFHL HD
Sbjct: 420 TPEIGDDIVRAVRAMNETLKQNRLLRERGDDNSFPNSPNNSSSDANLQKNVSNFHLDGHD 479
Query: 445 EISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLE 504
E RSALY+ RDQ SQKA+SLPSSPH+YG S+R GSS Y N E STWNKVLE
Sbjct: 480 E----RSALYSFQRDQGASQKAMSLPSSPHDYGGQASKRSGSSRYGVNDEMESTWNKVLE 535
Query: 505 SPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN 564
SPMF NKPLL YE+WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN
Sbjct: 536 SPMFNNKPLLPYEKWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN 595
Query: 565 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWR 624
MEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYMELGSLY+LIHL+GQKKKL+WR
Sbjct: 596 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMELGSLYYLIHLNGQKKKLNWR 655
Query: 625 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 684
R+L+MLRDIC+GLMCIHRMK+VHRDLKSANCLVNKHWTVKICDFGLSRI+T+SPMRDSSS
Sbjct: 656 RRLRMLRDICKGLMCIHRMKVVHRDLKSANCLVNKHWTVKICDFGLSRIMTESPMRDSSS 715
Query: 685 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE 744
AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV PERVVY+VANEGSRLE
Sbjct: 716 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVPPERVVYSVANEGSRLE 775
Query: 745 IPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 782
IPEGPLGRLI++CWAE ERPSCEEILSRL+D EYSLC
Sbjct: 776 IPEGPLGRLISECWAECHERPSCEEILSRLVDIEYSLC 813
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549852|ref|XP_003543304.1| PREDICTED: uncharacterized protein LOC100810612 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1276 bits (3303), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 633/818 (77%), Positives = 697/818 (85%), Gaps = 41/818 (5%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETR+DAG AEQG N WW DF+E FGSVSLGSQ+ETLSNKESPR+ +D LSS A
Sbjct: 1 MEETREDAGPAEQGPSNVLWWPSDFVEKFGSVSLGSQDETLSNKESPRHVVEDVLSSLKA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQ LW TGMLSEPIPNGFYSVIP+ RLKELF SIPT+DELHALGGEG +ADIILVDS+KD
Sbjct: 61 SQTLWQTGMLSEPIPNGFYSVIPETRLKELFYSIPTLDELHALGGEGFKADIILVDSEKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
KKLSMLKQLI+ALV+GLN+NPAA+IKKIAGLV+DFYKRP+VESPAKAAL+ETSHMFE RG
Sbjct: 121 KKLSMLKQLIMALVRGLNANPAAIIKKIAGLVSDFYKRPNVESPAKAALDETSHMFENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSV 240
VQ+LGQI+HGSCRPRAILFKVLADTVGLESRLMVGLPNDG +EC DSYKHMSVIVVLNS+
Sbjct: 181 VQMLGQIKHGSCRPRAILFKVLADTVGLESRLMVGLPNDGAIECQDSYKHMSVIVVLNSL 240
Query: 241 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 300
E+LVDLMRFPGQL+PRSTK++FM+HIS AGESDSAENDSCDSPLEPNSPL+GVSER+D +
Sbjct: 241 EMLVDLMRFPGQLLPRSTKSVFMTHIS-AGESDSAENDSCDSPLEPNSPLFGVSERLDSN 299
Query: 301 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSEPNIATTFWRRSRRKVIAE 360
S+EK+E+ Q R+ E +N+SG SLRN+MLR ++L SEPNIAT F RRSRRKVIAE
Sbjct: 300 SAEKEENLQFHRRFEASSNVSGLSLRNVMLRSNSNLSLSHSEPNIATAFGRRSRRKVIAE 359
Query: 361 QRTASS-------RSEGASTSEARRIRRRSIS---------------------------I 386
QRTASS R+ G S R R + I
Sbjct: 360 QRTASSSPEHPSFRARGRSMLSGDRTTFRDFTDDQATSSYRSDGTSSSEARRIRRRSISI 419
Query: 387 TPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSD--LPKNASNFHLGTHD 444
TPEIGDDIVRAVRAMNETLKQNRLL+ERG+D F S N+++SD L KN SNFHL HD
Sbjct: 420 TPEIGDDIVRAVRAMNETLKQNRLLRERGDDNSFPNSPNNSSSDANLQKNVSNFHLDGHD 479
Query: 445 EISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLE 504
E RSALY+ RDQ SQKA+SLPSSPH+Y SER G S Y N E STWNKVLE
Sbjct: 480 E----RSALYSFQRDQGTSQKAMSLPSSPHDYRGQASERSGPSRYGVNDEMESTWNKVLE 535
Query: 505 SPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN 564
SPMF NKPLL YE+WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN
Sbjct: 536 SPMFNNKPLLPYEKWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN 595
Query: 565 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWR 624
MEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYMELGSLY+L+HLSGQKKKL+WR
Sbjct: 596 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMELGSLYYLMHLSGQKKKLNWR 655
Query: 625 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 684
R+L+MLRDIC+GLMCIHRMK+VHRDLKSANCLVNKHWTVKICDFGLSRI+T+SPMRDSSS
Sbjct: 656 RRLRMLRDICKGLMCIHRMKVVHRDLKSANCLVNKHWTVKICDFGLSRIMTESPMRDSSS 715
Query: 685 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE 744
AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV PERVVY+VA+EGSRLE
Sbjct: 716 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVPPERVVYSVAHEGSRLE 775
Query: 745 IPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 782
IPEGPLGRLI++CWAE +RPSCEEILSRL+D EYSLC
Sbjct: 776 IPEGPLGRLISECWAECHQRPSCEEILSRLVDIEYSLC 813
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543916|ref|XP_003540404.1| PREDICTED: uncharacterized protein LOC100803469 isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1244 bits (3220), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 621/816 (76%), Positives = 688/816 (84%), Gaps = 59/816 (7%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETR+DAG AEQG N +WW DF+E FGSVSLGSQ+E LSNKESPR+F++D LSSQ A
Sbjct: 1 MEETREDAGPAEQGPSNVSWWPSDFVEKFGSVSLGSQDEILSNKESPRHFDKDVLSSQKA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQ LW G+LSEPIPNGFYSVIP+ RLKELFDSIPT+DELHALGGEG +ADIILVDS+KD
Sbjct: 61 SQTLWRIGVLSEPIPNGFYSVIPETRLKELFDSIPTLDELHALGGEGFKADIILVDSEKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
KKLSMLK+LI+ALV+GLNSNPAA+IKKIAGLV+DFYK P+VESPAKAAL+E+SHMFE RG
Sbjct: 121 KKLSMLKKLIMALVRGLNSNPAAIIKKIAGLVSDFYKCPNVESPAKAALDESSHMFENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSV 240
VQ+LGQI+HGSCRPRAILFKVLADTVGLESRLMVGLPNDG +EC DSYKHMSVIVVLNSV
Sbjct: 181 VQMLGQIKHGSCRPRAILFKVLADTVGLESRLMVGLPNDGAIECQDSYKHMSVIVVLNSV 240
Query: 241 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 300
E+LVDLMRFPGQL+PRSTKA+FM+HIS AGESDSAENDSCDSPLEPNSPL+GVSER+DP+
Sbjct: 241 EMLVDLMRFPGQLLPRSTKAVFMTHIS-AGESDSAENDSCDSPLEPNSPLFGVSERLDPN 299
Query: 301 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSEPNIATTFWRRSRRKVIAE 360
S+EK+E+ Q R+ E +N+SG SLRN+MLR +SL SEPNIAT F RRSRRKVIAE
Sbjct: 300 SAEKEENLQFHRRFEASSNVSGLSLRNVMLRSNSSLSLSHSEPNIATAFGRRSRRKVIAE 359
Query: 361 QRTASS-------RSEGASTSEARRIRRRSIS---------------------------I 386
QRTASS R+ G S R R + I
Sbjct: 360 QRTASSSPEHPSFRARGRSMLSGDRTTFRDFADDQATSSYRSDNTSSSEARRIRRRSISI 419
Query: 387 TPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEI 446
TPEIGDDIVRAVRAMNETLKQNRLL+ERG+D F S N+++SD
Sbjct: 420 TPEIGDDIVRAVRAMNETLKQNRLLRERGDDNSFPNSPNNSSSD---------------- 463
Query: 447 SGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESP 506
NL ++ ++SQKA+SLPSSPH+YG S+R GSS Y N E STWNKVLESP
Sbjct: 464 -------ANLQKN-VSSQKAMSLPSSPHDYGGQASKRSGSSRYGVNDEMESTWNKVLESP 515
Query: 507 MFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENME 566
MF NKPLL YE+WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENME
Sbjct: 516 MFNNKPLLPYEKWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENME 575
Query: 567 DFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 626
DFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYMELGSLY+LIHL+GQKKKL+WRR+
Sbjct: 576 DFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMELGSLYYLIHLNGQKKKLNWRRR 635
Query: 627 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 686
L+MLRDIC+GLMCIHRMK+VHRDLKSANCLVNKHWTVKICDFGLSRI+T+SPMRDSSSAG
Sbjct: 636 LRMLRDICKGLMCIHRMKVVHRDLKSANCLVNKHWTVKICDFGLSRIMTESPMRDSSSAG 695
Query: 687 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 746
TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV PERVVY+VANEGSRLEIP
Sbjct: 696 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVPPERVVYSVANEGSRLEIP 755
Query: 747 EGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 782
EGPLGRLI++CWAE ERPSCEEILSRL+D EYSLC
Sbjct: 756 EGPLGRLISECWAECHERPSCEEILSRLVDIEYSLC 791
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543086|ref|XP_003539994.1| PREDICTED: uncharacterized protein LOC100807193 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1242 bits (3213), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 627/820 (76%), Positives = 692/820 (84%), Gaps = 42/820 (5%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETR+DAG AE+ N +WW DF+E F SVSL SQ+ETL+NKESPR+ +D +S Q A
Sbjct: 1 MEETREDAGPAERRPSNMSWWPSDFVEKFESVSLSSQDETLNNKESPRHSNRDVMSPQKA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQILW TGMLSEPIPNGFYSVI +KRLK+LFDSIPT++EL ALGGEG RAD+I+VD++KD
Sbjct: 61 SQILWRTGMLSEPIPNGFYSVILEKRLKKLFDSIPTLEELQALGGEGFRADVIVVDAEKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
++LSMLKQLIVALV+GLNSNP AMIKKIAGLV+DFYKR +VESPAKAALEE+SHMFE RG
Sbjct: 121 RRLSMLKQLIVALVRGLNSNPPAMIKKIAGLVSDFYKRSNVESPAKAALEESSHMFENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSV 240
VQ+LGQIRHGSCRPRAILFKVLADTVGLESRLM+G PNDG ECVDSYKHMSVIVVLNSV
Sbjct: 181 VQMLGQIRHGSCRPRAILFKVLADTVGLESRLMMGFPNDGAAECVDSYKHMSVIVVLNSV 240
Query: 241 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 300
ELLVDLMRFPGQL+PRSTK+I M+HISAAGESDSAENDSCDSPLEPNSPLYGVSER+DP
Sbjct: 241 ELLVDLMRFPGQLLPRSTKSILMTHISAAGESDSAENDSCDSPLEPNSPLYGVSERLDPK 300
Query: 301 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLS----EPNIATTFWRRSRRK 356
EK+E+ Q R+ E +N+SG LRNMMLR SLDR S EPNIAT F RRSRRK
Sbjct: 301 CVEKEENLQFHRRFEVSSNVSGLPLRNMMLRSNTSLDRNWSFSHSEPNIATAFGRRSRRK 360
Query: 357 VIAEQRTASS--------------------------------RSEGASTSEARRIRRRSI 384
VIAEQRTASS +S+GAS+SEARRIRRRSI
Sbjct: 361 VIAEQRTASSSPEHPSLRAHGRSKLSGDRTSFRDFADDQSSYKSDGASSSEARRIRRRSI 420
Query: 385 SITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTS--DLPKNASNFHLGT 442
SITPEIGDDI RAVRAMN+TLKQ RL +E+G D + S D TS DL KN SNFHL
Sbjct: 421 SITPEIGDDIARAVRAMNKTLKQKRLPREQGGDSSLSHSPIDRTSSLDLQKNVSNFHLDG 480
Query: 443 HDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKV 502
H E RS LY L RD + SQKA+SLPSSPH+Y SER +S Y N E STWNK+
Sbjct: 481 HHE----RSPLYLLHRDPVTSQKAMSLPSSPHDYRVQASERSEASEYTTNDELESTWNKI 536
Query: 503 LESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 562
LESPMF N+PLL YEEWNIDF+EL VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA
Sbjct: 537 LESPMFSNRPLLPYEEWNIDFTELNVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 596
Query: 563 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 622
ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYME+GSL++LIH+SGQKKKLS
Sbjct: 597 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMEMGSLFYLIHVSGQKKKLS 656
Query: 623 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682
WRR+LKMLRDICRGLM IHRMKI+HRD+KSANCLV+KHW VKICDFGLSRIIT+SPMRDS
Sbjct: 657 WRRRLKMLRDICRGLMHIHRMKIIHRDVKSANCLVDKHWIVKICDFGLSRIITESPMRDS 716
Query: 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 742
SSAGTPEWMAPELIRNEPF+EKCDIFSLGVIMWELCTLNRPWEGV PERVVY VANEG+R
Sbjct: 717 SSAGTPEWMAPELIRNEPFSEKCDIFSLGVIMWELCTLNRPWEGVPPERVVYTVANEGAR 776
Query: 743 LEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 782
L+IPEGPLGRLI++CWAEP ERPSCEEILSRL+D EYS+C
Sbjct: 777 LDIPEGPLGRLISECWAEPHERPSCEEILSRLVDIEYSMC 816
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356517339|ref|XP_003527345.1| PREDICTED: uncharacterized protein LOC100806527 isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1240 bits (3208), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 614/824 (74%), Positives = 686/824 (83%), Gaps = 54/824 (6%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETR+DAG E+ N +WW DF++ F SVSL +Q+ETL+NKESPR+ QD +S Q A
Sbjct: 1 MEETREDAGQPERRPSNMSWWPSDFVDKFESVSLSAQDETLNNKESPRHSNQDVMSPQKA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQILW TGMLSEPIPNGFYSVIP+KRLK+LFDSIPT+DEL A+GGEG RAD+I+VD++KD
Sbjct: 61 SQILWRTGMLSEPIPNGFYSVIPEKRLKKLFDSIPTLDELQAMGGEGFRADVIVVDAEKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
++LSMLKQLIVALV+GLNSNP AMIKKIAGLV+DFYK P+VESPAKAALEE+ +MFE RG
Sbjct: 121 RRLSMLKQLIVALVRGLNSNPPAMIKKIAGLVSDFYKPPNVESPAKAALEESCNMFENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSV 240
VQ+LGQIRHGSC PRAILFKVLAD+VGLESRLM+G PNDG ECVDSYKHMSVIVVLN+V
Sbjct: 181 VQMLGQIRHGSCCPRAILFKVLADSVGLESRLMMGFPNDGAAECVDSYKHMSVIVVLNTV 240
Query: 241 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 300
ELLVDLMRFPGQL+PRSTK+I M+HISAAGESDSAENDSCDSPLEPNSPLYGVSE V
Sbjct: 241 ELLVDLMRFPGQLLPRSTKSILMTHISAAGESDSAENDSCDSPLEPNSPLYGVSESV--- 297
Query: 301 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLS----EPNIATTFWRRSRRK 356
EK+E+ Q R+ E +N+SG LRNMMLR SLDR LS EPNIAT F RRSRRK
Sbjct: 298 --EKEENLQFHRRFEVSSNVSGLPLRNMMLRSNTSLDRNLSFSHSEPNIATAFGRRSRRK 355
Query: 357 VIAEQRTASS------------------------------------RSEGASTSEARRIR 380
VIAEQRTASS +S+GAS+SEARRIR
Sbjct: 356 VIAEQRTASSSPEHPSLRAHGRSKLSGDRTAFRDFADDQSTLRSSYKSDGASSSEARRIR 415
Query: 381 RRSISITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTS--DLPKNASNF 438
R SISITPEIGDDI RAVRAMNETLKQNRLL+E+G D + S D TS DL KN SNF
Sbjct: 416 R-SISITPEIGDDIARAVRAMNETLKQNRLLREQGGDSSLSHSPIDRTSSADLQKNVSNF 474
Query: 439 HLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVST 498
HL H E RS LY RD + SQKA+SLPSSPH+Y SER +S Y+ N E T
Sbjct: 475 HLDNHHE----RSPLY--LRDPVTSQKAMSLPSSPHDYRGQASERSKASEYILNDELEFT 528
Query: 499 WNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ 558
WNK+LESPMF N+PLL YEEWNIDF+ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ
Sbjct: 529 WNKILESPMFSNRPLLPYEEWNIDFTELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ 588
Query: 559 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK 618
DLT ENMEDFCNEISILSRLRHPNVILFLGACT+PPRLSM+TEYME+GSL++LIH+SGQK
Sbjct: 589 DLTTENMEDFCNEISILSRLRHPNVILFLGACTRPPRLSMVTEYMEMGSLFYLIHVSGQK 648
Query: 619 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678
KKLSWRR+LKML+DICRGLM IHRMKI+HRD+KSANCLV+KHW VKICDFGLSRI+T+SP
Sbjct: 649 KKLSWRRRLKMLQDICRGLMHIHRMKIIHRDVKSANCLVDKHWIVKICDFGLSRIVTESP 708
Query: 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN 738
RDSSSAGTPEWMAPELIRNEPFTEKCDIFS GVI+WELCTLNRPWEGV PERVVY VAN
Sbjct: 709 TRDSSSAGTPEWMAPELIRNEPFTEKCDIFSFGVIIWELCTLNRPWEGVPPERVVYTVAN 768
Query: 739 EGSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 782
EG+RL+IP+GPLGRLI++CWAEP ERPSCEEILSRL+D EYS+C
Sbjct: 769 EGARLDIPDGPLGRLISECWAEPHERPSCEEILSRLVDIEYSMC 812
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357474617|ref|XP_003607593.1| Tyrosine-protein kinase ABL2 [Medicago truncatula] gi|355508648|gb|AES89790.1| Tyrosine-protein kinase ABL2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1203 bits (3112), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 614/823 (74%), Positives = 676/823 (82%), Gaps = 63/823 (7%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
ME TR+DA DFI FGSVSLG+Q+ETL+NKESPR+ QD +S Q A
Sbjct: 1 MERTREDAR-----------MPSDFIGKFGSVSLGTQDETLNNKESPRHSNQDFMSPQRA 49
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQILW TGMLSEPIPNGFYSV+P+KRLK+LFDSIPT+DEL ALGGEG RAD+I+VD+KKD
Sbjct: 50 SQILWHTGMLSEPIPNGFYSVVPEKRLKKLFDSIPTLDELQALGGEGFRADVIVVDAKKD 109
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
+KLSMLKQLIV LVKGLN+NP A+IKKIAGLV+DFYKRP+VESPAKAALEE+SHMFE+ G
Sbjct: 110 RKLSMLKQLIVTLVKGLNTNPGAIIKKIAGLVSDFYKRPNVESPAKAALEESSHMFESHG 169
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSV 240
VQ+LGQI+HGSCRPRAILFKVLADTVGLESRLM+G P DG +CVDSYKHMSVIV LNSV
Sbjct: 170 VQMLGQIKHGSCRPRAILFKVLADTVGLESRLMMGFPTDGAADCVDSYKHMSVIVALNSV 229
Query: 241 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 300
ELLVDLMRFPGQL+PRS K+I M+HISAAGESDSAENDSCDSPLEPNSPLYGVSE
Sbjct: 230 ELLVDLMRFPGQLLPRSIKSILMTHISAAGESDSAENDSCDSPLEPNSPLYGVSE----- 284
Query: 301 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLS----EPNIATTFWRRSRRK 356
S+EKD++ Q R+ E +N+S P LRNMMLR LDRKLS EPNIAT+F RRSRRK
Sbjct: 285 SAEKDDNLQFHRRFEASSNVSSPPLRNMMLRSNTCLDRKLSFSHSEPNIATSFGRRSRRK 344
Query: 357 VIAEQRTASS------------------------------------RSEGASTSEARRIR 380
VIAEQRTASS +S+GAS+S RRIR
Sbjct: 345 VIAEQRTASSSPEHPSFQARGQSKLGGEKTAFRDFADDQATSRSSYKSDGASSSGPRRIR 404
Query: 381 RRSISITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTS--DLPKNASNF 438
RRSISITPEIGDDI RAVRAMNE LKQNRLL+E+G+D S ND TS +L KN SNF
Sbjct: 405 RRSISITPEIGDDIARAVRAMNEKLKQNRLLREQGDDSSLPHSPNDRTSSAELQKNLSNF 464
Query: 439 HLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVST 498
L H+ S LY L RD + SQKA+SLPSSPH+Y SE GY N E ST
Sbjct: 465 RLDGHET-----SPLYPLYRDNVPSQKAVSLPSSPHDYRRQTSETSRPLGYELNDELEST 519
Query: 499 WNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ 558
WNK+LES M NKPLL YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ
Sbjct: 520 WNKILESSMADNKPLLPYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ 579
Query: 559 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK 618
DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYME+GSL++LIH+SGQK
Sbjct: 580 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMEMGSLFYLIHVSGQK 639
Query: 619 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678
KKLSWRR+LKMLRDICRGLM IHRMKI+HRD+KSANCLV+KHWTVK+CDFGLSRIIT+SP
Sbjct: 640 KKLSWRRRLKMLRDICRGLMHIHRMKIIHRDVKSANCLVDKHWTVKVCDFGLSRIITESP 699
Query: 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN 738
MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELC L+RPWEGV PERVVY VAN
Sbjct: 700 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCNLSRPWEGVPPERVVYTVAN 759
Query: 739 EGSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSL 781
EGSRLEIPEGPLGRLI++CWAEP ERPSCEEILSRL+D EYS+
Sbjct: 760 EGSRLEIPEGPLGRLISECWAEPNERPSCEEILSRLVDIEYSM 802
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356517341|ref|XP_003527346.1| PREDICTED: uncharacterized protein LOC100806527 isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1197 bits (3097), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 590/800 (73%), Positives = 660/800 (82%), Gaps = 69/800 (8%)
Query: 19 TWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTASQILWSTGMLSEPIPNGF 78
+WW DF++ F SVSL +Q+ETL+NKESPR+ QD +S Q ASQILW TGMLSEPIPNGF
Sbjct: 2 SWWPSDFVDKFESVSLSAQDETLNNKESPRHSNQDVMSPQKASQILWRTGMLSEPIPNGF 61
Query: 79 YSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKDKKLSMLKQLIVALVKGLN 138
YSVIP+KRLK+LFDSIPT+DEL A+GGEG RAD+I+VD++KD++LSMLKQLIVALV+GLN
Sbjct: 62 YSVIPEKRLKKLFDSIPTLDELQAMGGEGFRADVIVVDAEKDRRLSMLKQLIVALVRGLN 121
Query: 139 SNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRGVQLLGQIRHGSCRPRAIL 198
SNP AMIKKIAGLV+DFYK P+VESPAKAALEE+ +MFE RGVQ+LGQIRHGSC PRAIL
Sbjct: 122 SNPPAMIKKIAGLVSDFYKPPNVESPAKAALEESCNMFENRGVQMLGQIRHGSCCPRAIL 181
Query: 199 FKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSVELLVDLMRFPGQLIPRST 258
FKVLAD+VGLESRLM+G PNDG ECVDSYKHMSVIVVLN+VELLVDLMRFPGQL+PRST
Sbjct: 182 FKVLADSVGLESRLMMGFPNDGAAECVDSYKHMSVIVVLNTVELLVDLMRFPGQLLPRST 241
Query: 259 KAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPDSSEKDESFQVQRKLETPA 318
K+I M+HISAAGESDSAENDSCDSPLEPNSPLYGVSER+DP EK+E+ Q R+ E +
Sbjct: 242 KSILMTHISAAGESDSAENDSCDSPLEPNSPLYGVSERLDPKRVEKEENLQFHRRFEVSS 301
Query: 319 NISGPSLRNMMLRPAASLDRKLS----EPNIATTFWRRSRRKVIAEQRTASS-------- 366
N+SG LRNMMLR SLDR LS EPNIAT F RRSRRKVIAEQRTASS
Sbjct: 302 NVSGLPLRNMMLRSNTSLDRNLSFSHSEPNIATAFGRRSRRKVIAEQRTASSSPEHPSLR 361
Query: 367 ------------------------RSEGASTSEARRIRRRSISITPEIGDDIVRAVRAMN 402
+S+GAS+SEARRIRR SISITPEIGDDI RAVRAMN
Sbjct: 362 AHGRSKLSGDRTAFRDFADDQSSYKSDGASSSEARRIRR-SISITPEIGDDIARAVRAMN 420
Query: 403 ETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMN 462
ETLKQNRLL+E+G D S LY RD +
Sbjct: 421 ETLKQNRLLREQGGDSSL------------------------------SPLY--LRDPVT 448
Query: 463 SQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNID 522
SQKA+SLPSSPH+Y SER +S Y+ N E TWNK+LESPMF N+PLL YEEWNID
Sbjct: 449 SQKAMSLPSSPHDYRGQASERSKASEYILNDELEFTWNKILESPMFSNRPLLPYEEWNID 508
Query: 523 FSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN 582
F+ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLT ENMEDFCNEISILSRLRHPN
Sbjct: 509 FTELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTTENMEDFCNEISILSRLRHPN 568
Query: 583 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
VILFLGACT+PPRLSM+TEYME+GSL++LIH+SGQKKKLSWRR+LKML+DICRGLM IHR
Sbjct: 569 VILFLGACTRPPRLSMVTEYMEMGSLFYLIHVSGQKKKLSWRRRLKMLQDICRGLMHIHR 628
Query: 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 702
MKI+HRD+KSANCLV+KHW VKICDFGLSRI+T+SP RDSSSAGTPEWMAPELIRNEPFT
Sbjct: 629 MKIIHRDVKSANCLVDKHWIVKICDFGLSRIVTESPTRDSSSAGTPEWMAPELIRNEPFT 688
Query: 703 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQ 762
EKCDIFS GVI+WELCTLNRPWEGV PERVVY VANEG+RL+IP+GPLGRLI++CWAEP
Sbjct: 689 EKCDIFSFGVIIWELCTLNRPWEGVPPERVVYTVANEGARLDIPDGPLGRLISECWAEPH 748
Query: 763 ERPSCEEILSRLLDCEYSLC 782
ERPSCEEILSRL+D EYS+C
Sbjct: 749 ERPSCEEILSRLVDIEYSMC 768
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 782 | ||||||
| TAIR|locus:2076416 | 809 | AT3G58640 [Arabidopsis thalian | 0.537 | 0.519 | 0.725 | 2.1e-297 | |
| TAIR|locus:2052786 | 775 | AT2G31010 [Arabidopsis thalian | 0.969 | 0.978 | 0.650 | 6.7e-262 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.319 | 0.242 | 0.511 | 1.3e-80 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.326 | 0.257 | 0.498 | 2.2e-80 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.333 | 0.296 | 0.477 | 2.8e-80 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.340 | 0.285 | 0.460 | 5.8e-80 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.343 | 0.327 | 0.474 | 5.9e-76 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.343 | 0.365 | 0.45 | 5.6e-65 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.331 | 0.335 | 0.456 | 1.2e-60 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.329 | 0.337 | 0.441 | 1.5e-58 |
| TAIR|locus:2076416 AT3G58640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1616 (573.9 bits), Expect = 2.1e-297, Sum P(2) = 2.1e-297
Identities = 312/430 (72%), Positives = 344/430 (80%)
Query: 355 RKVIAEQRTASSRSEGXXXXXXXXXXXXXXXXXXXXGDDIVRAVRAMNETLKQNRLLQER 414
R + T+S +S G GDDIVRAVRAMNE LKQNRL +E+
Sbjct: 388 RDFTGDVATSSCKSVGGAKMETKRIRRRSISITPEIGDDIVRAVRAMNEALKQNRLSKEQ 447
Query: 415 GEDRPFTRSSNDNT--SDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSS 472
G+D S ND T S L KN S FHL HD++SGGRS L SR+ ++ QKAISLPSS
Sbjct: 448 GDDDSSPNSPNDRTESSHLQKNVSGFHLDAHDQVSGGRSTL---SREPLDPQKAISLPSS 504
Query: 473 PXXXXXXXXXXXXXXXXMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRV 532
P +++ W+KVL SPMFQNKPLL YEEWNIDFSELTVGTRV
Sbjct: 505 PQNYRSQYEQSGSSHRNISH-----IWDKVLGSPMFQNKPLLPYEEWNIDFSELTVGTRV 559
Query: 533 GIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 592
GIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK
Sbjct: 560 GIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 619
Query: 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 652
PPRLS+ITEYME+GSLY+L+HLSGQKK+LSWRRKLKMLRDICRGLMCIHRM IVHRD+KS
Sbjct: 620 PPRLSLITEYMEMGSLYYLLHLSGQKKRLSWRRKLKMLRDICRGLMCIHRMGIVHRDIKS 679
Query: 653 ANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGV 712
ANCL++ WTVKICDFGLSRI+T + MRD+ SAGTPEWMAPELIRNEPF+EKCDIFSLGV
Sbjct: 680 ANCLLSNKWTVKICDFGLSRIMTGTTMRDTVSAGTPEWMAPELIRNEPFSEKCDIFSLGV 739
Query: 713 IMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQERPSCEEILS 772
IMWELCTL RPWEGV PERVVYA+A EG+RLEIPEGPLG+LIADCW EP++RPSC EILS
Sbjct: 740 IMWELCTLTRPWEGVPPERVVYAIAYEGARLEIPEGPLGKLIADCWTEPEQRPSCNEILS 799
Query: 773 RLLDCEYSLC 782
RLLDCEYSLC
Sbjct: 800 RLLDCEYSLC 809
|
|
| TAIR|locus:2052786 AT2G31010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2520 (892.1 bits), Expect = 6.7e-262, P = 6.7e-262
Identities = 520/799 (65%), Positives = 596/799 (74%)
Query: 1 MEETRDDAGS-AEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQT 59
MEE RDD S QG + E +S SQ E LS K+SPR+ EQD Q
Sbjct: 1 MEERRDDESSPTHQG--------SELAERVKLLSFESQGEALS-KDSPRSVEQDCSPGQR 51
Query: 60 ASQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVXXXX 119
ASQ LW TG+LSEPIPNGFYSV+PDKR+KEL++ +PT ELHALG EG R ++ILV
Sbjct: 52 ASQHLWDTGILSEPIPNGFYSVVPDKRVKELYNRLPTPSELHALGEEGVRIEVILVDFQK 111
Query: 120 XXXXXXXXQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETR 179
QLI LV G +NPA +IKKIAG V+DFYKRP++ESP+K ALEE + +FE
Sbjct: 112 DKKLAMLKQLITTLVSGSGTNPALVIKKIAGTVSDFYKRPTLESPSKLALEENAFLFENH 171
Query: 180 GVQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNS 239
G QLLGQI+ G CR RAILFKVLADTVGLESRL+VGLP+DGT+ C+DS KHMSVIVVLNS
Sbjct: 172 GAQLLGQIKRGCCRARAILFKVLADTVGLESRLVVGLPSDGTVNCMDSNKHMSVIVVLNS 231
Query: 240 VELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDP 299
VELLVDL+RFPGQL+PRS KAIFMSHIS AGESDSAENDSCDSPLEPNSPLY ER DP
Sbjct: 232 VELLVDLIRFPGQLVPRSAKAIFMSHISPAGESDSAENDSCDSPLEPNSPLY---ERRDP 288
Query: 300 DSSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLS-----EPNIATTFWRRSR 354
+S+EKDE+ Q RKLE N SG SLR++MLRP+ +++RKLS EPN+AT FWRRSR
Sbjct: 289 ESTEKDENLQFYRKLEGYPNASGSSLRSLMLRPSTAIERKLSNTSHSEPNVATVFWRRSR 348
Query: 355 RKVIAEQRTASSRSEG-XXXXXXXXXXXXXXXXXXXXGDDIVRAVRAMNETLKQNR---- 409
RKVIAEQRTASS E G+ + + +E K R
Sbjct: 349 RKVIAEQRTASSSPEHPSMRRGRSMLSTGRNSFRDYTGEASSPSSSSTSEIRKTRRRSFR 408
Query: 410 LLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDE----ISGGRSALYNLSRDQMNSQK 465
+ E G+D S+ + K + G DE I S L+ L D++NS+K
Sbjct: 409 ITPEIGDD---IASAVREMYEKSKQ-NRLLQGREDENSSVIDNNVSGLH-LD-DELNSKK 462
Query: 466 AISLPSSPXXXXXXXXXXXXXXXXMANSEFV--STWNKVLESPMFQNKPLLAYEEWNIDF 523
+SLPSSP SEF TWNKV+ES QN+PLL Y+EW+IDF
Sbjct: 463 TMSLPSSPHAYRCQTFGRR------GPSEFAVKDTWNKVVESSTLQNQPLLPYQEWDIDF 516
Query: 524 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 583
SELTVGTRVGIGFFGEVFRG+WNGTDVAIK+FLEQDLTAENMEDFCNEISILSR+RHPNV
Sbjct: 517 SELTVGTRVGIGFFGEVFRGVWNGTDVAIKLFLEQDLTAENMEDFCNEISILSRVRHPNV 576
Query: 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
+LFLGACTKPPRLSMITEYMELGSLY+LIH+SGQKKKLSW R+L+MLRDICRGLMCIHRM
Sbjct: 577 VLFLGACTKPPRLSMITEYMELGSLYYLIHMSGQKKKLSWHRRLRMLRDICRGLMCIHRM 636
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTE 703
KIVHRDLKSANCLV+KHWTVKICDFGLSRI+TD M+D+SSAGTPEWMAPELIRN PFTE
Sbjct: 637 KIVHRDLKSANCLVDKHWTVKICDFGLSRIMTDENMKDTSSAGTPEWMAPELIRNRPFTE 696
Query: 704 KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQE 763
KCDIFSLGVIMWEL TL +PWEGV PE+VV+AVA+EGSRLEIP+GPL +LIADCWAEP+E
Sbjct: 697 KCDIFSLGVIMWELSTLRKPWEGVPPEKVVFAVAHEGSRLEIPDGPLSKLIADCWAEPEE 756
Query: 764 RPSCEEILSRLLDCEYSLC 782
RP+CEEIL LLDCEY+LC
Sbjct: 757 RPNCEEILRGLLDCEYTLC 775
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 688 (247.2 bits), Expect = 1.3e-80, Sum P(2) = 1.3e-80
Identities = 132/258 (51%), Positives = 185/258 (71%)
Query: 523 FSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN 582
+ E+TVG R+G+G +GEV+RG W+GT+VA+K FL+QDLT E +E+F +E+ I+ +LRHPN
Sbjct: 745 WEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVRIMKKLRHPN 804
Query: 583 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
++LF+GA T+PP LS++TE++ GSLY LIH + L RR+L+M D RG+ +H
Sbjct: 805 IVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQ--LDERRRLRMALDAARGMNYLHS 862
Query: 643 MK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 700
IVHRDLKS N LV+K+W VK+CDFGLSR+ + + S+AGT EWMAPE++RNEP
Sbjct: 863 CNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAPEVLRNEP 922
Query: 701 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE--GP-LGRLIADC 757
EKCD++S GVI+WEL TL +PW + P +VV AV + RL+IP+ P + LI+ C
Sbjct: 923 ADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPAIADLISKC 982
Query: 758 W-AEPQERPSCEEILSRL 774
W + + RPS EI++ L
Sbjct: 983 WQTDSKLRPSFAEIMASL 1000
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 680 (244.4 bits), Expect = 2.2e-80, Sum P(2) = 2.2e-80
Identities = 131/263 (49%), Positives = 184/263 (69%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 577
E I + E+TV R+G+G +GEV+RG W+GT VA+K F++QD+T E +E+F +E+ ++ R
Sbjct: 707 ECEILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVRMMRR 766
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
LRHPN++LF+GA T+PP LS++TE++ GSLY LIH + L R++L+M D RG+
Sbjct: 767 LRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQ--LDERKRLRMALDAARGM 824
Query: 638 MCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
+H IVHRDLKS N LV+K+W VK+CDFGLSR+ + + S+AGT EWMAPE+
Sbjct: 825 NYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMAPEV 884
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE--GP-LGR 752
+RNEP EKCD++S GVI+WEL TL +PW + P +VV AV + RL+IPE P +
Sbjct: 885 LRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPGIAD 944
Query: 753 LIADCW-AEPQERPSCEEILSRL 774
+I CW +P+ RPS EI+ L
Sbjct: 945 IIRKCWQTDPRLRPSFGEIMDSL 967
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 690 (248.0 bits), Expect = 2.8e-80, Sum P(2) = 2.8e-80
Identities = 129/270 (47%), Positives = 186/270 (68%)
Query: 512 PLLAYE-EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCN 570
PLL +W I + +L +G R+GIG +GEV+R WNGT+VA+K FL+QD + + + F +
Sbjct: 594 PLLGEAAKWEIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKS 653
Query: 571 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 630
EI I+ RLRHPNV+LF+GA T+PP S++TE++ GSLY L+H + L +R+++M
Sbjct: 654 EIEIMLRLRHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQ--LDEKRRMRMA 711
Query: 631 RDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 688
D+ +G+ +H +VHRDLKS N LV+K+W VK+CDFGLSR+ + + S+AGTP
Sbjct: 712 LDVAKGMNYLHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTP 771
Query: 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG 748
EWMAPE++RNEP EKCD++S GVI+WEL T PW+G+ P +VV AV + RLEIP+
Sbjct: 772 EWMAPEVLRNEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDD 831
Query: 749 ---PLGRLIADCW-AEPQERPSCEEILSRL 774
+ ++I +CW EP RPS +++ L
Sbjct: 832 IDLTVAQIIRECWQTEPHLRPSFTQLMQSL 861
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 5.8e-80, Sum P(2) = 5.8e-80
Identities = 128/278 (46%), Positives = 189/278 (67%)
Query: 503 LESPMFQNKPLLAYE----EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ 558
L+S ++N P + + E I +++L + R+G+G +GEV+ W+GT+VA+K FL+Q
Sbjct: 642 LDSTSYRNDPQVLDDADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQ 701
Query: 559 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK 618
D + + +F +E+ I+ RLRHPNV+ FLGA T+PP LS++TE++ GSLY ++H K
Sbjct: 702 DFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRP--K 759
Query: 619 KKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676
+ RR++KM D+ G+ C+H IVHRDLK+ N LV+ +W VK+ DFGLSR+ +
Sbjct: 760 SHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHN 819
Query: 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV 736
+ + S+AGTPEWMAPE++RNEP EKCD++S GVI+WEL TL PW G+ P +VV AV
Sbjct: 820 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAV 879
Query: 737 ANEGSRLEIPE--GPL-GRLIADCW-AEPQERPSCEEI 770
+ RLEIP+ P+ GR+I +CW +P RPS ++
Sbjct: 880 GFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQL 917
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 681 (244.8 bits), Expect = 5.9e-76, Sum P(2) = 5.9e-76
Identities = 131/276 (47%), Positives = 187/276 (67%)
Query: 506 PMFQNKPL-LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN 564
P N+ L L ++ +I + +L + ++G G FG V R W+G+DVA+K+ +EQD AE
Sbjct: 530 PNRANRELGLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER 589
Query: 565 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWR 624
+ +F E++I+ RLRHPN++LF+GA T+PP LS++TEY+ GSLY L+H SG +++L R
Sbjct: 590 VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDER 649
Query: 625 RKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682
R+L M D+ +G+ +H IVHRDLKS N LV+K +TVK+CDFGLSR+ + +
Sbjct: 650 RRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK 709
Query: 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 742
S+AGTPEWMAPE++R+EP EK D++S GVI+WEL TL +PW + P +VV AV + R
Sbjct: 710 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR 769
Query: 743 LEIPEG--P-LGRLIADCWA-EPQERPSCEEILSRL 774
LEIP P + +I CW EP +RPS I+ L
Sbjct: 770 LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 805
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 5.6e-65, Sum P(3) = 5.6e-65
Identities = 126/280 (45%), Positives = 184/280 (65%)
Query: 504 ESPMFQ-NKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 562
+SP+ Q N L+ I + +L +G VG G F V RG+WNG+DVAIKV+ + D A
Sbjct: 445 QSPVNQRNNRLVTDSSCEIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNA 504
Query: 563 ENMEDFCNEISILSRLRHPNVILFLGA-CTKPPRLSMITEYMELGSLYHLIHLSGQKKKL 621
+ + EI+I+ +LRHPNV+LF+GA CT+ + ++I EYM GSL+ ++H + Q L
Sbjct: 505 MTLTECKKEINIMKKLRHPNVLLFMGAVCTEE-KSAIIMEYMPRGSLFKILHNTNQP--L 561
Query: 622 SWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679
+R+L+M D+ RG+ +HR IVHRDLKS+N LV+K+W VK+ DFGLS+ + +
Sbjct: 562 DKKRRLRMALDVARGMNYLHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFL 621
Query: 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 739
S GTP+WMAPE++R+EP EKCD+FS GVI+WEL T PW+ + +VV V
Sbjct: 622 STKSGKGTPQWMAPEVLRSEPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFM 681
Query: 740 GSRLEIPEG--P-LGRLIADCW-AEPQERPSCEEILSRLL 775
RL++PEG P + +I DCW +P +RPS EE++S+++
Sbjct: 682 DRRLDLPEGLNPRIASIIQDCWQTDPAKRPSFEELISQMM 721
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 621 (223.7 bits), Expect = 1.2e-60, P = 1.2e-60
Identities = 122/267 (45%), Positives = 179/267 (67%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 577
E+ I + +LT+G +VG G G V+ G+W G+DVA+KVF +Q+ +AE +E F E+ ++ R
Sbjct: 486 EYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSKQEYSAEVIESFKQEVLLMKR 545
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
LRHPNV+LF+GA T P RL +++E++ GSL+ L+ S KL WRR++ M DI RG+
Sbjct: 546 LRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKS--TSKLDWRRRIHMALDIARGM 603
Query: 638 MCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
+H I+HRDLKS+N LV+K+WTVK+ DFGLSRI ++ + S GTP+WMAPE+
Sbjct: 604 NYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTSKSGKGTPQWMAPEV 663
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR--- 752
+RNE EK DI+S GV++WEL T PWE + +V+ AV RLEIP+ R
Sbjct: 664 LRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGFMDQRLEIPKDIDPRWIS 723
Query: 753 LIADCW-AEPQERPSCEEILSRLLDCE 778
L+ CW ++ + RP+ +E++ +L D +
Sbjct: 724 LMESCWHSDTKLRPTFQELMDKLRDLQ 750
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 601 (216.6 bits), Expect = 1.5e-58, P = 1.5e-58
Identities = 118/267 (44%), Positives = 178/267 (66%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 577
++ I + +LT+G ++G G G V+ G+W G+DVA+KVF +Q+ + E + F E+S++ R
Sbjct: 479 DYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITSFKQEVSLMKR 538
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
LRHPNV+LF+GA P RL ++TE++ GSL+ L L K KL RR++ M DI RG+
Sbjct: 539 LRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRL--LQRNKSKLDLRRRIHMASDIARGM 596
Query: 638 MCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
+H I+HRDLKS+N LV+++WTVK+ DFGLSRI ++ + ++ GTP+WMAPE+
Sbjct: 597 NYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLT-TNGRGTPQWMAPEV 655
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIA 755
+RNE EK D++S GV++WEL T PWE + +V+ AV RLE+P+ + IA
Sbjct: 656 LRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKDVDPQWIA 715
Query: 756 ---DCW-AEPQERPSCEEILSRLLDCE 778
CW +EPQ RPS +E++ +L + +
Sbjct: 716 LMESCWHSEPQCRPSFQELMDKLRELQ 742
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 782 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-77 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-75 | |
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 2e-75 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-73 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-73 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-69 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-66 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-62 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-54 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-50 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-50 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-48 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-47 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-46 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-46 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-45 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-45 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-44 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-42 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-42 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-42 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-42 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-40 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-40 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-40 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-39 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-39 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-39 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-39 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-38 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-38 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-38 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-37 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-37 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-37 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-37 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-37 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-37 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-37 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-37 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-36 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-36 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-36 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-36 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-36 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-35 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-35 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-35 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-35 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-35 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-35 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-34 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-34 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-34 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-33 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-33 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-32 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-32 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-32 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-32 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-32 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-32 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-32 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-31 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-31 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-31 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-31 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-30 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-30 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-30 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-30 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-30 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-30 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-30 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-29 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-29 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-29 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-29 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-28 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-28 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-28 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-28 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-28 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-28 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-27 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-27 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-26 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-26 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-26 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-26 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-26 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-26 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-25 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-25 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-25 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-25 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-24 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-24 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-24 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-23 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-23 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-22 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-22 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-21 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-21 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-21 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-20 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-20 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-20 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-19 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-19 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-17 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-17 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-16 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-14 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 248 bits (636), Expect = 7e-77
Identities = 100/262 (38%), Positives = 148/262 (56%), Gaps = 17/262 (6%)
Query: 526 LTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISILSRLR 579
L +G ++G G FGEV++G G T VA+K L++ + E E+F E SI+ +L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKT-LKEGASEEEREEFLEEASIMKKLS 59
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
HPN++ LG CT+ L ++TEYM G L L +KL+ + L+M I +G+
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLD--FLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTP-EWMAPELIR 697
+ VHRDL + NCLV ++ VKI DFGLSR I D R P +WMAPE ++
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 698 NEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 753
+ FT K D++S GV++WE+ TL +P+ G+ E V+ + +G RL PE L L
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELYEL 236
Query: 754 IADCWAE-PQERPSCEEILSRL 774
+ CWA P++RP+ E++ L
Sbjct: 237 MLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 244 bits (626), Expect = 2e-75
Identities = 100/261 (38%), Positives = 146/261 (55%), Gaps = 16/261 (6%)
Query: 526 LTVGTRVGIGFFGEVFRGIWNGT------DVAIKVFLEQDLTAENMEDFCNEISILSRLR 579
LT+G ++G G FGEV++G G +VA+K L++D + + +E+F E I+ +L
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
HPNV+ LG CT+ L ++ EYME G L L +L + KLS L I RG+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDL--LSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 698
+ +HRDL + NCLV ++ VKI DFGLSR + D P WMAPE ++
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 699 EPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 754
FT K D++S GV++WE+ TL +P+ G+ E V+ + N G RL P L L+
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN-GYRLPQPPNCPPELYDLM 236
Query: 755 ADCWAE-PQERPSCEEILSRL 774
CWAE P++RP+ E++ L
Sbjct: 237 LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 242 bits (621), Expect = 2e-75
Identities = 74/208 (35%), Positives = 113/208 (54%), Gaps = 11/208 (5%)
Query: 54 GLSSQTASQILWSTGMLS--EPIPNGFYSVIPDKRLKEL--FDSIPTVDELHALGGEGHR 109
S++ S W G LS + IP+GFY + +L F IP++++L A+
Sbjct: 1 RSSAEALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVPPGDSS 60
Query: 110 ADIILVDSKKDKKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAAL 169
+++LVD + D KL L+QL LV G +N AA+++K+AGLV+D P ++ + A
Sbjct: 61 FEVVLVDRRTDPKLKELEQLARCLVSGCGTNTAALVQKLAGLVSDHMGGPVKDAESMLAR 120
Query: 170 EE--TSHMFETRGVQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDS 227
+ ++ + E GV LG ++ G CR RA+LFKVLAD++GL RL+ G C
Sbjct: 121 WKECSNELKENSGVVPLGSLKIGLCRHRALLFKVLADSIGLPCRLVKGCKY-----CGSD 175
Query: 228 YKHMSVIVVLNSVELLVDLMRFPGQLIP 255
+++ + E LVDLM PG LIP
Sbjct: 176 DDASNLVKFDDGREYLVDLMGAPGTLIP 203
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 4e-73
Identities = 94/261 (36%), Positives = 142/261 (54%), Gaps = 15/261 (5%)
Query: 526 LTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISILSRLR 579
LT+G ++G G FGEV++G G +VA+K L++D + + +E+F E I+ +L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
HPN++ LG CT+ L ++ EYM G L + + K+LS L I RG+
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEY 118
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 698
+ +HRDL + NCLV ++ VKI DFGLSR + D P WMAPE ++
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 699 EPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 754
FT K D++S GV++WE+ TL P+ G+ V+ + G RL P L +L+
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK-GYRLPKPPNCPPELYKLM 237
Query: 755 ADCWAE-PQERPSCEEILSRL 774
CWAE P++RP+ E++ L
Sbjct: 238 LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 4e-73
Identities = 98/261 (37%), Positives = 144/261 (55%), Gaps = 20/261 (7%)
Query: 532 VGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 586
+G G FGEV++G G T+VA+K L++D + E +DF E ++ +L HPNV+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 587 LGACTKPPRLSMITEYMELGSLYHLI------HLSGQKKKLSWRRKLKMLRDICRGLMCI 640
LG CT+ L ++ EYME G L + S +K LS + L I +G+ +
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 641 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDSSSAGTP-EWMAPELIRN 698
K VHRDL + NCLV + VKI DFGLSR + D R + P WMAPE +++
Sbjct: 122 ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD 181
Query: 699 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 754
FT K D++S GV++WE+ TL P+ G+ E V+ + +G RL PE L L+
Sbjct: 182 GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-RKGYRLPKPEYCPDELYELM 240
Query: 755 ADCWA-EPQERPSCEEILSRL 774
CW +P++RP+ E++ RL
Sbjct: 241 LSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 227 bits (580), Expect = 8e-69
Identities = 79/253 (31%), Positives = 127/253 (50%), Gaps = 13/253 (5%)
Query: 527 TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+ ++G G FG+V+ T VAIKV +++ ++ E EI IL +L+HPN++
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKV-IKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
+L ++ EY E G L+ L+ ++ +LS LR I L +H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 704
IVHRDLK N L+++ VK+ DFGL+R + + GTPE+MAPE++ + + +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-TFVGTPEYMAPEVLLGKGYGKA 176
Query: 705 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEGPLGR----LIADCWA 759
DI+SLGVI++EL T P+ G ++ + PE + LI
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236
Query: 760 -EPQERPSCEEIL 771
+P++R + EE L
Sbjct: 237 KDPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 3e-66
Identities = 83/248 (33%), Positives = 123/248 (49%), Gaps = 38/248 (15%)
Query: 532 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589
+G G FG V+ T VAIK+ ++D + +E+ EI IL +L HPN++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 590 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 649
L ++ EY E GSL L+ + KLS L++L I GL +H I+HRD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 650 LKSANCLVNK-HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP-FTEKCDI 707
LK N L++ + VK+ DFGLS+++T + GTP +MAPE++ + ++EK DI
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 708 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPS 766
+SLGVI++EL L LI +P++RPS
Sbjct: 178 WSLGVILYELPELKD------------------------------LIRKMLQKDPEKRPS 207
Query: 767 CEEILSRL 774
+EIL L
Sbjct: 208 AKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 1e-62
Identities = 81/258 (31%), Positives = 129/258 (50%), Gaps = 15/258 (5%)
Query: 526 LTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 583
+ ++G G FG V++ GT VA+K+ ++ ++ + EI IL RL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
+ + A L ++ EY E G L+ + + LS K+ I RGL +H
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR-NEPFT 702
I+HRDLK N L++++ VKI DFGL++ + S ++ GTP +MAPE++ +
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 703 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR---LEIPEGPLGR-----LI 754
K D++SLGVI++EL T P+ G + + + P+ G LI
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 755 ADCWA-EPQERPSCEEIL 771
C +P +RP+ EEIL
Sbjct: 238 KKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 6e-54
Identities = 88/260 (33%), Positives = 132/260 (50%), Gaps = 18/260 (6%)
Query: 525 ELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN 582
E T G +G G FG V+ + G +A+K + E +E EI ILS L+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 583 VILFLGACTKPPR--LSMITEYMELGSLYHLIHLSGQKKKLSWR--RKLKMLRDICRGLM 638
++ + G+ + L++ EY+ GSL L+ + KL RK R I GL
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK---KFGKLPEPVIRKY--TRQILEGLA 115
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS--AGTPEWMAPELI 696
+H IVHRD+K AN LV+ VK+ DFG ++ + D + + GTP WMAPE+I
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG--PLGRL 753
R E + DI+SLG + E+ T PW + P +Y + + G EIPE +
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD 235
Query: 754 -IADCWA-EPQERPSCEEIL 771
+ C +P++RP+ +E+L
Sbjct: 236 FLRKCLRRDPKKRPTADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 7e-50
Identities = 79/254 (31%), Positives = 128/254 (50%), Gaps = 10/254 (3%)
Query: 525 ELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN 582
+G +G G FG V++G+ G VAIK + + E ++ EI +L L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 583 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
++ ++G+ L +I EY E GSL +I G + + +GL +H
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHE 117
Query: 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 702
++HRD+K+AN L K VK+ DFG++ + D D+S GTP WMAPE+I +
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 703 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA 759
DI+SLG + EL T N P+ + P ++ + + +PEG L + C+
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-DHPPLPEGISPELKDFLMQCFQ 236
Query: 760 -EPQERPSCEEILS 772
+P RP+ +++L
Sbjct: 237 KDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 7e-50
Identities = 90/265 (33%), Positives = 134/265 (50%), Gaps = 12/265 (4%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSR 577
W I L + ++G G FGEV+ G WNG T VA+K ++ E F E I+ +
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKK 57
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
LRH ++ C++ + ++TEYM GSL + SG+ KKL + + M I G+
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK-SGEGKKLRLPQLVDMAAQIAEGM 116
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 696
+ +HRDL + N LV ++ KI DFGL+R+I D A P +W APE
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGR 752
FT K D++S G+++ E+ T R P+ G+ V+ V G R+ P L
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELYD 235
Query: 753 LIADCW-AEPQERPSCEEILSRLLD 776
L+ CW +P+ERP+ E + S L D
Sbjct: 236 LMLQCWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 1e-48
Identities = 77/249 (30%), Positives = 131/249 (52%), Gaps = 8/249 (3%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589
+G G FG+V+ R +G +K +++ + ED NE+ IL +L HPN+I + +
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 590 CTKPPRLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMCIHRMKIVHR 648
+ +L ++ EY + G L I ++ K + L +C L +H KI+HR
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHR 127
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 708
D+K N + + VK+ DFG+S++++ + + GTP +++PEL +N+P+ K DI+
Sbjct: 128 DIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIW 187
Query: 709 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP---LGRLIADC-WAEPQER 764
SLG +++ELCTL P+EG + + G IP L L++ +P+ER
Sbjct: 188 SLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSELRNLVSSLLQKDPEER 246
Query: 765 PSCEEILSR 773
PS +IL
Sbjct: 247 PSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 8e-47
Identities = 94/262 (35%), Positives = 141/262 (53%), Gaps = 13/262 (4%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSRLR 579
ID SELT +G G FG V G W G DVAIK+ E + + +DF E ++ +L
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLS 57
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
HPN++ G CTK + ++TEYM G L L +L +K KL L M D+C +
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCL--LNYLRERKGKLGTEWLLDMCSDVCEAMEY 115
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 698
+ +HRDL + NCLV + VK+ DFGL+R + D S P +W PE+
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY 175
Query: 699 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GPLGRLI 754
F+ K D++S GV+MWE+ + + P+E VV +V+ G RL P+ + ++
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIM 234
Query: 755 ADCWAE-PQERPSCEEILSRLL 775
CW E P++RP+ +++LS+L
Sbjct: 235 YSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 99/266 (37%), Positives = 137/266 (51%), Gaps = 16/266 (6%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWNGT-----DVAIKVFLEQDLTAENMEDFCNEISIL 575
ID S +T+ +G G FGEV RG DVAIK L+ + + DF E SI+
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKT-LKAGSSDKQRLDFLTEASIM 59
Query: 576 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
+ HPN+I G TK + +ITEYME GSL L K + + + MLR I
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKF--LRENDGKFTVGQLVGMLRGIAS 117
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-PMRDSSSAGTP-EWMAP 693
G+ + M VHRDL + N LVN + K+ DFGLSR + DS + P W AP
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177
Query: 694 ELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPE---GP 749
E I FT D++S G++MWE+ + RP+ + + V+ AV +G RL P
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMDCPSA 236
Query: 750 LGRLIADCW-AEPQERPSCEEILSRL 774
L +L+ DCW + ERP+ +I+S L
Sbjct: 237 LYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 3e-46
Identities = 86/264 (32%), Positives = 134/264 (50%), Gaps = 31/264 (11%)
Query: 524 SELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSRLRH 580
T+ +G G FGEV++ I T+ VAIKV LE+ + +ED EI LS+ R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRS 58
Query: 581 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
P + + G+ K +L +I EY GS L+ KL +LR++ GL +
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYL 114
Query: 641 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 700
H +HRD+K+AN L+++ VK+ DFG+S +T + + ++ GTP WMAPE+I+
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 701 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAE 760
+ EK DI+SLG+ EL P + P RV++ IP+ L + +++
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF---------LIPKNNPPSLEGNKFSK 225
Query: 761 -------------PQERPSCEEIL 771
P+ERPS +E+L
Sbjct: 226 PFKDFVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 8e-46
Identities = 78/254 (30%), Positives = 134/254 (52%), Gaps = 12/254 (4%)
Query: 526 LTVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 583
++G G GEV++ T +VAIK L +N E NEI I+ +HPN+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKHPNI 77
Query: 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
+ + + L ++ EYM+ GSL +I + +++ + + R++ +GL +H
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQN--FVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTE 703
++HRD+KS N L++K +VK+ DFG + +T + +S GTP WMAPE+I+ + +
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 704 KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA 759
K DI+SLG++ E+ P+ P R ++ + +G L+ PE + C
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255
Query: 760 -EPQERPSCEEILS 772
+P++RPS EE+L
Sbjct: 256 KDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-45
Identities = 83/249 (33%), Positives = 134/249 (53%), Gaps = 12/249 (4%)
Query: 531 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588
++G G FGEV++ G +VAIKV + + E E NEI IL + +HPN++ + G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
+ K L ++ E+ GSL L+ + Q S + +++ +GL +H I+HR
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYV--CKELLKGLEYLHSNGIIHR 122
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 708
D+K+AN L+ VK+ DFGLS ++D+ R+ + GTP WMAPE+I +P+ K DI+
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-TMVGTPYWMAPEVINGKPYDYKADIW 181
Query: 709 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA-EPQE 763
SLG+ EL P+ + P + ++ +A G L PE + C P++
Sbjct: 182 SLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEK 241
Query: 764 RPSCEEILS 772
RP+ E++L
Sbjct: 242 RPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-45
Identities = 86/261 (32%), Positives = 145/261 (55%), Gaps = 13/261 (4%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 578
W I+ EL +G +G G FG+V G + G VA+K L+ D TA + F E S+++ L
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKC-LKDDSTA--AQAFLAEASVMTTL 57
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
RHPN++ LG + L ++TEYM GSL + G + ++ ++L D+C G+
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGME 116
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 698
+ VHRDL + N LV++ K+ DFGL++ ++ S +W APE +R
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTAPEALRE 173
Query: 699 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 754
+ F+ K D++S G+++WE+ + R P+ + + VV V G R+E PEG + +++
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYKVM 232
Query: 755 ADCW-AEPQERPSCEEILSRL 774
DCW +P +RP+ +++ +L
Sbjct: 233 KDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 5e-44
Identities = 85/267 (31%), Positives = 136/267 (50%), Gaps = 16/267 (5%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENM--EDFCNEISIL 575
W ID + + + ++G G FGEV+ G+WN T VA+K L M +DF E I+
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKT-----LKPGTMDPKDFLAEAQIM 55
Query: 576 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
+LRHP +I CT + ++TE M+ GSL + G + L + + M +
Sbjct: 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQ-GGAGRALKLPQLIDMAAQVAS 114
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPE 694
G+ + +HRDL + N LV ++ K+ DFGL+R+I + A P +W APE
Sbjct: 115 GMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PL 750
F+ K D++S G+++ E+ T R P+ G+ V+ V +G R+ P G L
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKEL 233
Query: 751 GRLIADCW-AEPQERPSCEEILSRLLD 776
++ DCW +P +RP+ E + +L D
Sbjct: 234 YDIMLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 88/262 (33%), Positives = 139/262 (53%), Gaps = 13/262 (4%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSRLR 579
ID +LT +G G FG V G W G DVAIK+ E ++ + +F E ++ +L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLS 57
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
H ++ G CTK + ++TEYM G L L +L K+ + L+M +D+C G+
Sbjct: 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCL--LNYLREHGKRFQPSQLLEMCKDVCEGMAY 115
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 698
+ + +HRDL + NCLV+ VK+ DFGLSR + D S + P W PE++
Sbjct: 116 LESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY 175
Query: 699 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEGPLGRLIA-- 755
F+ K D+++ GV+MWE+ +L + P+E V V+ +G RL P ++ A
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIM 234
Query: 756 -DCWAE-PQERPSCEEILSRLL 775
CW E +ERP+ +++LS +
Sbjct: 235 YSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 4e-42
Identities = 83/260 (31%), Positives = 144/260 (55%), Gaps = 13/260 (5%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILS 576
W ++ +++T+ ++G G +GEV+ G+W VA+K E + +E+F E +++
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMK 57
Query: 577 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
++HPN++ LG CT+ P +ITE+M G+L + +++++ L M I
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSA 116
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPEL 695
+ + + +HRDL + NCLV ++ VK+ DFGLSR++T + A P +W APE
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPEG---PLG 751
+ F+ K D+++ GV++WE+ T P+ G+ + VY + +G R+E PEG +
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGYRMERPEGCPPKVY 235
Query: 752 RLIADCWA-EPQERPSCEEI 770
L+ CW P +RPS EI
Sbjct: 236 ELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 5e-42
Identities = 92/261 (35%), Positives = 139/261 (53%), Gaps = 13/261 (4%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSRLR 579
I+ SELT +G G FG V G W VAIK E A + EDF E ++ +L
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE---GAMSEEDFIEEAKVMMKLS 57
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
HP ++ G CT+ L ++TE+ME G L + +L ++ KLS L M +D+C G+
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLN--YLRQRQGKLSKDMLLSMCQDVCEGMEY 115
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 698
+ R +HRDL + NCLV+ VK+ DFG++R + D SS A P +W PE+
Sbjct: 116 LERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF 175
Query: 699 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GPLGRLI 754
++ K D++S GV+MWE+ T + P+E VV ++ G RL P+ + ++
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVM 234
Query: 755 ADCWAE-PQERPSCEEILSRL 774
CW E P+ RP+ E+L +
Sbjct: 235 YSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 6e-42
Identities = 89/281 (31%), Positives = 142/281 (50%), Gaps = 27/281 (9%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 571
W + ++T+ +G G FG V+ G+ G T VAIK E E +E F NE
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNE 59
Query: 572 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK---------LS 622
S++ +V+ LG + ++ E M G L +L ++ + +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKS--YLRSRRPEAENNPGLGPPT 117
Query: 623 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMR 680
++ ++M +I G+ + K VHRDL + NC+V + TVKI DFG++R I TD +
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANE 739
WMAPE +++ FT K D++S GV++WE+ TL +P++G+ E V+ V +
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D 236
Query: 740 GSRLEIPEGP---LGRLIADCWA-EPQERPSCEEILSRLLD 776
G L++PE L L+ CW P+ RP+ EI+S L D
Sbjct: 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 85/250 (34%), Positives = 141/250 (56%), Gaps = 15/250 (6%)
Query: 532 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRH---PNVILF 586
+G G +G V+RG T VA+K+ + D +++ D E+++LS+LR PN+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKI-INLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
G+ K PRL +I EY E GS+ L+ ++ + ++R++ L IH++ ++
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVGVI 123
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKC 705
HRD+K+AN LV VK+CDFG++ ++ + + S+ GTP WMAPE+I + + K
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183
Query: 706 DIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPEGP--LGRLIADCW-AEP 761
DI+SLG+ ++E+ T N P+ V R + + ++ RLE L +A C EP
Sbjct: 184 DIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEP 243
Query: 762 QERPSCEEIL 771
+ER S EE+L
Sbjct: 244 KERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 83/263 (31%), Positives = 138/263 (52%), Gaps = 12/263 (4%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSR 577
W E T+ ++G G+FGEV+ G+W VAIK+ L+ D +DF E+ L R
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKI-LKSD-DLLKQQDFQKEVQALKR 58
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
LRH ++I C+ + +ITE ME GSL + S + + L + M + G+
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLR-SPEGQVLPVASLIDMACQVAEGM 117
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 696
+ +HRDL + N LV + K+ DFGL+R+I + + SS P +W APE
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAA 176
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIP-EGP--LGR 752
+ F+ K D++S G++++E+ T + P+ G+ V + G R+ P + P + +
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYK 235
Query: 753 LIADCW-AEPQERPSCEEILSRL 774
++ +CW AEP++RPS + + L
Sbjct: 236 IMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 6e-40
Identities = 82/267 (30%), Positives = 131/267 (49%), Gaps = 16/267 (5%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNEISIL 575
I ++T+G +G G FG+V++G++ VA+K + + E F E I+
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQEAYIM 61
Query: 576 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
+ HP+++ +G T+ P + ++ E LG L +L K L + +
Sbjct: 62 RQFDHPHIVKLIGVITENP-VWIVMELAPLGELRS--YLQVNKYSLDLASLILYSYQLST 118
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPE 694
L + + VHRD+ + N LV+ VK+ DFGLSR + D +S P +WMAPE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPEG---PL 750
I FT D++ GV MWE+ L +P++GV V+ + N G RL +P L
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN-GERLPMPPNCPPTL 237
Query: 751 GRLIADCWA-EPQERPSCEEILSRLLD 776
L+ CWA +P +RP E+ ++L D
Sbjct: 238 YSLMTKCWAYDPSKRPRFTELKAQLSD 264
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 77/251 (30%), Positives = 126/251 (50%), Gaps = 10/251 (3%)
Query: 532 VGIGFFGE--VFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589
+G G FGE ++R + + V K L+ + D NEI ILS L+HPN+I +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 590 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKL-SWRRKLKMLRDICRGLMCIHRMKIVHR 648
L + EY G+LY I QK +L L L I + IH+ I+HR
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR 125
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 708
D+K+ N + K +K+ DFG+S+I+ + GTP +M+PEL + + K DI+
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIW 185
Query: 709 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQER 764
+LG +++EL TL R ++ P +V + +G+ + L L+ +P++R
Sbjct: 186 ALGCVLYELLTLKRTFDATNPLNLVVKIV-QGNYTPVVSVYSSELISLVHSLLQQDPEKR 244
Query: 765 PSCEEILSRLL 775
P+ +E+L + L
Sbjct: 245 PTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 89/261 (34%), Positives = 137/261 (52%), Gaps = 13/261 (4%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 579
I SELT+ +G G FG V+ G W VAIK E A + EDF E ++ +L
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE---GAMSEEDFIEEAQVMMKLS 57
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
HP ++ G CT+ + ++ E+ME G L +L Q+ K S L M D+C G+
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMAY 115
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 698
+ ++HRDL + NCLV ++ VK+ DFG++R + D S+ P +W +PE+
Sbjct: 116 LESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF 175
Query: 699 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GPLGRLI 754
++ K D++S GV+MWE+ + + P+E VV + N G RL P + L+
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-NAGFRLYKPRLASQSVYELM 234
Query: 755 ADCWAE-PQERPSCEEILSRL 774
CW E P++RPS +L +L
Sbjct: 235 QHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 77/254 (30%), Positives = 134/254 (52%), Gaps = 16/254 (6%)
Query: 531 RVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589
++G G FG+V++G+ T+VA+K L + F E IL + HPN++ +G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKT-CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 590 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 649
C + + ++ E + GSL L L +K +L+ ++ L+M D G+ + +HRD
Sbjct: 61 CVQKQPIYIVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 650 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WMAPELIRNEPFTEKC 705
L + NCLV ++ +KI DFG+SR + + S G + W APE + +T +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 706 DIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-E 760
D++S G+++WE +L + P+ G+ ++ + G R+ P+ + RL+ CWA +
Sbjct: 177 DVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQCWAYD 235
Query: 761 PQERPSCEEILSRL 774
P+ RPS EI + L
Sbjct: 236 PENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 77/249 (30%), Positives = 129/249 (51%), Gaps = 15/249 (6%)
Query: 532 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589
+G G +G V++ I G VAIKV E++++ EISIL + P ++ + G+
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 590 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 649
K L ++ EY GS+ ++ ++ K L+ +L +GL +H K +HRD
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124
Query: 650 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPEWMAPELIRNEPFTEKCDIF 708
+K+ N L+N+ K+ DFG+S +TD+ M ++ GTP WMAPE+I+ + K DI+
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQLTDT-MAKRNTVIGTPFWMAPEVIQEIGYNNKADIW 183
Query: 709 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA-EPQE 763
SLG+ E+ P+ + P R ++ + N+ L PE + C +P+E
Sbjct: 184 SLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEE 243
Query: 764 RPSCEEILS 772
RPS ++L
Sbjct: 244 RPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 1e-38
Identities = 92/265 (34%), Positives = 135/265 (50%), Gaps = 13/265 (4%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSR 577
W I L + ++G G FGEV+ G WNG T VA+K ++ E+ F E I+ +
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---FLEEAQIMKK 57
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
LRH ++ ++ P + ++TEYM GSL + G+ + L + M + G+
Sbjct: 58 LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGM 115
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 696
I RM +HRDL+SAN LV KI DFGL+R+I D+ A P +W APE
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGR 752
FT K D++S G+++ EL T R P+ G + R V G R+ P+ L
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPG-MNNREVLEQVERGYRMPCPQDCPISLHE 234
Query: 753 LIADCW-AEPQERPSCEEILSRLLD 776
L+ CW +P+ERP+ E + S L D
Sbjct: 235 LMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 95/265 (35%), Positives = 136/265 (51%), Gaps = 13/265 (4%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSR 577
W I L + ++G G FGEV+ G WNGT VAIK + E F E I+ +
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKK 57
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
LRH ++ ++ P + ++TE+M GSL + G K L + + M I G+
Sbjct: 58 LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIADGM 115
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 696
I RM +HRDL++AN LV + KI DFGL+R+I D+ A P +W APE
Sbjct: 116 AYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGR 752
FT K D++S G+++ EL T R P+ G++ V+ V G R+ P+G L
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-ERGYRMPCPQGCPESLHE 234
Query: 753 LIADCW-AEPQERPSCEEILSRLLD 776
L+ CW +P ERP+ E I S L D
Sbjct: 235 LMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 82/281 (29%), Positives = 127/281 (45%), Gaps = 50/281 (17%)
Query: 532 VGIGFFGEVFRGIWNGTD------VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 585
+G G FG+V ++ VA+K L ++ DF EI IL L H N++
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKS-LNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 586 FLGACTKPPR--LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
+ G C KP L +I EY+ GSL +L + +++ +R L IC+G+ +
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRD--YLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRIIT------------DSPMRDSSSAGTPEWM 691
+ +HRDL + N LV VKI DFGL++++ +SP+ W
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF---------WY 179
Query: 692 APELIRNEPFTEKCDIFSLGVIMWELCTLNRP--------WEGVLPERVVYAVAN----- 738
APE +R F+ D++S GV ++EL T P + + V
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239
Query: 739 -EGSRLEIPEG-P--LGRLIADCW-AEPQERPSCEEILSRL 774
EG RL P P + L+ CW AEPQ+RPS +++ +
Sbjct: 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-37
Identities = 82/261 (31%), Positives = 145/261 (55%), Gaps = 15/261 (5%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 578
W ++ +LT+G +G G FG V +G + G VA+K ++ D+TA+ F E +++++L
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKN-IKCDVTAQA---FLEETAVMTKL 56
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
H N++ LG L ++ E M G+L + + G + +S + L+ D+ G+
Sbjct: 57 HHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGME 114
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 698
+ K+VHRDL + N LV++ K+ DFGL+R+ M +S +W APE +++
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVKWTAPEALKH 171
Query: 699 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 754
+ F+ K D++S GV++WE+ + R P+ + + V V +G R+E PEG + L+
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-EKGYRMEPPEGCPADVYVLM 230
Query: 755 ADCW-AEPQERPSCEEILSRL 774
CW EP++RPS ++ +L
Sbjct: 231 TSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-37
Identities = 94/266 (35%), Positives = 143/266 (53%), Gaps = 15/266 (5%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSR 577
W + L + ++G G FGEV+ G +NG T VAIK + ++ E F E +++ +
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQ 57
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
L+HP ++ T+ P + +ITEYME GSL + + + KL+ + + M I G+
Sbjct: 58 LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLK-TPEGIKLTINKLIDMAAQIAEGM 115
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 696
I R +HRDL++AN LV++ KI DFGL+R+I D+ A P +W APE I
Sbjct: 116 AFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVL-PERVVYAVANEGSRLEIPEG---PLG 751
FT K D++S G+++ E+ T R P+ G+ PE V G R+ P+ L
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGYRMPRPDNCPEELY 233
Query: 752 RLIADCWAE-PQERPSCEEILSRLLD 776
L+ CW E P+ERP+ E + S L D
Sbjct: 234 ELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-37
Identities = 82/256 (32%), Positives = 134/256 (52%), Gaps = 18/256 (7%)
Query: 527 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
V ++G G +G V++ + + A+K ++ + ED NEI IL+ + HPN+I
Sbjct: 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII 62
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKL-----SWRRKLKMLRDICRGLMC 639
+ A +L ++ EY G L I +K+KL WR +++ RGL
Sbjct: 63 SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL----LRGLQA 118
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 699
+H KI+HRDLKSAN L+ + VKI D G+S+++ + + + GTP +MAPE+ +
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK--TQIGTPHYMAPEVWKGR 176
Query: 700 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIAD 756
P++ K DI+SLG +++E+ T P+E + + Y V G IP L I
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-GKYPPIPPIYSQDLQNFIRS 235
Query: 757 CW-AEPQERPSCEEIL 771
+P+ RP+C++IL
Sbjct: 236 MLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-37
Identities = 85/267 (31%), Positives = 135/267 (50%), Gaps = 22/267 (8%)
Query: 530 TRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENME-DFCNEISILSRLRHP 581
T +G G FGEVF G + V +K + EN++ +F E+ + +L H
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHK 68
Query: 582 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK------KKLSWRRKLKMLRDICR 635
NV+ LG C + MI EY +LG L + + K LS ++K+ + I
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPE 694
G+ + + VHRDL + NCLV+ VK+ LS+ + +S +A P W+APE
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PL 750
++ + F+ K D++S GV+MWE+ T P+ G+ E V+ + L +PEG L
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRL 248
Query: 751 GRLIADCWA-EPQERPSCEEILSRLLD 776
+L+ CWA P++RPS E++S L +
Sbjct: 249 YKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 96/267 (35%), Positives = 137/267 (51%), Gaps = 17/267 (6%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISIL 575
ID S + + +G G FGEV G VAIK L+ T + DF +E SI+
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKT-LKAGYTEKQRRDFLSEASIM 59
Query: 576 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
+ HPN+I G TK + ++TEYME GSL L + + + + MLR I
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAF--LRKHDGQFTVIQLVGMLRGIAS 117
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP---EWMA 692
G+ + M VHRDL + N LVN + K+ DFGLSR++ D P ++ G W A
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177
Query: 693 PELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG--- 748
PE I FT D++S G++MWE+ + RP+ + + V+ A+ EG RL P
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-EEGYRLPAPMDCPA 236
Query: 749 PLGRLIADCW-AEPQERPSCEEILSRL 774
L +L+ DCW + ERP E+I+S L
Sbjct: 237 ALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 79/264 (29%), Positives = 136/264 (51%), Gaps = 18/264 (6%)
Query: 524 SELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSR 577
+EL +G G FG V++G+W VAIKV L ++ + + ++ +E +++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKV-LREETSPKANKEILDEAYVMAS 65
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
+ HP+V+ LG C ++ +IT+ M LG L L ++ K + + L I +G+
Sbjct: 66 VDHPHVVRLLGICLSS-QVQLITQLMPLGCL--LDYVRNHKDNIGSQYLLNWCVQIAKGM 122
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EWMAPEL 695
+ ++VHRDL + N LV VKI DFGL++++ D + P +WMA E
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPE---GPLG 751
I + +T K D++S GV +WEL T +P+EG+ P + + +G RL P +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICTIDVY 241
Query: 752 RLIADCWAEPQE-RPSCEEILSRL 774
++ CW E RP+ +E+++
Sbjct: 242 MVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 3e-37
Identities = 96/266 (36%), Positives = 141/266 (53%), Gaps = 15/266 (5%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSR 577
W I L + ++G G FGEV+ G WNGT VAIK ++ E F E ++ +
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKK 57
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRG 636
LRH ++ ++ P + ++TEYM GSL L L G+ K L + + M I G
Sbjct: 58 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASG 114
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPEL 695
+ + RM VHRDL++AN LV ++ K+ DFGL+R+I D+ A P +W APE
Sbjct: 115 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIP-EGP--LG 751
FT K D++S G+++ EL T R P+ G++ V+ V G R+ P E P L
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLH 233
Query: 752 RLIADCW-AEPQERPSCEEILSRLLD 776
L+ CW EP+ERP+ E + + L D
Sbjct: 234 DLMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 97/296 (32%), Positives = 139/296 (46%), Gaps = 59/296 (19%)
Query: 524 SELTVGTRVGIGFFGEV----------------FRGIWNG--TDVAIKVFLEQDLTAENM 565
L ++G G FGEV VA+KV L D +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKV-LRPDASDNAR 63
Query: 566 EDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-----YHLIHLSG---Q 617
EDF E+ ILSRL PN+ LG CT P L MI EYME G L H+ SG
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 618 KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677
K LS+ L M I G+ + + VHRDL + NCLV K++T+KI DFG+SR + S
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183
Query: 678 -----------PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR--PW 724
P+R WMA E + FT K D+++ GV +WE+ TL R P+
Sbjct: 184 DYYRVQGRAPLPIR---------WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234
Query: 725 EGVLPERVV----YAVANEGSRLEIPEGP-----LGRLIADCWA-EPQERPSCEEI 770
E + ++V+ + ++G ++ +P P + L+ +CW + ++RP+ EI
Sbjct: 235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 79/259 (30%), Positives = 116/259 (44%), Gaps = 16/259 (6%)
Query: 531 RVGIGFFGEVFRGIW---NGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 585
++G G FG V RG W G VA+K L+ D ++ M+DF E +I+ L H N+I
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKC-LKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 586 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
G P L M+TE LGSL + I G+ + +
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKD-ALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSR--IITDSPMRDSSSAGTP-EWMAPELIRNEPFT 702
+HRDL + N L+ VKI DFGL R + P W APE +R F+
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 703 EKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW 758
D++ GV +WE+ T PW G+ +++ + EG RLE PE + ++ CW
Sbjct: 179 HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW 238
Query: 759 A-EPQERPSCEEILSRLLD 776
A P +RP+ + L +
Sbjct: 239 AHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 93/258 (36%), Positives = 135/258 (52%), Gaps = 18/258 (6%)
Query: 532 VGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 586
+G G FGEVFRGI VAIK L+ T + +DF +E SI+ + H N+I
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKT-LKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
G TK +ITEYME G+L +L + S + + MLR I G+ + M V
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDK--YLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP---EWMAPELIRNEPFTE 703
HRDL + N LVN + K+ DFGLSR++ D P +++G W APE I FT
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 704 KCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW- 758
D++S G++MWE+ + RP+ + V+ A+ N+G RL P + +L+ CW
Sbjct: 190 ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPMDCPSAVYQLMLQCWQ 248
Query: 759 AEPQERPSCEEILSRLLD 776
+ RP +I++ LLD
Sbjct: 249 QDRARRPRFVDIVN-LLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 89/284 (31%), Positives = 143/284 (50%), Gaps = 37/284 (13%)
Query: 526 LTVGTRVGIGFFGEVFR-------GIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 578
L +G +G G FG+V + G T VA+K+ E ++E D +E ++L ++
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR-DLLSEFNLLKQV 60
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ--------------------- 617
HP+VI GAC++ L +I EY + GSL + S +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 618 KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--T 675
++ L+ + I RG+ + MK+VHRDL + N LV + +KI DFGLSR +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 676 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVY 734
DS ++ S +WMA E + + +T + D++S GV++WE+ TL P+ G+ PER ++
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-LF 239
Query: 735 AVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
+ G R+E PE + L+ CW EP +RP+ +I L
Sbjct: 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 85/286 (29%), Positives = 147/286 (51%), Gaps = 30/286 (10%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFC 569
EW + LT+G +G G FG+V + G D VA+K+ L+ D T +++ D
Sbjct: 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKM-LKDDATEKDLSDLV 63
Query: 570 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIHLS 615
+E+ ++ + +H N+I LG CT+ L ++ EY G+L
Sbjct: 64 SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123
Query: 616 GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675
++ L+ + + + RG+ + K +HRDL + N LV + +KI DFGL+R I
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183
Query: 676 DSPM-RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERV 732
R +++ P +WMAPE + + +T + D++S GV++WE+ TL P+ G+ P
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEE 242
Query: 733 VYAVANEGSRLEIPEG---PLGRLIADCWAE-PQERPSCEEILSRL 774
++ + EG R+E P+ L L+ DCW E P +RP+ ++++ L
Sbjct: 243 LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 83/271 (30%), Positives = 135/271 (49%), Gaps = 25/271 (9%)
Query: 526 LTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFCNEISILSRL 578
+T+ +G G FGEV+ G++ G D VA+K L + + ++ DF E I+S+
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKT-LPESCSEQDESDFLMEALIMSKF 66
Query: 579 RHPNVILFLGAC-TKPPRLSMITEYMELGSLYHLIHLS----GQKKKLSWRRKLKMLRDI 633
H N++ +G + PR ++ E M G L + + + L+ + L RD+
Sbjct: 67 NHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 634 CRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSR-IITDSPMRDSSSAGTP- 688
+G + +HRD+ + NCL+ KI DFG++R I S R A P
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE 747
+WM PE + FT K D++S GV++WE+ +L P+ G + V G RL+ P+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG-RTNQEVMEFVTGGGRLDPPK 244
Query: 748 G---PLGRLIADCW-AEPQERPSCEEILSRL 774
G P+ R++ DCW P++RP+ IL R+
Sbjct: 245 GCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 87/246 (35%), Positives = 140/246 (56%), Gaps = 10/246 (4%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588
++G G FGEVF+GI N T VAIK+ ++ + + +ED EI++LS+ P V + G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
+ K +L +I EY+ GS L+ + L + +LR+I +GL +H K +HR
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKKIHR 125
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 708
D+K+AN L+++H VK+ DFG++ +TD+ ++ ++ GTP WMAPE+I+ + K DI+
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIW 185
Query: 709 SLGVIMWELCTLNRPWEGVLPERVVYAV-ANEGSRLEIP-EGPLGRLIADCW-AEPQERP 765
SLG+ EL P + P +V++ + N LE PL + C EP RP
Sbjct: 186 SLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 245
Query: 766 SCEEIL 771
+ +E+L
Sbjct: 246 TAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 76/260 (29%), Positives = 129/260 (49%), Gaps = 18/260 (6%)
Query: 527 TVGTRVGIGFFGEVFRGI--WNGTDVA---IKVFLEQDLTAENMEDFCNEISILSRLRHP 581
+ ++G G F V++ I +G VA +++F D A+ +D EI +L +L HP
Sbjct: 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD--AKARQDCLKEIDLLKQLDHP 62
Query: 582 NVILFLGACTKPPRLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCI 640
NVI +L + + L+++ E + G L +I H QK+ + R K +C L +
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122
Query: 641 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 700
H +I+HRD+K AN + VK+ D GL R + S GTP +M+PE I
Sbjct: 123 HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 701 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-------LGRL 753
+ K DI+SLG +++E+ L P+ G + +Y++ + + + P P L L
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEKCDYPPLPADHYSEELRDL 240
Query: 754 IADCW-AEPQERPSCEEILS 772
++ C +P++RP +L
Sbjct: 241 VSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 86/272 (31%), Positives = 133/272 (48%), Gaps = 35/272 (12%)
Query: 532 VGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+G G FG VF+ G T VA+K+ L+++ +A+ DF E ++++ HPN++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 585 LFLGACTKPPRLSMITEYMELGSLYH-LIHLS------------------GQKKKLSWRR 625
LG C + ++ EYM G L L H S LS
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 626 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSS 683
+L + + + G+ + K VHRDL + NCLV ++ VKI DFGLSR I D +
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191
Query: 684 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSR 742
A WM PE I +T + D+++ GV++WE+ + +P+ G+ E V+Y V +G+
Sbjct: 192 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV-RDGNV 250
Query: 743 LEIPEG-PLG--RLIADCWA-EPQERPSCEEI 770
L P+ PL L+ CW+ P +RPS I
Sbjct: 251 LSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 78/255 (30%), Positives = 124/255 (48%), Gaps = 18/255 (7%)
Query: 529 GTRVGIGFFGEVFRGI--WNGTDVAIKVFL---EQDLTAENMEDFCNEISILSRLRHPNV 583
G +G G FG V+ G+ +G A+K + E ++ EI++LS+L+HPN+
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML--RDICRGLMCIH 641
+ +LG + L + E + GSL L+ KK S+ + L R I GL +H
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLL-----KKYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 642 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-P 700
VHRD+K AN LV+ + VK+ DFG+++ + + S G+P WMAPE+I +
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA-KSFKGSPYWMAPEVIAQQGG 178
Query: 701 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE--GPLGRL-IADC 757
+ DI+SLG + E+ T PW + V+ + IP+ + I C
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKC 238
Query: 758 W-AEPQERPSCEEIL 771
+P RP+ E+L
Sbjct: 239 LQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 82/261 (31%), Positives = 132/261 (50%), Gaps = 30/261 (11%)
Query: 531 RVGIGFFGEVF--RGIWNGTDVAIKVF-LEQDLTAENMEDFCNEISILSRLRHPNVILFL 587
R+G G +G+V+ R I G VAIKV LE ++ E EIS+L RHPN++ +
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYF 66
Query: 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK------MLRDICRGLMCIH 641
G+ + +L ++ EY GSL + ++ R L + R+ +GL +H
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIYQVT--------RGPLSELQIAYVCRETLKGLAYLH 118
Query: 642 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI---RN 698
+HRD+K AN L+ + VK+ DFG+S +T + + S GTP WMAPE+ R
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 699 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS---RLEIPE--GPLGRL 753
+ KCDI++LG+ EL L P + P R ++ ++ +L+ E P+
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238
Query: 754 -IADCWA-EPQERPSCEEILS 772
I C +P++RP+ ++L
Sbjct: 239 FIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 88/269 (32%), Positives = 137/269 (50%), Gaps = 33/269 (12%)
Query: 532 VGIGFFGEVFRG-----IWNGTD---VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 583
+G G FGEV+ G + G+ VA+K L + T + ++F E ++S HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKT-LRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK------LSWRRKLKMLRDICRGL 637
+ LG C +I E ME G L +L + + L+ + L + D+ +G
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLS--YLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 638 MCIHRMKIVHRDLKSANCLV-----NKHWTVKICDFGLSRIITDSPMRDSSSAG--TPEW 690
+ + +M +HRDL + NCLV + VKI DFGL+R I S G W
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 691 MAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPE-- 747
MAPE + + FT + D++S GV+MWE+ TL +P+ + + V+ V G RL+ PE
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RLQKPENC 238
Query: 748 -GPLGRLIADCWA-EPQERPS---CEEIL 771
+ +L+ +CWA +P ERP+ +EIL
Sbjct: 239 PDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 73/262 (27%), Positives = 123/262 (46%), Gaps = 29/262 (11%)
Query: 531 RVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENM-----EDFCNEISILSRLRHPNVIL 585
+G G FG V + K+ + +++ NM + +E++IL L+HPN++
Sbjct: 7 TIGKGSFGTVRKVRRKSDG---KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 586 FLGACTKPP--RLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
+ L ++ EY E G L LI ++K + ++L + L H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 643 -----MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 697
++HRDLK AN ++ + VK+ DFGL++I+ + GTP +M+PE +
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLN 183
Query: 698 NEPFTEKCDIFSLGVIMWELCTLNRPWEG----VLPERVVYAVANEGSRLEIPEG---PL 750
+ + EK DI+SLG +++ELC L+ P+ L ++ EG IP L
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-----KEGKFRRIPYRYSSEL 238
Query: 751 GRLIADCWA-EPQERPSCEEIL 771
+I +P +RPS EE+L
Sbjct: 239 NEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 85/268 (31%), Positives = 132/268 (49%), Gaps = 27/268 (10%)
Query: 532 VGIGFFGEVFRG----IWNGTD---VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+G G FG+VF G + D VA+K L++ + + +DF E +L+ +H N++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKT-LKETASNDARKDFEREAELLTNFQHENIV 71
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSG-----------QKKKLSWRRKLKMLRDI 633
F G CT+ M+ EYME G L + G +L+ + L++ I
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 634 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-EWM 691
G++ + VHRDL + NCLV VKI DFG+SR + T R P WM
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM 191
Query: 692 APELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG-P 749
PE I FT + D++S GV++WE+ T + PW G+ E V+ + +G L+ P P
Sbjct: 192 PPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI-TQGRLLQRPRTCP 250
Query: 750 LG--RLIADCW-AEPQERPSCEEILSRL 774
++ CW +PQ+R + ++I RL
Sbjct: 251 SEVYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 34/269 (12%)
Query: 524 SELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP 581
S+L +G G G V++ G A+K D E + E+ L P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHV-DGDEEFRKQLLRELKTLRSCESP 59
Query: 582 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 641
V+ GA K +S++ EYM+ GSL L+ + K+ + R I +GL +H
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 642 RM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 700
I+HRD+K +N L+N VKI DFG+S+++ ++ + ++ GT +M+PE I+ E
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176
Query: 701 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IPEGPLGRLIAD 756
++ DI+SLG+ + E G P + + S E I +GP L A+
Sbjct: 177 YSYAADIWSLGLTLLECAL------GKFP----FLPPGQPSFFELMQAICDGPPPSLPAE 226
Query: 757 CWA-------------EPQERPSCEEILS 772
++ +P++RPS E+L
Sbjct: 227 EFSPEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 94/269 (34%), Positives = 136/269 (50%), Gaps = 19/269 (7%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISIL 575
ID S + + +G G FGEV RG VAIK L+ T + DF +E SI+
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASIM 59
Query: 576 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDIC 634
+ HPN+I G TK + +ITE+ME G+L + + GQ + + + MLR I
Sbjct: 60 GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ---FTVIQLVGMLRGIA 116
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRDSSSAGT-P-E 689
G+ + M VHRDL + N LVN + K+ DFGLSR + D P SS G P
Sbjct: 117 AGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG 748
W APE I FT D++S G++MWE+ + RP+ + + V+ A+ + +
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDC 236
Query: 749 P--LGRLIADCWA-EPQERPSCEEILSRL 774
P L +L+ DCW + RP +I+S L
Sbjct: 237 PTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 5e-34
Identities = 84/255 (32%), Positives = 140/255 (54%), Gaps = 10/255 (3%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588
R+G G FGEV++GI N T VAIK+ ++ + + +ED EI++LS+ P + + G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
+ K +L +I EY+ GS L+ + L +LR+I +GL +H + +HR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERKIHR 125
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 708
D+K+AN L+++ VK+ DFG++ +TD+ ++ ++ GTP WMAPE+I+ + K DI+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIW 185
Query: 709 SLGVIMWELCTLNRPWEGVLPERVVYAV-ANEGSRLEIPEG-PLGRLIADCW-AEPQERP 765
SLG+ EL P + P RV++ + N LE P + C +P+ RP
Sbjct: 186 SLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRP 245
Query: 766 SCEEILSRLLDCEYS 780
+ +E+L Y+
Sbjct: 246 TAKELLKHKFITRYT 260
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 85/255 (33%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588
R+G G FGEVF+GI N T VAIK+ ++ + + +ED EI++LS+ P V + G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
+ K +L +I EY+ GS L+ +G + + ML++I +GL +H K +HR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEF---QIATMLKEILKGLDYLHSEKKIHR 125
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 708
D+K+AN L+++ VK+ DFG++ +TD+ ++ ++ GTP WMAPE+I+ + K DI+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185
Query: 709 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIAD-----------C 757
SLG+ EL P + P RV++ IP+ L + C
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMRVLF---------LIPKNNPPTLTGEFSKPFKEFIDAC 236
Query: 758 W-AEPQERPSCEEIL 771
+P RP+ +E+L
Sbjct: 237 LNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 92/282 (32%), Positives = 136/282 (48%), Gaps = 34/282 (12%)
Query: 520 NIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEI 572
+ F E +G G FG+V++G G T VAIK L+++ + ++F E
Sbjct: 6 AVRFLE-----ELGEGAFGKVYKGELTGPNERLSATSVAIKT-LKENAEPKVQQEFRQEA 59
Query: 573 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY-HLIHLS------------GQKK 619
++S L+HPN++ LG CTK M+ EY+ G L+ L+ S K
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 620 KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 678
L L + I G+ + VHRDL + NCLV + TVKI DFGLSR I +
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179
Query: 679 MRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAV 736
R S + P WM PE I FT + DI+S GV++WE+ + +P+ G + V+ +
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239
Query: 737 ANEGSRLEIPEG---PLGRLIADCWAE-PQERPSCEEILSRL 774
L PE + L+ +CW E P RP ++I +RL
Sbjct: 240 -RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 77/268 (28%), Positives = 127/268 (47%), Gaps = 16/268 (5%)
Query: 525 ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ-DLTAENMEDFCNEISILSRLRHPNV 583
+ ++G G FGEV+ + VA+KV ++ + ++ +E F EI IL+ L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 584 IL-FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
I+ L ++ EY++ GSL L+ G+K LS L +L I L +H
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 643 MKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDS------PMRDSSSAGTPEWMAPEL 695
I+HRD+K N L+++ VK+ DFGL++++ D P S+S GTP +MAPE+
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 696 IR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR 752
+ + DI+SLG+ ++EL T P+EG E+ A + + P
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG---EKNSSATSQTLKIILELPTPSLA 236
Query: 753 LIADCWAEPQERPSCEEILSRLLDCEYS 780
+ ++L +LL +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPK 264
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 73/259 (28%), Positives = 127/259 (49%), Gaps = 20/259 (7%)
Query: 529 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 586
G ++G G FG+V+ + G +A+K QD + +++ +E+ +L L+HPN++ +
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
G ++ + EY G+L L+ + R L GL +H IV
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL---LEGLAYLHSHGIV 121
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDS----PMRDSSSAGTPEWMAPELIRNEPFT 702
HRD+K AN ++ + +K+ DFG + + ++ S AGTP +MAPE+I
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 703 EK---CDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRLEIPE----GPLG-RL 753
DI+SLG ++ E+ T RPW + E ++++ V G + IP+ P G
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLSPEGKDF 240
Query: 754 IADCWA-EPQERPSCEEIL 771
+ C +P++RP+ E+L
Sbjct: 241 LDRCLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 79/272 (29%), Positives = 129/272 (47%), Gaps = 45/272 (16%)
Query: 532 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 588
+G G +G+V++ T VAIK+ D+ + E+ E +IL + HPN+ F G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 589 ACTKP------PRLSMITEYMELGSLYHLI---HLSGQKKKLSWRRKLKMLRDICRGLMC 639
A K +L ++ E GS+ L+ G++ K W + LR+ RGL
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI--LRETLRGLAY 128
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI--- 696
+H K++HRD+K N L+ K+ VK+ DFG+S + + R ++ GTP WMAPE+I
Sbjct: 129 LHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACD 188
Query: 697 --RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRL- 753
+ + + D++SLG+ EL P + P R ++ +IP P L
Sbjct: 189 EQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF---------KIPRNPPPTLK 239
Query: 754 ------------IADCWAE-PQERPSCEEILS 772
I++C + ++RP EE+L
Sbjct: 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 83/265 (31%), Positives = 136/265 (51%), Gaps = 12/265 (4%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSR 577
W I + + ++G G FGEV+ G + N T VA+K ++ ++ F E +++
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKT 57
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
L+H ++ TK + +ITEYM GSL + S + K+ + + I G+
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGM 116
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 696
I R +HRDL++AN LV++ KI DFGL+R+I D+ A P +W APE I
Sbjct: 117 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGR 752
FT K D++S G++++E+ T + P+ G+ V+ A+ G R+ E L
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYRMPRMENCPDELYD 235
Query: 753 LIADCWAE-PQERPSCEEILSRLLD 776
++ CW E +ERP+ + + S L D
Sbjct: 236 IMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 5e-32
Identities = 83/250 (33%), Positives = 126/250 (50%), Gaps = 24/250 (9%)
Query: 550 VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL- 608
VA+K+ L D+T DF EI I+SRL++PN+I LG C L MITEYME G L
Sbjct: 47 VAVKM-LRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 609 --------YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 660
+ +S L M I G+ + + VHRDL + NCLV H
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH 165
Query: 661 WTVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELC 718
+T+KI DFG+SR + + R A P WMA E I FT D+++ GV +WE+
Sbjct: 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225
Query: 719 TL--NRPWEGVLPERVVYAVA----NEGSRLEIPE-----GPLGRLIADCWA-EPQERPS 766
TL +P+ + E+V+ N+G ++ + + P+ +L+ CW+ + ++RP+
Sbjct: 226 TLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT 285
Query: 767 CEEILSRLLD 776
+I L +
Sbjct: 286 FNKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 80/263 (30%), Positives = 130/263 (49%), Gaps = 21/263 (7%)
Query: 531 RVGIGFFGEVFRGIW---NGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 585
+G G FG V +G++ +G +VA+K L+Q+ A ++F E S++++L HP ++
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKT-LKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 586 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK-MLRDICRGLMCIHRMK 644
+G C P L ++ E LG L + +K++ LK + + G+ +
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYLESKH 115
Query: 645 IVHRDLKSANCL-VNKHWTVKICDFGLSRII-TDSPMRDSSSAGT-P-EWMAPELIRNEP 700
VHRDL + N L VN+H KI DFG+SR + S +++AG P +W APE I
Sbjct: 116 FVHRDLAARNVLLVNRHQ-AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 701 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADC 757
F+ K D++S GV +WE + G + V A+ G RL PE + ++ C
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSC 234
Query: 758 WA-EPQERPSCEEILSRLLDCEY 779
W P++RP+ E+ S
Sbjct: 235 WKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 80/254 (31%), Positives = 133/254 (52%), Gaps = 19/254 (7%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589
+G G FG+++ + + IK + + E E+ +L++++HPN++ F +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 590 CTKPPRLSMITEYMELGSLYHLIH-----LSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
+ RL ++ EY + G L I+ L + + LSW I GL IH K
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIHDRK 121
Query: 645 IVHRDLKSANCLVNKHWTV-KICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTE 703
I+HRD+KS N ++K+ V K+ DFG++R + DS + GTP +++PE+ +N P+
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181
Query: 704 KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-A 759
K DI+SLG +++ELCTL P+EG ++V + +G I L LI+ +
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQLFKV 240
Query: 760 EPQERPSCEEILSR 773
P++RPS IL R
Sbjct: 241 SPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 8e-32
Identities = 80/262 (30%), Positives = 137/262 (52%), Gaps = 15/262 (5%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 578
W ++ EL + +G G FG+V G + G VA+K ++ D TA+ F E S++++L
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQA---FLAEASVMTQL 56
Query: 579 RHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
RH N++ LG + L ++TEYM GSL + G + L LK D+C +
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAM 115
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 697
+ VHRDL + N LV++ K+ DFGL++ S +D+ +W APE +R
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPV-KWTAPEALR 172
Query: 698 NEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 753
+ F+ K D++S G+++WE+ + R P+ + + VV V G +++ P+G + +
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDV 231
Query: 754 IADCWA-EPQERPSCEEILSRL 774
+ CW + RPS ++ +L
Sbjct: 232 MKQCWHLDAATRPSFLQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 84/276 (30%), Positives = 140/276 (50%), Gaps = 16/276 (5%)
Query: 514 LAYEE-WNIDFSELTVGTRVGIGFFGEVFRGIWNG---TDVAIKV---FLEQDLTAENME 566
L Y+ W + L+ G +G G FG+V G +D +KV L+ + E
Sbjct: 24 LPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE 83
Query: 567 DFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRR 625
+E+ I+S L H N++ LGACT + +ITEY G L + + ++ L+
Sbjct: 84 ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLED 142
Query: 626 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSS 684
L + +G+ + +HRDL + N L+ VKICDFGL+R I+ DS +
Sbjct: 143 LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN 202
Query: 685 AGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSR 742
A P +WMAPE I N +T + D++S G+++WE+ +L P+ G+ + Y + EG R
Sbjct: 203 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262
Query: 743 LEIPE---GPLGRLIADCWA-EPQERPSCEEILSRL 774
+ PE + ++ CW +P +RP+ ++I+ +
Sbjct: 263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 86/274 (31%), Positives = 137/274 (50%), Gaps = 25/274 (9%)
Query: 526 LTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEISILSRLRH 580
L +G +G G FG V G + D VA+K T +E+F +E + + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 581 PNVILFLGAC------TKPPRLSMITEYMELGSLYHLI---HLSGQKKKLSWRRKLKMLR 631
PNV+ +G C K P+ +I +M+ G L+ + L G +KL + LK +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 632 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-E 689
DI G+ + +HRDL + NC++ + TV + DFGLS+ I + R A P +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG 748
W+A E + + +T K D+++ GV MWE+ T + P+ GV +Y G+RL+ PE
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIYDYLRHGNRLKQPED 239
Query: 749 PLGRL---IADCW-AEPQERPS---CEEILSRLL 775
L L + CW A+P++RP+ E+L +L
Sbjct: 240 CLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 84/269 (31%), Positives = 131/269 (48%), Gaps = 21/269 (7%)
Query: 526 LTVGTRVGIGFFGEVFRGIWNGTD----VAIKVFLEQDLTAENMEDFCNEISILSRLRHP 581
L +G +G G FG V G N D VA+K T MEDF +E + HP
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 582 NVILFLGACTKP------PRLSMITEYMELGSLYHLI---HLSGQKKKLSWRRKLKMLRD 632
NV+ +G C + P +I +M+ G L+ + L + L + +K + D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-MRDSSSAGTP-EW 690
I G+ + +HRDL + NC++N++ V + DFGLS+ I + R A P +W
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 691 MAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEGP 749
+A E + + +T K D++S GV MWE+ T + P+ GV +Y +G+RL+ P
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV-ENSEIYDYLRQGNRLKQPPDC 239
Query: 750 LG---RLIADCWA-EPQERPSCEEILSRL 774
L L++ CW P++RPS E + L
Sbjct: 240 LDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 56/197 (28%), Positives = 110/197 (55%), Gaps = 3/197 (1%)
Query: 531 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588
++G G FG VF+ + + A+K + E+ +E +L++L +I +
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
+ +L+++ EY E G L+ L+ + + L + + I GL +H KI+HR
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLK-MQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR 125
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 708
D+KS N ++ + VKI D G++++++D+ ++ GTP +++PEL ++P+ EK D++
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVW 185
Query: 709 SLGVIMWELCTLNRPWE 725
+LGV+++E CT P++
Sbjct: 186 ALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 79/273 (28%), Positives = 129/273 (47%), Gaps = 35/273 (12%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDV--AIKVFLEQDLTAENMEDFCNEISI 574
+ W I EL G G FG+V++ T + A K+ + E +EDF EI I
Sbjct: 5 DIWEI-IGEL------GDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDI 55
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK------ 628
LS +HPN++ A +L ++ E+ + G+L ++ L R L
Sbjct: 56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIM--------LELERGLTEPQIRY 107
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 688
+ R + L +H K++HRDLK+ N L+ VK+ DFG+S + + + GTP
Sbjct: 108 VCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTP 167
Query: 689 EWMAPELI-----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSR 742
WMAPE++ ++ P+ K DI+SLG+ + EL + P + P RV+ + +E
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT 227
Query: 743 LEIPEG---PLGRLIADCWA-EPQERPSCEEIL 771
L+ P + C +P +RP+ E+L
Sbjct: 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 87/265 (32%), Positives = 134/265 (50%), Gaps = 13/265 (4%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSR 577
W I L + ++G G FGEV+ +N T VA+K ++ +E F E +++
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKT 57
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
L+H ++ TK P + +ITE+M GSL + S + K + + I G+
Sbjct: 58 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGM 115
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 696
I + +HRDL++AN LV+ KI DFGL+R+I D+ A P +W APE I
Sbjct: 116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGR 752
FT K D++S G+++ E+ T R P+ G+ V+ A+ G R+ PE L
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEELYN 234
Query: 753 LIADCW-AEPQERPSCEEILSRLLD 776
++ CW P+ERP+ E I S L D
Sbjct: 235 IMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 76/265 (28%), Positives = 129/265 (48%), Gaps = 21/265 (7%)
Query: 525 ELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC----NEISILSRL 578
E G ++G G F + R + GT +A+K T+ E+ EI +++RL
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
HP++I LGA + ++ E+M GS+ HL+ G K+ + + RGL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLS 117
Query: 639 CIHRMKIVHRDLKSANCLVNKH-WTVKICDFG----LSRIITDSPMRDSSSAGTPEWMAP 693
+H +I+HRD+K AN L++ ++I DFG L+ T + GT +MAP
Sbjct: 118 YLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 694 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER---VVYAVANEGSRLEIPE--G 748
E++R E + CD++S+G ++ E+ T PW +++ +A+ + IPE
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237
Query: 749 PLGRLIA-DCW-AEPQERPSCEEIL 771
P R + C +P++RP E+L
Sbjct: 238 PGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 6e-31
Identities = 83/249 (33%), Positives = 126/249 (50%), Gaps = 23/249 (9%)
Query: 550 VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 609
VA+K+ L +D DF EI I+SRL+ PN+I L C L MITEYME G L
Sbjct: 49 VAVKM-LREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 610 HLIH--------LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 661
+ +S+ + M I G+ + + VHRDL + NCLV K++
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167
Query: 662 TVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCT 719
T+KI DFG+SR + + R A P WM+ E I FT D+++ GV +WE+ T
Sbjct: 168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
Query: 720 L--NRPWEGVLPERVVYAVA----NEGSRLEIPEGP-----LGRLIADCW-AEPQERPSC 767
L +P+ + E+V+ ++G ++ +P+ L +L+ CW +ERPS
Sbjct: 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF 287
Query: 768 EEILSRLLD 776
+EI + LL+
Sbjct: 288 QEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 81/262 (30%), Positives = 131/262 (50%), Gaps = 27/262 (10%)
Query: 532 VGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 586
+G G FG V+ G +D A+K L + E +E F E I+ HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKS-LNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 587 LGACTKPPRLSMIT-EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
LG C ++ YM+ G L + I + + + + + +G+ + K
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIR--SETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRDSSSAGTP-EWMAPELIRNEPF 701
VHRDL + NC++++ +TVK+ DFGL+R I D + + + A P +WMA E ++ + F
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 702 TEKCDIFSLGVIMWELCTLNRPWEGVLPERVV--YAVAN---EGSRLEIPE---GPLGRL 753
T K D++S GV++WEL T G P V + + +G RL PE PL +
Sbjct: 180 TTKSDVWSFGVLLWELMT-----RGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV 234
Query: 754 IADCW-AEPQERPSCEEILSRL 774
+ CW +P+ RP+ E++SR+
Sbjct: 235 MLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 7e-31
Identities = 82/286 (28%), Positives = 146/286 (51%), Gaps = 32/286 (11%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---------VAIKVFLEQDLTAENMEDFC 569
W +LT+G +G G FG+V G D VA+K+ L+ D T +++ D
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLV 68
Query: 570 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSG------------ 616
+E+ ++ + +H N+I LGACT+ L +I EY G+L +
Sbjct: 69 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 617 -QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675
++++++ + + RG+ + K +HRDL + N LV ++ +KI DFGL+R +
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188
Query: 676 DSPMRDSSSAG--TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERV 732
+ ++ G +WMAPE + + +T + D++S GV+MWE+ TL P+ G+ P
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 247
Query: 733 VYAVANEGSRLEIP---EGPLGRLIADCW-AEPQERPSCEEILSRL 774
++ + EG R++ P L ++ DCW A P RP+ ++++ L
Sbjct: 248 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 59/220 (26%), Positives = 109/220 (49%), Gaps = 8/220 (3%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLG 588
+G G FG+V R G A+KV ++ + + E +ILSR+ HP ++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
A +L ++ EY G L+ + ++ + S R +I L +H + I++R
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLS---KEGRFSEERARFYAAEIVLALEYLHSLGIIYR 117
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 708
DLK N L++ +K+ DFGL++ ++ R ++ GTPE++APE++ + + + D +
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWW 177
Query: 709 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG 748
SLGV+++E+ T P+ + + + L PE
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEF 215
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 1e-30
Identities = 90/279 (32%), Positives = 144/279 (51%), Gaps = 23/279 (8%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 571
W + ++T+ +G G FG V+ GI G T VAIK E E +E F NE
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNE 59
Query: 572 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKK------LSWR 624
S++ +V+ LG ++ +I E M G L +L L + + S +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 625 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDS 682
+ ++M +I G+ ++ K VHRDL + NC+V + +TVKI DFG++R I TD +
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGS 741
WM+PE +++ FT D++S GV++WE+ TL +P++G+ E+V+ V EG
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGG 238
Query: 742 RLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLD 776
L+ P+ L L+ CW P+ RPS EI+S + +
Sbjct: 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 71/255 (27%), Positives = 124/255 (48%), Gaps = 16/255 (6%)
Query: 532 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589
+G+G V+ I N VAIK ++ + ++++ E+ +S+ HPNV+ + +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 590 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 649
L ++ Y+ GSL ++ S + L +L+++ +GL +H +HRD
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRD 127
Query: 650 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS----AGTPEWMAPELIRNEP-FTEK 704
+K+ N L+ + +VKI DFG+S + D R GTP WMAPE++ + K
Sbjct: 128 IKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK 187
Query: 705 CDIFSLGVIMWELCTLNRPWEGVLPERV-VYAVANEGSRLEIPE--GPLGR----LIADC 757
DI+S G+ EL T P+ P +V + + N+ LE + +I+ C
Sbjct: 188 ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLC 247
Query: 758 W-AEPQERPSCEEIL 771
+P +RP+ EE+L
Sbjct: 248 LQKDPSKRPTAEELL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 84/258 (32%), Positives = 119/258 (46%), Gaps = 37/258 (14%)
Query: 550 VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 609
VA+K+ L D DF E+ ILSRL+ PN+I LG C L MITEYME G L
Sbjct: 49 VAVKI-LRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 610 HLI---HL-------------SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 653
+ HL + +S+ L + I G+ + + VHRDL +
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167
Query: 654 NCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLG 711
NCLV ++ T+KI DFG+SR + R A P WMA E I FT D+++ G
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227
Query: 712 VIMWELCTLNR--PWEGVLPERVVYAVANEG------------SRLEIPEGPLGRLIADC 757
V +WE+ L + P+ + E+V + N G R L L+ C
Sbjct: 228 VTLWEILMLCKEQPYGELTDEQV---IENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQC 284
Query: 758 WA-EPQERPSCEEILSRL 774
W+ + +ERPS +I + L
Sbjct: 285 WSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 76/256 (29%), Positives = 119/256 (46%), Gaps = 17/256 (6%)
Query: 529 GTRVGIGFFGEVF--RGIWNGTDVAIKVF----LEQDLTAENMEDFCNEISILSRLRHPN 582
G +G G FG V+ + G ++A+K + E + EI +L L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKE-VNALECEIQLLKNLQHER 65
Query: 583 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
++ + G LS+ EYM GS+ + G L+ K R I G+ +H
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHS 122
Query: 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSR---IITDSPMRDSSSAGTPEWMAPELIRNE 699
IVHRD+K AN L + VK+ DFG S+ I S S GTP WM+PE+I E
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 700 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG--PLGR-LIAD 756
+ K D++S+G + E+ T PW ++ +A + + ++P P R +
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242
Query: 757 CWAEP-QERPSCEEIL 771
+ E ++RPS EE+L
Sbjct: 243 TFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 27/264 (10%)
Query: 535 GFFGEVFRGIWNGT------DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588
G FG +F GI +V +K ++ + + E +L L H N++ L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKT-VKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 589 ACTKPPRLSMITE-YMELGSLYHLI----HLSGQKKK-LSWRRKLKMLRDICRGLMCIHR 642
C + + YM G+L + + LS ++ + M I G+ +H+
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE-----WMAPELIR 697
++H+D+ + NC++++ VKI D LSR + PM D G E WMA E +
Sbjct: 136 RGVIHKDIAARNCVIDEELQVKITDNALSRDLF--PM-DYHCLGDNENRPVKWMALESLV 192
Query: 698 NEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIP---EGPLGRL 753
N+ ++ D++S GV++WEL TL + P+ + P + A +G RL P L +
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDGYRLAQPINCPDELFAV 251
Query: 754 IADCWA-EPQERPSCEEILSRLLD 776
+A CWA +P+ERPS +++ L D
Sbjct: 252 MACCWALDPEERPSFSQLVQCLTD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 83/270 (30%), Positives = 127/270 (47%), Gaps = 29/270 (10%)
Query: 532 VGIGFFGEVFRG-------IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+G G FG+VF + VA+K ++ + +DF E +L+ L+H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTVLQHQHIV 70
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK------------LSWRRKLKMLRD 632
F G CT+ L M+ EYM G L + G K L+ + L +
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSSSAGTPEW 690
I G++ + + VHRDL + NCLV + VKI DFG+SR I TD + W
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190
Query: 691 MAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE-- 747
M PE I FT + DI+S GV++WE+ T + PW + + + +G LE P
Sbjct: 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-TQGRELERPRTC 249
Query: 748 -GPLGRLIADCWA-EPQERPSCEEILSRLL 775
+ ++ CW EPQ+R ++I SRL
Sbjct: 250 PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDL-----TAENMEDFCNEISILSRLRHPN 582
++G G +G V++ T VA+K L+ + TA EIS+L L+HPN
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA------LREISLLKELKHPN 59
Query: 583 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
++ L +L ++ EY ++ L + + LS ++ + RGL H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDK--RPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APELIR 697
+I+HRDLK N L+N+ +K+ DFGL+R P+R T E W APE++
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFG-IPLRTY----THEVVTLWYRAPEILL 171
Query: 698 NEPF-TEKCDIFSLGVIMWELCTLNRP 723
+ DI+S+G I E+ T +P
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMIT-GKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 2e-29
Identities = 83/262 (31%), Positives = 133/262 (50%), Gaps = 22/262 (8%)
Query: 524 SELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSR 577
+EL +G G FG V++GIW VAIK+ E N+E F +E I++
Sbjct: 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMAS 65
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
+ HP+++ LG C P + ++T+ M G L +H K + + L I +G+
Sbjct: 66 MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVH--EHKDNIGSQLLLNWCVQIAKGM 122
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTP-EWMAPEL 695
M + ++VHRDL + N LV VKI DFGL+R++ D ++ P +WMA E
Sbjct: 123 MYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEGPLGRL- 753
I FT + D++S GV +WEL T +P++G+ P R + + +G RL P+ P+ +
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERL--PQPPICTID 239
Query: 754 ----IADCWA-EPQERPSCEEI 770
+ CW + RP +E+
Sbjct: 240 VYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 71/250 (28%), Positives = 130/250 (52%), Gaps = 10/250 (4%)
Query: 531 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588
++G G FG+ + +G IK ++ + E+ E+++LS ++HPN++ +
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKL-SWRRKLKMLRDICRGLMCIHRMKIVH 647
+ + L ++ +Y E G LY I + Q+ L + L IC L +H KI+H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124
Query: 648 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 707
RD+KS N + K T+K+ DFG++R++ + + GTP +++PE+ N P+ K DI
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDI 184
Query: 708 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWAE-PQE 763
++LG +++E+CTL +E + +V + GS + L L++ + P++
Sbjct: 185 WALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLFKRNPRD 243
Query: 764 RPSCEEILSR 773
RPS IL +
Sbjct: 244 RPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 74/255 (29%), Positives = 126/255 (49%), Gaps = 14/255 (5%)
Query: 523 FSELTVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLR 579
+ + ++G G F EV+R + +G VA+K DL A+ D EI +L +L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLM 638
HPNVI + + + L+++ E + G L +I H QK+ + + K +C L
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 698
+H +++HRD+K AN + VK+ D GL R + S GTP +M+PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 699 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-------LG 751
+ K DI+SLG +++E+ L P+ G + +Y++ + + + P P L
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238
Query: 752 RLIADCW-AEPQERP 765
+L+ C +P++RP
Sbjct: 239 QLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 84/286 (29%), Positives = 146/286 (51%), Gaps = 32/286 (11%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---------VAIKVFLEQDLTAENMEDFC 569
W + L +G +G G FG+V G D VA+K+ L+ D T +++ D
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKM-LKSDATEKDLSDLI 71
Query: 570 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHL-------------S 615
+E+ ++ + +H N+I LGACT+ L +I EY G+L +
Sbjct: 72 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 616 GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII- 674
+++LS++ + + RG+ + K +HRDL + N LV + +KI DFGL+R I
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191
Query: 675 -TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERV 732
D + ++ +WMAPE + + +T + D++S GV++WE+ TL P+ GV P
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 250
Query: 733 VYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 774
++ + EG R++ P L ++ DCW A P +RP+ ++++ L
Sbjct: 251 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 84/291 (28%), Positives = 146/291 (50%), Gaps = 35/291 (12%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---------VAIKVFLEQDLTAENMEDF 568
+W L +G +G G FG+V R G D VA+K+ L+ + T +++ D
Sbjct: 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM-LKDNATDKDLADL 64
Query: 569 CNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHL------------- 614
+E+ ++ + +H N+I LG CT+ L +I EY G+L +
Sbjct: 65 ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124
Query: 615 SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674
+++LS++ + + RG+ + + +HRDL + N LV + +KI DFGL+R +
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 675 TDSPMRDSSSAG--TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPER 731
D +S G +WMAPE + + +T + D++S G++MWE+ TL P+ G+ P
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVE 243
Query: 732 VVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPS---CEEILSRLL 775
++ + EG R++ P L L+ +CW A P +RP+ E L ++L
Sbjct: 244 ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-28
Identities = 83/292 (28%), Positives = 151/292 (51%), Gaps = 32/292 (10%)
Query: 513 LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---------VAIKVFLEQDLTAE 563
L A +W + + LT+G +G G FG+V G D VA+K+ L+ D T +
Sbjct: 1 LPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM-LKDDATDK 59
Query: 564 NMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------Y 609
++ D +E+ ++ + +H N+I LGACT+ L ++ EY G+L Y
Sbjct: 60 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDY 119
Query: 610 HLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 669
+++L+++ + + RG+ + K +HRDL + N LV + +KI DFG
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFG 179
Query: 670 LSRIITDSPMRDSSSAG--TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEG 726
L+R + + ++ G +WMAPE + + +T + D++S GV++WE+ TL P+ G
Sbjct: 180 LARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
Query: 727 VLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 774
+ P ++ + EG R++ P L ++ +CW A P +RP+ ++++ L
Sbjct: 240 I-PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 75/247 (30%), Positives = 126/247 (51%), Gaps = 17/247 (6%)
Query: 531 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588
R+G G FGEVF G + T VA+K E L + F E IL + HPN++ +G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
CT+ + ++ E ++ G L L + +L + ++M+ + G+ + +HR
Sbjct: 61 VCTQKQPIYIVMELVQGGDF--LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHR 118
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WMAPELIRNEPFTEK 704
DL + NCLV + +KI DFG+SR D +S+ G + W APE + ++ +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVY--ASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 705 CDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA- 759
D++S G+++WE +L P+ + ++ A+ +G RL PE + RL+ CW
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-EQGVRLPCPELCPDAVYRLMERCWEY 235
Query: 760 EPQERPS 766
+P +RPS
Sbjct: 236 DPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 5e-28
Identities = 75/250 (30%), Positives = 130/250 (52%), Gaps = 11/250 (4%)
Query: 532 VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 590
+G G FGEVF+G + + T VA+K ++DL E F +E IL + HPN++ +G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 591 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 650
T+ + ++ E + G L L +K +L ++ +K D G+ + +HRDL
Sbjct: 62 TQRQPIYIVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119
Query: 651 KSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFS 709
+ NCLV ++ +KI DFG+SR D S P +W APE + ++ + D++S
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWS 179
Query: 710 LGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQER 764
G+++WE +L P+ G+ ++ V +G R+ P+ + +++ CW +P+ R
Sbjct: 180 YGILLWETFSLGVCPYPGMTNQQAREQV-EKGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238
Query: 765 PSCEEILSRL 774
P E+ L
Sbjct: 239 PKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-28
Identities = 71/255 (27%), Positives = 129/255 (50%), Gaps = 14/255 (5%)
Query: 523 FSELTVGTRVGIGFFGEVFRG--IWNGTDVAIK-VFLEQDLTAENMEDFCNEISILSRLR 579
+ + ++G G F EV+R + + VA+K V + + + A+ +D EI +L +L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLM 638
HPNVI +L + + L+++ E + G L +I + QK+ + R K +C +
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 698
+H +++HRD+K AN + VK+ D GL R + S GTP +M+PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 699 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-------LG 751
+ K DI+SLG +++E+ L P+ G + ++++ + + + P P L
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238
Query: 752 RLIADC-WAEPQERP 765
L++ C + +P +RP
Sbjct: 239 ELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 10/202 (4%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIKVFL--EQDLTAENMEDFCNEISILSRLRHPNVILF 586
++G G +G V++ T VAIK + EI +L L HPN+I
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA--LREIKLLKELNHPNIIKL 63
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
L L ++ E+M+ LY LI +++ L L + +GL H I+
Sbjct: 64 LDVFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPF-TEKC 705
HRDLK N L+N +K+ DFGL+R + T + APEL+ + +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 706 DIFSLGVIMWELCTLNRPWEGV 727
DI+S+G I EL + + G
Sbjct: 181 DIWSVGCIFAELLSRRPLFPGK 202
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 77/247 (31%), Positives = 123/247 (49%), Gaps = 8/247 (3%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589
VG G FG V R + V IK + +T + NE +L L HPN+I +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 590 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 649
+ L ++ EY G+L I L L I L +H I+HRD
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKLILHRD 126
Query: 650 LKSANCLVNKHWTV-KICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 708
LK+ N L++KH V KI DFG+S+I++ S + + GTP +++PEL +P+ +K DI+
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVVGTPCYISPELCEGKPYNQKSDIW 185
Query: 709 SLGVIMWELCTLNRPWEGV-LPERVVYAVANEGSRLEIPEGP-LGRLIADCWA-EPQERP 765
+LG +++EL +L R +E LP V+ ++ + + P L +LI +P +RP
Sbjct: 186 ALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRP 245
Query: 766 SCEEILS 772
+I++
Sbjct: 246 QLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 71/218 (32%), Positives = 117/218 (53%), Gaps = 8/218 (3%)
Query: 561 TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK 620
++ +ED E +L++++HPN++ F + L ++ EY + G L I L Q+ K
Sbjct: 38 SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKL--QRGK 95
Query: 621 LSWRRK-LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679
L L+ +C G+ IH +++HRD+KS N + ++ VK+ DFG +R++T
Sbjct: 96 LFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155
Query: 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 739
+ GTP ++ PE+ N P+ K DI+SLG I++ELCTL P++ + ++ V +
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-Q 214
Query: 740 GSRLEIPEG---PLGRLIADCWAE-PQERPSCEEILSR 773
GS +P L LI + P+ RPS ILSR
Sbjct: 215 GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 86/278 (30%), Positives = 134/278 (48%), Gaps = 30/278 (10%)
Query: 520 NIDFSELTVGTRVGIGFFGEVFRG-IWNGTD------VAIKVFLEQDLTAENMEDFCNEI 572
+I ++ + +G G FG+VF +N + VA+K + L A +DF E
Sbjct: 1 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREA 58
Query: 573 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYH---------LIHLSGQ----KK 619
+L+ L+H +++ F G C L M+ EYM+ G L +I + GQ K
Sbjct: 59 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 620 KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 678
+L + L + I G++ + VHRDL + NCLV + VKI DFG+SR + +
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 679 MRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAV 736
R P WM PE I FT + D++S GVI+WE+ T + PW + V+ +
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238
Query: 737 ANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEI 770
+G LE P + ++ CW EPQ+R + +EI
Sbjct: 239 -TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 44/236 (18%)
Query: 522 DFSELTVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDF-CNEISILSRL 578
DF G +G G F V + AIK+ ++ L E + E +L+RL
Sbjct: 2 DFK---FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRL 58
Query: 579 -RHPNVI-LFLGACT--KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
HP +I L+ T L + EY G L I G L K R
Sbjct: 59 NGHPGIIKLY---YTFQDEENLYFVLEYAPNGELLQYIRKYG---SLD----EKCTRFYA 108
Query: 635 RGLMC----IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM----------- 679
++ +H I+HRDLK N L++K +KI DFG ++++ +
Sbjct: 109 AEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 680 ---------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
R +S GT E+++PEL+ +P + D+++LG I++++ T P+ G
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 21/264 (7%)
Query: 525 ELTVGTRVGIGFFGEVFRGIWN-GTDVAIK-VFLE---QDLTAENMEDFCNEISILSRLR 579
E T G +G G +G V+ G+ N G +A+K V L+ + E E+ +L L+
Sbjct: 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
H N++ +LG C +S+ E++ GS+ +++ G + + K + I G+
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC---KYTKQILDGVAY 117
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-------TDSPMRDSSSAGTPEWMA 692
+H +VHRD+K N ++ + +K+ DFG +R + T S M S GTP WMA
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYWMA 176
Query: 693 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPE---G 748
PE+I + K DI+S+G ++E+ T P + ++ + + +P+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236
Query: 749 PLGRLIADCWAEPQ-ERPSCEEIL 771
+ C Q ERPS ++L
Sbjct: 237 AAIDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 72/254 (28%), Positives = 118/254 (46%), Gaps = 32/254 (12%)
Query: 547 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM--ITEYME 604
G VA+K Q TAE++ DF EI IL L+H N++ + G C R ++ + EY+
Sbjct: 33 GEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 605 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 664
GSL +L +++L R+ L IC+G+ + + VHRDL + N LV VK
Sbjct: 91 YGSLRD--YLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVK 148
Query: 665 ICDFGLSRIITDSPMRDSSSAGTPE-----WMAPELIRNEPFTEKCDIFSLGVIMWEL-- 717
I DFGL++++ ++ P W APE + F+ D++S GV+++EL
Sbjct: 149 IGDFGLTKVLPQD--KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
Query: 718 -CTLNRPWEGVLPER---------VVYAVAN---EGSRLEIPEG---PLGRLIADCWA-E 760
+ +VY + RL P G + ++ +CW +
Sbjct: 207 YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNND 266
Query: 761 PQERPSCEEILSRL 774
P +RPS E+ ++
Sbjct: 267 PSQRPSFSELALQV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 78/270 (28%), Positives = 126/270 (46%), Gaps = 31/270 (11%)
Query: 532 VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMED--FCNEISILSRLRHPNVILFLG 588
+G G+FG+V G G A V E +A E F E+ L HPNV+ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 589 ACTKPPRLSMITEYMELGSLYHLI-----HLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
C + ++ E+ LG L + + ++ +K +M ++ GL+ +H+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK---DVLQRMACEVASGLLWLHQA 119
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGL--SRIITDSPMRDSSSAGTPEWMAPEL------ 695
+H DL NC + +VKI D+GL + D + A W+APEL
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 696 -IRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEGPLGRL 753
+ + T+K +I+SLGV MWEL T ++P+ + E+V+ V E +++P+ L
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-QDIKLPKPQLDLK 238
Query: 754 IAD--------CWAEPQERPSCEEILSRLL 775
+D CW +P+ RP+ EE+ LL
Sbjct: 239 YSDRWYEVMQFCWLDPETRPTAEEV-HELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 85/279 (30%), Positives = 140/279 (50%), Gaps = 23/279 (8%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 571
W + ++T+ +G G FG V+ G T VA+K E E +E F NE
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNE 59
Query: 572 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKK------LSWR 624
S++ +V+ LG +K ++ E M G L +L L + + + +
Sbjct: 60 ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 625 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDS 682
++M +I G+ ++ K VHRDL + NC+V +TVKI DFG++R I TD +
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGS 741
WMAPE +++ FT D++S GV++WE+ +L +P++G+ E+V+ V + G
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239
Query: 742 RLEIPEGPLGR---LIADCWA-EPQERPSCEEILSRLLD 776
L+ P+ R L+ CW P+ RP+ EI++ L D
Sbjct: 240 -LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 78/270 (28%), Positives = 136/270 (50%), Gaps = 22/270 (8%)
Query: 526 LTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEISILSRLRH 580
T+G +G G FG V D VA+K+ ++ ++E+F E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 581 PNVILFLG------ACTKPPRLSMITEYMELGSLYHLIHLS--GQKK-KLSWRRKLKMLR 631
PNVI +G A + P +I +M+ G L+ + +S G++ L + ++ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 632 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-E 689
DI G+ + +HRDL + NC++N++ TV + DFGLS+ I + R ++ P +
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG 748
W+A E + + +T D+++ GV MWE+ T + P+ GV +Y +G+RL+ P
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV-ENSEIYNYLIKGNRLKQPPD 239
Query: 749 PLG---RLIADCW-AEPQERPSCEEILSRL 774
L L+ CW EP+ RPS + + +L
Sbjct: 240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 80/264 (30%), Positives = 131/264 (49%), Gaps = 18/264 (6%)
Query: 524 SELTVGTRVGIGFFGEVFRGIW--NGTD----VAIKVFLEQDLTAENMEDFCNEISILSR 577
+EL +G G FG V++GIW +G + VAIKV E N E +E +++
Sbjct: 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE-ILDEAYVMAG 65
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
+ P V LG C + ++T+ M G L L ++ K ++ + L I +G+
Sbjct: 66 VGSPYVCRLLGICLTST-VQLVTQLMPYGCL--LDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EWMAPEL 695
+ +++VHRDL + N LV VKI DFGL+R++ D + P +WMA E
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIP---EGPLG 751
I + FT + D++S GV +WEL T +P++G+ P R + + +G RL P +
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVY 241
Query: 752 RLIADCWA-EPQERPSCEEILSRL 774
++ CW + + RP E++
Sbjct: 242 MIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 65/211 (30%), Positives = 112/211 (53%), Gaps = 18/211 (8%)
Query: 529 GTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAEN-------MEDFCNEISILSRLR 579
G +G G FG V+ G+ +G +A+K ++A + ++ EI++L L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
H N++ +LG+ L++ EY+ GS+ L++ G ++ R +R I +GL
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR---NFVRQILKGLNY 121
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR------IITDSPMRDSSSAGTPEWMAP 693
+H I+HRD+K AN LV+ +KI DFG+S+ + T + S G+ WMAP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 694 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 724
E+++ +T K DI+SLG ++ E+ T P+
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 19/197 (9%)
Query: 531 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588
VG G +G V R G VAIK F E + + + E+ +L +LRH N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 589 ACTKPPRLSMITEYMELGSLYHLIH-----LSGQK-KKLSWRRKLKMLRDICRGLMCIHR 642
A + RL ++ EY+E +L L+ L + W+ + + + H
Sbjct: 68 AFRRKGRLYLVFEYVE-RTLLELLEASPGGLPPDAVRSYIWQ--------LLQAIAYCHS 118
Query: 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APE-LIRNEP 700
I+HRD+K N LV++ +K+CDFG +R + P + W APE L+ +
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 701 FTEKCDIFSLGVIMWEL 717
+ + D++++G IM EL
Sbjct: 179 YGKPVDVWAIGCIMAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 78/253 (30%), Positives = 122/253 (48%), Gaps = 21/253 (8%)
Query: 533 GIGFFGEVF--RGIWNGTDVAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589
G G G V G +A+K + LE + + E+ IL + P ++ F GA
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ--ILRELDILHKCNSPYIVGFYGA 67
Query: 590 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHR 648
+S+ EYM+ GSL + L + ++ R K+ + +GL +H KI+HR
Sbjct: 68 FYNNGDISICMEYMDGGSLDKI--LKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR 125
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 708
D+K +N LVN +K+CDFG+S + +S + GT +MAPE I+ ++ K DI+
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT--FVGTSSYMAPERIQGNDYSVKSDIW 183
Query: 709 SLGVIMWELCTL-------NRPWEGVLPERVVYAVANEGSRL--EIPEGPLGRLIADCW- 758
SLG+ + EL T N P +G+ E + Y V RL + C
Sbjct: 184 SLGLSLIELATGRFPYPPENDPPDGIF-ELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLI 242
Query: 759 AEPQERPSCEEIL 771
+P+ERPS +E+L
Sbjct: 243 KDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-26
Identities = 81/280 (28%), Positives = 136/280 (48%), Gaps = 29/280 (10%)
Query: 523 FSELTVGTRVGIGFFGEVFRGI----WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 578
+ ++ +G G FG+V R + + AIK+ L++ + + DF E+ +L +L
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKM-LKEFASENDHRDFAGELEVLCKL 59
Query: 579 -RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLS-------------GQKKKLSWR 624
HPN+I LGAC L + EY G+L + S G L+ +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 625 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 684
+ L+ D+ G+ + + +HRDL + N LV ++ KI DFGLSR + ++ +
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-GEEVYVKKTMG 178
Query: 685 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRL 743
WMA E + +T K D++S GV++WE+ +L P+ G+ +Y +G R+
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRM 237
Query: 744 EIP---EGPLGRLIADCWAE-PQERPSCEEI---LSRLLD 776
E P + + L+ CW + P ERP +I LSR+L+
Sbjct: 238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 58/196 (29%), Positives = 94/196 (47%), Gaps = 14/196 (7%)
Query: 535 GFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEISILSRLRHPNVILFLGACT 591
G +G VF + G AIKV + D+ +N D E ILS+ + P V+ +
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 592 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLK 651
L ++ EY+ G L L+ G + R + +I L +H I+HRDLK
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR---IYIAEIVLALEYLHSNGIIHRDLK 120
Query: 652 SANCLVNKHWTVKICDFGLSRI--------ITDSPMRDSSSAGTPEWMAPELIRNEPFTE 703
N L++ + +K+ DFGLS++ + D D GTP+++APE+I + ++
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180
Query: 704 KCDIFSLGVIMWELCT 719
D +SLG I++E
Sbjct: 181 TVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 74/255 (29%), Positives = 126/255 (49%), Gaps = 22/255 (8%)
Query: 532 VGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 585
+G G FG V++G+W VAIK E N E +E +++ + +P+V
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMASVDNPHVCR 73
Query: 586 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
LG C + +IT+ M G L L ++ K + + L I +G+ + ++
Sbjct: 74 LLGICLTST-VQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTP-EWMAPELIRNEPFTE 703
VHRDL + N LV VKI DFGL++++ D + P +WMA E I + +T
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 704 KCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEGPLGR-----LIADC 757
+ D++S GV +WEL T ++P++G+ P + ++ +G RL P+ P+ ++ C
Sbjct: 191 QSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERL--PQPPICTIDVYMIMVKC 247
Query: 758 WA-EPQERPSCEEIL 771
W + RP E++
Sbjct: 248 WMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 9e-26
Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 27/270 (10%)
Query: 532 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL-RHPNVILFL 587
+G G FG+V + +G + + ++ +++ DF E+ +L +L HPN+I L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 588 GACTKPPRLSMITEYMELGSLYHLIHLS-------------GQKKKLSWRRKLKMLRDIC 634
GAC L + EY G+L + S LS ++ L D+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694
RG+ + + + +HRDL + N LV +++ KI DFGLSR + ++ + WMA E
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRWMAIE 181
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP---EGPL 750
+ +T D++S GV++WE+ +L P+ G+ +Y +G RLE P + +
Sbjct: 182 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEV 240
Query: 751 GRLIADCWAE-PQERPSCEEI---LSRLLD 776
L+ CW E P ERPS +I L+R+L+
Sbjct: 241 YDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 76/266 (28%), Positives = 122/266 (45%), Gaps = 25/266 (9%)
Query: 529 GTRVGIGFFGEVFRG--IWNGTDVAIK-VFLEQ-------DLTAENMEDFCNEISILSRL 578
G +G G +G V+ + G +A+K V L + ++ +EI L L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
H N++ +LG T LS+ EY+ GS+ + G+ ++ R + GL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR---FFTEQVLEGLA 122
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD--SPMRDSSSAGTPEWMAPELI 696
+H I+HRDLK+ N LV+ KI DFG+S+ D ++ S G+ WMAPE+I
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 697 RN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE------G 748
+ + ++ K DI+SLG ++ E+ RPW ++ + N+ S IP
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242
Query: 749 PLGR--LIADCWAEPQERPSCEEILS 772
P+ L A P RP+ E+L
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 69/231 (29%), Positives = 96/231 (41%), Gaps = 75/231 (32%)
Query: 532 VGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCN----EISILSRLRHP 581
+G G +G V + G VAIK VF DL EI +L LRH
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLI------DAKRILREIKLLRHLRHE 59
Query: 582 NVI----LFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 631
N+I + +PP ++TE ME L+ +I S Q L
Sbjct: 60 NIIGLLDIL-----RPPSPEDFNDVYIVTELMET-DLHKVIK-SPQP-----------LT 101
Query: 632 D---------ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682
D I RGL +H ++HRDLK +N LVN + +KICDFGL+R +
Sbjct: 102 DDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE---- 157
Query: 683 SSAGTPEWM----------APELIRNEP-FTEKCDIFSLGVIMWELCTLNR 722
++ APEL+ + +T+ DI+S+G I EL L R
Sbjct: 158 ---DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL--LTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 68/212 (32%), Positives = 111/212 (52%), Gaps = 16/212 (7%)
Query: 531 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC---NEISILSRLRHPNVIL 585
R+G G +G+V+ R + G AIKV + E EDF EI ++ +H N++
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKV-----IKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 586 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
+ G+ + +L + E+ GSL + H++G LS + + R+ +GL +H
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI---RNEPFT 702
+HRD+K AN L+ + VK+ DFG+S IT + + S GTP WMAPE+ R +
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 703 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 734
+ CDI+++G+ EL L P + P R ++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALF 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 81/277 (29%), Positives = 135/277 (48%), Gaps = 26/277 (9%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDFCNEISILS 576
++++++ +G G FG+V + D AIK +++ + ++ DF E+ +L
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVLC 62
Query: 577 RL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLS-------------GQKKKLS 622
+L HPN+I LGAC L + EY G+L + S LS
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 623 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682
++ L D+ RG+ + + + +HRDL + N LV +++ KI DFGLSR + ++ +
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKT 181
Query: 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGS 741
WMA E + +T D++S GV++WE+ +L P+ G+ +Y +G
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGY 240
Query: 742 RLEIP---EGPLGRLIADCWAE-PQERPSCEEILSRL 774
RLE P + + L+ CW E P ERPS +IL L
Sbjct: 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 80/265 (30%), Positives = 128/265 (48%), Gaps = 23/265 (8%)
Query: 532 VGIGFFGEVFRG-IWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 586
+G G FG+VF +N + + V +D + +DF E +L+ L+H +++ F
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQK----------KKLSWRRKLKMLRDICRG 636
G C + L M+ EYM+ G L + G +L+ + L + + I G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSSSAGTPEWMAPE 694
++ + VHRDL + NCLV ++ VKI DFG+SR + TD + WM PE
Sbjct: 133 MVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 192
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PL 750
I FT + D++SLGV++WE+ T + PW + V+ + +G L+ P +
Sbjct: 193 SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI-TQGRVLQRPRTCPKEV 251
Query: 751 GRLIADCWA-EPQERPSCEEILSRL 774
L+ CW EP R + +EI S L
Sbjct: 252 YDLMLGCWQREPHMRLNIKEIHSLL 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 7/195 (3%)
Query: 527 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+ R+G G G VF + G VA+K + L EI L +HP V+
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
L ++ EYM L ++ ++ L + +R + +G+ +H
Sbjct: 63 KLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-GTPEWMAPELIRNEP-FT 702
I+HRDLK AN L++ +KI DFGL+R+ ++ R S T + APEL+ +
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 703 EKCDIFSLGVIMWEL 717
D++++G I EL
Sbjct: 180 PGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 531 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC---NEISILSRLRHPNVIL 585
RVG G +G+V+ R + G A+K+ + E +DF EI ++ +H N++
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKI-----IKLEPGDDFSLIQQEIFMVKECKHCNIVA 70
Query: 586 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
+ G+ +L + EY GSL + H++G LS + + R+ +GL +H
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI---RNEPFT 702
+HRD+K AN L+ + VK+ DFG++ IT + + S GTP WMAPE+ +N +
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 703 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA 737
+ CDI+++G+ EL L P + P R ++ ++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 75/250 (30%), Positives = 128/250 (51%), Gaps = 11/250 (4%)
Query: 532 VGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589
VG G +GEV R +G IK ++ + + E +LS+L+HPN++ + +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 590 CT-KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK-LKMLRDICRGLMCIHRMKIVH 647
+ L ++ + E G LYH L QK KL + ++ I L +H I+H
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYH--KLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILH 125
Query: 648 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 707
RDLK+ N + + +K+ D G++R++ + S+ GTP +M+PEL N+P+ K D+
Sbjct: 126 RDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDV 185
Query: 708 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQE 763
++LG ++E+ TL + +VY + EG +P+ LG LIA + P++
Sbjct: 186 WALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATMLSKRPEK 244
Query: 764 RPSCEEILSR 773
RPS + IL +
Sbjct: 245 RPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 80/268 (29%), Positives = 133/268 (49%), Gaps = 42/268 (15%)
Query: 532 VGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 588
VG G +G+V++G + G AIKV D+T + E+ EI++L + H N+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 589 ACTK--PP----RLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIH 641
A K PP +L ++ E+ GS+ LI + G K W + R+I RGL +H
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI--CREILRGLSHLH 128
Query: 642 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR---- 697
+ K++HRD+K N L+ ++ VK+ DFG+S + + R ++ GTP WMAPE+I
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 188
Query: 698 -NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIAD 756
+ + K D++SLG+ E+ P + P R ++ IP P RL +
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---------IPRNPAPRLKSK 239
Query: 757 CWAEP-------------QERPSCEEIL 771
W++ +RP+ E+++
Sbjct: 240 KWSKKFQSFIESCLVKNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 67/217 (30%), Positives = 110/217 (50%), Gaps = 19/217 (8%)
Query: 532 VGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 591
+G G FG+V++ T + + + E +ED+ EI IL+ HP ++ LGA
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 592 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK--MLRDICR----GLMCIHRMKI 645
+L ++ E+ G++ ++ L R L ++ ICR L +H MKI
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIM--------LELDRGLTEPQIQVICRQMLEALQYLHSMKI 131
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI-----RNEP 700
+HRDLK+ N L+ +K+ DFG+S + R S GTP WMAPE++ ++ P
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 701 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA 737
+ K DI+SLG+ + E+ + P + P RV+ +A
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 228
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 74/248 (29%), Positives = 128/248 (51%), Gaps = 13/248 (5%)
Query: 531 RVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588
++G G G VF + G +VAIK Q + + NEI ++ L++PN++ FL
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFLD 83
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
+ L ++ EY+ GSL ++ + + + + R+ + L +H +++HR
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHANQVIHR 139
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 708
D+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K DI+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 709 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE--GPLGR-LIADCWA-EPQE 763
SLG++ E+ P+ P R +Y +A G+ L+ PE P+ R + C + ++
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEK 259
Query: 764 RPSCEEIL 771
R S +E+L
Sbjct: 260 RGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 79/262 (30%), Positives = 137/262 (52%), Gaps = 21/262 (8%)
Query: 532 VGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 587
+G G FG V +G++ DVAIKV L+ + ++ E I+ +L +P ++ +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKV-LKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 647
G C + L ++ E G L LSG+K +++ ++++ + G+ + VH
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKF--LSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 648 RDLKSANCL-VNKHWTVKICDFGLSRII--TDSPMRDSSSAGTP-EWMAPELIRNEPFTE 703
RDL + N L VN+H+ KI DFGLS+ + DS + S+ P +W APE I F+
Sbjct: 119 RDLAARNVLLVNQHYA-KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 704 KCDIFSLGVIMWELCTL-NRPWEGVL-PERVVYAVANEGSRLEIP-EGP--LGRLIADCW 758
+ D++S G+ MWE + +P++ + PE V + +G RL+ P E P + L+ DCW
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKRLDCPAECPPEMYALMKDCW 235
Query: 759 A-EPQERPSCEEILSRLLDCEY 779
+ ++RP+ ++ R+ Y
Sbjct: 236 IYKWEDRPNFAKVEERMRTYYY 257
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 6e-24
Identities = 77/257 (29%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 529 GTRVGIGFFGEVF--RGIWNGTDVAIK-VFLEQDL--TAENMEDFCNEISILSRLRHPNV 583
G +G G FGEV+ G ++A+K V + D T++ + EI +L LRH +
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 584 ILFLGACTKPP---RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
+ + G C + P +LS+ EYM GS+ + G L+ + R I +G+ +
Sbjct: 67 VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYL 122
Query: 641 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS---SSAGTPEWMAPELIR 697
H IVHRD+K AN L + VK+ DFG S+ I M + S GTP WM+PE+I
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 698 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 754
E + K D++S+ + E+ T PW ++ +A + ++ +P+G +
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFL 242
Query: 755 ADCWAEPQERPSCEEIL 771
+ E + RP+ E +L
Sbjct: 243 KQIFVEEKRRPTAEFLL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 524 SELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEISILSRLRH 580
+ +G G FG V R +G A+K+ + + + NE IL +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 581 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR----DICRG 636
P ++ G+ L ++ EY+ G L+ + SG R + R +
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQVVLA 113
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
L +H + IV+RDLK N L++ +KI DFG ++ + R + GTPE++APE+I
Sbjct: 114 LEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RTYTLCGTPEYLAPEII 170
Query: 697 RNEPFTEKCDIFSLGVIMWEL 717
++ + + D ++LG++++E+
Sbjct: 171 LSKGYGKAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 60/225 (26%), Positives = 114/225 (50%), Gaps = 16/225 (7%)
Query: 563 ENMEDFCNEISIL-SRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKK 620
+++ D +E++I+ +LRHPN++ + + RL ++ + +E L H L +K++
Sbjct: 50 KSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR 109
Query: 621 LSWRRKLKMLRDICRGLMCIHRMK-IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 678
+ R + + L +H+ K IVHRDL N ++ + V I DFGL++ P
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPE 167
Query: 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV----LPERVVY 734
+ +S GT + PE+++NEP+ EK D+++ G I++++CTL P+ L ++V
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227
Query: 735 AV---ANEGSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLD 776
AV EG E + + + + RP ++ + + D
Sbjct: 228 AVYEPLPEGMYSEDVTDVITSCLT---PDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 29/203 (14%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMED-----FCNEISILSRLRHPNV 583
++G G +G+V++ T VA+K EN ++ EI +L +LRHPN+
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRM-----ENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 584 ILFLGACTKPPR--LSMITEYME--LGSLYH--LIHLS-GQKKKLSWRRKLKMLRDICRG 636
+ T + + M+ EYM+ L L + + Q K ++ + G
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCY--------MKQLLEG 112
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APEL 695
L +H I+HRD+K +N L+N +K+ DFGL+R T D ++ W PEL
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 696 IRNEP-FTEKCDIFSLGVIMWEL 717
+ + + D++S+G I+ EL
Sbjct: 173 LLGATRYGPEVDMWSVGCILAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 4e-23
Identities = 77/270 (28%), Positives = 119/270 (44%), Gaps = 25/270 (9%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEISIL 575
+D + + +G G FGE+ RG VAI L + + F E L
Sbjct: 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHT-LRAGCSDKQRRGFLAEALTL 60
Query: 576 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
+ H N++ G T+ + ++TEYM G+L L + +L + + ML +
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSF--LRKHEGQLVAGQLMGMLPGLAS 118
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD------SPMRDSSSAGTPE 689
G+ + M VH+ L + LVN KI F R+ D + M S
Sbjct: 119 GMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPV---L 173
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP-- 746
W APE I+ F+ D++S G++MWE+ + RP+ + + V+ AV +G RL P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRN 232
Query: 747 -EGPLGRLIADCW-AEPQERPSCEEILSRL 774
L +L+ DCW E ERP +I S L
Sbjct: 233 CPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 80/268 (29%), Positives = 131/268 (48%), Gaps = 42/268 (15%)
Query: 532 VGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 588
VG G +G+V++G + G AIKV D+T + E+ EI++L + H N+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 589 ACTK--PP----RLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIH 641
A K PP +L ++ E+ GS+ L+ + G K W + R+I RGL +H
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI--CREILRGLAHLH 138
Query: 642 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR---- 697
K++HRD+K N L+ ++ VK+ DFG+S + + R ++ GTP WMAPE+I
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 198
Query: 698 -NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIAD 756
+ + + DI+SLG+ E+ P + P R ++ IP P +L +
Sbjct: 199 PDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL---------IPRNPPPKLKSK 249
Query: 757 CWAEP-------------QERPSCEEIL 771
W++ RPS E++L
Sbjct: 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 532 VGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 591
+G G FG+V++ T V + + E +ED+ EI IL+ HPN++ L A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 592 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK--MLRDICR----GLMCIHRMKI 645
L ++ E+ G++ ++ L R L +R +C+ L +H KI
Sbjct: 73 YENNLWILIEFCAGGAVDAVM--------LELERPLTEPQIRVVCKQTLEALNYLHENKI 124
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI-----RNEP 700
+HRDLK+ N L +K+ DFG+S T + R S GTP WMAPE++ ++ P
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 701 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA 737
+ K D++SLG+ + E+ + P + P RV+ +A
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA 221
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 7e-23
Identities = 77/258 (29%), Positives = 121/258 (46%), Gaps = 18/258 (6%)
Query: 529 GTRVGIGFFGEVF--RGIWNGTDVAIKVFL---EQDLTAENMEDFCNEISILSRLRHPNV 583
G +G G FG V+ + G ++A K E T++ + EI +L L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 584 ILFLGACTK---PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
+ + G C + L++ EYM GS+ + G + R K R I G+ +
Sbjct: 67 VQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR---KYTRQILEGMSYL 122
Query: 641 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS---SSAGTPEWMAPELIR 697
H IVHRD+K AN L + VK+ DFG S+ + M + S GTP WM+PE+I
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 698 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE--GPLGRLIA 755
E + K D++SLG + E+ T PW ++ +A + + ++P R
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL 242
Query: 756 DC-WAEPQERPSCEEILS 772
C + E + RPS EE+L
Sbjct: 243 GCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 532 VGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFC--NEISILSRLRHPNVILF 586
+G G + V++ T VAIK + L + A++ +F EI +L L+HPN+I
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIH-----LSGQKKKLSWRRKLKMLRDICRGLMCIH 641
L ++++ E+ME L +I L+ K S+ + M RGL +H
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIK-SY---MLMT---LRGLEYLH 119
Query: 642 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EP 700
I+HRDLK N L+ +K+ DFGL+R + + T + APEL+
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARH 179
Query: 701 FTEKCDIFSLGVIMWELCTLNRP 723
+ D++S+G I EL L P
Sbjct: 180 YGVGVDMWSVGCIFAELL-LRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 70/248 (28%), Positives = 111/248 (44%), Gaps = 28/248 (11%)
Query: 546 NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP--RLSMITEYM 603
G A+K D + + E+ I + P ++ + GA + + EY
Sbjct: 25 TGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83
Query: 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC----RGLMCIHRMKIVHRDLKSANCLVNK 659
E GSL + + KK R K+L I +GL +H KI+HRD+K +N L+ +
Sbjct: 84 EGGSLDSIY---KKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR 140
Query: 660 HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 719
VK+CDFG+S + +S + GT +MAPE I+ +P++ D++SLG+ + E+
Sbjct: 141 KGQVKLCDFGVSGELVNS--LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV-A 197
Query: 720 LNR---PWEGVLP----ERVVYAVANEGSRLEIPEG-------PLGRLIADCWA-EPQER 764
NR P EG P E + Y V L+ G I C +P R
Sbjct: 198 QNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR 257
Query: 765 PSCEEILS 772
P+ ++L
Sbjct: 258 PTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 75/257 (29%), Positives = 117/257 (45%), Gaps = 16/257 (6%)
Query: 528 VGTRVGIGFFGEVF--RGIWNGTDVAIKVFL---EQDLTAENMEDFCNEISILSRLRHPN 582
+G +G G FG V+ G ++A+K E T++ + EI +L L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 583 VILFLGACTKPPR--LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
++ + G P LS+ E+M GS+ + G L+ K R I G+ +
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYL 122
Query: 641 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSR---IITDSPMRDSSSAGTPEWMAPELIR 697
H IVHRD+K AN L + VK+ DFG S+ I S S GTP WM+PE+I
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 698 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 754
E + K DI+S+G + E+ T PW ++ +A + + +P +
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 755 ADCWAEPQERPSCEEIL 771
+ E + RPS +E+L
Sbjct: 243 KRIFVEAKLRPSADELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 76/258 (29%), Positives = 127/258 (49%), Gaps = 33/258 (12%)
Query: 532 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589
+G G G V++ +A+KV D+T E + +E+ IL + P +I F GA
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIP-LDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 590 CTKPPRLSMITEYMELGSL--YHLI--HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
R+S+ TE+M+ GSL Y I H+ G ++ + +GL + +KI
Sbjct: 68 FFVENRISICTEFMDGGSLDVYRKIPEHVLG-----------RIAVAVVKGLTYLWSLKI 116
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKC 705
+HRD+K +N LVN VK+CDFG+S + +S + + GT +MAPE I E +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK--TYVGTNAYMAPERISGEQYGIHS 174
Query: 706 DIFSLGVIMWELCTLNRPWEGV-------LPERVVYAVANEGSRLEIPEG----PLGRLI 754
D++SLG+ EL P+ + +P +++ + +E + +P G I
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-LPVGQFSEKFVHFI 233
Query: 755 ADCW-AEPQERPSCEEIL 771
C +P+ERP+ E ++
Sbjct: 234 TQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 6/158 (3%)
Query: 570 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLK 628
NE IL L HP ++ + + ++ + + G L YHL QK K S +
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKF 104
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 688
+ +I L +H I+HRD+K N L+++ V I DF ++ +T + S+S GTP
Sbjct: 105 WICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS-GTP 163
Query: 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
+MAPE++ + ++ D +SLGV +E RP+ G
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 3e-22
Identities = 78/260 (30%), Positives = 122/260 (46%), Gaps = 30/260 (11%)
Query: 531 RVGIGFFGEVFRGIWNGTDV--AIKVFLE---QDLTAENMEDFCNEISILSRLRHPNVIL 585
R+G G FG V+ +KV E +L E +LS+L HP ++
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 586 FLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
F + + +ITEY E L L L K LS + + + G+ +H+ +
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 704
I+HRDLK+ N + + +KI DFG+SR++ S ++ GTP +M+PE ++++ + K
Sbjct: 127 ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK 185
Query: 705 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA----- 759
DI+SLG I++E+C L +EG VV L I EGP L + ++
Sbjct: 186 SDIWSLGCILYEMCCLAHAFEGQNFLSVV---------LRIVEGPTPSL-PETYSRQLNS 235
Query: 760 --------EPQERPSCEEIL 771
+P RPS EIL
Sbjct: 236 IMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 46/228 (20%)
Query: 528 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFL---EQDL---TAENMEDFCNEISILSRLR 579
+ ++G G FGEV++ I G VA+K L E+D TA EI IL +L+
Sbjct: 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR------EIKILKKLK 65
Query: 580 HPNVILFLG-ACTKPPRLS-------MITEYME--LGSLYH--LIHLSGQKKKLSWRRKL 627
HPNV+ + A +P + M+T YM+ L L + L+ + K
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC------ 119
Query: 628 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--------- 678
+ + G+ +H I+HRD+K+AN L++ +KI DFGL+R P
Sbjct: 120 -YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 679 -MRDSSSAGTPEWM-APELIRNEP-FTEKCDIFSLGVIMWELCTLNRP 723
R ++ W PEL+ E +T DI+ +G + E+ T RP
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 3e-22
Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 532 VGIGFFGEVFRGIWNGTD------VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 585
+G G FG+V ++ + VA+K L+++ +N + EI+IL L H N++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKT-LKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 586 FLGACTKP--PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
+ G C++ L +I EY+ LGSL + K KL+ + L + IC G+ +H
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPE-WMAPELIRNEP 700
+HRDL + N L++ VKI DFGL++ + + R +P W A E ++
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 701 FTEKCDIFSLGVIMWELCT--------------LNRPWEGVLPERVVYAVANEGSRLEIP 746
F+ D++S GV ++EL T + P +G + + + G RL P
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCP 246
Query: 747 EG-PLG--RLIADCW-AEPQERPSCEEILSRL 774
+ P L+ +CW E + RP+ ++ L
Sbjct: 247 KNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 3e-22
Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 9/220 (4%)
Query: 531 RVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588
++G G G V+ I G +VAIK Q + + NEI ++ ++PN++ +L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLD 83
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
+ L ++ EY+ GSL ++ + + + + R+ + L +H +++HR
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSNQVIHR 139
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 708
D+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K DI+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 709 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE 747
SLG++ E+ P+ P R +Y +A G+ L+ PE
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 77/265 (29%), Positives = 120/265 (45%), Gaps = 29/265 (10%)
Query: 537 FGEVFRG--IWNGTD----VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 590
FG++++G G D VAIK L+ + +F E S+++ L HPN++ LG
Sbjct: 18 FGKIYKGHLYLPGMDHAQLVAIKT-LKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV 76
Query: 591 TKPPRLSMITEYMELGSLYHLIHLSGQ--------------KKKLSWRRKLKMLRDICRG 636
T+ + M+ EY+ G L+ + + K L L + I G
Sbjct: 77 TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAG 136
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-MRDSSSAGTP-EWMAPE 694
+ + VH+DL + N L+ + VKI D GLSR I + R + P WM PE
Sbjct: 137 MEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPE 196
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPEGPLGR- 752
I F+ DI+S GV++WE+ + +P+ G + V+ V L E R
Sbjct: 197 AIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-QLLPCSEDCPPRM 255
Query: 753 --LIADCWAE-PQERPSCEEILSRL 774
L+ +CW E P RP ++I +RL
Sbjct: 256 YSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 80/274 (29%), Positives = 131/274 (47%), Gaps = 48/274 (17%)
Query: 532 VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMED--FCNEISILSRLRHPNVILFLG 588
+G G+FG+V G + +G A V E ++A E F E L+H N++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR----DICRGLMCIHRMK 644
CT+ ++ E+ LG L +L +K L+ +I GL+ +H+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKG--YLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSR--------IITDS---PMRDSSSAGTPEWMAP 693
+H DL NCL+ TVKI D+GLS + D P+R W+AP
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR---------WIAP 171
Query: 694 ELIRNEPF--------TEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLE 744
EL+ +E T++ +++SLGV +WEL L ++P+ + E+V+ E +L+
Sbjct: 172 ELV-DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE-QQLK 229
Query: 745 IPEGPLGRLIAD--------CWAEPQERPSCEEI 770
+P+ L ++D CW +P++RPS EE+
Sbjct: 230 LPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLE--QDLTA-ENMEDFCNEISILSRL 578
+EL +G G FG V +GIW G + I V ++ QD + + ++ + + + L
Sbjct: 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL 66
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
H ++ LG C L ++T+ LGSL L H+ + L +R L I +G+
Sbjct: 67 DHAYIVRLLGICPGA-SLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAKGMY 123
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EWMAPELI 696
+ ++VHR+L + N L+ V+I DFG++ ++ D S TP +WMA E I
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPE---GPLGR 752
+T + D++S GV +WE+ + P+ G+ P V + +G RL P+ +
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGERLAQPQICTIDVYM 242
Query: 753 LIADCWA-EPQERPSCEEILS 772
++ CW + RP+ +E+ +
Sbjct: 243 VMVKCWMIDENVRPTFKELAN 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 6e-22
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 8/213 (3%)
Query: 531 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588
++G G G V+ I G +VAIK Q + E NEI ++ +HPN++ +L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK--ELIINEILVMRENKHPNIVNYLD 83
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
+ L ++ EY+ GSL ++ + + + + R+ + L +H +++HR
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQVIHR 139
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 708
D+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K DI+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 709 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 741
SLG++ E+ P+ P R +Y +A G+
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 6e-22
Identities = 73/204 (35%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCN--EISILSRL-RHP 581
V ++G G FG V+ G VAIK ++ + E+ N E+ L +L HP
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK---FYSWEECMNLREVKSLRKLNEHP 58
Query: 582 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 641
N++ + L + EYME G+LY L+ + K S ++ I +GL IH
Sbjct: 59 NIVKLKEVFRENDELYFVFEYME-GNLYQLM-KDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 642 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-PMRDSSSAGTPEWMAPE-LIRNE 699
+ HRDLK N LV+ VKI DFGL+R I P D S T + APE L+R+
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS--TRWYRAPEILLRST 174
Query: 700 PFTEKCDIFSLGVIMWELCTLNRP 723
++ DI++LG IM EL TL RP
Sbjct: 175 SYSSPVDIWALGCIMAELYTL-RP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 7e-22
Identities = 78/252 (30%), Positives = 120/252 (47%), Gaps = 17/252 (6%)
Query: 530 TRVGIGFFGEVF--RGIWNGTDVAIKVFL-EQDLTAENMEDFCNEISILSRLRHPNVILF 586
+G G FG V+ R + VAIK + E +D E+ L +LRHPN I +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
G + ++ EY LGS ++ + KK L + +GL +H + +
Sbjct: 81 KGCYLREHTAWLVMEYC-LGSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHERI 137
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI--RNE-PFTE 703
HRD+K+ N L+ + TVK+ DFG + ++ SP +S GTP WMAPE+I +E +
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLV--SPA--NSFVGTPYWMAPEVILAMDEGQYDG 193
Query: 704 KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPEGPLG--RLIADCWA- 759
K D++SLG+ EL P + +Y +A N+ L + + C
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQK 253
Query: 760 EPQERPSCEEIL 771
PQ+RPS EE+L
Sbjct: 254 IPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 7e-22
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 530 TRVGIGFFGEVF--RGIWNGTDVAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHP 581
++G G FGEVF R VA+K V +E + +TA EI IL L+H
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA------LREIKILQLLKHE 71
Query: 582 NVILFLGACTKPPRLSMITEYMELGSLYHLI-----H-----LSGQKKKLSWRRKLKMLR 631
NV+ + C T Y ++L+ H LS + K + K+++
Sbjct: 72 NVVNLIEICRTKA-----TPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMK 126
Query: 632 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI----ITDSPMRDSSSAGT 687
+ GL IHR KI+HRD+K+AN L+ K +K+ DFGL+R P R ++ T
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 688 PEWMAPELIRNE-PFTEKCDIFSLGVIMWELCT 719
+ PEL+ E + D++ G IM E+ T
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 77/270 (28%), Positives = 125/270 (46%), Gaps = 34/270 (12%)
Query: 532 VGIGFFGEVF------RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 585
+G G FG+V G G VA+K L+ + ++ D EI IL L H N++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 586 FLGACTKPP--RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
+ G CT+ + +I E++ GSL +L K K++ +++LK IC+G+ +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKE--YLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP----MRDSSSAGTPEWMAPELIRNE 699
+ VHRDL + N LV VKI DFGL++ I ++D + W APE +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV-FWYAPECLIQS 187
Query: 700 PFTEKCDIFSLGVIMWELCT--------------LNRPWEGVLPERVVYAVANEGSRLEI 745
F D++S GV ++EL T + P G + + V EG RL
Sbjct: 188 KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPR 247
Query: 746 PEG---PLGRLIADCW-AEPQERPSCEEIL 771
P + +L+ CW +P +R + + ++
Sbjct: 248 PPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 77/259 (29%), Positives = 126/259 (48%), Gaps = 22/259 (8%)
Query: 532 VGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLG 588
+G G +G+VF+ + NG+ A+K+ D + E+ E +IL L HPNV+ F G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL---DPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 589 ACTKPP-----RLSMITEYMELGSLYHLIH-LSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
K +L ++ E GS+ L+ + +++ +L + GL +H
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE--- 699
K +HRD+K N L+ VK+ DFG+S +T + +R ++S GTP WMAPE+I E
Sbjct: 143 NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202
Query: 700 --PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPE---GPLGRL 753
+ +CD++SLG+ EL + P + P R ++ + N L PE
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDF 262
Query: 754 IADCWAEPQE-RPSCEEIL 771
I C + E RP+ ++L
Sbjct: 263 IRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (237), Expect = 1e-21
Identities = 63/220 (28%), Positives = 113/220 (51%), Gaps = 9/220 (4%)
Query: 531 RVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588
++G G G V+ + G +VAI+ Q + + NEI ++ ++PN++ +L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLD 84
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
+ L ++ EY+ GSL ++ + + + + R+ + L +H +++HR
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 708
D+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K DI+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 709 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE 747
SLG++ E+ P+ P R +Y +A G+ L+ PE
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 68/258 (26%), Positives = 124/258 (48%), Gaps = 19/258 (7%)
Query: 530 TRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 585
+G G FG V +G++ VA+K+ + ++ E +++ +L +P ++
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 586 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
+G C + ++ E ELG L + + K ++ + +++ + G+ +
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 646 VHRDLKSANCL-VNKHWTVKICDFGLSRIIT-DSPMRDSSSAGT-P-EWMAPELIRNEPF 701
VHRDL + N L V +H+ KI DFGLS+ + D + + G P +W APE + F
Sbjct: 117 VHRDLAARNVLLVTQHYA-KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 702 TEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADC 757
+ K D++S GV+MWE + +P++G+ V + + G R+E P+ + L+ C
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-GERMECPQRCPPEMYDLMKLC 234
Query: 758 WA-EPQERPSCEEILSRL 774
W ERP + RL
Sbjct: 235 WTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 78/265 (29%), Positives = 131/265 (49%), Gaps = 14/265 (5%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISIL 575
E+ ++ E +G G +G V+ R + +AIK E+D + ++ EI++
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALH 59
Query: 576 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
S L+H N++ +LG+ ++ + E + GSL L+ K + + + + I
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAP 693
GL +H +IVHRD+K N LVN + VKI DFG S R+ +P ++ + GT ++MAP
Sbjct: 120 GLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GTLQYMAP 178
Query: 694 ELIRNEP--FTEKCDIFSLGVIMWELCTLNRPW-EGVLPERVVYAVANEGSRLEIPE--- 747
E+I P + DI+SLG + E+ T P+ E P+ ++ V EIPE
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238
Query: 748 GPLGRLIADCWA-EPQERPSCEEIL 771
I C+ +P +R S ++L
Sbjct: 239 AEAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 82/280 (29%), Positives = 126/280 (45%), Gaps = 27/280 (9%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFCNEIS 573
I+ S + +G FG+V++G GT VAIK L+ E+F +E
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKT-LKDKAEGPLREEFKHEAM 60
Query: 574 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKK 620
+ SRL+HPN++ LG TK LSMI Y L+ + + K
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 621 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSP 678
L + ++ I G+ + +VH+DL + N LV VKI D GL R + D
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY 180
Query: 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVA 737
+S WM+PE I F+ DI+S GV++WE+ + +P+ G + V+ +
Sbjct: 181 KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240
Query: 738 NEGSRLEIPEGP--LGRLIADCWAE-PQERPSCEEILSRL 774
N + P + L+ +CW E P RP ++I SRL
Sbjct: 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-21
Identities = 77/259 (29%), Positives = 126/259 (48%), Gaps = 22/259 (8%)
Query: 532 VGIGFFGEVFR--GIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 588
+G G +G+V++ +G+ A+K+ D ++ E+ E +IL L HPNV+ F G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEIEAEYNILQSLPNHPNVVKFYG 86
Query: 589 ACTKPPRLS-----MITEYMELGSLYHLIH-LSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
K +L ++ E GS+ L+ L ++L +L GL +H
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146
Query: 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE--- 699
+I+HRD+K N L+ VK+ DFG+S +T + +R ++S GTP WMAPE+I E
Sbjct: 147 NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206
Query: 700 --PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPEG---PLGRL 753
+ +CD++SLG+ EL + P + P + ++ + N L PE
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHF 266
Query: 754 IADCWAEPQE-RPSCEEIL 771
I+ C + E RPS +L
Sbjct: 267 ISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-21
Identities = 50/151 (33%), Positives = 86/151 (56%), Gaps = 7/151 (4%)
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--MRDSSSAGTPEW 690
+ +G+ + K +HRDL + N L++++ VKICDFGL+R I P +R + +W
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247
Query: 691 MAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPE-- 747
MAPE I + +T + D++S GV++WE+ +L P+ GV + EG+R+ P+
Sbjct: 248 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT 307
Query: 748 -GPLGRLIADCW-AEPQERPSCEEILSRLLD 776
+ + + DCW EP +RP+ E++ L +
Sbjct: 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 8e-21
Identities = 60/169 (35%), Positives = 93/169 (55%), Gaps = 16/169 (9%)
Query: 623 WRRKLKMLRDIC------RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676
W+ L M IC RG+ + K +HRDL + N L++++ VKICDFGL+R I
Sbjct: 167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 677 SP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVV 733
P +R S+ +WMAPE I ++ +T + D++S GV++WE+ +L P+ GV
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286
Query: 734 YAVANEGSRLEIPE---GPLGRLIADCW-AEPQERPSCE---EILSRLL 775
+G+R+ PE + R++ CW +P+ERP+ EIL LL
Sbjct: 287 CQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 71/208 (34%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 523 FSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMED-----FCNEISIL 575
SEL R+G G G V++ I T A+KV N ED C EI IL
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG------NHEDTVRRQICREIEIL 126
Query: 576 SRLRHPNVILFLGACTKPPRLSMITEYMELGSL--YHLIHLSGQKKKLSWRRKLKMLRDI 633
+ HPNV+ + ++ E+M+ GSL H+ ++ L+ + R I
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI----ADEQFLA-----DVARQI 177
Query: 634 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAP 693
G+ +HR IVHRD+K +N L+N VKI DFG+SRI+ + +SS GT +M+P
Sbjct: 178 LSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSP 237
Query: 694 ELIR---NEPFTEKC--DIFSLGVIMWE 716
E I N + DI+SLGV + E
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 79/261 (30%), Positives = 123/261 (47%), Gaps = 18/261 (6%)
Query: 522 DFSELTVGT-RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSR 577
D E+ VG +G G FG V+ + T+ VA+K + T E +D E+ L +
Sbjct: 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQ 77
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
L+HPN I + G K ++ EY LGS L+ + KK L + +GL
Sbjct: 78 LKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGL 134
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI- 696
+H ++HRD+K+ N L+ + VK+ DFG + + + +S GTP WMAPE+I
Sbjct: 135 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----NSFVGTPYWMAPEVIL 190
Query: 697 --RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPE--GPLG 751
+ K D++SLG+ EL P + +Y +A N+ L+ E
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFR 250
Query: 752 RLIADCWAE-PQERPSCEEIL 771
+ C + PQERP+ E+L
Sbjct: 251 GFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 49/172 (28%), Positives = 89/172 (51%), Gaps = 8/172 (4%)
Query: 547 GTDVAIKVFLEQDLTAENM-EDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 605
G VA+K + DL + E NE+ I+ +HPN++ + L ++ E++E
Sbjct: 44 GRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100
Query: 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 665
G+L ++ +++ + + + + L +H ++HRD+KS + L+ VK+
Sbjct: 101 GALTDIV----THTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKL 156
Query: 666 CDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 717
DFG ++ R S GTP WMAPE+I P+ + DI+SLG+++ E+
Sbjct: 157 SDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 65/247 (26%), Positives = 131/247 (53%), Gaps = 18/247 (7%)
Query: 540 VFRGIWNGTDVAIKVFLE-QDLTAENMEDFCNEISILSRLRHPNVI----LFLGACTKPP 594
+++GI+N +V I+ F + ++ NEI L R+ N++ + P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSA 653
RLS+I EY G L ++ ++K LS++ KL M D C+GL +++ +++L S
Sbjct: 96 RLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSV 152
Query: 654 NCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLG 711
+ LV +++ +KI GL +I++ P ++ + + +++ + +T K DI+SLG
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKN---VNFMVYFSYKMLNDIFSEYTIKDDIYSLG 209
Query: 712 VIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGP--LGRLIADCWA-EPQERPSC 767
V++WE+ T P+E + + + + N+ + L++P + P + ++ C + + +RP+
Sbjct: 210 VVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNI 269
Query: 768 EEILSRL 774
+EIL L
Sbjct: 270 KEILYNL 276
|
Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 76/265 (28%), Positives = 118/265 (44%), Gaps = 35/265 (13%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588
+G G FG V+ R + N VAIK + + E +D E+ L +LRHPN I + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
+ ++ EY LGS L+ + KK L + +GL +H ++HR
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI---RNEPFTEKC 705
D+K+ N L+++ VK+ DFG + I+ + + GTP WMAPE+I + K
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDGKV 195
Query: 706 DIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAE----- 760
D++SLG+ EL P + +Y +A E P L + W+E
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------ESPA--LQSGHWSEYFRNF 246
Query: 761 --------PQERPSCEEILSRLLDC 777
PQ+RP+ E +L
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 52/151 (34%), Positives = 87/151 (57%), Gaps = 7/151 (4%)
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--MRDSSSAGTPEW 690
+ RG+ + K +HRDL + N L++++ VKICDFGL+R I P +R + +W
Sbjct: 182 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241
Query: 691 MAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPE-- 747
MAPE I ++ +T + D++S GV++WE+ +L P+ GV + EG+R+ PE
Sbjct: 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYA 301
Query: 748 -GPLGRLIADCW-AEPQERPSCEEILSRLLD 776
+ ++ DCW P++RP+ E++ L D
Sbjct: 302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 3e-20
Identities = 78/263 (29%), Positives = 124/263 (47%), Gaps = 20/263 (7%)
Query: 523 FSELTVGTRVGIGFFGEVF--RGIWNGTDVAIK-VFLEQDLTAENMEDFCNEISILSRLR 579
F++L +G G FG V+ R + VAIK + + E +D E+ L R++
Sbjct: 27 FTDLR---EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
HPN I + G + ++ EY LGS L+ + KK L + +GL
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAY 140
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI--- 696
+H ++HRD+K+ N L+ + VK+ DFG + I + + +S GTP WMAPE+I
Sbjct: 141 LHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----NSFVGTPYWMAPEVILAM 196
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPEGP--LGRL 753
+ K D++SLG+ EL P + +Y +A NE L+ E
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256
Query: 754 IADCWAE-PQERPSCEEILSRLL 775
+ C + PQ+RP+ EE+L +
Sbjct: 257 VDSCLQKIPQDRPTSEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 528 VGTRVGIGFFGEVFRG--IWNGTDVAIK---VFLEQDLTAENMEDFCNEISILSRLR--- 579
+G G +G V++ + G VA+K V L ++ + EI++L +L
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST---LREIALLKQLESFE 59
Query: 580 HPNVILFLGACTKPPR-----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
HPN++ L C P L+++ E+++ +L K L ++R +
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLL 117
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694
RG+ +H +IVHRDLK N LV VKI DFGL+RI + M +S T + APE
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-MALTSVVVTLWYRAPE 176
Query: 695 LIRNEPFTEKCDIFSLGVIMWEL 717
++ + D++S+G I EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 7e-20
Identities = 72/209 (34%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 532 VGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFC----NEISILSRLRHPNVIL 585
+G G +G V G VAIK ++ + FC EI IL R +H N+I
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIK-----KISPFEHQTFCQRTLREIKILRRFKHENIIG 67
Query: 586 FLGACTKPPRLSM-----ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
L P S + E ME LY LI + + LS L I RGL I
Sbjct: 68 ILDIIRPPSFESFNDVYIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYI 122
Query: 641 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-----AGTPEWMAPEL 695
H ++HRDLK +N L+N + +KICDFGL+RI P D + T + APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD--PEHDHTGFLTEYVATRWYRAPEI 180
Query: 696 IRN-EPFTEKCDIFSLGVIMWELCTLNRP 723
+ N + +T+ DI+S+G I+ E+ + NRP
Sbjct: 181 MLNSKGYTKAIDIWSVGCILAEMLS-NRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 535 GFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRH-PNVILFLGAC 590
G FG V+ + G AIKV + D+ A+N + + E +I+ P V +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 591 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 650
L ++ EY+ G LI G W ++ + ++ G+ +H+ I+HRD+
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQ--YIAEVVLGVEDLHQRGIIHRDI 123
Query: 651 KSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSL 710
K N L+++ +K+ DFGLSR ++ GTP+++APE I + D +SL
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRNGLENK----KFVGTPDYLAPETILGVGDDKMSDWWSL 179
Query: 711 GVIMWELCTLNRPWEGVLPERV 732
G +++E P+ P+ V
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAV 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 9/201 (4%)
Query: 532 VGIGFFGEVFRGIWNGTD--VAIKVFLEQD--LTAENMEDFCNEISILSRLRHPNVILFL 587
+G G FG+V GTD A+KV L++D L +++E E +L+ + L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKV-LKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 588 GACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
+C + RL + EY+ G L I SG + R +I GL +H I+
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 706
+RDLK N L++ +KI DFG+ + + S+ GTP+++APE++ +P+ D
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVD 178
Query: 707 IFSLGVIMWELCTLNRPWEGV 727
++LGV+++E+ P+EG
Sbjct: 179 WWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 532 VGIGFFGEVF-----RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 586
+G G FG+VF G G A+KV + L + E IL+ + HP ++
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM-LRDICRGLMCIHRMKI 645
A +L +I +++ G L+ LS K+ + +K L ++ L +H + I
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLF--TRLS--KEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKC 705
++RDLK N L+++ +K+ DFGLS+ D + S GT E+MAPE++ T+
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 179
Query: 706 DIFSLGVIMWELCTLNRPWEG 726
D +S GV+M+E+ T + P++G
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 71/266 (26%), Positives = 122/266 (45%), Gaps = 24/266 (9%)
Query: 532 VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENME--DFCNEISILSRLRHPNVILFLG 588
+G G+FG+V I+ T VA V E A + E +F + L+HPN++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL-KMLRDICRGLMCIHRMKIVH 647
C + ++ EY ELG L + ++ S L +M +I G+ +H+ +H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLH 122
Query: 648 RDLKSANCLVNKHWTVKICDFGL--SRIITDSPMRDSSSAGTPEWMAPELIRN------- 698
DL NC + TVK+ D+G+ SR D + W+APEL+
Sbjct: 123 SDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLIT 182
Query: 699 EPFTEKCDIFSLGVIMWELC-TLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIAD- 756
T+ ++++LGV +WEL +P+ + V+ V + ++++ + L ++
Sbjct: 183 AEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD-QQVKLFKPQLELPYSER 241
Query: 757 -------CWAEPQERPSCEEILSRLL 775
CW P++R + EE+ RLL
Sbjct: 242 WYEVLQFCWLSPEKRATAEEV-HRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 67/268 (25%), Positives = 109/268 (40%), Gaps = 39/268 (14%)
Query: 533 GIGFFGEVFRGIW--NGTD----------VAIKVFLEQDLTAENMEDFCNEISILSRLRH 580
G G F +++G+ V +KV L D + F S++S+L H
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKV-LGSDH--RDSLAFFETASLMSQLSH 60
Query: 581 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
+++ G C + + M+ EY++ G L +H L W KL + + + L +
Sbjct: 61 KHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 641 HRMKIVHRDLKSANCLVNKHWT-------VKICDFGLSRIITDSPMRDSSSAGTPEWMAP 693
K+VH ++ N LV ++ +K+ D G+ + R W+AP
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP----WIAP 173
Query: 694 ELIRNEP--FTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVV--YAVANEGSRLEIPE- 747
E IRN T D +S G + E+C+ P + Y + RL +P+
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHRLPMPDC 230
Query: 748 GPLGRLIADCWA-EPQERPSCEEILSRL 774
L LI CW +P +RPS IL L
Sbjct: 231 AELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 65/197 (32%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 532 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589
VG G +G+V T VAIK +A + + E+ +L + H NVI L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 590 CTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
T L ++T M L +++ + +KLS ++ I RGL IH
Sbjct: 83 FTPASSLEDFQDVYLVTHLMG-ADLNNIV----KCQKLSDDHIQFLVYQILRGLKYIHSA 137
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFT 702
I+HRDLK +N VN+ +KI DFGL+R TD M T + APE++ N +
Sbjct: 138 GIIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDEMTG--YVATRWYRAPEIMLNWMHYN 194
Query: 703 EKCDIFSLGVIMWELCT 719
+ DI+S+G IM EL T
Sbjct: 195 QTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 531 RVGIGFFGEVFRG--IWNGTDVAIK----VF--LEQDLTAENMEDFCNEISILSRLR-HP 581
++G G F EV + G AIK F LEQ EI L RL HP
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-------LREIQALRRLSPHP 58
Query: 582 NVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
N++ + K RL+++ E M++ +LY LI G+K+ L +R + + + L
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELMDM-NLYELIK--GRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE-LIRN 698
+HR I HRD+K N L+ +K+ DFG R I P + T + APE L+ +
Sbjct: 116 MHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY-TEYISTRWYRAPECLLTD 173
Query: 699 EPFTEKCDIFSLGVIMWELCTLN 721
+ K DI+++G + +E+ +L
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 18/161 (11%)
Query: 571 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSW 623
E+ I+ R P ++ F GA + M E+M+ GSL + G K ++
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112
Query: 624 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 683
L L ++ HR I+HRD+K +N LVN +K+CDFG+S + +S +
Sbjct: 113 VEGLTYLYNV-------HR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--DT 161
Query: 684 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 724
GT +M+PE I+ +T K D++SLG+ + EL P+
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 6e-18
Identities = 48/136 (35%), Positives = 79/136 (58%), Gaps = 7/136 (5%)
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTE 703
+HRDL + N L+ KICDFGL+R I DS +A P +WMAPE I N +T
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295
Query: 704 KCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCW- 758
+ D++S G+++WE+ +L + P+ G+ + Y + EG R+ PE + ++ CW
Sbjct: 296 ESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWD 355
Query: 759 AEPQERPSCEEILSRL 774
A+P +RP+ ++I+ +
Sbjct: 356 ADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 34/214 (15%)
Query: 532 VGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDF----CNEISILSRLRHPNV 583
+G G +G V++ +G + AIK F + D E C EI++L L+H NV
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGD--KEQYTGISQSACREIALLRELKHENV 64
Query: 584 I----LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSW-RRKLK-MLRDICRGL 637
+ +FL K + ++ +Y E L+ +I Q K++S +K +L I G+
Sbjct: 65 VSLVEVFLEHADK--SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 638 MCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITDSPMRDSSSAG----TPE 689
+H ++HRDLK AN LV + VKI D GL+R+ ++P++ + T
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLADLDPVVVTIW 180
Query: 690 WMAPELI---RNEPFTEKCDIFSLGVIMWELCTL 720
+ APEL+ R+ +T+ DI+++G I EL TL
Sbjct: 181 YRAPELLLGARH--YTKAIDIWAIGCIFAELLTL 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-18
Identities = 49/137 (35%), Positives = 82/137 (59%), Gaps = 5/137 (3%)
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIR 697
+H ++HRD+KSAN L+ + VK+ DFG S++ + D + GTP ++APE+ R
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218
Query: 698 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY-AVANEGSRLEIPEGPLGRLIAD 756
+P+++K D+FSLGV+++EL TL RP++G E V++ +A L P + I
Sbjct: 219 RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVT 278
Query: 757 CW--AEPQERPSCEEIL 771
++P+ RPS ++L
Sbjct: 279 ALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 8/192 (4%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589
VG G +G V + G VAIK FLE + + EI +L +LRH N++ +
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 590 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 649
+ RL ++ E+++ L L L R K L I RG+ H I+HRD
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHNIIHRD 125
Query: 650 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APELIRNEP-FTEKCDI 707
+K N LV++ VK+CDFG +R + +P + W APEL+ + + DI
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLA-APGEVYTDYVATRWYRAPELLVGDTKYGRAVDI 184
Query: 708 FSLGVIMWELCT 719
+++G ++ E+ T
Sbjct: 185 WAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 522 DFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCN--EISILSR 577
DF+ L V +G G FG+V GTD AIK+ L++D+ ++ + C E +L+
Sbjct: 1 DFNFLMV---LGKGSFGKVMLAERKGTDELYAIKI-LKKDVIIQDDDVECTMVEKRVLAL 56
Query: 578 LRHPNVILFLGAC-TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
P + L +C RL + EY+ G L + I G+ K+ + +I G
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE---PHAVFYAAEIAIG 113
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
L +H I++RDLK N +++ +KI DFG+ + + GTP+++APE+I
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII 173
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
+P+ + D ++ GV+++E+ P++G
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 65/246 (26%), Positives = 118/246 (47%), Gaps = 17/246 (6%)
Query: 546 NGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLGACTKPPRLSMITEYME 604
+G VA+K+ DL + + NE+ I+ +H NV+ + L ++ E+++
Sbjct: 45 SGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101
Query: 605 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 664
G+L ++ + +L+ + + + + L +H ++HRD+KS + L+ VK
Sbjct: 102 GGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVK 157
Query: 665 ICDFGL-SRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 723
+ DFG ++I D P R S GTP WMAPE+I P+ + DI+SLG+++ E+ P
Sbjct: 158 LSDFGFCAQISKDVPKR-KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
Query: 724 WEGVLPERVVYAVANE---GSRLEIPEGPLGRLIADCW--AEPQERPSCEEILSR--LLD 776
+ P + + + + + P+ R + EPQER + +E+L LL
Sbjct: 217 YFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQ 276
Query: 777 CEYSLC 782
C
Sbjct: 277 TGLPEC 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-17
Identities = 55/165 (33%), Positives = 87/165 (52%), Gaps = 13/165 (7%)
Query: 570 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK- 628
+E+ L+ H ++ +L +I EY G L I K++L +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-----KQRLKEHLPFQE 168
Query: 629 -----MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD-- 681
+ I L +H K++HRDLKSAN + +K+ DFG S+ +DS D
Sbjct: 169 YEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
SS GTP ++APEL + +++K D++SLGVI++EL TL+RP++G
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 15/156 (9%)
Query: 628 KMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 686
K+ I + L +H ++ ++HRD+K +N L+N++ VK+CDFG+S + DS + + AG
Sbjct: 107 KIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-VAKTIDAG 165
Query: 687 TPEWMAPELIRNE----PFTEKCDIFSLGVIMWELCTLNRPWE--GVLPERVVYAVANEG 740
+MAPE I E + K D++SLG+ M EL T P++ +++ V E
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--EE 223
Query: 741 SRLEIPEGPLGRLIAD-----CWAEPQERPSCEEIL 771
++P D +ERP+ E+L
Sbjct: 224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 34/203 (16%)
Query: 535 GFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDF----CNEISILSRLRHPNVI--- 584
G +G V+R T VA+K + +E + E F EI+IL +L+HPN++
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKME-----KEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 585 -LFLGACTKPPRLSMITEYME--LGSLYHLIH---LSGQKKKLSWRRKLKMLRDICRGLM 638
+ +G + ++ M+ EY+E L SL + L + K L + + G+
Sbjct: 71 EVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL--------MLQLLSGVA 120
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APELIR 697
+H I+HRDLK++N L+N +KICDFGL+R SP++ + W APEL+
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVVTLWYRAPELLL 179
Query: 698 NEP-FTEKCDIFSLGVIMWELCT 719
++ D++S+G I EL T
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-17
Identities = 53/159 (33%), Positives = 85/159 (53%), Gaps = 10/159 (6%)
Query: 627 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSA 685
L + RG+ + VHRDL + N L+ + VKICDFGL+R I+ DS S
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGST 299
Query: 686 GTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRL 743
P +WMAPE I + +T D++S G+++WE+ +L P+ G++ + Y G R+
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM 359
Query: 744 EIPE---GPLGRLIADCW-AEPQERPS---CEEILSRLL 775
P+ + ++ CW +EP++RPS +I+ LL
Sbjct: 360 AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 7/190 (3%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLG 588
+G G FGEV + G A K ++ L E NE IL ++ ++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 589 ACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 647
A L ++ M G L YH+ ++ + R + I GL +H+ +IV+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 648 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 707
RDLK N L++ H V+I D GL+ + + AGTP +MAPE+++ E + D
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGK-KIKGRAGTPGYMAPEVLQGEVYDFSVDW 177
Query: 708 FSLGVIMWEL 717
F+LG ++E+
Sbjct: 178 FALGCTLYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-17
Identities = 48/141 (34%), Positives = 78/141 (55%), Gaps = 10/141 (7%)
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTE 703
+HRD+ + N L+ KICDFGL+R I+ DS +A P +WMAPE I + +T
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 704 KCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE-GPLG--RLIADCWA 759
+ D++S G+++WE+ +L + P+ G+L Y + G ++ P+ P ++ CW
Sbjct: 294 QSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN 353
Query: 760 -EPQERPSCEEI---LSRLLD 776
EP ERP+ +I + R L
Sbjct: 354 LEPTERPTFSQISQLIQRQLG 374
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 29/204 (14%)
Query: 531 RVGIGFFGEVF--RGIWNGTDVAIK-VFLEQDL-----TAENMEDFCNEISILSRLRHPN 582
++G G +G V+ R G VA+K + LE + TA EIS+L L HPN
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA------IREISLLKELNHPN 59
Query: 583 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM-LRDICRGLMCIH 641
++ L +L ++ E+++L ++ +K L + +G+ H
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLD---PPLIKSYLYQLLQGIAYCH 116
Query: 642 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APE-L 695
+++HRDLK N L+++ +K+ DFGL+R P+R T E W APE L
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVR----TYTHEVVTLWYRAPEIL 171
Query: 696 IRNEPFTEKCDIFSLGVIMWELCT 719
+ + ++ DI+S+G I E+
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 524 SELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAEN-MEDFCNEISILSRLRH 580
+ + T+VG G +G+VF T VA+K + L N + E IL+ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 581 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
++ L A L + EY+ G L++ G + R M + +
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR--FYMAEMFE-AVDAL 117
Query: 641 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTPEWMAPELIRNE 699
H + +HRDLK N L++ +K+ DFGLS+ I+T +S G+P++MAPE++R +
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGK 173
Query: 700 PFTEKCDIFSLGVIMWE-LCTLNRPWEGVLPERV 732
+ D +SLG +++E LC P+ G P
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFP-PFSGSTPNET 206
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 6e-17
Identities = 73/210 (34%), Positives = 101/210 (48%), Gaps = 43/210 (20%)
Query: 532 VGIGFFGEVFRGIWNGTD------VAIK----VFLEQDLTAENMEDFCNEISILSRLRHP 581
+G G FG V W+ TD VA+K VF Q+L + + E+ +L +H
Sbjct: 8 IGYGAFGVV----WSVTDPRDGKRVALKKMPNVF--QNLVS--CKRVFRELKMLCFFKHD 59
Query: 582 NVILFLGA--CTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 633
NV L A +PP + ++TE M+ S H I +S Q LS L I
Sbjct: 60 NV---LSALDILQPPHIDPFEEIYVVTELMQ--SDLHKIIVSPQP--LSSDHVKVFLYQI 112
Query: 634 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE---- 689
RGL +H I+HRD+K N LVN + +KICDFGL+R + P D S T E
Sbjct: 113 LRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR--VEEP--DESKHMTQEVVTQ 168
Query: 690 -WMAPELIRNEP-FTEKCDIFSLGVIMWEL 717
+ APE++ +T DI+S+G I EL
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 7e-17
Identities = 62/210 (29%), Positives = 111/210 (52%), Gaps = 12/210 (5%)
Query: 522 DFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCN--EISILSR 577
DF+ L V +G G FG+V GTD AIK+ L++D+ ++ + C E +L+
Sbjct: 1 DFNFLMV---LGKGSFGKVMLAERKGTDELYAIKI-LKKDVVIQDDDVECTMVEKRVLAL 56
Query: 578 LRHPNVILFLGACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
P + L +C + RL + EY+ G L + I G+ K+ + + +I G
Sbjct: 57 QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISVG 113
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
L +HR I++RDLK N +++ +KI DFG+ + + + GTP+++APE+I
Sbjct: 114 LFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII 173
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
+P+ + D ++ GV+++E+ P++G
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWN---GTDVAIKVFLEQDLT--AENMEDFCNEISI 574
+F L V +G G +G+VF R + G A+KV + + A+ E E +
Sbjct: 1 NFELLRV---LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQV 57
Query: 575 LSRLRH-PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 633
L +R P ++ A +L +I +Y+ G L+ HL Q++ + + +I
Sbjct: 58 LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELF--THLY-QREHFTESEVRVYIAEI 114
Query: 634 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI-ITDSPMRDSSSAGTPEWMA 692
L +H++ I++RD+K N L++ V + DFGLS+ + + R S GT E+MA
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 693 PELIRNEP--FTEKCDIFSLGVIMWELCT 719
PE+IR + D +SLGV+ +EL T
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 7e-17
Identities = 63/193 (32%), Positives = 96/193 (49%), Gaps = 18/193 (9%)
Query: 532 VGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI----L 585
VG+G FG V R G +VAIK ++ T + E+ +L LRH N+I +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 586 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
F+ + +TE + L+ L+ + L + L I RGL +H +
Sbjct: 78 FISPLED---IYFVTELLGT-DLHRLL----TSRPLEKQFIQYFLYQILRGLKYVHSAGV 129
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEK 704
VHRDLK +N L+N++ +KICDFGL+R I D M S T + APE++ + + +
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLAR-IQDPQMTGYVS--TRYYRAPEIMLTWQKYDVE 186
Query: 705 CDIFSLGVIMWEL 717
DI+S G I E+
Sbjct: 187 VDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 56/189 (29%), Positives = 96/189 (50%), Gaps = 9/189 (4%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQD-LTAENMEDFCNEISILSRLRHPNVILFLG 588
VG G FG V R + A+KV + + + + NE +L + HP +I
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
L M+ EY+ G L+ + SG + S L +I L +H +IV+R
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKEIVYR 125
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 708
DLK N L++K +K+ DFG ++ + D R + GTPE++APE+I+++ + D +
Sbjct: 126 DLKPENILLDKEGHIKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVIQSKGHNKAVDWW 182
Query: 709 SLGVIMWEL 717
+LG++++E+
Sbjct: 183 ALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 8e-17
Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 12/210 (5%)
Query: 522 DFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCN--EISILSR 577
DF+ L V +G G FG+V GTD AIK+ L++D+ ++ + C E +L+
Sbjct: 1 DFNFLMV---LGKGSFGKVMLAERKGTDELYAIKI-LKKDVVIQDDDVECTMVEKRVLAL 56
Query: 578 LRHPNVILFLGACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
P + L +C + RL + EY+ G L + I G+ K+ + +I G
Sbjct: 57 SGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKE---PHAVFYAAEIAIG 113
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
L +H I++RDLK N +++ +KI DFG+ + + + GTP+++APE+I
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII 173
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
+P+ + D ++ GV+++E+ P+EG
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 62/236 (26%), Positives = 115/236 (48%), Gaps = 21/236 (8%)
Query: 546 NGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLGACTKPPRLSMITEYME 604
+G VA+K + DL + + NE+ I+ +H NV+ + L ++ E++E
Sbjct: 44 SGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100
Query: 605 LGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 663
G+L ++ H +++++ + + + L +H ++HRD+KS + L+ V
Sbjct: 101 GGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRV 155
Query: 664 KICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 723
K+ DFG ++ R S GTP WMAPELI P+ + DI+SLG+++ E+ P
Sbjct: 156 KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
Query: 724 WEGVLPERVVYAVA-NEGSRLE-------IPEGPLGRLIADCWAEPQERPSCEEIL 771
+ P + + + N +L+ +G L RL+ +P +R + E+L
Sbjct: 216 YFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV---RDPAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 12/217 (5%)
Query: 533 GIGFFGEVFRGIWNGTD--VAIKVFLEQDLTA-ENMEDFCNEISIL---SRLRHPNVILF 586
G G FG+V + T AIK + D+ A + +E E I + RHP ++
Sbjct: 8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP-FLVN 66
Query: 587 LGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
L AC + + + EY G L IH S R + + GL +H KI
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENKI 122
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKC 705
V+RDLK N L++ VKI DFGL + R S+ GTPE++APE++ +T
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAV 182
Query: 706 DIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 742
D + LGV+++E+ P+ G E V ++ N+ R
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR 219
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 40/149 (26%), Positives = 83/149 (55%), Gaps = 3/149 (2%)
Query: 571 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 630
E ++L+++ P ++ + P +L ++ ++ G L+H HL + + R +
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFH--HLQREGRFDLSRARFYTA 100
Query: 631 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 690
+C L +H+ +++RDLK N L++ + +CDFGL ++ + ++ GTPE+
Sbjct: 101 ELLC-ALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159
Query: 691 MAPELIRNEPFTEKCDIFSLGVIMWELCT 719
+APEL+ +T+ D ++LGV+++E+ T
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 11/214 (5%)
Query: 532 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCN--EISILS-RLRHPNVI-L 585
+G G FG+V GT+ AIK L++D+ E+ + C E +L+ HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKA-LKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 586 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
F TK L + EY+ G L I + R +I GL +H+ I
Sbjct: 62 FCTFQTKE-HLFFVMEYLNGGDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKGI 117
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKC 705
++RDLK N L++K +KI DFG+ + + + S+ GTP+++APE+++ + + E
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV 177
Query: 706 DIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 739
D +S GV+++E+ P+ G + + ++ N+
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 530 TRVGIGFFGEVF--RGIWNGTDVAIKVFL--EQDLTAENMEDFCNEISILSRLRHPNVIL 585
+++G G +G VF R G VAIK F+ E D + + EI +L +L+HPN++
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--LREIRMLKQLKHPNLVN 64
Query: 586 FLGACTKPPRLSMITEYMELGSLYHL-IHLSG----QKKKLSWRRKLKMLRDICRGLMCI 640
+ + +L ++ EY + L L + G KK+ W+ + +
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ--------TLQAVNFC 116
Query: 641 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE- 699
H+ +HRD+K N L+ K +K+CDFG +RI+T + T + APEL+ +
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 700 PFTEKCDIFSLGVIMWELCTLNRPWEG 726
+ D++++G + EL T W G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 60/190 (31%), Positives = 100/190 (52%), Gaps = 8/190 (4%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 588
+G G FG+V R +G A+K+ ++ + A++ + E +L RHP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
+ RL + EY+ G L+ HLS +++ S R +I L +H KIV+R
Sbjct: 63 SFQTKDRLCFVMEYVNGGELF--FHLS-RERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 649 DLKSANCLVNKHWTVKICDFGLSRI-ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 707
DLK N +++K +KI DFGL + ITD+ + GTPE++APE++ + + D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATM-KTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 708 FSLGVIMWEL 717
+ LGV+M+E+
Sbjct: 179 WGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 532 VGIGFFGEVFRGIWNGTDV--AIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLG 588
+G+G FG V + A+K ++ + ++ +E IL HP ++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM-CI------- 640
+ M+ EY G L+ ++ R + R + C+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL-----------RDRGLFDEYTARFYIACVVLAFEYL 109
Query: 641 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 700
H I++RDLK N L++ + VK+ DFG ++ + S + + GTPE++APE+I N+
Sbjct: 110 HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTFCGTPEYVAPEIILNKG 168
Query: 701 FTEKCDIFSLGVIMWELCTLNRP 723
+ D +SLG++++EL T P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 5e-16
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQD-LTAENMEDFCNEISI 574
W + S+ +G +G G FG V GT AIK +++ L + ++ E SI
Sbjct: 14 SWKL--SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSI 71
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
L L HP ++ + + R+ + E++ G L+ HL R+ + D+
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELF--THL---------RKAGRFPNDVA 120
Query: 635 R--------GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 686
+ +H I++RDLK N L++ VK+ DFG ++ + D R + G
Sbjct: 121 KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD---RTFTLCG 177
Query: 687 TPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 717
TPE++APE+I+++ + D +++GV+++E
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208
|
Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 6e-16
Identities = 67/202 (33%), Positives = 97/202 (48%), Gaps = 27/202 (13%)
Query: 532 VGIGFFGEVFRGI--WNGTDVAIKVF---LEQDLTAENMEDFCNEISILSRLRHPNVILF 586
VG G +G V + G VAIK + +L A+ E+ +L ++H NVI
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY---RELRLLKHMKHENVIGL 79
Query: 587 LGACTKPPRLSMITEY--------MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
L T L ++ +LG L + +KLS R ++ + +GL
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLM-------KHEKLSEDRIQFLVYQMLKGLK 132
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 698
IH I+HRDLK N VN+ +KI DFGL+R TDS M + T + APE+I N
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEM--TGYVVTRWYRAPEVILN 189
Query: 699 -EPFTEKCDIFSLGVIMWELCT 719
+T+ DI+S+G IM E+ T
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 18/219 (8%)
Query: 532 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCN--EISILSRLR-HPNVILF 586
+G G FG+V GTD AIKV L++D+ ++ + C E IL+ HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKV-LKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
RL + EY+ G L I S +K R ++ LM +HR ++
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 706
+RDLK N L++ K+ DFG+ + + + ++ GTP+++APE+++ + D
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVD 178
Query: 707 IFSLGVIMWELCTLNRPWEG---------VLPERVVYAV 736
++LGV+M+E+ P+E +L + V+Y V
Sbjct: 179 WWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 48/180 (26%), Positives = 89/180 (49%), Gaps = 8/180 (4%)
Query: 546 NGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLGACTKPPRLSMITEYME 604
G VA+K + DL + + NE+ I+ H NV+ + L ++ E++E
Sbjct: 46 TGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102
Query: 605 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 664
G+L ++ +++ + + + R L +H ++HRD+KS + L+ +K
Sbjct: 103 GGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIK 158
Query: 665 ICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 724
+ DFG ++ + S GTP WMAPE+I P+ + DI+SLG+++ E+ P+
Sbjct: 159 LSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 524 SELTVGTRVGIGFFGEVFRGIWNGTDV--AIK-VFLEQDLTAENMEDFCNEISILSRLRH 580
E+ V +G G +G V++ + T V A+K + LE D + N E+ IL +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN--QIIMELDILHKAVS 58
Query: 581 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
P ++ F GA + M EYM+ GSL L + + ++ + +GL +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 641 -HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 699
I+HRD+K N LVN + VK+CDFG+S + S + ++ G +MAPE I++
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK--TNIGCQSYMAPERIKSG 176
Query: 700 ------PFTEKCDIFSLGVIMWEL 717
+T + D++SLG+ + E+
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 582
++G G +G V++G T VA+K + LE + TA EIS+L L+HPN
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA------IREISLLKELQHPN 60
Query: 583 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
++ + RL +I E++ + +L L + + K L I +G++ H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVK-SYLYQILQGILFCHS 119
Query: 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APELIRNEP- 700
+++HRDLK N L++ +K+ DFGL+R P+R + W APE++ P
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 701 FTEKCDIFSLGVIMWELCTLNRP 723
++ DI+S+G I E+ T +P
Sbjct: 179 YSTPVDIWSIGTIFAEMAT-KKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 53/230 (23%)
Query: 528 VGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENME-DFCNEISILSRLRHPNVI 584
V +G G FGEV+ R G A+KV + D+ N E IL+ P ++
Sbjct: 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD---------ICR 635
+ L ++ EYM G L ++ + + + +
Sbjct: 65 KLYYSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAELVL 112
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS------------------ 677
L +H++ +HRD+K N L++ +K+ DFGL + + +
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 678 ----------PMRDSSSA-GTPEWMAPELIRNEPFTEKCDIFSLGVIMWE 716
++S GTP+++APE++R P+ +CD +SLGVI++E
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 3/156 (1%)
Query: 571 EISILSRLRHPNVILFLG-ACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLK 628
E IL+++ H I+ L A L ++ M G L YH+ ++ + R
Sbjct: 43 EKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF 101
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 688
I GL +H+ +I++RDLK N L++ V+I D GL+ + D + AGTP
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161
Query: 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 724
+MAPEL++ E + D F+LGV ++E+ P+
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 10/191 (5%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 588
+G G FG+V R G A+K+ ++ + A++ + E +L RHP +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
A RL + EY G L+ HLS +++ + R +I L +H +V+R
Sbjct: 63 AFQTHDRLCFVMEYANGGELF--FHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 649 DLKSANCLVNKHWTVKICDFGLSR--IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 706
D+K N +++K +KI DFGL + I + M+ + GTPE++APE++ + + D
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 707 IFSLGVIMWEL 717
+ LGV+M+E+
Sbjct: 178 WWGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-15
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 547 GTDVAIKVFLEQDLTAENM-EDFCNEISILSRLRHPNVILFLGACTKPP-RLSMITEYME 604
G +VAIK+ E+ F E ++ +RL HPN++ L + PP L + EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 605 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-----K 659
+L ++ G L +++ + L C H IVHRDLK N +V+
Sbjct: 63 GRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 660 HWTVKICDFGLSRIITDSPMRDSSSA-------GTPEWMAPELIRNEPFTEKCDIFSLGV 712
H K+ DFG+ ++ D ++ GTP + APE +R EP T D+++ G+
Sbjct: 120 H--AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 713 IMWELCTLNRPWEGVLPERVVY 734
I E T R +G ++Y
Sbjct: 178 IFLECLTGQRVVQGASVAEILY 199
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 4/147 (2%)
Query: 571 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 630
E +L + HP+VI M+ + LY +L+ + + L + L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLY--TYLTKRSRPLPIDQALIIE 163
Query: 631 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 690
+ I GL +H +I+HRD+K+ N +N V I D G ++ +P AGT E
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA-FLGLAGTVET 222
Query: 691 MAPELIRNEPFTEKCDIFSLGVIMWEL 717
APE++ + + K DI+S G++++E+
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 28/256 (10%)
Query: 532 VGIGFFGEVF-----RGIWNGTDVAIKVFLEQDLT--AENMEDFCNEISILSRLRH-PNV 583
+G G +G+VF G +G A+KV + + A+ E E +L +R P +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
+ A +L +I +Y+ G L+ HLS Q+++ + +I L +H++
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELF--THLS-QRERFKEQEVQIYSGEIVLALEHLHKL 124
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTPEWMAPELIR--NEP 700
I++RD+K N L++ + V + DFGLS+ D R S GT E+MAP+++R +
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184
Query: 701 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAE 760
+ D +S+GV+M+EL T P+ + S+ EI R++
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASPFT---------VDGEKNSQAEISR----RILKSEPPY 231
Query: 761 PQE-RPSCEEILSRLL 775
PQE ++I+ RLL
Sbjct: 232 PQEMSALAKDIIQRLL 247
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 532 VGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCNEISILSRLRHPNVIL 585
+G G +G V I +G VAIK F L + E+ IL +H N+I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR----ELKILRHFKHDNIIA 68
Query: 586 FLGACTKPPRLSMITEY--MEL--GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 641
+PP Y M+L L+H+IH S Q R L + RGL IH
Sbjct: 69 IR-DILRPPGADFKDVYVVMDLMESDLHHIIH-SDQPLTEEHIRYF--LYQLLRGLKYIH 124
Query: 642 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS----SSAGTPEWMAPELIR 697
++HRDLK +N LVN+ ++I DFG++R ++ SP T + APEL+
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 698 NEP-FTEKCDIFSLGVIMWEL 717
+ P +T D++S+G I E+
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-15
Identities = 56/195 (28%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 532 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 588
+G G FG+V++ T A+KV ++++ A+ + E +IL R +G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 589 ---ACTKPPRLSMITEYMELGSLY-HLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
+ L ++T+YM G L+ HL + + S R + ++ L +H+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD 116
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP-FTE 703
IV+RDLK N L++ + +CDFGLS+ ++ GT E++APE++ +E +T+
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
Query: 704 KCDIFSLGVIMWELC 718
D +SLGV+++E+C
Sbjct: 177 HVDFWSLGVLVFEMC 191
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 51/190 (26%), Positives = 98/190 (51%), Gaps = 7/190 (3%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQD-LTAENMEDFCNEISILSR-LRHPNVILFL 587
+G G FG+V + +G+ A+KV ++ L + E ++L + L+HP ++
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 647
+ +L + +Y+ G L+ HL ++ L R + ++ + +H + I++
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARF-YAAEVASAIGYLHSLNIIY 119
Query: 648 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 707
RDLK N L++ V + DFGL + + S+ GTPE++APE++R EP+ D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 708 FSLGVIMWEL 717
+ LG +++E+
Sbjct: 180 WCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-14
Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 33/224 (14%)
Query: 532 VGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAEN---MEDFCNEISILSRLRHPNVILF 586
+G G GEV+ VA+K E DL +EN + F E I + L HP ++
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIRE-DL-SENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKL--------SWRRKLKMLRDICRGLM 638
C+ + Y+E +L L+ QK+ L S L + IC +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT---------DSPMRDSSSA---- 685
+H ++HRDLK N L+ V I D+G + D R+ +
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187
Query: 686 -----GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 724
GTP++MAPE + P +E DI++LGVI++++ TL+ P+
Sbjct: 188 PGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 49/132 (37%), Positives = 69/132 (52%), Gaps = 15/132 (11%)
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS--SAGTP----EWMAPELIRNE 699
VHRDL + N L+ + VKICDFGL+R I MRDS+ S G+ +WMAPE I N
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDI----MRDSNYISKGSTFLPLKWMAPESIFNN 316
Query: 700 PFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 755
+T D++S G+++WE+ TL P+ + Y G R+ P + ++
Sbjct: 317 LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQ 376
Query: 756 DCWAEPQE-RPS 766
CW E E RP
Sbjct: 377 KCWEEKFEIRPD 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 18/156 (11%)
Query: 571 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSW 623
E+ +L P ++ F GA +S+ E+M+ GSL ++ +G+ K ++
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108
Query: 624 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 683
R L LR+ KI+HRD+K +N LVN +K+CDFG+S + DS M + S
Sbjct: 109 LRGLTYLREK---------HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN-S 157
Query: 684 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 719
GT +M+PE ++ +T + DI+SLG+ + E+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 53/154 (34%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 571 EISILSRLRHPNVILFLGACTKPPR------LSMITEYMELGSLYHLIHLSGQKKKLSWR 624
EI +L L H NVI + PP + ++ E M+ L+ +I S Q LS
Sbjct: 54 EIKLLRHLDHENVIA-IKDIMPPPHREAFNDVYIVYELMDT-DLHQIIR-SSQT--LSDD 108
Query: 625 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 684
L + RGL IH ++HRDLK +N L+N + +KICDFGL+R ++ +
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEY 168
Query: 685 AGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWEL 717
T + APEL+ N +T D++S+G I EL
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 9/210 (4%)
Query: 532 VGIGFFGEVFRGIWNGTD--VAIKVFLEQD--LTAENMEDFCNEISILS-RLRHPNVILF 586
+G G FG+VF GT+ AIK L++D L +++E E +LS HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKA-LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
L + EY+ G L I S K L R +I GL +H IV
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQ-SCHKFDLP--RATFYAAEIICGLQFLHSKGIV 118
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 706
+RDLK N L++ +KI DFG+ + + + GTP+++APE++ + + D
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVD 178
Query: 707 IFSLGVIMWELCTLNRPWEGVLPERVVYAV 736
+S GV+++E+ P+ G E + ++
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 21/157 (13%)
Query: 571 EISILSRLRHPNVILFLGACTKPPRLSMITEY---MEL--GSLYHLIHLSGQKKKLSWRR 625
E+ ++ + H N+I L T L + MEL +L +I + +++S+
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY-- 122
Query: 626 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685
+L + G+ +H I+HRDLK +N +V T+KI DFGL+R S M
Sbjct: 123 ---LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----- 174
Query: 686 GTPE-----WMAPELIRNEPFTEKCDIFSLGVIMWEL 717
TP + APE+I + E DI+S+G IM E+
Sbjct: 175 -TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 12/232 (5%)
Query: 528 VGTRVGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVI 584
V + VG G FGEV R G A+KV + L A E + F E ILS P +
Sbjct: 5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIP 64
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
A L ++ EY G L L L+ + + L ++ + +H+M
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLSL--LNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR------ 697
VHRD+K N L+++ +K+ DFG + R+ + + GTP+++APE++
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 698 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP 749
+ +CD +SLGVI +E+ P+ + + N L+ PE P
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP 234
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 9/194 (4%)
Query: 531 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAE--NMEDFCNEISILSRLRHPNVILF 586
++G G + V++G G VA+K E L AE EIS++ L+H N++
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALK---EIHLDAEEGTPSTAIREISLMKELKHENIVRL 63
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
+L ++ EYM+ L + G + L + +G+ H +++
Sbjct: 64 HDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE-LIRNEPFTEKC 705
HRDLK N L+NK +K+ DFGL+R S+ T + AP+ L+ + ++
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSI 182
Query: 706 DIFSLGVIMWELCT 719
DI+S+G IM E+ T
Sbjct: 183 DIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 33/221 (14%)
Query: 528 VGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCN------------EIS 573
G +G G +G+V + G VAIK +++ + +D E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 574 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 633
I++ ++H N++ + + ++++ + M L + +K +L+ + +L I
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMA----SDLKKVVDRKIRLTESQVKCILLQI 128
Query: 634 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG------- 686
GL +H+ +HRDL AN +N KI DFGL+R P D+ S
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 687 --TPE----WM-APELIRN-EPFTEKCDIFSLGVIMWELCT 719
T + W APEL+ E + D++S+G I EL T
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 57/190 (30%), Positives = 95/190 (50%), Gaps = 8/190 (4%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLG 588
+G G FG+V R G A+K+ ++ + A + + E +L RHP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
+ RL + EY G L+ HLS +++ S R +I L +H +V+R
Sbjct: 63 SFQTHDRLCFVMEYANGGELF--FHLS-RERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 649 DLKSANCLVNKHWTVKICDFGLSRI-ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 707
DLK N +++K +KI DFGL + I+D + GTPE++APE++ + + D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 708 FSLGVIMWEL 717
+ LGV+M+E+
Sbjct: 179 WGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 44/141 (31%), Positives = 67/141 (47%), Gaps = 19/141 (13%)
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 704
++HRD+K +N L++ VK+CDFG+S + DS + SAG +MAPE I K
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS-KAKTRSAGCAAYMAPERIDPPDPNPK 194
Query: 705 CDI----FSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRLEIPEGPLG-------- 751
DI +SLG+ + EL T P++ E V+ + E E P P
Sbjct: 195 YDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE----EPPSLPPNEGFSPDFC 250
Query: 752 RLIADCWA-EPQERPSCEEIL 771
+ C + ++RP E+L
Sbjct: 251 SFVDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 54/157 (34%), Positives = 77/157 (49%), Gaps = 17/157 (10%)
Query: 571 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK-------KKLSW 623
E+ +L ++H NVI L T E +Y + HL G +KL+
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPA------RSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 119
Query: 624 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 683
++ I RGL IH I+HRDLK +N VN+ +KI DFGL+R TD M +
Sbjct: 120 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEM--TG 176
Query: 684 SAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCT 719
T + APE++ N + + DI+S+G IM EL T
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 9e-14
Identities = 54/194 (27%), Positives = 95/194 (48%), Gaps = 14/194 (7%)
Query: 571 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 630
E+ +L P ++ F GA +S+ E+M+ GSL ++ + K++ K+
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKVS 109
Query: 631 RDICRGLMCI-HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 689
+ RGL + + +I+HRD+K +N LVN +K+CDFG+S + DS +S GT
Sbjct: 110 IAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRS 167
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP--------WEGVLPERVVYAVANEGS 741
+M+PE ++ ++ + DI+S+G+ + EL P E + VV E
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227
Query: 742 RLEIPEGPLGRLIA 755
+ P GR ++
Sbjct: 228 SISPRPRPPGRPVS 241
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 7/190 (3%)
Query: 532 VGIGFFGEVFRGIWNGTDV--AIKVFLEQDLTAENMED--FCNEISILSRLRHPNVILFL 587
+G G FG+V + A+KV ++ + + E +L ++HP ++
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 647
+ +L + +Y+ G L++ HL ++ L R + +I L +H + IV+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFY--HLQRERCFLEPRARF-YAAEIASALGYLHSLNIVY 119
Query: 648 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 707
RDLK N L++ + + DFGL + + S+ GTPE++APE++ +P+ D
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 708 FSLGVIMWEL 717
+ LG +++E+
Sbjct: 180 WCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 46/162 (28%), Positives = 85/162 (52%), Gaps = 9/162 (5%)
Query: 568 FCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 627
F E I++ P V+ A L M+ EYM G L +L +S W +
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL--MSNYDVPEKWAKFY 147
Query: 628 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDSSSAG 686
++ L IH M ++HRD+K N L++KH +K+ DFG + ++ M R ++ G
Sbjct: 148 TA--EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 687 TPEWMAPELIRNEP----FTEKCDIFSLGVIMWELCTLNRPW 724
TP++++PE+++++ + +CD +S+GV ++E+ + P+
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 45/157 (28%), Positives = 80/157 (50%), Gaps = 4/157 (2%)
Query: 570 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLK 628
NE IL ++ V+ A L ++ M G L +H+ H+ + R +
Sbjct: 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG--EAGFEEGRAVF 106
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 688
+IC GL +H+ +IV+RDLK N L++ H ++I D GL+ + + GT
Sbjct: 107 YAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTV 165
Query: 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWE 725
+MAPE+++NE +T D ++LG +++E+ P++
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 50/212 (23%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 527 TVGTRVGIGFFG----EVFRGIWNGTDVAIKVFLEQDLTAENMEDFC---NEISILSRLR 579
+ T +G F + + T VA+K +L + + ED EI +L+
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKI---NLDSCSKEDLKLLQQEIITSRQLQ 57
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLI--HLSGQKKKLSWRRKLKMLRDICRGL 637
HPN++ ++ + L +++ M GS L+ H +L+ +L+D+ L
Sbjct: 58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF---ILKDVLNAL 114
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS----------RIITDSPMRDSSSAGT 687
IH +HR +K+++ L++ V + S R++ D P SS
Sbjct: 115 DYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK---SSVKN 171
Query: 688 PEWMAPELIRN--EPFTEKCDIFSLGVIMWEL 717
W++PE+++ + + EK DI+S+G+ EL
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 73/268 (27%), Positives = 114/268 (42%), Gaps = 30/268 (11%)
Query: 531 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFC--NEISILSRLRHPNVILF 586
++G G + V++GI NG VA+KV + E F E S+L L+H N++L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVI---SMKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
L+ + EYM ++I G + R L M + + RGL IH I+
Sbjct: 69 HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVR--LFMFQ-LLRGLAYIHGQHIL 125
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFTEK 704
HRDLK N L++ +K+ DFGL+R P + SS W P L+ ++
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 705 CDIFSLGVIMWELCTLNRPWEGV--LPERV-----VYAVANEG-----SRL-----EIPE 747
DI+ G I E+ + GV + E++ V V E S+L E
Sbjct: 185 LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFL 244
Query: 748 GPLGRLIADCWAEPQERPSCEEILSRLL 775
+ + W P E++ S++L
Sbjct: 245 PCKPQQLRVVWKRLSRPPKAEDLASQML 272
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 14/195 (7%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 587
R+G G +G V+R + VA+K V ++ + + EI++L LRHPN++
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-REITLLLNLRHPNIVELK 72
Query: 588 GACTKPPRLS--MITEYME--LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
S ++ EY E L SL L S + ++ + RGL +H
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASL-----LDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFT 702
I+HRDLK +N L+ +KI DFGL+R + T + APEL+ +T
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT 187
Query: 703 EKCDIFSLGVIMWEL 717
D++++G I+ EL
Sbjct: 188 TAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 587
++G G + V++G TD VA+K + LE + A E+S+L L+H N++
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHANIVTLH 70
Query: 588 GACTKPPRLSMITEYME------LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 641
L+++ EY++ L + I++ K L + RGL H
Sbjct: 71 DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKL---------FLFQLLRGLNYCH 121
Query: 642 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNE 699
R K++HRDLK N L+N+ +K+ DFGL+R P + S+ W P L+ +
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 700 PFTEKCDIFSLGVIMWELCTLNRP 723
++ + D++ +G I +E+ T RP
Sbjct: 181 DYSTQIDMWGVGCIFYEMST-GRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 46/154 (29%), Positives = 85/154 (55%), Gaps = 6/154 (3%)
Query: 571 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 630
E+ +L P ++ F GA +S+ E+M+ GSL ++ +G ++ + K+
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVS 109
Query: 631 RDICRGLMCI-HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 689
+ +GL + + KI+HRD+K +N LVN +K+CDFG+S + DS +S GT
Sbjct: 110 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRS 167
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 723
+M+PE ++ ++ + DI+S+G+ + E+ P
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 532 VGIGFFGEV----FRGIWNGTDVAIK----VFLEQDLTAENMEDFCNEISILSRLR-HPN 582
+G G +G V VAIK VF ++ L + E+ +L R H N
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63
Query: 583 VI-LFLGACTKPPRLSMITEYMEL--GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
+ L+ P + + Y EL L+ +I SGQ L+ + I GL
Sbjct: 64 ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR-SGQP--LTDAHFQSFIYQILCGLKY 120
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS----SSAGTPEWMAPE- 694
IH ++HRDLK N LVN +KICDFGL+R +++P ++ T + APE
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 695 LIRNEPFTEKCDIFSLGVIMWEL 717
++ + +T+ D++S+G I+ EL
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 37/128 (28%), Positives = 69/128 (53%), Gaps = 8/128 (6%)
Query: 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN 658
I +Y++ G L+ L+ ++ KLS K++R + L +H+ I+H D+K N L +
Sbjct: 87 IMDYIKDGDLFDLLK---KEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143
Query: 659 KH-WTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 717
+ + +CD+GL +II D GT ++ +PE I+ + D +++GV+ +EL
Sbjct: 144 RAKDRIYLCDYGLCKIIGTPSCYD----GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYEL 199
Query: 718 CTLNRPWE 725
T P++
Sbjct: 200 LTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 6/159 (3%)
Query: 570 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLK 628
NE IL ++ V+ A L ++ M G L +H+ ++ R +
Sbjct: 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG--NPGFDEERAVF 106
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-PMRDSSSAGT 687
+I GL +HR +IV+RDLK N L++ + ++I D GL+ I + +R GT
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR--GRVGT 164
Query: 688 PEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
+MAPE+++NE +T D + LG +++E+ P+
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 504 ESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---VAIKVFLEQDL 560
+ P +NK + YE++N + +G G FG V + D VAIK F + +
Sbjct: 19 KEPKRKNK--MKYEDFNFIRT-------LGTGSFGRVILATYKNEDFPPVAIKRFEKSKI 69
Query: 561 TAENMEDFC-NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKK 619
+ D +E IL+ + HP + G+ L ++ E++ G + +
Sbjct: 70 IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL------- 122
Query: 620 KLSWRRKLKMLRD--------ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671
RR + D I + + IV+RDLK N L++K +K+ DFG +
Sbjct: 123 ----RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178
Query: 672 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 717
+++ R + GTPE++APE++ N + D ++LG+ ++E+
Sbjct: 179 KVVD---TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221
|
Length = 340 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-13
Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 16/213 (7%)
Query: 522 DFSELTVGTRVGIGFFGEVF-----RGIWNGTDVAIKVFLEQDLT--AENMEDFCNEISI 574
+F L V +G G +G+VF G G A+KV + L A+ +E E ++
Sbjct: 1 NFELLKV---LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNV 57
Query: 575 LSRLRH-PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 633
L +R P ++ A +L +I +Y+ G ++ HL Q+ S +I
Sbjct: 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMF--THLY-QRDNFSEDEVRFYSGEI 114
Query: 634 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTPEWMA 692
L +H++ IV+RD+K N L++ V + DFGLS+ +++ R S GT E+MA
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 693 PELIRNEPFTEKC-DIFSLGVIMWELCTLNRPW 724
PE+IR + K D +SLG++++EL T P+
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC-NE---ISILSRLRHPNVIL 585
+G G FGEV+ R G A+K ++ + + E NE +S++S P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 586 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
A P +L I + M G L++ HLS Q S + +I GL +H +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHY--HLS-QHGVFSEKEMRFYATEIILGLEHMHNRFV 118
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI-RNEPFTEK 704
V+RDLK AN L+++H V+I D GL+ S + +S GT +MAPE++ + +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSS 176
Query: 705 CDIFSLGVIMWELCTLNRPW 724
D FSLG ++++L + P+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 6/189 (3%)
Query: 532 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589
VG G +G V + T VAIK F + + E E E+ +L L+ N++ A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 590 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 649
+ +L ++ EY+E L L + R + L + + H+ IVHRD
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL---IKAIHWCHKNDIVHRD 125
Query: 650 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APELIRNEPFTEKCDIF 708
+K N L++ + +K+CDFG +R +++ + + W +PEL+ P+ + D++
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMW 185
Query: 709 SLGVIMWEL 717
S+G I+ EL
Sbjct: 186 SVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 50/191 (26%), Positives = 93/191 (48%), Gaps = 9/191 (4%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED---FCNEISILSRLRHPNVILF 586
+G G FG+V + +G A+KV L++ + E +L ++HP ++
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKV-LQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
+ +L + +++ G L+ HL ++ R + +I L +H + IV
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARF-YAAEIASALGYLHSINIV 118
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 706
+RDLK N L++ V + DFGL + ++ GTPE++APE+IR +P+ D
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVD 178
Query: 707 IFSLGVIMWEL 717
+ LG +++E+
Sbjct: 179 WWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 532 VGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAENMEDF-CNEISILSRLRHPNVILFLG 588
+G G FGEV R A+K+ + ++ + F E I++ P V+
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
A L M+ EYM G L +L +S W R ++ L IH M +HR
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNL--MSNYDVPEKWARFYTA--EVVLALDAIHSMGFIHR 166
Query: 649 DLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIRNEP----FTE 703
D+K N L++K +K+ DFG ++ + +R ++ GTP++++PE+++++ +
Sbjct: 167 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226
Query: 704 KCDIFSLGVIMWELCTLNRPW 724
+CD +S+GV ++E+ + P+
Sbjct: 227 ECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 7/225 (3%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 588
+G G FG+V + G A+K+ ++ + A++ + E +L RHP +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK-IVH 647
+ RL + EY G L+ HLS +++ S R +I L +H K +V+
Sbjct: 63 SFQTHDRLCFVMEYANGGELF--FHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 648 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 707
RDLK N +++K +KI DFGL + + GTPE++APE++ + + D
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 179
Query: 708 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR 752
+ LGV+M+E+ P+ E++ + E R P +
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAK 224
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 49/190 (25%), Positives = 96/190 (50%), Gaps = 7/190 (3%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEISIL-SRLRHPNVILFL 587
+G G FG+V + +G A+KV ++ + + + E ++L ++HP ++
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 647
+ +L + +Y+ G L+ HL ++ R + +I L +H + I++
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFF--HLQRERSFPEPRARF-YAAEIASALGYLHSLNIIY 119
Query: 648 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 707
RDLK N L++ V + DFGL + + S+ GTPE++APE++R +P+ D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179
Query: 708 FSLGVIMWEL 717
+ LG +++E+
Sbjct: 180 WCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 529 GTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI--- 584
G +VG G +G V++ +G D + + T +M C EI++L L+HPNVI
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA-CREIALLRELKHPNVIALQ 64
Query: 585 -LFLGACTKPPRLSMITEYMELGSLYHLIHL----SGQKKKLSWRRKL--KMLRDICRGL 637
+FL + ++ ++ +Y E L+H+I KK + R + +L I G+
Sbjct: 65 KVFLSHSDR--KVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 638 MCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITD--SPMRDSSSAGTPEWM 691
+H ++HRDLK AN LV + VKI D G +R+ P+ D W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 692 -APELIRN-EPFTEKCDIFSLGVIMWELCT 719
APEL+ +T+ DI+++G I EL T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 532 VGIGFFGEVFR-----GIWNGTDVAIKVFLEQDLTAENMEDFCN---EISILSRLRHPNV 583
+G G +G+VF+ G G A+KV L++ N +D + E +IL ++HP +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKV-LKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM-------LRDICRG 636
+ + A +L +I EY+ G L+ +HL R + M L +I
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELF--MHLE--------REGIFMEDTACFYLSEISLA 112
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
L +H+ I++RDLK N L++ VK+ DFGL + + GT E+MAPE++
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL 172
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
+ D +SLG +M+++ T P+
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 30/87 (34%), Positives = 55/87 (63%), Gaps = 4/87 (4%)
Query: 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI---RNE 699
+KI+HRD+K +N L++++ +K+CDFG+S + DS + + AG +MAPE I +
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPERIDPSARD 185
Query: 700 PFTEKCDIFSLGVIMWELCTLNRPWEG 726
+ + D++SLG+ ++E+ T P+
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 587
++G G + VF+G T+ VA+K + LE + A E+S+L L+H N++
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA--IREVSLLKNLKHANIVTLH 69
Query: 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 647
L+++ EY++ L + G + K+ M + + RGL H+ KI+H
Sbjct: 70 DIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMH-NVKIFMFQ-LLRGLSYCHKRKILH 126
Query: 648 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFTEKC 705
RDLK N L+N+ +K+ DFGL+R P + S+ W P L+ + ++
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 706 DIFSLGVIMWELCTLNRP 723
D++ +G I++E+ T RP
Sbjct: 186 DMWGVGCILYEMAT-GRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 522 DFSELTVGTRVGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAE-NMEDFCNEISILSRL 578
DF + V +G G FGEV R + A+K+ + ++ + F E I++
Sbjct: 44 DFDVIKV---IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
++ A L M+ EYM G L +L +S W R ++ L
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL--MSNYDIPEKWARFYTA--EVVLALD 156
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR 697
IH M +HRD+K N L++K +K+ DFG ++ + +R ++ GTP++++PE+++
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK 216
Query: 698 NE----PFTEKCDIFSLGVIMWEL 717
++ + +CD +S+GV ++E+
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 529 GTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI--- 584
G +VG G +G V++ +G D + + T +M C EI++L L+HPNVI
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQ 64
Query: 585 -LFLGACTKPPRLSMITEYMELGSLYHLIHL----SGQKKKLSWRRKL--KMLRDICRGL 637
+FL + ++ ++ +Y E L+H+I KK + R + +L I G+
Sbjct: 65 KVFLSHADR--KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 638 MCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITD--SPMRDSSSAGTPEWM 691
+H ++HRDLK AN LV + VKI D G +R+ P+ D W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 692 -APELIRN-EPFTEKCDIFSLGVIMWELCT 719
APEL+ +T+ DI+++G I EL T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 52/177 (29%), Positives = 86/177 (48%), Gaps = 13/177 (7%)
Query: 547 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS------MIT 600
G +VA+K + + E+ +L + H N+I L T L ++
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 660
E M+ +L +IH+ +++S+ +L + G+ +H I+HRDLK +N +V
Sbjct: 106 ELMD-ANLCQVIHMELDHERMSY-----LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 159
Query: 661 WTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 717
T+KI DFGL+R + M + T + APE+I + E DI+S+G IM EL
Sbjct: 160 CTLKILDFGLARTACTNFMM-TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 3/131 (2%)
Query: 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSAN 654
RL ++ EY+ G L + H+ Q+K L +IC L +H I++RDLK N
Sbjct: 70 RLFLVIEYVNGGDL--MFHMQRQRK-LPEEHARFYAAEICIALNFLHERGIIYRDLKLDN 126
Query: 655 CLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIM 714
L++ +K+ D+G+ + S+ GTP ++APE++R E + D ++LGV+M
Sbjct: 127 VLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLM 186
Query: 715 WELCTLNRPWE 725
+E+ P++
Sbjct: 187 FEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 13/196 (6%)
Query: 531 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFL 587
++G G +G V+ R G VA+K + D E + EIS+L L HPN++ L
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 588 GACTKPPRLSMITEYM--ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
+L ++ E++ +L LSG L ++L+ GL H ++
Sbjct: 66 DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQ----GLAFCHSHRV 121
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APE-LIRNEPFTE 703
+HRDLK N L+N +K+ DFGL+R P+R + W APE L+ + ++
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 704 KCDIFSLGVIMWELCT 719
DI+SLG I E+ T
Sbjct: 181 AVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 18/217 (8%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQD--LTAENMEDFCNEISILSRLR-HPNVILF 586
+G G FG+V R +G A+KV L++D L +++E E ILS R HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKV-LKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
P RL + E++ G L I S ++ R +I LM +H I+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKGII 118
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 706
+RDLK N L++ K+ DFG+ + + S+ GTP+++APE+++ + D
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVD 178
Query: 707 IFSLGVIMWELCTLNRPWEG---------VLPERVVY 734
+++GV+++E+ + P+E +L + VVY
Sbjct: 179 WWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY 215
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC-NE---ISILSRLRHPNVIL 585
+G G FGEV+ R G A+K ++ + + E NE +S++S P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 586 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
A P +LS I + M G L++ HLS Q S +I GL +H +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHY--HLS-QHGVFSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE-LIRNEPFTEK 704
V+RDLK AN L+++H V+I D GL+ S + +S GT +MAPE L + +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 176
Query: 705 CDIFSLGVIMWELCTLNRPWEG 726
D FSLG ++++L + P+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 551 AIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 609
A+K +Q+L N ++ E IL+ +P V+ + L M+ EY+E G
Sbjct: 30 AMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCA 89
Query: 610 HLIHLSGQKKKLSWRRKLKMLR----DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 665
L+ G + M R + L +H IVHRDLK N L+ +K+
Sbjct: 90 TLLKNIGA-------LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKL 142
Query: 666 CDFGLSRI------------ITDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSL 710
DFGLS+I + R D GTPE++APE+I + + + D +++
Sbjct: 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 202
Query: 711 GVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG 748
G+I++E P+ G PE + V ++ +E PEG
Sbjct: 203 GIILYEFLVGCVPFFGDTPEELFGQVISD--DIEWPEG 238
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 587
++G G + VF+G T+ VA+K + LE + A E+S+L L+H N++
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHANIVTLH 70
Query: 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 647
L+++ EY++ L + G +S L I RGL HR K++H
Sbjct: 71 DIVHTDKSLTLVFEYLD-KDLKQYMDDCGNI--MSMHNVKIFLYQILRGLAYCHRRKVLH 127
Query: 648 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFTEKC 705
RDLK N L+N+ +K+ DFGL+R P + S+ W P L+ + ++ +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 706 DIFSLGVIMWELCTLNRP 723
D++ +G I +E+ + RP
Sbjct: 187 DMWGVGCIFFEMAS-GRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 532 VGIGFFGEVFRGIWNGTD--VAIKVFLEQD--LTAENMEDFCNEISILSRLRHPNVILFL 587
+G G FG+V G A+K L++D L +++E E +L+ L N L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKA-LKKDVVLIDDDVECTMVEKRVLA-LAWENPFLTH 60
Query: 588 GACT--KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
CT L + E++ G L I K + R +I GL +H I
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKC 705
++RDLK N ++++ +KI DFG+ + R S+ GTP+++APE+++ +T
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV 177
Query: 706 DIFSLGVIMWELCTLNRPWEG 726
D +S GV+++E+ P+ G
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 531 RVGIGFFGEVFRG---IWNGTDVAIKVFLEQD-----LTAENMEDFCNEISILSRLRHPN 582
++G G +G V++ + N T K+ LEQ+ TA EIS+L ++H N
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA------IREISLLKEMQHGN 62
Query: 583 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM-LRDICRGLMCIH 641
++ RL ++ EY++L H+ K R +K L I RG+ H
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP---RLIKTYLYQILRGIAYCH 119
Query: 642 RMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDSPMRDSSSAGTPEWM-APE-LIRN 698
+++HRDLK N L+++ +K+ DFGL+R P+R + W APE L+ +
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVVTLWYRAPEILLGS 178
Query: 699 EPFTEKCDIFSLGVIMWELCTLNRP 723
++ DI+S+G I E+ +P
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVN-QKP 202
|
Length = 294 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 24/202 (11%)
Query: 530 TRVGIGFFGEVFRGI--WNGTDVAIKVF---LEQDLTAENMEDFCNEISILSRLRHPNVI 584
+VG G +G V I G VAIK + ++ A+ E+++L ++H NVI
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY---RELTLLKHMQHENVI 77
Query: 585 LFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
L T ++ YM+ L + G LS + ++ + GL
Sbjct: 78 GLLDVFTSAVSGDEFQDFYLVMPYMQT----DLQKIMGHP--LSEDKVQYLVYQMLCGLK 131
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 698
IH I+HRDLK N VN+ +KI DFGL+R D+ M + T + APE+I N
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEM--TGYVVTRWYRAPEVILN 188
Query: 699 -EPFTEKCDIFSLGVIMWELCT 719
+ + DI+S+G IM E+ T
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 82/297 (27%), Positives = 120/297 (40%), Gaps = 71/297 (23%)
Query: 532 VGIGFFGEVFRGIWN--GTDVAIK----VFLEQDLTAENMED---FCNEISILSRLRHPN 582
+G G +G V I G VAIK VF E++ D EI +L LRHP+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVF-------EHVSDATRILREIKLLRLLRHPD 60
Query: 583 VILFLGACTKPPR-----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
++ P R + ++ E ME L+ +I L+ L + R L
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI---KANDDLTPEHHQFFLYQLLRAL 116
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI-ITDSPMRD--SSSAGTPEWMAPE 694
IH + HRDLK N L N +KICDFGL+R+ D+P + T + APE
Sbjct: 117 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176
Query: 695 LIRN--EPFTEKCDIFSLGVIMWELCTLNRP----------------WEGVLPERVVYAV 736
L + +T DI+S+G I E+ T +P G + V
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235
Query: 737 ANEGSRLEI----PEGP-----------------LGRLIADCWAEPQERPSCEEILS 772
NE +R + + P L RL+A +P++RP+ EE L+
Sbjct: 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLA---FDPKDRPTAEEALA 289
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 531 RVGIGFFGEVFRGI--WNGTDVAIK-VFLEQDLTAENMEDFC-NEISILSRLRHPNVILF 586
++G G +G VF+ VA+K V L+ D E + EI +L L+H N++
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRL 64
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
+L+++ EY + + +G + + + +GL H ++
Sbjct: 65 YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK---SFMFQLLKGLAFCHSHNVL 121
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFTEK 704
HRDLK N L+NK+ +K+ DFGL+R P+R S+ W P L + ++
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 180
Query: 705 CDIFSLGVIMWELCTLNRP 723
D++S G I EL RP
Sbjct: 181 IDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 67/267 (25%), Positives = 119/267 (44%), Gaps = 36/267 (13%)
Query: 532 VGIGFFGEVFRGI---------WNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHP 581
+G G F ++F+GI + T+V +KV D + N E F S++S+L H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVL---DKSHRNYSESFFEAASMMSQLSHK 59
Query: 582 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 641
+++L G C M+ EY++ GSL + + +SW KL++ + + L +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE 117
Query: 642 RMKIVHRDLKSANCLVNKHWT--------VKICDFGLSRIITDSPMRDSSSAGTPEWMAP 693
+ H ++ + N L+ + +K+ D G+S IT P ++ P W+ P
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLP-KEILLERIP-WVPP 173
Query: 694 ELIRN-EPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---G 748
E I N + + D +S G +WE+ + ++P + ++ + R ++P
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE---DRHQLPAPKWT 230
Query: 749 PLGRLIADC-WAEPQERPSCEEILSRL 774
L LI C EP RPS I+ L
Sbjct: 231 ELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 4/156 (2%)
Query: 571 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKM 629
E IL ++ P ++ A L ++ M G L YH+ ++ ++ L R +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVG--ERGLEMERVIHY 100
Query: 630 LRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 689
I G++ +H M IV+RD+K N L++ ++ D GL+ + D + AGT
Sbjct: 101 SAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNG 159
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWE 725
+MAPE+++ EP++ D F++G ++E+ P++
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 532 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-----FCNEISILSRLR---HP 581
+G+G +G V+ R +G VA+K + + ED E+++L RL HP
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALK-----SVRVQTNEDGLPLSTVREVALLKRLEAFDHP 62
Query: 582 NVILFLGACT-----KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
N++ + C + +++++ E+++ +L + + L +R RG
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDL--MRQFLRG 120
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
L +H IVHRDLK N LV VK+ DFGL+RI + M + T + APE++
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMALTPVVVTLWYRAPEVL 179
Query: 697 RNEPFTEKCDIFSLGVIMWEL 717
+ D++S+G I E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 68/263 (25%), Positives = 106/263 (40%), Gaps = 44/263 (16%)
Query: 522 DFSELTVGTRVGIGFFGEV--FRGIWNGTDVAIKVFLEQD-LTAENMEDFCNEISILSRL 578
DF L V +G G FGEV + G A+K+ + D L E + E IL
Sbjct: 2 DFESLKV---IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA 58
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
V+ + L +I E++ G + L+ +K LS + + +
Sbjct: 59 DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAID 115
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS------------RIITDSPMRD----- 681
IH++ +HRD+K N L++ VK+ DFGL R +T +P D
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 682 ------------------SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 723
S+ GTP+++APE+ + + CD +SLGVIM+E+ P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 724 WEGVLPERVVYAVANEGSRLEIP 746
+ P+ V N L P
Sbjct: 236 FCSETPQETYRKVMNWKETLVFP 258
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 50/155 (32%), Positives = 76/155 (49%), Gaps = 17/155 (10%)
Query: 571 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK-------KKLSW 623
E+ +L ++H NVI L T + E +Y + +L G +KLS
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPATSIENFNE------VYLVTNLMGADLNNIVKCQKLSD 117
Query: 624 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 683
++ + RGL IH I+HRDLK +N VN+ ++I DFGL+R D M +
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDEM--TG 174
Query: 684 SAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWEL 717
T + APE++ N + + DI+S+G IM EL
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 532 VGIGFFGEVF--RGIWNGTD-VAIKVFLEQDLTAENME-DFCNEISILSRLR---HPNVI 584
+G G +G+VF R + NG VA+K Q E M E+++L L HPNV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 585 LFLGACT-----KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
CT + +L+++ E+++ +L + + + M+ + RGL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDF 125
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 699
+H ++VHRDLK N LV +K+ DFGL+RI + M +S T + APE++
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQS 184
Query: 700 PFTEKCDIFSLGVIMWEL 717
+ D++S+G I E+
Sbjct: 185 SYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 27/84 (32%), Positives = 55/84 (65%), Gaps = 6/84 (7%)
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR- 697
+H++ VHRD+K N L++K+ +++ DFG R++ D ++ + + GTP++++PE+++
Sbjct: 118 VHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177
Query: 698 ----NEPFTEKCDIFSLGVIMWEL 717
+ +CD +SLGV M+E+
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 13/153 (8%)
Query: 571 EISILSRLRHPNVILFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWR 624
E+ ++ + H N+I L T L ++ E M+ +L +I + +++S+
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY- 123
Query: 625 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 684
+L + G+ +H I+HRDLK +N +V T+KI DFGL+R S M +
Sbjct: 124 ----LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPY 178
Query: 685 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 717
T + APE+I + E DI+S+G IM E+
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 3/148 (2%)
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
HP ++ RL + EY+ G L + H+ Q+K L +I L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK-LPEEHARFYSAEISLALNY 111
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 699
+H I++RDLK N L++ +K+ D+G+ + S+ GTP ++APE++R E
Sbjct: 112 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 700 PFTEKCDIFSLGVIMWELCTLNRPWEGV 727
+ D ++LGV+M+E+ P++ V
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 532 VGIGFFGEVFRGIWNGTD--VAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPNV 583
+G G +G+V++ T VA+K V L+ + +TA EI IL +L H N+
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA------IREIKILRQLNHRNI 68
Query: 584 ILFLGACT----------KPPRLSMITEYME---LGSLYH-LIHLSGQKKKLSWRRKLKM 629
+ T ++ EYM+ +G L L+H S K
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-------SF 121
Query: 630 LRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 689
++ + GL H+ +HRD+K +N L+N +K+ DFGL+R+ R ++
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181
Query: 690 WMAPE--LIRNEPFTEKCDIFSLGVIMWELCTLNRP 723
W P L+ E + D++S G I+ EL T +P
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 2e-10
Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 40/169 (23%)
Query: 571 EISILSRLR-HPNVILFLGACTKPPR------LSMITEYMELGSLYHLIHLSGQKKKLSW 623
EI L L HPN++ L + + ++ EYME L+ +I + +
Sbjct: 56 EIMFLQELGDHPNIVKLLNVI----KAENDKDIYLVFEYME-TDLHAVI-----RANI-- 103
Query: 624 RRKLKMLRDI---------CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674
L D+ + L IH ++HRDLK +N L+N VK+ DFGL+R +
Sbjct: 104 ------LEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157
Query: 675 TDSPMRDSSSAGT----PEWM-APE-LIRNEPFTEKCDIFSLGVIMWEL 717
++ + T W APE L+ + +T+ D++S+G I+ E+
Sbjct: 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEM 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 6/159 (3%)
Query: 570 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM 629
NE IL ++ V+ A L ++ M G L I+ G R L
Sbjct: 49 NEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFY 107
Query: 630 LRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS--SSAGT 687
+I GL +HR V+RDLK N L++ + ++I D GL+ I P +S GT
Sbjct: 108 AAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI---PEGESIRGRVGT 164
Query: 688 PEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
+MAPE++ N+ +T D + LG +++E+ P+ G
Sbjct: 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 43/150 (28%), Positives = 75/150 (50%), Gaps = 5/150 (3%)
Query: 571 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 630
E IL + HP++I G T +I + LY +L+ K+ ++ L +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLY--CYLAA-KRNIAICDILAIE 188
Query: 631 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD-SPMRDSSSAGTPE 689
R + R + +H +I+HRD+K+ N +N V + DFG + D + + AGT
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCT 719
APEL+ +P+ DI+S G++++E+ T
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 13/153 (8%)
Query: 571 EISILSRLRHPNVILFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWR 624
E+ ++ + H N+I L T L ++ E M+ +L +I + +++S+
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY- 130
Query: 625 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 684
+L + G+ +H I+HRDLK +N +V T+KI DFGL+R S M
Sbjct: 131 ----LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 685 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 717
T + APE+I + E DI+S+G IM E+
Sbjct: 187 V-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 41/161 (25%), Positives = 66/161 (40%), Gaps = 45/161 (27%)
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS---RIITDS--------PMRDS------ 682
+H+M +HRD+K N L+++ +K+ DFGL R DS +DS
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 683 --------------------------SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWE 716
S GTP ++APE++ +T+ CD +S+GVI++E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 717 LCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADC 757
+ P+ P V N + L IP +L +
Sbjct: 237 MLVGQPPFLADTPAETQLKVINWETTLHIP--SQAKLSREA 275
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 4/156 (2%)
Query: 570 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLK 628
NE IL ++ V+ A L ++ M G L +H+ ++ +R +
Sbjct: 49 NEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG--NPGFDEQRAIF 106
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 688
++C GL + R +IV+RDLK N L++ ++I D GL+ I + GT
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTV 165
Query: 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 724
+MAPE+I NE +T D + LG +++E+ P+
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 37/133 (27%), Positives = 69/133 (51%), Gaps = 3/133 (2%)
Query: 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 652
RL + E++ G L + H+ +++KL +I L +H I++RDLK
Sbjct: 68 ESRLFFVIEFVSGGDL--MFHMQ-RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKL 124
Query: 653 ANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGV 712
N L++ +K+ D+G+ + S+ GTP ++APE++R E + D ++LGV
Sbjct: 125 DNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 184
Query: 713 IMWELCTLNRPWE 725
+M+E+ P++
Sbjct: 185 LMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 528 VGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 585
+G +G G FG V+ I T VAIK L QD +N E+ I+ L H N+I
Sbjct: 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVL-QDPQYKN-----RELLIMKNLNHINIIF 123
Query: 586 ----FLGACTKPPR----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
+ C K L+++ E++ ++ H + L +CR L
Sbjct: 124 LKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183
Query: 638 MCIHRMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
IH I HRDLK N L+ N H T+K+CDFG ++ + + R S + + APEL
Sbjct: 184 AYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAKNLL-AGQRSVSYICSRFYRAPEL 241
Query: 696 IRNEP-FTEKCDIFSLGVIMWEL 717
+ +T D++SLG I+ E+
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 38/116 (32%)
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS------------RIITDSPMRDS----- 682
IH++ +HRD+K N L++ +K+ DFGL RI++ + +
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 683 ---------------------SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 717
S+ GTP+++APE+ + ++CD +SLGVIM+E+
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 36/213 (16%)
Query: 532 VGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNV----- 583
+G G G VF + + D VA+K + L ++++ EI I+ RL H N+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 584 ILFLGACTKPPRLSMIT---------EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
+L + +T EYME L ++ Q +L M + +
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMET----DLANVLEQGPLSEEHARLFMYQ-LL 124
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTV-KICDFGLSRIITDSPMRDS---SSAGTPEW 690
RGL IH ++HRDLK AN +N V KI DFGL+RI+ D S +W
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV-DPHYSHKGYLSEGLVTKW 183
Query: 691 M-APELI---RNEPFTEKCDIFSLGVIMWELCT 719
+P L+ N +T+ D+++ G I E+ T
Sbjct: 184 YRSPRLLLSPNN--YTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 21/197 (10%)
Query: 533 GIGFFGEVFRGIWNGTD--VAIKVF-LEQD----LTAENMEDFCNEISILSRLRHPNVIL 585
G G + V++G T VA+K LE + TA E S+L L+H N++
Sbjct: 14 GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA------IREASLLKDLKHANIVT 67
Query: 586 FLGACTKPPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
L+++ EY++ Y G LS L + RGL H+ +
Sbjct: 68 LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG----LSMHNVRLFLFQLLRGLAYCHQRR 123
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFT 702
++HRDLK N L+++ +K+ DFGL+R P + S+ W P L+ + ++
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 703 EKCDIFSLGVIMWELCT 719
D++ +G I +E+ T
Sbjct: 183 TSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 6/158 (3%)
Query: 571 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 630
EI IL + H +I + A + M+ + L+ + SG L + + +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSG---PLPLEQAITIQ 191
Query: 631 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTP 688
R + L +H I+HRD+K+ N +++ + DFG + + P + +GT
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTL 251
Query: 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
E +PEL+ +P+ K DI+S G++++E+ N G
Sbjct: 252 ETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 30/113 (26%), Positives = 61/113 (53%), Gaps = 6/113 (5%)
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR- 697
+H++ VHRD+K N L++ + +++ DFG +++ D ++ S + GTP++++PE+++
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 698 ----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 746
+ +CD +SLGV M+E+ P+ + N R + P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 68/274 (24%), Positives = 110/274 (40%), Gaps = 45/274 (16%)
Query: 522 DFSELTVGTRVGIGFFGEV--FRGIWNGTDVAIKVFLEQD-LTAENMEDFCNEISILSRL 578
DF L V +G G FGEV + G A+K+ + D L E + E IL
Sbjct: 2 DFESLKV---IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA 58
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
V+ + L +I E++ G + L+ +K L+ + + +
Sbjct: 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAID 115
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGL---------------------------- 670
IH++ +HRD+K N L++ VK+ DFGL
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 671 --SRIITDSPMRDS-----SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 723
S+ ++ R+ S+ GTP+++APE+ + + CD +SLGVIM+E+ P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 724 WEGVLPERVVYAVANEGSRLEI-PEGPLGRLIAD 756
+ P+ V N L PE P+ D
Sbjct: 236 FCSETPQETYKKVMNWKETLIFPPEVPISEKAKD 269
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 64/265 (24%), Positives = 106/265 (40%), Gaps = 53/265 (20%)
Query: 532 VGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 588
+GIG FGEV R + A+K ++D+ N + E IL+ + V+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
+ L + +Y+ G + L+ G + R + L C + +H+M +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAEL--TC-AVESVHKMGFIHR 125
Query: 649 DLKSANCLVNKHWTVKICDFGLS---RIITDS--------PMRDS--------------- 682
D+K N L+++ +K+ DFGL R DS +DS
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185
Query: 683 ---------------------SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN 721
S GTP ++APE++ +T+ CD +S+GVI++E+
Sbjct: 186 GDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245
Query: 722 RPWEGVLPERVVYAVANEGSRLEIP 746
P+ P V N + L IP
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIP 270
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 570 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK--L 627
NEI L RL H N++ MIT+ + LY ++ + W+ + L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMY----DEAFDWKDRPLL 266
Query: 628 KMLRDICRGLMC----IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDS 682
K R I + L+C IH K++HRD+K N +N + + DFG + D
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 717
GT +PE++ + + E DI+S G+I+ ++
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 6e-09
Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 32/240 (13%)
Query: 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEIS 573
Y++ +E V ++G G FGEVF T K + L E++
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 574 ILSRLRHPNVILFLGACTKPP--RLSMITEYMELGSLYHLIHLSGQK-KKLSWRRKLKML 630
++ L+H N++ ++ +L ++ E+ + G L I + K+ + +
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124
Query: 631 RDICRGLMCIHRMK-------IVHRDLKSANCLV-----------------NKHWTVKIC 666
R + L H +K ++HRDLK N + N KI
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 667 DFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCTLNRPW 724
DFGLS+ I M S GTP + +PEL+ +E + +K D+++LG I++ELC+ P+
Sbjct: 185 DFGLSKNIGIESMA-HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 31/113 (27%), Positives = 60/113 (53%), Gaps = 6/113 (5%)
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIRN 698
IH++ VHRD+K N L++ + +++ DFG ++ D ++ S + GTP++++PE+++
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 699 E-----PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 746
+ +CD +SLGV M+E+ P+ + N R + P
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 13/193 (6%)
Query: 531 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFC--NEISILSRLRHPNVILF 586
++G G + V++G NG VA+KV Q+ E F E S+L L+H N++L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQE---EEGTPFTAIREASLLKGLKHANIVLL 68
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
L+++ EY+ ++ G L L + RGL IH+ I+
Sbjct: 69 HDIIHTKETLTLVFEYVHTDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQRYIL 125
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFTEK 704
HRDLK N L++ +K+ DFGL+R P S+ W P L+ + ++
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 705 CDIFSLGVIMWEL 717
D++ +G I E+
Sbjct: 185 LDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 26/199 (13%)
Query: 547 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 606
GT V +++ ++ T E+++ NE+ + RHPN++ T L +I+ +M G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 607 SLYHLIHL---SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 663
S L+ G + L +L RGL +H+ +HR++K+++ L++ V
Sbjct: 85 SANSLLKTYFPEGMSEALIG----NILFGALRGLNYLHQNGYIHRNIKASHILISGDGLV 140
Query: 664 KICDFGLS------------RIITDSPMRDSSSAGTPEWMAPELIRNE--PFTEKCDIFS 709
+ GLS +++ D P S++ P W++PEL+R + + K DI+S
Sbjct: 141 SLS--GLSHLYSLVRNGQKAKVVYDFP--QFSTSVLP-WLSPELLRQDLYGYNVKSDIYS 195
Query: 710 LGVIMWELCTLNRPWEGVL 728
+G+ EL T P++ +L
Sbjct: 196 VGITACELATGRVPFQDML 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 61/266 (22%), Positives = 105/266 (39%), Gaps = 55/266 (20%)
Query: 532 VGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 588
+GIG FGEV + A+K ++D+ N + E IL+ + V+
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
+ L + +Y+ G + L+ ++ R + ++ + +H+M +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARF---YIAELTLAIESVHKMGFIHR 125
Query: 649 DLKSANCLVNKHWTVKICDFGL----------------SRIITDSPMRDS---------- 682
D+K N L++ +K+ DFGL S I DS M S
Sbjct: 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS-MEPSDLWDDVSNCR 184
Query: 683 ----------------------SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL 720
S GTP ++APE++ + +T+ CD +S+GVI++E+
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG 244
Query: 721 NRPWEGVLPERVVYAVANEGSRLEIP 746
P+ P V N + L IP
Sbjct: 245 QPPFLAPTPTETQLKVINWENTLHIP 270
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 33/131 (25%), Positives = 59/131 (45%), Gaps = 48/131 (36%)
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-------------RIIT----------- 675
+H++ +HRD+K N L+++ +K+ DFGLS +++
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 676 DSPMRDS-----------------------SSAGTPEWMAPELIRNEPFTEKCDIFSLGV 712
+S DS S+ GTP+++APE+ + + ++CD +SLG
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236
Query: 713 IMWELCTLNRP 723
IM+E C + P
Sbjct: 237 IMFE-CLIGWP 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 531 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED------FCNEISILSRLRHPN 582
++G G +G+V+ R G VA+K T M++ EIS+L L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKK------TRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 583 VILFLGAC------TKPPRLSMITEYM--ELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
I+ L P L ++ EY+ +L + + G + L + + +
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKK-FMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTV-KICDFGLSRIITDSPMRDSSSAGTPEWM-A 692
+G+ H+ ++HRDLK N LV+K + KI D GL R + P++ + W A
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-IPVKSYTHEIVTLWYRA 179
Query: 693 PE-LIRNEPFTEKCDIFSLGVIMWELCTLN 721
PE L+ + ++ DI+S+G I E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 46/206 (22%), Positives = 83/206 (40%), Gaps = 49/206 (23%)
Query: 551 AIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 609
A+KV ++++ N ++ E IL+ L HP + + L ++ +Y G L+
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 610 HLIHLSGQKKKLSWRRKLKMLRD---------ICRGLMCIHRMKIVHRDLKSANCLVNKH 660
L+ R+ K L + + L +H + IV+RDLK N L+++
Sbjct: 90 RLLQ----------RQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES 139
Query: 661 WTVKICDFGLS----------RIITDSPMRDSSSA-------------------GTPEWM 691
+ + DF LS R SS GT E++
Sbjct: 140 GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYI 199
Query: 692 APELIRNEPFTEKCDIFSLGVIMWEL 717
APE+I + D ++LG++++E+
Sbjct: 200 APEVISGDGHGSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 21/157 (13%)
Query: 570 NEISILSRLRHPNVILFLG-------ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 622
+E +L RL HP V+ L C P+ LY +L + + L
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR--------SDLY--TYLGARLRPLG 258
Query: 623 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG---LSRIITDSPM 679
+ + R + + IH I+HRD+K+ N LVN + + DFG +R +P
Sbjct: 259 LAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWE 716
AGT + APE++ +P+T DI+S G++++E
Sbjct: 319 H-YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-07
Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 14/153 (9%)
Query: 570 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM 629
+EI+ + +L+HPN++ +G C +I EY+E +L ++ + LSW R+ K+
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKI 785
Query: 630 LRDICRGLMCIH---RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 686
I + L +H +V +L +++ + L ++ SSA
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA- 843
Query: 687 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 719
++APE + TEK DI+ G+I+ EL T
Sbjct: 844 ---YVAPETRETKDITEKSDIYGFGLILIELLT 873
|
Length = 968 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-07
Identities = 39/142 (27%), Positives = 69/142 (48%), Gaps = 6/142 (4%)
Query: 535 GFFGEVF--RGIWNGTDVAIKVFLEQDLTAENM-EDFCNEISILSRLRHPNVILFLGACT 591
G FG+V+ R N A+KV + D+ +NM E L+ + P ++ +
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 592 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLK 651
+ ++ EY+ G + L+H+ G +K + ++ L +HR I+HRDLK
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGY---FDEEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 652 SANCLVNKHWTVKICDFGLSRI 673
N L++ +K+ DFGLS++
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 33/100 (33%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 569
E+W L G +G G FG+V G VA+K+ L+ + E
Sbjct: 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKM-LKASAHTDEREALM 89
Query: 570 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL 608
+E+ ILS L +H N++ LGACT + +ITEY G L
Sbjct: 90 SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 9/103 (8%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 571
W + L +G +G G FG V +G VA+K+ ++E + +E
Sbjct: 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEK-QALMSE 90
Query: 572 ISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH 613
+ I+S L H N++ LGACTK + +ITEY G L +H
Sbjct: 91 LKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 45/196 (22%), Positives = 85/196 (43%), Gaps = 24/196 (12%)
Query: 546 NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 605
G V ++ + T E + E+ + HPN++ + L ++T +M
Sbjct: 24 TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83
Query: 606 GSLYHLI--HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 663
GS LI H +L+ +L+ + + L IH M VHR +K+++ L++
Sbjct: 84 GSAKDLICTHFMDGMSELAIAY---ILQGVLKALDYIHHMGYVHRSVKASHILISVDG-- 138
Query: 664 KICDFGL------------SRIITDSPMRDSSSAGTPEWMAPELIRN--EPFTEKCDIFS 709
K+ GL R++ D P S W++PE+++ + + K DI+S
Sbjct: 139 KVYLSGLRSNLSMINHGQRLRVVHDFP---KYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 195
Query: 710 LGVIMWELCTLNRPWE 725
+G+ EL + P++
Sbjct: 196 VGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 24/221 (10%)
Query: 568 FCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 627
F S++S++ H ++ G C + M+ E++E G L + + ++W K+
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 628 KMLRDICRGLMCIHRMKIVHRDLKSANCLV-------NKHWTVKICDFGLSRIITDSPMR 680
+ + + L + +VH ++ + N L+ +K+ D G+S R
Sbjct: 121 TVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS---R 177
Query: 681 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELC-TLNRPWEGVLP---ERVVYA 735
+ P W+APE + + D +S G + E+C P + P ER
Sbjct: 178 EERVERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY-- 234
Query: 736 VANEGSRLEIPEGP-LGRLIADCWA-EPQERPSCEEILSRL 774
+ RL P L LI+ C EP +RPS IL L
Sbjct: 235 --EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFCN 570
+W L +G +G G FG+V G D VA+K+ L++ TA + +
Sbjct: 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKM-LKEGATASEHKALMS 59
Query: 571 EISILSRL-RHPNVILFLGACTKPP-RLSMITEYMELGSL 608
E+ IL + H NV+ LGACTKP L +I E+ + G+L
Sbjct: 60 ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 35/159 (22%), Positives = 68/159 (42%), Gaps = 14/159 (8%)
Query: 568 FCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 627
F S++ ++ H +++L G C + M+ E++E G L +H W K
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108
Query: 628 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT-------VKICDFGLSRIITDSPMR 680
K+ + + L + +VH ++ + N L+ + +K+ D G+ + R
Sbjct: 109 KVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS---R 165
Query: 681 DSSSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELC 718
P W+APE + + + D +S G +WE+C
Sbjct: 166 QECVERIP-WIAPECVEDSKNLSIAADKWSFGTTLWEIC 203
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 9/103 (8%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 571
W L +G +G G FG+V G G VA+K+ ++E + +E
Sbjct: 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEK-QALMSE 90
Query: 572 ISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH 613
+ I++ L H N++ LGACTK + +ITEY G L + +H
Sbjct: 91 LKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 3/83 (3%)
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
L +HR IV RDL N L++ +++ F + DS ++ + APE+
Sbjct: 98 LDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVEN---MYCAPEVG 154
Query: 697 RNEPFTEKCDIFSLGVIMWELCT 719
TE CD +SLG I++EL T
Sbjct: 155 GISEETEACDWWSLGAILFELLT 177
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 12/101 (11%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFCN 570
+W L +G +G G FG+V + G + VA+K+ L++ TA +
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKM-LKEGATASEYKALMT 59
Query: 571 EISILSRL-RHPNVILFLGACTKP--PRLSMITEYMELGSL 608
E+ IL + H NV+ LGACTKP P L +I EY + G+L
Sbjct: 60 ELKILIHIGHHLNVVNLLGACTKPGGP-LMVIVEYCKFGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 10/100 (10%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFCN 570
+W L +G +G G FG+V G D VA+K+ L++ T +
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRALMS 59
Query: 571 EISILSRL-RHPNVILFLGACTKP-PRLSMITEYMELGSL 608
E+ IL + H NV+ LGACTKP L +I E+ + G+L
Sbjct: 60 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 20/41 (48%), Positives = 26/41 (63%)
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 669
++R + GL +HR+ IVHRD+K N LV VKI DFG
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 32/150 (21%), Positives = 55/150 (36%), Gaps = 35/150 (23%)
Query: 539 EVFRGIWNGTDVAIKV---------FLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589
++ + G +K L++ L E E IL++ R G
Sbjct: 11 IIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTR---REARILAKARE------AGV 61
Query: 590 CT------KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
P ++ EY+E G L K + +LR++ R + +H+
Sbjct: 62 PVPIVYDVDPDNGLIVMEYIE-GELL---------KDALEEARPDLLREVGRLVGKLHKA 111
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRI 673
IVH DL ++N +++ I DFGL
Sbjct: 112 GIVHGDLTTSNIILSGGRIYFI-DFGLGEF 140
|
Length = 204 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 16/34 (47%), Positives = 25/34 (73%)
Query: 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWE 716
S P +MAPE+I+ + +TEK DI+SLG+ ++E
Sbjct: 63 QSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYE 96
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 782 | |||
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.12 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.72 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.44 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.38 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.31 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.31 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.19 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.11 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.06 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.92 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.92 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.72 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.7 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.69 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.68 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.63 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.52 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.42 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.3 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.23 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 97.15 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.11 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.11 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.1 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.08 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.92 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.82 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.76 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.62 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.24 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.22 | |
| PF01841 | 113 | Transglut_core: Transglutaminase-like superfamily; | 96.15 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.11 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.94 | |
| COG5279 | 521 | CYK3 Uncharacterized protein involved in cytokines | 95.83 | |
| PLN02236 | 344 | choline kinase | 95.28 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.18 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.14 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.06 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.93 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.78 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.57 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.03 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.96 | |
| COG1305 | 319 | Transglutaminase-like enzymes, putative cysteine p | 92.82 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.33 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 92.26 | |
| PTZ00384 | 383 | choline kinase; Provisional | 91.79 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 91.42 |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-60 Score=482.32 Aligned_cols=196 Identities=39% Similarity=0.612 Sum_probs=178.9
Q ss_pred Cchhhhhhhhhcccccc--cccCCcceEeeccc---hhhhhcCCCCChhhhhhcCCCCceeEEEEEecccchhHHHHHHH
Q 003971 55 LSSQTASQILWSTGMLS--EPIPNGFYSVIPDK---RLKELFDSIPTVDELHALGGEGHRADIILVDSKKDKKLSMLKQL 129 (782)
Q Consensus 55 ~~~~~~s~~~w~~~~~~--~~~~~gfy~~~~~~---~~~~~~~~~p~~~~l~~~~~~~~~~~~i~vd~~~d~~~~~l~~l 129 (782)
+++|++|||||++|+|| |+||||||+|+||+ .|++.++||||+++|++++++++++||||||+..|++|.+|+|.
T Consensus 1 ~~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~~~~~~~EvIlVDr~~D~~L~~L~~~ 80 (204)
T PF14381_consen 1 SSAESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVPPDDSSREVILVDRRRDPSLKELEQR 80 (204)
T ss_pred CcHHHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCCCCCCCeeEEEEccccCHHHHHHHHH
Confidence 47899999999999999 99999999999995 67788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChHHHHHHHHHHHHhhhCCCCCCChhh--hhHHHHHHHHhh-cceeEeccccccccchhhHHHHHHhhhc
Q 003971 130 IVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAK--AALEETSHMFET-RGVQLLGQIRHGSCRPRAILFKVLADTV 206 (782)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~a~~v~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~g~i~~g~~r~ra~lfkvlad~~ 206 (782)
+..+.++++++++++|++||++||++|||+ +..++. ..|++.++.|++ +|++|||+|++|+|||||||||||||+|
T Consensus 81 a~~~~~~~~~~~~~~v~~LA~lVa~~MGG~-~~~~~~~~~~w~~~s~~lk~~s~~vplG~l~~G~~rhRALLFKvLAD~i 159 (204)
T PF14381_consen 81 AHELSKGLSTNTKELVQKLAKLVADRMGGP-VSDAEDMLFRWELRSEKLKENSGVVPLGSLRIGLCRHRALLFKVLADRI 159 (204)
T ss_pred HHHHHhccccCHHHHHHHHHHHHHHHhCCC-CCcchhhhHHHHHHHHHHHhCCCeEEEeeecccchHHHHHHHHHHHHhc
Confidence 999999999889999999999999999999 444333 889998876655 4499999999999999999999999999
Q ss_pred CCccccccccCCCCccccccccCcceEEEEeCCeeeeeecccCCCcccc
Q 003971 207 GLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSVELLVDLMRFPGQLIP 255 (782)
Q Consensus 207 ~l~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (782)
|||||||||++..|+ +..+|+.+|+..+++|||||||++||+|+|
T Consensus 160 glpCrLvrG~~y~g~----~~~~a~~~V~~~~~~eyiVDLm~~PG~L~P 204 (204)
T PF14381_consen 160 GLPCRLVRGCYYCGW----DDDDASNLVKFDDGREYIVDLMGAPGQLIP 204 (204)
T ss_pred CCCceEEeeccCCcc----CCCCceEEEEcCCCcEEEEEcCCCCCCcCC
Confidence 999999999997776 555677777777999999999999999998
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=447.13 Aligned_cols=360 Identities=30% Similarity=0.514 Sum_probs=288.9
Q ss_pred HHHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCcc-CCCcccccccccccccccccCCCCCCCc
Q 003971 397 AVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEIS-GGRSALYNLSRDQMNSQKAISLPSSPHE 475 (782)
Q Consensus 397 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~rs~~~~l~r~~~~s~~~~slPssp~~ 475 (782)
-+++|.|.+++++|+++++..|+|++|+|+ ..++++.+++...+... +...+||.+......... + .++....
T Consensus 84 f~~~isR~~ae~~ll~p~~~~G~flvR~se----~~~g~yslsv~~~~~~~~~~~v~hyri~~~~~~~~~-~-~~~~~~~ 157 (468)
T KOG0197|consen 84 FFGKISREEAERQLLAPENKEGAFLVRESE----SDKGDYSLSVREGDSGGLGAKVKHYRIRQLDGGGLY-P-YIDEREL 157 (468)
T ss_pred hhccccHHHHHHhhcCCCCCccceeeeccc----CCcCCeeEEEEeccccCCccceeeeeeeEcCCCCee-c-CCCHHHh
Confidence 478999999999999999999999999998 88999999888776554 778888877654211110 0 0111111
Q ss_pred cCC------CCCCCCCCCCCCCCchhhhhhhhhccCCccc---CCC---ccccccccccCCCeeEeeEEeeeCcEEEEEE
Q 003971 476 YGS------HGSERGGSSGYMANSEFVSTWNKVLESPMFQ---NKP---LLAYEEWNIDFSELTVGTRVGIGFFGEVFRG 543 (782)
Q Consensus 476 ~~s------~~S~~~~ss~~~~~s~~~s~~~~~l~sp~~~---~~p---~~~~~e~~i~~s~y~i~~~LG~G~fG~VYkg 543 (782)
+.+ +.+..+ .+ ....+..|... ..| ....+.|+++.+.+++.+.||+|.||+||.|
T Consensus 158 F~~l~~lv~~~~~~~--~g----------l~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g 225 (468)
T KOG0197|consen 158 FSSLQQLVNYYSKNA--DG----------LCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLG 225 (468)
T ss_pred hhhHHHHHhhhhccC--cc----------hhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEE
Confidence 110 000000 00 00111111111 111 2237889999999999999999999999999
Q ss_pred EECCe-EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccchhhHHHhhcccccch
Q 003971 544 IWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 622 (782)
Q Consensus 544 ~~~g~-~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls 622 (782)
.+++. +||+|.++...+. .+.|.+|+++|++|+|+|||+++++|..++.+|||||||+.|+|.++|.. ..+..+.
T Consensus 226 ~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~-~~~~~l~ 301 (468)
T KOG0197|consen 226 KWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT-REGGLLN 301 (468)
T ss_pred EEcCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh-cCCCccc
Confidence 99877 9999999876554 36789999999999999999999999998899999999999999999974 3567899
Q ss_pred HHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCC-CCCCCcccCccccccCCC
Q 003971 623 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS-SAGTPEWMAPELIRNEPF 701 (782)
Q Consensus 623 ~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~-~~GT~~Y~APEvl~~~~~ 701 (782)
..+.+.++.|||+||+||+++++|||||.+.||||+++..+||+|||||+...++.+.... ..-...|+|||.+..+.+
T Consensus 302 ~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~F 381 (468)
T KOG0197|consen 302 LPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKF 381 (468)
T ss_pred hHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCc
Confidence 9999999999999999999999999999999999999999999999999976665554333 233458999999999999
Q ss_pred CchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCh---HHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 702 TEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 702 s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~~---~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
+.|+|||||||+||||+| |+.||.+.+..+++..+ ..+++++.|+. .+++||..||. +|++||||+.+...|++
T Consensus 382 S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 382 SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 999999999999999997 67899999998888765 56888888854 69999999999 99999999999999998
Q ss_pred hhh
Q 003971 777 CEY 779 (782)
Q Consensus 777 i~~ 779 (782)
+-.
T Consensus 461 ~~~ 463 (468)
T KOG0197|consen 461 FFT 463 (468)
T ss_pred hhh
Confidence 753
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=418.03 Aligned_cols=264 Identities=46% Similarity=0.768 Sum_probs=239.8
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEECCeE-EEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~-VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
..+|.++..++.+.+.||+|+||+||+|.+.|+. ||||++..........+.|.+|+.+|.+++|||||+|+|+|.++.
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred ccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3567778888888899999999999999999999 999999877766555789999999999999999999999999988
Q ss_pred -ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc-ccccCCCcccEEEcCCC-eEEEEecCcc
Q 003971 595 -RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK-IVHRDLKSANCLVNKHW-TVKICDFGLS 671 (782)
Q Consensus 595 -~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g-IIHrDIKPeNILLd~~g-~VKLaDFGLA 671 (782)
.+.+||||+++|+|.++++.. ....+++..++.++.||++||.|||+++ ||||||||+||||+.++ ++||+|||++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 799999999999999999843 4678999999999999999999999999 99999999999999998 9999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccc--cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh-
Q 003971 672 RIITDSPMRDSSSAGTPEWMAPELIR--NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG- 748 (782)
Q Consensus 672 ~~l~~~~~~~~~~~GT~~Y~APEvl~--~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~~- 748 (782)
+.........+...||+.|||||++. ..+|+.|+||||||++||||+||+.||.+..+..+...+...+.++.+|..
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 88765433444578999999999999 669999999999999999999999999999998888899889999998863
Q ss_pred --HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 749 --PLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 749 --~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
.+..|+..||. ||.+||++.+|+..|+.+...
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 58899999999 999999999999999988653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=414.08 Aligned_cols=247 Identities=30% Similarity=0.461 Sum_probs=227.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
..|..++.||+|||+.||.+.+ .|..||+|++.+..+ .....+.+.+||++.+.|+|||||+|+++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999976 799999999977654 3445678899999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
|+|..++|..+++ ..+.+++..++.+++||+.||.|||+++|||||||..|+||+++.+|||+|||||..+..+...
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 9999999999987 5679999999999999999999999999999999999999999999999999999999877677
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHHHhhh
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIADCWA 759 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-~~~L~~LI~~CL~ 759 (782)
..+.||||.|+|||++....++..+||||+||+||.||+|++||......+.+..+....+..+-. ..+..+||.++|.
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 789999999999999999999999999999999999999999999999999999988766655433 3468999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003971 760 -EPQERPSCEEILSR 773 (782)
Q Consensus 760 -DP~kRPSa~EIL~~ 773 (782)
||.+|||+++|+.+
T Consensus 255 ~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDH 269 (592)
T ss_pred CCcccCCCHHHHhcC
Confidence 99999999999976
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=390.03 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=222.7
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
...++|.+++.||+|+||+||.++. +++.||+|++++..... ...+....|..+|..++||+||+++..|++...+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 4568999999999999999999965 68899999998776543 35678889999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+|+||+.||.|+.+|. ..+.+++..++-++.+|+.||.|||++|||||||||+|||||.+|+++|+||||++.....
T Consensus 102 lVld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999999997 5678999999999999999999999999999999999999999999999999999976655
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CC-CCChHHHHHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LE-IPEGPLGRLIA 755 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~-~~-ip~~~L~~LI~ 755 (782)
.....+.|||+.|||||++.+..|+..+|+||||+++|||++|..||.+.+.......+...... ++ .-....++++.
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 55666789999999999999999999999999999999999999999999999999988876622 22 23457899999
Q ss_pred Hhhh-CCCCCC----CHHHHHHH
Q 003971 756 DCWA-EPQERP----SCEEILSR 773 (782)
Q Consensus 756 ~CL~-DP~kRP----Sa~EIL~~ 773 (782)
.++. ||++|. ++.+|.+|
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcC
Confidence 9999 999995 56665443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=387.90 Aligned_cols=247 Identities=27% Similarity=0.519 Sum_probs=217.0
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
..+|.+.++||+|+||+||+|.+ ++..||||.+.+..+..+..+.+..|+.+|+.++|||||.|++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 46899999999999999999987 6889999999988888888899999999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC------CeEEEEecCccccc
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH------WTVKICDFGLSRII 674 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~------g~VKLaDFGLA~~l 674 (782)
|||.||+|.++++ ..+.+++..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.+
T Consensus 89 EyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999998 45589999999999999999999999999999999999999764 57999999999998
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC----hHH
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE----GPL 750 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~----~~L 750 (782)
... ....+.||+|-|||||++..+.|+.|+|+||+|++||+|++|+.||...+..+....+.......+.++ .++
T Consensus 166 ~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 166 QPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL 244 (429)
T ss_pred Cch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence 754 445689999999999999999999999999999999999999999999999988886655444444332 245
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 751 GRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 751 ~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+|+...++ +|..|.++.+...+
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhh
Confidence 567777676 88888777765543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=387.12 Aligned_cols=246 Identities=32% Similarity=0.516 Sum_probs=218.9
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc-eE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR-LS 597 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~-l~ 597 (782)
+..+++..++.||+|..|+||++.+ +++.+|+|++. -..+....+++.+|+++++.++||+||.+||+|..+.. ++
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 4456788889999999999999988 48899999984 34556667899999999999999999999999999984 99
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++||||++|+|.+++. ..+.+++.....++.+|++||.|||+ ++||||||||+|||++..|.|||||||.+..+.+
T Consensus 155 I~mEYMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred eehhhcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999999997 34689999999999999999999996 9999999999999999999999999999998876
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcCCCCCCCCh---
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV-----LPERVVYAVANEGSRLEIPEG--- 748 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~-----~~~evl~~i~~~~~~~~ip~~--- 748 (782)
. ...+.+||..|||||.+.+..|+.++||||||++++||.+|+.||... ...+.+..++. ...+..|.+
T Consensus 232 S--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~lP~~~fS 308 (364)
T KOG0581|consen 232 S--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRLPEGEFS 308 (364)
T ss_pred h--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCCCcccCC
Confidence 5 557899999999999999999999999999999999999999999764 55666666665 344555543
Q ss_pred -HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 749 -PLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 749 -~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+++.++..|++ ||.+||++.++++|
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 69999999999 99999999999987
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=390.71 Aligned_cols=247 Identities=26% Similarity=0.408 Sum_probs=209.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH-----HHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE-----NMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~-----~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
.+.|.+.+.||+|+||.|-+|.. +|+.||||++.+...... ......+|+++|++|+|||||+++++|...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35688889999999999999966 689999999987654321 22345699999999999999999999999999
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC---CeEEEEecCccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH---WTVKICDFGLSR 672 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~---g~VKLaDFGLA~ 672 (782)
.||||||+.||.|++.+- .++.+.+..-+.+++|++.|+.|||++||+||||||+|||+..+ -.+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999986 56788888899999999999999999999999999999999766 789999999999
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCC--
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVANEGSRLEIP-- 746 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~---~s~ksDVWSLGvILyELLTGk~PF~~~~~~e-vl~~i~~~~~~~~ip-- 746 (782)
.... .....+.||||.|.|||++.++. +..++|+||+||+||-+++|.+||.+..... ...++..+.+...-+
T Consensus 328 ~~g~-~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 328 VSGE-GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred cccc-ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 8864 34567899999999999998754 3348899999999999999999998776655 555554444333222
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 ---EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+...+||..||. ||++|||+.|+|+|
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2357889999999 99999999999976
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=377.03 Aligned_cols=253 Identities=29% Similarity=0.526 Sum_probs=223.2
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEec-cccCCCc-eE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG-ACTKPPR-LS 597 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g-~~~d~~~-l~ 597 (782)
...+|.+.++||.|.||+||++.. +|..+|.|.++...++....+....|+.+|++|+|||||++++ -+.+++. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 346789999999999999999965 8999999999888888888899999999999999999999999 4555554 99
Q ss_pred EEEEEecccchhhHHHhh-cccccchHHHHHHHHHHHHHHHHHHHh--cc--ccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 598 MITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHR--MK--IVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~gL~yLHs--~g--IIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
++||||.+|+|..+++.. ..++.+++..+|+++.|++.||.+||+ .+ |+||||||.||+|+.+|.|||+||||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999998743 345678999999999999999999999 45 9999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC----h
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE----G 748 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~----~ 748 (782)
.+........+.+|||.||+||.+...+|+.|+||||+||++|||+.-+.||.+.+-.++...+.+. ..+++|. .
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~~~YS~ 255 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPDEHYST 255 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcHHHhhh
Confidence 9987766677899999999999999999999999999999999999999999999887777777665 4555663 4
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~ 775 (782)
.+..|+..|+. ||..||+...+++.+.
T Consensus 256 ~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 69999999999 9999999655555443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=384.42 Aligned_cols=261 Identities=36% Similarity=0.698 Sum_probs=226.6
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
.++|++..+++.++..||+|.||+||+|.|.| +||||++.......+..+.|.+|+.++++-+|.||+-|.|+|..+..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 37899999999999999999999999999998 58999999999888999999999999999999999999999998876
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.+|+.+|.|.+|+.+++. ....|...+.+.|++||++||.|||.++|||||||..||+|.+++.|||+||||+....
T Consensus 463 -AIiTqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred -eeeehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 999999999999999984 34689999999999999999999999999999999999999999999999999997643
Q ss_pred CC--CCCCCCCCCCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----
Q 003971 676 DS--PMRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---- 746 (782)
Q Consensus 676 ~~--~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---- 746 (782)
.- ........|...|||||+++. .+|+..+|||||||++|||+||..||.....+.++..+-.+-..+...
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence 21 112234457788999999864 479999999999999999999999999777766666654442223221
Q ss_pred --ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 747 --EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 747 --~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
+..+.+|+..||. ++++||.+.+|+..|+++..+
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1258899999999 999999999999998887653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=383.45 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=221.1
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHHhC-CCCceeeEeccccCCCc
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 595 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~ 595 (782)
....++|.+++.||+|+|++|++|+. .++.||||++.+..+.. ..++-+..|-.+|.+| .||.|++|+..|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44568999999999999999999976 68899999997766533 3355667899999999 79999999999999999
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+|+|+||+++|+|.++++ +-+.|++..++.++.||+.||+|||++|||||||||+||||+.+++++|+|||-|+.+.
T Consensus 149 LYFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred eEEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999999998 55789999999999999999999999999999999999999999999999999999885
Q ss_pred CCCCC---------C----CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 003971 676 DSPMR---------D----SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 742 (782)
Q Consensus 676 ~~~~~---------~----~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~ 742 (782)
..... . ..++||..|.+||++.++..+..+|+|+|||+||+|+.|.+||.+.+.-.+.+.+....+.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~ 305 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE 305 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence 43211 1 3478999999999999999999999999999999999999999999998888888765543
Q ss_pred CCCC-ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 LEIP-EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 ~~ip-~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+-- +..+.+|+.++|. ||.+|+++.+|.+|
T Consensus 306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 3211 2468999999999 99999999999887
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=364.48 Aligned_cols=260 Identities=32% Similarity=0.592 Sum_probs=212.1
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccc
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGAC 590 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~ 590 (782)
|.+..++|++.++||+|+||.||+|.+ .++.||||++.... .......+.+|+.++..+ +||||++++++|
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 667788999999999999999999964 24579999986433 233456789999999999 899999999988
Q ss_pred cCC-CceEEEEEEecccchhhHHHhhcc----------------------------------------------------
Q 003971 591 TKP-PRLSMITEYMELGSLYHLIHLSGQ---------------------------------------------------- 617 (782)
Q Consensus 591 ~d~-~~l~LV~Ey~~gGsL~dlL~~~~~---------------------------------------------------- 617 (782)
... ..++++|||+++|+|.+++.....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 458999999999999998864211
Q ss_pred -------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCC
Q 003971 618 -------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTP 688 (782)
Q Consensus 618 -------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~ 688 (782)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......+++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 13478889999999999999999999999999999999999999999999999986543211 112334667
Q ss_pred cccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCC
Q 003971 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 689 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~k 763 (782)
.|+|||++.+..++.++|||||||++|||++ |..||.+.............+.....+ ...+.+|+.+||. ||.+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 320 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE 320 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 8999999999899999999999999999997 999998765544444444444333333 3468999999999 9999
Q ss_pred CCCHHHHHHHHHhhhh
Q 003971 764 RPSCEEILSRLLDCEY 779 (782)
Q Consensus 764 RPSa~EIL~~L~di~~ 779 (782)
||++.+|++.|+++..
T Consensus 321 RPs~~el~~~l~~~~~ 336 (338)
T cd05102 321 RPTFSALVEILGDLLQ 336 (338)
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=374.00 Aligned_cols=250 Identities=29% Similarity=0.454 Sum_probs=217.2
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC---hHHHHHHHHHHHHHHhCC-CCceeeEeccccCCC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT---AENMEDFCNEISILSRLR-HPNVILFLGACTKPP 594 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~---~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~ 594 (782)
.....|.+++.||+|+||+|+.|.+ .+..||+|++..+... ....+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999977 6899999987654221 122456668999999999 999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC-CeEEEEecCcccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRI 673 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~-g~VKLaDFGLA~~ 673 (782)
.+|+||||+.||.|++++. ..+++.+..++.+++|++.|++|||++||+||||||+|||++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999997 35788999999999999999999999999999999999999999 9999999999998
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCC-CC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--ChH
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRNEP-FT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--EGP 749 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~~~-~s-~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip--~~~ 749 (782)
.........+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.+...+...+.......+-. ...
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 742334567899999999999999987 86 78999999999999999999999988888887766554433322 556
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...|+.+|+. ||.+|+++.+|+.+
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhC
Confidence 8999999999 99999999999954
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=357.64 Aligned_cols=238 Identities=24% Similarity=0.405 Sum_probs=216.9
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
...++|...+.||.|+||+|.+++. +|..||+|++.++.. .-.+++...+|..+|+.+.||+++++++.|.+...+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 4567899999999999999999976 688999999987764 4456788999999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
|||||++||.|+.+++ +.+++++..++-++.||+.||+|||+++|++|||||+|||||.+|++||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999999998 5568999999999999999999999999999999999999999999999999999988653
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIAD 756 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-~~~L~~LI~~ 756 (782)
..+.||||.|+|||++..++|+.++|+|||||++|||+.|..||.+.++..++..++......+-- ...+++|+..
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 357899999999999999999999999999999999999999999999999999998876555432 4468999999
Q ss_pred hhh-CCCCC
Q 003971 757 CWA-EPQER 764 (782)
Q Consensus 757 CL~-DP~kR 764 (782)
+++ |-.+|
T Consensus 275 LL~vD~t~R 283 (355)
T KOG0616|consen 275 LLQVDLTKR 283 (355)
T ss_pred HHhhhhHhh
Confidence 998 88888
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=360.01 Aligned_cols=247 Identities=27% Similarity=0.431 Sum_probs=212.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
+.|..+.++|+|+||+||++++ +|+.||||+|.....++...+-.++||.+|++++|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4677888999999999999976 68899999998776666666778899999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
||+..-|.++-+ ....++...+..+++|++.|+.|||++++|||||||+|||++.+|.+||||||+|+.+..++...
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 999744444433 34568899999999999999999999999999999999999999999999999999987655566
Q ss_pred CCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-------------------C
Q 003971 682 SSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG-------------------S 741 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~-------------------~ 741 (782)
+..+-|.+|.|||++.+ .+|...+||||+||++.||++|..-|++.+.-..++.+...- .
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 77889999999999877 789999999999999999999999999998888877765311 1
Q ss_pred CCCCCC-------------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 RLEIPE-------------GPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 ~~~ip~-------------~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+.|. ..+-+|++.|+. ||.+|++.++++.|
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111 136689999999 99999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=378.62 Aligned_cols=251 Identities=26% Similarity=0.442 Sum_probs=222.5
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
.+..++|.+++.||+|+||.||+|+. +|..||+|++++..+ ...+++.+..|-.+|....+|+||+||..|++...+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 44678999999999999999999965 688999999988775 455678899999999999999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
||||||++||++..+|. ..+.|++..++.++.+++.||+.||+.|+|||||||+|+|||..|++||+||||+.-+..
T Consensus 217 YLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999997 567999999999999999999999999999999999999999999999999999864321
Q ss_pred C----------------------CCC-------------------------CCCCCCCCcccCccccccCCCCchhHHHH
Q 003971 677 S----------------------PMR-------------------------DSSSAGTPEWMAPELIRNEPFTEKCDIFS 709 (782)
Q Consensus 677 ~----------------------~~~-------------------------~~~~~GT~~Y~APEvl~~~~~s~ksDVWS 709 (782)
. ... ....+|||.|+|||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 000 02356999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh-----HHHHHHHHhhhCCCCCC---CHHHHHHH
Q 003971 710 LGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG-----PLGRLIADCWAEPQERP---SCEEILSR 773 (782)
Q Consensus 710 LGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~~-----~L~~LI~~CL~DP~kRP---Sa~EIL~~ 773 (782)
||||+||||.|.+||.+.++.++...+.+.......|.+ +..+||.+|+.||.+|. .++||.+|
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcC
Confidence 999999999999999999999999999987766666643 68899999999999995 57777655
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=352.25 Aligned_cols=244 Identities=27% Similarity=0.475 Sum_probs=213.2
Q ss_pred eEEeeeCcEEEEEEEECCeEEEEEEeeccccCh-HHHHHHHHHHHHHHhCCCCceeeEeccccC----CCceEEEEEEec
Q 003971 530 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTK----PPRLSMITEYME 604 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d----~~~l~LV~Ey~~ 604 (782)
..||+|+++.||+|.++|+.||||++....... ...+.|.+|+.+|++++||||+++++++.+ ...++++|||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 579999999999999999999999987654332 235778899999999999999999999866 356899999999
Q ss_pred ccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003971 605 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 683 (782)
Q Consensus 605 gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~ 683 (782)
+|+|.+++. ....+++...+.++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++.+.... ..
T Consensus 106 ~g~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~ 179 (283)
T PHA02988 106 RGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FK 179 (283)
T ss_pred CCcHHHHHh---hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---cc
Confidence 999999987 34578999999999999999999998 499999999999999999999999999998764432 24
Q ss_pred CCCCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003971 684 SAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 758 (782)
Q Consensus 684 ~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL 758 (782)
..|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.....++..+ +..+.+|+.+||
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 568899999999976 679999999999999999999999999988888877776666666555 346999999999
Q ss_pred h-CCCCCCCHHHHHHHHHhhhh
Q 003971 759 A-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 759 ~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+ ||.+|||+.++++.|+++++
T Consensus 260 ~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 260 SHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred cCCcccCcCHHHHHHHHHHHHh
Confidence 9 99999999999999999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=375.86 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=223.5
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCC
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLR-HPNVILFLGACTKPP 594 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~ 594 (782)
..+..++|.+.++||+|.||+|+++.. +++.||||++++... ....++..+.|..++.... ||.+++++.+|++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 456778999999999999999999977 577899999988774 4566889999999998885 999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
++|+||||+.||++..+. ..+.+++..++-|+..|+.||.|||++||||||||.+|||||.+|++||+|||+++..
T Consensus 443 ~l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred eEEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999999966655 3568999999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHH
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRL 753 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-~~~L~~L 753 (782)
-.......++||||.|+|||++.+..|+..+|+|+|||+||||+.|+.||.+.+.+++...|.+.....++- ..+...|
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~i 598 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAI 598 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHH
Confidence 544556679999999999999999999999999999999999999999999999999999999876655543 4568889
Q ss_pred HHHhhh-CCCCCCC-----HHHHHHH
Q 003971 754 IADCWA-EPQERPS-----CEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPS-----a~EIL~~ 773 (782)
+++++. +|++|.- +.+|.+|
T Consensus 599 l~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred HHHHhccCcccccCCCCCCchhhhhC
Confidence 999999 9999964 4555543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=369.60 Aligned_cols=264 Identities=32% Similarity=0.547 Sum_probs=213.5
Q ss_pred CccccccccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 003971 512 PLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 590 (782)
Q Consensus 512 p~~~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~ 590 (782)
..+++.++..++++|...+.||+|+||.||+|.. +|+.||||.+....... ..+|.+|+.++.+++|||+|+|+|||
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 4567888888999999999999999999999987 45899999876544332 35699999999999999999999999
Q ss_pred cCCC-ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc---ccccCCCcccEEEcCCCeEEEE
Q 003971 591 TKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK---IVHRDLKSANCLVNKHWTVKIC 666 (782)
Q Consensus 591 ~d~~-~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g---IIHrDIKPeNILLd~~g~VKLa 666 (782)
.+.+ ..++||||+++|+|.++++..... .++|.++.+|+.++|+||+|||... |||||||++|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9988 499999999999999999843322 8999999999999999999999854 9999999999999999999999
Q ss_pred ecCccccccCCCCCCCCC-CCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---h---HHHHHHHHhc
Q 003971 667 DFGLSRIITDSPMRDSSS-AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL---P---ERVVYAVANE 739 (782)
Q Consensus 667 DFGLA~~l~~~~~~~~~~-~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~---~---~evl~~i~~~ 739 (782)
|||+|+............ .||.+|+|||++..+..+.|+||||||++|+||+||+.|.+... . ..........
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999997654311222223 89999999999999999999999999999999999998876432 1 1111122222
Q ss_pred CCCCC----------CCC-hH---HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 740 GSRLE----------IPE-GP---LGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 740 ~~~~~----------ip~-~~---L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
+...+ .+. .. +..+...|++ +|.+||+|.++++.|+.+.
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 21111 111 12 4456788999 9999999999999996653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=361.80 Aligned_cols=248 Identities=34% Similarity=0.547 Sum_probs=209.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC--ceEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP--RLSM 598 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~--~l~L 598 (782)
..++..++.||+|+||.||++.+. |...|||......... .+.+.+|+.+|++++|||||+++|...... .+++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 345777899999999999999874 7999999987653222 677889999999999999999999855544 5999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC-CCeEEEEecCccccccC-
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRIITD- 676 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~-~g~VKLaDFGLA~~l~~- 676 (782)
+|||+++|+|.+++...+ +.+++..++.+.+||++||+|||++||||+||||+|||++. ++.+||+|||+++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eeeccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999999997432 27999999999999999999999999999999999999999 79999999999987753
Q ss_pred --CCCCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCCCCh---H
Q 003971 677 --SPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEG-VLPERVVYAVANEGSRLEIPEG---P 749 (782)
Q Consensus 677 --~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~-~~~~evl~~i~~~~~~~~ip~~---~ 749 (782)
.........||+.|||||++.++ ....++|||||||++.||+||+.||.. ......+..+......+.+|.. .
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~ 251 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDE 251 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHH
Confidence 11223457899999999999964 233599999999999999999999988 5566666666666656667654 6
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L 774 (782)
.++++..|+. ||.+|||+.++|+|-
T Consensus 252 a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 252 AKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 8999999999 999999999999884
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=374.71 Aligned_cols=246 Identities=28% Similarity=0.493 Sum_probs=224.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|.+.+.||+|.||.||+|+. +.+.||+|.+.+.....+.++.+.+|+++++.++|||||.++++|+...++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5788999999999999999965 67789999998887777788999999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+.| +|+.++. ..+.++++++..++.+++.||.|||+.+|+|||+||.|||++.+|.+|+||||+|+.+.......
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9987 9999997 56789999999999999999999999999999999999999999999999999999998766666
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHHHhhh-
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIADCWA- 759 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-~~~L~~LI~~CL~- 759 (782)
+...|||.|||||++.+++|+..+|+||+||++|||++|++||....-...+..|......++.. ...+.+++..++.
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIK 237 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhc
Confidence 78899999999999999999999999999999999999999999988888888877665544432 3468999999999
Q ss_pred CCCCCCCHHHHHHH
Q 003971 760 EPQERPSCEEILSR 773 (782)
Q Consensus 760 DP~kRPSa~EIL~~ 773 (782)
||.+|.++.+++.|
T Consensus 238 dP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 238 DPAQRLTWTDLLGH 251 (808)
T ss_pred ChhhcccHHHHhcC
Confidence 99999999999876
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=349.29 Aligned_cols=244 Identities=24% Similarity=0.353 Sum_probs=211.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|++.+.||+|+||.||+|.+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+...+|++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4789999999999999999987 488999999865433 2234567889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++|+|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 9999999999886 3457899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHHhhh
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIADCWA 759 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-p~~~L~~LI~~CL~ 759 (782)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+. -...+.+|+.+||.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 23457999999999999988999999999999999999999999998887777776654332221 23468999999999
Q ss_pred -CCCCCCC-----HHHHHHH
Q 003971 760 -EPQERPS-----CEEILSR 773 (782)
Q Consensus 760 -DP~kRPS-----a~EIL~~ 773 (782)
||.+||+ +.++++|
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCHHHccCCccCCHHHHhcC
Confidence 9999995 8998876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=373.05 Aligned_cols=245 Identities=32% Similarity=0.518 Sum_probs=220.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
...|....+||+|+.|.||.+.. .++.||||.+....... .+-+++|+.+|+..+|+|||.+++.|...+.+|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 35677778999999999999965 67789999987665544 367889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||++||+|.+.+. ...+++.++..|++++++||+|||.+||+|||||.+|||++.+|.+||+|||++..+......
T Consensus 350 Eym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 350 EYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred eecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 9999999999985 446999999999999999999999999999999999999999999999999999998776656
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-C---ChHHHHHHHH
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-P---EGPLGRLIAD 756 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-p---~~~L~~LI~~ 756 (782)
..+.+|||+|||||++....|+.|+||||||++++||+.|+.||-..++...++.+.+.+..... + ...+++++.+
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 67889999999999999999999999999999999999999999999999999988776643322 2 3369999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003971 757 CWA-EPQERPSCEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~ 773 (782)
||. |+.+|+++.|||+|
T Consensus 506 cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEH 523 (550)
T ss_pred HhhcchhcCCCHHHHhcC
Confidence 999 99999999999987
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=356.01 Aligned_cols=247 Identities=22% Similarity=0.400 Sum_probs=213.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
...++|.+.+.||+|+||.||+|.+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 3458899999999999999999987 578899999875532 2234567889999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
++|||+.+|+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEcCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999999886 3457889999999999999999999999999999999999999999999999999876443
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIAD 756 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip~~~L~~LI~~ 756 (782)
. ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+....... ...+..+.+|+.+
T Consensus 172 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 172 T---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred c---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence 2 34679999999999999999999999999999999999999999888877776665443221 1224568999999
Q ss_pred hhh-CCCCCCC-----HHHHHHH
Q 003971 757 CWA-EPQERPS-----CEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPS-----a~EIL~~ 773 (782)
||. ||.+||+ +.+++.|
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcC
Confidence 999 9999986 7888866
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=354.90 Aligned_cols=241 Identities=25% Similarity=0.383 Sum_probs=206.5
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEeccc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
+.||+|+||.||++.+ +|+.||||++..... .......+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 588999999875432 2334567889999999999999999999999999999999999999
Q ss_pred chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCC
Q 003971 607 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 686 (782)
Q Consensus 607 sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~G 686 (782)
+|.+++. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 9998886 3457899999999999999999999999999999999999999999999999999764333333345679
Q ss_pred CCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCCC
Q 003971 687 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQER 764 (782)
Q Consensus 687 T~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~kR 764 (782)
|+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.......+ .-...+.+|+.+||. ||.+|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 9999999999999999999999999999999999999998887776666654432221 123468999999999 99999
Q ss_pred C-----CHHHHHHH
Q 003971 765 P-----SCEEILSR 773 (782)
Q Consensus 765 P-----Sa~EIL~~ 773 (782)
| ++.++++|
T Consensus 238 ~~~~~~~~~~ll~h 251 (323)
T cd05571 238 LGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCHHHHHcC
Confidence 9 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.05 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=205.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|.+.+.||+|+||.||++.+ +++.||+|++..........+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3689999999999999999987 47789999987655444456778899999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-C
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-R 680 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~-~ 680 (782)
|++++.+..+.. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 999877765543 235689999999999999999999999999999999999999999999999999987643221 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------------
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR------------------ 742 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~------------------ 742 (782)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 23457899999999999888999999999999999999999999887655443332211000
Q ss_pred --CC-------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 --LE-------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 --~~-------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+. .-+..+.+|+.+||. ||.+|||++++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 012348899999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=353.29 Aligned_cols=244 Identities=25% Similarity=0.363 Sum_probs=211.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|.+.+.||+|+||.||+|.+ .++.||||++...... ......+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3689999999999999999987 5789999998755432 234567889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++|+|.+++. ....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~ 154 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y 154 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence 9999999999986 345789999999999999999999999999999999999999999999999999986543 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CC------ChHHH
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---IP------EGPLG 751 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~---ip------~~~L~ 751 (782)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+........ .. ...+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 3456799999999999999999999999999999999999999998888777666554322221 11 34688
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+++.+||. +|.+||++.+++++
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhC
Confidence 99999999 89999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=374.27 Aligned_cols=246 Identities=26% Similarity=0.433 Sum_probs=220.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecc-ccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQ-DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~-~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.-|++++.||.|+.|.|.+|++ +|+.+|||++.+. .........+.+||-+|+.+.||||+++|++|+++..+|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4467889999999999999987 7999999999766 445555677889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++|.|++++- .++++++..+.++++||+.|+.|||..+|+||||||+|+||+..+++||+|||+|...... ..
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-kl 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KL 167 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC-cc
Confidence 9999999999997 5678999999999999999999999999999999999999999999999999999876543 45
Q ss_pred CCCCCCCCcccCccccccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHHhh
Q 003971 681 DSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIADCW 758 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-p~~~L~~LI~~CL 758 (782)
..+.||+|.|.|||++.+.+|. .++||||+|||||.|+||+.||++.+-..++..+..+.+.++- -....++|+.+|+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRML 247 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHh
Confidence 5689999999999999999985 6899999999999999999999999888888887766554432 1346899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003971 759 A-EPQERPSCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRPSa~EIL~~ 773 (782)
. ||.+|.|++||++|
T Consensus 248 ~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKH 263 (786)
T ss_pred ccCccccccHHHHhhC
Confidence 9 99999999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=355.58 Aligned_cols=255 Identities=25% Similarity=0.449 Sum_probs=222.4
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
..|..+.++|.+...||.|..++||+|+. .+..||||++..+..+.. ++.+.+|+..|+.++||||++++..|..+.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 45667789999999999999999999976 689999999988776655 789999999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+|+||.||.+|++.+++... ....+++..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||.+..+
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~-~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTY-YPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHH-ccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 999999999999999999743 3456999999999999999999999999999999999999999999999999998877
Q ss_pred cCCCCC----CCCCCCCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---
Q 003971 675 TDSPMR----DSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--- 745 (782)
Q Consensus 675 ~~~~~~----~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i--- 745 (782)
.+.+.. ..+.+||++|||||++.. ..|+.|+||||||++..||.+|+.||....+..++..-+++......
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG 256 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence 654422 156789999999999654 35999999999999999999999999999998887776654432111
Q ss_pred -C-------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 -P-------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 -p-------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+ ...++.++..|++ ||.+|||+++++++
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1 1257889999999 99999999999976
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=374.48 Aligned_cols=250 Identities=37% Similarity=0.638 Sum_probs=226.2
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 515 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 515 ~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
..+.|++.|+.+.-++-||.|+.|-||+|+..++.||||..... -..+|.-|++|+||||+.|.|+|....
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence 45779999999999999999999999999999999999986321 125788899999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.++||||||..|.|+..|+ ....++......+..+||.||.|||.+.|||||||.-||||+.+..|||+|||-++..
T Consensus 186 cyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhh
Confidence 9999999999999999997 5668889999999999999999999999999999999999999999999999999887
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh---HHH
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 751 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~~---~L~ 751 (782)
.+. .+.-.++||..|||||++++.+.++|+|||||||+||||+||..||.+.+...+++.+-.....+++|.. -+.
T Consensus 263 ~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfk 341 (904)
T KOG4721|consen 263 SDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFK 341 (904)
T ss_pred hhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHH
Confidence 654 3445789999999999999999999999999999999999999999999888888877777777777754 488
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 752 RLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
-|+++||+ .|..||+|.+|+.||.=.
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 89999999 999999999999998744
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=370.24 Aligned_cols=266 Identities=33% Similarity=0.611 Sum_probs=231.6
Q ss_pred CccccccccccCCCeeEeeEEeeeCcEEEEEEEE--C-C--eE-EEEEEeec-cccChHHHHHHHHHHHHHHhCCCCcee
Q 003971 512 PLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--N-G--TD-VAIKVFLE-QDLTAENMEDFCNEISILSRLRHPNVI 584 (782)
Q Consensus 512 p~~~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~-g--~~-VAVKil~~-~~~~~~~~e~f~~EI~iLk~L~HPNIV 584 (782)
.......|++..++..+.++||+|+||+||+|.. . + .. ||||..+. .....+..++|++|+++|+.++|||||
T Consensus 145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 3445678999999999999999999999999965 2 2 23 89998875 336678889999999999999999999
Q ss_pred eEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEE
Q 003971 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 664 (782)
Q Consensus 585 kL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VK 664 (782)
+|||++.....+++|||+|.||+|.++|... ...++..+...++.+++.||+|||++++|||||..+|||++.++.+|
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEE
Confidence 9999999999999999999999999999732 23699999999999999999999999999999999999999999999
Q ss_pred EEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 003971 665 ICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL 743 (782)
Q Consensus 665 LaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~ 743 (782)
|+|||+++.............-...|+|||.+....|+.++|||||||++||+++ |..||.+....++...+...+++.
T Consensus 303 ISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~ 382 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM 382 (474)
T ss_pred eCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC
Confidence 9999998765422111112234568999999999999999999999999999998 788999999999999988888888
Q ss_pred CCCCh---HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 744 EIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 744 ~ip~~---~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
..|.. .+..++.+||. +|+.||+|.++.+.|+.+..
T Consensus 383 ~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 383 PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 77643 58889999999 99999999999999998754
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=354.74 Aligned_cols=247 Identities=27% Similarity=0.452 Sum_probs=213.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccCh-HHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|.+.+.||+|+||+||+|.+. ++.||||++....... .....+..|+.++..++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999874 8899999987654322 44567889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC--
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 678 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~-- 678 (782)
||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999999873 3678999999999999999999999999999999999999999999999999998765432
Q ss_pred ---------------------------CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 003971 679 ---------------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER 731 (782)
Q Consensus 679 ---------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~e 731 (782)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 12234579999999999999999999999999999999999999999888777
Q ss_pred HHHHHHhcCCCCCC---C--ChHHHHHHHHhhhCCCCCCC-HHHHHHH
Q 003971 732 VVYAVANEGSRLEI---P--EGPLGRLIADCWAEPQERPS-CEEILSR 773 (782)
Q Consensus 732 vl~~i~~~~~~~~i---p--~~~L~~LI~~CL~DP~kRPS-a~EIL~~ 773 (782)
....+......... + +..+.+|+.+|+.||.+||+ +.+++++
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcC
Confidence 77766652222222 2 45689999999999999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=355.95 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=211.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|++.+.||+|+||+||++.+ +++.||||++..... .......+.+|+.++..++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999987 578999999975432 2334567889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 679 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~- 679 (782)
||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999886 345789999999999999999999999999999999999999999999999999876432110
Q ss_pred -------------------------------------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCC
Q 003971 680 -------------------------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR 722 (782)
Q Consensus 680 -------------------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~ 722 (782)
.....+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0113469999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhhCCCCCCC---HHHHHHH
Q 003971 723 PWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWAEPQERPS---CEEILSR 773 (782)
Q Consensus 723 PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~LI~~CL~DP~kRPS---a~EIL~~ 773 (782)
||.+.........+.........+ ...+.+|+.+|+.+|.+|++ +.+++++
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcC
Confidence 999988877777766544433333 23588899999889999997 9998875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=354.49 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=207.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|++.+.||+|+||+||++.+ +++.||||++.+... .......+..|+.++..++|+||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999999977 578999999875433 2334567888999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 679 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~- 679 (782)
||+++|+|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999999986 345789999999999999999999999999999999999999999999999999875432100
Q ss_pred ----------------------------------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 003971 680 ----------------------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWE 725 (782)
Q Consensus 680 ----------------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~ 725 (782)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0123579999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhh---CCCCCCCHHHHHHH
Q 003971 726 GVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWA---EPQERPSCEEILSR 773 (782)
Q Consensus 726 ~~~~~evl~~i~~~~~~~~ip-----~~~L~~LI~~CL~---DP~kRPSa~EIL~~ 773 (782)
+.........+........+| .....+++.+++. ++..||++.+|++|
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 988888777776543333333 2357777776544 44467999999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=339.64 Aligned_cols=254 Identities=32% Similarity=0.524 Sum_probs=205.9
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC------------------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCce
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWN------------------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 583 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~------------------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI 583 (782)
...+|.+.++||+|+||.||+|.++ +..||+|++.... .......|.+|+.++..++||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4468999999999999999999752 3369999986543 34445789999999999999999
Q ss_pred eeEeccccCCCceEEEEEEecccchhhHHHhhc----------------ccccchHHHHHHHHHHHHHHHHHHHhccccc
Q 003971 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSG----------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 647 (782)
Q Consensus 584 VkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~----------------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIH 647 (782)
+++++++.+.+..+++|||+.+|+|.+++.... ....+++..++.++.||+.||.|||+.||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999886321 1134688899999999999999999999999
Q ss_pred cCCCcccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh--CCCC
Q 003971 648 RDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT--LNRP 723 (782)
Q Consensus 648 rDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT--Gk~P 723 (782)
|||||+|||++.++.+||+|||++........ ......++..|+|||++....++.++|||||||++|+|++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543221 1123446788999999988889999999999999999986 5678
Q ss_pred CCCCChHHHHHHHHh---cC-C-----CCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 724 WEGVLPERVVYAVAN---EG-S-----RLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 724 F~~~~~~evl~~i~~---~~-~-----~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
|.............. .. . .+..-+..+.+|+.+||. ||.+|||+.+|.+.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 887776655443321 11 0 111113468999999999 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=333.55 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=212.2
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
++..+|++.+.||+|+||.||+|.++ +..||+|++.... .......|.+|+.+++.++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 45678999999999999999999752 5689999986543 23345678999999999999999999999999999
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++|++||||||+|||++.++.++|+|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred cEEEEEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999998863 23578999999999999999999999999999999999999999999999999876543
Q ss_pred CCCC-CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003971 676 DSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 750 (782)
Q Consensus 676 ~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L 750 (782)
.... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||.+.........+.. +...+.+ +..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED-GFRLPAPRNCPNLL 237 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CCCCCCCCCCCHHH
Confidence 2211 1122345678999999999999999999999999999775 9999998887776666543 3333333 3468
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 751 GRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 751 ~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
.+++.+||+ +|.+||++.+|++.|.+.
T Consensus 238 ~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 238 HQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999999999 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=339.23 Aligned_cols=248 Identities=22% Similarity=0.299 Sum_probs=204.2
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
..++|.+.++||.|+||.||+|.. +++.||+|++...... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 357899999999999999999977 5789999998654322 2235677999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+++ +|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~e~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EeCCCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 999985 88887753 234578899999999999999999999999999999999999999999999999986544333
Q ss_pred CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 003971 680 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------------- 743 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~--------------- 743 (782)
......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+......+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 3345678999999998865 568999999999999999999999998877766555443211100
Q ss_pred ----------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ----------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ----------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+....+|+.+|+. ||.+|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0012357789999999 99999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=354.54 Aligned_cols=247 Identities=28% Similarity=0.481 Sum_probs=226.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|.+.+.||+|.||+|-++.. .|+.||||.+.+... ++.++-.+.+||+||..|+||||+.+|.+|+..+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 6899999999999999999965 699999999977765 3455778899999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||..+|.|++++. ..+.|++..++.+++||..|+.|||+++++|||||.+|||||+++++||+||||+..+.+.. .
T Consensus 133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k-f 208 (668)
T KOG0611|consen 133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK-F 208 (668)
T ss_pred EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc-H
Confidence 9999999999997 45689999999999999999999999999999999999999999999999999998886653 4
Q ss_pred CCCCCCCCcccCccccccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh
Q 003971 681 DSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA 759 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~~~L~~LI~~CL~ 759 (782)
.+++||+|-|.+||++++.+|. +.+|-||||++||.|+.|..||++.+...++.++..+.++.+-.+....-||+.||.
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWMLM 288 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHHHh
Confidence 5789999999999999999985 679999999999999999999999999999999998888776666668889999998
Q ss_pred -CCCCCCCHHHHHHHH
Q 003971 760 -EPQERPSCEEILSRL 774 (782)
Q Consensus 760 -DP~kRPSa~EIL~~L 774 (782)
||.+|.|+++|..|.
T Consensus 289 VNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 289 VNPERRATIEDIASHW 304 (668)
T ss_pred cCcccchhHHHHhhhh
Confidence 999999999999884
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=329.83 Aligned_cols=254 Identities=30% Similarity=0.556 Sum_probs=215.7
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
|.+..++|++.++||+|+||.||+|.. +++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++......+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 567789999999999999999999976 567899998764332 3568899999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+++||+++++|.+++... ....+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 78 IITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999999988643 3456888999999999999999999999999999999999999999999999999876543
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003971 678 PMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 752 (782)
Q Consensus 678 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~ 752 (782)
... .....++..|+|||.+....++.++|||||||++|+|++ |+.||...........+.... ..+.+ +..+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 235 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-RMPRMENCPDELYD 235 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHH
Confidence 221 123345678999999988889999999999999999998 999999887777666655432 22221 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 753 LIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
++.+||. +|++||+++++++.|+++
T Consensus 236 li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 236 IMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=348.71 Aligned_cols=241 Identities=24% Similarity=0.388 Sum_probs=206.1
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEeccc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
+.||+|+||.||++.+ +|+.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999976 588999999875432 2334567889999999999999999999999999999999999999
Q ss_pred chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCC
Q 003971 607 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 686 (782)
Q Consensus 607 sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~G 686 (782)
+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............|
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 9998876 3457899999999999999999999999999999999999999999999999998764333333345679
Q ss_pred CCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCCC
Q 003971 687 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQER 764 (782)
Q Consensus 687 T~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~kR 764 (782)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.......+ .-...+.+++.+||. ||.+|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 9999999999999999999999999999999999999998887777766654433222 123568999999999 99999
Q ss_pred C-----CHHHHHHH
Q 003971 765 P-----SCEEILSR 773 (782)
Q Consensus 765 P-----Sa~EIL~~ 773 (782)
| ++.+++++
T Consensus 238 ~~~~~~~~~~~l~h 251 (323)
T cd05595 238 LGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCCHHHHHcC
Confidence 8 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=354.42 Aligned_cols=261 Identities=28% Similarity=0.519 Sum_probs=215.7
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEe
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 587 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 587 (782)
...|.+..++|.++++||+|+||.||+|.+ .+..||||++..... ....+.+.+|+.++..+ +||||++++
T Consensus 27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~ 105 (375)
T cd05104 27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLL 105 (375)
T ss_pred ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeee
Confidence 345777778999999999999999999964 255799999864432 23356788999999999 899999999
Q ss_pred ccccCCCceEEEEEEecccchhhHHHhhcc--------------------------------------------------
Q 003971 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------------------------------------------- 617 (782)
Q Consensus 588 g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~-------------------------------------------------- 617 (782)
++|......++||||+++|+|.+++.....
T Consensus 106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (375)
T cd05104 106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK 185 (375)
T ss_pred eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence 999999999999999999999988863210
Q ss_pred ----------------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 618 ----------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 618 ----------------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 1247888999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCC---CChH
Q 003971 676 DSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEI---PEGP 749 (782)
Q Consensus 676 ~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~i---p~~~ 749 (782)
..... .....++..|+|||++.+..++.++|||||||++|||++ |..||...............+.+... .+..
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE 345 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHH
Confidence 33211 112335567999999999999999999999999999998 88899887665555555555544433 3457
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
+.+|+..||+ ||.+||++.+|++.|++.
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 9999999999 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=352.46 Aligned_cols=249 Identities=20% Similarity=0.368 Sum_probs=214.3
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEEC---CeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIWN---GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~~---g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
..+..++|.+.+.||+|+||.||+|.+. +..||+|++..... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4556789999999999999999999763 35799999865432 2334567889999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+|++|||+.+|+|.+++. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999999986 3457899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHH
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRL 753 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip~~~L~~L 753 (782)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.++......+....... ...+..+.++
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred CCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 432 235679999999999998889999999999999999999999999988877777766543322 2224468999
Q ss_pred HHHhhh-CCCCCC-----CHHHHHHH
Q 003971 754 IADCWA-EPQERP-----SCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRP-----Sa~EIL~~ 773 (782)
+.+|+. ||.+|+ +++++++|
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 999999 999995 89999876
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=346.78 Aligned_cols=239 Identities=22% Similarity=0.405 Sum_probs=203.8
Q ss_pred EeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccch
Q 003971 532 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 608 (782)
Q Consensus 532 LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL 608 (782)
||+|+||.||++.+ +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999987 477899999865432 334457788999999999999999999999999999999999999999
Q ss_pred hhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003971 609 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 688 (782)
Q Consensus 609 ~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~ 688 (782)
.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++............+||+
T Consensus 81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 99886 345789999999999999999999999999999999999999999999999999986543333334567999
Q ss_pred cccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCCCCC
Q 003971 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQERPS 766 (782)
Q Consensus 689 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~kRPS 766 (782)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ ..+..+.+++.+||. ||.+||+
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 99999999999999999999999999999999999998888777776655433221 123468999999999 9999974
Q ss_pred ---HHHHHHH
Q 003971 767 ---CEEILSR 773 (782)
Q Consensus 767 ---a~EIL~~ 773 (782)
+.+++.|
T Consensus 238 ~~~~~e~l~h 247 (312)
T cd05585 238 YNGAQEIKNH 247 (312)
T ss_pred CCCHHHHHcC
Confidence 6777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=362.87 Aligned_cols=247 Identities=27% Similarity=0.410 Sum_probs=211.6
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCC-ceE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPP-RLS 597 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~-~l~ 597 (782)
..++|.+.++||.|.||.||+|+. .|..||||.++++....+.. .=++|+..|++|+ |||||++.+++.+.+ .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 347899999999999999999976 68899999987665554332 2357999999999 999999999999988 899
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+|||||+. +|+++++. .+..|++..++.|++||++||+|+|++|+.|||+||+|||+..+..|||+|||+|+.....
T Consensus 87 fVfE~Md~-NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhh-hHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 99999985 99999974 3789999999999999999999999999999999999999998889999999999987654
Q ss_pred CCCCCCCCCCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----------
Q 003971 678 PMRDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI----------- 745 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i----------- 745 (782)
+ ..+..+.|.+|.|||++. .+-|+.+.|+||+|||++|+++-+..|+|.+..+.++.++.--..+..
T Consensus 164 p-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 164 P-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred C-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 3 345788999999999874 567999999999999999999999999999999888888653333221
Q ss_pred ---------C-----------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 ---------P-----------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 ---------p-----------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+ .....++|.+|+. ||.+|||+.+.+++
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1 1135578899999 99999999999876
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=338.33 Aligned_cols=247 Identities=23% Similarity=0.289 Sum_probs=203.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
.|++.+.||+|+||.||++.+ +++.||+|.+...... ......+.+|+.+++.++|+||+++++++.+.+.+++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999976 6889999998655432 2233567899999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+++|+|.+++... ....+++..++.++.|++.||+|||++||+||||||+|||+++++.++|+|||++....... ..
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TV 158 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-ee
Confidence 99999998877532 23468999999999999999999999999999999999999999999999999998764322 22
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--cCCCCCC---CChHHHHHHHH
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN--EGSRLEI---PEGPLGRLIAD 756 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~--~~~~~~i---p~~~L~~LI~~ 756 (782)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. ....... -...+.+|+.+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence 356799999999999999999999999999999999999999987654322221111 1111112 23468999999
Q ss_pred hhh-CCCCCCC-----HHHHHHH
Q 003971 757 CWA-EPQERPS-----CEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPS-----a~EIL~~ 773 (782)
||. ||.+||+ +++++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcC
Confidence 999 9999997 8898875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=343.42 Aligned_cols=245 Identities=28% Similarity=0.396 Sum_probs=197.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC-----CceE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PRLS 597 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-----~~l~ 597 (782)
+|++.++||+|+||.||+|.+ ++..||||++............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999987 578999999865433334456788999999999999999999987543 2489
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
++|||+. ++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999996 57888775 3456899999999999999999999999999999999999999999999999999865322
Q ss_pred CC---CCCCCCCCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------
Q 003971 678 PM---RDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS----------- 741 (782)
Q Consensus 678 ~~---~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~----------- 741 (782)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 11 1234579999999999876 6789999999999999999999999987654433222111000
Q ss_pred -------------CCC------C--CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 -------------RLE------I--PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 -------------~~~------i--p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
... . -+..+.+++.+||. ||.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 0 12347789999999 99999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=362.09 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=212.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC--CceE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLS 597 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l~ 597 (782)
..+.|..+.+||+|.||.||++++ +|+.||+|.+..............+||.||++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 345688889999999999999987 688899999988877777778888999999999999999999998776 6799
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
||+|||+. +|.-++. ...-.|++.++..|+.||+.||+|||.+||+|||||.+|||||.+|.+||+|||||+++...
T Consensus 195 lVFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99999997 7777765 24568999999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-CCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------CCC-
Q 003971 678 PMR-DSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------EIP- 746 (782)
Q Consensus 678 ~~~-~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~--------~ip- 746 (782)
... .+..+-|++|.|||++.+. .|+.++|+||.||||.||++|+..|++.+..+.+..|...-..+ .+|
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 432 5678899999999998875 69999999999999999999999999999888888776432222 111
Q ss_pred ---------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 ---------------------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ---------------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+...-+|+..+|. ||.+|.|+.+.|+.
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0123457888999 99999999998853
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=334.49 Aligned_cols=255 Identities=34% Similarity=0.591 Sum_probs=213.7
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEECC-------eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~g-------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
+..++|++.+.||+|+||.||+|...+ ..+|+|.+.... .......|.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 345689999999999999999997632 469999886443 334456789999999999999999999999998
Q ss_pred CceEEEEEEecccchhhHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 660 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~ 660 (782)
...+++|||+++++|.+++..... ...+++..++.++.|++.||.|||++|++|+||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 899999999999999998864321 1458889999999999999999999999999999999999999
Q ss_pred CeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 003971 661 WTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVA 737 (782)
Q Consensus 661 g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~ 737 (782)
+.++|+|||++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999986533221 1234456788999999988889999999999999999998 999999888877666554
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 738 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 738 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
. ......+ +..+.+|+.+||. ||.+||++.+|+++|+.+
T Consensus 241 ~-~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 241 S-RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred c-CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 3 3333333 3469999999999 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=355.01 Aligned_cols=261 Identities=29% Similarity=0.547 Sum_probs=216.4
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEe
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 587 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 587 (782)
.+.|.+..++|.+++.||+|+||.||+|.+. +..||||++...... ...+.+.+|+.+++.+ +|+||++++
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEe
Confidence 3567788889999999999999999998752 247999998754432 3356788999999999 899999999
Q ss_pred ccccCCCceEEEEEEecccchhhHHHhhcc--------------------------------------------------
Q 003971 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------------------------------------------- 617 (782)
Q Consensus 588 g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~-------------------------------------------------- 617 (782)
++|...+.++++|||+++|+|.+++.....
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 999999999999999999999998853211
Q ss_pred -----------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003971 618 -----------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 679 (782)
Q Consensus 618 -----------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~- 679 (782)
...+++.+++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+++.......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 12478889999999999999999999999999999999999999999999999986543211
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003971 680 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 754 (782)
Q Consensus 680 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI 754 (782)
......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...............+.....+ +..+.+++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence 1112335668999999998889999999999999999997 999998876655555555544444333 35699999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 755 ADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
.+||+ ||.+||++.++++.|+++
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=379.73 Aligned_cols=261 Identities=33% Similarity=0.566 Sum_probs=226.6
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEec
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g 588 (782)
....++..++....+.||+|+||+||+|... ...||||.++.... ....++|.+|++++..++|||||+|+|
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 4556778889999999999999999999652 45799999976543 335689999999999999999999999
Q ss_pred cccCCCceEEEEEEecccchhhHHHhhcc-----------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE
Q 003971 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQ-----------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV 657 (782)
Q Consensus 589 ~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~-----------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL 657 (782)
+|.+++.++||+|||..|+|..+|..... ..+|+..+.+.|+.|||.||+||-++.+|||||.+.|+||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 99999999999999999999999964321 1238899999999999999999999999999999999999
Q ss_pred cCCCeEEEEecCccccccCCCCCC-C-CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 003971 658 NKHWTVKICDFGLSRIITDSPMRD-S-SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVY 734 (782)
Q Consensus 658 d~~g~VKLaDFGLA~~l~~~~~~~-~-~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~ 734 (782)
+++..|||+||||++......+.. . ...-..+|||||.+...+|+.++|||||||+|||+++ |+.||.+..+++++.
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 999999999999999876544332 1 2334569999999999999999999999999999996 788999999999998
Q ss_pred HHHhcCCCCCCCCh---HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 735 AVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 735 ~i~~~~~~~~ip~~---~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
.+..+.. ...|+. .++.||..||+ +|.+||+|.||-..|+..-
T Consensus 717 ~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 717 CIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 8766544 777754 69999999999 9999999999999998763
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=333.78 Aligned_cols=245 Identities=34% Similarity=0.644 Sum_probs=203.4
Q ss_pred eEeeEEeeeCcEEEEEEEEC------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 527 TVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 527 ~i~~~LG~G~fG~VYkg~~~------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.+.+.||.|.||.||+|.+. +..|+||++.. .......+.|.+|++.+++++||||++++|++...+..++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 46789999999999999876 67899999954 334445789999999999999999999999999888899999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 679 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~- 679 (782)
||+++|+|.+++... ....+++.+++.++.||+.||.|||+++++|+||+++|||++.++.+||+|||++........
T Consensus 81 e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp E--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999743 246789999999999999999999999999999999999999999999999999987732211
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003971 680 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 754 (782)
Q Consensus 680 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI 754 (782)
..........|+|||.+.+..++.++||||||+++|||++ |+.||.+....+....+ ..+.+...+ +..+.+++
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHH
Confidence 1223446678999999999889999999999999999999 67999999888777776 445554444 34699999
Q ss_pred HHhhh-CCCCCCCHHHHHHHH
Q 003971 755 ADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~L 774 (782)
.+||. ||.+||++.+|++.|
T Consensus 239 ~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHT-SSGGGS--HHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHhcC
Confidence 99999 999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=355.73 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=207.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|++.+.||+|+||.||++.+ .++.||||++.+... .....+.+.+|+.+++.++|+||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4799999999999999999986 578999999865432 2233567889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC---
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS--- 677 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~--- 677 (782)
||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999986 3456889999999999999999999999999999999999999999999999997532100
Q ss_pred ----------------------------------------CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHH
Q 003971 678 ----------------------------------------PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 717 (782)
Q Consensus 678 ----------------------------------------~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyEL 717 (782)
.......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001234799999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhhCCCCCC---CHHHHHHH
Q 003971 718 CTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWAEPQERP---SCEEILSR 773 (782)
Q Consensus 718 LTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~LI~~CL~DP~kRP---Sa~EIL~~ 773 (782)
++|+.||.+.........+........++ ...+.+++.+|+.+|.+|+ ++.++++|
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCC
Confidence 99999999888777666665443333333 2357788888777999999 99999977
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=354.80 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=207.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|.+.++||+|+||+||++.+ +++.||||++.+... .....+.+.+|+++++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4789999999999999999976 688999999865432 2334577889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC--
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 678 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~-- 678 (782)
||+++|+|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999999999886 34578899999999999999999999999999999999999999999999999986432100
Q ss_pred -----------C----------------------------------CCCCCCCCCcccCccccccCCCCchhHHHHHHHH
Q 003971 679 -----------M----------------------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVI 713 (782)
Q Consensus 679 -----------~----------------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvI 713 (782)
. .....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0 0012469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC-----hHHHHHHHHhhhCCCC---CCCHHHHHHH
Q 003971 714 MWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE-----GPLGRLIADCWAEPQE---RPSCEEILSR 773 (782)
Q Consensus 714 LyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~-----~~L~~LI~~CL~DP~k---RPSa~EIL~~ 773 (782)
+|||++|..||.+.........+........+|. ..+.+|+.+|+.+|.+ |+++.+++.+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcC
Confidence 9999999999998887777766665443344332 3688999999986665 4699999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=348.47 Aligned_cols=241 Identities=25% Similarity=0.388 Sum_probs=205.2
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEeccc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
+.||+|+||.||++.+ +++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 588999999875532 2344578889999999999999999999999999999999999999
Q ss_pred chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCC
Q 003971 607 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 686 (782)
Q Consensus 607 sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~G 686 (782)
+|...+. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 9998876 3457899999999999999999999999999999999999999999999999998764333223345679
Q ss_pred CCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCCC
Q 003971 687 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQER 764 (782)
Q Consensus 687 T~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~kR 764 (782)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.......+ .-...+.+++.+||. ||.+|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 9999999999998899999999999999999999999988877766665543332211 123468999999999 99999
Q ss_pred C-----CHHHHHHH
Q 003971 765 P-----SCEEILSR 773 (782)
Q Consensus 765 P-----Sa~EIL~~ 773 (782)
| ++.+++++
T Consensus 238 ~~~~~~~~~~il~h 251 (328)
T cd05593 238 LGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCCHHHHhcC
Confidence 7 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=353.34 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=206.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
+.|.+++.||+|+||+||+|.+ +++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 3688999999999999999987 577899999976543 3345678899999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC--
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 678 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~-- 678 (782)
||+++|+|.+++. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++++||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999999886 34568899999999999999999999999999999999999999999999999975431100
Q ss_pred ---------------------------------------------CCCCCCCCCCcccCccccccCCCCchhHHHHHHHH
Q 003971 679 ---------------------------------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVI 713 (782)
Q Consensus 679 ---------------------------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvI 713 (782)
......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123579999999999999889999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhh--h-CCCCCCCHHHHHHH
Q 003971 714 MWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCW--A-EPQERPSCEEILSR 773 (782)
Q Consensus 714 LyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~LI~~CL--~-DP~kRPSa~EIL~~ 773 (782)
+|||++|+.||...........+........+| ...+.+|+.+|+ . +|..||++.++++|
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999999888777666665433333333 235788888744 4 66679999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=354.40 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=207.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
+.|.++++||+|+||+||+|.+ +++.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 3688999999999999999987 578899999875443 2344577889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC---
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS--- 677 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~--- 677 (782)
||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999998863 356889999999999999999999999999999999999999999999999997532100
Q ss_pred --------------------------------------------CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHH
Q 003971 678 --------------------------------------------PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVI 713 (782)
Q Consensus 678 --------------------------------------------~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvI 713 (782)
.......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000123479999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhhCCCCCCC---HHHHHHH
Q 003971 714 MWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWAEPQERPS---CEEILSR 773 (782)
Q Consensus 714 LyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~LI~~CL~DP~kRPS---a~EIL~~ 773 (782)
+|||++|+.||.+.++.+....+.........| .....+++.+|+.+|.+|++ +.++++|
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcC
Confidence 999999999999988877777766544444333 23577778777669999987 8888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=334.74 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=201.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE---CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC---CCCceeeEecccc-----C
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RHPNVILFLGACT-----K 592 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~---~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L---~HPNIVkL~g~~~-----d 592 (782)
++|++.+.||+|+||+||+|.+ .++.||+|++............+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4789999999999999999976 367899999875544333345667788877766 6999999999874 3
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
...+++++||+. ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 456899999997 5888887632 23458999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------- 743 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~--------- 743 (782)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+......+..+......+
T Consensus 159 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 159 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred eccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 76543 23345678999999999988889999999999999999999999999887776666654321100
Q ss_pred -------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 -------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 -------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..-+..+.+|+.+||. ||++|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0012346789999999 99999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.88 Aligned_cols=247 Identities=26% Similarity=0.507 Sum_probs=214.9
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|.+.+.||+|+||.||++.+ +++.|++|.+..........+.+.+|+.+++.++||||+++++++.+.+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 578889999999999999987 578999999876666666678899999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 9999999998743 245789999999999999999999999999999999999999999999999999987655433334
Q ss_pred CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003971 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 759 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~ 759 (782)
...|++.|+|||++.+..++.++|+|||||++|+|++|+.||...........+.. +....++ +..+.+++.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-GVFPPVSQMYSQQLAQLIDQCLT 238 (256)
T ss_pred ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHHHcc
Confidence 55788999999999998899999999999999999999999988877666655544 3333333 3468999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003971 760 -EPQERPSCEEILSR 773 (782)
Q Consensus 760 -DP~kRPSa~EIL~~ 773 (782)
+|++||++.+++++
T Consensus 239 ~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 239 KDYRQRPDTFQLLRN 253 (256)
T ss_pred CCcccCcCHHHHhhC
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=344.27 Aligned_cols=244 Identities=27% Similarity=0.422 Sum_probs=205.4
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHH---HhCCCCceeeEeccccCCCceEEE
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISIL---SRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iL---k~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
|.+.+.||+|+||.||++.+ +++.||||++..... .....+.+..|+.++ +.++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67889999999999999987 578999999875432 223345677776665 456799999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+++++|...+. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999999988774 34689999999999999999999999999999999999999999999999999876433333
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhh
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCW 758 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL 758 (782)
.....+|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.........+.......+ .-+..+.+++.+||
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 33456799999999999999999999999999999999999999999888777777665443322 12446889999999
Q ss_pred h-CCCCCC-----CHHHHHHH
Q 003971 759 A-EPQERP-----SCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRP-----Sa~EIL~~ 773 (782)
. ||.+|| ++.+++++
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhC
Confidence 9 999999 67777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.45 Aligned_cols=248 Identities=33% Similarity=0.600 Sum_probs=209.0
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
+.++|++.+.||+|+||.||++.++ +..+|+|.+...... .+.|.+|+.+++.++||||+++++++......+++|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 4567899999999999999999874 558999987644333 357889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++|+|.+++... ...+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 79 EFMENGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EcCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999999988632 246889999999999999999999999999999999999999999999999999865433222
Q ss_pred C-CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC--CCCCChHHHHHHHH
Q 003971 681 D-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR--LEIPEGPLGRLIAD 756 (782)
Q Consensus 681 ~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~--~~ip~~~L~~LI~~ 756 (782)
. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+...... +......+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1 12335568999999998889999999999999999999 89999988877777766543321 22223468999999
Q ss_pred hhh-CCCCCCCHHHHHHHH
Q 003971 757 CWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~L 774 (782)
||. +|.+||++.++++.|
T Consensus 237 c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 237 CWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HccCCcccCcCHHHHHHhh
Confidence 999 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.85 Aligned_cols=247 Identities=23% Similarity=0.301 Sum_probs=199.0
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|.+.++||+|+||.||+|.. +++.||||++...... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 46899999999999999999987 5889999998654322 22346778999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+. ++|.+++.. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 9996 567666652 3356889999999999999999999999999999999999999999999999999765433333
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCC---------------
Q 003971 681 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRL--------------- 743 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~-evl~~i~~~~~~~--------------- 743 (782)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... ..+..+......+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 345678999999998865 45889999999999999999999999876432 2222221100000
Q ss_pred ------CCC------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ------EIP------------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ------~ip------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..+ ...+.+|+.+|++ ||.+|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000 1246789999999 99999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=343.35 Aligned_cols=246 Identities=22% Similarity=0.363 Sum_probs=206.8
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCC-ceeeEeccccCCCceEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHP-NVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HP-NIVkL~g~~~d~~~l~LV~ 600 (782)
+|++.+.||+|+||.||+|.+ .++.||||++.+... .....+.+..|+.++..++|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 588999999999999999987 466899999875432 233456788999999999764 6889999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 9999999998886 3456889999999999999999999999999999999999999999999999998754332223
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHHhhh
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIADCWA 759 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip~~~L~~LI~~CL~ 759 (782)
....+||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.........+....... ......+.+++.+||.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 345679999999999999999999999999999999999999999988887777766543322 1224468899999999
Q ss_pred -CCCCCCCH-----HHHHHH
Q 003971 760 -EPQERPSC-----EEILSR 773 (782)
Q Consensus 760 -DP~kRPSa-----~EIL~~ 773 (782)
||.+|++. .+++++
T Consensus 238 ~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcC
Confidence 99999976 566654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.96 Aligned_cols=254 Identities=31% Similarity=0.657 Sum_probs=215.1
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
|++...+|.+.++||+|+||.||+|.+ .++.+|+|++.... ...+.+.+|+.+++.++|+||+++++++...+.+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 567778899999999999999999976 47889999986432 2356789999999999999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
+++|||+++++|.+++... ....+++..++.++.|++.||+|||++|++||||||+||++++++.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 78 YIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEEEeCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999999999988632 345689999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCC-CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHH
Q 003971 677 SPMRD-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLG 751 (782)
Q Consensus 677 ~~~~~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~ 751 (782)
..... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. .......+ +..+.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVY 235 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHH
Confidence 32221 12234568999999998889999999999999999998 899998877766555543 33334433 24699
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 752 RLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
+++.+||. ||.+||++.++++.|+++
T Consensus 236 ~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 236 ELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 99999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=344.67 Aligned_cols=241 Identities=24% Similarity=0.356 Sum_probs=204.3
Q ss_pred eEEeeeCcEEEEEEEE-----CCeEEEEEEeecccc--ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 530 TRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~--~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+.||+|+||.||++.. .++.||||++..... .......+.+|+.+++.++||||+++++++..++.+|++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 477899999875432 122345678899999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+++++|.+.+. ....+.+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 99999999886 345678889999999999999999999999999999999999999999999999876543333334
Q ss_pred CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHHhhh-C
Q 003971 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIADCWA-E 760 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip~~~L~~LI~~CL~-D 760 (782)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+....... ..-...+.+++.+||. |
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccC
Confidence 5679999999999998889999999999999999999999999888777777665543221 1123468999999999 9
Q ss_pred CCCCC-----CHHHHHHH
Q 003971 761 PQERP-----SCEEILSR 773 (782)
Q Consensus 761 P~kRP-----Sa~EIL~~ 773 (782)
|.+|| ++.+++++
T Consensus 239 p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 239 PSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HhHcCCCCCCCHHHHhcC
Confidence 99999 88888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.07 Aligned_cols=254 Identities=27% Similarity=0.493 Sum_probs=211.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccc-cChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD-LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~-~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|.+.+.||+|+||.||+|.. +++.||||.+.... ........+.+|+.+++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999976 68899999876533 33444567899999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 601 EYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
||+++++|.+++.... ....+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 9999999998885322 234588999999999999999999999999999999999999999999999999987654332
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCCCCC----ChHHHHH
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP--ERVVYAVANEGSRLEIP----EGPLGRL 753 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~--~evl~~i~~~~~~~~ip----~~~L~~L 753 (782)
......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......+ .....+..+ +..+.++
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l 240 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPPLPTEHYSEKLREL 240 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCCCChhhcCHHHHHH
Confidence 23345688899999999888899999999999999999999999965432 2333333 222233332 2468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 754 IADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
+.+||. +|.+||++.++++.|++..
T Consensus 241 i~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 241 VSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 999999 9999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=325.40 Aligned_cols=254 Identities=30% Similarity=0.594 Sum_probs=214.6
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
|++..++|++.+.||.|+||.||+|.+ .++.||+|.+...... .+.+.+|+.++++++||||+++++++...+.++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 456778899999999999999999987 5668999998654332 467889999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
++|||+++++|.+++... ....+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 78 IVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeecccCCcHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999999998632 2346899999999999999999999999999999999999999999999999999876533
Q ss_pred CCCC-CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003971 678 PMRD-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 752 (782)
Q Consensus 678 ~~~~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~ 752 (782)
.... .....+..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.........+... .....+ ...+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPCPPGCPKELYD 235 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHH
Confidence 2211 11223457999999998889999999999999999999 99999988877766665443 222222 356899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 753 LIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
++.+||. +|.+||++.++++.|+++
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 9999999 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=329.15 Aligned_cols=256 Identities=32% Similarity=0.578 Sum_probs=211.8
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 591 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 591 (782)
|.+..++|++.+.||+|+||.||+|.+. ++.||+|++.... ......+|.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 5667788999999999999999998753 3579999875432 2234567899999999999999999999999
Q ss_pred CCCceEEEEEEecccchhhHHHhhcc-------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEE
Q 003971 592 KPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 664 (782)
Q Consensus 592 d~~~l~LV~Ey~~gGsL~dlL~~~~~-------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VK 664 (782)
.....+++|||+++++|.+++..... ...+++..++.++.|++.||+|||+.|++|+||||+||++++++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 99999999999999999998864221 12467888999999999999999999999999999999999999999
Q ss_pred EEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003971 665 ICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 741 (782)
Q Consensus 665 LaDFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~ 741 (782)
|+|||++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.........+....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~- 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG- 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-
Confidence 9999998765432211 112345778999999998889999999999999999999 688999888777666555433
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 742 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 742 ~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
....+ ...+.+++.+||+ ||.+||++.++++.|+.
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 22222 3468999999999 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=340.82 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=206.9
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
+..++|++.+.||+|+||.||++.+ .+..+|+|++.... .....+.+.+|+++++.++||||+++++++...+.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3457899999999999999999987 47789999986542 33445789999999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc-cccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~-gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+|||+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999999986 344688999999999999999999986 6999999999999999999999999999766432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-------------------
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN------------------- 738 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~------------------- 738 (782)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 22345799999999999998999999999999999999999999976655443221110
Q ss_pred --------------------------cCCCCCCC----ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003971 739 --------------------------EGSRLEIP----EGPLGRLIADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 739 --------------------------~~~~~~ip----~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 774 (782)
....+..+ ...+.+|+.+||. ||++|||+.+++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 01111111 2358899999999 999999999999873
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.23 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=207.5
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
+|.+.+.||+|+||.||+|.+ +++.||||++.+... .....+.+..|+.++..+ +|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999987 467899999875432 223345677888888877 5899999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++|+|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 9999999998886 3456899999999999999999999999999999999999999999999999999765433333
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA 759 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL~ 759 (782)
....+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.........+.......+ .....+.+++.+|+.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 4466799999999999999999999999999999999999999999888887777765443222 123468899999999
Q ss_pred -CCCCCCCH-----HHHHHH
Q 003971 760 -EPQERPSC-----EEILSR 773 (782)
Q Consensus 760 -DP~kRPSa-----~EIL~~ 773 (782)
||.+|++. .+++++
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcC
Confidence 99999984 666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=359.15 Aligned_cols=260 Identities=31% Similarity=0.664 Sum_probs=230.6
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC
Q 003971 515 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 592 (782)
Q Consensus 515 ~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 592 (782)
.+++|+.+..++.+.++||-|.||.||.|+|+ .-.||||.++...+ .+++|+.|+.+|+.++|||+|+|+|+|..
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 35899999999999999999999999999985 45799999876544 36899999999999999999999999999
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
...+|||+|||..|+|.++|...+ ...++....+.++.||..||+||..+++|||||...|||+.++..||++||||++
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhh
Confidence 999999999999999999998653 4567778889999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCC-CCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCh--
Q 003971 673 IITDSPMRDSS-SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPEG-- 748 (782)
Q Consensus 673 ~l~~~~~~~~~-~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~~-- 748 (782)
++..+.+.... ..-.+.|.|||-+....++.|+|||+|||+|||+.| |..||++.+..+ ++.++.++++++-|.+
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-VY~LLEkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYGLLEKGYRMDGPEGCP 492 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-HHHHHhccccccCCCCCC
Confidence 99876554332 233458999999999999999999999999999987 566999987754 5567788999998876
Q ss_pred -HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 749 -PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 749 -~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.++.||++||+ .|..||++.||-+.+++...
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 48999999999 99999999999999998744
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=345.58 Aligned_cols=237 Identities=25% Similarity=0.372 Sum_probs=202.9
Q ss_pred eEEeeeCcEEEEEEEE-----CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEec
Q 003971 530 TRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 604 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 604 (782)
+.||+|+||.||++.. .|+.||+|++............+.+|++++++++||||+++++++.+.+.+|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999998864 47899999997655444445667889999999999999999999999999999999999
Q ss_pred ccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCC
Q 003971 605 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 684 (782)
Q Consensus 605 gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~ 684 (782)
+|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 999998886 34578999999999999999999999999999999999999999999999999998765443333456
Q ss_pred CCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCC
Q 003971 685 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQ 762 (782)
Q Consensus 685 ~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~ 762 (782)
.||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+.......+ .-+..+.+|+.+||+ ||.
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHh
Confidence 799999999999988899999999999999999999999998888777776655433221 224468999999999 999
Q ss_pred CCCCHHH
Q 003971 763 ERPSCEE 769 (782)
Q Consensus 763 kRPSa~E 769 (782)
+||++.+
T Consensus 239 ~R~~a~~ 245 (318)
T cd05582 239 NRLGAGP 245 (318)
T ss_pred HcCCCCC
Confidence 9999433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=345.82 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=211.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|.+.+.||+|+||+||++.+ +++.||+|++..... .....+.+..|+.+++.++|+||+++++++.+...+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4689999999999999999976 688999999876543 2334567889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 679 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~- 679 (782)
||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999998632 35789999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCCCCCCcccCccccc------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----Ch
Q 003971 680 RDSSSAGTPEWMAPELIR------NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EG 748 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~------~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~ 748 (782)
......||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+.........| ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 223457899999999986 4567899999999999999999999999888777777666544333332 34
Q ss_pred HHHHHHHHhhhCCCCCCCHHHHHHH
Q 003971 749 PLGRLIADCWAEPQERPSCEEILSR 773 (782)
Q Consensus 749 ~L~~LI~~CL~DP~kRPSa~EIL~~ 773 (782)
.+.+|+..|+.+|.+||++.++++|
T Consensus 239 ~~~~li~~ll~~p~~R~t~~~l~~h 263 (330)
T cd05601 239 DFLDLIQSLLCGQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHccChhhCCCHHHHhCC
Confidence 6889999999999999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=342.91 Aligned_cols=241 Identities=22% Similarity=0.364 Sum_probs=205.8
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEEEEEecc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.||+|+||.||+|.+ .++.||||++..... .....+.+..|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 467899999875432 233456778899999876 799999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
++|...+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 99998886 345789999999999999999999999999999999999999999999999999976543333344567
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 763 (782)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.......+ .-...+.+++.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 99999999999999999999999999999999999999999988888877765443322 224568999999999 9999
Q ss_pred CC-------CHHHHHHH
Q 003971 764 RP-------SCEEILSR 773 (782)
Q Consensus 764 RP-------Sa~EIL~~ 773 (782)
|| ++.+++++
T Consensus 238 R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 238 RLGCVASQGGEDAIKQH 254 (321)
T ss_pred cCCCCCCCCCHHHHhcC
Confidence 99 88888865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.38 Aligned_cols=253 Identities=31% Similarity=0.605 Sum_probs=215.9
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
....+|++.++||.|+||.||+|.+ .++.+|+|++..... .....+..|+.+++.++|+||+++++++.+....+++
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4456799999999999999999987 567899999865432 2346788999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+++++|.+++... ....+++.+++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 81 TELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EeecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999999743 345689999999999999999999999999999999999999999999999999987755433
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 755 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~ 755 (782)
......++..|+|||.+....++.++||||||+++|+|++ |+.||......+....+.. ..+...+ +..+.+++.
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-GYRMPCPAKCPQEIYKIML 238 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-CCcCCCCCCCCHHHHHHHH
Confidence 3334456778999999988889999999999999999998 8999988887776666553 3333332 346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHHhh
Q 003971 756 DCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 756 ~CL~-DP~kRPSa~EIL~~L~di 777 (782)
+||. ||.+|||+.++++.|+++
T Consensus 239 ~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 239 ECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHcCCCchhCcCHHHHHHHHhcC
Confidence 9999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=343.73 Aligned_cols=244 Identities=31% Similarity=0.403 Sum_probs=197.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
.+++|...++||+|+||.||++.+ +++.||||++.... .....+.+.+|+++++.++|+||+++++++.+.+.++++
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 456788889999999999999987 58899999986543 233457789999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+.+++|.... ...+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999999986532 345777889999999999999999999999999999999999999999999987654322
Q ss_pred CCCCCCCCCcccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHhcCCCCCCC---ChH
Q 003971 680 RDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA--VANEGSRLEIP---EGP 749 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~--i~~~~~~~~ip---~~~ 749 (782)
......||..|+|||++.. ...+.++|||||||++|||++|+.||........... ..........+ ...
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE 303 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence 2345679999999998743 2345689999999999999999999974332221111 11112222222 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+|+.+||. ||.+||++.|+++|
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999 99999999999987
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=345.45 Aligned_cols=241 Identities=24% Similarity=0.380 Sum_probs=204.9
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEeccc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
+.||+|+||.||++.+ +++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 688999999876543 2334567789999999999999999999999999999999999999
Q ss_pred chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 607 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 607 sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
+|..++. ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 9998876 34578999999999999999999997 7999999999999999999999999999876433333334567
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 763 (782)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ .-...+.+|+.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 99999999999998999999999999999999999999998887766666554332221 223468999999999 9999
Q ss_pred CC-----CHHHHHHH
Q 003971 764 RP-----SCEEILSR 773 (782)
Q Consensus 764 RP-----Sa~EIL~~ 773 (782)
|+ ++.++++|
T Consensus 238 R~~~~~~~~~~il~h 252 (325)
T cd05594 238 RLGGGPDDAKEIMQH 252 (325)
T ss_pred hCCCCCCCHHHHhcC
Confidence 96 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=350.63 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=213.5
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
.+....++|.+.+.||+|+||.||++.+ +++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 4456678999999999999999999987 578999999865432 2233456788999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999998852 35788899999999999999999999999999999999999999999999999876
Q ss_pred cCCCC-CCCCCCCCCcccCccccccC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003971 675 TDSPM-RDSSSAGTPEWMAPELIRNE----PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--- 746 (782)
Q Consensus 675 ~~~~~-~~~~~~GT~~Y~APEvl~~~----~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip--- 746 (782)
..... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+........+|
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence 43322 22456799999999998653 47889999999999999999999999988877777776544333333
Q ss_pred --ChHHHHHHHHhhh-CCCC--CCCHHHHHHH
Q 003971 747 --EGPLGRLIADCWA-EPQE--RPSCEEILSR 773 (782)
Q Consensus 747 --~~~L~~LI~~CL~-DP~k--RPSa~EIL~~ 773 (782)
...+.+|+.+|+. +|.+ |+++.++++|
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 3468899999998 8887 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=352.32 Aligned_cols=249 Identities=29% Similarity=0.419 Sum_probs=210.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH------------HHHHHHHHHHHHHhCCCCceeeEe
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE------------NMEDFCNEISILSRLRHPNVILFL 587 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~------------~~e~f~~EI~iLk~L~HPNIVkL~ 587 (782)
..++|++...||+|.||+|-+|.+ +++.||||++.+..+... ..+...+||.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 457899999999999999999987 689999999976543221 146889999999999999999999
Q ss_pred ccccCC--CceEEEEEEecccchhhHHHhhccccc-chHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEE
Q 003971 588 GACTKP--PRLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 664 (782)
Q Consensus 588 g~~~d~--~~l~LV~Ey~~gGsL~dlL~~~~~~~~-Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VK 664 (782)
++..+. +.+|||+|||..|.+...- ..+. +++.+++.|++.++.||+|||.+|||||||||+|+||+++|+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 998765 5699999999999887643 2334 99999999999999999999999999999999999999999999
Q ss_pred EEecCccccccCCC-----CCCCCCCCCCcccCccccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 003971 665 ICDFGLSRIITDSP-----MRDSSSAGTPEWMAPELIRNEP----FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA 735 (782)
Q Consensus 665 LaDFGLA~~l~~~~-----~~~~~~~GT~~Y~APEvl~~~~----~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~ 735 (782)
|+|||.+....... ......+|||.|+|||+..+.. .+.+.||||+||+||.|+.|+.||-+....++...
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 99999998763221 1123478999999999987632 35688999999999999999999999999999999
Q ss_pred HHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003971 736 VANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 736 i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 774 (782)
|.+.....+.- ...+++||.++|. ||++|.+..+|..|.
T Consensus 331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 98766544332 2368999999999 999999999998774
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=324.58 Aligned_cols=252 Identities=38% Similarity=0.605 Sum_probs=212.1
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
..++|++.+.||+|+||.||+|.+. ...||||++.... .......|.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 3467999999999999999999763 3479999876443 334457789999999999999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
+++|||+++++|.+++.. ....+++..++.++.|++.||+|||+++|+|+||||+|||+++++.++|+|||++.....
T Consensus 81 ~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 81 MIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999999863 234789999999999999999999999999999999999999999999999999987742
Q ss_pred CC--CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003971 677 SP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 750 (782)
Q Consensus 677 ~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L 750 (782)
.. .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+.. ....+.+ +..+
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 237 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-GYRLPPPMDCPSAL 237 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHH
Confidence 21 11123345678999999998889999999999999999998 9999988877776665543 2222222 3468
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 751 GRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 751 ~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
.+++.+||+ +|.+||++.+++++|.++
T Consensus 238 ~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 238 YQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=326.66 Aligned_cols=256 Identities=32% Similarity=0.585 Sum_probs=214.8
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 591 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 591 (782)
|++..++|.+.+.||+|+||.||+|... +..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 5667789999999999999999999763 2679999975433 3334567889999999999999999999999
Q ss_pred CCCceEEEEEEecccchhhHHHhhcc-------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEE
Q 003971 592 KPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 664 (782)
Q Consensus 592 d~~~l~LV~Ey~~gGsL~dlL~~~~~-------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VK 664 (782)
.....+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+|+|+||||+|||++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 99999999999999999998864221 23478889999999999999999999999999999999999999999
Q ss_pred EEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003971 665 ICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 741 (782)
Q Consensus 665 LaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~ 741 (782)
|+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.........+. .+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~ 238 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGG 238 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCC
Confidence 999999986644321 1223456789999999988889999999999999999998 899999888777766665 333
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 742 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 742 ~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
....| +..+.+++.+||+ +|.+|||+.++++.|++
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 33333 3468999999999 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.47 Aligned_cols=241 Identities=24% Similarity=0.383 Sum_probs=204.2
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEEEEEecc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.||+|+||+||++.+ +++.||||++.+... .....+.+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 478899999875432 233456778899998877 699999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
|+|.+++. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 99998886 345789999999999999999999999999999999999999999999999999876533333344567
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHHhhh-CCCC
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip~~~L~~LI~~CL~-DP~k 763 (782)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....... ......+.+++.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999999899999999999999999999999999988888777766543222 1224568999999999 9999
Q ss_pred CCCH------HHHHHH
Q 003971 764 RPSC------EEILSR 773 (782)
Q Consensus 764 RPSa------~EIL~~ 773 (782)
||++ .++++|
T Consensus 238 R~~~~~~~~~~~~~~h 253 (320)
T cd05590 238 RLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCCCCCHHHHHcC
Confidence 9998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=323.84 Aligned_cols=244 Identities=26% Similarity=0.545 Sum_probs=206.1
Q ss_pred EEeeeCcEEEEEEEE----CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEeccc
Q 003971 531 RVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
+||+|+||.||+|.+ ++..+|+|++..........+.+.+|+.+++.++||||+++++++.. ...+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999965 46789999987665555566889999999999999999999998864 4678999999999
Q ss_pred chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC---CCC
Q 003971 607 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR---DSS 683 (782)
Q Consensus 607 sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~---~~~ 683 (782)
+|.+++. ....+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++......... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999886 3346899999999999999999999999999999999999999999999999999876443221 122
Q ss_pred CCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003971 684 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 759 (782)
Q Consensus 684 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~ 759 (782)
..++..|+|||.+....++.++|+|||||++|||++ |+.||...........+. .+..+..| +..+.++|.+||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHhc
Confidence 334578999999988889999999999999999998 999999887766666554 33344444 3469999999999
Q ss_pred -CCCCCCCHHHHHHHHHhhhh
Q 003971 760 -EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 760 -DP~kRPSa~EIL~~L~di~~ 779 (782)
||++||++.+|.+.|+++.|
T Consensus 237 ~~p~~Rp~~~~i~~~l~~~~~ 257 (257)
T cd05116 237 YGVDERPGFAVVELRLRNYYY 257 (257)
T ss_pred cCchhCcCHHHHHHHHhcccC
Confidence 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=329.51 Aligned_cols=247 Identities=24% Similarity=0.316 Sum_probs=213.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
.+|...++||+|.||.||+|.+ +|+.||||.++..+.....--...+||..|+.++|+||+.++++|.+.+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677788999999999999987 68899999997765544334567899999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|++. +|...++ .+...++..++..++.++++||+|||.+.|+||||||.|+|++++|.+||+|||+|+.+.......
T Consensus 82 fm~t-dLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 9984 8888886 456789999999999999999999999999999999999999999999999999999987665555
Q ss_pred CCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CC-----------
Q 003971 682 SSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---IP----------- 746 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~---ip----------- 746 (782)
...+-|.+|.|||++.+ +.|+..+|+||.||++.||+-|.+-|++.+.-+.+..+...-..+. +|
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 55688999999998876 4699999999999999999999999999988888777765443331 11
Q ss_pred ---------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 ---------------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ---------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
....-+|+..+|. ||.+|+++.|.+++
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1134578999999 99999999999976
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=323.56 Aligned_cols=251 Identities=31% Similarity=0.568 Sum_probs=206.1
Q ss_pred eeEeeEEeeeCcEEEEEEEEC--Ce--EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC------Cc
Q 003971 526 LTVGTRVGIGFFGEVFRGIWN--GT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------PR 595 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~~--g~--~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------~~ 595 (782)
|.+++.||+|+||.||+|.+. +. .+|+|.+..........+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356789999999999999873 32 589998876555556678899999999999999999999986432 24
Q ss_pred eEEEEEEecccchhhHHHhh---cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 596 LSMITEYMELGSLYHLIHLS---GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~---~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
.++++||+.+|+|..++... .....+++..++.++.|++.||+|||+++|+||||||+|||+++++.++|+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 68999999999998877422 123458999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003971 673 IITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP--- 746 (782)
Q Consensus 673 ~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip--- 746 (782)
.+...... .....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+.........+.... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 239 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQPPDC 239 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCC
Confidence 76443211 123346678999999999889999999999999999999 789998887776666554433 22222
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 747 EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 747 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
...+.+++.+||. ||.+|||+.+|++.|+++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 240 LDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 3468999999999 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.72 Aligned_cols=240 Identities=23% Similarity=0.405 Sum_probs=200.5
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEEEEEecc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.||+|+||+||+|.+ +++.||||++..... .....+.+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 467899999875432 223345666777777654 799999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
|+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 99998886 345789999999999999999999999999999999999999999999999999986543333344567
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHHhhh-CCCC
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip~~~L~~LI~~CL~-DP~k 763 (782)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....... ......+.+++.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999999899999999999999999999999999988877777665433221 1123468899999999 9999
Q ss_pred CCCHH-HHHH
Q 003971 764 RPSCE-EILS 772 (782)
Q Consensus 764 RPSa~-EIL~ 772 (782)
||++. ++++
T Consensus 238 R~~~~~~l~~ 247 (316)
T cd05592 238 RLGVDGDIRQ 247 (316)
T ss_pred cCCChHHHHc
Confidence 99875 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=321.18 Aligned_cols=247 Identities=28% Similarity=0.470 Sum_probs=210.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC---hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT---AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~---~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
++|.+.+.||+|+||.||++.. .++.+|+|.+...... ....+.+.+|++++++++||||+++++++.....+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999976 5789999998654332 2234678899999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
++||+++++|.+.+. ....+++..+..++.|++.||.|||+.||+|+||+|+||++++++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999999886 33468899999999999999999999999999999999999999999999999987653321
Q ss_pred CCC---CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003971 679 MRD---SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 752 (782)
Q Consensus 679 ~~~---~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~ 752 (782)
... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||....................++ ...+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 111 23567889999999999889999999999999999999999998877666666555544444444 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003971 753 LIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
++.+||. +|.+||++.+++++
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhC
Confidence 9999999 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=326.85 Aligned_cols=254 Identities=28% Similarity=0.521 Sum_probs=211.2
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
+.+++|++.+.||+|+||+||+|.+ .+..+|+|.+.... .......|.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4567899999999999999999974 35689999986433 3344578899999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcc--------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQ--------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 660 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~--------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~ 660 (782)
..+++|||+++++|.+++..... ...+++.+++.++.|++.||+|||++||+|+||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 99999999999999998853211 2357889999999999999999999999999999999999999
Q ss_pred CeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 003971 661 WTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVA 737 (782)
Q Consensus 661 g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~ 737 (782)
+.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999987643221 1233446678999999988889999999999999999998 899998887766655554
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 738 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 738 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
... .+..+ +..+.+++.+||+ ||.+||++.+|+++|..
T Consensus 241 ~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 KRQ-LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred cCC-cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 332 33333 3468999999999 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=343.39 Aligned_cols=261 Identities=32% Similarity=0.589 Sum_probs=213.7
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEecc
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGA 589 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~ 589 (782)
.|++..++|++.+.||.|+||.||+|.+. ++.||+|++.... .....+.+.+|+.++.++ +|+||++++++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 37778889999999999999999999642 3679999986443 233456788999999999 79999999998
Q ss_pred ccC-CCceEEEEEEecccchhhHHHhhcc---------------------------------------------------
Q 003971 590 CTK-PPRLSMITEYMELGSLYHLIHLSGQ--------------------------------------------------- 617 (782)
Q Consensus 590 ~~d-~~~l~LV~Ey~~gGsL~dlL~~~~~--------------------------------------------------- 617 (782)
|.. ...+++++||+++++|.+++.....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 864 4568899999999999988853211
Q ss_pred -------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCC
Q 003971 618 -------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTP 688 (782)
Q Consensus 618 -------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~ 688 (782)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+..... ......++.
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 13688999999999999999999999999999999999999999999999999987643221 122344567
Q ss_pred cccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCC
Q 003971 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 689 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~k 763 (782)
.|+|||++.+..++.++|||||||++|||++ |..||.+....+........+.....+ ...+.+++.+||+ +|.+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 319 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED 319 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence 8999999999999999999999999999998 999998766555544444444443333 3468999999999 9999
Q ss_pred CCCHHHHHHHHHhhhh
Q 003971 764 RPSCEEILSRLLDCEY 779 (782)
Q Consensus 764 RPSa~EIL~~L~di~~ 779 (782)
||++.+++++|+++..
T Consensus 320 RPs~~ell~~l~~~~~ 335 (337)
T cd05054 320 RPTFSELVEILGDLLQ 335 (337)
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=322.18 Aligned_cols=251 Identities=29% Similarity=0.539 Sum_probs=209.1
Q ss_pred eeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc-----
Q 003971 526 LTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR----- 595 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~----- 595 (782)
|++++.||+|+||.||+|... +..||+|++............+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999762 3679999987665555567789999999999999999999998866544
Q ss_pred -eEEEEEEecccchhhHHHhhc---ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 596 -LSMITEYMELGSLYHLIHLSG---QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 596 -l~LV~Ey~~gGsL~dlL~~~~---~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
.++++||+++++|..++.... ....+++..++.++.|++.||.|||+.+|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 799999999999998875331 2346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003971 672 RIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP-- 746 (782)
Q Consensus 672 ~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip-- 746 (782)
+........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+... .....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 239 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-NRLKQPED 239 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcC
Confidence 876443221 112335678999999988889999999999999999999 88999888877766655443 233333
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 747 -EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 747 -~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
...+.+++.+||. ||.+||++.+++++|+++
T Consensus 240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 240 CLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 3468999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=349.23 Aligned_cols=261 Identities=30% Similarity=0.547 Sum_probs=216.6
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEec
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLG 588 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g 588 (782)
..|.++.++|.+++.||+|+||.||+|.+. +..||||++.... .....+.|.+|+.+++++. ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 457788899999999999999999999762 2469999986543 3344578999999999996 999999999
Q ss_pred cccCCCceEEEEEEecccchhhHHHhhcc---------------------------------------------------
Q 003971 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQ--------------------------------------------------- 617 (782)
Q Consensus 589 ~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~--------------------------------------------------- 617 (782)
+|.+...+|+||||+++|+|.+++.....
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 99999999999999999999988864210
Q ss_pred ------------------------------------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccE
Q 003971 618 ------------------------------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANC 655 (782)
Q Consensus 618 ------------------------------------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNI 655 (782)
...+++..++.++.||+.||+|||+.+|+|+||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 12477888999999999999999999999999999999
Q ss_pred EEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 003971 656 LVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERV 732 (782)
Q Consensus 656 LLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~ev 732 (782)
|++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 999999999999999987643221 1223456788999999998889999999999999999997 8999987765555
Q ss_pred HHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 733 VYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 733 l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
.......+.++..+ +..+.+++.+||. ||.+||++.+|.+.|+++.
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 55555555444433 2368999999999 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.69 Aligned_cols=247 Identities=27% Similarity=0.393 Sum_probs=208.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|++.+.||+|+||.||++.. .++.||||++..... .......+..|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688999999999999999987 578999999875432 2334567889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC--
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 678 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~-- 678 (782)
||+++|+|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999999886 34578999999999999999999999999999999999999999999999999987542210
Q ss_pred ---------------------------------CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 003971 679 ---------------------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWE 725 (782)
Q Consensus 679 ---------------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~ 725 (782)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123579999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhhCCCCCCC---HHHHHHH
Q 003971 726 GVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWAEPQERPS---CEEILSR 773 (782)
Q Consensus 726 ~~~~~evl~~i~~~~~~~~ip-----~~~L~~LI~~CL~DP~kRPS---a~EIL~~ 773 (782)
+..+......+........+| ...+.+|+.+|+.||.+|++ +.++++|
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcC
Confidence 988888777776544333333 23578888887669999984 7787766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=323.31 Aligned_cols=245 Identities=33% Similarity=0.530 Sum_probs=206.1
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEe
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 603 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 603 (782)
|++++.||+|+||+||++.. +++.||+|++...............|+.+++.++||||+++++++.+....+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78999999999999999988 4668999999877655544445567999999999999999999999999999999999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 683 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~ 683 (782)
.+++|.+++. ....+++..++.++.|+++||.|||+.||+|+||||+||+++.++.++|+|||.+............
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999987 4567899999999999999999999999999999999999999999999999999764333334456
Q ss_pred CCCCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCCC-----CChHHHHHH
Q 003971 684 SAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV---ANEGSRLEI-----PEGPLGRLI 754 (782)
Q Consensus 684 ~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i---~~~~~~~~i-----p~~~L~~LI 754 (782)
..++..|+|||++. +..++.++||||||+++|+|++|..||...........+ ......... ....+.+++
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 77899999999998 788999999999999999999999999987333322222 211111111 125799999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003971 755 ADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~ 773 (782)
..||+ ||.+||++.+++++
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999 99999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=378.53 Aligned_cols=257 Identities=32% Similarity=0.596 Sum_probs=222.3
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE---CCe----EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW---NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~---~g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
++....++...||+|+||.||.|.. +|. .||||.+.+. .......+|++|..+|++++|||||+++|+|.+.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 5567788899999999999999976 233 4888887543 3456678999999999999999999999999999
Q ss_pred CceEEEEEEecccchhhHHHhhcc----cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecC
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQ----KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 669 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~----~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFG 669 (782)
...++++|||.+|+|..+|+.... ...++....+.++.+||+|+.||+++++|||||.++||||+....|||+|||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999999985421 3568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCC--CCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003971 670 LSRIITDSPMRDSSSA--GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP 746 (782)
Q Consensus 670 LA~~l~~~~~~~~~~~--GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip 746 (782)
+|+.+.+..+...... -...|||||.+..+.++.|+|||||||+|||++| |..||.+.++.++...+..++ +++.|
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P 926 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPP 926 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCC
Confidence 9996655443332222 3358999999999999999999999999999997 678999999999888777766 77777
Q ss_pred C---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 747 E---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 747 ~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
. +.++++|..||+ +|++||+|..|++.+.++..
T Consensus 927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 5 469999999999 99999999999998887654
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=356.09 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=215.0
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC---
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP--- 594 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~--- 594 (782)
.....+|.+.+.||+|+||+||++.+ +++.||||++............+.+|+.++..++|+||++++..+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457999999999999999999976 6889999999777666666778899999999999999999988765432
Q ss_pred -----ceEEEEEEecccchhhHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEec
Q 003971 595 -----RLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 668 (782)
Q Consensus 595 -----~l~LV~Ey~~gGsL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDF 668 (782)
.+++||||+++|+|.+++... .....+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 368999999999999988632 23457899999999999999999999999999999999999999999999999
Q ss_pred CccccccCC--CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003971 669 GLSRIITDS--PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 746 (782)
Q Consensus 669 GLA~~l~~~--~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip 746 (782)
|+++.+... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+...... .++
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~-~~~ 266 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-PLP 266 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-CCC
Confidence 999876432 11223567999999999999999999999999999999999999999998887777766554332 222
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 ---EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+.+++..||. ||.+||++.+++++
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 3469999999999 99999999999875
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.49 Aligned_cols=251 Identities=31% Similarity=0.639 Sum_probs=214.7
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
|.+...+|++.+.||.|+||.||++...|+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+....++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 345667899999999999999999999999999999865432 45789999999999999999999999998899999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
+|||+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999999998632 22368999999999999999999999999999999999999999999999999998764321
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 754 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI 754 (782)
.....+..|+|||.+....++.++||||||+++|+|++ |..||...........+.. ......+ +..+.+++
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCCCccCCCHHHHHHH
Confidence 13344568999999988889999999999999999997 9999988877666555443 3333333 35689999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 755 ADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
.+||. +|.+||++.++++.|+++
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 233 KDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHhccChhhCcCHHHHHHHHhcC
Confidence 99999 999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=355.31 Aligned_cols=249 Identities=29% Similarity=0.483 Sum_probs=226.7
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc-eEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR-LSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~-l~LV 599 (782)
.++|.+++++|+|+||.++.+.+ +++.|++|.+..............+|+.++++++|||||.+++.|.+++. ++|+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 46889999999999999998865 67789999998877766666688899999999999999999999999999 9999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|+|++||+|.+.+.... +..++++++..++.|++.|+.|||+++|+|||||+.||+++.++.|+|+|||+|+.+.....
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999999998553 67899999999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHH
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIAD 756 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~ 756 (782)
...+..||+.|+.||++.+.+|+.|+|||||||++|||++-+.+|...+...++..+..... .++| ...++.||..
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~-~Plp~~ys~el~~lv~~ 240 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY-SPLPSMYSSELRSLVKS 240 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC-CCCCccccHHHHHHHHH
Confidence 66788999999999999999999999999999999999999999999999999998887663 3333 3479999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003971 757 CWA-EPQERPSCEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~ 773 (782)
|+. +|..||++.++|.+
T Consensus 241 ~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 241 MLRKNPEHRPSALELLRR 258 (426)
T ss_pred HhhcCCccCCCHHHHhhC
Confidence 999 99999999999976
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=339.07 Aligned_cols=241 Identities=24% Similarity=0.419 Sum_probs=204.4
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEEEEEecc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.||+|+||+||++.+ +++.||||++.+... .......+..|+.++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 467899999875532 223456778899999888 699999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
|+|...+. ....+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||++.............+
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 99998886 345789999999999999999999999999999999999999999999999999875433322334567
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 763 (782)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ ..+..+.+|+.+||. ||.+
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 99999999999999999999999999999999999999998887777766655433222 224568999999999 9999
Q ss_pred CCCH-----HHHHHH
Q 003971 764 RPSC-----EEILSR 773 (782)
Q Consensus 764 RPSa-----~EIL~~ 773 (782)
||++ .+++++
T Consensus 238 R~s~~~~~~~~ll~~ 252 (318)
T cd05570 238 RLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCCCCCCHHHHhcC
Confidence 9999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=333.17 Aligned_cols=252 Identities=27% Similarity=0.556 Sum_probs=208.3
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCe----EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
...+|++.+.||+|+||.||+|.+ ++. .||+|++.... .....+.+.+|+.+++.++||||++++++|... .
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 346799999999999999999976 333 48999986432 334457889999999999999999999998775 4
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.++++||+++|+|.+++.. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 83 VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred ceeeeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 7899999999999998873 23468889999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003971 676 DSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 749 (782)
Q Consensus 676 ~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~ 749 (782)
..... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.+....+.. .+...+.....+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTID 239 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCCCCCCCHH
Confidence 33221 122344678999999999999999999999999999997 99999887766544 344444444333 246
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
+..++.+||. +|.+||++.+++..|.++.
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 8899999999 9999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.19 Aligned_cols=259 Identities=29% Similarity=0.587 Sum_probs=216.7
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEec
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 588 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g 588 (782)
..|.+..++|++.+.||+|+||.||++.+. ...+|+|++.... .......+.+|+.+++.+ +|+||+++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 357778889999999999999999999763 2579999986543 334456789999999999 7999999999
Q ss_pred cccCCCceEEEEEEecccchhhHHHhh-------------cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccE
Q 003971 589 ACTKPPRLSMITEYMELGSLYHLIHLS-------------GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANC 655 (782)
Q Consensus 589 ~~~d~~~l~LV~Ey~~gGsL~dlL~~~-------------~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNI 655 (782)
++.....++++|||+++|+|..++... .....+++..++.++.|++.||+|||+.||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999998632 1245789999999999999999999999999999999999
Q ss_pred EEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 003971 656 LVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERV 732 (782)
Q Consensus 656 LLd~~g~VKLaDFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~ev 732 (782)
|++.++.+||+|||+++.+...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 9999999999999999876443211 122335578999999988889999999999999999997 8999998877666
Q ss_pred HHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 733 VYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 733 l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
...+.. ......+ ...+.+|+.+||. ||.+|||+.++++.|+++
T Consensus 244 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 FKLLKE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 655443 3333333 3468999999999 999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.16 Aligned_cols=257 Identities=30% Similarity=0.537 Sum_probs=214.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
++.++|.+.+.||+|+||+||++.. ++..+|+|.+... .....+.+.+|++++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4567899999999999999999974 2356888987543 233457799999999999999999999999999
Q ss_pred CceEEEEEEecccchhhHHHhhc----------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeE
Q 003971 594 PRLSMITEYMELGSLYHLIHLSG----------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 663 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~----------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~V 663 (782)
+.+++++||+++++|.+++.... ....+++.+++.++.|++.||+|||++|++||||||+|||+++++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999886332 12358999999999999999999999999999999999999999999
Q ss_pred EEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 003971 664 KICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEG 740 (782)
Q Consensus 664 KLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~ 740 (782)
+|+|||++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999986543221 1223345778999999998889999999999999999998 899999888777766665433
Q ss_pred CCC--CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 741 SRL--EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 741 ~~~--~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
... ...+..+.+|+.+||+ ||.+||++.++++.|+++..
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 221 1223479999999999 99999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=348.58 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=211.5
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
......++|++.+.||+|+||.||++.+ +++.+|+|++.+... .....+.+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3455668999999999999999999987 477899999865332 2233456789999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999999998852 35788999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC-CCCCCCCCCcccCccccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC--
Q 003971 675 TDSPM-RDSSSAGTPEWMAPELIRNEP----FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE-- 747 (782)
Q Consensus 675 ~~~~~-~~~~~~GT~~Y~APEvl~~~~----~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~-- 747 (782)
..... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+........+|.
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence 43322 224567999999999987643 78899999999999999999999998888777777766544444443
Q ss_pred ---hHHHHHHHHhhh-CCC--CCCCHHHHHHH
Q 003971 748 ---GPLGRLIADCWA-EPQ--ERPSCEEILSR 773 (782)
Q Consensus 748 ---~~L~~LI~~CL~-DP~--kRPSa~EIL~~ 773 (782)
..+.+++..|+. ++. .|+++.++++|
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 357889999997 443 38899999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=325.96 Aligned_cols=247 Identities=27% Similarity=0.466 Sum_probs=204.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
..+|++.+.||+|+||.||+|.. +++.||+|++..... .....+.+|+.+++.++||||+++++++...+.+++++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 36799999999999999999986 678899999864432 23456789999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++++|.+++. ....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.........
T Consensus 86 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 86 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 9999999999886 3456899999999999999999999999999999999999999999999999999876443222
Q ss_pred CCCCCCCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------ChHHH
Q 003971 681 DSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EGPLG 751 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip------~~~L~ 751 (782)
.....|++.|+|||.+. ...++.++|||||||++|+|++|+.||....+......+.......+.. ...+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 33456889999999874 3457889999999999999999999997665544433332222222111 24689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~L 774 (782)
+++.+||. +|.+||++++++++|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCC
Confidence 99999999 999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=323.21 Aligned_cols=249 Identities=31% Similarity=0.600 Sum_probs=209.0
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEECC-eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~g-~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
+.++|++.+.||+|+||.||.+.+.+ ..+|+|.+...... .+.|.+|+.+++.++||||+++++++......+++|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 45689999999999999999998754 46999987644332 367899999999999999999999999988999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+.+++|.+++... ...+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.+||+|||+++........
T Consensus 79 e~~~~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 79 EYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EcCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999999988632 236899999999999999999999999999999999999999999999999998866443221
Q ss_pred C-CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC--CCCCChHHHHHHHH
Q 003971 681 D-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR--LEIPEGPLGRLIAD 756 (782)
Q Consensus 681 ~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~--~~ip~~~L~~LI~~ 756 (782)
. ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+...... +......+.+++.+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 1 12335568999999998889999999999999999998 99999888777666666543221 12234579999999
Q ss_pred hhh-CCCCCCCHHHHHHHHH
Q 003971 757 CWA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~L~ 775 (782)
||. +|.+||++.+|++.|+
T Consensus 237 cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 237 CWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HcCCCcccCCCHHHHHHhhC
Confidence 999 9999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=325.87 Aligned_cols=254 Identities=30% Similarity=0.549 Sum_probs=212.1
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
...+|.+.+.||+|+||.||+|... +..||||.+..... .+..+.|.+|+++++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 3467889999999999999999752 36799999865432 334578999999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhc-----------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeE
Q 003971 595 RLSMITEYMELGSLYHLIHLSG-----------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 663 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~-----------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~V 663 (782)
..+++|||+++++|.+++.... ....+++..+..++.|++.||+|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999986432 13457899999999999999999999999999999999999999999
Q ss_pred EEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 003971 664 KICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEG 740 (782)
Q Consensus 664 KLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~ 740 (782)
+|+|||++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999976533221 1223446788999999999999999999999999999998 999998888777776665332
Q ss_pred CCC--CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 741 SRL--EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 741 ~~~--~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
... ...+..+.+++.+||. ||.+||++.|+++.|++
T Consensus 242 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 242 LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 221 1224579999999999 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.40 Aligned_cols=253 Identities=34% Similarity=0.596 Sum_probs=213.1
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
|++..++|++.++||+|+||.||+|.. +++.||+|.+...... .+.|.+|+.+++.++|+||+++++++. ....+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 456678899999999999999999976 6788999998654433 357889999999999999999999874 45689
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+++||+.+++|.+++... ....+++.++..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 77 IITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999999988633 3457899999999999999999999999999999999999999999999999999876532
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003971 678 PMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 752 (782)
Q Consensus 678 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~ 752 (782)
... .....++..|+|||.+....++.++||||||+++|+|++ |+.||.+.........+.. ....+.+ +..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-GYRMPRPDNCPEELYE 234 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCCCCCCCCCCHHHHH
Confidence 221 223345678999999998889999999999999999999 9999998877766665543 3333333 346999
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 753 LIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
++.+||. +|++||++++++..|+++
T Consensus 235 li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 235 LMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHHccCChhhCCCHHHHHHHhhcC
Confidence 9999999 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=338.50 Aligned_cols=246 Identities=26% Similarity=0.366 Sum_probs=200.4
Q ss_pred CeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeecccc--ChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCce
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRL 596 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~--~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l 596 (782)
+|++.+.||+|+||.||++.. .++.||+|++.+... .....+.+..|+.+++.++ |+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999865 478899999865432 2233467889999999994 99999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
+++|||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999999886 345689999999999999999999999999999999999999999999999999986543
Q ss_pred CC-CCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCC-CCCCChH
Q 003971 677 SP-MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGV----LPERVVYAVANEGSR-LEIPEGP 749 (782)
Q Consensus 677 ~~-~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~----~~~evl~~i~~~~~~-~~ip~~~ 749 (782)
.. ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||... ........+...... +......
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 22 122346799999999999865 4788999999999999999999999643 222333333322211 1122346
Q ss_pred HHHHHHHhhh-CCCCCC-----CHHHHHHH
Q 003971 750 LGRLIADCWA-EPQERP-----SCEEILSR 773 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRP-----Sa~EIL~~ 773 (782)
+.+++.+||. ||.+|| ++++++++
T Consensus 238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 8999999999 999999 78888865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.82 Aligned_cols=241 Identities=22% Similarity=0.368 Sum_probs=200.2
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEEEEEecc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.||+|+||.||+|.+ +|+.||+|++...... ....+.+..|+.++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999987 5778999998754321 22345677788888765 899999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
|+|..++. ....+++.++..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++............+
T Consensus 81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 99998886 345789999999999999999999999999999999999999999999999999875432222334567
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHHhhh-CCCC
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip~~~L~~LI~~CL~-DP~k 763 (782)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+....... ..-...+.+++.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999999999999999999999999999999999888777666554432211 1223468999999999 9999
Q ss_pred CCCHH-HHHHH
Q 003971 764 RPSCE-EILSR 773 (782)
Q Consensus 764 RPSa~-EIL~~ 773 (782)
||++. ++++|
T Consensus 238 R~~~~~~~~~h 248 (316)
T cd05620 238 RLGVVGNIRGH 248 (316)
T ss_pred cCCChHHHHcC
Confidence 99984 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.01 Aligned_cols=250 Identities=29% Similarity=0.572 Sum_probs=211.1
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccc-cCCCceE
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC-TKPPRLS 597 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~-~d~~~l~ 597 (782)
|.++..+|++.+.||+|+||.||++...|+.+|+|.+.... ..+.|.+|+.+++.++|+||+++++++ ......+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 55677899999999999999999999999999999975332 246788999999999999999999975 4556789
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+++||+++++|.+++... ....+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEECCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999999988632 2345889999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRL 753 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~L 753 (782)
. ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...........+.. +.....+ +..+.++
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDV 231 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHH
Confidence 1 23345678999999998889999999999999999997 9999988777666555533 3333332 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 754 IADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
+.+||. +|.+||++.++++.|+++
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHhcCChhhCcCHHHHHHHHhcC
Confidence 999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=337.96 Aligned_cols=240 Identities=24% Similarity=0.383 Sum_probs=200.4
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEEEEEecc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.||+|+||+||+|.+ .++.||||++..... .......+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 467899999876532 123345677788888764 899999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
|+|..++. ....+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 99999886 335688999999999999999999999999999999999999999999999999875432222334567
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHHhhh-CCCC
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip~~~L~~LI~~CL~-DP~k 763 (782)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+....... ......+.+++.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999999899999999999999999999999999888777766654433221 1224568999999999 9999
Q ss_pred CCCHH-HHHH
Q 003971 764 RPSCE-EILS 772 (782)
Q Consensus 764 RPSa~-EIL~ 772 (782)
||++. ++++
T Consensus 238 R~~~~~~l~~ 247 (316)
T cd05619 238 RLGVKGDIRQ 247 (316)
T ss_pred cCCChHHHHc
Confidence 99997 6655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=328.20 Aligned_cols=255 Identities=31% Similarity=0.489 Sum_probs=211.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
++..+|.+.+.||+|+||.||+|.+. +..||+|++.... .....+.|.+|+.++..++||||+++++++.+.
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 45667889999999999999999763 4679999986443 233456788999999999999999999999999
Q ss_pred CceEEEEEEecccchhhHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC
Q 003971 594 PRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 660 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~ 660 (782)
...++++||+.+++|.+++.... ....+++..++.++.|++.||+|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 99999999999999998885221 12357888999999999999999999999999999999999999
Q ss_pred CeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 003971 661 WTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVA 737 (782)
Q Consensus 661 g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~ 737 (782)
+.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999886543221 1123446778999999988889999999999999999998 888998888877766655
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 738 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 738 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
... ....+ +..+.+|+..||+ +|.+||++.+|++.|+++
T Consensus 241 ~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 241 NRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred cCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 443 22333 2358999999999 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=337.21 Aligned_cols=247 Identities=23% Similarity=0.381 Sum_probs=204.9
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
+..++|++.++||.|+||.||++.+ .+..+|+|++.... .....+.+.+|+++++.++||||++++++|.+.+.+++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3457899999999999999999987 47789999876542 33445778999999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc-cccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~-gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+|||+++++|.+++. ....+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999999986 345688999999999999999999985 7999999999999999999999999999765432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---------------------
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV--------------------- 736 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i--------------------- 736 (782)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 223457899999999999888999999999999999999999999765443322111
Q ss_pred ----------------------HhcCCCCCCC----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 737 ----------------------ANEGSRLEIP----EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 737 ----------------------~~~~~~~~ip----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
......+..+ +..+.+|+.+||+ ||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0011111111 2457899999999 99999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=329.39 Aligned_cols=240 Identities=25% Similarity=0.382 Sum_probs=198.0
Q ss_pred EeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccch
Q 003971 532 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 608 (782)
Q Consensus 532 LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL 608 (782)
||+|+||+||++.+ +++.||+|.+...... ....+.+..|+.+++.++|+||+++.+++.....++++|||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999976 5789999998654432 22346778899999999999999999999999999999999999999
Q ss_pred hhHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCC
Q 003971 609 YHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT 687 (782)
Q Consensus 609 ~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT 687 (782)
.+.+... .....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..+...........||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 8877432 234578999999999999999999999999999999999999999999999999998765443333456799
Q ss_pred CcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-
Q 003971 688 PEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE----RVVYAVANEGSRLEIP---EGPLGRLIADCWA- 759 (782)
Q Consensus 688 ~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~----evl~~i~~~~~~~~ip---~~~L~~LI~~CL~- 759 (782)
+.|+|||.+.+..++.++|||||||++|+|++|+.||...... .....+... ...++ ...+.+++.+||.
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999999765432 222222211 11222 3468999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 003971 760 EPQERP-----SCEEILSR 773 (782)
Q Consensus 760 DP~kRP-----Sa~EIL~~ 773 (782)
||.+|| +++++++|
T Consensus 239 ~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CHHHhcCCCCCCHHHHhcC
Confidence 999999 77888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=339.45 Aligned_cols=236 Identities=22% Similarity=0.396 Sum_probs=198.3
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHH-HHHhCCCCceeeEeccccCCCceEEEEEEecc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEIS-ILSRLRHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~-iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.||+|+||+||+|.+ +|+.||+|++...... ......+..|.. +++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999987 5889999998754332 223345566655 56789999999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
|+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 99998886 345789999999999999999999999999999999999999999999999999876433333334567
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 763 (782)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+........ .....+.+++.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 99999999999999999999999999999999999999999888777777665432221 124468999999999 9999
Q ss_pred CCCHH
Q 003971 764 RPSCE 768 (782)
Q Consensus 764 RPSa~ 768 (782)
||++.
T Consensus 238 R~~~~ 242 (323)
T cd05575 238 RLGAK 242 (323)
T ss_pred CCCCC
Confidence 99884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=317.34 Aligned_cols=254 Identities=28% Similarity=0.511 Sum_probs=212.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.+|++.+.||.|+||.||+|.. +|+.||+|.+..... .....+.+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999987 588999998865433 3344678999999999999999999999999999999999
Q ss_pred EEecccchhhHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 601 EYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
||+++++|..++... .....+++.+++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999999888642 2245689999999999999999999999999999999999999999999999999887654333
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCC----ChHHHHH
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--PERVVYAVANEGSRLEIP----EGPLGRL 753 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~--~~evl~~i~~~~~~~~ip----~~~L~~L 753 (782)
......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.... .......+. .+...+.+ ...+.++
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLPADHYSEELRDL 240 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCCCCCChhhcCHHHHHH
Confidence 3334568899999999988889999999999999999999999996543 223333322 22333333 2368999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 754 IADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
+.+||. +|.+||++.+|++.|+++.
T Consensus 241 i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 241 VSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 999999 9999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.93 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=202.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|++.+.||+|+||.||+|.+ ++..||||++..........+.+.+|+.+++.++||||+++++++.++..+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999987 578999999865544444456788999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+. ++|.+++........+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 98 57887776444446789999999999999999999999999999999999999999999999999976543322233
Q ss_pred CCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------------------
Q 003971 683 SSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR------------------- 742 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~------------------- 742 (782)
...+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||.+................
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 4567889999998865 45789999999999999999999999876654443332211100
Q ss_pred -----------CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 -----------LEIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 -----------~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
....+..+.+++.+||. ||.+|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00012356789999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.70 Aligned_cols=253 Identities=33% Similarity=0.587 Sum_probs=211.8
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
|.+..++|++.++||+|+||.||+|.. .+..+|+|.+...... .+.|.+|+.++++++|+||+++++++.. ...+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence 456678899999999999999999976 4667999998654433 3568899999999999999999998854 5589
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
++|||+++++|.+++... ....+++..++.++.|++.||+|||+.||+|+||||+||++++++.++|+|||++..+...
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999999988632 3346899999999999999999999999999999999999999999999999999876443
Q ss_pred CCCC-CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003971 678 PMRD-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 752 (782)
Q Consensus 678 ~~~~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~ 752 (782)
.... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+....+... ...+.+ +..+.+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHE 234 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHH
Confidence 2211 22345668999999988889999999999999999999 88999888877766665543 233333 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 753 LIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
|+.+||. +|.+|||+.++++.|+++
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~~l~~~ 260 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQSFLEDY 260 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHHhcC
Confidence 9999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.26 Aligned_cols=246 Identities=30% Similarity=0.525 Sum_probs=210.8
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|++.+.||.|+||.||++.+ ++..+|+|.+..... ....+.+.+|+.+++.++|+||+++++++.+...+|+++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 588999999999999999977 578899999864432 33457788999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+++++|.+++... ....+++..++.++.|++.||.|||++||+|+||||+||++++++.++|+|||++...........
T Consensus 80 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 80 CDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 9999999887632 345688999999999999999999999999999999999999999999999999987755433334
Q ss_pred CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003971 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 759 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~ 759 (782)
...|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+.... ...++ ...+.+++.+||.
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~ 237 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS-YKPLPSHYSYELRSLIKQMFK 237 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC-CCCCCcccCHHHHHHHHHHHh
Confidence 5678899999999998889999999999999999999999999887766666554433 32233 3468899999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003971 760 -EPQERPSCEEILSR 773 (782)
Q Consensus 760 -DP~kRPSa~EIL~~ 773 (782)
||.+||++.+++..
T Consensus 238 ~~P~~Rp~~~~il~~ 252 (255)
T cd08219 238 RNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCCCHHHHhhc
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.59 Aligned_cols=243 Identities=21% Similarity=0.356 Sum_probs=200.1
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHH-HHHhCCCCceeeEeccccCCCceEEEEEEecc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEIS-ILSRLRHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~-iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.||+|+||+||++.+ +++.||+|++...... ......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 4678999998754322 122334455544 56788999999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 99999886 345688889999999999999999999999999999999999999999999999976543333344567
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 763 (782)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+........ .-...+.+++.+||+ ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 99999999999999999999999999999999999999998888777776655432221 123468999999999 9999
Q ss_pred CCCHHHHHHHHH
Q 003971 764 RPSCEEILSRLL 775 (782)
Q Consensus 764 RPSa~EIL~~L~ 775 (782)
||++.+.+..+.
T Consensus 238 R~~~~~~~~~i~ 249 (325)
T cd05602 238 RLGAKDDFMEIK 249 (325)
T ss_pred CCCCCCCHHHHh
Confidence 998875444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=335.17 Aligned_cols=246 Identities=25% Similarity=0.396 Sum_probs=219.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|.+-+.||+|.|+.||++.+ .|+.+|+|++..........+++.+|+.|.+.|+|||||++.+.+......|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 5688889999999999999976 68899999987777766677899999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc---CCCeEEEEecCccccccCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd---~~g~VKLaDFGLA~~l~~~~ 678 (782)
++.|+.|..-+- ....+++..+-.+++||+++|.|||.+||||||+||+|+||- ....+||+|||+|..+. ..
T Consensus 91 ~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g 166 (355)
T KOG0033|consen 91 LVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DG 166 (355)
T ss_pred cccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Cc
Confidence 999999985443 225689999999999999999999999999999999999994 44579999999999987 34
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~L 753 (782)
......+|||+|||||+++..+|+..+|||+.||+||-|+.|.+||.+.+...++.++....+..+-| ....++|
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 44557899999999999999999999999999999999999999999999999999998776655443 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+++|+. ||.+|.|+.|.|+|
T Consensus 247 vrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHhccChhhhccHHHHhCC
Confidence 999999 99999999999875
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.00 Aligned_cols=257 Identities=30% Similarity=0.551 Sum_probs=212.3
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 591 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 591 (782)
|+++.++|++.+.||+|+||.||+|..+ +..||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 6677889999999999999999998642 44799998764432 233456889999999999999999999999
Q ss_pred CCCceEEEEEEecccchhhHHHhhcc-------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEE
Q 003971 592 KPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 664 (782)
Q Consensus 592 d~~~l~LV~Ey~~gGsL~dlL~~~~~-------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VK 664 (782)
+....+++|||+++|+|.+++..... ...++...++.++.|++.||.|||+++|+||||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999999964321 23456778899999999999999999999999999999999999999
Q ss_pred EEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003971 665 ICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 741 (782)
Q Consensus 665 LaDFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~ 741 (782)
|+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~- 238 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG- 238 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 9999999865432211 122345678999999998889999999999999999998 788999888777666554432
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 742 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 742 ~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
....+ +..+.+++..||+ ||.+||++.++++.|++.
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 22222 3469999999999 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.80 Aligned_cols=244 Identities=26% Similarity=0.348 Sum_probs=199.0
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC------
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 594 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------ 594 (782)
.++|++.+.||+|+||.||++.+ .|..||||++............+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 47899999999999999999976 5789999998765444455677889999999999999999999886543
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+|++|||+.+ +|...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999986 4555443 24788889999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------- 741 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~------------- 741 (782)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 174 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 174 CTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 432 223456789999999999999999999999999999999999999987765433222211100
Q ss_pred ----------CC--------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 ----------RL--------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 ----------~~--------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.. ......+.+|+.+||. ||.+|||+.|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0012357899999999 99999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=355.41 Aligned_cols=245 Identities=33% Similarity=0.542 Sum_probs=216.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
..|+....||+|.||.||+|.+ .++.||+|++..... +..++++.+|+.+|..++++||.++|+.+..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4566678999999999999987 578899999876543 3446889999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
||.||++.++++ ....+.+..+..++++++.||.|||..+.+|||||+.|||+..+|.|||+|||.+..+.......
T Consensus 92 y~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999999997 34455888888999999999999999999999999999999999999999999999988776666
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 758 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL 758 (782)
.+++|||.|||||++....|+.|+||||||++.+||++|.+||.+..+..++..+.... .+.+. ...+++++..|+
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~-PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA-PPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC-CCccccccCHHHHHHHHHHh
Confidence 88999999999999998899999999999999999999999999999877666554322 22222 235999999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003971 759 A-EPQERPSCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRPSa~EIL~~ 773 (782)
. ||+.||++.++|+|
T Consensus 248 ~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKH 263 (467)
T ss_pred hcCcccCcCHHHHhhh
Confidence 9 99999999999987
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=317.51 Aligned_cols=254 Identities=32% Similarity=0.595 Sum_probs=214.3
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
|++..++|.+.++||+|+||.||++.. .+..+|||.+...... .+.+.+|+.+++.++|+||+++++++......+
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 567778999999999999999999976 4567999998754432 367889999999999999999999999888999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
++|||+++++|.+++... ....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 78 ~v~e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEeccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999999998632 2346899999999999999999999999999999999999999999999999999876432
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003971 678 PMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 752 (782)
Q Consensus 678 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~ 752 (782)
... .....++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.........+... .....+ +..+.+
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPRPPNCPEELYD 235 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHH
Confidence 111 112334568999999998889999999999999999998 99999888877766665443 222222 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 753 LIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
++.+||. +|.+||++.++++.|+++
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HHHHHcccCcccCCCHHHHHHHHhcC
Confidence 9999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.96 Aligned_cols=259 Identities=27% Similarity=0.479 Sum_probs=214.9
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEEC------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC-
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK- 592 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~~------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d- 592 (782)
.+..++|.+.+.||+|+||.||+|.+. +..|++|++.. .......+.+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 356688999999999999999999873 47789998753 3344556788999999999999999999998766
Q ss_pred CCceEEEEEEecccchhhHHHhhccc-----ccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEe
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQK-----KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICD 667 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~-----~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaD 667 (782)
+...+++++|+++++|.+++...... ..+++..++.++.|++.||+|||+++++|+||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 46789999999999999988643222 4689999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC
Q 003971 668 FGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLE 744 (782)
Q Consensus 668 FGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ 744 (782)
||+++.+...... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||....+.+....+.. .....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-GYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-CCCCC
Confidence 9999866433221 123345678999999998889999999999999999999 9999998877665544433 33333
Q ss_pred CC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 745 IP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 745 ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
.+ +..+.+++.+||. ||++||++.++++.|+++...
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 22 3468999999999 999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.23 Aligned_cols=247 Identities=24% Similarity=0.283 Sum_probs=204.5
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
.|++.+.||+|+||+||++.+ +++.||||++....... .....+.+|+.+++.++||||+++++++...+.++++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478899999999999999986 58899999986544322 223567889999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+.+|+|.+++... ....+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TI 158 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-cc
Confidence 99999999887532 33568999999999999999999999999999999999999999999999999998764322 22
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCC---CChHHHHHHHH
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--GSRLEI---PEGPLGRLIAD 756 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~--~~~~~i---p~~~L~~LI~~ 756 (782)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+... ...... -...+.+|+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHH
Confidence 3457899999999999888999999999999999999999999876554332222111 111122 23468999999
Q ss_pred hhh-CCCCCC-----CHHHHHHH
Q 003971 757 CWA-EPQERP-----SCEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRP-----Sa~EIL~~ 773 (782)
||. ||.+|| ++.+++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhcC
Confidence 999 999999 89899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=315.22 Aligned_cols=247 Identities=28% Similarity=0.477 Sum_probs=209.8
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC-CCceEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLSMITE 601 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-~~~l~LV~E 601 (782)
.|++.+.||.|+||.||++.+ .++.+|+|.+..........+.+.+|+++++.++|+||+++++.+.. ...+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488999999999999999976 57789999987665555556778999999999999999999998764 445899999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+++++|.+++... ....+++.+++.++.|++.||+|||++||+|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 99999999888632 34568999999999999999999999999999999999999999999999999998765433333
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 758 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL 758 (782)
....+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.... .+..+ +..+.+++.+||
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l 238 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-LPPMPKDYSPELGELIATML 238 (257)
T ss_pred ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCCccccCHHHHHHHHHHh
Confidence 45678899999999999989999999999999999999999998877766665554432 22222 346899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003971 759 A-EPQERPSCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRPSa~EIL~~ 773 (782)
. ||.+||++.+++++
T Consensus 239 ~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 239 SKRPEKRPSVKSILRQ 254 (257)
T ss_pred ccCcccCCCHHHHhcC
Confidence 9 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=335.65 Aligned_cols=240 Identities=23% Similarity=0.374 Sum_probs=203.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~ 600 (782)
+|.+.+.||+|+||.||++.+ +|+.||+|++.+... .....+.+..|+.++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467889999999999999987 578999999875432 2334567888999998886 577888999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++|+|.+++. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 9999999998886 3457899999999999999999999999999999999999999999999999999765433333
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA 759 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL~ 759 (782)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ .....+.+++.+||.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 3456799999999999999999999999999999999999999999888777777665443221 223468899999999
Q ss_pred -CCCCCCCH
Q 003971 760 -EPQERPSC 767 (782)
Q Consensus 760 -DP~kRPSa 767 (782)
+|.+|++.
T Consensus 238 ~~p~~R~~~ 246 (323)
T cd05615 238 KHPSKRLGC 246 (323)
T ss_pred cCHhhCCCC
Confidence 99999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.00 Aligned_cols=253 Identities=28% Similarity=0.506 Sum_probs=211.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|++.+.||.|+||.||++.+ +++.+|||.+..... .....+.+.+|+.+++.++||||+++++++...+..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788899999999999999985 688999998765432 3344578899999999999999999999999999999999
Q ss_pred EEecccchhhHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 601 EYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
||+++++|.+++... .....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 999999999988632 2345689999999999999999999999999999999999999999999999999887654333
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCCCCCCC----ChHHHHH
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--RVVYAVANEGSRLEIP----EGPLGRL 753 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~--evl~~i~~~~~~~~ip----~~~L~~L 753 (782)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.... .....+.. ...+..+ ...+.++
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 240 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPPLPSDHYSEELRQL 240 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-CCCCCCCcccccHHHHHH
Confidence 333557889999999999888999999999999999999999999755432 22222222 2222222 3469999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 754 IADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
+.+||. ||.+|||+.+|++.++++
T Consensus 241 i~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 241 VNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHhcCCCcccCCCHHHHHHHHhhh
Confidence 999999 999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=351.50 Aligned_cols=248 Identities=27% Similarity=0.371 Sum_probs=210.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--C-CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--N-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
...|.+.+.||+|+||.||++.. + +..||+|.+.... ......+.+|+.+++.++|||||+++++|...+.+|+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 45599999999999999999976 3 5678888764332 33446778899999999999999999999999999999
Q ss_pred EEEecccchhhHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 600 TEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
|||+++|+|.+++... .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999999887532 234568999999999999999999999999999999999999999999999999998765432
Q ss_pred C--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHH
Q 003971 679 M--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRL 753 (782)
Q Consensus 679 ~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~L 753 (782)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+...... ..+ ...+.++
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~l 302 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKAL 302 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCccCCHHHHHH
Confidence 1 233567999999999999999999999999999999999999999988887777776654332 222 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+..||. ||.+||++.+++.+
T Consensus 303 i~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 303 LDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHhccChhhCcCHHHHHhC
Confidence 999999 99999999999864
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=319.88 Aligned_cols=254 Identities=33% Similarity=0.597 Sum_probs=210.8
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
|.+...+|++.++||+|+||.||+|.++ ...||+|++...... .+.|.+|+++++.++||||+++++++.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 4566788999999999999999999874 457999998654332 3578899999999999999999998754 4589
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
++|||+++|+|.+++... ....+++..++.++.|++.||+|||+.+|+|+||||+||++++++.++|+|||++......
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999999998632 2346789999999999999999999999999999999999999999999999999876443
Q ss_pred CCCC-CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003971 678 PMRD-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 752 (782)
Q Consensus 678 ~~~~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~ 752 (782)
.... ....++..|+|||...+..++.++|||||||++|+|++ |..||.+.........+... .....+ +..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 234 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHD 234 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-CCCCCccccCHHHHH
Confidence 2211 23346678999999988889999999999999999999 78899888777766655432 222222 346889
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 753 LIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
|+.+||. ||.+||++.++++.|+++-
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 9999999 9999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=315.83 Aligned_cols=249 Identities=29% Similarity=0.424 Sum_probs=215.4
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|++.+.||.|+||.||.+.. ++..+++|.+............+.+|++++++++|+||+++++++.+...++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 488999999999999988865 678899999877666666677899999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+++++|.+++... ....+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 9999999988633 245689999999999999999999999999999999999999999999999999987655433334
Q ss_pred CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--ChHHHHHHHHhhh-
Q 003971 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--EGPLGRLIADCWA- 759 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip--~~~L~~LI~~CL~- 759 (782)
...+++.|+|||.+.+..++.++|||||||++|+|++|..||......+....+.........+ ...+.+++..||.
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccc
Confidence 5678999999999988888999999999999999999999999888777777665543332221 3468899999998
Q ss_pred CCCCCCCHHHHHHHH
Q 003971 760 EPQERPSCEEILSRL 774 (782)
Q Consensus 760 DP~kRPSa~EIL~~L 774 (782)
+|.+||++.++++++
T Consensus 240 ~p~~R~s~~~ll~~~ 254 (256)
T cd08221 240 DPEKRPTADEVLDQP 254 (256)
T ss_pred CcccCCCHHHHhhCc
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=344.59 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=212.8
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
..+.+..++|++.+.||+|+||.||++.+ .++.+|+|++..... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 44566778999999999999999999987 577899999865332 223345678899999999999999999999999
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
..+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 999999999999999998852 3578889999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CCCCCCCCCcccCccccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003971 674 ITDSPM-RDSSSAGTPEWMAPELIRNEP----FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-- 746 (782)
Q Consensus 674 l~~~~~-~~~~~~GT~~Y~APEvl~~~~----~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-- 746 (782)
...... .....+||+.|+|||++.... ++.++|||||||++|||++|+.||.+.+.......+........+|
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 271 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCc
Confidence 654322 223567999999999987543 7889999999999999999999999988877777776654443333
Q ss_pred ---ChHHHHHHHHhhhCCCC---CCCHHHHHHHH
Q 003971 747 ---EGPLGRLIADCWAEPQE---RPSCEEILSRL 774 (782)
Q Consensus 747 ---~~~L~~LI~~CL~DP~k---RPSa~EIL~~L 774 (782)
...+.+++..|+.+|.. |+++.++++|.
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 23588999999984443 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=319.34 Aligned_cols=247 Identities=35% Similarity=0.642 Sum_probs=206.8
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
+..+|++.+.||+|+||.||++.+. +..+|+|++...... ...|.+|+++++.++||||+++++++......++++
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 3457889999999999999999874 457999998654433 246888999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++++|.+++... ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++...+....
T Consensus 79 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 79 EYMANGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred ecCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999999999988632 346899999999999999999999999999999999999999999999999999866433211
Q ss_pred C-CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCC---CChHHHHHHH
Q 003971 681 D-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEI---PEGPLGRLIA 755 (782)
Q Consensus 681 ~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~i---p~~~L~~LI~ 755 (782)
. ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||......+....+.. ...... .+..+.+++.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-GYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHH
Confidence 1 12234457999999998889999999999999999999 7899988877766665543 322222 2457999999
Q ss_pred Hhhh-CCCCCCCHHHHHHHH
Q 003971 756 DCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 756 ~CL~-DP~kRPSa~EIL~~L 774 (782)
+||. +|++||++.++++.|
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhcCChhhCcCHHHHHHHh
Confidence 9999 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=327.79 Aligned_cols=260 Identities=30% Similarity=0.572 Sum_probs=214.5
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEe
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 587 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 587 (782)
.|++..++|.+++.||+|+||.||++.+. ...+|+|.+.... .......+..|+.+++.+ +||||++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 46677789999999999999999999752 2469999986543 334456788999999999 799999999
Q ss_pred ccccCCCceEEEEEEecccchhhHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCccc
Q 003971 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSAN 654 (782)
Q Consensus 588 g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeN 654 (782)
+++......|+++||+++|+|.+++..... ...+++.+++.++.|++.||+|||++|++||||||+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 999999999999999999999999874321 2358899999999999999999999999999999999
Q ss_pred EEEcCCCeEEEEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 003971 655 CLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPER 731 (782)
Q Consensus 655 ILLd~~g~VKLaDFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~e 731 (782)
||++.++.++|+|||++.......... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 999999999999999987654322111 12234568999999998889999999999999999998 888998877665
Q ss_pred HHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 732 VVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 732 vl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
....+ ........+ ...+.+|+.+||. +|.+||++.++++.|.++..
T Consensus 251 ~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 251 LFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHH-HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 55544 334344443 3468899999999 99999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=337.83 Aligned_cols=241 Identities=22% Similarity=0.350 Sum_probs=197.1
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEEEEEecc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.||+|+||.||++.+ +++.||+|++...... ......+..|+.++..+ +||||+++++++.+...+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999987 5788999999765432 33456788999999988 699999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
|+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 99998876 345799999999999999999999999999999999999999999999999999875433223334568
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------hHH-HHHHHHhcCCCCC-CCChHHHHHHH
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--------PER-VVYAVANEGSRLE-IPEGPLGRLIA 755 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~--------~~e-vl~~i~~~~~~~~-ip~~~L~~LI~ 755 (782)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ... ....+.......+ .-...+.+++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999999999999999999999999999999996321 112 2222322222211 11346889999
Q ss_pred Hhhh-CCCCCCC------HHHHHHH
Q 003971 756 DCWA-EPQERPS------CEEILSR 773 (782)
Q Consensus 756 ~CL~-DP~kRPS------a~EIL~~ 773 (782)
+||. ||.+|++ +.++++|
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcC
Confidence 9999 9999997 6777765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=339.08 Aligned_cols=241 Identities=22% Similarity=0.356 Sum_probs=199.4
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHH-HHHhCCCCceeeEeccccCCCceEEEEEEecc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEIS-ILSRLRHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~-iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.||+|+||+||++.+ +|+.||+|++..... .......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999987 588999999865432 2233455666665 46779999999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
|+|...+. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 99988876 345789999999999999999999999999999999999999999999999999876433323334567
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 763 (782)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+........ .....+.+++.+|+. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 99999999999999999999999999999999999999998887777776655332211 123468899999999 9999
Q ss_pred CCCHHHHHHH
Q 003971 764 RPSCEEILSR 773 (782)
Q Consensus 764 RPSa~EIL~~ 773 (782)
||++.+.++.
T Consensus 238 R~~~~~~~~~ 247 (325)
T cd05604 238 RLGAKEDFLE 247 (325)
T ss_pred cCCCCCCHHH
Confidence 9987643333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=344.65 Aligned_cols=261 Identities=29% Similarity=0.528 Sum_probs=218.7
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEe
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFL 587 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~ 587 (782)
...|.+..++|.++++||+|+||.||+|.+. ++.||||++..... ....+.+.+|+.+|..+. ||||++++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 3458889999999999999999999999863 35799999965432 333467889999999997 99999999
Q ss_pred ccccCCCceEEEEEEecccchhhHHHhhcc--------------------------------------------------
Q 003971 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------------------------------------------- 617 (782)
Q Consensus 588 g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~-------------------------------------------------- 617 (782)
++|......++|+||+++|+|.++++....
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 999999999999999999999999864311
Q ss_pred ---------------------------------------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCc
Q 003971 618 ---------------------------------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 652 (782)
Q Consensus 618 ---------------------------------------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKP 652 (782)
...+++..++.++.||+.||+|||+.+|+||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp 267 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA 267 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence 12467788899999999999999999999999999
Q ss_pred ccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 003971 653 ANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLP 729 (782)
Q Consensus 653 eNILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~ 729 (782)
+|||++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986533211 1123456788999999998889999999999999999998 8899988776
Q ss_pred HHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 730 ERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 730 ~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
.+........+.++..| ...+.+|+.+||. +|.+||++.+|++.|+++
T Consensus 348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 66666655555555444 3469999999999 999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=336.76 Aligned_cols=236 Identities=22% Similarity=0.379 Sum_probs=196.1
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHH-HHHhCCCCceeeEeccccCCCceEEEEEEecc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEIS-ILSRLRHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~-iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.||+|+||.||+|.+ +++.||+|++.+.... ......+..|+. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 5789999998754322 222345556654 67889999999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
++|...+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 99988775 345788999999999999999999999999999999999999999999999999876433333334567
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 763 (782)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+ .....+.+++.+||+ ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 99999999999998999999999999999999999999998887777666654332211 123468899999999 9999
Q ss_pred CCCHH
Q 003971 764 RPSCE 768 (782)
Q Consensus 764 RPSa~ 768 (782)
||++.
T Consensus 238 R~~~~ 242 (321)
T cd05603 238 RLGAK 242 (321)
T ss_pred cCCCC
Confidence 98764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.14 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=201.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
..++|.+.++||+|+||.||+|.+ .++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..+++
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 347899999999999999999976 5778999998654322 2234677899999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+++ +|...+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 83 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EeCCCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 999985 77776652 234578899999999999999999999999999999999999999999999999976544333
Q ss_pred CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------------
Q 003971 680 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR---------------- 742 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~---------------- 742 (782)
......+|+.|+|||.+.+ ..++.++|||||||++|+|+||+.||.+.+..+....+......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 3345578899999998865 46889999999999999999999999887665544433221000
Q ss_pred ----CC-----------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 ----LE-----------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 ----~~-----------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+. .-+..+.+|+.+|+. ||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00 012357789999999 99999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.47 Aligned_cols=254 Identities=35% Similarity=0.586 Sum_probs=208.9
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEECC------------------eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCce
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWNG------------------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 583 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~g------------------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI 583 (782)
...+|.+.++||+|+||.||++.+.+ ..||+|++..... ....+.+.+|+++++.++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCE
Confidence 45689999999999999999987632 4589999865432 3456789999999999999999
Q ss_pred eeEeccccCCCceEEEEEEecccchhhHHHhhc--------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccE
Q 003971 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSG--------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANC 655 (782)
Q Consensus 584 VkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~--------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNI 655 (782)
+++++++..+...++++||+.+++|..++.... ....+++..++.++.|++.||+|||+.||+|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999886432 112689999999999999999999999999999999999
Q ss_pred EEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCChHH
Q 003971 656 LVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT--LNRPWEGVLPER 731 (782)
Q Consensus 656 LLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT--Gk~PF~~~~~~e 731 (782)
+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|||||||++|||++ +..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999976543221 1223456778999999988889999999999999999998 677998777666
Q ss_pred HHHHHHhc----CCCC--CCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 732 VVYAVANE----GSRL--EIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 732 vl~~i~~~----~~~~--~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
........ .... ..+ +..+.+++.+||+ ||.+||++.+|++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 65554432 1111 111 2469999999999 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=324.29 Aligned_cols=256 Identities=31% Similarity=0.559 Sum_probs=213.1
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
+...+|.+.+.||+|+||.||+|... +..+++|.+.... ....+.+.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 34568999999999999999999742 3458888875432 33346788999999999999999999999999
Q ss_pred CceEEEEEEecccchhhHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC
Q 003971 594 PRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 660 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~ 660 (782)
...++||||+++++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999986432 12358999999999999999999999999999999999999999
Q ss_pred CeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 003971 661 WTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVA 737 (782)
Q Consensus 661 g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~ 737 (782)
+.++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|+| |..||...........+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999999976543221 1234456788999999998889999999999999999998 999998887777666554
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 738 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 738 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
. +.....+ +..+.+++.+||+ +|.+||++.++++.|.++..
T Consensus 240 ~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 240 Q-GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred C-CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 3 3232222 3468999999999 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=313.42 Aligned_cols=244 Identities=37% Similarity=0.682 Sum_probs=209.0
Q ss_pred eEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEec
Q 003971 530 TRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 604 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 604 (782)
+.||+|+||.||++... +..+++|++....... ..+.+.+|+.+++.++|+||+++++++......++++||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 36899999999999874 7789999987654433 46789999999999999999999999999999999999999
Q ss_pred ccchhhHHHhhcc------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 605 LGSLYHLIHLSGQ------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 605 gGsL~dlL~~~~~------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
+++|.+++..... ...+++..++.++.|++.||+|||++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 9999999874311 3678999999999999999999999999999999999999999999999999998775432
Q ss_pred --CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003971 679 --MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 752 (782)
Q Consensus 679 --~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~ 752 (782)
.......+++.|+|||.+....++.++|||||||++|+|++ |..||...........+.. +.....+ +..+.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDELYE 238 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHHHH
Confidence 12334567889999999988889999999999999999999 5999999887777766654 3333333 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHH
Q 003971 753 LIADCWA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~L~ 775 (782)
++.+||. +|.+||++.+++++|+
T Consensus 239 li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 239 LMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHccCCcccCcCHHHHHHhhC
Confidence 9999999 9999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=315.82 Aligned_cols=253 Identities=35% Similarity=0.608 Sum_probs=209.7
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
|++...+|.+...||+|+||.||++.+. +..+|+|.+..... ..+.+.+|+.+++.++|+||+++++++.. +..+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence 4455678999999999999999999874 44799998754432 23568899999999999999999998754 5589
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
++|||+.+++|.+++... ....+++..+..++.|++.||+|||+.|++|+||||+||++++++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEcCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999999999988632 3345789999999999999999999999999999999999999999999999999776433
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003971 678 PMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 752 (782)
Q Consensus 678 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~ 752 (782)
... .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+....+....+.. ......+ +..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMPCPQGCPESLHE 234 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHH
Confidence 221 123345678999999988889999999999999999999 8999998877766665543 3333333 346999
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 753 LIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
++.+||. ||.+||++.++++.|+++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred HHHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.43 Aligned_cols=241 Identities=22% Similarity=0.357 Sum_probs=195.8
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEEEEEecc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.||+|+||+||++.+ +++.||+|++.+... .....+.+..|+.++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 577899999876543 233456678899988777 799999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
|+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 99988775 345789999999999999999999999999999999999999999999999999976433333334567
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC--------ChHH-HHHHHHhcCCCC-CCCChHHHHHHH
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV--------LPER-VVYAVANEGSRL-EIPEGPLGRLIA 755 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~--------~~~e-vl~~i~~~~~~~-~ip~~~L~~LI~ 755 (782)
||+.|+|||++.+..++.++|||||||++|+|++|+.||... .... ....+....... ......+.+++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 999999999999999999999999999999999999999521 1112 222222222211 112346889999
Q ss_pred Hhhh-CCCCCCC------HHHHHHH
Q 003971 756 DCWA-EPQERPS------CEEILSR 773 (782)
Q Consensus 756 ~CL~-DP~kRPS------a~EIL~~ 773 (782)
+||. ||.+||+ +.++++|
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 9999 9999998 4677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=314.65 Aligned_cols=242 Identities=29% Similarity=0.585 Sum_probs=201.4
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGS 607 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGs 607 (782)
+.||+|+||.||+|.+ +++.+|+|.+... ........|.+|+++++.++||||++++++|......++|+||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 3689999999999976 6889999987533 334445779999999999999999999999999999999999999999
Q ss_pred hhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC--CCCC
Q 003971 608 LYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSA 685 (782)
Q Consensus 608 L~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~--~~~~ 685 (782)
|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++.......... ....
T Consensus 80 L~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 80 FLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9998863 23468899999999999999999999999999999999999999999999999987654321111 1112
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-C
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-E 760 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-D 760 (782)
.+..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+ +..+.+|+.+||. +
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~ 236 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLPCPELCPDAVYRLMERCWEYD 236 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCcccCCHHHHHHHHHHcCCC
Confidence 3457999999998889999999999999999997 8889988777665555443 2233333 3468899999999 9
Q ss_pred CCCCCCHHHHHHHHH
Q 003971 761 PQERPSCEEILSRLL 775 (782)
Q Consensus 761 P~kRPSa~EIL~~L~ 775 (782)
|.+||++.++++.|+
T Consensus 237 p~~Rps~~~~~~~l~ 251 (252)
T cd05084 237 PGQRPSFSTVHQELQ 251 (252)
T ss_pred hhhCcCHHHHHHHHh
Confidence 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=318.69 Aligned_cols=252 Identities=36% Similarity=0.589 Sum_probs=210.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
+..+|++.+.||+|+||.||+|.+. +..+|+|.+.... .....+.|.+|+.+++.++||||+++++++.+.+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3468899999999999999999762 3368999886443 234457889999999999999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
+++|||+++++|.+++... ...+++.++..++.|++.||+|||++|++|+||||+|||++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999998632 34689999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCC---CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003971 677 SPMRD---SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 749 (782)
Q Consensus 677 ~~~~~---~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~ 749 (782)
..... ....++..|+|||.+.+..++.++|+|||||++|++++ |+.||......+....+... ...+.+ +..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAA 237 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHH
Confidence 32111 12233568999999998889999999999999999886 99999888776666655443 333332 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
+.+++.+||+ +|.+||++.++++.|.++
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 238 LHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 8999999999 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=323.84 Aligned_cols=254 Identities=30% Similarity=0.564 Sum_probs=207.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--Ce--EEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWN--GT--DVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~--g~--~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~ 597 (782)
+++|++.+.||+|+||.||+|... +. .+++|.+... ......+.|.+|+.++.++ +||||+++++++.....++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 368999999999999999999763 33 4688877532 2233456789999999999 7999999999999999999
Q ss_pred EEEEEecccchhhHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEE
Q 003971 598 MITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 664 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VK 664 (782)
+++||+++++|.+++.... ....+++..++.++.|++.||+|||++||+||||||+|||+++++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999986421 113588999999999999999999999999999999999999999999
Q ss_pred EEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 003971 665 ICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL 743 (782)
Q Consensus 665 LaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~ 743 (782)
|+|||++...... ........+..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+.. +...
T Consensus 160 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-~~~~ 237 (297)
T cd05089 160 IADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRM 237 (297)
T ss_pred ECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CCCC
Confidence 9999998643221 11112233557999999998889999999999999999997 9999998888776665543 2233
Q ss_pred CCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 744 EIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 744 ~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
..+ +..+.+|+.+||. +|.+||++.++++.|.++..
T Consensus 238 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 323 3468999999999 99999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=334.20 Aligned_cols=248 Identities=21% Similarity=0.327 Sum_probs=206.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|.+.+.||+|+||+||++.. +++.||+|++.+... .....+.+.+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999987 578999999865332 2334567889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++|+|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999999999863 2456899999999999999999999999999999999999999999999999998765443222
Q ss_pred -CCCCCCCCcccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------Ch
Q 003971 681 -DSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EG 748 (782)
Q Consensus 681 -~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip------~~ 748 (782)
.....||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+....+....+........++ ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 223569999999999863 457889999999999999999999999888777766665544333322 34
Q ss_pred HHHHHHHHhhh---CCCCCCCHHHHHHH
Q 003971 749 PLGRLIADCWA---EPQERPSCEEILSR 773 (782)
Q Consensus 749 ~L~~LI~~CL~---DP~kRPSa~EIL~~ 773 (782)
.+.+++.+|+. ++..|+++.++++|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 68899999886 34447899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=324.99 Aligned_cols=260 Identities=28% Similarity=0.580 Sum_probs=215.8
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE---------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEe
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIW---------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 587 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~---------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 587 (782)
.|.+...+|.+.+.||+|+||.||++.+ ++..+|+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 3567778999999999999999999964 23468999876432 334457889999999999 799999999
Q ss_pred ccccCCCceEEEEEEecccchhhHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCccc
Q 003971 588 GACTKPPRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSAN 654 (782)
Q Consensus 588 g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeN 654 (782)
+++......|++|||+++|+|.+++.... ....+++.+++.++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 99999999999999999999999987431 12357888999999999999999999999999999999
Q ss_pred EEEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 003971 655 CLVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPER 731 (782)
Q Consensus 655 ILLd~~g~VKLaDFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~e 731 (782)
||++.++.+||+|||+++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99999999999999999876432221 123345678999999988889999999999999999998 788998887777
Q ss_pred HHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 732 VVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 732 vl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
....+.. ......+ ...+.+++.+||. +|.+||++.++++.|+++..
T Consensus 248 ~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 248 LFKLLKE-GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 6665543 3333333 3468999999999 99999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=339.22 Aligned_cols=245 Identities=26% Similarity=0.385 Sum_probs=201.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC-----ceE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-----RLS 597 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~-----~l~ 597 (782)
+|++.++||+|+||.||++.+ +++.||||++..........+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 6889999998654334444577889999999999999999999998776 789
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+++||+. ++|...+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999997 46776664 3457899999999999999999999999999999999999999999999999999865432
Q ss_pred C-CCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----------------
Q 003971 678 P-MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE---------------- 739 (782)
Q Consensus 678 ~-~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~---------------- 739 (782)
. .......+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.++...+..+...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 2 122345688999999998774 4789999999999999999999999887766555443321
Q ss_pred -------CCCCC----------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 740 -------GSRLE----------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 740 -------~~~~~----------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+. .....+.+|+.+||. ||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 11110 012357889999999 99999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=319.43 Aligned_cols=247 Identities=26% Similarity=0.438 Sum_probs=203.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|++.+.||+|+||.||+|.+ +++.||+|++..........+.+.+|+.+++.++||||+++++++.....++++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4688999999999999999987 58899999986544333334567899999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|++++.|..++. ....+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 999988887765 34468999999999999999999999999999999999999999999999999998775443223
Q ss_pred CCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------------
Q 003971 682 SSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------------- 741 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~------------------- 741 (782)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34567889999999876 5578999999999999999999999988776554443321100
Q ss_pred CCC-------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 RLE-------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 ~~~-------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..+ ..+..+.+|+.+||. +|.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 012357899999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.99 Aligned_cols=249 Identities=25% Similarity=0.443 Sum_probs=219.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
..++|.+++.||+|-||.||.|.. ++-.||+|++.+..+.. ....++.+|+++-..|+||||+++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 457999999999999999999976 46679999997765433 234678899999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
++||.+.|+++..|.. .....+++.....++.|++.||.|||.++||||||||+|+|++..+.+||+|||.+..-. .
T Consensus 100 ilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--S 176 (281)
T ss_pred EEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--C
Confidence 9999999999998863 345679999999999999999999999999999999999999999999999999997654 2
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHh
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADC 757 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~C 757 (782)
....+.|||..|++||...+..++..+|+|++|++.||++.|..||......+.+..+.......+ .......++|..|
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~l 256 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRL 256 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHH
Confidence 344688999999999999999999999999999999999999999999998888888765443332 2345689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
+. +|.+|.+..|++.|
T Consensus 257 l~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 257 LVKNPIERLALTEVMDH 273 (281)
T ss_pred hccCccccccHHHHhhh
Confidence 99 99999999999987
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=319.65 Aligned_cols=253 Identities=29% Similarity=0.553 Sum_probs=208.6
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCe----EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
...+|++.++||+|+||+||+|.+ ++. .||+|++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 346899999999999999999976 444 48999986543 334457888999999999999999999998764 4
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.+++++|+++|+|.+++.. ....+++..++.++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++...
T Consensus 83 ~~l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred cEEEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 7899999999999998863 23568999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003971 676 DSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 749 (782)
Q Consensus 676 ~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~ 749 (782)
..... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||........... ...+.....+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 239 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL-LEKGERLPQPPICTID 239 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCcCCCCccCCHH
Confidence 33221 122345678999999998889999999999999999998 8999988776655543 3334333333 236
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+.+++.+||. ||++||++.++++.|.++..
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 8899999999 99999999999999987753
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=334.92 Aligned_cols=245 Identities=25% Similarity=0.328 Sum_probs=200.2
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC------
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------ 593 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------ 593 (782)
..++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 357899999999999999999976 578999999876554555567888999999999999999999987543
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
...|++|||+++ ++...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 347999999976 5555553 2478889999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----------
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR----------- 742 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~----------- 742 (782)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 169 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 169 AGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 5433 2234567899999999999999999999999999999999999999877654433322211000
Q ss_pred --------------C------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 --------------L------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 --------------~------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. ......+.+|+.+|+. ||.+|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 0012347899999999 99999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=320.78 Aligned_cols=252 Identities=27% Similarity=0.526 Sum_probs=206.3
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCe----EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
...+|++.+.||+|+||+||+|.+ ++. .+++|.+... .......++..|+.+++.+.||||+++++++.. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 346788999999999999999987 444 4777776432 223334678889999999999999999998764 45
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.++++||+++|+|.+++.. ....+++..++.++.||+.||+|||++|++|+||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred cEEEEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 7899999999999999863 23568999999999999999999999999999999999999999999999999998764
Q ss_pred CCC--CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003971 676 DSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 749 (782)
Q Consensus 676 ~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~ 749 (782)
... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+ ..+..+..+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQPQICTID 239 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCCCCCCCHH
Confidence 322 12234456778999999998889999999999999999998 99999888776554443 444443333 336
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
+..++.+||. ||.+||++.++++.|..+.
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 8889999999 9999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=314.74 Aligned_cols=247 Identities=30% Similarity=0.526 Sum_probs=209.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|.+.+.||.|+||.||++.+ .++.+++|++...... ..+.+.+|+.+++.++||||+++++++.....++++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 36899999999999999999986 4678999998755332 4578899999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++++|.+++... ...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred eCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 999999999988632 257899999999999999999999999999999999999999999999999999876543223
Q ss_pred CCCCCCCCcccCccccccC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------ChHHH
Q 003971 681 DSSSAGTPEWMAPELIRNE---PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EGPLG 751 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~---~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip------~~~L~ 751 (782)
.....++..|+|||.+... .++.++|+|||||++|+|++|+.||....+......+.......... +..+.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 3455788899999999776 78999999999999999999999998887766665554442222111 23588
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+++.+||. +|.+||++.+|+.+
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhcC
Confidence 99999999 99999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=335.22 Aligned_cols=244 Identities=25% Similarity=0.312 Sum_probs=201.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC------C
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------P 594 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------~ 594 (782)
.++|.+.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999987 578899999876544445567788999999999999999999987543 3
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+|+||||+++ +|...+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 47999999976 5665553 24788889999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 743 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~----------- 743 (782)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 177 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 177 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 433 22345678999999999999999999999999999999999999998877665554443211100
Q ss_pred ---------C-----------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ---------E-----------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ---------~-----------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. .....+.+|+.+|+. ||.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 011247789999999 99999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.22 Aligned_cols=260 Identities=32% Similarity=0.573 Sum_probs=210.3
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccc
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGAC 590 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~ 590 (782)
|.+..++|++.+.||+|+||+||+|.+ .++.||||++..... ......+.+|+.++.++ +||||++++++|
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 667778999999999999999999974 367899999865432 33456788999999999 689999999988
Q ss_pred cCC-CceEEEEEEecccchhhHHHhhcc----------------------------------------------------
Q 003971 591 TKP-PRLSMITEYMELGSLYHLIHLSGQ---------------------------------------------------- 617 (782)
Q Consensus 591 ~d~-~~l~LV~Ey~~gGsL~dlL~~~~~---------------------------------------------------- 617 (782)
... ..++++|||+++|+|.+++.....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 568999999999999998863210
Q ss_pred ------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC--CCCC
Q 003971 618 ------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSS 683 (782)
Q Consensus 618 ------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~--~~~~ 683 (782)
...+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12467888999999999999999999999999999999999999999999999986533211 1122
Q ss_pred CCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003971 684 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 759 (782)
Q Consensus 684 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~ 759 (782)
..+++.|+|||.+.+..++.++|||||||++|+|++ |..||...............+.....+ ...+.+++..||+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence 345678999999988889999999999999999997 899998765444344444444443333 3468999999999
Q ss_pred -CCCCCCCHHHHHHHHHhhhh
Q 003971 760 -EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 760 -DP~kRPSa~EIL~~L~di~~ 779 (782)
||.+||++.+|+++|+++..
T Consensus 321 ~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 321 GEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=320.98 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=196.8
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC---CCCceeeEeccccC-----CC
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RHPNVILFLGACTK-----PP 594 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L---~HPNIVkL~g~~~d-----~~ 594 (782)
+|.+.+.||+|+||+||+|.+ +++.||+|.+............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588999999999999999987 578899999865433322234556777777665 69999999998764 24
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+++++||+.+ +|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 58999999985 787777532 2345899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 743 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~----------- 743 (782)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 159 SCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred cCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 4332 2234578999999999998889999999999999999999999998876665554443211000
Q ss_pred -----------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 -----------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 -----------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..-+..+.+++.+|+. ||.+|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0012347899999999 99999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=326.29 Aligned_cols=261 Identities=29% Similarity=0.578 Sum_probs=215.5
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeE
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 586 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL 586 (782)
..|.+...+|.+.++||+|+||.||++... ...+|+|++.... .......+.+|+.+++.+ +||||+++
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence 346677789999999999999999999652 3468999876433 334467789999999999 59999999
Q ss_pred eccccCCCceEEEEEEecccchhhHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcc
Q 003971 587 LGACTKPPRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 653 (782)
Q Consensus 587 ~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPe 653 (782)
++++.....+++++||+++|+|.+++.... ....+++..+..++.|++.||.|||++||+|+||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 999999899999999999999999986421 1245889999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 003971 654 NCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 730 (782)
Q Consensus 654 NILLd~~g~VKLaDFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~ 730 (782)
|||++.++.+||+|||+++......... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998764322111 12234467999999998889999999999999999999 88999888776
Q ss_pred HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 731 RVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 731 evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.....+.. ......+ ...+.+++.+||. +|.+||++.++++.|.++..
T Consensus 244 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 244 ELFKLLRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 66655543 3333333 2468899999999 99999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=319.81 Aligned_cols=253 Identities=30% Similarity=0.560 Sum_probs=207.0
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
...+|.+.+.||+|+||.||+|.+. +..||+|.+.... .......|.+|+.+++.++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4567999999999999999999774 3578888765332 2334467899999999999999999999999988
Q ss_pred ceEEEEEEecccchhhHHHhhcc----cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC---eEEEEe
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQ----KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICD 667 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~----~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g---~VKLaD 667 (782)
..+++|||+++++|.+++..... ...+++..++.++.||+.||+|||+++++|+||||+|||++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999999864321 13589999999999999999999999999999999999998654 699999
Q ss_pred cCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC
Q 003971 668 FGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLE 744 (782)
Q Consensus 668 FGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ 744 (782)
||+++........ ......+..|+|||++.+..++.++|||||||++|+|++ |..||...........+.. .....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG-GGRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCcCC
Confidence 9999876432211 112233568999999998889999999999999999997 9999998877766655443 22333
Q ss_pred CC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 745 IP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 745 ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
.+ +..+.+++.+||. +|.+||++.+++++|++
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 22 2468899999999 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=313.95 Aligned_cols=247 Identities=27% Similarity=0.523 Sum_probs=212.5
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|++.+.||+|+||.||++.. +|+.||+|.+..........+++.+|+.+++.++||||+++++++...+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588999999999999999976 678999999876555555567899999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+.+++|.+.+... ....+++.+++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 9999999888632 234578999999999999999999999999999999999999999999999999987654332233
Q ss_pred CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003971 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 759 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~ 759 (782)
...|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...........+.... .+..+ ...+.+++.+||.
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS-YPPVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC-CCCCcccCCHHHHHHHHHHhh
Confidence 4568889999999998889999999999999999999999998887777776665433 22233 3468999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003971 760 -EPQERPSCEEILSR 773 (782)
Q Consensus 760 -DP~kRPSa~EIL~~ 773 (782)
+|.+||++.+++++
T Consensus 239 ~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 239 RNPRDRPSVNSILEK 253 (256)
T ss_pred CChhhCcCHHHHhhC
Confidence 99999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=324.91 Aligned_cols=258 Identities=29% Similarity=0.558 Sum_probs=215.0
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEecc
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGA 589 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~ 589 (782)
.|.+..++|.+.+.||+|+||.||++.+ .+..+|+|++..... ....+.+.+|+.+++++ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 4666778899999999999999999964 234799998765432 33457789999999999 79999999999
Q ss_pred ccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecC
Q 003971 590 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 669 (782)
Q Consensus 590 ~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFG 669 (782)
+...+..++++||+++|+|.+++... ....+++.++..++.|++.||+|||+++|+|+||||+|||++.++.++|+|||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999999998632 22348999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003971 670 LSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP 746 (782)
Q Consensus 670 LA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip 746 (782)
++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...............+.....+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 266 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP 266 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC
Confidence 9986543221 1122345678999999998889999999999999999998 999998877666555555544443332
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 747 ---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 747 ---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
+..+.+++.+||. +|++||++.++++.|.+.
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 3469999999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=315.25 Aligned_cols=253 Identities=36% Similarity=0.582 Sum_probs=210.2
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC--C---eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWN--G---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~--g---~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
+..++|+..+.||+|+||.||+|... + ..+|+|.+.... .....+.+.+|+++++.++||||+++++++.+.+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 34567889999999999999999762 3 368999875432 33445789999999999999999999999999999
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.+++|||+++++|.+++.. ....+++.++..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 81 AMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred cEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999998863 33578999999999999999999999999999999999999999999999999997664
Q ss_pred CCCCCC---CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---Ch
Q 003971 676 DSPMRD---SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EG 748 (782)
Q Consensus 676 ~~~~~~---~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~ 748 (782)
...... .....++.|+|||++.+..++.++|||||||++|||++ |+.||...........+... ...+.+ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~ 237 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPAPMDCPS 237 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-CCCCCCCCCCH
Confidence 322111 11223457999999988889999999999999999997 99999888777766666543 232222 34
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
.+.+++.+||. +|.+||++.++++.|+++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 68899999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=321.24 Aligned_cols=252 Identities=33% Similarity=0.609 Sum_probs=208.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
+|++.+.||+|+||.||+|... ...+++|.+.... .......+.+|+.+++.++||||+++++.|...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4778899999999999999763 2468888876443 2344578999999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhc---------------------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEE
Q 003971 598 MITEYMELGSLYHLIHLSG---------------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCL 656 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~---------------------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNIL 656 (782)
+++||+.+++|.+++.... ....+++..++.++.|++.||+|||+++|+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 9999999999999876321 1235789999999999999999999999999999999999
Q ss_pred EcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 003971 657 VNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVV 733 (782)
Q Consensus 657 Ld~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl 733 (782)
+++++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+..+....
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999976533221 1123345678999999988889999999999999999998 99999888776655
Q ss_pred HHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 734 YAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 734 ~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
..+ ........+ ...+.+++..||. +|.+||++.++++.|+++-
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 240 NLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHH-hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 543 333333333 2468999999999 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=334.11 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=220.8
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEECC--eEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~~g--~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
..+..+.|++++.||.|.-|+||++...+ ..+|+|++.+..+. .........|.+||+.+.||.++.||..|+.++.
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 45667889999999999999999998855 78999999777654 4456778899999999999999999999999999
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.+++||||+||+|..+++++ .++.+++..++-|+.+|+-||+|||.+|||+|||||+||||.++|+|-|+||.|+....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eEEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999999988755 56789999999999999999999999999999999999999999999999999875431
Q ss_pred CC----------------------------------C----------------------CCCCCCCCCCcccCccccccC
Q 003971 676 DS----------------------------------P----------------------MRDSSSAGTPEWMAPELIRNE 699 (782)
Q Consensus 676 ~~----------------------------------~----------------------~~~~~~~GT~~Y~APEvl~~~ 699 (782)
.. . .....++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 10 0 011235699999999999999
Q ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCC----HHHHH
Q 003971 700 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPS----CEEIL 771 (782)
Q Consensus 700 ~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPS----a~EIL 771 (782)
..+.++|+|+|||++|||+.|..||.+.+..+.+..++......+-.. ...++||+++|. ||++|.- +.||.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 999999999999999999999999999999999999987655444333 468999999998 9999988 88887
Q ss_pred HH
Q 003971 772 SR 773 (782)
Q Consensus 772 ~~ 773 (782)
+|
T Consensus 391 ~H 392 (459)
T KOG0610|consen 391 RH 392 (459)
T ss_pred cC
Confidence 65
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.05 Aligned_cols=246 Identities=27% Similarity=0.475 Sum_probs=205.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|.+.+.||+|+||.||+|.+ +++.||+|++..... .....+.+|+.+++.++||||+++++++...+.+++++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 35788889999999999999987 578999999865432 23456788999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++++|.+++. ..+.+++.+++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 86 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 86 EFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred eccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 9999999999886 3457899999999999999999999999999999999999999999999999998766543333
Q ss_pred CCCCCCCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------ChHHH
Q 003971 681 DSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EGPLG 751 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip------~~~L~ 751 (782)
.....|++.|+|||++. ...++.++|+|||||++|+|++|+.||....+.............+... +..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 34557899999999874 4568899999999999999999999997766555444433332222111 23588
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+++.+||. +|++||++.+|+++
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhcC
Confidence 99999999 99999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=320.17 Aligned_cols=252 Identities=32% Similarity=0.577 Sum_probs=209.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
++..+|.+.++||+|+||.||++.. ++..+|+|.+... .....+.|.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4567899999999999999999963 3557889987543 334457899999999999999999999999999
Q ss_pred CceEEEEEEecccchhhHHHhhcc------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQ------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 661 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g 661 (782)
...++++||+++++|.+++..... ...+++..++.++.|++.||+|||++|++|+||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 999999999999999999864321 13578999999999999999999999999999999999999999
Q ss_pred eEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 003971 662 TVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVAN 738 (782)
Q Consensus 662 ~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~ 738 (782)
.+||+|||++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999999976543211 1123345678999999998889999999999999999998 8999988877766665543
Q ss_pred cCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003971 739 EGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 739 ~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~ 775 (782)
.. ....+ +..+.+|+.+||. ||.+||++.+|++.|+
T Consensus 240 ~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 240 GR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred Cc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 32 22222 3468999999999 9999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.46 Aligned_cols=248 Identities=29% Similarity=0.501 Sum_probs=211.3
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC--CCceEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRLSMIT 600 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~l~LV~ 600 (782)
+|.+.+.||.|+||.||++.+ +++.+|+|++..........+.+.+|+++++.++||||+++++++.. ...+++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588899999999999999976 57889999987766666667789999999999999999999997753 45689999
Q ss_pred EEecccchhhHHHhh-cccccchHHHHHHHHHHHHHHHHHHH-----hccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 601 EYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIH-----RMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~gL~yLH-----s~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
||+++++|.+++... .....+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999988643 22457899999999999999999999 889999999999999999999999999999887
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHH
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLG 751 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~ 751 (782)
...........+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.. +....++ ...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-GKFRRIPYRYSSELN 239 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc-CCCCCCccccCHHHH
Confidence 6543323456789999999999988899999999999999999999999998876655555443 3333333 34689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+++.+||. +|.+||++.+|+++
T Consensus 240 ~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 240 EVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHccCCcccCCCHHHHhhC
Confidence 99999999 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.53 Aligned_cols=244 Identities=27% Similarity=0.537 Sum_probs=202.0
Q ss_pred EEeeeCcEEEEEEEEC----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEeccc
Q 003971 531 RVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
.||+|+||.||+|.+. +..||+|++.... .....+.|.+|+.+++.++||||+++++++.. ...++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 3899999999999762 4569999986443 34445779999999999999999999998864 4689999999999
Q ss_pred chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC---CC
Q 003971 607 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD---SS 683 (782)
Q Consensus 607 sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~---~~ 683 (782)
+|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+|||++.++.+||+|||++.......... ..
T Consensus 80 ~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 80 PLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99998862 34578999999999999999999999999999999999999999999999999998654332111 12
Q ss_pred CCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003971 684 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 759 (782)
Q Consensus 684 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~ 759 (782)
..+++.|+|||.+....++.++|||||||++|+|++ |..||.+.........+ ..+.....+ ...+.+++.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~c~~ 236 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-EQGKRLDCPAECPPEMYALMKDCWI 236 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCCCCCCCHHHHHHHHHHcC
Confidence 234578999999988889999999999999999996 99999988777665544 334444443 3468999999999
Q ss_pred -CCCCCCCHHHHHHHHHhhhh
Q 003971 760 -EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 760 -DP~kRPSa~EIL~~L~di~~ 779 (782)
+|++||++.+|++.|+++.+
T Consensus 237 ~~~~~Rp~~~~i~~~l~~~~~ 257 (257)
T cd05115 237 YKWEDRPNFAKVEERMRTYYY 257 (257)
T ss_pred CChhhCcCHHHHHHHHhhhcC
Confidence 99999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.26 Aligned_cols=249 Identities=31% Similarity=0.629 Sum_probs=208.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
+..+|++.+.||.|+||.||++.+ +++.+|+|.+...... ...|.+|+++++.++||||+++++++......++++
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 456899999999999999999977 4788999988654433 356889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+.+++|.+++.. ....+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 79 EFMEHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EcCCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999988862 2346789999999999999999999999999999999999999999999999998765433211
Q ss_pred -CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC--CCCCCChHHHHHHHH
Q 003971 681 -DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS--RLEIPEGPLGRLIAD 756 (782)
Q Consensus 681 -~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~--~~~ip~~~L~~LI~~ 756 (782)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+..... .+......+.+|+.+
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 122335678999999998889999999999999999998 8999988777666665543221 122234579999999
Q ss_pred hhh-CCCCCCCHHHHHHHHH
Q 003971 757 CWA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~L~ 775 (782)
||. +|.+||++.+++++|.
T Consensus 237 ~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HcccChhhCCCHHHHHHhhC
Confidence 999 9999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=319.80 Aligned_cols=254 Identities=31% Similarity=0.559 Sum_probs=210.3
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
++..+|++.+.||+|+||.||++.+ .++.||+|++.... .......|.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 3457899999999999999999976 35689999986433 334456789999999999999999999999999
Q ss_pred CceEEEEEEecccchhhHHHhhc-------------------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCccc
Q 003971 594 PRLSMITEYMELGSLYHLIHLSG-------------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSAN 654 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~-------------------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeN 654 (782)
...++++||+++++|.+++.... ....+++..++.++.|++.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999886321 11347888999999999999999999999999999999
Q ss_pred EEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 003971 655 CLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPER 731 (782)
Q Consensus 655 ILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~e 731 (782)
|+++.++.++|+|||++........ .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876533211 1122345667999999998889999999999999999997 888998888777
Q ss_pred HHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 732 VVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 732 vl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
....+.... ....+ ...+.+++.+||+ +|.+||++.|+++.|++
T Consensus 241 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 666554432 22222 3468999999999 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=341.13 Aligned_cols=246 Identities=28% Similarity=0.480 Sum_probs=219.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~L 598 (782)
...|.+++.||.|.||.||+++. +|+.+|+|++.+.... ....+.+.+|+++|+++. |||||.++++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 36799999999999999999987 5889999999776653 234578899999999998 9999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC----CCeEEEEecCccccc
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK----HWTVKICDFGLSRII 674 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~----~g~VKLaDFGLA~~l 674 (782)
|||++.||.|++.+... .+++..+..++.|++.+++|||+.||+||||||+|+|+.. ++.+|++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999988743 3999999999999999999999999999999999999953 358999999999988
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChH
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGP 749 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~ 749 (782)
.. .......+||+.|+|||++...+|+..+||||+||++|.|++|..||.+.........+.........+ ...
T Consensus 190 ~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 190 KP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred cC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 76 556678999999999999999999999999999999999999999999999888888887766544322 236
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..+++..|+. ||.+|+++.++|+|
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcC
Confidence 8999999999 99999999999987
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=336.92 Aligned_cols=239 Identities=25% Similarity=0.414 Sum_probs=198.6
Q ss_pred EeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhC---CCCceeeEeccccCCCceEEEEEEecc
Q 003971 532 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL---RHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 532 LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L---~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
||+|+||+||+|.+ .++.||||++.+... .......+..|..++..+ +||||+++++++.+...+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999987 588999999865432 222345566777777665 699999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
|+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.............+
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 99998886 345789999999999999999999999999999999999999999999999999976433333334567
Q ss_pred CCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CChHHHHHHHHhhh-CC
Q 003971 686 GTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--PEGPLGRLIADCWA-EP 761 (782)
Q Consensus 686 GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i--p~~~L~~LI~~CL~-DP 761 (782)
||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+......... -...+.+++.+||. ||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P 237 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCH
Confidence 99999999998754 4789999999999999999999999988877777666554433322 24568899999999 99
Q ss_pred CCCC----CHHHHHHH
Q 003971 762 QERP----SCEEILSR 773 (782)
Q Consensus 762 ~kRP----Sa~EIL~~ 773 (782)
.+|| ++.++++|
T Consensus 238 ~~R~~~~~~~~~ll~h 253 (330)
T cd05586 238 QHRLGAHRDAVELKEH 253 (330)
T ss_pred HHCCCCCCCHHHHhcC
Confidence 9998 57777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=312.57 Aligned_cols=253 Identities=32% Similarity=0.562 Sum_probs=211.4
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
|++..++|.+.++||+|+||.||++.+ .+..+|+|.+.... ...+.|.+|+.+++.++|+||+++++++.+ ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 567788999999999999999999976 55679999876432 234678899999999999999999999887 6789
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
++|||+++++|.+++... ....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 77 IITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEeCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999999998632 3456788999999999999999999999999999999999999999999999999766433
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003971 678 PMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 752 (782)
Q Consensus 678 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~ 752 (782)
... .....++..|+|||++....++.++|+|||||++|++++ |+.||.+.........+.. +...+.+ ...+.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPENCPEELYN 234 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-CCCCCCcccCCHHHHH
Confidence 221 122345677999999998889999999999999999998 8999998777666655433 3232222 246889
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 753 LIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
++.+||. +|++||++.++++.|+++
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHHhcC
Confidence 9999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=331.61 Aligned_cols=240 Identities=24% Similarity=0.401 Sum_probs=196.9
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEEEEEecc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.||+|+||+||++.. +++.||+|++.+.... ....+.+.+|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999976 5778999999765432 33456788999999888 599999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
|+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 99998876 345789999999999999999999999999999999999999999999999999976433223334567
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHhcCCCCCCC---ChHHHHHHHH
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV------LPERVVYAVANEGSRLEIP---EGPLGRLIAD 756 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~------~~~evl~~i~~~~~~~~ip---~~~L~~LI~~ 756 (782)
||+.|+|||++.+..++.++|||||||++|+|++|+.||... ............. ...+| +..+.+++.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999999532 2222333332222 12223 3468899999
Q ss_pred hhh-CCCCCCC------HHHHHHH
Q 003971 757 CWA-EPQERPS------CEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPS------a~EIL~~ 773 (782)
||. ||.+|++ +.++++|
T Consensus 237 ~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 237 FLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HhccCHHHcCCCCCCCCHHHHHcC
Confidence 999 9999998 4577655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.17 Aligned_cols=247 Identities=29% Similarity=0.464 Sum_probs=205.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc---ChHHHHHHHHHHHHHHhCCCCceeeEeccccCC--Cce
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRL 596 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~---~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l 596 (782)
.+|++.+.||+|+||.||++.+ +++.||||.+..... .....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5789999999999999999986 578999998754321 233457888999999999999999999988764 468
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++++||+++++|.+++.. ...+++..++.++.|++.||+|||+.+|+|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 899999999999998862 34578889999999999999999999999999999999999999999999999876532
Q ss_pred CCC---CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hHH
Q 003971 677 SPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPL 750 (782)
Q Consensus 677 ~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~---~~L 750 (782)
... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||..................+..|. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 111 12234688899999999888899999999999999999999999988766665555544433444442 357
Q ss_pred HHHHHHhhhCCCCCCCHHHHHHH
Q 003971 751 GRLIADCWAEPQERPSCEEILSR 773 (782)
Q Consensus 751 ~~LI~~CL~DP~kRPSa~EIL~~ 773 (782)
.+++.+||.+|.+||++++|+++
T Consensus 239 ~~~i~~~l~~p~~Rp~~~~il~~ 261 (265)
T cd06652 239 RDFLKRIFVEAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHhcChhhCCCHHHHhcC
Confidence 88999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.16 Aligned_cols=243 Identities=26% Similarity=0.547 Sum_probs=202.1
Q ss_pred eEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEec
Q 003971 530 TRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 604 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 604 (782)
++||+|+||.||+|.+. +..+|+|.+...... ...+.+.+|+++++.+.|+||+++++++.. +..+++|||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 46999999999999762 257999998765543 445788999999999999999999998764 46899999999
Q ss_pred ccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC---
Q 003971 605 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--- 681 (782)
Q Consensus 605 gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~--- 681 (782)
+++|.+++.. ...+++..++.++.|++.||+|||..+++|+||||+|||++.++.+||+|||+++.........
T Consensus 79 ~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999873 3478999999999999999999999999999999999999999999999999998764332211
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADC 757 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~C 757 (782)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.. ......+ +..+.+++.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES-GERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHH
Confidence 11223467999999998889999999999999999998 9999988877666555433 3333333 24688999999
Q ss_pred hh-CCCCCCCHHHHHHHHHhhh
Q 003971 758 WA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~L~di~ 778 (782)
|. +|.+||++.++++.|+++.
T Consensus 235 l~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 235 WKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred hcCChhhCcCHHHHHHHHHhcc
Confidence 99 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=315.98 Aligned_cols=247 Identities=28% Similarity=0.477 Sum_probs=202.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCC------
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKP------ 593 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~------ 593 (782)
...|.+.+.||+|+||.||+|.+ .++.+|+|++..... ....+.+|+.+++.+ +|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35688889999999999999977 578899999865432 235678999999998 699999999998653
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
..+|++|||+++++|.+++... ....+++..+..++.|++.||+|||+++|+|+||||+||++++++.++|+|||++..
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4589999999999999988632 345688999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--- 745 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i--- 745 (782)
............|++.|+|||++. +..++.++|||||||++|+|++|+.||.....................
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 643322334567899999999986 345788999999999999999999999877666555544433222211
Q ss_pred CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
....+.+|+.+||. +|.+||++.+++.+
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 13468999999999 99999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.68 Aligned_cols=255 Identities=31% Similarity=0.574 Sum_probs=207.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeE--EEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCc
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTD--VAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 595 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~--VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~ 595 (782)
+.+++|++.+.||+|+||.||+|.+ ++.. +|+|.+... ........|.+|+.++.++ +||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 3567899999999999999999976 3443 566665432 2334457888999999999 89999999999999999
Q ss_pred eEEEEEEecccchhhHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe
Q 003971 596 LSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 662 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~ 662 (782)
+|+++||+++++|.+++.... ....+++.+++.++.|++.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999999999999986432 1236889999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003971 663 VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 741 (782)
Q Consensus 663 VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~ 741 (782)
+||+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|+| |..||.+....+....+.. ..
T Consensus 163 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~ 240 (303)
T cd05088 163 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GY 240 (303)
T ss_pred EEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-CC
Confidence 999999998643211 11112234567999999988889999999999999999998 9999988777665554432 22
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 742 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 742 ~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
....+ ...+.+|+.+||. +|.+||++.++++.|.++.
T Consensus 241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 22222 3468899999999 9999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=331.89 Aligned_cols=248 Identities=21% Similarity=0.335 Sum_probs=207.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|.+.++||+|+||.||++.+ .++.+|+|++.+... .......+..|+.++..++|+||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4789999999999999999987 467899999865332 2223456888999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 679 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~- 679 (782)
||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999999999732 35689999999999999999999999999999999999999999999999999976543222
Q ss_pred CCCCCCCCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------Ch
Q 003971 680 RDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EG 748 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip------~~ 748 (782)
.....+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+........+| ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 223457999999999986 3467889999999999999999999999988888887776655443333 34
Q ss_pred HHHHHHHHhhh---CCCCCCCHHHHHHH
Q 003971 749 PLGRLIADCWA---EPQERPSCEEILSR 773 (782)
Q Consensus 749 ~L~~LI~~CL~---DP~kRPSa~EIL~~ 773 (782)
.+.+|+.+|+. ++..|+++.++++|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 58899999886 34447899999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.50 Aligned_cols=249 Identities=28% Similarity=0.477 Sum_probs=210.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|++.+.||.|+||+||+|.. ++..+++|++....... ....+.+|+.+++.++|+||+++++.+......++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4789999999999999999976 57789999986554433 56789999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC-
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR- 680 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~- 680 (782)
|+++++|.+++........+++..+..++.|++.||+|||+.||+|+||+|+||++++++.++|+|||++..+......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 9999999999874433357899999999999999999999999999999999999999999999999999876543222
Q ss_pred ---CCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC------ChH
Q 003971 681 ---DSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP------EGP 749 (782)
Q Consensus 681 ---~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip------~~~ 749 (782)
.....|+..|+|||.+... .++.++|+|||||++|+|++|+.||................... ... ...
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHH
Confidence 1334688999999998776 78999999999999999999999998877666555554432211 111 235
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+++.+||. ||.+||++.+++.+
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 240 FRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhC
Confidence 7899999999 99999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.51 Aligned_cols=245 Identities=28% Similarity=0.482 Sum_probs=207.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
..+|++.+.||.|+||.||+|.+ ++..||+|.+...... ..+.+.+|+.+++.+.|+||+++++.+......++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 36899999999999999999986 5789999998765433 2467889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++++|.+++. ...+++.++..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 97 e~~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 97 EYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred cccCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 9999999999885 235788999999999999999999999999999999999999999999999998866443323
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChHHHHHHHH
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGPLGRLIAD 756 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~-~~ip---~~~L~~LI~~ 756 (782)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+......+...... ...+ ...+.+++.+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence 33457889999999999888999999999999999999999999887765544444332211 1122 2358899999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003971 757 CWA-EPQERPSCEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~ 773 (782)
||. +|.+||++.+++++
T Consensus 253 ~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 253 CLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HCcCCcccCcCHHHHhhC
Confidence 999 99999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.42 Aligned_cols=260 Identities=28% Similarity=0.573 Sum_probs=215.8
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeE
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 586 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL 586 (782)
.+|++...+|++++.||+|+||.||++.+. +..||+|++... ......+.+.+|+++++++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 457777789999999999999999999752 236899987643 3334467899999999999 79999999
Q ss_pred eccccCCCceEEEEEEecccchhhHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcc
Q 003971 587 LGACTKPPRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 653 (782)
Q Consensus 587 ~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPe 653 (782)
+++|...+.+++++||+++|+|.+++.... ....+++..++.++.|++.||+|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999986421 1235788999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 003971 654 NCLVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 730 (782)
Q Consensus 654 NILLd~~g~VKLaDFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~ 730 (782)
|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999999866432211 122334567999999999889999999999999999998 88899988777
Q ss_pred HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 731 RVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 731 evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
.....+.. ......+ ...+.+++.+||. +|.+||++.+++++|+++.
T Consensus 244 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 ELFKLLKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 76665543 3333333 3468899999999 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=343.97 Aligned_cols=244 Identities=25% Similarity=0.355 Sum_probs=194.5
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC------
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------ 593 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------ 593 (782)
...+|.+++.||+|+||.||+|.+ .++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 346799999999999999999987 57899999875432 2234799999999999999998876321
Q ss_pred --CceEEEEEEecccchhhHHHh-hcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC-eEEEEecC
Q 003971 594 --PRLSMITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFG 669 (782)
Q Consensus 594 --~~l~LV~Ey~~gGsL~dlL~~-~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g-~VKLaDFG 669 (782)
..+++||||+++ +|.+++.. ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 246789999985 66655542 22456789999999999999999999999999999999999998664 79999999
Q ss_pred ccccccCCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----
Q 003971 670 LSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----- 743 (782)
Q Consensus 670 LA~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~----- 743 (782)
+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+......+..+......+
T Consensus 217 la~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 217 SAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred cchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 998764332 2235678999999998865 468999999999999999999999999887666555443211100
Q ss_pred -------------C---------CC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 -------------E---------IP---EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 -------------~---------ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. +| +..+.+|+.+||. ||.+|||+.++++|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 11 2357889999999 99999999999966
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=332.41 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=206.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|.+.+.||+|+||.||++.+ .++.||+|++.+... .......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999987 577899999865322 2233456888999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 679 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~- 679 (782)
||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999998732 35688999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCCCCCCcccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------Ch
Q 003971 680 RDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EG 748 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip------~~ 748 (782)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.....+..+| ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 2234579999999999875 467889999999999999999999999888877777766554444333 24
Q ss_pred HHHHHHHHhhh-CCCC--CCCHHHHHHH
Q 003971 749 PLGRLIADCWA-EPQE--RPSCEEILSR 773 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~k--RPSa~EIL~~ 773 (782)
.+.+++.+|+. ++.+ |++++++++|
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 68899999988 4333 4688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.89 Aligned_cols=257 Identities=28% Similarity=0.494 Sum_probs=207.6
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEecccc
Q 003971 515 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACT 591 (782)
Q Consensus 515 ~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~ 591 (782)
..+.+....++|++.+.||+|+||.||++.+ .++.+|+|++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 3455666778999999999999999999977 578899998754321 235677899999999 6999999999873
Q ss_pred -----CCCceEEEEEEecccchhhHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEE
Q 003971 592 -----KPPRLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 665 (782)
Q Consensus 592 -----d~~~l~LV~Ey~~gGsL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKL 665 (782)
..+.++++|||+++++|.+++... .....+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEE
Confidence 445689999999999999887532 23456889999999999999999999999999999999999999999999
Q ss_pred EecCccccccCCCCCCCCCCCCCcccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 003971 666 CDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 740 (782)
Q Consensus 666 aDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~ 740 (782)
+|||++..+...........|++.|+|||++.. ..++.++|||||||++|+|++|+.||....+...........
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 999999876543333345578999999998753 457889999999999999999999998776655443332211
Q ss_pred C-CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003971 741 S-RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 741 ~-~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 774 (782)
. ....+ ...+.+++.+||+ ||.+||++.++++++
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1 11112 3468999999999 999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.88 Aligned_cols=243 Identities=31% Similarity=0.571 Sum_probs=206.0
Q ss_pred eEEeeeCcEEEEEEEEC---Ce--EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEec
Q 003971 530 TRVGIGFFGEVFRGIWN---GT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 604 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~---g~--~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 604 (782)
+.||+|+||.||+|.+. ++ .+|||.+...... ...+.|.+|+.++++++||||+++++++.. ...++++||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 36899999999999762 22 6899998765543 556789999999999999999999999988 88999999999
Q ss_pred ccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC---C
Q 003971 605 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR---D 681 (782)
Q Consensus 605 gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~---~ 681 (782)
+++|.+.+..... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++..+...... .
T Consensus 79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999998874322 57899999999999999999999999999999999999999999999999999876442211 1
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADC 757 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~C 757 (782)
....++..|+|||.+.+..++.++|||||||++|+|++ |+.||......+....+.........+ +..+.+++.+|
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence 13456788999999998889999999999999999998 999998888877776666544444333 34689999999
Q ss_pred hh-CCCCCCCHHHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~L~ 775 (782)
|. +|.+||++.++++.|.
T Consensus 238 l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 238 WAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCcccCCCHHHHHHHhc
Confidence 99 9999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.40 Aligned_cols=252 Identities=35% Similarity=0.586 Sum_probs=209.0
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC--C---eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWN--G---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~--g---~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
...+|++.+.||+|+||.||+|... + ..||||++... ......+.|..|+.+++.++||||+++++++.+....
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3467899999999999999999763 3 36999998643 2344567899999999999999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++++||+++++|.+++.. ....+++.+++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 81 MIITEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEEecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999998863 235689999999999999999999999999999999999999999999999999876543
Q ss_pred CCCC--CCC-C--CCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003971 677 SPMR--DSS-S--AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 747 (782)
Q Consensus 677 ~~~~--~~~-~--~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~ 747 (782)
.... ... . ..+..|+|||.+.+..++.++|||||||++|||++ |..||...........+.. ....+.+ +
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~ 237 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-DYRLPPPMDCP 237 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCcCCCcccCC
Confidence 2211 111 1 12357999999998889999999999999999886 9999988877766666543 2222222 2
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 748 GPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 748 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
..+.+++.+||. +|.+||++.+++..|+++
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 238 TALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 468999999999 999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=330.71 Aligned_cols=248 Identities=25% Similarity=0.294 Sum_probs=211.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC--CCceEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRLSM 598 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~l~L 598 (782)
.++|..+++|++|.||.||+|++ +++.||+|.++.........-..++||.+|.+++|||||.+-.+..- -+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 46788999999999999999987 57889999997665444334566799999999999999999887643 356999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
|||||+. +|..+++.. ..++...+++.++.|+++|++|||.+.|+|||||++|+|++..|.+||+|||+|+.+..+.
T Consensus 155 VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9999986 888888733 3689999999999999999999999999999999999999999999999999999998876
Q ss_pred CCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---C---------
Q 003971 679 MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---I--------- 745 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~---i--------- 745 (782)
...+..+-|.+|.|||++.+. .|+...|+||+|||+.||+++++.|.+......++.+...-..+. +
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 677788999999999998775 699999999999999999999999999988888888765332221 0
Q ss_pred --------CC-------------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 --------PE-------------GPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 --------p~-------------~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
|. +.-.+|+..++. ||.+|.|+.+.|++
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 10 123468899999 99999999999876
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.76 Aligned_cols=246 Identities=28% Similarity=0.507 Sum_probs=207.0
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|.+.+.||+|+||.||+|.. +++.|++|.+..........+.+..|+.+++.++|+||+++++++...+.+++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588899999999999999976 578999999987665555678899999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC-
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD- 681 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~- 681 (782)
+++++|.+++. ....+++..+..++.|++.||+|||+.||+|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99999999986 33467899999999999999999999999999999999999999999999999998765432221
Q ss_pred ---CCCCCCCcccCccccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHH
Q 003971 682 ---SSSAGTPEWMAPELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPL 750 (782)
Q Consensus 682 ---~~~~GT~~Y~APEvl~~~~---~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L 750 (782)
....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||..................+.+| ...+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence 1356788999999998765 8899999999999999999999997664333222222223333333 2358
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 751 GRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 751 ~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+++..||+ +|.+||++.+++.+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcC
Confidence 899999999 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.71 Aligned_cols=246 Identities=27% Similarity=0.473 Sum_probs=205.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccC----hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLT----AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~----~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
+|++++.||.|+||.||+|.. +++.+|+|.+...... ......+.+|+++++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999976 6888999988654321 23346788999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC-
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 678 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~- 678 (782)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+|+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999999863 3468899999999999999999999999999999999999999999999999987653211
Q ss_pred -----CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCCCCC---ChH
Q 003971 679 -----MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE-GSRLEIP---EGP 749 (782)
Q Consensus 679 -----~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~-~~~~~ip---~~~ 749 (782)
.......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+... ...+.++ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 1122456889999999999888999999999999999999999999877655544443332 2222233 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+++.+||. +|.+||++.+++++
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcC
Confidence 8999999999 99999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=321.40 Aligned_cols=244 Identities=23% Similarity=0.326 Sum_probs=196.7
Q ss_pred EeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccch
Q 003971 532 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 608 (782)
Q Consensus 532 LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL 608 (782)
||+|+||.||++.. .|+.||+|.+....... .....+..|+++++.++||||+++++++.+...++++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999976 58899999986544322 1234556799999999999999999999999999999999999999
Q ss_pred hhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003971 609 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 688 (782)
Q Consensus 609 ~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~ 688 (782)
.+++... ....+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++....... ......|++
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTN 158 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCC
Confidence 8887532 33458899999999999999999999999999999999999999999999999998764422 223457899
Q ss_pred cccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCCCC--CCCChHHHHHHHHhhh-CC
Q 003971 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE----RVVYAVANEGSRL--EIPEGPLGRLIADCWA-EP 761 (782)
Q Consensus 689 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~----evl~~i~~~~~~~--~ip~~~L~~LI~~CL~-DP 761 (782)
.|+|||++.+..++.++|||||||++|+|++|+.||...... .+........... ......+.+|+.+||. ||
T Consensus 159 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P 238 (277)
T cd05607 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKP 238 (277)
T ss_pred CccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCH
Confidence 999999999888999999999999999999999999765332 2222222211111 1124468999999999 99
Q ss_pred CCCCCHHHHHHHHHhh
Q 003971 762 QERPSCEEILSRLLDC 777 (782)
Q Consensus 762 ~kRPSa~EIL~~L~di 777 (782)
.+||++.|+++.+...
T Consensus 239 ~~R~~~~~~~~~~~~h 254 (277)
T cd05607 239 EDRLGSREKNDDPRKH 254 (277)
T ss_pred hhCCCCccchhhhhcC
Confidence 9999997766555443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=332.09 Aligned_cols=243 Identities=26% Similarity=0.329 Sum_probs=198.7
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC------C
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------P 594 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------~ 594 (782)
.++|.+.+.||.|+||+||+|.+ .++.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 37899999999999999999976 577899999865443334456788999999999999999999988543 3
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
..|++++++ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 94 ~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 468899987 678887764 346899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------- 743 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~---------- 743 (782)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+.......
T Consensus 169 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred CCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 432 235678999999999876 568999999999999999999999998776555444432211100
Q ss_pred -----------CCC-----------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 -----------EIP-----------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 -----------~ip-----------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..+ ...+.+|+.+|+. ||.+|||+.++++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 001 1236789999999 99999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.72 Aligned_cols=245 Identities=28% Similarity=0.534 Sum_probs=204.9
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-------HHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-------ENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-------~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
+|.++..||+|+||.||+|.+ .++.+|+|.+....... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999976 57889999886543321 224678899999999999999999999999999
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.++++||+++++|.+++. ....+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 999999999999999986 33568899999999999999999999999999999999999999999999999998765
Q ss_pred CCCC------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003971 676 DSPM------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--- 746 (782)
Q Consensus 676 ~~~~------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip--- 746 (782)
.... ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+.. ...+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNI 236 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCccc
Confidence 3211 11234578899999999988899999999999999999999999988766555544433 2233333
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+..+.+++.+||+ ||.+||++.+++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 3468999999999 99999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.47 Aligned_cols=244 Identities=34% Similarity=0.557 Sum_probs=209.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|.+.+.||.|+||.||+|.+ +++.+|+|++.... .......+.+|+++++.++|+||+++++++.+...+++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 3688889999999999999987 57899999986543 23345678899999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+++++|.+++.. ..+++..++.++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++..+.......
T Consensus 80 ~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 80 YCGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eeCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 9999999998862 278999999999999999999999999999999999999999999999999998876543333
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChHHHHHHHHh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGPLGRLIADC 757 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip----~~~L~~LI~~C 757 (782)
....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+......+... ..+.++ +..+.+++.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCcccccCHHHHHHHHHH
Confidence 4567888999999999888999999999999999999999999887766655544433 222222 23589999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. +|.+||++.+++++
T Consensus 235 l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 235 LNKDPKERPSAKELLKH 251 (274)
T ss_pred hhCChhhCcCHHHHhhC
Confidence 98 99999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=317.57 Aligned_cols=247 Identities=28% Similarity=0.399 Sum_probs=203.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|++.++||+|+||.||+|.+ .++.||+|++..........+.+.+|+++++.++||||+++++++......++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4688999999999999999987 47899999986554444445678899999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|++++.|..+.. ....+++.+++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 999998887765 23458999999999999999999999999999999999999999999999999998765443333
Q ss_pred CCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------------
Q 003971 682 SSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR------------------ 742 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~------------------ 742 (782)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 34568889999998875 45788999999999999999999999866654433333211000
Q ss_pred --CC------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 --LE------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 --~~------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+. -....+.+++.+||. +|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 012358899999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.78 Aligned_cols=254 Identities=33% Similarity=0.567 Sum_probs=205.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEECC----------------eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceee
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWNG----------------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 585 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~g----------------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVk 585 (782)
...+|.+.++||+|+||.||++.+.+ ..||+|.+... ........|.+|++++++++|+||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 45689999999999999999986532 24899998643 33444567999999999999999999
Q ss_pred EeccccCCCceEEEEEEecccchhhHHHhhcc---------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEE
Q 003971 586 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQ---------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCL 656 (782)
Q Consensus 586 L~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~---------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNIL 656 (782)
+++++......+++|||+++++|.+++..... ...+++..++.++.|++.||+|||+.|++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 99999999999999999999999998863221 124688999999999999999999999999999999999
Q ss_pred EcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCChHHH
Q 003971 657 VNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT--LNRPWEGVLPERV 732 (782)
Q Consensus 657 Ld~~g~VKLaDFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT--Gk~PF~~~~~~ev 732 (782)
++.++.+||+|||++......... .....++..|+|||.+.+..++.++|||||||++|+|++ +..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 999999999999999765432211 122345678999999988889999999999999999998 5679988776665
Q ss_pred HHHHHh----cCC--C---CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 733 VYAVAN----EGS--R---LEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 733 l~~i~~----~~~--~---~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
...... ... . ...-+..+.+|+.+||. ||.+||++.+|++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 544322 111 1 11123469999999999 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=311.80 Aligned_cols=244 Identities=30% Similarity=0.571 Sum_probs=207.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|++.+.||.|+||.||+|.+. +..+++|.+..... .+.+.+|+.+++.++|+||+++++++.....+|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 57889999999999999999873 68899999864321 5789999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+++++|.+++.. ....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..........
T Consensus 79 ~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 79 YCGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred cCCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 9999999998863 24578999999999999999999999999999999999999999999999999998775543233
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChHHHHHHHHh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGPLGRLIADC 757 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~-~~ip---~~~L~~LI~~C 757 (782)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||....+......+...... ...+ ...+.+++.+|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 3456888999999999888999999999999999999999999877665544443221111 1111 24688999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. ||.+||++.+++++
T Consensus 237 l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 237 LVKDPEERPSAIQLLQH 253 (256)
T ss_pred HhcChhhCcCHHHHhcC
Confidence 99 99999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.67 Aligned_cols=246 Identities=23% Similarity=0.301 Sum_probs=197.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|.+.+.||+|+||.||+|.+ +|+.+|+|.+............+.+|+.+++.++||||+++++++.+...+++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478899999999999999987 588999999876544333346678899999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+.+ +|.+.+.. ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 975 67766642 245689999999999999999999999999999999999999999999999999986643322233
Q ss_pred CCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHhcCC------------------C
Q 003971 683 SSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPW-EGVLPERVVYAVANEGS------------------R 742 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF-~~~~~~evl~~i~~~~~------------------~ 742 (782)
...+++.|+|||.+.+. .++.++|||||||++|+|+||..|| .+.+....+..+..... .
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 45678899999998764 4789999999999999999999885 44443333332211100 0
Q ss_pred C------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 L------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 ~------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. ......+.+++.+||. ||.+|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 0112357789999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.84 Aligned_cols=245 Identities=30% Similarity=0.503 Sum_probs=208.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
..+|++.+.||.|+||.||+|.+ +++.|++|.+...... ..+.+.+|+.+++.++||||+++++++...+.+++++
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 46799999999999999999975 6889999998654432 3467889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++++|..++. ...+++.++..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 96 EYLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EecCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 9999999998875 235899999999999999999999999999999999999999999999999998876543333
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCC---ChHHHHHHHH
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIP---EGPLGRLIAD 756 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~-~~~ip---~~~L~~LI~~ 756 (782)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+......+..... ....+ ...+.+++.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 3345788999999999988899999999999999999999999988877665554443221 11122 3468899999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003971 757 CWA-EPQERPSCEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~ 773 (782)
||. ||.+||++.+++++
T Consensus 252 ~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 252 CLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HhhcChhhCCCHHHHhhC
Confidence 999 99999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.38 Aligned_cols=249 Identities=29% Similarity=0.490 Sum_probs=206.7
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
...+.|++.++||.|+||.||+|.+ .+..+++|++... .....+.+.+|+.+++.++||||+++++++..+..+++
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 3447799999999999999999987 4788999998643 34446788999999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
+|||+++++|..++.. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 87 MIEFCPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EEecCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999999999887753 23468999999999999999999999999999999999999999999999999987654332
Q ss_pred CCCCCCCCCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChH
Q 003971 679 MRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGP 749 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~-~~ip---~~~ 749 (782)
.......+++.|+|||++. ...++.++|||||||++|+|++|+.||...........+...... ...+ ...
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence 2334456888999999984 445788999999999999999999999887766555554332221 1112 236
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+++.+||. ||.+||++.+++++
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcC
Confidence 8899999999 99999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=336.76 Aligned_cols=247 Identities=19% Similarity=0.257 Sum_probs=194.2
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCC------CceeeEec
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH------PNVILFLG 588 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H------PNIVkL~g 588 (782)
++......+|++.++||+|+||+||+|.+ .++.||||++.... .....+..|+.+++.++| .+|+++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 34455568899999999999999999977 57789999985321 223445667777777654 45889998
Q ss_pred cccCC-CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCC-----
Q 003971 589 ACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHW----- 661 (782)
Q Consensus 589 ~~~d~-~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g----- 661 (782)
++... ..+++||+++ +++|.+++. ....+++..+..++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 88765 4678888887 668887775 34578999999999999999999998 5999999999999998765
Q ss_pred -----------eEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 003971 662 -----------TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE 730 (782)
Q Consensus 662 -----------~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~ 730 (782)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998864322 234568999999999999999999999999999999999999999887765
Q ss_pred HHHHHHHhcCCCC-------------------------------------------CCCChHHHHHHHHhhh-CCCCCCC
Q 003971 731 RVVYAVANEGSRL-------------------------------------------EIPEGPLGRLIADCWA-EPQERPS 766 (782)
Q Consensus 731 evl~~i~~~~~~~-------------------------------------------~ip~~~L~~LI~~CL~-DP~kRPS 766 (782)
+.+..+......+ .+....+.+||..||. ||.+|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 5444332211000 0012236689999999 9999999
Q ss_pred HHHHHHH
Q 003971 767 CEEILSR 773 (782)
Q Consensus 767 a~EIL~~ 773 (782)
+.|+++|
T Consensus 432 a~e~L~H 438 (467)
T PTZ00284 432 ARQMTTH 438 (467)
T ss_pred HHHHhcC
Confidence 9999985
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.59 Aligned_cols=245 Identities=31% Similarity=0.508 Sum_probs=207.6
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc---ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~---~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
+|+..+.||+|+||+||+|.. +++.|++|.+..... ..+..+.+.+|+.+++.++|+||+++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 366778999999999999987 588999999865432 234567899999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999999999863 3468899999999999999999999999999999999999999999999999988764432
Q ss_pred CCCCCCCCCcccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003971 680 RDSSSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 755 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~-~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~ 755 (782)
......|++.|++||.+.... ++.++|+|||||++|+|++|+.||...........+........++ ...+.+++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 236 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL 236 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHH
Confidence 223566889999999987766 8999999999999999999999998777655555544433344443 346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003971 756 DCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 756 ~CL~-DP~kRPSa~EIL~~ 773 (782)
+||. +|.+||++.+++.+
T Consensus 237 ~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 237 KCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHhhcCcccCcCHHHHhcC
Confidence 9999 99999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=338.60 Aligned_cols=241 Identities=26% Similarity=0.357 Sum_probs=194.1
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
+...+|.+.+.||+|+||.||++.+ .++.||+|... ...+.+|+++++.++||||+++++++......++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 4557899999999999999999987 57889999743 2346789999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC-
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS- 677 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~- 677 (782)
++|++. ++|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 161 v~e~~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999996 57877775 3456889999999999999999999999999999999999999999999999999754322
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHh------------
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL-------PERVVYAVAN------------ 738 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~-------~~evl~~i~~------------ 738 (782)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+..+..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 112335679999999999999999999999999999999999998764321 1111111110
Q ss_pred --------------cCCCC--CCC--------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 739 --------------EGSRL--EIP--------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 739 --------------~~~~~--~ip--------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..... ..+ +..+.+|+.+||. ||.+|||+.|++++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 000 1247789999999 99999999999975
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.91 Aligned_cols=248 Identities=22% Similarity=0.326 Sum_probs=201.5
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
..++|.+.++||.|+||.||+|.+ .++.||+|.+...... .....+.+|+.+++.++||||+++++++.....++++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 357899999999999999999977 5788999998654322 2234677899999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
+||+. ++|..++.. ....+++..+..++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 83 ~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 83 FEYLD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred Eeccc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 99998 478777753 234688999999999999999999999999999999999999999999999999976543332
Q ss_pred CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------------
Q 003971 680 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS----------------- 741 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~----------------- 741 (782)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+....+.....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 3334567899999998865 4578899999999999999999999988776554433221100
Q ss_pred CCCC--------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 RLEI--------------PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 ~~~i--------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.... -+..+.+|+.+|+. ||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 12347889999999 99999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.97 Aligned_cols=246 Identities=30% Similarity=0.564 Sum_probs=207.4
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
+...+|++.+.||+|+||.||++...++.+|+|.+.... ..+.+.+|+.+++.++||||+++++++... ..+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred ccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 456789999999999999999999999999999985432 236788999999999999999999998765 479999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++++|.+++... ....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 78 ELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred ECCCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999999998643 2346889999999999999999999999999999999999999999999999998765322
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHH
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIAD 756 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~ 756 (782)
......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||......+....+. .+.....+ +..+.+++.+
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHH
Confidence 122334568999999988889999999999999999997 999999888776655543 33333332 2468899999
Q ss_pred hhh-CCCCCCCHHHHHHHHHh
Q 003971 757 CWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~L~d 776 (782)
||. +|.+||++.+++..|++
T Consensus 233 ~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 233 CWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HcCCChhhCcCHHHHHHHHcc
Confidence 999 99999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=316.41 Aligned_cols=248 Identities=28% Similarity=0.491 Sum_probs=198.9
Q ss_pred eeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC--CceE
Q 003971 526 LTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLS 597 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l~ 597 (782)
|++.+.||+|+||+||++.+ .+..||+|++..... ....+.|.+|+++++.++||||+++++++... ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 38889999999999988653 467899999865432 23456788999999999999999999987653 4589
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
++|||+++++|.+++.. ..+++.+++.++.|++.||.|||++||+|+||||+|||+++++.++|+|||++......
T Consensus 85 lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999998862 35899999999999999999999999999999999999999999999999999876443
Q ss_pred CCC---CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHHHHhcC
Q 003971 678 PMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER--------------VVYAVANEG 740 (782)
Q Consensus 678 ~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~e--------------vl~~i~~~~ 740 (782)
... .....++..|+|||.+.+..++.++|||||||++|+|++|..||....... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 211 122345667999999988889999999999999999999999986443211 111111112
Q ss_pred CCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 741 SRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 741 ~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
.....+ +..+.+++.+||. +|.+||++.++++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 222222 3468999999999 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=311.81 Aligned_cols=254 Identities=30% Similarity=0.545 Sum_probs=209.9
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEECC-----eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~g-----~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
+...+|.+.+.||+|+||.||+|.+.. ..+|||...... .....+.+.+|+.+++.+.||||+++++++.+. .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~ 80 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-P 80 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-C
Confidence 455779999999999999999997632 368889875432 244567899999999999999999999988764 5
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.+++|||+++++|.+++.. ....+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 81 VWIVMELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred cEEEEEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 7899999999999999863 23468999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC-CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003971 676 DSPMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 750 (782)
Q Consensus 676 ~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L 750 (782)
..... .....++..|+|||.+....++.++|||||||++|+|++ |..||.+....+....+... .....+ +..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG-ERLPMPPNCPPTL 237 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHH
Confidence 43221 122334568999999988889999999999999999986 99999888877666555443 233332 3469
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 751 GRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 751 ~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.+++.+||. +|.+||++.++++.|.++..
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=318.31 Aligned_cols=247 Identities=29% Similarity=0.524 Sum_probs=208.7
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|.+.+.||.|+||.||++.+ ++..+|+|++... .....+.|.+|+.+++.++||||+++++++..+...+++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 35788999999999999999987 5788999998643 3344578999999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++++|.+++... ...+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999999988632 346899999999999999999999999999999999999999999999999998765443333
Q ss_pred CCCCCCCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChHHH
Q 003971 681 DSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGPLG 751 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~-~~ip---~~~L~ 751 (782)
.....+++.|+|||.+. ...++.++|+|||||++|+|++|+.||...........+...... ...+ ...+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 34456899999999874 345778999999999999999999999988776666555443221 1122 34689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+++.+||. +|.+||++.+++++
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcC
Confidence 99999999 99999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=312.19 Aligned_cols=244 Identities=29% Similarity=0.511 Sum_probs=194.6
Q ss_pred EEeeeCcEEEEEEEE-C---CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEeccc
Q 003971 531 RVGIGFFGEVFRGIW-N---GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~-~---g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
.||+|+||.||+|.. + ...+++|.+.... .......|.+|+.+++.++|+||+++++.+.+...++++|||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 589999999999964 2 3468888765432 3344567889999999999999999999999999999999999999
Q ss_pred chhhHHHhhcc--cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC--CC
Q 003971 607 SLYHLIHLSGQ--KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR--DS 682 (782)
Q Consensus 607 sL~dlL~~~~~--~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~--~~ 682 (782)
+|.+++..... ....++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 99999864322 234567888999999999999999999999999999999999999999999998754332211 12
Q ss_pred CCCCCCcccCcccccc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC-CCCC------C
Q 003971 683 SSAGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR-LEIP------E 747 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~-------~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~-~~ip------~ 747 (782)
...+++.|+|||++.. ..++.++|||||||++|||++ |..||....+............. ...+ .
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence 3345678999998743 356889999999999999999 78899888776666655443321 1111 2
Q ss_pred hHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 003971 748 GPLGRLIADCWAEPQERPSCEEILSRLL 775 (782)
Q Consensus 748 ~~L~~LI~~CL~DP~kRPSa~EIL~~L~ 775 (782)
..+..++..||.||.+||++.+|++.|.
T Consensus 241 ~~~~~~~~~~~~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 241 DRWYEVMQFCWLDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHHHHHHHhcCcccccCHHHHHHHhc
Confidence 3577899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.27 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=202.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|++.++||+|+||.||++.+ ++..+|+|.+.... .......+.+|+++++.++||||++++++|.+++.+++++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 3689999999999999999987 57788999876432 33445678899999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
|+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++...... .
T Consensus 80 y~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~ 154 (308)
T cd06615 80 HMDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--M 154 (308)
T ss_pred ccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--c
Confidence 9999999999873 3578999999999999999999997 58999999999999999999999999998765432 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---------------------
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--------------------- 739 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~--------------------- 739 (782)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...........+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 23567889999999998888999999999999999999999999765443322221110
Q ss_pred --------------CCCCCCC----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 740 --------------GSRLEIP----EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 740 --------------~~~~~ip----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+..| ...+.+++.+||. +|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111 2358899999999 99999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.28 Aligned_cols=246 Identities=29% Similarity=0.473 Sum_probs=202.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc---ChHHHHHHHHHHHHHHhCCCCceeeEeccccC--CCce
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRL 596 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~---~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~l 596 (782)
.+|++.+.||+|+||.||++.+ .++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999976 578999998865432 22345678899999999999999999998865 3568
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++++||+++++|.+++. ....+++...+.++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 89999999999999886 334688999999999999999999999999999999999999999999999999876532
Q ss_pred CC---CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003971 677 SP---MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 750 (782)
Q Consensus 677 ~~---~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L 750 (782)
.. .......++..|+|||.+.+..++.++|||||||++|+|++|+.||..................+.++ ...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence 11 11123458889999999998889999999999999999999999998877666555555444444444 3457
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 751 GRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 751 ~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..++ .||. +|.+||++.+|+.|
T Consensus 239 ~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHHhcC
Confidence 7787 5666 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.97 Aligned_cols=248 Identities=31% Similarity=0.532 Sum_probs=209.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|.+.+.||.|+||.||++.. +|..+|+|.+..........+.+.+|+.+++.++|+||+++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 588999999999999999987 578899999876554444556788999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC-eEEEEecCccccccCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g-~VKLaDFGLA~~l~~~~~~~ 681 (782)
+++++|.+++... ....+++..++.++.|++.||.|||+.+++|+||||+||++++++ .++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 9999999988632 234579999999999999999999999999999999999998875 57999999998765443333
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--ChHHHHHHHHhhh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--EGPLGRLIADCWA 759 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip--~~~L~~LI~~CL~ 759 (782)
....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.........+ ...+.+++.+||.
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhc
Confidence 34568899999999988889999999999999999999999998877766666554433222111 3469999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003971 760 -EPQERPSCEEILSR 773 (782)
Q Consensus 760 -DP~kRPSa~EIL~~ 773 (782)
+|.+||++.+++++
T Consensus 240 ~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 240 VSPRDRPSITSILKR 254 (257)
T ss_pred cChhhCcCHHHHhhC
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.11 Aligned_cols=246 Identities=23% Similarity=0.265 Sum_probs=203.1
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
|+..+.||+|+||+||++.+ +++.+|+|.+....... .....+.+|+++++.++|+||+.+++++..++..++++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67788999999999999987 57899999986554332 2245678899999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+.+++|.+++... ....+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++....... ...
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIR 159 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-ccc
Confidence 9999999887632 23468999999999999999999999999999999999999999999999999997654322 223
Q ss_pred CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCC---CChHHHHHHHHh
Q 003971 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS--RLEI---PEGPLGRLIADC 757 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~--~~~i---p~~~L~~LI~~C 757 (782)
...|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.........+..... .... -...+.+|+..|
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 45789999999999988899999999999999999999999987765443333322111 1111 234688999999
Q ss_pred hh-CCCCCCC-----HHHHHHH
Q 003971 758 WA-EPQERPS-----CEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPS-----a~EIL~~ 773 (782)
|. ||.+||+ +.+++.+
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcC
Confidence 99 9999999 7777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.83 Aligned_cols=244 Identities=28% Similarity=0.478 Sum_probs=204.5
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEe
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 603 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 603 (782)
|++.+.||.|+||.||++.+ .+..+++|.+... .....+.+.+|+++++.++||||+++++++......++++||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 56778999999999999987 4677888887543 2345678899999999999999999999999999999999999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 683 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~ 683 (782)
++++|..++.. ....+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++............
T Consensus 85 ~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 85 AGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 99999887752 2457899999999999999999999999999999999999999999999999999765443333345
Q ss_pred CCCCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCC---ChHHHHHH
Q 003971 684 SAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIP---EGPLGRLI 754 (782)
Q Consensus 684 ~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~-~~~ip---~~~L~~LI 754 (782)
..+++.|+|||++. +..++.++|||||||++|+|++|+.||...........+..... ....+ +..+.+++
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence 67899999999984 44578899999999999999999999998877666665543322 11222 34699999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003971 755 ADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+||. ||.+||++.+++++
T Consensus 243 ~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 243 KKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999 99999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.65 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=202.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|++.+.||.|+||.||+|.+ +++.||||.+............+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478899999999999999987 578999998865544444446788999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+. ++|..++... ....+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 96 5788877532 345789999999999999999999999999999999999999999999999999876644322233
Q ss_pred CCCCCCcccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------------
Q 003971 683 SSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------ 743 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~-~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~------------------ 743 (782)
...+++.|+|||.+.+.. ++.++|||||||++|+|+||+.||.+.........+......+
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 446788999999887644 6889999999999999999999998776555444433211110
Q ss_pred ------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..-...+.+++.+||. ||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0112357789999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=306.94 Aligned_cols=246 Identities=30% Similarity=0.462 Sum_probs=210.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|.+.+.||+|+||.||++.. ++..+|+|.+............+.+|+.+++.++||||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999876 678899999877665555678899999999999999999999999988999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC-CeEEEEecCccccccCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~-g~VKLaDFGLA~~l~~~~~~~ 681 (782)
+++++|.+++... ....+++..+..++.|++.||+|||++|++|+||+|+||+++++ +.++|+|||++....... ..
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~ 158 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KA 158 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-cc
Confidence 9999999998632 23458999999999999999999999999999999999999854 468999999998765432 22
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 758 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL 758 (782)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+..... ..++ ...+.+++..||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l 237 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-APISDRYSPDLRQLILSML 237 (256)
T ss_pred cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-CCCCCCcCHHHHHHHHHHc
Confidence 345688899999999988889999999999999999999999988877666665544332 2233 346899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003971 759 A-EPQERPSCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRPSa~EIL~~ 773 (782)
. +|.+||++.+++++
T Consensus 238 ~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 238 NLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCChhhCCCHHHHhhC
Confidence 9 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=317.74 Aligned_cols=254 Identities=33% Similarity=0.562 Sum_probs=204.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC------------------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCce
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWN------------------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 583 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~------------------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI 583 (782)
..++|++.++||+|+||.||++.+. +..+|+|++.... .......|.+|+.+++.++|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3467999999999999999998542 3368999986442 33445789999999999999999
Q ss_pred eeEeccccCCCceEEEEEEecccchhhHHHhhcc--------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccE
Q 003971 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ--------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANC 655 (782)
Q Consensus 584 VkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~--------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNI 655 (782)
+++++++......+++|||+++++|.+++..... ...+++.+++.++.|++.||+|||+.||+|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999999999999999999999999998864221 13477889999999999999999999999999999999
Q ss_pred EEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCChHH
Q 003971 656 LVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT--LNRPWEGVLPER 731 (782)
Q Consensus 656 LLd~~g~VKLaDFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT--Gk~PF~~~~~~e 731 (782)
|++.++.++|+|||++..+...... .....+++.|++||......++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999865432211 112334678999999888889999999999999999998 678998776655
Q ss_pred HHHHHHh---c---CCCCCC---CChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 732 VVYAVAN---E---GSRLEI---PEGPLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 732 vl~~i~~---~---~~~~~i---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
....... . ....+. .+..+.+|+.+||+ ||.+||++.+|++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 5443211 0 111111 13568999999999 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=306.73 Aligned_cols=241 Identities=29% Similarity=0.561 Sum_probs=201.8
Q ss_pred EEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccchh
Q 003971 531 RVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 609 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL~ 609 (782)
.||+|+||.||+|.. +++.+|+|++.... .......|.+|+++++.++||||+++++++......+++|||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 689999999999976 57789999876443 3334457889999999999999999999999999999999999999999
Q ss_pred hHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC-CCCCCC
Q 003971 610 HLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS-SSAGTP 688 (782)
Q Consensus 610 dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~-~~~GT~ 688 (782)
+++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........... ...+++
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 98863 234678999999999999999999999999999999999999999999999999976543322111 223456
Q ss_pred cccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCC
Q 003971 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 689 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~k 763 (782)
.|+|||++.+..++.++||||||+++|++++ |..||.+.........+.. ..+...+ ...+.+++.+||. +|++
T Consensus 159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (250)
T cd05085 159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-GYRMSCPQKCPDDVYKVMQRCWDYKPEN 237 (250)
T ss_pred cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcccCccc
Confidence 7999999998889999999999999999998 9999998877766655543 3333333 2468999999999 9999
Q ss_pred CCCHHHHHHHHH
Q 003971 764 RPSCEEILSRLL 775 (782)
Q Consensus 764 RPSa~EIL~~L~ 775 (782)
||++.++++.|.
T Consensus 238 Rp~~~~l~~~l~ 249 (250)
T cd05085 238 RPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHhc
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=319.72 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=211.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.+|++.+.||+|+||.||++.. .++.||+|.+....... ...+.+..|+++++.++|+||+++++.+.+....+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3689999999999999999987 47899999997665442 34577899999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 679 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~- 679 (782)
||+.+++|.+++... ....+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 999999999988632 345789999999999999999999999999999999999999999999999999875432110
Q ss_pred ----------------------------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 003971 680 ----------------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER 731 (782)
Q Consensus 680 ----------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~e 731 (782)
......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 1113467889999999998889999999999999999999999999888777
Q ss_pred HHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCC----HHHHHHH
Q 003971 732 VVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPS----CEEILSR 773 (782)
Q Consensus 732 vl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS----a~EIL~~ 773 (782)
....+.......... +..+.+++.+||. ||.+||+ +.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 766665443333222 4569999999999 9999999 8888875
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=312.55 Aligned_cols=244 Identities=28% Similarity=0.464 Sum_probs=195.1
Q ss_pred EEeeeCcEEEEEEEEC----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEeccc
Q 003971 531 RVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
.||+|+||.||+|... +..+|+|.+..... ......|.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 5899999999999753 34689998765443 233457889999999999999999999999988999999999999
Q ss_pred chhhHHHhhc--ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC--CCC
Q 003971 607 SLYHLIHLSG--QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDS 682 (782)
Q Consensus 607 sL~dlL~~~~--~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~--~~~ 682 (782)
+|.+++.... ....+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 9999986432 123567778889999999999999999999999999999999999999999999976543221 122
Q ss_pred CCCCCCcccCccccccC-------CCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC-CCCCC------CC
Q 003971 683 SSAGTPEWMAPELIRNE-------PFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEG-SRLEI------PE 747 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~-------~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~-~~~~i------p~ 747 (782)
...+++.|+|||++.+. .++.++|||||||++|||++ |+.||......+......... ..... ..
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence 34577889999998642 35789999999999999996 999998877666544433221 11111 12
Q ss_pred hHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 003971 748 GPLGRLIADCWAEPQERPSCEEILSRLL 775 (782)
Q Consensus 748 ~~L~~LI~~CL~DP~kRPSa~EIL~~L~ 775 (782)
..+.+++.+||.+|.+||++.+|+..|.
T Consensus 241 ~~~~~l~~~c~~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 241 DRWYEVMQFCWLQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hHHHHHHHHHhcCcccCCCHHHHHHHhc
Confidence 3578899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.71 Aligned_cols=239 Identities=29% Similarity=0.455 Sum_probs=198.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|++.+.||+|+||.||+|.+ +++.||+|++.... .......|.+|+.++++++||||+++++++...+..++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3678889999999999999986 67889999986543 33445679999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++...... ..
T Consensus 80 ~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~ 150 (279)
T cd06619 80 FMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IA 150 (279)
T ss_pred cCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cc
Confidence 99999986542 4678888999999999999999999999999999999999999999999999866433 23
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCC----CChHH
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-------ERVVYAVANEGSRLEI----PEGPL 750 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~-------~evl~~i~~~~~~~~i----p~~~L 750 (782)
....|+..|+|||.+.+..++.++|+|||||++|+|++|+.||..... ......+.... .... ....+
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-PPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-CCCCCCCcCCHHH
Confidence 356789999999999988899999999999999999999999965322 12222222221 1111 23468
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 751 GRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 751 ~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+++.+||+ +|.+||++.+++++
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcC
Confidence 899999999 99999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.44 Aligned_cols=244 Identities=29% Similarity=0.482 Sum_probs=206.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
.+|++.+.||.|+||.||++.. +++.||+|.+...... ..+.+.+|+.+++.++|+||+++++++......++|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 7899999999999999999986 6889999998654433 24668899999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+++++|.+++. ...+++.++..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++..........
T Consensus 97 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 97 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred ccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 999999999885 2357889999999999999999999999999999999999999999999999998765443333
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC---ChHHHHHHHHh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP---EGPLGRLIADC 757 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip---~~~L~~LI~~C 757 (782)
....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||....+......+...+... ..+ ...+.+++.+|
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence 45578899999999999889999999999999999999999998766544433333222111 112 34588999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. +|.+||++.+++++
T Consensus 253 l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 253 LEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99 99999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=312.55 Aligned_cols=246 Identities=25% Similarity=0.332 Sum_probs=205.8
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|++.+.||.|+||.||+|.+ +|+.||+|++..........+.+.+|+.+++.++||||+++++++.....+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999986 588999999877655455567899999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-CC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RD 681 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~-~~ 681 (782)
+ +++|.+++... ...+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 99999988632 35689999999999999999999999999999999999999999999999999987654321 12
Q ss_pred CCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------------
Q 003971 682 SSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------------- 743 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~----------------- 743 (782)
....++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.........+......+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345688999999998654 46899999999999999999988888776655544433211100
Q ss_pred --------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 --------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 --------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.-.+..+.+++.+|+. +|.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0012467889999999 99999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.51 Aligned_cols=249 Identities=30% Similarity=0.489 Sum_probs=204.8
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCC----
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPP---- 594 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~---- 594 (782)
..++|++.+.||.|+||.||+|.+ +++.+++|++..... ..+.+.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 357899999999999999999987 567899999865432 346788999999999 6999999999986544
Q ss_pred --ceEEEEEEecccchhhHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 595 --RLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 595 --~l~LV~Ey~~gGsL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
.++++|||+++++|.+++.... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 4899999999999999886422 2457899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCCCcccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-
Q 003971 672 RIITDSPMRDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI- 745 (782)
Q Consensus 672 ~~l~~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i- 745 (782)
..............|++.|+|||.+.. ..++.++|||||||++|+|++|+.||...........+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence 766443333345668899999998753 34678999999999999999999999877666655555443221111
Q ss_pred C---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 P---EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 p---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+ ...+.+|+.+||. ||++|||+.+++++
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 2368899999999 99999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=316.58 Aligned_cols=244 Identities=23% Similarity=0.396 Sum_probs=208.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|++.+.||+|+||.||++.+ .++.+|+|++..... .....+.+.+|+++++.++||||+++++++.+...++++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4789999999999999999987 578999999865433 2334577889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|.|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 99999999999863 357899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHHhhh
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIADCWA 759 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip~~~L~~LI~~CL~ 759 (782)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+....... ..-+..+.+++.+||.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 234578999999999988888999999999999999999999998877666665555332221 1124578999999999
Q ss_pred -CCCCCC-----CHHHHHHH
Q 003971 760 -EPQERP-----SCEEILSR 773 (782)
Q Consensus 760 -DP~kRP-----Sa~EIL~~ 773 (782)
||.+|+ ++.+++++
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CCHHHccCcccCCHHHHHcC
Confidence 999998 77777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=308.22 Aligned_cols=245 Identities=31% Similarity=0.564 Sum_probs=198.0
Q ss_pred eEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc-CCCceEEEEEEe
Q 003971 530 TRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT-KPPRLSMITEYM 603 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~-d~~~l~LV~Ey~ 603 (782)
+.||+|+||.||+|.+. +..+|+|.+... ......+.+.+|+.+++.++||||+++++++. .+...++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 36899999999999752 357999987532 23344678899999999999999999999775 455689999999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC----
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM---- 679 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~---- 679 (782)
.+++|.+++... ...+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 80 KHGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999998632 33467778889999999999999999999999999999999999999999999976543211
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 755 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG-k~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~ 755 (782)
......+++.|+|||.+.+..++.++|||||||++|||++| ..||...........+.. +..+..+ +..+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-GRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCCHHHHHHHH
Confidence 11233456789999999888899999999999999999995 567877776665555443 3233322 346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 756 DCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 756 ~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
+||. +|++||++.++++.|+++.
T Consensus 237 ~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 237 SCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHcCCChhhCCCHHHHHHHHHHHh
Confidence 9999 9999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=328.43 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=213.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCc-eeeEeccccCCC-----
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN-VILFLGACTKPP----- 594 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN-IVkL~g~~~d~~----- 594 (782)
...|..+++||+|+||+||+|+. +|+.||+|.+......+.......+|+.+|+.++|+| ||.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45677778899999999999976 6889999998766543333456789999999999999 999999998877
Q ss_pred -ceEEEEEEecccchhhHHHhhccc-ccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 595 -RLSMITEYMELGSLYHLIHLSGQK-KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 595 -~l~LV~Ey~~gGsL~dlL~~~~~~-~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
.+++|+||++. +|..++...... ..++...++.+++||+.||+|||+++|+||||||.||||+++|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 79999999985 888888744322 457778999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CC--
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---IP-- 746 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~---ip-- 746 (782)
.+.-+....+..++|.+|.|||++.+. .|+...||||+|||++||++++.-|++....+.+..+...-..+. +|
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 876555556678899999999999876 799999999999999999999999999998888887765433331 11
Q ss_pred --------------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhh
Q 003971 747 --------------------------EGPLGRLIADCWA-EPQERPSCEEILSR--LLDC 777 (782)
Q Consensus 747 --------------------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~--L~di 777 (782)
.....+++..|++ +|.+|.|+...+.| +...
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 0135678999999 99999999999987 5544
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=311.61 Aligned_cols=253 Identities=32% Similarity=0.550 Sum_probs=209.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
..++|++.+.||.|+||.||+|... ...+++|.+..... ....+.+.+|+.++++++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4478999999999999999999752 45689998754332 234578999999999999999999999999989
Q ss_pred ceEEEEEEecccchhhHHHhhccc------ccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEec
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQK------KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 668 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~------~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDF 668 (782)
..+++|||+++++|.+++...... ..+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999998743321 26899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCC-CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003971 669 GLSRIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP 746 (782)
Q Consensus 669 GLA~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip 746 (782)
|++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........+............+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 99875433221 2223456778999999988888999999999999999998 788998877766666554333222222
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003971 747 ---EGPLGRLIADCWA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 747 ---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~ 775 (782)
+..+.+++.+||. +|.+||++.++++.|.
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 3469999999999 9999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=314.03 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=204.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
.+|++.+.||+|+||.||+|.+ +++.||+|++..........+.+.+|+++++.++|+||+++++++...+.+++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3689999999999999999987 47789999987654444455788999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-C
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-R 680 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~-~ 680 (782)
|++++.+..+.. ....+++.++..++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 999877766554 345689999999999999999999999999999999999999999999999999987654432 2
Q ss_pred CCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------------------
Q 003971 681 DSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------------ 741 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~------------------ 741 (782)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||.+.........+.....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 2345678899999999887 789999999999999999999999987655444333221000
Q ss_pred ---------------CCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 ---------------RLEIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 ---------------~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+..-+..+.+++.+||. +|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000113458899999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=311.45 Aligned_cols=250 Identities=30% Similarity=0.538 Sum_probs=199.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC--CCc
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPR 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~ 595 (782)
.+|++.+.||+|+||.||++.. ++..||+|.+... .....+.|.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5788999999999999999864 4678999997643 23446788999999999999999999998643 346
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+++++||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 8999999999999999863 23468999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC---CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---------------HHHHHH
Q 003971 676 DSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER---------------VVYAVA 737 (782)
Q Consensus 676 ~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~e---------------vl~~i~ 737 (782)
..... .....++..|+|||.+.+..++.++|||||||++|||++|..|+....... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 32211 111223456999999998889999999999999999999877654322110 011122
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 738 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 738 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
........+ +..+.+|+.+||. +|++|||+.+|++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 222222222 2368999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=311.84 Aligned_cols=252 Identities=30% Similarity=0.575 Sum_probs=210.0
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCe----EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
...+|++.+.||+|+||.||+|.+ +|. .+|+|.+..... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 346889999999999999999976 232 589998765433 4445788999999999999999999999887 67
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.++++||+++|+|.+++.. ....+++..++.++.|++.||+|||+.||+|+||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred eEEEEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999998863 23458999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003971 676 DSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 749 (782)
Q Consensus 676 ~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~ 749 (782)
..... .....++..|+|||.+....++.++|+|||||++||+++ |+.||.+....+....+.. +.....+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-GERLPQPPICTID 239 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-CCCCCCCCCCCHH
Confidence 32211 112234568999999988889999999999999999998 9999999887776665543 3333333 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
+.+++.+||. ||.+||++.++++.|.++.
T Consensus 240 ~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 240 VYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 8899999999 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.78 Aligned_cols=247 Identities=26% Similarity=0.459 Sum_probs=204.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|++.+.||+|+||.||++.+ .++.||+|.+... ........+.+|+.++++++|+||+++++++...+.+++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4688899999999999999987 4889999988643 233445788999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
|+++++|..++........+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++..+... .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--L 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--c
Confidence 99999999888643223478999999999999999999997 59999999999999999999999999999766432 2
Q ss_pred CCCCCCCCcccCccccccC------CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--hcCCCCCCC---ChH
Q 003971 681 DSSSAGTPEWMAPELIRNE------PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA--NEGSRLEIP---EGP 749 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~------~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~--~~~~~~~ip---~~~ 749 (782)
.....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+. ..+....++ +..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 2345688899999998554 35789999999999999999999997665544433322 122223333 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+++.+||. +|.+||++.+++.+
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHHHcccCcccCCCHHHHhcC
Confidence 8899999999 99999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=311.55 Aligned_cols=244 Identities=33% Similarity=0.588 Sum_probs=199.1
Q ss_pred EEeeeCcEEEEEEEEC--Ce--EEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEEEEEecc
Q 003971 531 RVGIGFFGEVFRGIWN--GT--DVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~~--g~--~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
.||+|+||.||+|... +. .+++|.+... ......+.+.+|+++++++ +||||+++++++......+++|||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 5899999999999863 33 4678876532 2334456888999999999 799999999999999999999999999
Q ss_pred cchhhHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 606 GSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 606 GsL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
|+|.+++.... ....+++.+++.++.|++.||+|||+.|++|+||||+|||+++++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999986421 12357899999999999999999999999999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---Ch
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EG 748 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~ 748 (782)
..... ........+..|+|||++....++.++|||||||++|||++ |..||.+.........+.. ......+ ..
T Consensus 161 ~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (270)
T cd05047 161 GQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDD 238 (270)
T ss_pred ccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CCCCCCCCcCCH
Confidence 43211 11112234567999999988889999999999999999997 9999988777666555433 2233322 34
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
.+.+|+.+||. ||.+||++.++++.|.++
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 239 EVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 68899999999 999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.69 Aligned_cols=247 Identities=25% Similarity=0.316 Sum_probs=202.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
.|++.+.||+|+||.||++.+ .++.||+|.+....... .....+.+|+.+++.++|+||+.+++.+.+.+.++++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367788999999999999987 57899999986554332 234567889999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+++++|.+++... ....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TI 158 (285)
T ss_pred ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-cc
Confidence 99999999888532 23468999999999999999999999999999999999999999999999999987654322 22
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCC--CCCCCChHHHHHHHH
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---RVVYAVANEGS--RLEIPEGPLGRLIAD 756 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~---evl~~i~~~~~--~~~ip~~~L~~LI~~ 756 (782)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ........... .+......+.+|+..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM 238 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHH
Confidence 3457899999999999989999999999999999999999999865422 22222211111 111123468999999
Q ss_pred hhh-CCCCCCC-----HHHHHHH
Q 003971 757 CWA-EPQERPS-----CEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPS-----a~EIL~~ 773 (782)
||+ ||.+||+ +.+++++
T Consensus 239 ~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 239 LLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HhhcCHHHccCCCCCchHHHHcC
Confidence 999 9999999 8899875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=337.01 Aligned_cols=246 Identities=25% Similarity=0.387 Sum_probs=220.5
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
=|.+.+.||+|.|+.|-++.+ .|..||||++.+..++.-....+.+|+..|+.++|||||+||++......+|+|+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 467778999999999999965 899999999998888777777899999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc-CCCeEEEEecCccccccCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd-~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
-++|+|++++-+ ....+.+..+.+|+.||+.|+.|||+..+|||||||+||.+. +.|-|||+|||++..+... ...
T Consensus 99 GD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL 175 (864)
T KOG4717|consen 99 GDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKL 175 (864)
T ss_pred cCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc-chh
Confidence 999999999863 456799999999999999999999999999999999999875 5689999999999877543 456
Q ss_pred CCCCCCCcccCccccccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHHhhh
Q 003971 682 SSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIADCWA 759 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-p~~~L~~LI~~CL~ 759 (782)
.+.||++.|.|||++.+..|+ +++||||||||||.|++|+.||...+..+.+..+....+..+- ...+.++||..||.
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLv 255 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLV 255 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHh
Confidence 789999999999999998886 5789999999999999999999999999999988887765543 24568999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003971 760 -EPQERPSCEEILSR 773 (782)
Q Consensus 760 -DP~kRPSa~EIL~~ 773 (782)
||.+|.+.++|...
T Consensus 256 RdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 256 RDPKKRASLEEIVST 270 (864)
T ss_pred cCchhhccHHHHhcc
Confidence 99999999999864
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=305.82 Aligned_cols=245 Identities=29% Similarity=0.438 Sum_probs=209.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|.+.+.||.|++|.||++.+ +++.|+||++...... .....+.+|+..+..++|+||+++++++.....+++++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 3688999999999999999987 4889999998665432 446789999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
|+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999863 3678999999999999999999999 99999999999999999999999999999877544333
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCCCC----ChHHHHH
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL---PERVVYAVANEGSRLEIP----EGPLGRL 753 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~---~~evl~~i~~~~~~~~ip----~~~L~~L 753 (782)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..+....+. .......+ +..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHH
Confidence 335568889999999998889999999999999999999999997773 333443333 23333333 2369999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. +|.+||++.+++++
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHccCChhhCCCHHHHHhC
Confidence 999999 99999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=314.02 Aligned_cols=244 Identities=34% Similarity=0.582 Sum_probs=207.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
..|+..+.||.|+||.||+|.+ .+..||+|++..... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 3577788999999999999986 578999999865432 3345789999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+++++|.+++. ...+++.++..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 999999999885 2357889999999999999999999999999999999999999999999999998765443333
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 758 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL 758 (782)
....++..|+|||.+.+..++.++|+|||||++|+|++|+.||....+......+.. ...+.++ +..+.+++.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK-NNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc-CCCCCCchhhhHHHHHHHHHHc
Confidence 345688899999999888899999999999999999999999988777665554432 2223322 235889999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003971 759 A-EPQERPSCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRPSa~EIL~~ 773 (782)
. +|.+||++.+++++
T Consensus 238 ~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 238 NKDPSFRPTAKELLKH 253 (277)
T ss_pred ccCcccCcCHHHHHhC
Confidence 9 99999999999877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.06 Aligned_cols=243 Identities=33% Similarity=0.580 Sum_probs=205.5
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
.|+..+.||+|+||.||+|.+ .++.||+|.+..... ....+.+.+|+.+++.++||||+++++++..+...++|+||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 466678899999999999976 577899999864433 23457889999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+++++|.+++. ...+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++..+........
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 99999998875 24688999999999999999999999999999999999999999999999999987654333333
Q ss_pred CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003971 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 759 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~ 759 (782)
...++..|+|||.+.+..++.++|+|||||++|+|++|+.||....+......+.. .....++ ...+.+++.+||.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK-NSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc-CCCCCCCcccCHHHHHHHHHHcc
Confidence 45688899999999988899999999999999999999999987766555544332 2222222 3468999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003971 760 -EPQERPSCEEILSR 773 (782)
Q Consensus 760 -DP~kRPSa~EIL~~ 773 (782)
+|.+||++.+++++
T Consensus 239 ~~p~~Rp~~~~il~~ 253 (277)
T cd06642 239 KDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCcCHHHHHHh
Confidence 99999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=360.58 Aligned_cols=256 Identities=25% Similarity=0.423 Sum_probs=210.1
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC--
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-- 592 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-- 592 (782)
........+|.++++||.|+||+||++.+ .+..+|+|++............|..|+.+++.++|||||+++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 34455678999999999999999999987 56789999987766666667889999999999999999999998854
Q ss_pred CCceEEEEEEecccchhhHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhc-------cccccCCCcccEEEcC-----
Q 003971 593 PPRLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRM-------KIVHRDLKSANCLVNK----- 659 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~-------gIIHrDIKPeNILLd~----- 659 (782)
...+|+||||+++|+|.+++... .....+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 45689999999999999988642 2235799999999999999999999985 4999999999999964
Q ss_pred ------------CCeEEEEecCccccccCCCCCCCCCCCCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 003971 660 ------------HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWE 725 (782)
Q Consensus 660 ------------~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTGk~PF~ 725 (782)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||+|+||..||.
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 2358999999998764432 2235679999999999854 458899999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCCC--ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 726 GVLPERVVYAVANEGSRLEIP--EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 726 ~~~~~evl~~i~~~~~~~~ip--~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.......+...+......+++ ...+.+||..||. +|.+||++.++|.+
T Consensus 245 ~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 245 KANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred cCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 766555444444443333332 3469999999999 99999999999954
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=323.30 Aligned_cols=245 Identities=20% Similarity=0.317 Sum_probs=196.5
Q ss_pred EeeEEeee--CcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEe
Q 003971 528 VGTRVGIG--FFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 603 (782)
Q Consensus 528 i~~~LG~G--~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 603 (782)
++++||+| +|++||++.. +|+.||+|++..........+.+.+|+.+++.++||||++++++|..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999976 6889999998765544455567788999999999999999999999999999999999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC----
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM---- 679 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~---- 679 (782)
++|+|.+++... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999988632 234589999999999999999999999999999999999999999999999987654322111
Q ss_pred ---CCCCCCCCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 003971 680 ---RDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---------- 744 (782)
Q Consensus 680 ---~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~---------- 744 (782)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 1122356778999999876 4689999999999999999999999987655444333322110000
Q ss_pred ----------------------------------C---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 ----------------------------------I---PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 ----------------------------------i---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. -+..+.+|+.+||+ ||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 01247789999999 99999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=308.48 Aligned_cols=234 Identities=27% Similarity=0.511 Sum_probs=191.3
Q ss_pred eEEeeeCcEEEEEEEECCe------------EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 530 TRVGIGFFGEVFRGIWNGT------------DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~g~------------~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
+.||+|+||.||+|.+.+. .+++|++...... ...|.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 3689999999999987432 3777876543221 5788899999999999999999999888 7789
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC-------eEEEEecCc
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-------TVKICDFGL 670 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g-------~VKLaDFGL 670 (782)
+++||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 77 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 77 MVEEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999998732 22688999999999999999999999999999999999999887 899999999
Q ss_pred cccccCCCCCCCCCCCCCcccCccccccC--CCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 003971 671 SRIITDSPMRDSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP- 746 (782)
Q Consensus 671 A~~l~~~~~~~~~~~GT~~Y~APEvl~~~--~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip- 746 (782)
+..... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||............. .......+
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~ 229 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPD 229 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCC
Confidence 987543 2234567789999999876 78999999999999999999 577887765444333322 22222222
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003971 747 EGPLGRLIADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 747 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 774 (782)
...+.+++.+||. +|.+||++.++++.|
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 3578999999999 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.92 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=200.3
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
+++.+++.....||+|+||.||+|.+ ++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 44555666667899999999999976 46789999876443 334568899999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccc--hHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC-CCeEEEEecCccccc
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKL--SWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRII 674 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~L--s~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~-~g~VKLaDFGLA~~l 674 (782)
+++||+++++|.+++.... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999886322 334 78888999999999999999999999999999999976 679999999998766
Q ss_pred cCCCCCCCCCCCCCcccCccccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCC---Ch
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVANEGSRLEIP---EG 748 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~--~s~ksDVWSLGvILyELLTGk~PF~~~~~~e-vl~~i~~~~~~~~ip---~~ 748 (782)
...........|++.|+|||.+.... ++.++|+||||+++|+|++|+.||....... ...........+.++ ..
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA 239 (268)
T ss_pred ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence 43322333456889999999986543 7889999999999999999999997654322 222221112222333 34
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+.+++.+||. +|.+||++.+++.+
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 68899999999 99999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=312.35 Aligned_cols=236 Identities=22% Similarity=0.435 Sum_probs=190.3
Q ss_pred eEEeeeCcEEEEEEEEC--------------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 530 TRVGIGFFGEVFRGIWN--------------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~--------------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
+.||+|+||.||+|... ...+++|++.... ......|..|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 36899999999999742 2258888865432 2334678889999999999999999999999889
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe-------EEEEec
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT-------VKICDF 668 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~-------VKLaDF 668 (782)
.+++|||+++++|..++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CEEEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999888763 2356899999999999999999999999999999999999986654 899999
Q ss_pred CccccccCCCCCCCCCCCCCcccCccccc-cCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003971 669 GLSRIITDSPMRDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELC-TLNRPWEGVLPERVVYAVANEGSRLEIP 746 (782)
Q Consensus 669 GLA~~l~~~~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELL-TGk~PF~~~~~~evl~~i~~~~~~~~ip 746 (782)
|++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+... ..........+
T Consensus 157 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~ 231 (262)
T cd05077 157 GIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVTP 231 (262)
T ss_pred CCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCCCC
Confidence 998765322 2456788999999886 466899999999999999998 5888887765444332 22222222222
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003971 747 -EGPLGRLIADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 747 -~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 774 (782)
...+.+|+.+||+ ||.+||++.+|+++|
T Consensus 232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 232 SCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 2468899999999 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.99 Aligned_cols=254 Identities=29% Similarity=0.460 Sum_probs=206.3
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCC
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKP 593 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~ 593 (782)
..+....++|.+.+.||+|+||.||++.. .++.+|+|++..... ....+.+|+.+++++ +||||+++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 44444568899999999999999999977 578899999854322 235677899999999 799999999998653
Q ss_pred -----CceEEEEEEecccchhhHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEe
Q 003971 594 -----PRLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICD 667 (782)
Q Consensus 594 -----~~l~LV~Ey~~gGsL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaD 667 (782)
..+++++||+++++|.++++.. .....+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence 3589999999999999988632 2345789999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCCCCCCCCCCcccCccccccC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 003971 668 FGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-----PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 742 (782)
Q Consensus 668 FGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-----~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~ 742 (782)
||++..............|+..|+|||.+... .++.++|||||||++|+|++|+.||........+..+......
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 251 (291)
T cd06639 172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP 251 (291)
T ss_pred cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence 99998765433333455788999999998643 3678999999999999999999999887766555554432211
Q ss_pred -CCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 -LEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 -~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+ ...+.+++.+||+ +|++||++.+++++
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1112 2358899999999 99999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=304.52 Aligned_cols=246 Identities=37% Similarity=0.694 Sum_probs=205.6
Q ss_pred eeEeeEEeeeCcEEEEEEEECC------eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 526 LTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~~g------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
+++.+.||.|+||.||++.+.. ..+|+|++..... ....+.+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567899999999999998743 7899999854432 22467899999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+++++|.+++.... ...+++.++..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 80 MEYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EeccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999986322 12289999999999999999999999999999999999999999999999999987654422
Q ss_pred CCC-CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003971 680 RDS-SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 754 (782)
Q Consensus 680 ~~~-~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI 754 (782)
... ...+++.|+|||.+.+..++.++|||||||++|+|++ |+.||...........+.... ....+ +..+.+++
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i 237 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLPKPENCPPEIYKLM 237 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCcCCHHHHHHH
Confidence 211 2346789999999988889999999999999999998 788998877777666655433 32222 34688999
Q ss_pred HHhhh-CCCCCCCHHHHHHHH
Q 003971 755 ADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~L 774 (782)
.+||. ||.+|||+.++++.|
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 238 LQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHCcCChhhCcCHHHHHhhC
Confidence 99999 999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=308.45 Aligned_cols=251 Identities=28% Similarity=0.527 Sum_probs=205.2
Q ss_pred eeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC------
Q 003971 526 LTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 594 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------ 594 (782)
|.+.+.||+|+||.||+|.+ ++..+|||++..+.......+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 56788999999999999975 3578999999766555566788999999999999999999999875432
Q ss_pred ceEEEEEEecccchhhHHHhhc---ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 595 RLSMITEYMELGSLYHLIHLSG---QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~---~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
..+++++|+.+|+|.+++.... ....+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 2478899999999988764321 1235788999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003971 672 RIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP-- 746 (782)
Q Consensus 672 ~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip-- 746 (782)
+....... ......+++.|++||.+.+..++.++|||||||++|+|++ |+.||.+.........+.... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 239 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQPPD 239 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCCCCCC
Confidence 87643221 1123345678999999998889999999999999999999 889998877766555554332 22222
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 747 -EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 747 -~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
...+.+++.+||. +|.+||++.++++.|+++
T Consensus 240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2468999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=311.61 Aligned_cols=248 Identities=29% Similarity=0.469 Sum_probs=202.2
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccC------
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK------ 592 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d------ 592 (782)
....|++.+.||.|+||.||+|.+ .++.+|+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 446788999999999999999987 57889999975432 2345688899999998 69999999999853
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
...++++|||+++|+|.+++... ....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 45689999999999999988632 34468888999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-- 745 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-- 745 (782)
.............|++.|+|||.+. ...++.++|||||||++|+|++|..||....+......+.........
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 249 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK 249 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence 6543322334567899999999875 346788999999999999999999999877665555443332221111
Q ss_pred -CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 -PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 -p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
-+..+.+++.+||. ||.+||++.+|+++
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 13468999999999 99999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=313.83 Aligned_cols=246 Identities=23% Similarity=0.274 Sum_probs=201.8
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC---hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT---AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~---~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
+|.+.+.||+|+||.||+|.+ +++.||||.+...... ......+..|+.+++.++|+||+++++++.+.+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999987 5789999998765443 22345677899999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+ +++|.+++... ...+++..++.++.||++||.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999 88999988632 23789999999999999999999999999999999999999999999999999987755433
Q ss_pred CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 003971 680 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------------- 743 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~--------------- 743 (782)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 3334457788999998854 467899999999999999999988887766555444433211000
Q ss_pred ------CC--------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ------EI--------PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ------~i--------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.. -...+.+++.+||. ||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 02357789999999 99999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=317.33 Aligned_cols=240 Identities=26% Similarity=0.400 Sum_probs=184.7
Q ss_pred eeEEeeeCcEEEEEEEE----CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC--CCceEEEEEE
Q 003971 529 GTRVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRLSMITEY 602 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~l~LV~Ey 602 (782)
+++||+|+||+||+|.+ .++.||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+++++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 46899999999999975 356899999865432 2456789999999999999999998854 4568899999
Q ss_pred ecccchhhHHHhhc------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE----cCCCeEEEEecCccc
Q 003971 603 MELGSLYHLIHLSG------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSR 672 (782)
Q Consensus 603 ~~gGsL~dlL~~~~------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL----d~~g~VKLaDFGLA~ 672 (782)
+.+ +|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||++.
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 875 7777764321 12358999999999999999999999999999999999999 456799999999998
Q ss_pred cccCCCC---CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHhc
Q 003971 673 IITDSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---------RVVYAVANE 739 (782)
Q Consensus 673 ~l~~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~---------evl~~i~~~ 739 (782)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 7643221 1234678999999999876 45899999999999999999999999643221 111111110
Q ss_pred CCC---------------------------------------CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 740 GSR---------------------------------------LEIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 740 ~~~---------------------------------------~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
... ...++..+.+|+.+||+ ||.+|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 00112346789999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=353.31 Aligned_cols=257 Identities=27% Similarity=0.476 Sum_probs=212.2
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE-CC-eEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccc-cC
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-NG-TDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGAC-TK 592 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g-~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~-~d 592 (782)
..+.+...+++|.+.|.+|||+.||++.. .+ ..||+|++... ++.....+.+||++|+.|+ |+|||.+++.. ..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 44667778899999999999999999987 34 89999998755 5677889999999999997 99999999932 11
Q ss_pred ---C---CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--ccccCCCcccEEEcCCCeEE
Q 003971 593 ---P---PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVK 664 (782)
Q Consensus 593 ---~---~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g--IIHrDIKPeNILLd~~g~VK 664 (782)
+ ..++|+||||.||.|-+++...... .|++.++++|++++++|+++||... |||||||.+||||+.+|+.|
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 1 2478999999999999999754433 4999999999999999999999987 99999999999999999999
Q ss_pred EEecCccccccCCCCCC---------CCCCCCCcccCcccc---ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 003971 665 ICDFGLSRIITDSPMRD---------SSSAGTPEWMAPELI---RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV 732 (782)
Q Consensus 665 LaDFGLA~~l~~~~~~~---------~~~~GT~~Y~APEvl---~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~ev 732 (782)
|||||.+.......... -....|+.|+|||++ .+.+.++|+|||+|||+||-||....||.+.....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la- 265 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA- 265 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-
Confidence 99999997654332111 123478999999976 57789999999999999999999999998864432
Q ss_pred HHHHHhcCCCCCC-CC--hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 733 VYAVANEGSRLEI-PE--GPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 733 l~~i~~~~~~~~i-p~--~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
|++..+..+. |. ..+.+||..||+ ||.+||++.+++.++-.+...
T Consensus 266 ---Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 266 ---ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ---EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 3444444433 32 369999999999 999999999999998877543
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=308.79 Aligned_cols=246 Identities=28% Similarity=0.471 Sum_probs=203.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC--------hHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT--------AENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~--------~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
+|.+.+.||.|+||.||+|.. +++.+|+|.+...... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999976 6889999987542211 112457888999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
..++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999998863 357899999999999999999999999999999999999999999999999999765
Q ss_pred cCCC--CCCCCCCCCCcccCccccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----
Q 003971 675 TDSP--MRDSSSAGTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---- 746 (782)
Q Consensus 675 ~~~~--~~~~~~~GT~~Y~APEvl~~~~--~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---- 746 (782)
.... .......|+..|+|||.+.... ++.++|+||||+++|+|++|..||...........+........++
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 4321 1123456888999999987654 7889999999999999999999998766555444443333233222
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 ---EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+.+++.+||. +|.+||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 2368899999999 99999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.54 Aligned_cols=251 Identities=24% Similarity=0.433 Sum_probs=209.3
Q ss_pred CeeEeeEEeeeCcEEEEEEEEC---CeEEEEEEeeccc--------cChHHHHHHHHHHHHHHh-CCCCceeeEeccccC
Q 003971 525 ELTVGTRVGIGFFGEVFRGIWN---GTDVAIKVFLEQD--------LTAENMEDFCNEISILSR-LRHPNVILFLGACTK 592 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~~---g~~VAVKil~~~~--------~~~~~~e~f~~EI~iLk~-L~HPNIVkL~g~~~d 592 (782)
.|++.+.||+|+||.||+|.+. ++.+|+|.+.... .......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778899999999999999874 4789999875432 122345667889988865 799999999999999
Q ss_pred CCceEEEEEEecccchhhHHHhh-cccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGL 670 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGL 670 (782)
++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999999887532 234568999999999999999999996 7899999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---CC
Q 003971 671 SRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI---PE 747 (782)
Q Consensus 671 A~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i---p~ 747 (782)
+....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+......+.. ..
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 161 AKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred eeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 98765443 334567889999999999888999999999999999999999999887776666655544333221 23
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 748 GPLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 748 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
..+.+++.+||. ||.+||++.++..++.+
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 469999999999 99999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.62 Aligned_cols=242 Identities=29% Similarity=0.591 Sum_probs=202.5
Q ss_pred eEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccch
Q 003971 530 TRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 608 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL 608 (782)
++||.|+||.||++.++ ++.||+|.+...... ...+.+.+|++++++++|+||+++++++.+....++++||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 36899999999999774 889999988655433 4457899999999999999999999999999999999999999999
Q ss_pred hhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC--CCCCC
Q 003971 609 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAG 686 (782)
Q Consensus 609 ~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~--~~~~G 686 (782)
.+++.. ....+++..+..++.+++.||.|||+++++||||||+||+++.++.++|+|||++.......... ....+
T Consensus 80 ~~~l~~--~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 998863 23467899999999999999999999999999999999999999999999999998654321111 12233
Q ss_pred CCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CC
Q 003971 687 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EP 761 (782)
Q Consensus 687 T~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP 761 (782)
+..|+|||.+.+..++.++|+|||||++|+|+| |..||...........+.. ......+ +..+.+++.+||. +|
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999988889999999999999999999 7889988877665555443 2233233 3468999999999 99
Q ss_pred CCCCCHHHHHHHHH
Q 003971 762 QERPSCEEILSRLL 775 (782)
Q Consensus 762 ~kRPSa~EIL~~L~ 775 (782)
.+||++.++++.|.
T Consensus 237 ~~Rp~~~ell~~l~ 250 (251)
T cd05041 237 ENRPSFSEIYNELQ 250 (251)
T ss_pred hhCcCHHHHHHHhh
Confidence 99999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.61 Aligned_cols=249 Identities=25% Similarity=0.349 Sum_probs=205.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|.+.+.||+|+||.||++.+ .++.|++|.+...... ....+.+.+|+.+++.++||||+++++.+..+..++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3688999999999999999987 4678999998765432 233567889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC--
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 678 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~-- 678 (782)
||+++++|.+++. ....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999999986 33568999999999999999999999999999999999999999999999999986421100
Q ss_pred -------------CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 003971 679 -------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI 745 (782)
Q Consensus 679 -------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i 745 (782)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+..+.+............+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 0112345788999999998888999999999999999999999999988877777666544322211
Q ss_pred ----CChHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003971 746 ----PEGPLGRLIADCWA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 746 ----p~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~ 775 (782)
.+..+.+++.+||. ||.+||++.++++.|+
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 13458999999999 9999998544444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=298.69 Aligned_cols=246 Identities=35% Similarity=0.578 Sum_probs=209.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC--CceEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLSMIT 600 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l~LV~ 600 (782)
+|++.+.||+|++|.||+|... ++.+++|++..........+.+.+|+.++++++|+||+++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999874 88999999876655455678899999999999999999999999888 8899999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 679 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~- 679 (782)
||+++++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999873 33889999999999999999999999999999999999999999999999999987755432
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003971 680 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIP---EGPLGRLI 754 (782)
Q Consensus 680 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~-~~evl~~i~~~~~~~~ip---~~~L~~LI 754 (782)
......++..|+|||.+....++.++||||||+++|+|++|..||.... .......+........++ ...+.+++
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 1335678889999999988889999999999999999999999998765 333333333223333333 34699999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003971 755 ADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+|+. ||.+||++.+++.+
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHhCcCChhhCCCHHHHhhC
Confidence 99999 99999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.52 Aligned_cols=249 Identities=21% Similarity=0.272 Sum_probs=199.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCc-----
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPR----- 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~----- 595 (782)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688999999999999999987 5889999987654433333467889999999995 6999999999877655
Q ss_pred eEEEEEEecccchhhHHHhhcc--cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC-CCeEEEEecCccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQ--KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSR 672 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~--~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~-~g~VKLaDFGLA~ 672 (782)
.|++|||+++ +|..++..... ...+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999986 78777753322 346899999999999999999999999999999999999998 8899999999998
Q ss_pred cccCCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-------- 743 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-------- 743 (782)
.+...........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+......+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 66433222234467889999998865 457899999999999999999999998876665554433211000
Q ss_pred ---------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ---------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ---------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.-...+.++|.+||. ||.+||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0012358889999999 99999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=309.41 Aligned_cols=252 Identities=31% Similarity=0.543 Sum_probs=204.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC--CC
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PP 594 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~ 594 (782)
...|++.+.||+|+||.||++.++ ++.+|||++...... ...+.|.+|+++++.++|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 356888899999999999999753 678999998755443 346789999999999999999999999877 55
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
..++++||+++++|.+++... ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 789999999999999998632 336899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC---CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHHHH
Q 003971 675 TDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER--------------VVYAVA 737 (782)
Q Consensus 675 ~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~e--------------vl~~i~ 737 (782)
...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||....... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 532111 112344567999999988889999999999999999999999986543221 112222
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 738 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 738 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
........+ +..+.+|+.+||. +|.+||++.+|++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 222222222 2468899999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=307.92 Aligned_cols=244 Identities=33% Similarity=0.605 Sum_probs=201.0
Q ss_pred EEeeeCcEEEEEEEECC--------eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 531 RVGIGFFGEVFRGIWNG--------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~~g--------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
.||+|+||.||+|.... ..+|+|.+.... .......+.+|+.+++.++||||+++++++......+++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999997632 578999875432 223456889999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhc----ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC-----eEEEEecCcccc
Q 003971 603 MELGSLYHLIHLSG----QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-----TVKICDFGLSRI 673 (782)
Q Consensus 603 ~~gGsL~dlL~~~~----~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g-----~VKLaDFGLA~~ 673 (782)
+++++|.+++.... ....+++.+++.++.|++.||+|||+.+++|+||||+||+++.++ .++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 99999999886432 223578899999999999999999999999999999999999877 899999999976
Q ss_pred ccCCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003971 674 ITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 747 (782)
Q Consensus 674 l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~ 747 (782)
....... .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||......+....+... .....+ +
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GRLQKPENCP 239 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-CccCCcccch
Confidence 5432211 123345678999999999889999999999999999998 99999887776665554432 222222 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 748 GPLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 748 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
..+.+++.+||. +|.+||++.++++.|++
T Consensus 240 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 240 DKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 468899999999 99999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=308.59 Aligned_cols=242 Identities=24% Similarity=0.343 Sum_probs=204.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
+|++.+.||.|+||.||++.+ .++.||+|++...... ....+.+.+|++++++++||||+++++++.....+++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 488999999999999999987 4889999998765432 2456789999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+.+++|..++.. ...+++..+..++.|+++||.|||++|++|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 9999999998863 3578999999999999999999999999999999999999999999999999988765432 22
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP---ERVVYAVANEGSRLEIP---EGPLGRLIA 755 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~---~evl~~i~~~~~~~~ip---~~~L~~LI~ 755 (782)
....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........ . .....+ +..+.+++.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE-T-ADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-c-ccccCcccCcHHHHHHHH
Confidence 345688899999999988899999999999999999999999987763 33332222 1 222222 346899999
Q ss_pred Hhhh-CCCCCCCH--HHHHH
Q 003971 756 DCWA-EPQERPSC--EEILS 772 (782)
Q Consensus 756 ~CL~-DP~kRPSa--~EIL~ 772 (782)
+||. ||.+||++ .++++
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHccCChhHcCCccHHHHhc
Confidence 9999 99999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=300.03 Aligned_cols=245 Identities=31% Similarity=0.568 Sum_probs=211.6
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|++.+.||+|++|.||++.+ .++.|++|.+..........+.+.+|++++++++|+|++++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 578899999999999999976 577899999987766556678899999999999999999999999998999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+++++|.+++.. ...+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 999999998863 35789999999999999999999999999999999999999999999999999987765433334
Q ss_pred CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003971 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 759 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~ 759 (782)
...++..|+|||.+.+..++.++|||+||+++|+|++|+.||................ ...++ ...+.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-CCCCCCCCCHHHHHHHHHHHh
Confidence 4578899999999988888999999999999999999999998877655555544322 22232 3468999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003971 760 -EPQERPSCEEILSR 773 (782)
Q Consensus 760 -DP~kRPSa~EIL~~ 773 (782)
+|++||++.+++.+
T Consensus 237 ~~p~~R~~~~~~l~~ 251 (254)
T cd06627 237 KDPNLRPTAKQLLKH 251 (254)
T ss_pred CChhhCcCHHHHhcC
Confidence 99999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=314.17 Aligned_cols=247 Identities=26% Similarity=0.420 Sum_probs=205.3
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
++.++|++.+.||+|+||+||++.+ .++.||+|++..... ....+.+.+|+++++.++||||+++++++.....+++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3457899999999999999999987 488999998865432 3345788999999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
|+||+++++|.+++. ..+.+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 81 CMEFMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEecCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999998886 34568999999999999999999997 58999999999999999999999999998765332
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHhcCCCCCCC
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-----------RVVYAVANEGSRLEIP 746 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~-----------evl~~i~~~~~~~~ip 746 (782)
......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...... .....+... ..+.++
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 234 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRLP 234 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCCCC
Confidence 123457899999999998888999999999999999999999999865442 222222221 122222
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003971 747 ----EGPLGRLIADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 747 ----~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 774 (782)
+..+.+|+.+||. ||.+||++.+++++.
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 2358899999999 999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=305.49 Aligned_cols=247 Identities=29% Similarity=0.485 Sum_probs=207.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccc---cChHHHHHHHHHHHHHHhCCCCceeeEeccccCC--Cce
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD---LTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRL 596 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~---~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l 596 (782)
.+|.+.+.||+|+||.||++.+ ++..||+|++.... ........+.+|++++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5789999999999999999976 58899999875432 2234457889999999999999999999998664 458
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++++||+++++|.+++. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 89999999999999886 234588999999999999999999999999999999999999999999999999986532
Q ss_pred CC---CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hHH
Q 003971 677 SP---MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPL 750 (782)
Q Consensus 677 ~~---~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~---~~L 750 (782)
.. .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+......+.+|. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 11 112235688999999999988889999999999999999999999988776666665554444444443 469
Q ss_pred HHHHHHhhhCCCCCCCHHHHHHH
Q 003971 751 GRLIADCWAEPQERPSCEEILSR 773 (782)
Q Consensus 751 ~~LI~~CL~DP~kRPSa~EIL~~ 773 (782)
.+++.+||.+|.+||++.+++.|
T Consensus 239 ~~~i~~~l~~~~~r~~~~~~~~~ 261 (264)
T cd06653 239 RDFLKQIFVEEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHhcCcccCccHHHHhcC
Confidence 99999999988999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.99 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=202.5
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|++.++||.|++|.||+|.+ +|+.||||++...... ...+.+.+|+.+++.++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 588999999999999999987 5889999998655432 2346677899999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+++ +|.+++........+++..+..++.|++.||+|||+.|++|+||||+||++++++.++|+|||++...........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 985 7887776444345789999999999999999999999999999999999999999999999999976644322333
Q ss_pred CCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------C-
Q 003971 683 SSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------------E- 744 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~----------------~- 744 (782)
...+++.|++||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+......+ .
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 45678899999988654 57889999999999999999999998777665554443211000 0
Q ss_pred -------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 -------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 -------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.....+.+++..|++ ||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 012346789999999 99999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.33 Aligned_cols=252 Identities=31% Similarity=0.592 Sum_probs=205.5
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCe----EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
...+|+..+.||+|+||.||+|.+ ++. .+|+|.+..... ......+.+|+.+++.++||||++++++|... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 346788899999999999999976 343 578888754332 33345788999999999999999999998764 4
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.++++||+++|+|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred ceeeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 6799999999999998863 23468899999999999999999999999999999999999999999999999998764
Q ss_pred CCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003971 676 DSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 749 (782)
Q Consensus 676 ~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~ 749 (782)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+......... ...+.....+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 239 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-LEKGERLPQPPICTID 239 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHCCCCCCCCCCCCHH
Confidence 3221 1223345678999999998889999999999999999997 8999988766554443 3334333332 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
+.+++..||. +|++||++.++++.|..+.
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 8899999999 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.36 Aligned_cols=251 Identities=29% Similarity=0.499 Sum_probs=201.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC--Cc
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PR 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~ 595 (782)
.-|++.+.||+|+||.||++.+ .+..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3478889999999999999864 36789999986443 234457899999999999999999999998775 56
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.+++|||+++++|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 89999999999999988632 3468999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC---CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------------hHHHHHHHHh
Q 003971 676 DSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--------------PERVVYAVAN 738 (782)
Q Consensus 676 ~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~--------------~~evl~~i~~ 738 (782)
.... ......++..|+|||.+.+..++.++|||||||++|+|+++..|+.... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 3221 1123456778999999988889999999999999999999876542211 1111111222
Q ss_pred cCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 739 EGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 739 ~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
.+...+.+ ...+.+|+.+||+ ||.+||++.++++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 23333333 2468999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.80 Aligned_cols=247 Identities=22% Similarity=0.316 Sum_probs=197.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|.+.+.||.|+||.||+|.. +++.||||.+...... .....+.+|+++++.++|+||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 47899999999999999999976 5789999998654322 12345678999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+.+ +|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.........
T Consensus 83 e~~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 99985 888877632 346889999999999999999999999999999999999999999999999998765332222
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCC----------------
Q 003971 681 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSR---------------- 742 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~-~~evl~~i~~~~~~---------------- 742 (782)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.. ..+....+......
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 233456889999998865 458899999999999999999999997665 22222222110000
Q ss_pred ----------------CCCC-ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 ----------------LEIP-EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 ----------------~~ip-~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..+. ...+.+++.+|+. +|.+||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 1346789999999 99999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.76 Aligned_cols=236 Identities=22% Similarity=0.375 Sum_probs=189.6
Q ss_pred EEeeeCcEEEEEEEEC--------------------------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCcee
Q 003971 531 RVGIGFFGEVFRGIWN--------------------------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~~--------------------------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIV 584 (782)
+||+|+||.||+|... ...|++|++.... ......|.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 5999999999998631 1358888875432 23346788999999999999999
Q ss_pred eEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC---
Q 003971 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW--- 661 (782)
Q Consensus 585 kL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g--- 661 (782)
+++++|......++||||+++|+|..++.. ....+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999988863 345788999999999999999999999999999999999997543
Q ss_pred ----eEEEEecCccccccCCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHHH
Q 003971 662 ----TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELC-TLNRPWEGVLPERVVYA 735 (782)
Q Consensus 662 ----~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELL-TGk~PF~~~~~~evl~~ 735 (782)
.++|+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....+......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred CccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999998654321 23457788999998865 56899999999999999985 78999987766554332
Q ss_pred HHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003971 736 VANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 736 i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 774 (782)
.......+......+.+++.+||. +|.+||++.+|++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 234 YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 222111111122468999999999 999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=311.77 Aligned_cols=236 Identities=25% Similarity=0.432 Sum_probs=190.4
Q ss_pred EEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 531 RVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
.||.|+||.||+|.+. ...+|+|.+.... ....+.+..|+.+++.+.||||+++++++..+...++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 5899999999999763 2247888764332 2335678899999999999999999999999889999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe--------EEEEecCcccc
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--------VKICDFGLSRI 673 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~--------VKLaDFGLA~~ 673 (782)
|+++|+|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++|||++..
T Consensus 80 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 80 YVKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred cCCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999998632 346889999999999999999999999999999999999987664 69999999876
Q ss_pred ccCCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhcCCCCCCCChHHH
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPEGPLG 751 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk-~PF~~~~~~evl~~i~~~~~~~~ip~~~L~ 751 (782)
.... ....+++.|+|||++.+ ..++.++|||||||++|+|++|. .||..................+......+.
T Consensus 158 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd05078 158 VLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELA 233 (258)
T ss_pred cCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHH
Confidence 5332 23567889999999986 45789999999999999999995 677666555443322221111222235689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~L 774 (782)
+|+.+||+ ||.+|||+.+|++.|
T Consensus 234 ~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 234 NLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHhccChhhCCCHHHHHHhc
Confidence 99999999 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.85 Aligned_cols=246 Identities=28% Similarity=0.532 Sum_probs=202.6
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC----hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT----AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~----~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
+|+..+.||+|+||.||++.. +++.+|+|++...... ....+.+.+|+.+++.++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999976 6889999998644321 2235788999999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC-eEEEEecCccccccCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDS 677 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g-~VKLaDFGLA~~l~~~ 677 (782)
++||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999998863 35788999999999999999999999999999999999998775 6999999999876543
Q ss_pred CCC----CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCCCCC---C
Q 003971 678 PMR----DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---RVVYAVANEGSRLEIP---E 747 (782)
Q Consensus 678 ~~~----~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~---evl~~i~~~~~~~~ip---~ 747 (782)
... .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...... .....+.........+ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 211 12346788999999998888999999999999999999999999754332 2222222233333443 2
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 748 GPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 748 ~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..+.+++.+||. +|.+||++.+++++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 468899999998 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.29 Aligned_cols=244 Identities=24% Similarity=0.467 Sum_probs=193.6
Q ss_pred EEeeeCcEEEEEEEE-CCe---EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEeccc
Q 003971 531 RVGIGFFGEVFRGIW-NGT---DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~-~g~---~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
.||+|+||.||++.. ++. .+++|.+..... ....+.|.+|+.+++.++||||+++++.|.+....+++|||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 599999999999964 332 455666543322 334578999999999999999999999999999999999999999
Q ss_pred chhhHHHhhcc-cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC--CCCCC
Q 003971 607 SLYHLIHLSGQ-KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--MRDSS 683 (782)
Q Consensus 607 sL~dlL~~~~~-~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~--~~~~~ 683 (782)
+|.+++..... ...+++..++.++.||+.||+|||+.+++||||||+|||++.++.++|+|||++....... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 99998874322 2456777888999999999999999999999999999999999999999999986532211 12234
Q ss_pred CCCCCcccCcccccc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC----CCCC---Ch
Q 003971 684 SAGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR----LEIP---EG 748 (782)
Q Consensus 684 ~~GT~~Y~APEvl~~-------~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~----~~ip---~~ 748 (782)
..++..|+|||++.. ..++.++|||||||++|||++ |..||......+....+...... +.++ ..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 568889999998753 245789999999999999997 46789887777666665443321 1111 33
Q ss_pred HHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 003971 749 PLGRLIADCWAEPQERPSCEEILSRLL 775 (782)
Q Consensus 749 ~L~~LI~~CL~DP~kRPSa~EIL~~L~ 775 (782)
.+.+++..||.+|.+||++.+|++.|.
T Consensus 241 ~~~~l~~~c~~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 241 RWYEVLQFCWLSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHHhhCcccCCCHHHHHHHhc
Confidence 578899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=325.14 Aligned_cols=240 Identities=24% Similarity=0.336 Sum_probs=194.6
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
..+|.+.+.||.|+||.||++... +..||+|.+... ..+.+|+.+++.++||||+++++++.....+++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 357999999999999999999753 467899987532 234579999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
+||++. ++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 164 v~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999996 57777774 44678999999999999999999999999999999999999999999999999997664432
Q ss_pred CC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhc--------------
Q 003971 679 MR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---RVVYAVANE-------------- 739 (782)
Q Consensus 679 ~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~---evl~~i~~~-------------- 739 (782)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..+..+...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 21 23467999999999999999999999999999999999999999764321 111111110
Q ss_pred -----------CCCCC--CC--------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 740 -----------GSRLE--IP--------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 740 -----------~~~~~--ip--------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..+.. ++ ...+.++|.+||. ||.+||++.+++.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00110 11 1246789999999 99999999999976
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=296.76 Aligned_cols=243 Identities=32% Similarity=0.592 Sum_probs=207.6
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|.+.+.||.|++|.||++.+ ++..+++|++..... ...+.+.+|+.+++.++|+||+++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 578889999999999999987 488899999865443 3457889999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++........ ..
T Consensus 79 ~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 155 (253)
T cd05122 79 CSGGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN 155 (253)
T ss_pred CCCCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence 9999999988632 25789999999999999999999999999999999999999999999999999987654322 34
Q ss_pred CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHh
Q 003971 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADC 757 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~LI~~C 757 (782)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............. ......+ ...+.+++.+|
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHH
Confidence 55688899999999888899999999999999999999999988765555544433 2222222 34689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. ||.+||++.+++++
T Consensus 235 l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 235 LQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCChhhCCCHHHHhcC
Confidence 99 99999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.31 Aligned_cols=248 Identities=30% Similarity=0.547 Sum_probs=214.8
Q ss_pred CeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|.+.+.||.|+||.||++.+. +..+++|++..........+.+.+|+++++.++|+|++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999874 88999999977666556677899999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 603 MELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 603 ~~gGsL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
+++++|.+++.... ....+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 99999999886431 24678999999999999999999999999999999999999999999999999998765543233
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 758 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL 758 (782)
....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||................ ...++ ...+.+++.+||
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l 239 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPSQYSSELRNLVSSLL 239 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHc
Confidence 44578899999999988889999999999999999999999998887766666655432 33333 357999999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003971 759 A-EPQERPSCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRPSa~EIL~~ 773 (782)
. +|.+||++.+++++
T Consensus 240 ~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 240 QKDPEERPSIAQILQS 255 (258)
T ss_pred CCChhhCcCHHHHhcC
Confidence 9 99999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=300.88 Aligned_cols=246 Identities=31% Similarity=0.548 Sum_probs=211.9
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|++.+.||.|+||.||++.+ ++..+++|.+............+.+|+.+++.++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588899999999999999976 577899999876665555567888999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 603 MELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 603 ~~gGsL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
+++++|..++.... ....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~ 158 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MA 158 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--Cc
Confidence 99999998886422 2356899999999999999999999999999999999999999999999999999877554 22
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 758 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL 758 (782)
....+++.|++||.+.+..++.++|+||||+++|+|++|+.||......+....+... ....++ ...+.+++.+||
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG-KYPPIPPIYSQDLQNFIRSML 237 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCchhhCHHHHHHHHHHc
Confidence 3456889999999999988999999999999999999999999988876665555433 233332 245899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003971 759 A-EPQERPSCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRPSa~EIL~~ 773 (782)
. +|.+||++.+++++
T Consensus 238 ~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 238 QVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCcccCCCHHHHhcC
Confidence 8 99999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.99 Aligned_cols=247 Identities=24% Similarity=0.305 Sum_probs=195.7
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
..+|.+.+.||+|+||.||+|.. +++.||+|++...... .....+.+|+.+++.++|+||+++++++......++++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 46899999999999999999976 5889999998654322 22346778999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+. +++...+.. ....+++..+..++.||+.||+|||+.||+|+||||+|||++.++.++|+|||+++........
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 9996 566655542 2345788888999999999999999999999999999999999999999999999765443323
Q ss_pred CCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCC----------------C
Q 003971 681 DSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGS----------------R 742 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~-evl~~i~~~~~----------------~ 742 (782)
.....+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.... +.+........ .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 3445678999999998754 5788999999999999999999999765432 22111111000 0
Q ss_pred CC-----------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 LE-----------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 ~~-----------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.. .....+.+++.+|+. ||.+|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 012357889999999 99999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=307.61 Aligned_cols=243 Identities=34% Similarity=0.599 Sum_probs=206.6
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
-|++.+.||.|+||.||+|.+ +++.+|||++..... ....+.+.+|+.+++.++||||+++++++..+...++|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 366788999999999999976 578999998764433 23456788999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+++++|..++. ...+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++..+........
T Consensus 84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 99999998885 24688999999999999999999999999999999999999999999999999877654332333
Q ss_pred CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003971 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 759 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~ 759 (782)
...++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.. ...+.++ +..+.+++.+||.
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-CCCCCCCcccCHHHHHHHHHHcc
Confidence 45688899999999888889999999999999999999999988776665555433 2233222 3468999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003971 760 -EPQERPSCEEILSR 773 (782)
Q Consensus 760 -DP~kRPSa~EIL~~ 773 (782)
+|.+||++.+++++
T Consensus 239 ~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 239 KEPSFRPTAKELLKH 253 (277)
T ss_pred CChhhCcCHHHHHhC
Confidence 99999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.20 Aligned_cols=248 Identities=26% Similarity=0.329 Sum_probs=202.7
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC--CceEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLSM 598 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l~L 598 (782)
.++|++.+.||.|+||.||+|.+ +++.+|+|.+............+.+|+.+++.++||||+++++++... ...|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 45788999999999999999987 478899999876554443445678899999999999999999998776 78999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
++||+.+ +|.+++... ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 84 v~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999985 888887632 3468999999999999999999999999999999999999999999999999998775543
Q ss_pred CCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----------------
Q 003971 679 MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS---------------- 741 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~---------------- 741 (782)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+...-.
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 233345678899999998764 468899999999999999999999987766554443321100
Q ss_pred -------------CCCC----CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 -------------RLEI----PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 -------------~~~i----p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+ -...+.+++.+||+ ||++||++.|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0001 13357899999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.61 Aligned_cols=249 Identities=25% Similarity=0.314 Sum_probs=203.1
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC--CceE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLS 597 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l~ 597 (782)
..++|.+.+.||.|+||.||+|.+ +|+.||+|++............+.+|+.+++.++|+||+++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 457899999999999999999987 588999999865543333334567899999999999999999998654 4689
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+|+||+.+ +|.+++... ...+++.+++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 85 lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999975 777777532 356899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--------------
Q 003971 678 PMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-------------- 742 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~-------------- 742 (782)
........+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 222233456788999999865 55789999999999999999999999988877766655442110
Q ss_pred ---CC--------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 ---LE--------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 ---~~--------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.. .....+.++|.+|+. ||++||++.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 012346789999999 99999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=307.41 Aligned_cols=244 Identities=29% Similarity=0.451 Sum_probs=204.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|++.+.||.|+||.||++.+. ++.+|+|.+..... ....+.+.+|+++++.++||||+++++++.....+++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 35778889999999999999874 78899999876543 3445788999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
|+++++|.+++... ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 80 YMDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred ecCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 99999999998732 2678899999999999999999999 9999999999999999999999999999876643221
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcCCCCCCC----ChHHH
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV-----LPERVVYAVANEGSRLEIP----EGPLG 751 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~-----~~~evl~~i~~~~~~~~ip----~~~L~ 751 (782)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||... ........+.. ...+..+ ...+.
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPPPRLPSGKFSPDFQ 234 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-CCCCCCChhhcCHHHH
Confidence 1267888999999999889999999999999999999999999754 22233333322 2233332 33689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
++|.+||. ||.+||++.+++.+
T Consensus 235 ~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 235 DFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHcCCCchhCcCHHHHhhC
Confidence 99999999 99999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.48 Aligned_cols=246 Identities=28% Similarity=0.364 Sum_probs=204.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC-----CCce
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-----PPRL 596 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-----~~~l 596 (782)
..|...+.||.|+||.|+.+.+ +|+.||||.+...-...-..+...+|+.+|++++|+||+.+++++.. -+.+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4555578999999999999977 68899999986544455567889999999999999999999999865 2458
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
|+|+|+|+ .+|...++ .+..|+...+..+++||+.||.|+|+.+|+||||||.|+|++.+..+||+|||+|+....
T Consensus 102 YiV~elMe-tDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 102 YLVFELME-TDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EEehhHHh-hHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99999994 57888886 445699999999999999999999999999999999999999999999999999998753
Q ss_pred C--CCCCCCCCCCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------
Q 003971 677 S--PMRDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--------- 744 (782)
Q Consensus 677 ~--~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~--------- 744 (782)
. ....+..+-|.+|.|||++. ...|+...||||+|||+.||++|+.-|.+.+....+..+..--..+.
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2 12335678899999999875 46799999999999999999999999998877766665554222221
Q ss_pred ---------------CC--------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 ---------------IP--------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 ---------------ip--------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.| ....-+|+.+||. ||.+|+|++|.|+|
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11 1135578999999 99999999999987
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=308.37 Aligned_cols=246 Identities=22% Similarity=0.316 Sum_probs=200.3
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEe
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 603 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 603 (782)
|++.+.||.|++|.||+|.+ +|+.||+|++............+.+|+.+++.++||||+++++++.+.+..|+++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999976 6889999998765544444467889999999999999999999999999999999999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 683 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~ 683 (782)
. ++|.+++... ....+++..++.++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++............
T Consensus 81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 5 5888887632 2246899999999999999999999999999999999999999999999999999765433222233
Q ss_pred CCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------------
Q 003971 684 SAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------- 743 (782)
Q Consensus 684 ~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~------------------- 743 (782)
..+++.|+|||++.+. .++.++|||||||++|+|++|+.||...........+......+
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 4568899999987654 57889999999999999999999998776654444332211100
Q ss_pred -----------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 -----------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 -----------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
......+.+++.+||+ ||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0012357889999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.36 Aligned_cols=238 Identities=24% Similarity=0.406 Sum_probs=203.1
Q ss_pred EeeeCcEEEEEEEEC--CeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccch
Q 003971 532 VGIGFFGEVFRGIWN--GTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 608 (782)
Q Consensus 532 LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL 608 (782)
||.|+||.||++.+. ++.+|+|++...... ....+.+.+|+.+++.++||||+++++++.++..+++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999885 889999998765432 33457899999999999999999999999999999999999999999
Q ss_pred hhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003971 609 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 688 (782)
Q Consensus 609 ~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~ 688 (782)
.+++. ....+++..+..++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||++....... ......+++
T Consensus 81 ~~~l~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 156 (262)
T cd05572 81 WTILR---DRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP 156 (262)
T ss_pred HHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence 99986 33468999999999999999999999999999999999999999999999999998775432 223457889
Q ss_pred cccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCC
Q 003971 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--PERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQ 762 (782)
Q Consensus 689 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~--~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~ 762 (782)
.|++||.+.+..++.++|+||||+++|+|++|..||.... .......+.........| +..+.+++.+||. +|.
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999999988889999999999999999999999998776 555555555323333333 3579999999999 999
Q ss_pred CCCC-----HHHHHHH
Q 003971 763 ERPS-----CEEILSR 773 (782)
Q Consensus 763 kRPS-----a~EIL~~ 773 (782)
+||+ +.|++++
T Consensus 237 ~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 237 ERLGNLKGGIKDIKKH 252 (262)
T ss_pred hCcCCcccCHHHHhcC
Confidence 9999 8888874
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=315.52 Aligned_cols=247 Identities=26% Similarity=0.408 Sum_probs=213.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc------ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCC
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL------TAENMEDFCNEISILSRL-RHPNVILFLGACTKP 593 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~------~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~ 593 (782)
+..|...+.||.|..+.|.++.+ .|..+|+|++..... ..+-.+.-.+|+.+|+++ .||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 35666778899999999999866 578899998843321 122356677899999998 599999999999999
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
..+++|+|.|+.|.|+|++. ..-.++++..++|++|+++|++|||.++||||||||+|||++++.++||+|||+++.
T Consensus 96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999999999997 566899999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCCCCCcccCcccccc------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRN------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE 747 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~------~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~ 747 (782)
+... ......||||+|+|||.++. ..|+..+|+|++||++|.|+.|-.||....+.-++..+..+.+...-|.
T Consensus 173 l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 173 LEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred cCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 8654 34568899999999999864 3478899999999999999999999988777777777776666554442
Q ss_pred -----hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 748 -----GPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 748 -----~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...++||.+|++ ||.+|.|++|.|+|
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 358899999999 99999999999986
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=312.65 Aligned_cols=240 Identities=26% Similarity=0.416 Sum_probs=183.7
Q ss_pred eeEEeeeCcEEEEEEEEC----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc--CCCceEEEEEE
Q 003971 529 GTRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT--KPPRLSMITEY 602 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~--d~~~l~LV~Ey 602 (782)
+.+||+|+||+||+|... +..||+|.+..... ...+.+|+.+++.++||||+++++++. .+..+++++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 468999999999999863 46799998864432 245778999999999999999999884 35568999999
Q ss_pred ecccchhhHHHhhc------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE----cCCCeEEEEecCccc
Q 003971 603 MELGSLYHLIHLSG------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSR 672 (782)
Q Consensus 603 ~~gGsL~dlL~~~~------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL----d~~g~VKLaDFGLA~ 672 (782)
+.+ +|.+++.... ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 875 6766664211 12358899999999999999999999999999999999999 566799999999998
Q ss_pred cccCCCC---CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHhc
Q 003971 673 IITDSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---------RVVYAVANE 739 (782)
Q Consensus 673 ~l~~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~---------evl~~i~~~ 739 (782)
....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 7644321 1234568999999999876 45799999999999999999999999643211 000000000
Q ss_pred -C-----------------------C---------------CCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 740 -G-----------------------S---------------RLEIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 740 -~-----------------------~---------------~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+ . ....++..+.+|+.+|+. ||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 0 000112347789999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=316.34 Aligned_cols=242 Identities=24% Similarity=0.405 Sum_probs=203.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
.|.....||.|+||.||++.. ++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 344456799999999999976 57889999986433 23456788999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+++++|.+++. ...+++..++.++.||+.||+|||++||+||||||+||++++++.++|+|||++...........
T Consensus 101 ~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 101 LEGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 99999998874 23588999999999999999999999999999999999999999999999999876543322233
Q ss_pred CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHHHHHh
Q 003971 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRLIADC 757 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-----p~~~L~~LI~~C 757 (782)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+.... .... ....+.+++..|
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-PPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCccccccccCHHHHHHHHHH
Confidence 4568899999999988889999999999999999999999998877666555443321 1111 134688999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. ||.+||++.+++++
T Consensus 256 l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 256 LVREPSQRATAQELLQH 272 (292)
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99 99999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=307.42 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=200.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|++.+.||.|++|.||+|.+ +++.||+|.+............+.+|+.+++.++||||+++++++......++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5799999999999999999976 57889999986554444445678899999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC-CCeEEEEecCccccccCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~-~g~VKLaDFGLA~~l~~~~~~ 680 (782)
|+++ +|...+... ....+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++.........
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 9964 777666422 2334688889999999999999999999999999999999985 568999999999765433222
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------
Q 003971 681 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------------- 743 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~---------------- 743 (782)
.....+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||...........+......+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 334567889999998866 457899999999999999999999998776665555443211000
Q ss_pred --------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 --------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 --------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.-...+.+++.+|++ +|.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0012347889999999 99999999999975
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.43 Aligned_cols=246 Identities=27% Similarity=0.424 Sum_probs=196.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHH-HHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISI-LSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~i-Lk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|++.+.||+|+||.||++.+ +|+.||+|++........ ...+..|+.+ ++.++||||+++++++..++..|+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4789999999999999999987 588999999875543332 3455566665 66678999999999999999999999
Q ss_pred EEecccchhhHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhc-cccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 601 EYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~-gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
||++ |+|.+++... .....+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9997 5777776532 2345789999999999999999999997 99999999999999999999999999998764321
Q ss_pred CCCCCCCCCCcccCcccccc----CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCC----ChH
Q 003971 679 MRDSSSAGTPEWMAPELIRN----EPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIP----EGP 749 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~----~~~s~ksDVWSLGvILyELLTGk~PF~~~~-~~evl~~i~~~~~~~~ip----~~~ 749 (782)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.... ..+.+..... .....++ +..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (283)
T cd06617 159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAEKFSPE 236 (283)
T ss_pred -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCCCccccCHH
Confidence 2233568889999998864 456889999999999999999999997532 2233333332 2223222 246
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+++.+||. +|.+||++.+++++
T Consensus 237 l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 237 FQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 8899999999 99999999999974
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=341.16 Aligned_cols=244 Identities=27% Similarity=0.494 Sum_probs=210.8
Q ss_pred eeEeeEEeeeCcEEEEEEEECCe--EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEe
Q 003971 526 LTVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 603 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~~g~--~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 603 (782)
+.|+..||.|+||+||+++.+.+ ..|-|++..+ ..+.+++|+-||+||..+.||+||+|+++|...+.++|+.|||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 44567899999999999987533 4567877543 3456799999999999999999999999999999999999999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 683 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~ 683 (782)
.||-+..++-. -+..|++.++..+++|++.||.|||+++|||||||+.|||++-+|.++|+|||.+............
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence 99999987753 3468999999999999999999999999999999999999999999999999998765444344567
Q ss_pred CCCCCcccCcccc-----ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCC---hHHHHHH
Q 003971 684 SAGTPEWMAPELI-----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPE---GPLGRLI 754 (782)
Q Consensus 684 ~~GT~~Y~APEvl-----~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~---~~L~~LI 754 (782)
+.|||+|||||++ ++.+|+.++||||||++|.||.-+.+|-...++..++..+........ .|. ..+.+++
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfL 269 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFL 269 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHH
Confidence 8999999999986 467899999999999999999999999999999999888875443322 232 3689999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003971 755 ADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~ 773 (782)
..||. ||..||++.+|++|
T Consensus 270 k~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 270 KRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHhcCCccCCCHHHHhhC
Confidence 99999 99999999999986
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=351.71 Aligned_cols=254 Identities=26% Similarity=0.335 Sum_probs=204.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.+|.+.++||+|+||.||+|.+ .++.||||++..... .....+.|.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 6899999999999999999987 578999999865432 2334567999999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcc--------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 601 EYMELGSLYHLIHLSGQ--------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~--------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
||++|++|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 99999999998863211 2345677889999999999999999999999999999999999999999999998
Q ss_pred cccCCC------------------CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 003971 673 IITDSP------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 734 (782)
Q Consensus 673 ~l~~~~------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~ 734 (782)
...... ......+||+.|+|||.+.+..++.++|||||||++|||+||+.||..........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~ 241 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence 662110 01113469999999999999999999999999999999999999998765544333
Q ss_pred HHHhcCCCCC----CCChHHHHHHHHhhh-CCCCCC-CHHHHHHHHHhh
Q 003971 735 AVANEGSRLE----IPEGPLGRLIADCWA-EPQERP-SCEEILSRLLDC 777 (782)
Q Consensus 735 ~i~~~~~~~~----ip~~~L~~LI~~CL~-DP~kRP-Sa~EIL~~L~di 777 (782)
.......... --+..+.+++.+|+. ||.+|| +++++++.|+++
T Consensus 242 ~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 242 RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2111111000 112358899999999 999995 667777777765
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.75 Aligned_cols=242 Identities=26% Similarity=0.411 Sum_probs=203.0
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEe
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 603 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 603 (782)
|.....||.|+||.||++.. .++.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..++++||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 33445799999999999976 5889999998654332 2467889999999999999999999999999999999999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 683 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~ 683 (782)
++++|..++. ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++............
T Consensus 101 ~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 101 QGGALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred CCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 9999998774 246889999999999999999999999999999999999999999999999998765443323345
Q ss_pred CCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----CCChHHHHHHHHhhh
Q 003971 684 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IPEGPLGRLIADCWA 759 (782)
Q Consensus 684 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~----ip~~~L~~LI~~CL~ 759 (782)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||...........+........ .....+.+++.+||.
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~ 256 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence 6789999999999988899999999999999999999999987776665555433221111 112468999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003971 760 -EPQERPSCEEILSR 773 (782)
Q Consensus 760 -DP~kRPSa~EIL~~ 773 (782)
+|.+||++.+++++
T Consensus 257 ~~P~~Rps~~~ll~~ 271 (297)
T cd06659 257 REPQERATAQELLDH 271 (297)
T ss_pred CCcccCcCHHHHhhC
Confidence 99999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.54 Aligned_cols=244 Identities=30% Similarity=0.490 Sum_probs=206.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
..+|.+.+.||+|+||.||++.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 36899999999999999999975 678899999854332 23467889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999998852 35788899999999999999999999999999999999999999999999998766544333
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--C---ChHHHHHHH
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--P---EGPLGRLIA 755 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i--p---~~~L~~LI~ 755 (782)
.....+++.|+|||.+....++.++|+|||||++|+|++|+.||...........+.... .+.. + ...+.+++.
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHHHHHHHH
Confidence 344568889999999988889999999999999999999999998776655444333222 1211 1 235889999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003971 756 DCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 756 ~CL~-DP~kRPSa~EIL~~ 773 (782)
+||. +|.+||++.+++.+
T Consensus 251 ~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 251 RCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999 99999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=336.44 Aligned_cols=249 Identities=25% Similarity=0.449 Sum_probs=227.3
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
.....|.+.++||+|.|++|.++.+ .++.||||++.+...+....+.+.+|+++|+.++|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3457899999999999999999987 68999999999988888877889999999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
||||+.+|.+++++. +.+.+.+..+..++.|+..|++|||+++|+|||||++||||+.+.++||+|||++..+.. .
T Consensus 133 V~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-~ 208 (596)
T KOG0586|consen 133 VMEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-G 208 (596)
T ss_pred EEEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc-c
Confidence 999999999999997 556777899999999999999999999999999999999999999999999999998864 3
Q ss_pred CCCCCCCCCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIAD 756 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-~~~L~~LI~~ 756 (782)
....+.||++.|.|||++.+..| .+.+|+||+|+++|.|++|..||++.+-.+.....+...++.+.. .....+||++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk 288 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK 288 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHH
Confidence 45578999999999999999877 478999999999999999999999998888888888877777765 3468899999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003971 757 CWA-EPQERPSCEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~ 773 (782)
++. +|.+|+++++|.++
T Consensus 289 ~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred hhccCccccCCHHHhhhh
Confidence 998 99999999999875
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=305.60 Aligned_cols=243 Identities=33% Similarity=0.591 Sum_probs=203.6
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC---CCceeeEeccccCCCceEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR---HPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~---HPNIVkL~g~~~d~~~l~LV 599 (782)
.|++.+.||.|+||.||+|.+ +++.||+|.+.... .....+.+.+|+.+++.++ ||||+++++++......+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477788999999999999987 57899999986543 2334567889999999997 99999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 81 MEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998852 3689999999999999999999999999999999999999999999999999987755433
Q ss_pred CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChHHHHHH
Q 003971 680 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGPLGRLI 754 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip----~~~L~~LI 754 (782)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+... ..+.++ ...+.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLEDNGYSKLLREFV 235 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCcccCCHHHHHHH
Confidence 3345578899999998865 45788999999999999999999999887665544433222 222222 23689999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003971 755 ADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+||. ||.+||++.+++.+
T Consensus 236 ~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 236 AACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHcCCCcccCcCHHHHhhC
Confidence 99999 99999999999865
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=334.05 Aligned_cols=258 Identities=33% Similarity=0.605 Sum_probs=222.6
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC----Ce--EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN----GT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 590 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~----g~--~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~ 590 (782)
..+++..+...+.++||.|-||.||+|++. |. .||||..+... ..++.+.|+.|.-+|+.++|||||+++|+|
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 456677778888899999999999999873 33 47888876543 445578999999999999999999999999
Q ss_pred cCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCc
Q 003971 591 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 670 (782)
Q Consensus 591 ~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGL 670 (782)
.+.. .++|||.++.|.|..+++. +...|+.....-+++||+.||+|||+.++|||||...|||+.....|||+|||+
T Consensus 461 ~e~P-~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 461 VEQP-MWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eccc-eeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccch
Confidence 8865 8999999999999999973 456788899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCC-CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCCCCCCCCh
Q 003971 671 SRIITDSPMRDS-SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELC-TLNRPWEGVLPERVVYAVANEGSRLEIPEG 748 (782)
Q Consensus 671 A~~l~~~~~~~~-~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELL-TGk~PF~~~~~~evl~~i~~~~~~~~ip~~ 748 (782)
++.+.+..+... ...-...|||||.++-..++.++|||.|||.+||++ .|..||.+..+..++-.+ ..+.+++.|+.
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-EnGeRlP~P~n 616 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-ENGERLPCPPN 616 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-cCCCCCCCCCC
Confidence 999987755443 333456899999999999999999999999999987 588899999887776655 55778888765
Q ss_pred ---HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 749 ---PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 749 ---~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.++.|+.+||. +|.+||.+.+|...|.++..
T Consensus 617 CPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 617 CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 48999999999 99999999999999887643
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.37 Aligned_cols=247 Identities=30% Similarity=0.498 Sum_probs=209.6
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
....|.+.+.||+|+||.||++.+. +..+++|++..... ..+.+.+|+++++.++|+||+++++++......+++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 3466888899999999999999884 88999999865433 456788999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 99999999999997322 3789999999999999999999999999999999999999999999999999876544322
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----CChHHHHHHH
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI----PEGPLGRLIA 755 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i----p~~~L~~LI~ 755 (782)
......+++.|++||.+.+..++.++|+|||||++|+|++|+.||....+......+......... .+..+.+++.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 223445788999999999888999999999999999999999999888776655555443322111 1346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003971 756 DCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 756 ~CL~-DP~kRPSa~EIL~~ 773 (782)
+||. +|.+||++.+++.+
T Consensus 252 ~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHhccChhhCcCHHHHhhC
Confidence 9999 99999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.40 Aligned_cols=246 Identities=25% Similarity=0.427 Sum_probs=201.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC--CCceEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRLSMI 599 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~l~LV 599 (782)
++|...+.||.|++|.||++.+ .++.+|+|.+..... ......+.+|+++++.++||||++++++|.. .+.++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 3688999999999999999987 578999999875433 2445778999999999999999999998854 3468999
Q ss_pred EEEecccchhhHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 600 TEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
|||+++++|.+++... .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 9999999999887532 234568899999999999999999999999999999999999999999999999987654321
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcCCCCCCC-------
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV-----LPERVVYAVANEGSRLEIP------- 746 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~-----~~~evl~~i~~~~~~~~ip------- 746 (782)
.....++..|+|||.+.+..++.++|||||||++|+|++|..||... ...+....+.. ...+.++
T Consensus 160 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (287)
T cd06621 160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPGNGI 236 (287)
T ss_pred --cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCCCCC
Confidence 12456788999999999888999999999999999999999999765 22333333222 1122111
Q ss_pred --ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 --EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 --~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+.+++.+||. +|.+|||+.|++++
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 2358899999999 99999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=307.30 Aligned_cols=249 Identities=27% Similarity=0.373 Sum_probs=196.8
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC-----
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP----- 594 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~----- 594 (782)
..++|++.++||+|+||.||++.. +++.||||.+............+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 456899999999999999999987 5889999988654433333345678999999999999999999886543
Q ss_pred ---ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 595 ---RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 595 ---~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
..++++||+.+ +|.+.+.. ....+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 35999999975 77766652 2346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC----CCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----
Q 003971 672 RIITDSPMR----DSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR---- 742 (782)
Q Consensus 672 ~~l~~~~~~----~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~---- 742 (782)
......... .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||.+.........+......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 866432211 1234577889999988664 4788999999999999999999999877655443322221000
Q ss_pred -----------------------------CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 -----------------------------LEIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 -----------------------------~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..+....+.+|+.+||. ||.+||++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00112346789999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=317.28 Aligned_cols=244 Identities=25% Similarity=0.335 Sum_probs=199.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC------C
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------P 594 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------~ 594 (782)
..+|++.+.||+|+||.||++.+ +++.||+|++............+.+|+.+++.++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 37899999999999999999986 688999999865544445556788999999999999999999987644 3
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
..|+|+||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 47999999975 77776642 2888999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 743 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~----------- 743 (782)
.... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...-..+
T Consensus 169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 169 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 4432 2234568899999999999999999999999999999999999998766544333332110000
Q ss_pred ---------------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ---------------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ---------------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
......+.+++.+||. ||++||++.+++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011246789999999 99999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=300.40 Aligned_cols=238 Identities=27% Similarity=0.409 Sum_probs=200.5
Q ss_pred EeeeCcEEEEEEEEC--CeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccch
Q 003971 532 VGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 608 (782)
Q Consensus 532 LG~G~fG~VYkg~~~--g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL 608 (782)
||.|+||.||++.+. |+.+++|++..... .....+.+.+|++++++++||||+++++.+......|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999884 88999999865443 234467888999999999999999999999999999999999999999
Q ss_pred hhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC--------C
Q 003971 609 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--------R 680 (782)
Q Consensus 609 ~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~--------~ 680 (782)
.+++.. ...+++..+..++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999873 23789999999999999999999999999999999999999999999999999876543211 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHh
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADC 757 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~C 757 (782)
.....++..|+|||.+....++.++||||||+++|+|++|..||...........+.......... ...+.+++.+|
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 237 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKL 237 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHH
Confidence 234567889999999988888999999999999999999999999888877776665533332222 45689999999
Q ss_pred hh-CCCCCCCHHHHHH
Q 003971 758 WA-EPQERPSCEEILS 772 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~ 772 (782)
|+ +|.+||++..+.+
T Consensus 238 l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 238 LVPDPEKRLGAKSIEE 253 (265)
T ss_pred hcCCHhhcCCCccHHH
Confidence 99 9999999944433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=302.04 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=208.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV 599 (782)
++|.+.+.||+|+||.||++.. ++..||+|++..... .....+.+..|+.++++++ ||||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4789999999999999999987 688999999876433 2334567889999999998 99999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+.+++|.+++. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999886 334799999999999999999999999999999999999999999999999999987644321
Q ss_pred --------------------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 003971 680 --------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 739 (782)
Q Consensus 680 --------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~ 739 (782)
......++..|+|||.+....++.++|+||||++++++++|+.||...........+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 112345788999999998888999999999999999999999999988766655555432
Q ss_pred CCCCC-CCChHHHHHHHHhhh-CCCCCCCH----HHHHHH
Q 003971 740 GSRLE-IPEGPLGRLIADCWA-EPQERPSC----EEILSR 773 (782)
Q Consensus 740 ~~~~~-ip~~~L~~LI~~CL~-DP~kRPSa----~EIL~~ 773 (782)
..... ..+..+.+++..||. +|.+||++ .+++++
T Consensus 238 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 238 EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 22221 123468999999999 99999999 777754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=307.13 Aligned_cols=242 Identities=24% Similarity=0.413 Sum_probs=204.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
.|...+.||.|++|.||++.. .++.+++|.+.... ....+.+.+|+.+++.++||||+++++++...+..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 344557899999999999976 57889999875432 23346788999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++...........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 98 LEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999999998863 4688999999999999999999999999999999999999999999999999876544322233
Q ss_pred CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHHHHHh
Q 003971 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRLIADC 757 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-----p~~~L~~LI~~C 757 (782)
...|++.|+|||.+.+..++.++|||||||++|+|++|+.||...++......+.... .... .+..+.+++.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCCCcccccCCHHHHHHHHHH
Confidence 4568899999999998889999999999999999999999998877766665554332 1111 134699999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. +|.+||++.+++++
T Consensus 253 l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 253 LVRDPAQRATAAELLNH 269 (285)
T ss_pred cccChhhCcCHHHHccC
Confidence 99 99999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=308.40 Aligned_cols=258 Identities=26% Similarity=0.345 Sum_probs=208.8
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
....++-++|++.++||+|||+.||+++. ++..||+|++.... .+..+..++|++..++++|||+++++++...+.
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 34557779999999999999999999875 78899999987665 455688999999999999999999999875544
Q ss_pred c-----eEEEEEEecccchhhHHHhhcc-cccchHHHHHHHHHHHHHHHHHHHhcc--ccccCCCcccEEEcCCCeEEEE
Q 003971 595 R-----LSMITEYMELGSLYHLIHLSGQ-KKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKIC 666 (782)
Q Consensus 595 ~-----l~LV~Ey~~gGsL~dlL~~~~~-~~~Ls~~~~l~Ia~QIa~gL~yLHs~g--IIHrDIKPeNILLd~~g~VKLa 666 (782)
. .|+++.|...|+|.+.+....- +..+++.+++.|+.+|++||++||... ++||||||.|||+++.+.++|.
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence 3 8999999999999998875543 448999999999999999999999998 9999999999999999999999
Q ss_pred ecCccccccCCCCC---------CCCCCCCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HH
Q 003971 667 DFGLSRIITDSPMR---------DSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--RV 732 (782)
Q Consensus 667 DFGLA~~l~~~~~~---------~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~--ev 732 (782)
|||.++...-.... ......|..|.|||++.- ...++++|||||||+||+|+.|..||...-.. .+
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 99998765321110 012346889999999864 45688999999999999999999999632110 11
Q ss_pred HHHHHhcCCCCCCC-----ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 733 VYAVANEGSRLEIP-----EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 733 l~~i~~~~~~~~ip-----~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
...+.+ ....+| .+.+.++++.|++ ||.+||++.+++.++.++.
T Consensus 252 aLAv~n--~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 ALAVQN--AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EEeeec--cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111 112222 3468999999999 9999999999999998764
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.70 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=219.9
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
.+..++|..++.||+|.||+|-+++. .++.||+|++++... ....+..-+.|-.+|+..+||.+..+...|+.++.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 45668899999999999999999965 689999999987764 345567778899999999999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++||||..||.|+-++. ....+++...+.+-.+|+.||.|||+++||+||||.+|+|||.+|++||+|||+++.--.
T Consensus 244 CFVMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999998886 456899999999999999999999999999999999999999999999999999987655
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHH
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIA 755 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-~~~L~~LI~ 755 (782)
......++||||.|+|||++....|..++|+|.+||++|||++|+.||+..+...+...+..+..+.+-. ..+...|+.
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLs 400 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLS 400 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHH
Confidence 5556678999999999999999999999999999999999999999999998888887777655444322 346788999
Q ss_pred Hhhh-CCCCCC-----CHHHHHHH
Q 003971 756 DCWA-EPQERP-----SCEEILSR 773 (782)
Q Consensus 756 ~CL~-DP~kRP-----Sa~EIL~~ 773 (782)
.++. ||.+|. .+.||.++
T Consensus 401 GLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 401 GLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHhhcChHhhcCCCchhHHHHHhh
Confidence 9998 999993 45566544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=343.15 Aligned_cols=255 Identities=36% Similarity=0.599 Sum_probs=223.6
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
+++.+..+|.+.||.|.||+||+|..+ ...||||.++.. ..+.+..+|+.|+.||-++.||||++|.|+.....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 466678889999999999999999762 346999998754 45666789999999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
...+|+|||++|+|..+|+. +.+.+++.++..+++.|+.||.||-++|+|||||.+.|||++.+...|++||||++.+
T Consensus 704 PvMIiTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999999999984 3467999999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCCCC-CCCC--CCcccCccccccCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCCCCCCCCh--
Q 003971 675 TDSPMRDS-SSAG--TPEWMAPELIRNEPFTEKCDIFSLGVIMWELC-TLNRPWEGVLPERVVYAVANEGSRLEIPEG-- 748 (782)
Q Consensus 675 ~~~~~~~~-~~~G--T~~Y~APEvl~~~~~s~ksDVWSLGvILyELL-TGk~PF~~~~~~evl~~i~~~~~~~~ip~~-- 748 (782)
.++..... +..| ..+|.|||.+...+++.++||||||++|||.+ .|.+||-+..+.+++..+ ..+++++-|-+
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-e~gyRLPpPmDCP 860 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EQGYRLPPPMDCP 860 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH-HhccCCCCCCCCc
Confidence 76543222 2222 35899999999999999999999999999987 589999999999888876 45677766644
Q ss_pred -HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 749 -PLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 749 -~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
.|.+|+..||+ |-..||.|.+|+..|.++.
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 59999999999 9999999999999998763
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=301.45 Aligned_cols=245 Identities=26% Similarity=0.351 Sum_probs=203.2
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEe
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 603 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 603 (782)
|.+.+.||.|++|.||++.. +++.+++|.+............+.+|+++++.++|+||+++++++..+..+++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999987 5888999998765544445578889999999999999999999999999999999999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 683 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~ 683 (782)
++ +|.+++.. ....+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||.+............
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 85 77777753 2357899999999999999999999999999999999999999999999999999877554322334
Q ss_pred CCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------------
Q 003971 684 SAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------- 743 (782)
Q Consensus 684 ~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~------------------- 743 (782)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+......+
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 5678899999998776 78999999999999999999999998777655544433211110
Q ss_pred ------C------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ------E------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ------~------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. ..+..+.+++.+||. ||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 012358899999999 99999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=308.52 Aligned_cols=242 Identities=30% Similarity=0.487 Sum_probs=202.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
..|.+.+.||+|+||.||+|.. .++.||+|++..... .....+.+.+|+.+++.++||||++++++|.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5688889999999999999976 588999999865432 3444577899999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+. |++.+++.. ....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 9997 466666542 2346899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChHHHHH
Q 003971 681 DSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGPLGRL 753 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip----~~~L~~L 753 (782)
....+++.|+|||++. ...++.++||||||+++|+|++|+.||...........+..... +..+ ...+.++
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 246 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS-PTLSSNDWSDYFRNF 246 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-CCCCchhhCHHHHHH
Confidence 2456788999999874 45688899999999999999999999988777666655543322 2221 2368999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. +|.+||++.+++.+
T Consensus 247 i~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 247 VDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHhcCChhhCcCHHHHhcC
Confidence 999999 99999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.19 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=200.5
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC--CceEEEEE
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLSMITE 601 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l~LV~E 601 (782)
|.+.+.||.|+||.||+|.+ +++.+|+|.+............+.+|+.+++.++|+||+++++++... ...++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67889999999999999987 468999999976643344456788999999999999999999999887 78999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-C
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-R 680 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~-~ 680 (782)
|+++ +|..++.. ....+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9985 78877752 225789999999999999999999999999999999999999999999999999987654321 1
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------
Q 003971 681 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------------- 743 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~---------------- 743 (782)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+......+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 233456788999998765 457899999999999999999999998877655554443211100
Q ss_pred ----------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ----------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ----------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
......+.+++.+||. +|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0002357789999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=319.59 Aligned_cols=240 Identities=25% Similarity=0.316 Sum_probs=189.1
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
...+|.+.+.||+|+||.||+|.+ .++.||+|+.... .+..|+.+++.++||||+++++++......++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 345799999999999999999988 4568999974322 234689999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
+||+. ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 136 ~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EEccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 99996 577777752 34578999999999999999999999999999999999999999999999999997543221
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCC-CCCChH---------HHHHHHHhc-CC-CCCCC-
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW-EGVLPE---------RVVYAVANE-GS-RLEIP- 746 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF-~~~~~~---------evl~~i~~~-~~-~~~ip- 746 (782)
......||+.|+|||++.+..++.++|||||||++|||+++..|+ ...... ..+..+... +. ...++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 223567999999999999999999999999999999999876544 332111 111111110 00 00000
Q ss_pred --------------------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 --------------------------------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 --------------------------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+.+||.+||+ ||.+|||+.|+++|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 1134569999999 99999999999976
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=308.02 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=193.8
Q ss_pred CeeEeeEEeeeCcEEEEEEEE----CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCC--CceE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW----NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLS 597 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~----~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l~ 597 (782)
.|.+.++||+|+||.||+|.. .++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 478899999999999999987 468999999876431 122235678899999999999999999999888 7899
Q ss_pred EEEEEecccchhhHHHhhc--ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC----CCeEEEEecCcc
Q 003971 598 MITEYMELGSLYHLIHLSG--QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK----HWTVKICDFGLS 671 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~--~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~----~g~VKLaDFGLA 671 (782)
+||||+.+ +|.+++.... ....+++..++.++.||+.||+|||+.+|+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999986 5655554221 2237899999999999999999999999999999999999999 999999999999
Q ss_pred ccccCCCC---CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHHHh
Q 003971 672 RIITDSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER---------VVYAVAN 738 (782)
Q Consensus 672 ~~l~~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~e---------vl~~i~~ 738 (782)
........ ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+..... ....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 87643321 2234567889999998866 457899999999999999999999997554321 0000000
Q ss_pred ------------------------cCCCCCCC--------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 739 ------------------------EGSRLEIP--------------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 739 ------------------------~~~~~~ip--------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.......+ ...+.+++.+|+. ||.+|||+.+++++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00011111 2247789999999 99999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.71 Aligned_cols=242 Identities=26% Similarity=0.392 Sum_probs=194.1
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCC--CceEEEE
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKP--PRLSMIT 600 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~--~~l~LV~ 600 (782)
|++.++||+|+||.||+|.. +++.||+|++......... ....+|+.++.++. |+||+++++++.+. +.+++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67889999999999999986 6789999998654332222 34457899999885 99999999999887 8899999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+.+ +|.+.+.. ....+++..++.++.|++.||+|||+.|++|+||+|+||+++. +.+||+|||++....... .
T Consensus 80 e~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-~ 154 (282)
T cd07831 80 ELMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-P 154 (282)
T ss_pred ecCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC-C
Confidence 99975 77776652 2357899999999999999999999999999999999999999 999999999998764332 2
Q ss_pred CCCCCCCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----------------CC
Q 003971 681 DSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS----------------RL 743 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~----------------~~ 743 (782)
.....+++.|+|||.+. +..++.++|||||||++|||++|..||.+.+..+.+..+..... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 23456788999999764 45578899999999999999999999988766554443322110 00
Q ss_pred CC--------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 EI--------------PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ~i--------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.. -...+.+++.+||. +|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 01 12458899999999 99999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=305.72 Aligned_cols=246 Identities=24% Similarity=0.389 Sum_probs=195.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|...+.||+|+||.||++.+ +++.+|+|.+...... .....+.+|+.++.++. |+||+++++++..+...+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4667778999999999999987 5789999998654433 34567889999999996 999999999999988999999
Q ss_pred EEecccchhhHHHh--hcccccchHHHHHHHHHHHHHHHHHHHhc-cccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 601 EYMELGSLYHLIHL--SGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 601 Ey~~gGsL~dlL~~--~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~-gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
||+.. ++.++... ......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 99874 44443221 11345789999999999999999999974 9999999999999999999999999999766443
Q ss_pred CCCCCCCCCCCcccCccccccC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCC-------
Q 003971 678 PMRDSSSAGTPEWMAPELIRNE---PFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRLEIP------- 746 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~---~~s~ksDVWSLGvILyELLTGk~PF~~~~~~-evl~~i~~~~~~~~ip------- 746 (782)
. ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...... ........ +..+.++
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (288)
T cd06616 162 I-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK-GDPPILSNSEEREF 239 (288)
T ss_pred C-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC-CCCCcCCCcCCCcc
Confidence 2 22344688999999998765 6899999999999999999999999765421 12222211 1111221
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+.+|+.+||. ||.+||++.+|+.+
T Consensus 240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 240 SPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2358899999999 99999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=329.80 Aligned_cols=240 Identities=22% Similarity=0.297 Sum_probs=191.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
...|.+.+.||+|+||.||++.+ .++.||||... ...+.+|+++|++++|+|||++++++......+++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 45799999999999999999988 46789999632 134568999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 679 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~- 679 (782)
|++. ++|..++.. ....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 240 e~~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 240 PKYR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EccC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9996 678777752 234789999999999999999999999999999999999999999999999999986643211
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcCC----------
Q 003971 680 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL-------PERVVYAVANEGS---------- 741 (782)
Q Consensus 680 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~-------~~evl~~i~~~~~---------- 741 (782)
......||+.|+|||++.+..++.++|||||||+||||++|..|+.... ....+..++....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1224579999999999999999999999999999999999876542211 1111222221110
Q ss_pred ----------------CCC----------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 ----------------RLE----------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 ----------------~~~----------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.. .....+.+|+.+||. ||.+|||+.|+|++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 001247789999999 99999999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=313.04 Aligned_cols=246 Identities=26% Similarity=0.369 Sum_probs=199.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC----CCceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPRLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d----~~~l~ 597 (782)
++|.+.+.||.|+||.||+|.. +|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6799999999999999999976 58899999987654333445778889999999999999999998753 34689
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+|+||+. ++|.+++. ....+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999996 58888775 3456899999999999999999999999999999999999999999999999999876433
Q ss_pred CCC----CCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC------------
Q 003971 678 PMR----DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG------------ 740 (782)
Q Consensus 678 ~~~----~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~------------ 740 (782)
... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 211 124578899999998865 468899999999999999999999998765443333222111
Q ss_pred ------------CCCCC--------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 741 ------------SRLEI--------PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 741 ------------~~~~i--------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..... ....+.+++.+||+ +|.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01111 13458899999999 99999999999976
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=355.67 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=224.6
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccC
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTK 592 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 592 (782)
..++....++|.+++.||+|+||.|..+++ .++.||+|++.+-.+- ......|..|-.+|..-+.+-|+.++.+|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 355677889999999999999999999987 5778999998764432 2334678889999999999999999999999
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
+.++|+||||++||+|..++. +...+++.+++.|+.+|+.||.-||+.|+|||||||+|||||..|++||+|||.+-
T Consensus 147 ~~~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ccceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence 999999999999999999997 33489999999999999999999999999999999999999999999999999998
Q ss_pred cccCC-CCCCCCCCCCCcccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003971 673 IITDS-PMRDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 746 (782)
Q Consensus 673 ~l~~~-~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip 746 (782)
.+... .......+|||.|++||++.. +.|+..+|+||+||++|||+.|..||+.....+.+-.|.+......+|
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 87643 444567889999999999852 568999999999999999999999999999999999998877677777
Q ss_pred C-----hHHHHHHHHhhhCCCCCCC---HHHHHHH
Q 003971 747 E-----GPLGRLIADCWAEPQERPS---CEEILSR 773 (782)
Q Consensus 747 ~-----~~L~~LI~~CL~DP~kRPS---a~EIL~~ 773 (782)
+ ...++||.+++.+|..|.. +++|..|
T Consensus 304 ~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 304 DETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred cccccCHHHHHHHHHHhcChhhhcccccHHHHHhC
Confidence 3 3589999999999999988 8888876
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.39 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=200.1
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC----
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP---- 594 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~---- 594 (782)
...++|++.+.||+|+||.||+|.+ +++.||+|++............+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3457899999999999999999987 5789999998765443334456788999999999999999999987654
Q ss_pred ------ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEec
Q 003971 595 ------RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 668 (782)
Q Consensus 595 ------~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDF 668 (782)
.+++++||+++ ++...+.. ....+++..++.++.||+.||+|||+.||+|+||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999986 66665542 2346899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCC-CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----
Q 003971 669 GLSRIITDSPM-RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR---- 742 (782)
Q Consensus 669 GLA~~l~~~~~-~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~---- 742 (782)
|++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........+..+......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99987654321 1123356778999998865 45788999999999999999999999876655444333221100
Q ss_pred ---------------------------CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 ---------------------------LEIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 ---------------------------~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...-+..+.+++.+||. ||.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00113468899999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.70 Aligned_cols=249 Identities=28% Similarity=0.372 Sum_probs=206.5
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC-----ceE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-----RLS 597 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~-----~l~ 597 (782)
+|.+.+.||.|+||.||+|.. .++.+|||.+..........+.+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 588999999999999999987 4789999998755433445578899999999999999999999998775 789
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
++|||+.+ +|..++. ....+++..++.++.||+.||+|||+.||+|+||||.|||++.++.++|+|||++......
T Consensus 81 lv~e~~~~-~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMET-DLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhh-hHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999984 7887775 3448999999999999999999999999999999999999999999999999999887554
Q ss_pred C---CCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------
Q 003971 678 P---MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--------- 744 (782)
Q Consensus 678 ~---~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~--------- 744 (782)
. .......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+....+....+......+.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 3 123345678899999999887 789999999999999999999999988876665554443211110
Q ss_pred ---------------------C--CChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhh
Q 003971 745 ---------------------I--PEGPLGRLIADCWA-EPQERPSCEEILSR--LLDC 777 (782)
Q Consensus 745 ---------------------i--p~~~L~~LI~~CL~-DP~kRPSa~EIL~~--L~di 777 (782)
. -...+.+++.+||. +|.+||++.+++.+ ++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0 12347789999999 99999999999986 5443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=303.81 Aligned_cols=250 Identities=16% Similarity=0.187 Sum_probs=184.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHH---------HHHHHHHHHHHHhCCCCceeeE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAEN---------MEDFCNEISILSRLRHPNVILF 586 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~---------~e~f~~EI~iLk~L~HPNIVkL 586 (782)
+...+|.+.++||+|+||+||+|.+. +..+|+|+.......... ......+...+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 44578999999999999999999874 335677764322211100 0112234445566789999999
Q ss_pred eccccCCC----ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe
Q 003971 587 LGACTKPP----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 662 (782)
Q Consensus 587 ~g~~~d~~----~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~ 662 (782)
++++.... ..+++++++.. ++.+.+.. ....++..++.++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence 98765443 23566676643 55555542 234577888999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCC-------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHH--
Q 003971 663 VKICDFGLSRIITDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-ERV-- 732 (782)
Q Consensus 663 VKLaDFGLA~~l~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~-~ev-- 732 (782)
++|+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999987632211 11234699999999999999999999999999999999999999987632 221
Q ss_pred ------HHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003971 733 ------VYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 733 ------l~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 774 (782)
...+..........+..+.+++..||. +|.+||++.+|++.|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 122222212222234568999999999 999999999999876
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=306.54 Aligned_cols=244 Identities=29% Similarity=0.462 Sum_probs=204.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
.|...+.||+|+||.||++.+ ++..+|+|++..... .......+.+|+++++.++|||++++++++.+....+++||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 467788999999999999986 578999999865432 33445688999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+.+ +|.+++.. ....+++.++..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 9975 77776642 2456899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCCCCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003971 682 SSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 755 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~ 755 (782)
....|++.|+|||.+. ...++.++|||||||++|+|++|+.||...........+.........+ ...+.+++.
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 258 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 258 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence 3456888999999873 4568899999999999999999999998877766666665544322222 346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHH
Q 003971 756 DCWA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 756 ~CL~-DP~kRPSa~EIL~~L~ 775 (782)
+||+ +|.+||++.++++++-
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred HHccCCcccCcCHHHHHhChh
Confidence 9999 9999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=331.39 Aligned_cols=205 Identities=27% Similarity=0.364 Sum_probs=180.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CC-----ceeeEeccccCCCce
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HP-----NVILFLGACTKPPRL 596 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HP-----NIVkL~g~~~d~~~l 596 (782)
+|.|.+.||+|+||.|.+|.+ +++.||||+++.+ +....+...|+.+|..|+ |. |||+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 899999999999999999987 5889999998644 334566778999999997 43 899999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC--eEEEEecCccccc
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW--TVKICDFGLSRII 674 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g--~VKLaDFGLA~~l 674 (782)
+||+|.+. -+|+++++. ++-..++...++.++.||+.||.+||+.||||+||||+||||.+.+ .|||+|||.++..
T Consensus 264 ciVfELL~-~NLYellK~-n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 264 CIVFELLS-TNLYELLKN-NKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeehhhh-hhHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999997 499999974 3455799999999999999999999999999999999999996543 7999999999987
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA 737 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~ 737 (782)
....+ +.+.+..|.|||++.+.+|+.+.||||||||++||++|...|++.+..+.+..+.
T Consensus 342 ~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~ 401 (586)
T KOG0667|consen 342 SQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARII 401 (586)
T ss_pred CCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHH
Confidence 65432 6677889999999999999999999999999999999999999888777766654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=322.87 Aligned_cols=256 Identities=33% Similarity=0.556 Sum_probs=215.9
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEECC-eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~~g-~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
++..+.+.++++||+|-||+|.++...+ ..||||++..... .....+|.+|+++|.+|+|||||.++|+|..++.+++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 4567888999999999999999998765 9999999976543 3345899999999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
++||+++|+|..++..... ..+......+|+.||+.||+||.+.++|||||.+.|||++.++++||+|||+++.+....
T Consensus 613 I~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999999974422 235666778899999999999999999999999999999999999999999999776554
Q ss_pred CCC-C-CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHh---cCCCC---CCC--
Q 003971 679 MRD-S-SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELC--TLNRPWEGVLPERVVYAVAN---EGSRL---EIP-- 746 (782)
Q Consensus 679 ~~~-~-~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELL--TGk~PF~~~~~~evl~~i~~---~~~~~---~ip-- 746 (782)
+.. . ..+-..+|||+|.+..++++.++|+|+||+++||++ +.+.||.....++++..... ..... ..|
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~ 771 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPA 771 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCc
Confidence 432 2 234567999999999999999999999999999986 56889999988887776542 11111 112
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 747 -EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 747 -~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
+..+++++..||. |..+||+++++..+|++.
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 3468899999999 999999999999999864
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.87 Aligned_cols=240 Identities=25% Similarity=0.325 Sum_probs=194.4
Q ss_pred EeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccch
Q 003971 532 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 608 (782)
Q Consensus 532 LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL 608 (782)
||+|+||+||++.+ +|+.||+|++...... ......+.+|+.+++.++||||+++++++...+..|+++||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999976 5889999998754432 22345677899999999999999999999999999999999999999
Q ss_pred hhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003971 609 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 688 (782)
Q Consensus 609 ~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~ 688 (782)
.+++... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .......++.
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTP 158 (277)
T ss_pred HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCC
Confidence 9888633 2246899999999999999999999999999999999999999999999999998766432 2223456788
Q ss_pred cccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCC---CChHHHHHHHHhhh-CCC
Q 003971 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--GSRLEI---PEGPLGRLIADCWA-EPQ 762 (782)
Q Consensus 689 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~--~~~~~i---p~~~L~~LI~~CL~-DP~ 762 (782)
.|+|||.+.+..++.++|||||||++|+|++|+.||...........+... ...... -+..+.+++.+||+ ||.
T Consensus 159 ~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (277)
T cd05577 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE 238 (277)
T ss_pred CcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChh
Confidence 999999998888999999999999999999999999765432111111111 111112 24468999999999 999
Q ss_pred CCC-----CHHHHHHH
Q 003971 763 ERP-----SCEEILSR 773 (782)
Q Consensus 763 kRP-----Sa~EIL~~ 773 (782)
+|| ++.+++.+
T Consensus 239 ~R~~~~~~~~~~ll~h 254 (277)
T cd05577 239 KRLGCRGGSADEVREH 254 (277)
T ss_pred HccCCCcccHHHHHhC
Confidence 999 66667754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.69 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=196.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC-------
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------- 593 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------- 593 (782)
.++|++.++||.|+||.||+|.+ +++.+|||++............+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999987 578899999865543333335677899999999999999999987543
Q ss_pred -CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 594 -PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 594 -~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
..++++++|+.+ ++...+.. ....+++.+++.++.|+++||+|||++||+|+||||+||++++++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 346999999975 56555542 34579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC-----------CCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 003971 673 IITDSPMR-----------DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 740 (782)
Q Consensus 673 ~l~~~~~~-----------~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~ 740 (782)
........ .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 65432211 122356788999998765 457899999999999999999999998877665544443211
Q ss_pred CCC---------------------CCC----------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 741 SRL---------------------EIP----------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 741 ~~~---------------------~ip----------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..+ ..+ ...+.+++.+|+. ||.+|||+.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 110 000 1246789999999 99999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.47 Aligned_cols=247 Identities=20% Similarity=0.324 Sum_probs=198.8
Q ss_pred eeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecc
Q 003971 526 LTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.+++.+|.|+++.||++..+++.||||++..........+.+.+|+.+++.++|+||+++++++......+++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34556667777777777777899999999977655566678899999999999999999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC------
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM------ 679 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~------ 679 (782)
++|.+++... ....+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||.+........
T Consensus 84 ~~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 84 GSCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred CCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9999998743 234688999999999999999999999999999999999999999999999999876532211
Q ss_pred -CCCCCCCCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------
Q 003971 680 -RDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------- 743 (782)
Q Consensus 680 -~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~------------- 743 (782)
......++..|+|||++.. ..++.++|+|||||++|+|++|+.||...................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence 1123457788999999876 357889999999999999999999998776544433222111000
Q ss_pred -C----------------CC-----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 -E----------------IP-----EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 -~----------------ip-----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. .+ ...+.+++..||. ||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 00 1246789999999 99999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=297.57 Aligned_cols=245 Identities=27% Similarity=0.344 Sum_probs=198.9
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC---CCCceeeEeccccCCCc-----
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RHPNVILFLGACTKPPR----- 595 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L---~HPNIVkL~g~~~d~~~----- 595 (782)
|++.+.||+|+||.||+|.+ +++.||+|++............+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67889999999999999987 478999999875544333345677788877766 59999999999988776
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
++++|||+.+ +|.+++... ....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999985 788877632 23368999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------ 743 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~------------ 743 (782)
... ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.+....+....+.......
T Consensus 159 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 159 FEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred CCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 432 2234457889999999998889999999999999999999999998887766655544311100
Q ss_pred -----C---C------C--ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 -----E---I------P--EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 -----~---i------p--~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. . + ...+.+++.+||+ ||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 0 0 1246789999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=310.73 Aligned_cols=246 Identities=27% Similarity=0.338 Sum_probs=198.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC-----Cce
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PRL 596 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-----~~l 596 (782)
.+|.+.+.||+|+||+||++.+ +++.||||.+............+.+|+.+++.++|+||+++++++... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5799999999999999999986 578999999865433344456778899999999999999999988654 347
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
|+++||+. ++|.+++. ....+++..++.++.|++.||.|||+++++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999996 57887775 345799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC---------------
Q 003971 677 SPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG--------------- 740 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~--------------- 740 (782)
.........++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 3223344568889999998765 468899999999999999999999998765433222221100
Q ss_pred ---------C--CC------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 741 ---------S--RL------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 741 ---------~--~~------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. .. +--...+.+++.+||+ +|.+||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 00 0012347899999999 99999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=309.08 Aligned_cols=244 Identities=29% Similarity=0.405 Sum_probs=194.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC-----Cce
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PRL 596 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-----~~l 596 (782)
++|++.++||+|+||.||+|.+ +|+.||+|++..... ......+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 6899999999999999999976 588999999854322 23346788999999999999999999886543 357
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
|+++||+.+ +|..++. ...+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 999999975 7776664 34689999999999999999999999999999999999999999999999999987643
Q ss_pred CCC---CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC------------
Q 003971 677 SPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG------------ 740 (782)
Q Consensus 677 ~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~------------ 740 (782)
... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 221 1123568899999998654 568999999999999999999999997765433322221100
Q ss_pred ------------CCCCC--------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 741 ------------SRLEI--------PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 741 ------------~~~~i--------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..... ....+.+++.+||. +|.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 12357899999999 99999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=327.50 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=207.4
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCC
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPP 594 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~ 594 (782)
+-+.++.+.|+++++||+||.+.||++.. +.+.||+|.......+...+..|.+|+..|.+|+ |.+||+||+|-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 44667789999999999999999999987 5667888877666666777899999999999996 999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+||||||-+ .+|..+|... ...++.-.++.|..|++.++.++|+.||||.||||.|+|+-. |.+||+|||+|..+
T Consensus 434 ~lYmvmE~Gd-~DL~kiL~k~--~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 434 YLYMVMECGD-IDLNKILKKK--KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred eEEEEeeccc-ccHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 9999999875 4888888732 223333478899999999999999999999999999999954 69999999999988
Q ss_pred cCCC--CCCCCCCCCCcccCccccccC-----------CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcC
Q 003971 675 TDSP--MRDSSSAGTPEWMAPELIRNE-----------PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY-AVANEG 740 (782)
Q Consensus 675 ~~~~--~~~~~~~GT~~Y~APEvl~~~-----------~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~-~i~~~~ 740 (782)
..+. ......+||+.||+||.+... +.+.++||||||||||+|+.|+.||.......... .+.+-+
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~ 589 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN 589 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence 6542 233567899999999998542 24678999999999999999999998876443333 333332
Q ss_pred C---CCCCCCh-HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 741 S---RLEIPEG-PLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 741 ~---~~~ip~~-~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. .+.++.. ++.++++.||. ||.+||++.++|++
T Consensus 590 ~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 590 HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 3 2334433 48999999999 99999999999986
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=301.93 Aligned_cols=251 Identities=24% Similarity=0.403 Sum_probs=202.2
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCC
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKP 593 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~ 593 (782)
.++.+..++|.+.+.||+|+||.||+|.++ ++.||||.+...... .....+..|+.++.++. ||||+++++++.+.
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 456778899999999999999999999885 889999998755432 23456677887777775 99999999999999
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
..+|++|||+.+ ++.+++... ...+++..+..++.|++.||+|||+ .||+||||+|+||++++++.+||+|||++.
T Consensus 87 ~~~~~v~e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 87 SDVFICMELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred CeEEEEeeccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 999999999864 666666432 3478999999999999999999997 599999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCC-
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRNEP----FTEKCDIFSLGVIMWELCTLNRPWEGVLP-ERVVYAVANEGSRLEIP- 746 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~----~s~ksDVWSLGvILyELLTGk~PF~~~~~-~evl~~i~~~~~~~~ip- 746 (782)
.+..... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .+.+..+.... ....+
T Consensus 164 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 241 (296)
T cd06618 164 RLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PPSLPP 241 (296)
T ss_pred hccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCCCC
Confidence 7644322 23345788999999987553 78899999999999999999999976433 23333333322 22221
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 ----EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+.+|+.+||. ||.+||++.+++.+
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 3468999999999 99999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=294.85 Aligned_cols=237 Identities=25% Similarity=0.372 Sum_probs=194.0
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHH-HhCCCCceeeEeccccCCCceEEEEEEecc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISIL-SRLRHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iL-k~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.||.|+||.||+|.+ .++.||+|++...... ......+..|..++ ...+|+||+++++++...+.+|+++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999987 5789999998654432 22233455565554 445899999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
++|.+++. ....+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++..... .....
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~ 154 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFV 154 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCC
Confidence 99999986 335689999999999999999999999999999999999999999999999999876533 23456
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CC---CChHHHHHHHHhhh-
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--EI---PEGPLGRLIADCWA- 759 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~--~i---p~~~L~~LI~~CL~- 759 (782)
+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+....... .. -+..+.+++.+||.
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 8889999999988888999999999999999999999998887777666554433211 11 13468999999999
Q ss_pred CCCCCCCH---HHHHHH
Q 003971 760 EPQERPSC---EEILSR 773 (782)
Q Consensus 760 DP~kRPSa---~EIL~~ 773 (782)
+|.+||++ .|++.+
T Consensus 235 ~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 235 DPAKRLGANGYQEIKSH 251 (260)
T ss_pred CHHHccCCCcHHHHHcC
Confidence 99999966 565544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=314.48 Aligned_cols=241 Identities=27% Similarity=0.395 Sum_probs=195.8
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC-----ceE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-----RLS 597 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~-----~l~ 597 (782)
.|...+.+|+|+||.||+|.. .++.||||.......-. -+|+++|+.+.|||||++..+|.... .+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 466778999999999999976 57799999764332211 26999999999999999998874421 456
Q ss_pred EEEEEecccchhhHHHh-hcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC-CeEEEEecCcccccc
Q 003971 598 MITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIIT 675 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~-~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~-g~VKLaDFGLA~~l~ 675 (782)
+||||++. +|...++. ...+..++...++-+.+||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+.+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 89999996 88877752 2235678888899999999999999999999999999999999966 999999999999886
Q ss_pred CCCCCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---------
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--------- 745 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i--------- 745 (782)
... .......|..|.|||++.+. .|+.+.||||.||++.||+-|+.-|.+.+...++..++.--..+.-
T Consensus 178 ~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 178 KGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred cCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 542 23456678899999998764 6999999999999999999999999999888877777643322210
Q ss_pred ------C---------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 ------P---------------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 ------p---------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
| +....+|+.+++. +|.+|.++.+++.+
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 1246789999999 99999999999865
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=296.62 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=202.0
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEe
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 603 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 603 (782)
|++.+.||+|+||.||+|.. +++.+|+|++..........+.+.+|+.+++.++|+||+++++++......++++||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56778899999999999987 4789999998766534444567889999999999999999999999999999999999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 683 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~ 683 (782)
. ++|.+++... ...+++..++.++.|++.||+|||+.||+|+||+|+||++++++.++|+|||++............
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 8 4899888732 246899999999999999999999999999999999999999999999999999876544333334
Q ss_pred CCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------------CC
Q 003971 684 SAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-------------------RL 743 (782)
Q Consensus 684 ~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~-------------------~~ 743 (782)
..++..|+|||.+.+. .++.++|||||||++|||++|+.||........+..+..... ..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 5567889999998766 789999999999999999999999987765544433322100 00
Q ss_pred ---------CC--CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ---------EI--PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ---------~i--p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+ -+..+.+++.+||. ||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00 12358899999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=293.88 Aligned_cols=247 Identities=30% Similarity=0.479 Sum_probs=202.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeecc---ccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQ---DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~---~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
+|.+.+.||+|+||.||++.+. +..+++|+++.- .........+..|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4888999999999999999774 345666665432 22333345677899999999999999999999999999999
Q ss_pred EEEecccchhhHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 600 TEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
+||+++++|.+++... .....+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 9999999999888642 23457899999999999999999999999999999999999975 569999999998765443
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 755 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~ 755 (782)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+.. +..+..+ +..+.+++.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCCcchhcHHHHHHHH
Confidence 333455688899999999888889999999999999999999999987766665555443 2233333 246889999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003971 756 DCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 756 ~CL~-DP~kRPSa~EIL~~ 773 (782)
+||. +|.+||++.+++++
T Consensus 239 ~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHhcCChhhCcCHHHHhhC
Confidence 9999 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=290.23 Aligned_cols=236 Identities=28% Similarity=0.448 Sum_probs=201.0
Q ss_pred EeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccch
Q 003971 532 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 608 (782)
Q Consensus 532 LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL 608 (782)
||.|+||.||++.+ +++.+|+|++...... ......+..|+.+++.++|+||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999987 4789999998765432 23567889999999999999999999999999999999999999999
Q ss_pred hhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003971 609 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 688 (782)
Q Consensus 609 ~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~ 688 (782)
.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..............++.
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 999863 34689999999999999999999999999999999999999999999999999987654322334566888
Q ss_pred cccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCC
Q 003971 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQER 764 (782)
Q Consensus 689 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kR 764 (782)
.|++||.+.+...+.++|+||||+++|+|++|+.||...........+.... ..++ +..+.+++.+||. ||.+|
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~p~~R 235 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP--LRFPEFLSPEARDLISGLLQKDPTKR 235 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence 9999999988888999999999999999999999998877666555554422 2232 4578999999999 99999
Q ss_pred CCH---HHHHH
Q 003971 765 PSC---EEILS 772 (782)
Q Consensus 765 PSa---~EIL~ 772 (782)
|++ .++++
T Consensus 236 ~~~~~~~~l~~ 246 (250)
T cd05123 236 LGSGGAEEIKA 246 (250)
T ss_pred CCcccHHHHHh
Confidence 999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=331.07 Aligned_cols=249 Identities=31% Similarity=0.568 Sum_probs=215.1
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC---Ce--EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWN---GT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~---g~--~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
..+++.+.++||+|.||.|++|.|+ |+ .||||.+....... ...+|++|+.+|.+|+|+|+++|||+..+ ..+
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 3456777889999999999999884 33 69999987665544 57899999999999999999999999988 568
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
.||+|.++.|+|.+.|+. .....|-......|+.||+.||.||..+++|||||...|+||-....|||+||||.+.+..
T Consensus 186 mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999999986 5667888999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC---CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCh---H
Q 003971 677 SPMRD---SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPEG---P 749 (782)
Q Consensus 677 ~~~~~---~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~~---~ 749 (782)
....+ ....-...|+|||.++...++.++|||+|||++|||+| |+.||.+.....++..+- .+.+++-|.. .
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csed 343 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSED 343 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHH
Confidence 32221 12233457999999999999999999999999999997 567999999999888876 7777777654 5
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L 774 (782)
++++++.||. +|.+||+|..|.+.+
T Consensus 344 IY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 344 IYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHHHhccCCccccccHHHHHHhH
Confidence 9999999999 999999999997543
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=305.93 Aligned_cols=242 Identities=24% Similarity=0.393 Sum_probs=194.1
Q ss_pred EEeee--CcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEeccc
Q 003971 531 RVGIG--FFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 531 ~LG~G--~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
.||+| +||+||++.+ .|+.||+|++..........+.+.+|+.+++.++||||++++++|...+.+++++||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999987 6899999998766555556688999999999999999999999999999999999999999
Q ss_pred chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC------
Q 003971 607 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR------ 680 (782)
Q Consensus 607 sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~------ 680 (782)
+|.+++... ....+++..+..++.|++.||+|||++||+||||||+|||++.++.++++||+.+.........
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 85 SANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 999988643 2345899999999999999999999999999999999999999999999999865433221110
Q ss_pred -CCCCCCCCcccCccccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-------------
Q 003971 681 -DSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE------------- 744 (782)
Q Consensus 681 -~~~~~GT~~Y~APEvl~~~--~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~------------- 744 (782)
.....++..|+|||++.+. .++.++|||||||++|+|++|+.||...................+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 0112345679999998763 478999999999999999999999987765554433322111000
Q ss_pred ------------------------------CC-----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 ------------------------------IP-----EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 ------------------------------ip-----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+ ...+.+|+.+||. ||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 1247889999999 99999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=299.73 Aligned_cols=237 Identities=26% Similarity=0.363 Sum_probs=187.8
Q ss_pred EEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH-HHHHHHHHHHHHHh---CCCCceeeEeccccCCCceEEEEEEec
Q 003971 531 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE-NMEDFCNEISILSR---LRHPNVILFLGACTKPPRLSMITEYME 604 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~-~~e~f~~EI~iLk~---L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 604 (782)
.||+|+||.||++.+ +++.+|+|.+........ ....+.+|..+++. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999999977 578999999865543222 22334455544443 479999999999999889999999999
Q ss_pred ccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCC
Q 003971 605 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 684 (782)
Q Consensus 605 gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~ 684 (782)
+++|.+++. ....+++..+..++.|++.||+|||+.+|+|+||||+|||++.++.++|+|||++...... .....
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 155 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCc
Confidence 999998886 3457999999999999999999999999999999999999999999999999998765432 22345
Q ss_pred CCCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003971 685 AGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--RVVYAVANEGSRLEIP---EGPLGRLIADCW 758 (782)
Q Consensus 685 ~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~--evl~~i~~~~~~~~ip---~~~L~~LI~~CL 758 (782)
.|++.|+|||.+. +..++.++|||||||++|+|++|+.||...... ....... ......++ ...+.+++.+||
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGLL 234 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHHh
Confidence 7899999999886 456889999999999999999999999754321 1121111 11122222 346899999999
Q ss_pred h-CCCCCC-----CHHHHHHH
Q 003971 759 A-EPQERP-----SCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRP-----Sa~EIL~~ 773 (782)
. ||.+|| ++.++++|
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhC
Confidence 9 999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.40 Aligned_cols=241 Identities=31% Similarity=0.478 Sum_probs=209.7
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
|.-++.||.|+||-||.+.+ +...||||.+..... ..+...++++|+..|+.++|||++.+.|+|......|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 34456799999999999976 677899998866543 345678999999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
|- |+-.|++.- ..+++-+..+..|..+.+.||+|||+.+.||||||..||||++.|.|||+|||.|..... ..
T Consensus 108 Cl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----An 180 (948)
T KOG0577|consen 108 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----AN 180 (948)
T ss_pred Hh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc----hh
Confidence 97 588888863 457899999999999999999999999999999999999999999999999999987654 35
Q ss_pred CCCCCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHH
Q 003971 683 SSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIAD 756 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~ 756 (782)
.++|||.|||||++. .+.|+-|+||||||+++.||...++|+-..+....++.|.......... .+.+.+++..
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence 789999999999885 4679999999999999999999999999999999999887644332221 2368999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003971 757 CWA-EPQERPSCEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~ 773 (782)
|++ -|.+|||.++++.|
T Consensus 261 CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHhhCcccCCcHHHHhhc
Confidence 999 89999999999876
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=308.20 Aligned_cols=245 Identities=24% Similarity=0.357 Sum_probs=197.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCC--CceEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKP--PRLSM 598 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~--~~l~L 598 (782)
.+|++.+.||+|+||.||+|.+ .++.+|+|.+............+.+|+.+++++ +||||++++++|... ..+++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 6788999999999999999987 578999998865433334456778899999999 999999999988653 35899
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
|+||+. ++|..++.. ..+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 87 v~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 87 VFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred Eecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 999998 488877752 277889999999999999999999999999999999999999999999999998764332
Q ss_pred C-----CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Q 003971 679 M-----RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------- 743 (782)
Q Consensus 679 ~-----~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~--------- 743 (782)
. ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+.......
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 1 1223468899999998754 457889999999999999999999998766555444332221110
Q ss_pred -----------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 -----------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 -----------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..-...+.+++.+||+ ||.+||++.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0012457899999999 99999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.43 Aligned_cols=243 Identities=28% Similarity=0.521 Sum_probs=215.4
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
-|.++.+||+|+||.||++.+ .|..+|||.... ..+++++.+|+.++++++.|++|++||.|..+..+++||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 356788999999999999977 688999998643 34578999999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
|..|++.++++. .+++|++..+..+++..++||+|||...-||||||..||||+.+|+.||+|||.|-.+++.--...
T Consensus 110 CGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 110 CGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred cCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 999999999974 567899999999999999999999999999999999999999999999999999998877654556
Q ss_pred CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----CCCChHHHHHHHHhh
Q 003971 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----EIPEGPLGRLIADCW 758 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~----~ip~~~L~~LI~~CL 758 (782)
+..|||.|||||++..-.|+.++||||||++..||..|++||.+..+.+.+..+-...... +...+.+.++++.|+
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL 267 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL 267 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence 7899999999999999889999999999999999999999999998887776654433211 112346899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003971 759 A-EPQERPSCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRPSa~EIL~~ 773 (782)
. +|++|-|+.++++|
T Consensus 268 iK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 268 IKKPEERKTALRLCEH 283 (502)
T ss_pred cCCHHHHHHHHHHhhh
Confidence 8 99999999999987
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.55 Aligned_cols=243 Identities=26% Similarity=0.327 Sum_probs=197.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC------
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 594 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------ 594 (782)
.++|++.+.||+|+||.||++.. +++.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 36799999999999999999976 5889999998654433334567889999999999999999999987654
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.++++++|+ +++|..++. ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999998 678887774 346899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------- 743 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~---------- 743 (782)
... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.........+.......
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 169 DSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred ccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 432 234567889999999876 458899999999999999999999998776544443332211100
Q ss_pred ----------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ----------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ----------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
......+.+++.+|+. ||.+||++.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0112247789999999 99999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.96 Aligned_cols=244 Identities=30% Similarity=0.410 Sum_probs=197.9
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEEEEE
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
|++.+.||.|+||+||+|.. .++.|+||.+....... ......+|+..+++++ |+||+++++++.+++..+++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999987 57789999986543322 2234557999999999 99999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+ +++|.+.+... ....+++..++.++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 80 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~ 156 (283)
T cd07830 80 M-EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYT 156 (283)
T ss_pred C-CCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcC
Confidence 9 78898887632 23478999999999999999999999999999999999999999999999999998765432 223
Q ss_pred CCCCCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------------
Q 003971 683 SSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------ 743 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~------------------ 743 (782)
...++..|+|||.+. ...++.++|+||||+++++|++|+.||...........+......+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 456888999999875 4557899999999999999999999998776555444332211100
Q ss_pred -------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 -------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 -------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
......+.+++.+||+ +|.+||++.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0012458899999999 99999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=328.99 Aligned_cols=238 Identities=31% Similarity=0.483 Sum_probs=201.8
Q ss_pred EEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccch
Q 003971 531 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 608 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL 608 (782)
.||+|.||+||-|.+ +...+|||.+...+. ...+-+..||.+.+.|+|.|||+++|.|.+++.+-++||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 699999999999987 455788998765443 3356678899999999999999999999999999999999999999
Q ss_pred hhHHHhhcccccc--hHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc-CCCeEEEEecCccccccCCCCCCCCCC
Q 003971 609 YHLIHLSGQKKKL--SWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 609 ~dlL~~~~~~~~L--s~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd-~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
.+++... =+++ .+..+-.+..||++||.|||.+.|||||||-+|||++ -.|.+||+|||-++.+..-+-...++.
T Consensus 660 SsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 660 SSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 9999743 2455 7888889999999999999999999999999999995 679999999999988754333445788
Q ss_pred CCCcccCccccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCh---HHHHHHHHhhh
Q 003971 686 GTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG---PLGRLIADCWA 759 (782)
Q Consensus 686 GT~~Y~APEvl~~~~--~s~ksDVWSLGvILyELLTGk~PF~~~~-~~evl~~i~~~~~~~~ip~~---~L~~LI~~CL~ 759 (782)
||..|||||++..++ |..++|||||||++.||.||++||.... +......+-.-+..+++|.. ..+++|.+|+.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe 817 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE 817 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence 999999999998754 8889999999999999999999997664 44444444444556777765 57899999999
Q ss_pred -CCCCCCCHHHHHH
Q 003971 760 -EPQERPSCEEILS 772 (782)
Q Consensus 760 -DP~kRPSa~EIL~ 772 (782)
||.+||++.++|.
T Consensus 818 pd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 818 PDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcccCccHHHhcc
Confidence 9999999999985
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=301.28 Aligned_cols=239 Identities=25% Similarity=0.406 Sum_probs=200.0
Q ss_pred eeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEeccc
Q 003971 529 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
..+||+|+||.||++.. ++..+|||.+.... ......+.+|+.+++.++|+||+++++++...+..+++|||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 35799999999999976 68899999875332 234567889999999999999999999999999999999999999
Q ss_pred chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCC
Q 003971 607 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 686 (782)
Q Consensus 607 sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~G 686 (782)
+|.+++. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..............|
T Consensus 103 ~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 103 ALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred cHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 9998774 235789999999999999999999999999999999999999999999999998766443222334568
Q ss_pred CCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----CCCChHHHHHHHHhhh-CC
Q 003971 687 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----EIPEGPLGRLIADCWA-EP 761 (782)
Q Consensus 687 T~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~----~ip~~~L~~LI~~CL~-DP 761 (782)
++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.........+....... ...+..+.+++.+||. +|
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence 899999999988888999999999999999999999998877665554443221111 1123468899999999 99
Q ss_pred CCCCCHHHHHHH
Q 003971 762 QERPSCEEILSR 773 (782)
Q Consensus 762 ~kRPSa~EIL~~ 773 (782)
.+||++.+++.+
T Consensus 259 ~~R~~~~~ll~~ 270 (292)
T cd06657 259 AQRATAAELLKH 270 (292)
T ss_pred ccCcCHHHHhcC
Confidence 999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=298.10 Aligned_cols=244 Identities=25% Similarity=0.396 Sum_probs=196.9
Q ss_pred CeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeecccc--ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCce
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 596 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~--~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l 596 (782)
+|++.+.||.|+||.||++.. +|..||+|++..... .....+.+.+|+.+++.+ +|+||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999975 578899999865432 122346778899999999 599999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
|+++||+++++|.+++. ....+++..+..++.|++.||.|||+.|++||||+|+|||++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999999886 345688999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-CCCCCCCCCcccCccccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCCCCC---
Q 003971 677 SPM-RDSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCTLNRPWEGVLP----ERVVYAVANEGSRLEIP--- 746 (782)
Q Consensus 677 ~~~-~~~~~~GT~~Y~APEvl~~~--~~s~ksDVWSLGvILyELLTGk~PF~~~~~----~evl~~i~~~~~~~~ip--- 746 (782)
... ......|+..|+|||.+... .++.++||||||+++|+|++|..||..... ......+.... ...+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 235 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEM 235 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--CCCCccC
Confidence 221 12245688999999998753 467899999999999999999999964322 22222222221 2222
Q ss_pred ChHHHHHHHHhhh-CCCCCC-----CHHHHHHH
Q 003971 747 EGPLGRLIADCWA-EPQERP-----SCEEILSR 773 (782)
Q Consensus 747 ~~~L~~LI~~CL~-DP~kRP-----Sa~EIL~~ 773 (782)
...+.+++.+||. ||.+|| ++.+++.+
T Consensus 236 ~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 3458899999999 999997 77887765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=304.82 Aligned_cols=246 Identities=24% Similarity=0.300 Sum_probs=197.2
Q ss_pred CCee-EeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHH------------HHHHHHHHHHHHhCCCCceeeEec
Q 003971 524 SELT-VGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN------------MEDFCNEISILSRLRHPNVILFLG 588 (782)
Q Consensus 524 s~y~-i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~------------~e~f~~EI~iLk~L~HPNIVkL~g 588 (782)
.+|. +.+.||.|+||+||+|.+ .++.||||++......... ...+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 457799999999999986 5889999998654332210 125778999999999999999999
Q ss_pred cccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEec
Q 003971 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 668 (782)
Q Consensus 589 ~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDF 668 (782)
++...+..+++|||+. ++|.+++. ....+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999997 58888875 3456899999999999999999999999999999999999999999999999
Q ss_pred CccccccCC--------------CCCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 003971 669 GLSRIITDS--------------PMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVV 733 (782)
Q Consensus 669 GLA~~l~~~--------------~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl 733 (782)
|++...... ........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+......+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999766411 1111233567889999998764 4689999999999999999999999888776655
Q ss_pred HHHHhcCCCC-----------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 734 YAVANEGSRL-----------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 734 ~~i~~~~~~~-----------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..+......+ ......+.+++..||. +|.+||++.+++.+
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 4443211100 0012357799999999 99999999999975
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=307.14 Aligned_cols=243 Identities=28% Similarity=0.352 Sum_probs=201.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc-----
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR----- 595 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~----- 595 (782)
.++|.+.+.||+|+||.||+|.+ .++.||+|++..........+.+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 46899999999999999999987 47889999986544444455678899999999999999999998866554
Q ss_pred -eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 596 -LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 596 -l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.++++||+ +++|.+++. ...+++..++.++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999998 568888875 246899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--------- 744 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~--------- 744 (782)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+......+..+......+.
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred ccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 432 234567889999998865 3678999999999999999999999987776655554433211100
Q ss_pred -----------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 -----------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 -----------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.....+.+++.+||. ||.+|||+.+|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 013457899999999 99999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.99 Aligned_cols=241 Identities=29% Similarity=0.456 Sum_probs=200.2
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
|...++||+|+||+||+|.+ .++.|++|++..... .....+.+.+|+.+++.++|||++++++++.+....|++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999986 688999999865433 333456788999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+. +++.+++.. ....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~ 175 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----AN 175 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----CC
Confidence 96 477776652 235689999999999999999999999999999999999999999999999999865322 23
Q ss_pred CCCCCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---CChHHHHHHHH
Q 003971 683 SSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI---PEGPLGRLIAD 756 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i---p~~~L~~LI~~ 756 (782)
...|+..|+|||++. ...++.++|||||||++|+|++|+.||...........+......... ....+.+++.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 457889999999984 456888999999999999999999999887776666655443322211 12468999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003971 757 CWA-EPQERPSCEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~ 773 (782)
||+ +|.+||++.+++.+
T Consensus 256 ~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 256 CLQKIPQERPASAELLRH 273 (313)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999 99999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.85 Aligned_cols=245 Identities=26% Similarity=0.325 Sum_probs=196.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC------c
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------R 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------~ 595 (782)
.+|.+.+.||+|+||.||+|.+ +|+.||||++............+.+|+.+++.++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 6899999999999999999986 5889999998654333333466889999999999999999999986543 4
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+++++||+.. +|..+. ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 95 ~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 6899999864 555443 2357899999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR------------ 742 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~------------ 742 (782)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+......+..+......
T Consensus 169 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 169 A---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred C---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 2 2234567889999999876 46889999999999999999999999887655444433321100
Q ss_pred ---------CC-----------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhh
Q 003971 743 ---------LE-----------IPEGPLGRLIADCWA-EPQERPSCEEILSR--LLDC 777 (782)
Q Consensus 743 ---------~~-----------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~--L~di 777 (782)
+. ..+..+.+++.+||+ ||.+||++.+++.+ ++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00 012347799999999 99999999999976 5443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=328.38 Aligned_cols=240 Identities=30% Similarity=0.534 Sum_probs=203.4
Q ss_pred EeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc--ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc--eEEEEE
Q 003971 528 VGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRLRHPNVILFLGACTKPPR--LSMITE 601 (782)
Q Consensus 528 i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~--~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~--l~LV~E 601 (782)
....||+|+|-+||+|.+ .|..||.-.++..+. .+...+.|..|+.+|+.|+||||++||.+|.+... +.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 456899999999999987 466666544433332 34556899999999999999999999999977654 889999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--ccccCCCcccEEEc-CCCeEEEEecCccccccCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g--IIHrDIKPeNILLd-~~g~VKLaDFGLA~~l~~~~ 678 (782)
.+..|+|..+++ +.+.++...+..|++||++||.|||++. |||||||.+||+|+ ..|.|||+|+|||..+...
T Consensus 124 L~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 124 LFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred cccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 999999999997 5568899999999999999999999985 99999999999996 5689999999999988654
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----CCChHHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IPEGPLGRLI 754 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~----ip~~~L~~LI 754 (782)
+.....|||.|||||++. ..|++.+||||||+.++||+|+.+||........++.-+..|..+. +.+.++++||
T Consensus 200 -~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 200 -HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFI 277 (632)
T ss_pred -ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHH
Confidence 444579999999999998 6699999999999999999999999988766666665555555442 3455799999
Q ss_pred HHhhhCCCCCCCHHHHHHH
Q 003971 755 ADCWAEPQERPSCEEILSR 773 (782)
Q Consensus 755 ~~CL~DP~kRPSa~EIL~~ 773 (782)
.+|+.-..+|||+.|+|.+
T Consensus 278 ekCl~~~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 278 EKCLATKSERLSAKELLKD 296 (632)
T ss_pred HHHhcCchhccCHHHHhhC
Confidence 9999988999999999964
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=328.07 Aligned_cols=250 Identities=20% Similarity=0.289 Sum_probs=185.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC---CeEEEEEE--------------ee-ccccChHHHHHHHHHHHHHHhCCCCcee
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWN---GTDVAIKV--------------FL-EQDLTAENMEDFCNEISILSRLRHPNVI 584 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~---g~~VAVKi--------------l~-~~~~~~~~~e~f~~EI~iLk~L~HPNIV 584 (782)
..+|+++++||+|+||+||++... +...++|. +. ...........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998652 11122221 10 0111222346788999999999999999
Q ss_pred eEeccccCCCceEEEEEEecccchhhHHHhhc--ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe
Q 003971 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSG--QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 662 (782)
Q Consensus 585 kL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~--~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~ 662 (782)
++++++...+..|++++++.+ +|..++.... .........++.++.||+.||+|||++|||||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999864 6666553211 1223346677889999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCC-CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCC-CCCCC--ChHHHHHHHHh
Q 003971 663 VKICDFGLSRIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGV--LPERVVYAVAN 738 (782)
Q Consensus 663 VKLaDFGLA~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~-PF~~~--~~~evl~~i~~ 738 (782)
+||+|||++..+..... ......||+.|+|||++.+..++.++|||||||++|||++|.. ||... .+...+..+..
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~ 385 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence 99999999987654322 2235679999999999999999999999999999999999986 44322 22222222211
Q ss_pred cCC--CCCC-------------------------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 739 EGS--RLEI-------------------------------PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 739 ~~~--~~~i-------------------------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
... ...+ .+..+.+++.+|+. ||.+|||+.|++++
T Consensus 386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 100 0000 01235667889999 99999999999975
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=294.64 Aligned_cols=236 Identities=26% Similarity=0.355 Sum_probs=189.0
Q ss_pred EEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHH---HHhCCCCceeeEeccccCCCceEEEEEEec
Q 003971 531 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISI---LSRLRHPNVILFLGACTKPPRLSMITEYME 604 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~i---Lk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 604 (782)
.||+|+||.||++.+ +++.||+|.+....... .....+..|..+ ++...||||+++++++...+..++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999976 57899999987654332 112234444443 444579999999999999999999999999
Q ss_pred ccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCC
Q 003971 605 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 684 (782)
Q Consensus 605 gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~ 684 (782)
+++|..++. ....+++..++.++.|++.||+|||+.+|+||||||+||+++.++.++|+|||++..+... .....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 155 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCc
Confidence 999998876 3457999999999999999999999999999999999999999999999999998765432 22345
Q ss_pred CCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCCCC---ChHHHHHHHHh
Q 003971 685 AGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVL---PERVVYAVANEGSRLEIP---EGPLGRLIADC 757 (782)
Q Consensus 685 ~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~---~~evl~~i~~~~~~~~ip---~~~L~~LI~~C 757 (782)
.|+..|+|||.+.+. .++.++|||||||++|+|++|+.||.... ......... .....++ +..+.+++.+|
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~ 233 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPELRSLLEGL 233 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh--ccCCCCCCcCCHHHHHHHHHH
Confidence 789999999998754 68899999999999999999999998663 222222211 1222232 35789999999
Q ss_pred hh-CCCCCC-----CHHHHHHH
Q 003971 758 WA-EPQERP-----SCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRP-----Sa~EIL~~ 773 (782)
+. +|.+|| ++.+++++
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHhC
Confidence 99 999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.99 Aligned_cols=245 Identities=29% Similarity=0.453 Sum_probs=201.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
..|...+.||.|+||.||+|.+ ++..+|+|.+..... .......+.+|+++++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4477778899999999999987 577899998864322 3344567889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+. |++.+.+.. ....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9997 577776642 2346889999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CCChHHHHHH
Q 003971 681 DSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---IPEGPLGRLI 754 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~---ip~~~L~~LI 754 (782)
....+++.|+|||.+. ...++.++|||||||++|+|++|..||...........+........ .....+.+|+
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence 3456888999999874 35578899999999999999999999988776666555544332221 1234689999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHH
Q 003971 755 ADCWA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~L~ 775 (782)
.+||. +|.+||++.+++.+-.
T Consensus 248 ~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 248 DSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHhhCCcccCCCHHHHhhCcc
Confidence 99999 9999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.68 Aligned_cols=236 Identities=22% Similarity=0.359 Sum_probs=187.7
Q ss_pred CCeeEeeEE--eeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEE
Q 003971 524 SELTVGTRV--GIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 524 s~y~i~~~L--G~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~L 598 (782)
++|.+.+.+ |.|+||.||++.. ++..+|+|++....... .|+.....+ +||||+++++.+...+.+++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 355555555 9999999999976 57889999986543321 122222222 69999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC-eEEEEecCccccccCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDS 677 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g-~VKLaDFGLA~~l~~~ 677 (782)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 9999999999999863 34889999999999999999999999999999999999999988 9999999998766432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhc-CCCCCC---CChHHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVV-YAVANE-GSRLEI---PEGPLGR 752 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl-~~i~~~-~~~~~i---p~~~L~~ 752 (782)
....++..|+|||++.+..++.++|||||||++|+|++|+.||......... ..+... ...... .+..+.+
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND 239 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence 2346889999999999988999999999999999999999999865433221 111111 111111 2346899
Q ss_pred HHHHhhh-CCCCCCC-HHHHHHH
Q 003971 753 LIADCWA-EPQERPS-CEEILSR 773 (782)
Q Consensus 753 LI~~CL~-DP~kRPS-a~EIL~~ 773 (782)
++.+||+ +|.+||+ +++++++
T Consensus 240 li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHhccChhhCCchHHHHhcC
Confidence 9999999 9999995 6999864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=330.77 Aligned_cols=259 Identities=33% Similarity=0.624 Sum_probs=222.2
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEe
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFL 587 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~ 587 (782)
.|++..++..+.+.||+|.||.|++|... ...||||+++..... ...+.+..|+++|+.+. |+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 68888888889999999999999999642 346999998766655 56789999999999995 99999999
Q ss_pred ccccCCCceEEEEEEecccchhhHHHhhc-----------cc--ccchHHHHHHHHHHHHHHHHHHHhccccccCCCccc
Q 003971 588 GACTKPPRLSMITEYMELGSLYHLIHLSG-----------QK--KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSAN 654 (782)
Q Consensus 588 g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~-----------~~--~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeN 654 (782)
|+|.+...+++|+||+..|+|.+++.... .. ..++....+.++.||+.|++||++.++|||||.+.|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999997443 00 238899999999999999999999999999999999
Q ss_pred EEEcCCCeEEEEecCccccccCCCCCC-CCCCC--CCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 003971 655 CLVNKHWTVKICDFGLSRIITDSPMRD-SSSAG--TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 730 (782)
Q Consensus 655 ILLd~~g~VKLaDFGLA~~l~~~~~~~-~~~~G--T~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~ 730 (782)
||++++..+||+|||+++...+..... ....| ...|||||.+....|+.|+||||||++|||++| |..||++....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999999999765543322 22333 346999999999999999999999999999998 56799997734
Q ss_pred HHHHHHHhcCCCCCCCCh---HHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 731 RVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 731 evl~~i~~~~~~~~ip~~---~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
..+...+..+.+...|.. .++++++.||+ +|.+||++.++.+.+.+.
T Consensus 529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 444667888999888865 58899999999 999999999999998873
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=353.76 Aligned_cols=246 Identities=28% Similarity=0.462 Sum_probs=212.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+++-+..||.|.||.||.+.. +|...|+|.+..+.......+.+..|..++..++|||+|++||+-.+.+..+|+|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 445578899999999999976 788999999877776655667788999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC---
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--- 679 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~--- 679 (782)
|.+|+|.+++. .++-.++.....+..|++.|++|||+.|||||||||.||+|+.+|.+|++|||.|..+.....
T Consensus 1316 C~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred hccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 99999999997 445677888888999999999999999999999999999999999999999999988765421
Q ss_pred -CCCCCCCCCcccCccccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh---HHHH
Q 003971 680 -RDSSSAGTPEWMAPELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGR 752 (782)
Q Consensus 680 -~~~~~~GT~~Y~APEvl~~~~---~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~~---~L~~ 752 (782)
......||+-|||||++.+.. ...+.|||||||++.||+||++||...+..-.+.--+..+..+.+|.. .-.+
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence 123568999999999997643 456899999999999999999999877666555545566778888864 4678
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003971 753 LIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
++..|+. ||.+|.++.||+++
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHh
Confidence 9999999 99999999998876
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=303.13 Aligned_cols=244 Identities=26% Similarity=0.320 Sum_probs=196.3
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC------
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------ 593 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------ 593 (782)
..++|.+.+.||+|+||.||++.+ +++.||+|++..........+.+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 347899999999999999999975 688999999875443333456788999999999999999999987543
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
...+++++++ +++|.+++. ...+++..++.++.|++.||+|||+.||+||||||+||++++++.++|+|||++..
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3467777776 678887775 23589999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS----------- 741 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~----------- 741 (782)
... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 170 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 170 TDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred ccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 533 2234568889999998866 5688899999999999999999999987665444333221110
Q ss_pred -------------CCC--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 -------------RLE--------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 -------------~~~--------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+. .....+.+++..|++ ||.+||++.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 112357889999999 99999999999976
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=300.80 Aligned_cols=244 Identities=27% Similarity=0.365 Sum_probs=196.8
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC-CCceEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLSM 598 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-~~~l~L 598 (782)
...+|++.+.||.|+||.||++.. +++.||||++.+........+.+.+|+.+++.++||||++++++|.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 346799999999999999999976 57889999886544434445778899999999999999999998865 557899
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
++||+. ++|..++. ...+++..+..++.|++.||+|||++||+|+||+|.||++++++.++|+|||++.....
T Consensus 88 v~e~~~-~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 88 VTELLG-TDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-- 160 (328)
T ss_pred Eeehhc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--
Confidence 999984 58887774 34578888899999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc------------------
Q 003971 679 MRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE------------------ 739 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~------------------ 739 (782)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+...
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 2234567889999998765 56899999999999999999999999876553322221110
Q ss_pred ------CCCCC--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 740 ------GSRLE--------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 740 ------~~~~~--------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..... ..+..+.+++.+||+ +|.+||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 112468899999999 99999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.39 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=198.4
Q ss_pred CeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeeccccC--hHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCce
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLT--AENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 596 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~~--~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l 596 (782)
+|++.+.||+|+||.||++.. +++.||||++.+.... ....+.+.+|+.++..+ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999864 4678999998654321 22346788999999999 599999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++||||+++++|...+. ....+++..++.++.|++.||.|||+.+++|+||+|.||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999998886 335688999999999999999999999999999999999999999999999999876543
Q ss_pred CCC-CCCCCCCCCcccCccccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCC-CCCCh
Q 003971 677 SPM-RDSSSAGTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVL----PERVVYAVANEGSRL-EIPEG 748 (782)
Q Consensus 677 ~~~-~~~~~~GT~~Y~APEvl~~~~--~s~ksDVWSLGvILyELLTGk~PF~~~~----~~evl~~i~~~~~~~-~ip~~ 748 (782)
... ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||.... .......+....... ..-..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence 321 122346889999999987654 7889999999999999999999996432 222222222221111 11134
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
.+.+++.+||. ||++|||+.++.+.|..
T Consensus 238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 238 EARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 68999999999 99999998777665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=300.39 Aligned_cols=245 Identities=25% Similarity=0.315 Sum_probs=193.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEEC----CeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccC----CCc
Q 003971 525 ELTVGTRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK----PPR 595 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d----~~~ 595 (782)
+|++.+.||+|+||.||++.+. +..||+|.+..........+.+.+|+.+++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999874 56899999864333333456788999999999 59999999987532 245
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+|++++|+. ++|...+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 788888886 58887775 34578999999999999999999999999999999999999999999999999998664
Q ss_pred CCCC----CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----------
Q 003971 676 DSPM----RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG---------- 740 (782)
Q Consensus 676 ~~~~----~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~---------- 740 (782)
.... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+...-
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3211 1223568999999998765 568999999999999999999999998765433332221100
Q ss_pred ----------------CCCC------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 741 ----------------SRLE------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 741 ----------------~~~~------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.... .....+.+++.+|+. ||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 113468899999999 99999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=302.95 Aligned_cols=243 Identities=25% Similarity=0.342 Sum_probs=194.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC--------
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-------- 593 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-------- 593 (782)
.+|.+.+.||.|+||.||+|.. +++.||+|++..... ...+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 6899999999999999999987 578999999865543 3356788999999999999999999876553
Q ss_pred ------CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc-CCCeEEEE
Q 003971 594 ------PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKIC 666 (782)
Q Consensus 594 ------~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd-~~g~VKLa 666 (782)
...++++||+. ++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+||+++ .++.++|+
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 47877764 24688999999999999999999999999999999999997 45678999
Q ss_pred ecCccccccCCCC---CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-
Q 003971 667 DFGLSRIITDSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS- 741 (782)
Q Consensus 667 DFGLA~~l~~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~- 741 (782)
|||++........ ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999976543211 1123457889999998654 5678899999999999999999999987766554444332110
Q ss_pred ----------------------CCC--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 ----------------------RLE--------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 ----------------------~~~--------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
... .....+.+++.+||. ||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 112357789999999 99999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=316.95 Aligned_cols=364 Identities=19% Similarity=0.231 Sum_probs=252.8
Q ss_pred hhhHhhhhccccccCccchhHHHHHHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccc
Q 003971 374 SEARRIRRRSISITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSAL 453 (782)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~ 453 (782)
-..+||-+-...++.|+.-.+-+.|++|+...-+|||.. |.||.--|...+...-+.|+.- ...+.++.+
T Consensus 194 ~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~--~~~~~~eik~h~f~~~i~~~~l--------~~r~~~~~f 263 (612)
T KOG0603|consen 194 DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGA--GPDGVDEIKQHEFFQSIDWNEL--------EARSRPPPF 263 (612)
T ss_pred HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc--CcchhHHHhccchheeeeHhhH--------hhcCCCCCC
Confidence 678999999999999999999999999999999999864 5566655555542222222211 111111111
Q ss_pred cccc-ccccccccccCCCCCCCccCCCCCCCCCCCCCCCCchhhhhhhhhccCCcccCCCccccccccccCCCeeEeeEE
Q 003971 454 YNLS-RDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRV 532 (782)
Q Consensus 454 ~~l~-r~~~~s~~~~slPssp~~~~s~~S~~~~ss~~~~~s~~~s~~~~~l~sp~~~~~p~~~~~e~~i~~s~y~i~~~L 532 (782)
-+-. +...+.+.....++.........+ ..+ .... +...+.+........-.-...+++|.+...+
T Consensus 264 kp~~~~e~~~~~fd~eft~~~P~dsp~~~-~~~-----s~~~-------if~g~sfva~~il~~~~~~~~~~~y~~~~~~ 330 (612)
T KOG0603|consen 264 KPGSITERDVAQFDPEFTSQVPADSPLLS-ASG-----SDHT-------IFSGPSFVAPGVLEDAVTAPFTESYEFREEL 330 (612)
T ss_pred CCcccchhhhhhcCchhccCCcccCCCCC-CCc-----cccc-------hhcCCCccChHHhhccccCCcchhhcccccc
Confidence 1100 111111111111111111100000 000 0000 0001111110000000001135778888889
Q ss_pred eeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEEEEEecccchh
Q 003971 533 GIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLY 609 (782)
Q Consensus 533 G~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL~ 609 (782)
|.|+|+.|..+.+ +++.+++|++.+... +-.+|+.++... +||||+++.+.+.++...|+|||++.|+.+.
T Consensus 331 ~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell 404 (612)
T KOG0603|consen 331 GEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL 404 (612)
T ss_pred CCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence 9999999999976 678899999876522 223577666555 6999999999999999999999999999998
Q ss_pred hHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE-cCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003971 610 HLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV-NKHWTVKICDFGLSRIITDSPMRDSSSAGTP 688 (782)
Q Consensus 610 dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL-d~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~ 688 (782)
+.+. ..+.+. ..+..|+.+|+.|+.|||.+|+|||||||+|||+ ++.++++|+|||.++..... ..+.+-|.
T Consensus 405 ~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~ 477 (612)
T KOG0603|consen 405 RRIR---SKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTPALTL 477 (612)
T ss_pred HHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---hcccchhh
Confidence 8775 333344 7778899999999999999999999999999999 69999999999999887654 33557788
Q ss_pred cccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCH
Q 003971 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSC 767 (782)
Q Consensus 689 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa 767 (782)
.|.|||++....|++++||||||++||+|++|+.||........+...+..+..........++|+.+||+ ||.+||++
T Consensus 478 ~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~ 557 (612)
T KOG0603|consen 478 QYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGA 557 (612)
T ss_pred cccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcCh
Confidence 99999999999999999999999999999999999987766644443333333335556689999999999 99999999
Q ss_pred HHHHHH
Q 003971 768 EEILSR 773 (782)
Q Consensus 768 ~EIL~~ 773 (782)
.+++.+
T Consensus 558 ~~i~~h 563 (612)
T KOG0603|consen 558 DEIGAH 563 (612)
T ss_pred hhhccC
Confidence 999865
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=318.91 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=223.1
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEECCeE--EEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~--VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
+.-++..+++.++..||-|+||.|-++..++.. +|+|++++... ...+.+.+..|.++|..++.|.||++|-.|.+.
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS 492 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence 344567788889999999999999999876655 89999876654 455678899999999999999999999999999
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
+.+||+||-|-||.|+.++. ..+.++....+.++..+++|++|||++|||+|||||+|++|+.+|-+||.|||+|+.
T Consensus 493 kyvYmLmEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred hhhhhhHHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHH
Confidence 99999999999999999997 567899999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh---HH
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PL 750 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~~---~L 750 (782)
+.... ...++||||.|.|||++.++..+.++|.||||+++|||++|.+||.+.++...+..++.+.....+|.. ..
T Consensus 570 i~~g~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a 648 (732)
T KOG0614|consen 570 IGSGR-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTA 648 (732)
T ss_pred hccCC-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhH
Confidence 87653 345899999999999999999999999999999999999999999999999999999887777777743 35
Q ss_pred HHHHHHhhh-CCCCCCC-----HHHHHHH
Q 003971 751 GRLIADCWA-EPQERPS-----CEEILSR 773 (782)
Q Consensus 751 ~~LI~~CL~-DP~kRPS-----a~EIL~~ 773 (782)
.+||+++.. +|.+|.- +.+|.+|
T Consensus 649 ~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 649 TDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred HHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 667766555 9999964 6677665
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=307.47 Aligned_cols=243 Identities=23% Similarity=0.373 Sum_probs=208.5
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEECCe--EEEEEEeecccc-ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCc
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 595 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~~g~--~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~ 595 (782)
.+...+|..+..||+|+||+|.++..+|+ .||||++++... ...+++--+.|..+|... +-|.+++++.+|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 34557888999999999999999987654 699999987653 344456667788888766 47889999999999999
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+|+||||+.||+|-..++ .-+.+.+..+.-++.+|+-||-|||++|||+||||.+||||+.+|++||+|||+++.--
T Consensus 425 LyFVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999998887 34578889999999999999999999999999999999999999999999999998755
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHH
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLI 754 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-~~~L~~LI 754 (782)
-...+..+.||||.|+|||++..++|...+|+|||||+||||+.|+.||++.+..++...+.......+.. ..+...+.
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 55556678999999999999999999999999999999999999999999999999999887655433322 33566777
Q ss_pred HHhhh-CCCCCC
Q 003971 755 ADCWA-EPQERP 765 (782)
Q Consensus 755 ~~CL~-DP~kRP 765 (782)
...+. .|.+|.
T Consensus 582 kg~ltK~P~kRL 593 (683)
T KOG0696|consen 582 KGLLTKHPGKRL 593 (683)
T ss_pred HHHhhcCCcccc
Confidence 77787 999994
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=324.49 Aligned_cols=147 Identities=24% Similarity=0.409 Sum_probs=132.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
+++|.+.++||.|+||+||+|.+. ++.||||++..... .......+..|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 578999999999999999999885 88999999875443 334457788999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||.++|+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999863 3468889999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=309.62 Aligned_cols=245 Identities=26% Similarity=0.341 Sum_probs=203.9
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHH-HHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~-~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
+.+..+.|..-++||+|+||.||-++. +|+-||+|.+.++.+.... ....++|..+|.+++.+.||.+-.+|++.+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 345567788889999999999998754 7889999998776654332 3456789999999999999999999999999
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+++|+..|.||+|.-++...+ +..+++..++.++.+|+-||++||+.+||+||+||+|||||+.|+|+|+|+|||..+.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred eEEEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999999998776443 4689999999999999999999999999999999999999999999999999999886
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---H-HHHHHHHhcCCCCCCC---Ch
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP---E-RVVYAVANEGSRLEIP---EG 748 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~---~-evl~~i~~~~~~~~ip---~~ 748 (782)
... .....+||.+|||||++.+..|+...|+|+|||++|||+.|+.||..... . ++-..+.+. ....+ ..
T Consensus 339 ~g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~--~~ey~~kFS~ 415 (591)
T KOG0986|consen 339 EGK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED--PEEYSDKFSE 415 (591)
T ss_pred CCC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc--hhhcccccCH
Confidence 643 33466999999999999999999999999999999999999999964422 2 232332221 12222 23
Q ss_pred HHHHHHHHhhh-CCCCCCCH
Q 003971 749 PLGRLIADCWA-EPQERPSC 767 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa 767 (782)
..+.|...+|. ||.+|.-.
T Consensus 416 eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHHHHHccCHHHhccC
Confidence 68889999998 99999543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=317.94 Aligned_cols=248 Identities=27% Similarity=0.461 Sum_probs=198.7
Q ss_pred EeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC------ceEEE
Q 003971 528 VGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------RLSMI 599 (782)
Q Consensus 528 i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------~l~LV 599 (782)
..+.||+|+||.||+|.+ .|+.||||.+.... .....+...+|+++|++++|+|||+++++-.+.. ...++
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 456799999999999986 69999999987654 3344678889999999999999999999865544 35899
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc--CCC--eEEEEecCcccccc
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN--KHW--TVKICDFGLSRIIT 675 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd--~~g--~VKLaDFGLA~~l~ 675 (782)
||||.||+|...+....+...|++.+.+.++..+..||.|||++||+||||||.||++- .+| ..||+|||.|+.+.
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~ 175 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD 175 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence 99999999999998777778999999999999999999999999999999999999983 333 57999999999987
Q ss_pred CCCCCCCCCCCCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCC-------
Q 003971 676 DSPMRDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVL----PERVVYAVANEGSRL------- 743 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTGk~PF~~~~----~~evl~~i~~~~~~~------- 743 (782)
+.. .....+||+.|++||++. .+.|+..+|.|||||++|+++||..||.... ..++.+.+..+....
T Consensus 176 d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~ 254 (732)
T KOG4250|consen 176 DNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQE 254 (732)
T ss_pred CCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeec
Confidence 654 556889999999999998 4889999999999999999999999995332 333555554433211
Q ss_pred ------------CCCCh-------HHHHHHHHhhh-CCCCCC--CHHHHHHHHHhh
Q 003971 744 ------------EIPEG-------PLGRLIADCWA-EPQERP--SCEEILSRLLDC 777 (782)
Q Consensus 744 ------------~ip~~-------~L~~LI~~CL~-DP~kRP--Sa~EIL~~L~di 777 (782)
+.|.. .+...+..++. +|++|. .+.+.-..+.++
T Consensus 255 ~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 255 EENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred ccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 11111 24455666677 888887 666555555544
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=292.80 Aligned_cols=242 Identities=25% Similarity=0.418 Sum_probs=199.1
Q ss_pred CCCeeEe-eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccC----CC
Q 003971 523 FSELTVG-TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK----PP 594 (782)
Q Consensus 523 ~s~y~i~-~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d----~~ 594 (782)
+++|++- ++||-|-.|+|..+.+ +++.+|+|++... ....+|+++.-.. .|||||.++++|.. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 3566664 4789999999999976 5889999997421 3456888887666 59999999999854 35
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc---CCCeEEEEecCcc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN---KHWTVKICDFGLS 671 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd---~~g~VKLaDFGLA 671 (782)
++.+|||.++||.|++.+... ....+++.++..|+.||+.|+.|||+.+|.||||||+|+|.. .+..+||+|||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 689999999999999999743 456799999999999999999999999999999999999996 4568999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCCCCCC
Q 003971 672 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL----PERVVYAVANEGSRLEIPE 747 (782)
Q Consensus 672 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~----~~evl~~i~~~~~~~~ip~ 747 (782)
+.-.. .....+.|-||.|.|||++...+|+..+|+||+||++|-|++|..||+... ...+...+..+.+.++-|+
T Consensus 212 K~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 212 KETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred cccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 87653 334567889999999999999999999999999999999999999997543 2334445555444443331
Q ss_pred -----hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 748 -----GPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 748 -----~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+++|+.+|. +|.+|.|+.+++++
T Consensus 291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 247789999999 99999999999876
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=282.31 Aligned_cols=250 Identities=24% Similarity=0.422 Sum_probs=205.6
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCC
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPP 594 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~ 594 (782)
....+.++++.+..||.|.-|.|+++.+ .|..+|||....... .+..+.++..+.++...+ +|+||+.+|+|..+.
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 3445667777888999999999999977 468999999876554 455688888898887775 999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
..++.||.|.. .+..++.+ -.+++++.-+-++...++.||.||.. ++|||||+||+|||+|+.|++||||||++-.
T Consensus 165 dV~IcMelMs~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 165 DVFICMELMST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred hHHHHHHHHHH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence 99999998853 44455543 24568888888999999999999986 5899999999999999999999999999998
Q ss_pred ccCCCCCCCCCCCCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCh-
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG- 748 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTGk~PF~~~~-~~evl~~i~~~~~~~~ip~~- 748 (782)
+.+.. ..+...|.+.|||||.+.- ..|+.++||||||++|+||.||+.||.+.+ ..+++..+.+ ...+-++..
T Consensus 242 lvdSk-AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~ 319 (391)
T KOG0983|consen 242 LVDSK-AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHM 319 (391)
T ss_pred eeccc-ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCccc
Confidence 87653 3456789999999999853 468999999999999999999999999865 4455555555 333444432
Q ss_pred ----HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 749 ----PLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 749 ----~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+.+++..||. |+.+||...++++|
T Consensus 320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 48899999999 99999999999976
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=310.64 Aligned_cols=241 Identities=24% Similarity=0.370 Sum_probs=205.4
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccc-cChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD-LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~-~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
.+.+-|..++.||-|+||+|.++.. +...||+|.+.+.+ +...++.....|..||.....+-||+||..|++.+.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 4456788999999999999999954 56679999987665 34566788889999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+||+|++||++-.+|. ..+-|.+..++.++.++.-|+++.|+.|+|||||||+|||||.+|++||+||||+.-+.-.
T Consensus 706 FVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999999887 4468999999999999999999999999999999999999999999999999998754210
Q ss_pred --------C----------------------------------CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHH
Q 003971 678 --------P----------------------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMW 715 (782)
Q Consensus 678 --------~----------------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILy 715 (782)
+ ......+||+.|+|||++....|+..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0 0012356999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh-----HHHHHHHHhhhCCCCC
Q 003971 716 ELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG-----PLGRLIADCWAEPQER 764 (782)
Q Consensus 716 ELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~~-----~L~~LI~~CL~DP~kR 764 (782)
||+.|+.||....+.+..+.+++....+.++.. +..++|.++..+++.|
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~R 916 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSR 916 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhh
Confidence 999999999999998888888887777777632 3555666655556666
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=326.20 Aligned_cols=243 Identities=28% Similarity=0.445 Sum_probs=189.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC---------
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--------- 592 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--------- 592 (782)
.+|..+..||+||||.||+++. +|+.||||.+.... .......+.+|+..|.+|+|||||+++..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 5667778899999999999976 89999999987665 44556778899999999999999998865310
Q ss_pred ---------------------------------------------------------------------C----------
Q 003971 593 ---------------------------------------------------------------------P---------- 593 (782)
Q Consensus 593 ---------------------------------------------------------------------~---------- 593 (782)
.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CceEEEEEEecccchhhHHHhhcccccc-hHHHHHHHHHHHHHHHHHHH
Q 003971 594 -------------------------------PRLSMITEYMELGSLYHLIHLSGQKKKL-SWRRKLKMLRDICRGLMCIH 641 (782)
Q Consensus 594 -------------------------------~~l~LV~Ey~~gGsL~dlL~~~~~~~~L-s~~~~l~Ia~QIa~gL~yLH 641 (782)
-.+||-||||+..++.++++.. ... .....+++++||++||.|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHHHHH
Confidence 1257889999998888888732 222 46778999999999999999
Q ss_pred hccccccCCCcccEEEcCCCeEEEEecCcccccc------C------------CCCCCCCCCCCCcccCccccccC---C
Q 003971 642 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT------D------------SPMRDSSSAGTPEWMAPELIRNE---P 700 (782)
Q Consensus 642 s~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~------~------------~~~~~~~~~GT~~Y~APEvl~~~---~ 700 (782)
++|||||||||.||+|+++..|||+|||+|+... + .....+..+||.-|+|||++.+. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998721 0 01123567899999999999765 4
Q ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---CC---hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 701 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI---PE---GPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 701 ~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i---p~---~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
|+.|+|+||||+++|||+. ||.........-.-+..+..+.. .. ..-..+|..+++ ||.+|||+.|+|..
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 9999999999999999996 78765443333222232222221 11 124568999999 99999999999863
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=313.00 Aligned_cols=248 Identities=30% Similarity=0.589 Sum_probs=212.2
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CC----eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NG----TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g----~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
.+..++||.|+||+||+|.| +| -+||+|++......+ .-.+++.|+-+|.++.|||+++|+++|.... +.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~-~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK-ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch-hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34457899999999999987 43 369999987655433 3478999999999999999999999998876 8899
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
++|+++|+|.++++. ....+-.+..+.|.+||++||.|||.++++||||.+.||||.+..++||.|||+++.+.....
T Consensus 776 tq~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999984 456788888999999999999999999999999999999999999999999999998865533
Q ss_pred CC--CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCh---HHHHH
Q 003971 680 RD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 753 (782)
Q Consensus 680 ~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~~---~L~~L 753 (782)
.. ....-.+.|||-|.+...+|+.++|||||||++||++| |..||.+....++.. ++..+.++..|+. .++.+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d-lle~geRLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD-LLEKGERLSQPPICTIDVYMV 932 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH-HHhccccCCCCCCccHHHHHH
Confidence 32 33445568999999999999999999999999999986 888999998877655 4566777777765 58889
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 754 IADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
+.+||. |+..||+|+++...+....
T Consensus 933 mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 933 MVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred HHHHhccCcccCccHHHHHHHHHHHh
Confidence 999999 9999999999998887653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=276.77 Aligned_cols=214 Identities=22% Similarity=0.249 Sum_probs=175.8
Q ss_pred eCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccchhhHH
Q 003971 535 GFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLI 612 (782)
Q Consensus 535 G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL 612 (782)
|.||.||++.+ +++.||+|.+.... .+..|...+....||||+++++++.+....+++|||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999987 68899999986542 2334555566667999999999999999999999999999999988
Q ss_pred HhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccC
Q 003971 613 HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMA 692 (782)
Q Consensus 613 ~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~A 692 (782)
.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...... .....++..|+|
T Consensus 77 ~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~a 150 (237)
T cd05576 77 SK---FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCA 150 (237)
T ss_pred HH---hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccC
Confidence 63 345899999999999999999999999999999999999999999999999988665432 223456778999
Q ss_pred ccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCH
Q 003971 693 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSC 767 (782)
Q Consensus 693 PEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa 767 (782)
||.+....++.++|+||+||++|+|++|+.||....... .......+| ...+.+++.+||+ ||.+||++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 999988889999999999999999999998876432211 111112222 3468999999999 99999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-31 Score=263.85 Aligned_cols=233 Identities=31% Similarity=0.468 Sum_probs=194.6
Q ss_pred CcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccchhhHHH
Q 003971 536 FFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH 613 (782)
Q Consensus 536 ~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~ 613 (782)
+||.||+|.+. ++.+|+|++........ .+.+.+|++.++.++|+||+++++++......++++||+.+++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999874 68999999875544322 5789999999999999999999999999899999999999999999886
Q ss_pred hhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCc
Q 003971 614 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAP 693 (782)
Q Consensus 614 ~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~AP 693 (782)
.. ..+++..++.++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||++....... ......++..|++|
T Consensus 80 ~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KR---GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred hc---cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 32 238899999999999999999999999999999999999999999999999998775432 23456688899999
Q ss_pred cccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHHHHHhhh-CCCCCCCH
Q 003971 694 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRLIADCWA-EPQERPSC 767 (782)
Q Consensus 694 Evl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-----p~~~L~~LI~~CL~-DP~kRPSa 767 (782)
|.+....++.++|||+||+++|+|++|..||..................... -...+.+++.+||. +|.+||++
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 235 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA 235 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCH
Confidence 9998888899999999999999999999999873333333333333322221 23468899999999 99999999
Q ss_pred HHHHHH
Q 003971 768 EEILSR 773 (782)
Q Consensus 768 ~EIL~~ 773 (782)
.+++++
T Consensus 236 ~~~~~~ 241 (244)
T smart00220 236 EEALQH 241 (244)
T ss_pred HHHhhC
Confidence 999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=329.02 Aligned_cols=238 Identities=23% Similarity=0.394 Sum_probs=188.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
.|...+.||+|+||.||+|.+ ++..||||.+...... ...|++++++++|||||+++++|.+....|+||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 455667899999999999986 6889999988543221 12468899999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHH---hccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH---RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLH---s~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
+++|+|.++++ .+++.++..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999985 3789999999999999999999 6699999999999999998888875 666544322
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcC-----CCC------
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-----ERVVYAVANEG-----SRL------ 743 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~-----~evl~~i~~~~-----~~~------ 743 (782)
.....+|+.|+|||++.+..++.++|||||||++|||+||+.||..... ........... ..+
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 1234688999999999999999999999999999999999999853211 01110000000 000
Q ss_pred CCCCh---HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 744 EIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 744 ~ip~~---~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
..+.. .+.+++.+||. ||++||++.++++.|+++..
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 11111 35678899999 99999999999999998743
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-33 Score=303.87 Aligned_cols=240 Identities=29% Similarity=0.448 Sum_probs=203.4
Q ss_pred eeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEeccc
Q 003971 529 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
.+.||.|.||+||-|++ +|+.||||++.+-........++.+|+.||+.++||.||.|...|++.+.+++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 46899999999999976 7999999999888877777789999999999999999999999999999999999999875
Q ss_pred chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC---CeEEEEecCccccccCCCCCCCC
Q 003971 607 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH---WTVKICDFGLSRIITDSPMRDSS 683 (782)
Q Consensus 607 sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~---g~VKLaDFGLA~~l~~~~~~~~~ 683 (782)
-|.-++. ...++|++.....++.||+.||.|||.++|+|+||||+||||.+. -++||||||+|+.+...... ..
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR-rs 725 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR-RS 725 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh-hh
Confidence 5555554 356789999999999999999999999999999999999999643 37999999999998765433 57
Q ss_pred CCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCCC----hHHHHHHHHhh
Q 003971 684 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIPE----GPLGRLIADCW 758 (782)
Q Consensus 684 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~-~~ip~----~~L~~LI~~CL 758 (782)
.+|||.|+|||++.++.|+..-|+||.|||+|--++|..||.... ++-.++.+...- ++-|. ...-+||..++
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~LL 803 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNLL 803 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHHHH
Confidence 899999999999999999999999999999999999999996542 333344443322 22222 23567899999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003971 759 A-EPQERPSCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRPSa~EIL~~ 773 (782)
+ .-++|.|.+..+.|
T Consensus 804 qVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 804 QVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHhcchHhhccc
Confidence 9 89999999988876
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=285.72 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=195.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC-CCce
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRL 596 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-~~~l 596 (782)
..|.+...||+|.||.||++... ...+|||.++.+......-....+|+.+++.++||||+.+..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 56888899999999999999542 2369999987663322333567899999999999999999999987 7789
Q ss_pred EEEEEEecccchhhHHHhh--cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC----CeEEEEecCc
Q 003971 597 SMITEYMELGSLYHLIHLS--GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH----WTVKICDFGL 670 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~--~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~----g~VKLaDFGL 670 (782)
++++||.+. +|+++++.. .....++...++.|+.||+.|+.|||++-|+||||||.|||+..+ |.|||+|||+
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999999987 888888643 234578999999999999999999999999999999999999877 8999999999
Q ss_pred cccccCCCC---CCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHH
Q 003971 671 SRIITDSPM---RDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVL---------PERVVYAVA 737 (782)
Q Consensus 671 A~~l~~~~~---~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~---------~~evl~~i~ 737 (782)
++.+.+.-. .....+-|.+|.|||++.+. .|+.+.|||+.|||+.||+|-++.|.+.. ....+..+.
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 998866422 23456789999999998875 58999999999999999999887774321 112222332
Q ss_pred hcCCCCC---C------C-----------------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 738 NEGSRLE---I------P-----------------------------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 738 ~~~~~~~---i------p-----------------------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.--..+. . | +....+|+.+++. ||-+|.|+++.+++
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 2111110 0 1 0124568889999 99999999999876
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=281.43 Aligned_cols=245 Identities=22% Similarity=0.393 Sum_probs=203.9
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhC-CCCceeeEeccccC
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRL-RHPNVILFLGACTK 592 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d 592 (782)
..|.+...+|.+++.||+|+|++|..+.+ +.+.||+|++++.-.+ .+++.-...|..+.... +||.+|.+..+|++
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 45677889999999999999999999976 5678999998776543 33455566777777665 69999999999999
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
...+++|.||++||+|.-+++ ....++++.++.+..+|+.||.|||++|||+||||.+|||++..|++||+|+|+++
T Consensus 323 esrlffvieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred cceEEEEEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhh
Confidence 999999999999999987776 45689999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCC-------CCChHHHHHHHHhcCCCCCC
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWE-------GVLPERVVYAVANEGSRLEI 745 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~-------~~~~~evl~~i~~~~~~~~i 745 (782)
.--.+.....++||||.|+|||++.+..|...+|+|+|||+++||+.|+.||+ +.+.+..+.+++-+. ..-+
T Consensus 400 e~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek-qiri 478 (593)
T KOG0695|consen 400 EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK-QIRI 478 (593)
T ss_pred cCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-cccc
Confidence 76555566678999999999999999999999999999999999999999995 233444444444322 2223
Q ss_pred CCh---HHHHHHHHhhh-CCCCCC
Q 003971 746 PEG---PLGRLIADCWA-EPQERP 765 (782)
Q Consensus 746 p~~---~L~~LI~~CL~-DP~kRP 765 (782)
|.. ....+++..+. ||.+|.
T Consensus 479 prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cceeehhhHHHHHHhhcCCcHHhc
Confidence 322 34567777787 999984
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=289.22 Aligned_cols=247 Identities=33% Similarity=0.584 Sum_probs=202.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHh--CCCCceeeEeccccCCC----ceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR--LRHPNVILFLGACTKPP----RLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~--L~HPNIVkL~g~~~d~~----~l~ 597 (782)
.+.++.+.||+|.||+||+|.|.|+.||||+|...+ ...+.+|.++++- |+|+||+.|++.-..+. +++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 567889999999999999999999999999996543 2566788888765 59999999998865543 589
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc--------cccccCCCcccEEEcCCCeEEEEecC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM--------KIVHRDLKSANCLVNKHWTVKICDFG 669 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~--------gIIHrDIKPeNILLd~~g~VKLaDFG 669 (782)
+|++|.+.|+|+|+|. ...++....++++..++.||++||.. .|.|||||..|||+.+++..-|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999996 35789999999999999999999963 49999999999999999999999999
Q ss_pred ccccccCCC----CCCCCCCCCCcccCccccccCC----C--CchhHHHHHHHHHHHHHh----C------CCCCCCC--
Q 003971 670 LSRIITDSP----MRDSSSAGTPEWMAPELIRNEP----F--TEKCDIFSLGVIMWELCT----L------NRPWEGV-- 727 (782)
Q Consensus 670 LA~~l~~~~----~~~~~~~GT~~Y~APEvl~~~~----~--s~ksDVWSLGvILyELLT----G------k~PF~~~-- 727 (782)
||....... ......+||.+|||||++...- + -..+||||||.++||++. | +.||++.
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 998765432 2335678999999999986542 1 235899999999999875 2 4688644
Q ss_pred ---ChHHHHHHHHhcCCCCCCCCh--------HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 728 ---LPERVVYAVANEGSRLEIPEG--------PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 728 ---~~~evl~~i~~~~~~~~ip~~--------~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+-+++..-+.....++.+|.. .+.+||+.||. ||.-|-|+--|.+.|.++..
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 444555555667777777742 36778999999 99999999999999988753
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=284.42 Aligned_cols=238 Identities=26% Similarity=0.460 Sum_probs=192.8
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEEEEEeccc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
+.||+|+|+.|-.++. +|..||||++.++ .......+.+|++++..++ |+||+.|+++|+++..+|+|||-|.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 5799999999998854 8999999999766 3344678899999999996 999999999999999999999999999
Q ss_pred chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC---eEEEEecCccccccC--CC---
Q 003971 607 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSRIITD--SP--- 678 (782)
Q Consensus 607 sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g---~VKLaDFGLA~~l~~--~~--- 678 (782)
.|..+++ +.+.+++..+.++..+|+.||.|||.+||.||||||+|||..... .||||||.|..-+.. +.
T Consensus 162 plLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 162 PLLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred hHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 9998887 567899999999999999999999999999999999999996554 589999988754321 10
Q ss_pred --CCCCCCCCCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCC--------------ChHHHHHHHH
Q 003971 679 --MRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGV--------------LPERVVYAVA 737 (782)
Q Consensus 679 --~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTGk~PF~~~--------------~~~evl~~i~ 737 (782)
....+.+|+..|||||+.. ...|+.++|.||||||||-|++|+.||.+. .-.+.+..-+
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI 318 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 318 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence 1123567889999999863 235889999999999999999999999632 1122233323
Q ss_pred hcCCCCCCCCh-------HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 738 NEGSRLEIPEG-------PLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 738 ~~~~~~~ip~~-------~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.++ ..++|+. ...+|+..++. |+..|.++.+++.+
T Consensus 319 QEG-kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 319 QEG-KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred hcc-CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 322 3344433 46788999998 99999999998873
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=262.19 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=204.3
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|.-.++||+|.||+||++.. .++.||+|.....+.++.......+|+.+|+.++|.|||+++++...++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455667899999999999976 577899999877666555567788999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
|.. .|..+... -++.++.+.++.++.|+++||.|||++++.|||+||.|+|++.+|.+||+|||+++.+.-+..-..
T Consensus 83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 975 66666552 357889999999999999999999999999999999999999999999999999998876544445
Q ss_pred CCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC---------CCC----
Q 003971 683 SSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLE---------IPE---- 747 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~---------ip~---- 747 (782)
..+-|.+|.+|.++.+. -|+...|+||.||++.|+.. |++.|++.+....+..+...-..+. +|+
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 66789999999998775 48899999999999999985 5666899888888777764222111 111
Q ss_pred -----------------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 748 -----------------GPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 748 -----------------~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..-++|+..++. +|..|.++++.+++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 013467888888 99999999998876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=288.43 Aligned_cols=245 Identities=29% Similarity=0.538 Sum_probs=203.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhC--CCCceeeEeccccCCC----ceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL--RHPNVILFLGACTKPP----RLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L--~HPNIVkL~g~~~d~~----~l~ 597 (782)
....+.+.||+|.||.||+|+.+++.||||+|. .+..+.|.+|.+|++.. +|+||++|+++-.... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345567889999999999999999999999985 34567899999988765 6999999999876554 799
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc---------cccccCCCcccEEEcCCCeEEEEec
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM---------KIVHRDLKSANCLVNKHWTVKICDF 668 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~---------gIIHrDIKPeNILLd~~g~VKLaDF 668 (782)
+|++|.+.|+|.++|. ...++|....+++.-+++||+|||+. .|+|||||..||||.+|++..|+||
T Consensus 285 LVt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999996 45789999999999999999999963 4999999999999999999999999
Q ss_pred CccccccCCCCC--CCCCCCCCcccCccccccCC-CC-----chhHHHHHHHHHHHHHhC------------CCCCC---
Q 003971 669 GLSRIITDSPMR--DSSSAGTPEWMAPELIRNEP-FT-----EKCDIFSLGVIMWELCTL------------NRPWE--- 725 (782)
Q Consensus 669 GLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~-~s-----~ksDVWSLGvILyELLTG------------k~PF~--- 725 (782)
|||..+...... ....+||.+|||||++.+.. +. .+.||||+|.+||||++. +.||.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999887643221 23478999999999997642 22 368999999999999974 23453
Q ss_pred --CCChHHHHHHHHhcCCCCCCCCh--------HHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 726 --GVLPERVVYAVANEGSRLEIPEG--------PLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 726 --~~~~~evl~~i~~~~~~~~ip~~--------~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
...-+++...+..+..++.+|+. .+.+.+..||. ||+-|.|+.=+.+++.++
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 33555667777788889988853 48889999999 999999998888877665
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=302.24 Aligned_cols=249 Identities=29% Similarity=0.492 Sum_probs=211.7
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEE--ECCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccC-----
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK----- 592 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~--~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d----- 592 (782)
.....|.+...||.|.+|.||+++ ++++..|+|++..... .-+++..|.++|+.+ .|||++.++|+|..
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 344667889999999999999885 4799999999864432 235666788999887 59999999999843
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
++++|+|||||.+|++.|+++... +..+.|..+..|++.++.|+.+||+..++|||||-.|||++.++.|||+|||++.
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 467999999999999999998554 7789999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCcccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-C
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-P 746 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-p 746 (782)
.++..-....+..|||.|||||++.. ..|+..+|+||||++..||.-|.+|+-+..+...+..+......... |
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp 251 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRP 251 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccch
Confidence 88776556678899999999999854 34778999999999999999999999999998888776543322222 2
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 ---EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+.++|..|+. |-.+||++.++++|
T Consensus 252 ~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 252 KKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 2358889999998 99999999999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=276.47 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=203.0
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHH-hCCCCceeeEeccccCC
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILS-RLRHPNVILFLGACTKP 593 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk-~L~HPNIVkL~g~~~d~ 593 (782)
.-|.+...+++-+..||.|+||+|++..+ .|+..|||.+...... ...++++.|.+... .-+.||||+|||++..+
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 34566667777788999999999999987 5889999999776653 34578888887654 45799999999999999
Q ss_pred CceEEEEEEecccchhhHHH--hhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCc
Q 003971 594 PRLSMITEYMELGSLYHLIH--LSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGL 670 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~--~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGL 670 (782)
+..|+.||.|+- +|..+.+ .......+++.-+-.|....+.||.||.. .+|||||+||+||||+..|.|||||||+
T Consensus 136 GdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 136 GDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred CceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccc
Confidence 999999999973 4443322 12345678888888999999999999986 6899999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC-
Q 003971 671 SRIITDSPMRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE- 747 (782)
Q Consensus 671 A~~l~~~~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~- 747 (782)
+-.+.+. ...+..+|...|||||.+.. ..|+.++||||||++|||+.||+.||.+.+..-.....+..+..+.+..
T Consensus 215 cGqLv~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 215 CGQLVDS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred hHhHHHH-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc
Confidence 9877553 23345678889999999864 3589999999999999999999999998876443333444444443321
Q ss_pred -------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 748 -------GPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 748 -------~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.++..+|.-|+. |-..||...+++++
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 258889999998 99999999998864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=295.17 Aligned_cols=247 Identities=19% Similarity=0.235 Sum_probs=169.6
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--C----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecc---
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW--N----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA--- 589 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~--~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~--- 589 (782)
..+..++|.+.++||+|+||.||+|.+ + +..||+|.+..... .+.+..+ .+....+.++..++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 445678999999999999999999987 3 67899998753221 1111111 1222223333332222
Q ss_pred ---ccCCCceEEEEEEecccchhhHHHhhcc-----------------cccchHHHHHHHHHHHHHHHHHHHhccccccC
Q 003971 590 ---CTKPPRLSMITEYMELGSLYHLIHLSGQ-----------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 649 (782)
Q Consensus 590 ---~~d~~~l~LV~Ey~~gGsL~dlL~~~~~-----------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrD 649 (782)
+.....+++++||+.+++|.+++..... ........+..++.||+.||+|||+++|+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2455679999999999999988863211 01122345678999999999999999999999
Q ss_pred CCcccEEEcC-CCeEEEEecCccccccCC-CCCCCCCCCCCcccCccccccC----------------------CCCchh
Q 003971 650 LKSANCLVNK-HWTVKICDFGLSRIITDS-PMRDSSSAGTPEWMAPELIRNE----------------------PFTEKC 705 (782)
Q Consensus 650 IKPeNILLd~-~g~VKLaDFGLA~~l~~~-~~~~~~~~GT~~Y~APEvl~~~----------------------~~s~ks 705 (782)
|||+|||++. ++.+||+|||+++.+... ........+|+.|+|||.+... .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999985 579999999999865432 2233466889999999965322 234567
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-cC-------------CCCC---------CCChHHHHHHHHhhh-CC
Q 003971 706 DIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN-EG-------------SRLE---------IPEGPLGRLIADCWA-EP 761 (782)
Q Consensus 706 DVWSLGvILyELLTGk~PF~~~~~~evl~~i~~-~~-------------~~~~---------ip~~~L~~LI~~CL~-DP 761 (782)
|||||||+||||+++..|+.... ........ .+ .... .......+|+.+|+. ||
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNL--IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHH--HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 99999999999999877654321 11111111 00 0000 011124489999999 99
Q ss_pred CCCCCHHHHHHH
Q 003971 762 QERPSCEEILSR 773 (782)
Q Consensus 762 ~kRPSa~EIL~~ 773 (782)
.+|||+.++++|
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999986
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=274.79 Aligned_cols=249 Identities=28% Similarity=0.435 Sum_probs=200.5
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC------
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------ 593 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------ 593 (782)
..+.|.-..+||+|.||+||++.. .|+.||+|+....+.........++|+.+|..++|+|++.+++.|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 446677788999999999999965 577889887655444444456678999999999999999999998542
Q ss_pred --CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 594 --PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 594 --~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
..+|+||.+|+. +|..++. +....++...+.+++.+++.||.|+|...|+|||+|+.|+|++.+|.+||+|||++
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 248999999986 7777775 34468899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC----CCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--cCCCCC
Q 003971 672 RIITDSP----MRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN--EGSRLE 744 (782)
Q Consensus 672 ~~l~~~~----~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~--~~~~~~ 744 (782)
+.+.... ...+..+-|.+|.+||.+.+ ..|+.+.|||..||++.||+|+..-|.+......+..+.. +....+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 8764321 22456677999999998876 5699999999999999999999999998887776665532 111111
Q ss_pred ------------------CC----------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 ------------------IP----------------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 ------------------ip----------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+| ++...+|+..++. ||.+|+++.+++.|
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11 1134568899999 99999999999876
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=274.22 Aligned_cols=263 Identities=23% Similarity=0.452 Sum_probs=219.0
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEec
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g 588 (782)
..++.+...+++....+-+|.||.||+|.+. .+.+.+|.++.+. ..-++..++.|...+..+.|||+..+.+
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 3456667778888889999999999999763 2345566654332 3445678899999999999999999999
Q ss_pred cccCC-CceEEEEEEecccchhhHHHh-----hcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe
Q 003971 589 ACTKP-PRLSMITEYMELGSLYHLIHL-----SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 662 (782)
Q Consensus 589 ~~~d~-~~l~LV~Ey~~gGsL~dlL~~-----~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~ 662 (782)
++.+. ...++++.++.-|+|..++.. ......++..+...++.|++.|++|||+.|+||.||...|+++++..+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence 98654 457888999999999999973 233456888899999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 003971 663 VKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANE 739 (782)
Q Consensus 663 VKLaDFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~ 739 (782)
|||+|=.+++.+....++. ...-....||+||.+.+..|+.++|+|||||+||||+| |+.||...++.++.. .+..
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-ylkd 513 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-YLKD 513 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-HHhc
Confidence 9999999999876554432 23345568999999999999999999999999999997 788999999987665 4566
Q ss_pred CCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 740 GSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 740 ~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
+++...|. +++..++..||. +|++||+++++...|.++...
T Consensus 514 GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 514 GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 88887774 468999999999 999999999999999988654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=282.94 Aligned_cols=246 Identities=23% Similarity=0.388 Sum_probs=196.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccc-cC----hHHHHHHHHHHHHHHhCCCCceeeEeccccC-CCc
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD-LT----AENMEDFCNEISILSRLRHPNVILFLGACTK-PPR 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~-~~----~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-~~~ 595 (782)
++|-+++.||+|+|++||++.+ ..+.||||+-.... +. ....+...+|..|.+.|.||.||++|++|.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 6788899999999999999966 68899999875433 11 2235678899999999999999999999854 466
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc--cccccCCCcccEEEc---CCCeEEEEecCc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM--KIVHRDLKSANCLVN---KHWTVKICDFGL 670 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~--gIIHrDIKPeNILLd---~~g~VKLaDFGL 670 (782)
++-|+|||+|.+|.-+|+ ..+.++++.++.|+.||+.||.||... .|||-||||.||||- .-|.+||+||||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 889999999999999997 567899999999999999999999976 499999999999994 457899999999
Q ss_pred cccccCCCCC-------CCCCCCCCcccCccccccC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHH-HHH
Q 003971 671 SRIITDSPMR-------DSSSAGTPEWMAPELIRNE----PFTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVY-AVA 737 (782)
Q Consensus 671 A~~l~~~~~~-------~~~~~GT~~Y~APEvl~~~----~~s~ksDVWSLGvILyELLTGk~PF~~~~~~e-vl~-~i~ 737 (782)
++.+.++.+. .....||.+|++||.+.-. +.+.|+||||+|||+|.++.|+.||....... ++. ..+
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 9998765433 2346799999999987533 46789999999999999999999997654332 222 112
Q ss_pred hcCCCCCCC-----ChHHHHHHHHhhh-CCCCCCCHHHHHH
Q 003971 738 NEGSRLEIP-----EGPLGRLIADCWA-EPQERPSCEEILS 772 (782)
Q Consensus 738 ~~~~~~~ip-----~~~L~~LI~~CL~-DP~kRPSa~EIL~ 772 (782)
-+.....+| ....+.+|++||+ --+.|....++..
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 222222233 3468899999998 7778888777653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=238.09 Aligned_cols=210 Identities=40% Similarity=0.641 Sum_probs=183.5
Q ss_pred EeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccchh
Q 003971 532 VGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 609 (782)
Q Consensus 532 LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL~ 609 (782)
||+|.+|.||++... ++.+++|++....... ..+.+.+|++.++.++|++|+++++++......++++||+.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999886 8899999987554322 3467899999999999999999999999989999999999999999
Q ss_pred hHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC-CCeEEEEecCccccccCCCCCCCCCCCCC
Q 003971 610 HLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRIITDSPMRDSSSAGTP 688 (782)
Q Consensus 610 dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~-~g~VKLaDFGLA~~l~~~~~~~~~~~GT~ 688 (782)
+++... ...+++..++.++.+++.++.|||+.|++|+||+|.||+++. ++.++|+|||.+..............+..
T Consensus 80 ~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 80 DLLKEN--EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 988632 146889999999999999999999999999999999999999 89999999999987654422233456778
Q ss_pred cccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCC
Q 003971 689 EWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPS 766 (782)
Q Consensus 689 ~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPS 766 (782)
.|++||.+... .++.+.|+|++|+++++| ..+.+++..|+. +|.+||+
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------~~~~~~l~~~l~~~p~~R~~ 207 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------PELKDLIRKMLQKDPEKRPS 207 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------HHHHHHHHHHhhCCcccCcC
Confidence 99999999887 788999999999999999 458889999998 9999999
Q ss_pred HHHHHHHH
Q 003971 767 CEEILSRL 774 (782)
Q Consensus 767 a~EIL~~L 774 (782)
+.++++++
T Consensus 208 ~~~l~~~~ 215 (215)
T cd00180 208 AKEILEHL 215 (215)
T ss_pred HHHHhhCC
Confidence 99998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=277.50 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=199.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCC--C----ceeeEeccccC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH--P----NVILFLGACTK 592 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H--P----NIVkL~g~~~d 592 (782)
.-..+|.+...||+|.||.|-.+.+ .+..||||+++.- ....+..+-|+++|+++.+ | -+|.+.++|..
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 3468899999999999999999987 4678999997532 2234566789999999942 2 38899999999
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC-------------
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK------------- 659 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~------------- 659 (782)
.++.++|+|.+ |-++++++.. ++..+++..+++.+++|++++++|||+.+++|.||||+|||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred cCceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 99999999998 4599999973 34568999999999999999999999999999999999999931
Q ss_pred -------CCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 003971 660 -------HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV 732 (782)
Q Consensus 660 -------~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~ev 732 (782)
+..|+|+|||.|+.... .....+.|..|.|||++.+-.++.++||||+||||+|++||...|++..+.+.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred ceeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 34689999999987543 33677899999999999999999999999999999999999999998876664
Q ss_pred HHHHHhcC-------------------CCCCCC----------------------------ChHHHHHHHHhhh-CCCCC
Q 003971 733 VYAVANEG-------------------SRLEIP----------------------------EGPLGRLIADCWA-EPQER 764 (782)
Q Consensus 733 l~~i~~~~-------------------~~~~ip----------------------------~~~L~~LI~~CL~-DP~kR 764 (782)
+..+..-- .+.+.+ ...+.+|+.+||. ||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 33221100 011111 0147789999999 99999
Q ss_pred CCHHHHHHH
Q 003971 765 PSCEEILSR 773 (782)
Q Consensus 765 PSa~EIL~~ 773 (782)
+|+.|+++|
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999999976
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=281.60 Aligned_cols=254 Identities=19% Similarity=0.252 Sum_probs=180.1
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE------------------CCeEEEEEEeeccccCh------------HHHHHHH
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW------------------NGTDVAIKVFLEQDLTA------------ENMEDFC 569 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~------------------~g~~VAVKil~~~~~~~------------~~~e~f~ 569 (782)
....++|.+.++||+|+||+||+|.+ .++.||||.+....... ...+.+.
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 44678999999999999999999963 34679999986432110 0112334
Q ss_pred HHHHHHHhCCCCce-----eeEeccccC--------CCceEEEEEEecccchhhHHHhhcc-------------------
Q 003971 570 NEISILSRLRHPNV-----ILFLGACTK--------PPRLSMITEYMELGSLYHLIHLSGQ------------------- 617 (782)
Q Consensus 570 ~EI~iLk~L~HPNI-----VkL~g~~~d--------~~~l~LV~Ey~~gGsL~dlL~~~~~------------------- 617 (782)
.|+.++.+++|.++ ++++++|.. ....++||||+++++|.++++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 56777777776554 677777653 3458999999999999998863210
Q ss_pred --cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-CCCCCCCCCcccCcc
Q 003971 618 --KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDSSSAGTPEWMAPE 694 (782)
Q Consensus 618 --~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~-~~~~~~GT~~Y~APE 694 (782)
...+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+..... ......+|+.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 12346778899999999999999999999999999999999999999999999976543221 111234578999999
Q ss_pred ccccCC--------------------C--CchhHHHHHHHHHHHHHhCCC-CCCCCChHHHHH--------HHH-hcCCC
Q 003971 695 LIRNEP--------------------F--TEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVY--------AVA-NEGSR 742 (782)
Q Consensus 695 vl~~~~--------------------~--s~ksDVWSLGvILyELLTGk~-PF~~~~~~evl~--------~i~-~~~~~ 742 (782)
.+.... | ..+.||||+||++|+|++|.. ||.+........ .+. .....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 875322 1 124799999999999999986 775432111110 000 01111
Q ss_pred CCCC-----ChHHHHHHHHhhh-CC---CCCCCHHHHHHH
Q 003971 743 LEIP-----EGPLGRLIADCWA-EP---QERPSCEEILSR 773 (782)
Q Consensus 743 ~~ip-----~~~L~~LI~~CL~-DP---~kRPSa~EIL~~ 773 (782)
..++ .+...+|+.+|+. +| .+|+|+.|+|+|
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1121 3457889999997 54 689999999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=238.15 Aligned_cols=214 Identities=35% Similarity=0.540 Sum_probs=180.3
Q ss_pred eeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEe
Q 003971 526 LTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 603 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 603 (782)
|.+.+.||.|++|.||++... +..+++|.+...... ...+.+.+|++.++.++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 567889999999999999874 688999998755433 24678899999999999999999999999889999999999
Q ss_pred cccchhhHHHhhccccc-chHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC-CCC
Q 003971 604 ELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-MRD 681 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~-Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~-~~~ 681 (782)
++++|.+++... .. +++..+..++.+++.++.|||+.+++|+||+|.||+++.++.++|+|||++....... ...
T Consensus 80 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 80 EGGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 999999998732 23 7899999999999999999999999999999999999999999999999998775432 122
Q ss_pred CCCCCCCcccCcccc-ccCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCC
Q 003971 682 SSSAGTPEWMAPELI-RNEPFTEKCDIFSLGVIMWELCTLNRPWEG-VLPERVVYAVANEGSRL 743 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl-~~~~~s~ksDVWSLGvILyELLTGk~PF~~-~~~~evl~~i~~~~~~~ 743 (782)
....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. ..+...+...+..+...
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 220 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL 220 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence 345677889999998 667788899999999999999999999987 55554555544444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=291.95 Aligned_cols=236 Identities=34% Similarity=0.525 Sum_probs=188.8
Q ss_pred eEEeeeCcEE-EEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEEEEEecccc
Q 003971 530 TRVGIGFFGE-VFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMELGS 607 (782)
Q Consensus 530 ~~LG~G~fG~-VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey~~gGs 607 (782)
+.+|.|+-|+ ||+|.+.|+.||||.+... ...-..+||..|+.-. |||||++++.-.+...+|+..|.|. .+
T Consensus 515 eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred HHcccCCCCcEEEEEeeCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 4689999985 7999999999999987532 2345678999999885 9999999999999999999999997 59
Q ss_pred hhhHHHhhccc-ccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC---C--CeEEEEecCccccccCCCC--
Q 003971 608 LYHLIHLSGQK-KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---H--WTVKICDFGLSRIITDSPM-- 679 (782)
Q Consensus 608 L~dlL~~~~~~-~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~---~--g~VKLaDFGLA~~l~~~~~-- 679 (782)
|.+++...... ........+.++.|++.||++||+.+||||||||.||||+. + ..++|+|||+++.+.....
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~ 668 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF 668 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence 99999743111 11111445788999999999999999999999999999975 2 4789999999998864422
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCC----CCChHHHHH
Q 003971 680 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLE----IPEGPLGRL 753 (782)
Q Consensus 680 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG-k~PF~~~~~~evl~~i~~~~~~~~----ip~~~L~~L 753 (782)
+..+..||-+|+|||.+....-+.++|||||||++|+.++| ..||.+.-..+ ..+.+...... .++....+|
T Consensus 669 ~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~eA~dL 746 (903)
T KOG1027|consen 669 SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDCEAKDL 746 (903)
T ss_pred hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchHHHHHH
Confidence 23467799999999999988888899999999999999987 77998764432 23444333322 122268899
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
|.+|+. +|..||++.+++.|
T Consensus 747 I~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 747 ISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHHhcCCCcccCCCHHHHhCC
Confidence 999999 99999999999865
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=247.00 Aligned_cols=224 Identities=27% Similarity=0.407 Sum_probs=179.3
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEE--ECCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCc
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 595 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~--~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~ 595 (782)
+++.-+++..+..||+|+||.|-+.+ .+|+..|+|.+...-. .+..+..++|+.+..+. .+|.+|+|||.+.....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 44555677778899999999876554 5899999999865543 44457788899887655 69999999999999999
Q ss_pred eEEEEEEecccchhhHHHh-hcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 596 LSMITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~-~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
.++.||.|.. +|..+... ...++.+++..+-+|+..+.+||.|||+ ..+||||+||+|||++.+|+||+||||.+-.
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 9999999974 66544432 2356789999999999999999999997 5899999999999999999999999999988
Q ss_pred ccCCCCCCCCCCCCCcccCcccccc----CCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCC
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRN----EPFTEKCDIFSLGVIMWELCTLNRPWEGV-LPERVVYAVANEGSRLEIP 746 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~----~~~s~ksDVWSLGvILyELLTGk~PF~~~-~~~evl~~i~~~~~~~~ip 746 (782)
+.+.. ..+...|...|||||.+.. ..|+.|+||||||++++||.+++.||... ++.+.+.++..+ ..+.+|
T Consensus 199 L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee-p~P~Lp 274 (282)
T KOG0984|consen 199 LVDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE-PSPQLP 274 (282)
T ss_pred ehhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC-CCCCCc
Confidence 76642 2233567789999998853 46899999999999999999999999865 455566655543 334444
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=252.08 Aligned_cols=240 Identities=23% Similarity=0.376 Sum_probs=192.6
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCC--Cce
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKP--PRL 596 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~--~~l 596 (782)
..++|++.+++|+|.|++||.|.. +++.++||+++.- ..+.+.+|+.+|+.|. ||||++++++..++ ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 568999999999999999999974 7889999998632 3467889999999997 99999999998775 357
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC-CCeEEEEecCcccccc
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRIIT 675 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~-~g~VKLaDFGLA~~l~ 675 (782)
.+++||+.+.+...+. ..++...++.++.|++.||.|||++||+|||+||.|++++. .-.++|+|+|+|.++.
T Consensus 111 aLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 8999999986665544 36788889999999999999999999999999999999985 4579999999998875
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHhc-----------CCC
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPW-EGVLPERVVYAVANE-----------GSR 742 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF-~~~~~~evl~~i~~~-----------~~~ 742 (782)
.. ....-.+.+..|-.||++.+ +.|+..-|+|||||+|..|+..+.|| .+.++...+..+..- .+.
T Consensus 185 p~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 185 PG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred CC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 43 33445667778999999876 45888999999999999999999987 455544444333210 011
Q ss_pred CCCC---------------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 LEIP---------------------------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 ~~ip---------------------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..++ ..+.-+|+..++. |-++|+|+.|.+.|
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1111 1246678999999 99999999998865
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-29 Score=283.05 Aligned_cols=246 Identities=30% Similarity=0.507 Sum_probs=217.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|.+..++|.|.||.||++++ .++..|+|+++.... .+..-+.+|+.+++.++|||||.++|.+...+.++++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 46899999999999999999976 688999999876543 33566778999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
|||.+|+|.+..+ ..+.+++.++....++.++||+|||+.|=+|||||-.|||+++.|.+||+|||.+..++.....
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 9999999999887 5678999999999999999999999999999999999999999999999999999887665445
Q ss_pred CCCCCCCCcccCcccc---ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC------hHHH
Q 003971 681 DSSSAGTPEWMAPELI---RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE------GPLG 751 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl---~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~------~~L~ 751 (782)
...+.||+.|||||+. +.+.|..++|||++|+...|+-.-+.|.-+..+.+.++.....++.++.-. ..+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence 5678999999999976 456799999999999999999999999888888888888887777665432 2588
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
++++.|+. +|.+||+++.+|+|
T Consensus 249 ~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHHhcCCCccCCChhhheec
Confidence 99999998 99999999988864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=277.45 Aligned_cols=201 Identities=26% Similarity=0.439 Sum_probs=175.1
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh------HHHHHHHHHHHHHHhCC---CCceeeEecc
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA------ENMEDFCNEISILSRLR---HPNVILFLGA 589 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~------~~~e~f~~EI~iLk~L~---HPNIVkL~g~ 589 (782)
-++++|+..+.||.|+||.|+.+.+ +...|+||++.+.+.-. ..+-.+-.||+||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 3568899999999999999999988 45678999987765321 11234557999999997 9999999999
Q ss_pred ccCCCceEEEEEEec-ccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEec
Q 003971 590 CTKPPRLSMITEYME-LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 668 (782)
Q Consensus 590 ~~d~~~l~LV~Ey~~-gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDF 668 (782)
|++++.+|++||... +-+|++++. -++.+++..+..|+.||+.|+++||+.||||||||-+||.++.+|-+||+||
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 999999999999754 567888887 5678999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCCCcccCccccccCCCC-chhHHHHHHHHHHHHHhCCCCCCC
Q 003971 669 GLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEG 726 (782)
Q Consensus 669 GLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvILyELLTGk~PF~~ 726 (782)
|.+......+ ...++||..|.|||++.+.+|- ..-|||++|++||.++....||+.
T Consensus 715 gsaa~~ksgp--fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYTKSGP--FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhcCCC--cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9998776553 3578999999999999998874 568999999999999999999975
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=271.58 Aligned_cols=244 Identities=21% Similarity=0.352 Sum_probs=203.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC------CCceeeEeccccCCCc
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR------HPNVILFLGACTKPPR 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~------HPNIVkL~g~~~d~~~ 595 (782)
.+|.+....|+|-|++|.+|.+ .|..||||++..... -.+.=+.|+++|++|+ --|+++|+-.|.+.++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 6788888999999999999977 577999999964432 2345568999999996 3489999999999999
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC-CeEEEEecCccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRII 674 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~-g~VKLaDFGLA~~l 674 (782)
++||+|.+. .+|.++|+.-+.+..|....++.|+.|++.||..|...||+|.||||+|||+++. ..+||||||.|...
T Consensus 509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccc
Confidence 999999986 4999999988888899999999999999999999999999999999999999865 47899999999877
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---------
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--------- 745 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i--------- 745 (782)
..... +...-+..|.|||++.+.+|+...|+||+||+||||+||+..|++.++..++..........+-
T Consensus 588 ~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~ 665 (752)
T KOG0670|consen 588 SENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFK 665 (752)
T ss_pred ccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchh
Confidence 55432 2333455799999999999999999999999999999999999999888776654322111100
Q ss_pred -------------------------------C---------------Ch------HHHHHHHHhhh-CCCCCCCHHHHHH
Q 003971 746 -------------------------------P---------------EG------PLGRLIADCWA-EPQERPSCEEILS 772 (782)
Q Consensus 746 -------------------------------p---------------~~------~L~~LI~~CL~-DP~kRPSa~EIL~ 772 (782)
| .+ .+.+|+..|+. ||++|.|..+.|.
T Consensus 666 dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 666 DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1 01 36678999999 9999999999987
Q ss_pred H
Q 003971 773 R 773 (782)
Q Consensus 773 ~ 773 (782)
|
T Consensus 746 H 746 (752)
T KOG0670|consen 746 H 746 (752)
T ss_pred C
Confidence 6
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=260.19 Aligned_cols=245 Identities=28% Similarity=0.393 Sum_probs=192.0
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC-----ceEE
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-----RLSM 598 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~-----~l~L 598 (782)
.+..+.||.|+||.||.+.+ +|+.||+|.+..-..+-..-+.+.+|+.+|..++|.|++..++..+-.. .+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999877 7999999987533333334578999999999999999999988765443 2677
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
++|.+.. +|..++- ....++.+.++-+++||++||.|||+.||.||||||.|+|++.+-.+||||||+++......
T Consensus 135 ~TELmQS-DLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHh-hhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 7787763 5655553 45678999999999999999999999999999999999999999999999999998764332
Q ss_pred -CCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----------
Q 003971 679 -MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI----------- 745 (782)
Q Consensus 679 -~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i----------- 745 (782)
.+.+..+-|..|.|||++.+. .|+.+.||||.|||+.||+..+..|...++.+.+..+...-..+..
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 233345678899999999875 5899999999999999999999899888887777766543322221
Q ss_pred ----------CC--------------hHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003971 746 ----------PE--------------GPLGRLIADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 746 ----------p~--------------~~L~~LI~~CL~-DP~kRPSa~EIL~~L 774 (782)
|+ ...-.++..++. ||.+|.+.++.+.++
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 10 022345556667 999999999988764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=247.94 Aligned_cols=131 Identities=27% Similarity=0.383 Sum_probs=110.2
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-----C---CceeeEecccc
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----H---PNVILFLGACT 591 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-----H---PNIVkL~g~~~ 591 (782)
+..+|.+.++||-|.|++||++.+ ..+.||+|+.+.. ....+..+.||.+|++++ | .+||+|++.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 447899999999999999999987 5788999997533 223466788999999984 2 37999999996
Q ss_pred CC----CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEE
Q 003971 592 KP----PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLV 657 (782)
Q Consensus 592 d~----~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILL 657 (782)
.. .+++||+|++ |.+|..++... ..+.++...+++|++||+.||.|||. .||||.||||+|||+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 53 4699999999 55787777655 35678999999999999999999997 599999999999998
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=248.42 Aligned_cols=242 Identities=25% Similarity=0.325 Sum_probs=195.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC------c
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------R 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------~ 595 (782)
.+|.-+..+|.|+- .|..+.+ .++.||+|.......+....+...+|..++..++|+||++++.+|.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888888 6666654 6889999988666545555678889999999999999999999986544 3
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.|+||||+.. +|...+. ..++-..+..+++|++.|++|||+.||+||||||+||++..+..+||.|||+|+...
T Consensus 96 ~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 7999999974 7776665 346778889999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----------
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----------- 744 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~----------- 744 (782)
.. ...+..+.|..|.|||++.+-.|.+.+||||+||++.||++|+.-|.+.+.-.....+...-..+.
T Consensus 170 ~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 170 TD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred cc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 43 456677889999999999988899999999999999999999998876655444333332111110
Q ss_pred ------------------CCC--------------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 ------------------IPE--------------GPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 ------------------ip~--------------~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+|+ +-.++++.+||. ||++|.|+.++|+|
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111 136788899998 99999999999986
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=273.63 Aligned_cols=192 Identities=19% Similarity=0.169 Sum_probs=139.9
Q ss_pred hCCC-CceeeEeccc-------cCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccc
Q 003971 577 RLRH-PNVILFLGAC-------TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648 (782)
Q Consensus 577 ~L~H-PNIVkL~g~~-------~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHr 648 (782)
.++| +||++++++| .+...+++++||+ +++|.+++.. ....+++.+++.++.||+.||+|||++||+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 3455 5888888877 3334678888987 4599999862 24569999999999999999999999999999
Q ss_pred CCCcccEEEcCC-------------------CeEEEEecCccccccCCC----------------CCCCCCCCCCcccCc
Q 003971 649 DLKSANCLVNKH-------------------WTVKICDFGLSRIITDSP----------------MRDSSSAGTPEWMAP 693 (782)
Q Consensus 649 DIKPeNILLd~~-------------------g~VKLaDFGLA~~l~~~~----------------~~~~~~~GT~~Y~AP 693 (782)
||||+||||+.. +.+||+|||+++...... .......||+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 999999999654 445566666665321100 001124588999999
Q ss_pred cccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CChHHHHHHHHhhh-CCCCCCCHHHH
Q 003971 694 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--PEGPLGRLIADCWA-EPQERPSCEEI 770 (782)
Q Consensus 694 Evl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i--p~~~L~~LI~~CL~-DP~kRPSa~EI 770 (782)
|++.+..|+.++|||||||+||||++|..|+..... ....+......+.. .......++..||. +|.+||++.++
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 999999999999999999999999999888764321 12222111111111 12245678889999 99999999999
Q ss_pred HHH
Q 003971 771 LSR 773 (782)
Q Consensus 771 L~~ 773 (782)
+++
T Consensus 263 l~h 265 (793)
T PLN00181 263 LQS 265 (793)
T ss_pred hhc
Confidence 875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=213.10 Aligned_cols=159 Identities=23% Similarity=0.298 Sum_probs=127.6
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
|+|.+++.. .+..+++.+++.++.||+.||+|||+.+ ||+|||++.++.+++ ||++...... ...
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~ 65 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSR 65 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCC
Confidence 688888863 2456999999999999999999999998 999999999999999 9999876442 236
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCC-----CC---Ch--HHHHHH
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRLE-----IP---EG--PLGRLI 754 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~-evl~~i~~~~~~~~-----ip---~~--~L~~LI 754 (782)
||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+........ .+ .. .+.+++
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 889999999999999999999999999999999999999765432 22222222111110 00 11 488999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 755 ADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.+||. +|.+||++.++++++.....
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHH
Confidence 99999 99999999999999877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-23 Score=210.55 Aligned_cols=247 Identities=31% Similarity=0.470 Sum_probs=201.9
Q ss_pred eeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChH-HHHHHHHHHHHHHhCCCC-ceeeEeccccCCCceEEEEEEe
Q 003971 526 LTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE-NMEDFCNEISILSRLRHP-NVILFLGACTKPPRLSMITEYM 603 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~-~~e~f~~EI~iLk~L~HP-NIVkL~g~~~d~~~l~LV~Ey~ 603 (782)
|.+.+.||.|+|+.||++.+. ..+++|.+........ ....|.+|+.++..+.|+ +|+++++.+......+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 778899999999999999888 7889999876655443 568899999999999988 7999999997777789999999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC-eEEEEecCccccccCCCC---
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDSPM--- 679 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g-~VKLaDFGLA~~l~~~~~--- 679 (782)
.++++.+++........++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence 9999996665211112688999999999999999999999999999999999999988 799999999986654332
Q ss_pred ---CCCCCCCCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCC---CCCC
Q 003971 680 ---RDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP----ERVVYAVANEGSR---LEIP 746 (782)
Q Consensus 680 ---~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTGk~PF~~~~~----~evl~~i~~~~~~---~~ip 746 (782)
......||..|++||.+.+ ..+....|+|++|++++++++|..||..... ......+...... ....
T Consensus 161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (384)
T COG0515 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240 (384)
T ss_pred ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccC
Confidence 2356789999999999987 5788899999999999999999999887763 3444444433322 1222
Q ss_pred C-------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 E-------GPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ~-------~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. ..+.+++..|+. +|..|.+..+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 2 257889999998 99999998887764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=225.94 Aligned_cols=237 Identities=21% Similarity=0.310 Sum_probs=177.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEecc-ccCCCceEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGA-CTKPPRLSMI 599 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~-~~d~~~l~LV 599 (782)
+.|.+.+.||+|.||.+-++.+. ++.+++|.+..... ..++|.+|...--.| .|.||+.-|++ |+..+.++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 67899999999999999999884 67899998765432 357899998776666 49999987765 6777888899
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc--CCCeEEEEecCccccccCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN--KHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd--~~g~VKLaDFGLA~~l~~~ 677 (782)
+||++.|+|...+. ...+-+.....++.|++.||.|+|++++||||||.+|||+- +..+|||||||+.+.....
T Consensus 101 qE~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999999998774 34577888899999999999999999999999999999993 3348999999998765332
Q ss_pred CCCCCCCCCCCcccCccccccC-----CCCchhHHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCCCCCCh-
Q 003971 678 PMRDSSSAGTPEWMAPELIRNE-----PFTEKCDIFSLGVIMWELCTLNRPWEGV---LPERVVYAVANEGSRLEIPEG- 748 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~-----~~s~ksDVWSLGvILyELLTGk~PF~~~---~~~evl~~i~~~~~~~~ip~~- 748 (782)
.....-+..|.+||+.... ...+..|+|.||+++|.++||..||+.. ++.-.-+....++..+..|..
T Consensus 177 ---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F 253 (378)
T KOG1345|consen 177 ---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF 253 (378)
T ss_pred ---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence 1223345678999976432 3467799999999999999999999732 222222333334444444432
Q ss_pred -----HHHHHHHHhhh-CCCCCCCHHHH
Q 003971 749 -----PLGRLIADCWA-EPQERPSCEEI 770 (782)
Q Consensus 749 -----~L~~LI~~CL~-DP~kRPSa~EI 770 (782)
.+..+.++-+. +|++|--..+.
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred cccCHHHHHHHHHhcCCcccccchhHHH
Confidence 34455566666 88888444433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=237.02 Aligned_cols=192 Identities=29% Similarity=0.432 Sum_probs=161.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~ 597 (782)
..|.+.++||.|.|++||++.+ ..+.||+|.+..... ...+.+|+++|..+. +.||+++.+++..++...
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 5688899999999999999954 456899998865443 356889999999995 999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC-CCeEEEEecCccccccC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRIITD 676 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~-~g~VKLaDFGLA~~l~~ 676 (782)
+|+||++...-.++.. .++...+..+++.++.||+++|.+|||||||||.|+|.+. .++-.|+|||+|.....
T Consensus 112 ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred EEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 9999999988888775 4678899999999999999999999999999999999974 46788999999972210
Q ss_pred C---------------C-----------------------------CCCCCCCCCCcccCccccccC-CCCchhHHHHHH
Q 003971 677 S---------------P-----------------------------MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLG 711 (782)
Q Consensus 677 ~---------------~-----------------------------~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLG 711 (782)
. . .......||++|.|||++... .-+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 0 001234699999999998654 468899999999
Q ss_pred HHHHHHHhCCCCCC
Q 003971 712 VIMWELCTLNRPWE 725 (782)
Q Consensus 712 vILyELLTGk~PF~ 725 (782)
+|++.+++++.||-
T Consensus 266 VI~Lslls~~~PFf 279 (418)
T KOG1167|consen 266 VILLSLLSRRYPFF 279 (418)
T ss_pred ceeehhhccccccc
Confidence 99999999999984
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-22 Score=218.58 Aligned_cols=251 Identities=19% Similarity=0.227 Sum_probs=194.4
Q ss_pred CeeEeeEEeeeCcEEEEEEEECC---eEEEEEEeeccccChHHHHHHHHHHHHHHhCCC----CceeeEeccc-cCCCce
Q 003971 525 ELTVGTRVGIGFFGEVFRGIWNG---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRH----PNVILFLGAC-TKPPRL 596 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~~g---~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H----PNIVkL~g~~-~d~~~l 596 (782)
+|.+.++||+|+||.||.+.+.. ..+|+|+......... ..+..|+.++..+.. .++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 89999999999999999998743 4688888654432221 156788888888863 6888999888 466678
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC-----CeEEEEecCcc
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-----WTVKICDFGLS 671 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~-----g~VKLaDFGLA 671 (782)
|+||+.+ |.+|.++..... ...++...+..++.|++.+|++||+.|++||||||.|++++.. ..+.|.|||++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 8998877 679999886443 6789999999999999999999999999999999999999754 46999999999
Q ss_pred c--cccCCCC-------C-CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 003971 672 R--IITDSPM-------R-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 741 (782)
Q Consensus 672 ~--~l~~~~~-------~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~ 741 (782)
+ .+..... . .....||..|+++....+...+.+.|+||++.++.+++.|..||.................
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 3322111 1 1235599999999999999999999999999999999999999977654332222222111
Q ss_pred CC------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 742 RL------EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 742 ~~------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.. ..++..+..+...+-. +...+|....+...|++...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 11 2233456667666666 89999999999998876643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-23 Score=214.10 Aligned_cols=250 Identities=31% Similarity=0.616 Sum_probs=213.0
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
.++++++.+..+|.+...|+.|+|+|+|..+++|++.........-.+|..|.-.|+-+.||||+.++++|..+.++.++
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 45667778888999999999999999999999999987777666667898999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--ccccCCCcccEEEcCCCeEEEE--ecCcccccc
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKIC--DFGLSRIIT 675 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g--IIHrDIKPeNILLd~~g~VKLa--DFGLA~~l~ 675 (782)
..||+.|+|+..++.. .+-..+..++.+++..+++|++|||+.. |----|....+++|++.+.+|. |--++..
T Consensus 266 sq~mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq-- 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-- 342 (448)
T ss_pred eeeccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee--
Confidence 9999999999999843 3456788999999999999999999975 3334678899999999877764 3332221
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCC---chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh---H
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRNEPFT---EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---P 749 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~~~~s---~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~~---~ 749 (782)
.....-.|.|++||.+..++-+ .++|+|||.+++|||.|...||.+..+.+.-..+.-++.+..+|++ -
T Consensus 343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~h 417 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRH 417 (448)
T ss_pred -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHH
Confidence 1234456899999999887644 4799999999999999999999999999999999999999999976 4
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
...|+.-|+. ||.+||.+..|+-.|+..
T Consensus 418 m~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 7789999999 999999999998888764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=218.57 Aligned_cols=163 Identities=20% Similarity=0.199 Sum_probs=128.2
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE---CCeEEEEEEeecccc---ChHHHHHHHHHHHHHHhCCCCceee-EeccccCCC
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVIL-FLGACTKPP 594 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~---~g~~VAVKil~~~~~---~~~~~e~f~~EI~iLk~L~HPNIVk-L~g~~~d~~ 594 (782)
-..+|.+.+.||+|+||+||+|.+ +++.+|||++..... .....+.|.+|+++|+.++|+||+. ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 447899999999999999999976 467789998753311 2233567899999999999999985 5442 3
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCC-CcccEEEcCCCeEEEEecCcccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL-KSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDI-KPeNILLd~~g~VKLaDFGLA~~ 673 (782)
..|+||||++|++|... . ... ...++.|++++|.|||++||+|||| ||+|||++.++.+||+|||+++.
T Consensus 92 ~~~LVmE~~~G~~L~~~-~---~~~------~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R---PHG------DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred CcEEEEEccCCCCHHHh-C---ccc------hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 57999999999999632 1 111 1467899999999999999999999 99999999999999999999997
Q ss_pred ccCCCCC--------CCCCCCCCcccCcccccc
Q 003971 674 ITDSPMR--------DSSSAGTPEWMAPELIRN 698 (782)
Q Consensus 674 l~~~~~~--------~~~~~GT~~Y~APEvl~~ 698 (782)
+...... ..+..+++.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 6543211 124568888999998853
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-22 Score=236.33 Aligned_cols=241 Identities=24% Similarity=0.312 Sum_probs=186.4
Q ss_pred CeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccC--hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLT--AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~--~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+|...+.||.+.|=+|.+|+++...|+||++.++... -...++-+.|++ ...++|||.+.+.-+-..+...|||.+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 7888899999999999999987667999999776522 222233334444 4556899999999988888889999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc---CCC-
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT---DSP- 678 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~---~~~- 678 (782)
+.+ +|+|.+. ..+.+...+.+.|+.||+.||..||..||+|+|||.+||||+.-..+.|+||...+... +.+
T Consensus 103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 976 8999886 56678888999999999999999999999999999999999999999999998766432 111
Q ss_pred ---CCCCCCCCCCcccCccccccC----------C-CCchhHHHHHHHHHHHHHh-CCCCCCC-----------CChHHH
Q 003971 679 ---MRDSSSAGTPEWMAPELIRNE----------P-FTEKCDIFSLGVIMWELCT-LNRPWEG-----------VLPERV 732 (782)
Q Consensus 679 ---~~~~~~~GT~~Y~APEvl~~~----------~-~s~ksDVWSLGvILyELLT-Gk~PF~~-----------~~~~ev 732 (782)
+...+...-..|+|||.+... + .+++.||||+||+++||++ |++||.- ..++.+
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 122333344579999987541 2 5778999999999999986 4667741 111111
Q ss_pred HHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 733 VYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 733 l~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+. .+++..+++++..|++ ||.+|.++++.|+.-+-..|
T Consensus 259 Le---------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 259 LE---------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred HH---------hCcCccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 11 2455579999999999 99999999999998655444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-22 Score=229.77 Aligned_cols=242 Identities=23% Similarity=0.326 Sum_probs=182.7
Q ss_pred EeeEEeeeCcEEEEEEEE--CCeEEEEEEeec---cccChH-HHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 528 VGTRVGIGFFGEVFRGIW--NGTDVAIKVFLE---QDLTAE-NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 528 i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~---~~~~~~-~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
....+|.|++|.|+.... ....++.|.+.. ...... ....+..|..+-..+.||||+..+..+.+....+..||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 456799999997776654 233344443321 111111 12236667778888999999998888888777777799
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC---
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--- 678 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~--- 678 (782)
||++ +|+.++. ....++...+-.++.|++.|++|||+.||.|||+|++|++++.+|.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9999 9999886 33578889999999999999999999999999999999999999999999999998765432
Q ss_pred -CCCCCCCCCCcccCccccccCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHh-cCCCCCCC--------
Q 003971 679 -MRDSSSAGTPEWMAPELIRNEPFTE-KCDIFSLGVIMWELCTLNRPWEGVLPERVVY-AVAN-EGSRLEIP-------- 746 (782)
Q Consensus 679 -~~~~~~~GT~~Y~APEvl~~~~~s~-ksDVWSLGvILyELLTGk~PF~~~~~~evl~-~i~~-~~~~~~ip-------- 746 (782)
......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||.........+ .... ........
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 2345678999999999999999876 5799999999999999999997554433321 1111 11111111
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+..-+.+|.++++ ||.+|.++++|++-
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhC
Confidence 1235668889999 99999999999863
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-20 Score=198.63 Aligned_cols=246 Identities=18% Similarity=0.262 Sum_probs=189.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~ 600 (782)
-.|+++++||+|+||+.+.|.. ++..||||.-..+.. .-++..|....+.|. .++|...|.+-..+.+-.||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 4689999999999999999965 899999998543322 345667888888885 789999988888888888999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC-----CeEEEEecCcccccc
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-----WTVKICDFGLSRIIT 675 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~-----g~VKLaDFGLA~~l~ 675 (782)
|.+ |-+|.|+..-+ +..++.+.+..++.|++.-++|+|.+.+|+|||||+|+||... ..|.|+|||+|+.+.
T Consensus 104 dLL-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhh-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 988 67999988754 4689999999999999999999999999999999999999643 468999999999887
Q ss_pred CCCC-------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCCC
Q 003971 676 DSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL---PERVVYAVANEGSRLEI 745 (782)
Q Consensus 676 ~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~---~~evl~~i~~~~~~~~i 745 (782)
++.. ......||.+||+-....+..-+.+-|+=|||-+++..+-|..||.+.. ..+.+..|-......++
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 6532 1245679999999988888888999999999999999999999998764 44444444433333322
Q ss_pred CC------hHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 746 PE------GPLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 746 p~------~~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
.. .++...+.-.-. +-.+-|+.+-+...+.+
T Consensus 261 ~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 261 EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11 123333333333 55566666655554443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.3e-22 Score=223.65 Aligned_cols=221 Identities=25% Similarity=0.379 Sum_probs=184.0
Q ss_pred EeeeCcEEEEEEE-----ECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEEEEEecc
Q 003971 532 VGIGFFGEVFRGI-----WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 532 LG~G~fG~VYkg~-----~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+|+|+||.|+++. +.|..||+|++++.............|..++..++ ||.+|++..+++.+..++++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7899999999763 35788999998776654333335667889999997 99999999999999999999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
|.|+..+. ....+++.....+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++....... .|
T Consensus 82 g~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~c 154 (612)
T KOG0603|consen 82 GDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----AC 154 (612)
T ss_pred chhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----cc
Confidence 99998876 556788888889999999999999999999999999999999999999999999988765432 29
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CC
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EP 761 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP 761 (782)
||..|||||+++ ......|+||||+++|||+||..||.+ ++...+.... +..| ....+.++..++. +|
T Consensus 155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE--LEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc--cCCchhhhHHHHHHHHHHHhhCH
Confidence 999999999999 567889999999999999999999998 4444444422 2233 2357788888888 89
Q ss_pred CCCCCH
Q 003971 762 QERPSC 767 (782)
Q Consensus 762 ~kRPSa 767 (782)
.+|.-.
T Consensus 227 ~nrLg~ 232 (612)
T KOG0603|consen 227 ENRLGA 232 (612)
T ss_pred HHHhcc
Confidence 888544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-20 Score=188.83 Aligned_cols=248 Identities=18% Similarity=0.271 Sum_probs=189.4
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCC-CceeeEeccccCCCceE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH-PNVILFLGACTKPPRLS 597 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H-PNIVkL~g~~~d~~~l~ 597 (782)
+-...|.++++||.|+||.+|.|.. .|..||||+-..... ..++.-|..+...|++ ..|..+..+..+...-.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 3457899999999999999999976 799999998543322 2356678999999974 67777788888888889
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC---CeEEEEecCccccc
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH---WTVKICDFGLSRII 674 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~---g~VKLaDFGLA~~l 674 (782)
+||+.+ |.+|.+++... ...++..+++.++-|++.-++|+|.+++|||||||+|+|..-+ ..+.|+|||+|+.+
T Consensus 88 lVMdLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 999988 67999988754 4678999999999999999999999999999999999999633 47999999999987
Q ss_pred cCCCC-------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhcCCCCC
Q 003971 675 TDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVV---YAVANEGSRLE 744 (782)
Q Consensus 675 ~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl---~~i~~~~~~~~ 744 (782)
.+... ......||.+|.+-....+..-+..-|+=|+|.+|..+.-|..||++....... ..+........
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 54321 234567999999887777777788899999999999999999999987554332 23333332222
Q ss_pred CC------ChHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003971 745 IP------EGPLGRLIADCWA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 745 ip------~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~ 775 (782)
+. +.++.-.+.-|-. --.+-|...-+.+.++
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 21 2245556666665 5555566655554443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-20 Score=186.28 Aligned_cols=140 Identities=17% Similarity=0.134 Sum_probs=107.4
Q ss_pred eeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHH------------------------HHHHHHHHHHHHhCCCCce
Q 003971 529 GTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAEN------------------------MEDFCNEISILSRLRHPNV 583 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~------------------------~e~f~~EI~iLk~L~HPNI 583 (782)
...||+|+||.||+|.. +|+.||||++......... ......|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999987 6899999998654321111 1122359999999987776
Q ss_pred eeEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHH-HhccccccCCCcccEEEcCCCe
Q 003971 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI-HRMKIVHRDLKSANCLVNKHWT 662 (782)
Q Consensus 584 VkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yL-Hs~gIIHrDIKPeNILLd~~g~ 662 (782)
.....+.. ...++||||++++++..... ....++...+..++.|++.+|.|| |+.||+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 43222211 22389999999887764432 235688999999999999999999 699999999999999998 478
Q ss_pred EEEEecCccccc
Q 003971 663 VKICDFGLSRII 674 (782)
Q Consensus 663 VKLaDFGLA~~l 674 (782)
++|+|||++...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=189.44 Aligned_cols=172 Identities=17% Similarity=0.102 Sum_probs=134.0
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChH-HHHH------HHHHHHHHHhCCCCceeeEeccccCC--
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE-NMED------FCNEISILSRLRHPNVILFLGACTKP-- 593 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~-~~e~------f~~EI~iLk~L~HPNIVkL~g~~~d~-- 593 (782)
..+|++.+.||.|+||.||+...++..+|||++.......+ ..+. +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 37899999999999999999877788999999975543332 2223 57899999999999999988875533
Q ss_pred ------CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEe
Q 003971 594 ------PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICD 667 (782)
Q Consensus 594 ------~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaD 667 (782)
...+++|||++|.+|.++.. +++ ..+.+++.+|..||+.|++|||+||.||+++.+| ++|+|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 35789999999999987642 222 2456999999999999999999999999999988 99999
Q ss_pred cCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHH
Q 003971 668 FGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELC 718 (782)
Q Consensus 668 FGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELL 718 (782)
||........... ..++....|..++|+|+||+++.-+.
T Consensus 178 fg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9988655321110 01334445678999999999887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.5e-19 Score=178.23 Aligned_cols=142 Identities=15% Similarity=0.136 Sum_probs=110.2
Q ss_pred eeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChH------------------------HHHHHHHHHHHHHhCCCCce
Q 003971 529 GTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAE------------------------NMEDFCNEISILSRLRHPNV 583 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~------------------------~~e~f~~EI~iLk~L~HPNI 583 (782)
...||+|+||.||+|.+ +|+.||||++........ ....+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999987 599999999875432100 01234578999999999887
Q ss_pred eeEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCe
Q 003971 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWT 662 (782)
Q Consensus 584 VkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~ 662 (782)
.....+.... .++||||++|+++..... ....++......++.|++.++.+||+ .||+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 5433332222 489999999886543321 22457788899999999999999999 9999999999999999 789
Q ss_pred EEEEecCccccccC
Q 003971 663 VKICDFGLSRIITD 676 (782)
Q Consensus 663 VKLaDFGLA~~l~~ 676 (782)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=179.10 Aligned_cols=186 Identities=18% Similarity=0.105 Sum_probs=140.7
Q ss_pred eEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChH--HHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEEEEEe
Q 003971 527 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE--NMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYM 603 (782)
Q Consensus 527 ~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~--~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey~ 603 (782)
.+...|+.|+||+||.+...+.+++.+.+.....-.. ....|.+|+++|++|. |++|.+++++ +..+++|+|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 3567899999999998877888888887754433111 1235789999999995 5889999886 3479999999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCC-CcccEEEcCCCeEEEEecCccccccCCCCC--
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL-KSANCLVNKHWTVKICDFGLSRIITDSPMR-- 680 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDI-KPeNILLd~~g~VKLaDFGLA~~l~~~~~~-- 680 (782)
.|.+|...... ....++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99988754321 11357889999999999999999999 799999999999999999999855432210
Q ss_pred --C---------CCCCCCCcccCccccccC-CCC-chhHHHHHHHHHHHHHhCCCCCCC
Q 003971 681 --D---------SSSAGTPEWMAPELIRNE-PFT-EKCDIFSLGVIMWELCTLNRPWEG 726 (782)
Q Consensus 681 --~---------~~~~GT~~Y~APEvl~~~-~~s-~ksDVWSLGvILyELLTGk~PF~~ 726 (782)
. .-...++.|++|+...-- ..+ ...++++.|+-+|.++|+..|+-+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 012257788888754322 223 567999999999999999998644
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=186.43 Aligned_cols=233 Identities=22% Similarity=0.278 Sum_probs=149.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCC----------Cc------eee
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRH----------PN------VIL 585 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~H----------PN------IVk 585 (782)
.+..+..||.|+++.||.+.+ +|+.+|||++...... ....+++.+|.-....+.+ -. +++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 466788999999999999998 4699999998655432 3346777777655555332 11 222
Q ss_pred Eecc---ccCC---C-----ceEEEEEEecccchhhHHHh---hc-ccccchHHHHHHHHHHHHHHHHHHHhccccccCC
Q 003971 586 FLGA---CTKP---P-----RLSMITEYMELGSLYHLIHL---SG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 650 (782)
Q Consensus 586 L~g~---~~d~---~-----~l~LV~Ey~~gGsL~dlL~~---~~-~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDI 650 (782)
+-+- +... . +.+++|+-+. ++|.+++.. .. ....+....++.+..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 2110 0111 1 2355666664 577776542 11 1234555666777799999999999999999999
Q ss_pred CcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCcccccc--------CCCCchhHHHHHHHHHHHHHhCCC
Q 003971 651 KSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN--------EPFTEKCDIFSLGVIMWELCTLNR 722 (782)
Q Consensus 651 KPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~--------~~~s~ksDVWSLGvILyELLTGk~ 722 (782)
+|+|++++.+|.++|+||+.......... ....+..|.+||.... -.++.+.|.|+||+++|.|++|..
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999988766543211 1234467999997743 257889999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCC
Q 003971 723 PWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQER 764 (782)
Q Consensus 723 PF~~~~~~evl~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kR 764 (782)
||....+....... -..-. -.++.++.||..+++ ||.+|
T Consensus 249 Pf~~~~~~~~~~~~-f~~C~--~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEWD-FSRCR--DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGGG-GTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCcccccccc-chhcC--CcCHHHHHHHHHHccCCcccC
Confidence 99865433222111 11111 234569999999999 99887
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-18 Score=209.34 Aligned_cols=242 Identities=20% Similarity=0.269 Sum_probs=187.4
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC---CCceeeEecccc
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR---HPNVILFLGACT 591 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~---HPNIVkL~g~~~ 591 (782)
..+.++....|.|.+.||+|+||.||+|.. +|+.+|+|+=+.... -+|.--.+++.+|+ -+.|.++..++.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~-----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP-----WEFYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc-----eeeeehHHHHHhhchhhhcchHHHHHHHc
Confidence 455666778899999999999999999976 789999998544332 12333345555665 345667777777
Q ss_pred CCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc-------CCCeEE
Q 003971 592 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-------KHWTVK 664 (782)
Q Consensus 592 d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd-------~~g~VK 664 (782)
-.+..++|+||.+.|+|.+++. ..+.+++..+..++.|++..+++||..+|||+||||+|+||. ...-++
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cCCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceE
Confidence 7788899999999999999997 677899999999999999999999999999999999999994 234689
Q ss_pred EEecCcccccc--CCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 003971 665 ICDFGLSRIIT--DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 742 (782)
Q Consensus 665 LaDFGLA~~l~--~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~ 742 (782)
|+|||.+..+. .+.......++|-.+-.+|+..+.+++..+|.|.|+.+++-|+.|+.-= ...+..
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------~~~g~~ 909 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------VKNGSS 909 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------hcCCcc
Confidence 99999997653 2233455678899999999999999999999999999999999997531 111211
Q ss_pred CCCC--------ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 743 LEIP--------EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 743 ~~ip--------~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
..+. .+.+.+++..+|. |...=|...+|...++..
T Consensus 910 ~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 910 WMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred eeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence 1111 1235667777777 655668888887777654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=186.32 Aligned_cols=192 Identities=22% Similarity=0.328 Sum_probs=140.0
Q ss_pred CCCceeeEeccccC---------------------------CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHH
Q 003971 579 RHPNVILFLGACTK---------------------------PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 631 (782)
Q Consensus 579 ~HPNIVkL~g~~~d---------------------------~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~ 631 (782)
+|||||++.++|.+ +..+|+||...+. +|..++- ....+....+-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh----cCCCchHHHHHHHH
Confidence 59999999988743 2347888887764 7887774 33556777788999
Q ss_pred HHHHHHHHHHhccccccCCCcccEEE--cCCC--eEEEEecCccccccCCC----C--CCCCCCCCCcccCccccccCCC
Q 003971 632 DICRGLMCIHRMKIVHRDLKSANCLV--NKHW--TVKICDFGLSRIITDSP----M--RDSSSAGTPEWMAPELIRNEPF 701 (782)
Q Consensus 632 QIa~gL~yLHs~gIIHrDIKPeNILL--d~~g--~VKLaDFGLA~~l~~~~----~--~~~~~~GT~~Y~APEvl~~~~~ 701 (782)
|+++|+.|||++||.|||+|.+|||+ ++++ .+.|+|||.+-.-.... + ..-...|....||||+....+-
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 99999999999999999999999999 3443 68899999874332211 1 1123457778999999875431
Q ss_pred ------CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh---HHHHHHHHhhh-CCCCCCCHHHHH
Q 003971 702 ------TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEIL 771 (782)
Q Consensus 702 ------s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~~---~L~~LI~~CL~-DP~kRPSa~EIL 771 (782)
-.|+|.|+.|.+.||+++...||++......-..-..+...+.+|+. .+++|+..+++ ||.+|++..-..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 24899999999999999999999874332222222333444455533 58999999999 999999876555
Q ss_pred HHHH
Q 003971 772 SRLL 775 (782)
Q Consensus 772 ~~L~ 775 (782)
..|.
T Consensus 509 Nvl~ 512 (598)
T KOG4158|consen 509 NVLN 512 (598)
T ss_pred hHHH
Confidence 5443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.3e-18 Score=202.48 Aligned_cols=199 Identities=28% Similarity=0.400 Sum_probs=149.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|..++.|-.|+||-||.+.++ .+.+|+|+ +++++-.. + ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lilR------n---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILR------N---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccchhhh------c---cccccCCccee-----------------
Confidence 57788899999999999999875 77889855 32221110 0 22222333333
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC----
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---- 677 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~---- 677 (782)
|+-..+++ ..+.++... +.+++|||+.||+|||+||+|+||+.-|++|++|||+++.....
T Consensus 136 ----gDc~tllk---~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLK---NIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhcc---cCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 34444443 333454443 77899999999999999999999999999999999998754211
Q ss_pred -----------CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-
Q 003971 678 -----------PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI- 745 (782)
Q Consensus 678 -----------~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i- 745 (782)
.......||||.|+|||++..+.|...+|+|++|+|+||.+.|..||.+..+++++..++......+-
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 11224568999999999999999999999999999999999999999999999998887754322211
Q ss_pred ---CChHHHHHHHHhhh-CCCCC
Q 003971 746 ---PEGPLGRLIADCWA-EPQER 764 (782)
Q Consensus 746 ---p~~~L~~LI~~CL~-DP~kR 764 (782)
...+.++++..++. +|..|
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhh
Confidence 12358899999998 99999
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-17 Score=166.14 Aligned_cols=136 Identities=25% Similarity=0.346 Sum_probs=114.4
Q ss_pred eEEeeeCcEEEEEEEECCeEEEEEEeeccccChH------HHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEe
Q 003971 530 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE------NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 603 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~------~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 603 (782)
+.||+|++|.||+|.+.|..+++|+......... ....+.+|+.++..+.|++|.....++.+....+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999999999998654332211 1246788999999999999877776666777789999999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
+|++|.+++... .. .+..++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999988622 12 7788999999999999999999999999999999 78999999999865
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-17 Score=188.48 Aligned_cols=202 Identities=37% Similarity=0.659 Sum_probs=160.7
Q ss_pred HHhCCCCceeeEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccc-cccCCCcc
Q 003971 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI-VHRDLKSA 653 (782)
Q Consensus 575 Lk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gI-IHrDIKPe 653 (782)
|+.+.|.|+.+|+|.+.+++..+.|.+||..|+|.+.+.. ....+++-....+++.|+.||+|||+-.| .|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 3568899999999999999999999999999999999973 45678999999999999999999998655 99999999
Q ss_pred cEEEcCCCeEEEEecCccccccCC--CCCCCCCCCCCcccCccccccCC-------CCchhHHHHHHHHHHHHHhCCCCC
Q 003971 654 NCLVNKHWTVKICDFGLSRIITDS--PMRDSSSAGTPEWMAPELIRNEP-------FTEKCDIFSLGVIMWELCTLNRPW 724 (782)
Q Consensus 654 NILLd~~g~VKLaDFGLA~~l~~~--~~~~~~~~GT~~Y~APEvl~~~~-------~s~ksDVWSLGvILyELLTGk~PF 724 (782)
|++++..+.+||+|||+....... ........-..-|.|||++.... .+.++||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998776421 11111222334699999997631 467799999999999999999999
Q ss_pred CC----CChHHHHHHHHhcCC---CCCCCC-----hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 725 EG----VLPERVVYAVANEGS---RLEIPE-----GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 725 ~~----~~~~evl~~i~~~~~---~~~ip~-----~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
.. ..+.+++..+...+. ++.+.. ..+..++..||. +|.+||++.++-..++.+.
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 64 233455555444233 222221 147788999999 9999999999998887653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.6e-17 Score=168.36 Aligned_cols=134 Identities=15% Similarity=0.205 Sum_probs=103.7
Q ss_pred eeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-----CCCceeeEeccccCCC---ceE-EE
Q 003971 529 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-----RHPNVILFLGACTKPP---RLS-MI 599 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-----~HPNIVkL~g~~~d~~---~l~-LV 599 (782)
.+.||+|+||.||....++.. +||++..... ...+.+.+|+.+++.+ .||||++++|++.++. .++ +|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 467999999999963334444 6888765432 2346789999999999 5799999999998874 323 68
Q ss_pred EEE--ecccchhhHHHhhcccccchHHHHHHHHHHHHHHH-HHHHhccccccCCCcccEEEcC----CCeEEEEecCcc
Q 003971 600 TEY--MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL-MCIHRMKIVHRDLKSANCLVNK----HWTVKICDFGLS 671 (782)
Q Consensus 600 ~Ey--~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL-~yLHs~gIIHrDIKPeNILLd~----~g~VKLaDFGLA 671 (782)
+|| +.+++|.+++.. ..+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 557999999963 235555 35678888887 9999999999999999999974 348999995444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.1e-17 Score=162.63 Aligned_cols=132 Identities=27% Similarity=0.343 Sum_probs=107.7
Q ss_pred EeeeCcEEEEEEEECCeEEEEEEeeccccCh------HHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecc
Q 003971 532 VGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA------ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 532 LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~------~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
||+|+||.||+|.+++..+++|++....... .....+.+|++++..++|+++.....++......+++|||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 7999999999999999999999975433211 1235677899999999988765444444556667999999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
++|.+++... .. .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++...
T Consensus 82 ~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 82 KPLKDVIEEG---ND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ccHHHHHhhc---HH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999877521 11 7899999999999999999999999999999 789999999998663
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.6e-17 Score=169.06 Aligned_cols=144 Identities=19% Similarity=0.193 Sum_probs=111.4
Q ss_pred CeeEeeEEeeeCcEEEEEEE-E--CCeEEEEEEeeccccCh----------------------HHHHHHHHHHHHHHhCC
Q 003971 525 ELTVGTRVGIGFFGEVFRGI-W--NGTDVAIKVFLEQDLTA----------------------ENMEDFCNEISILSRLR 579 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~-~--~g~~VAVKil~~~~~~~----------------------~~~e~f~~EI~iLk~L~ 579 (782)
-|.+.+.||+|+||.||+|. + +|+.||||++....... .....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 3 68999999986543110 01134568999999997
Q ss_pred CCc--eeeEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc-ccccCCCcccEE
Q 003971 580 HPN--VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK-IVHRDLKSANCL 656 (782)
Q Consensus 580 HPN--IVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g-IIHrDIKPeNIL 656 (782)
+.+ +.++++. ...++||||+++++|..... ....+....+..++.|++.+|.+||+.| |+|+||||+||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 533 3344442 23589999999988876542 2334566677899999999999999999 999999999999
Q ss_pred EcCCCeEEEEecCccccccC
Q 003971 657 VNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 657 Ld~~g~VKLaDFGLA~~l~~ 676 (782)
++ ++.++|+|||.+.....
T Consensus 182 i~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EE-CCCEEEEEChhhhccCC
Confidence 99 78999999999875543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-16 Score=182.95 Aligned_cols=138 Identities=22% Similarity=0.300 Sum_probs=114.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccCh------HHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA------ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~------~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
.|...+.||+|+||+||+|.+.+..+++|+........ ...+.+.+|+++++.++|++|+..+.++......++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 34567899999999999999877777777643322111 123568899999999999999887777777777899
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
+|||+++++|.+++. ....++.+++.+|.|||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus 414 v~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 414 VMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999999998774 246789999999999999999999999999999 6779999999998653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.9e-16 Score=157.35 Aligned_cols=139 Identities=20% Similarity=0.234 Sum_probs=108.5
Q ss_pred CeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccCh--------------------HHHHHHHHHHHHHHhCCCCc-
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTA--------------------ENMEDFCNEISILSRLRHPN- 582 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~--------------------~~~e~f~~EI~iLk~L~HPN- 582 (782)
.|.+.+.||+|+||.||++.. +|+.+|||++....... .....+..|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 377789999999999999977 68999999875432110 01123667889999988774
Q ss_pred -eeeEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC
Q 003971 583 -VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 661 (782)
Q Consensus 583 -IVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g 661 (782)
+...++. ...+++|||++|++|..+.. ......++.+++.++.++|+.||+|+||||+||++++++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 4444432 34589999999999876542 023467889999999999999999999999999999999
Q ss_pred eEEEEecCccccccC
Q 003971 662 TVKICDFGLSRIITD 676 (782)
Q Consensus 662 ~VKLaDFGLA~~l~~ 676 (782)
.++|+|||++.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999966543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.1e-15 Score=136.57 Aligned_cols=132 Identities=20% Similarity=0.185 Sum_probs=112.4
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCC--CceeeEeccccCCCceEEEEEEecc
Q 003971 528 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH--PNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 528 i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H--PNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
+.+.||.|.++.||++..++..+++|....... ...+..|+.++..++| .++.+++.++...+..++++||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 357899999999999999888999999754432 3578899999999976 5899999988888889999999998
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc---cccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM---KIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~---gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
+.+..+ +......++.+++.+|++||.. +++|+|++|.||++++.+.++++|||.+..
T Consensus 78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777643 3455667889999999999984 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.9e-15 Score=146.08 Aligned_cols=138 Identities=21% Similarity=0.251 Sum_probs=98.2
Q ss_pred eeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHH----------------------HHHHHHHHhCCCCc--e
Q 003971 529 GTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDF----------------------CNEISILSRLRHPN--V 583 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f----------------------~~EI~iLk~L~HPN--I 583 (782)
++.||+|+||.||+|.+. ++.||||++............+ ..|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999874 8999999986543222111111 24555565554332 3
Q ss_pred eeEeccccCCCceEEEEEEecccchhh-HHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCC
Q 003971 584 ILFLGACTKPPRLSMITEYMELGSLYH-LIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHW 661 (782)
Q Consensus 584 VkL~g~~~d~~~l~LV~Ey~~gGsL~d-lL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g 661 (782)
.+.+++ ...+++|||++++.+.. .+... ... .....++.+++.++.++|. .||+|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 444433 23589999999955432 12110 011 5678899999999999999 9999999999999999 88
Q ss_pred eEEEEecCccccccC
Q 003971 662 TVKICDFGLSRIITD 676 (782)
Q Consensus 662 ~VKLaDFGLA~~l~~ 676 (782)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.6e-16 Score=173.23 Aligned_cols=169 Identities=26% Similarity=0.388 Sum_probs=130.9
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+|+.|++|...+|.+++.........++...+.++.|++.|++| ++.+|+|+||.||++..+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 578999999999999999755556677888899999999999999 99999999999999999999999999999877
Q ss_pred cCCC------CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-C-CC
Q 003971 675 TDSP------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-E-IP 746 (782)
Q Consensus 675 ~~~~------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~-ip 746 (782)
.... ...+...||..||+||.+.+..|+.|+||||||++|+|++. +|............+..+..+ . +.
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~~~~ 483 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPEFLQ 483 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChHHhh
Confidence 5543 12356789999999999999999999999999999999998 333222222222222222222 1 11
Q ss_pred ChH-HHHHHHHhhh-CCCCCCCHHH
Q 003971 747 EGP-LGRLIADCWA-EPQERPSCEE 769 (782)
Q Consensus 747 ~~~-L~~LI~~CL~-DP~kRPSa~E 769 (782)
+.+ -..|+.+++. .|.+||++.+
T Consensus 484 d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 484 DYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCcHHHHHHHHhcCCCcccCchHHH
Confidence 222 3478888888 9999994433
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.9e-14 Score=150.72 Aligned_cols=136 Identities=18% Similarity=0.174 Sum_probs=105.6
Q ss_pred eEEe-eeCcEEEEEEEECCeEEEEEEeecccc-----------ChHHHHHHHHHHHHHHhCCCCce--eeEeccccCCCc
Q 003971 530 TRVG-IGFFGEVFRGIWNGTDVAIKVFLEQDL-----------TAENMEDFCNEISILSRLRHPNV--ILFLGACTKPPR 595 (782)
Q Consensus 530 ~~LG-~G~fG~VYkg~~~g~~VAVKil~~~~~-----------~~~~~e~f~~EI~iLk~L~HPNI--VkL~g~~~d~~~ 595 (782)
..|| .|+.|+||.+...+..++||.+..... .......+.+|+.++..++|++| +..+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4687 899999999988899999998854321 11223567889999999998875 666665433222
Q ss_pred ----eEEEEEEecc-cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCc
Q 003971 596 ----LSMITEYMEL-GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 670 (782)
Q Consensus 596 ----l~LV~Ey~~g-GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGL 670 (782)
.++|+|+++| .+|.+++.. ..++.. .+.+|+.+|.+||++||+|+||||.|||++.++.++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 3599999997 688887752 234443 357899999999999999999999999999989999999998
Q ss_pred ccc
Q 003971 671 SRI 673 (782)
Q Consensus 671 A~~ 673 (782)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.1e-16 Score=181.27 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=188.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE---CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~---~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV 599 (782)
..|.+.+.||+|+|+.|-.... ....+|+|.+..........+....|..+-+.+. |.|++++++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 4566777799999999987754 3345666666544333334456667888888887 99999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHH-hccccccCCCcccEEEcCCC-eEEEEecCccccccC-
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITD- 676 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLH-s~gIIHrDIKPeNILLd~~g-~VKLaDFGLA~~l~~- 676 (782)
++|..|++++..+. .......+....-.++.|+..++.|+| ..++.|+||||+|.+++..+ .++++|||+|..+..
T Consensus 100 ~~~s~g~~~f~~i~-~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 100 LSYSDGGSLFSKIS-HPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cCcccccccccccc-cCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999998772 112225666777889999999999999 99999999999999999999 999999999998766
Q ss_pred CCC--CCCCCCC-CCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCC-CCCC----
Q 003971 677 SPM--RDSSSAG-TPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY-AVANEGSR-LEIP---- 746 (782)
Q Consensus 677 ~~~--~~~~~~G-T~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~-~i~~~~~~-~~ip---- 746 (782)
.+. .....+| ++.|+|||...+. ......|+||.|+++..+++|..||.........+ .+...... ...+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 221 2235678 9999999999884 44667899999999999999999997654443222 22222111 1122
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHH
Q 003971 747 EGPLGRLIADCWA-EPQERPSCEEILS 772 (782)
Q Consensus 747 ~~~L~~LI~~CL~-DP~kRPSa~EIL~ 772 (782)
.....+++.+++. +|..|.+.+++..
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ChhhhhcccccccCCchhccccccccc
Confidence 1246677888886 9999999887753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.2e-11 Score=134.73 Aligned_cols=140 Identities=21% Similarity=0.258 Sum_probs=97.2
Q ss_pred eEEeeeCcEEEEEEEE-CCeEEEEEEeeccccCh----------------------------HH----------HHHHHH
Q 003971 530 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTA----------------------------EN----------MEDFCN 570 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~----------------------------~~----------~e~f~~ 570 (782)
+.||.|++|.||+|+. +|+.||||+........ .. .-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999976 79999999975431000 00 013555
Q ss_pred HHHHHHhCC-----CCceeeEeccc-cCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHH-HHHHHHhc
Q 003971 571 EISILSRLR-----HPNVILFLGAC-TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR-GLMCIHRM 643 (782)
Q Consensus 571 EI~iLk~L~-----HPNIVkL~g~~-~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~-gL~yLHs~ 643 (782)
|+..+.+++ +++| .+-.++ ......+++|||++|++|.++...... .. ....++.+++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 666666552 3333 222222 223446999999999999987652211 11 22345566655 46889999
Q ss_pred cccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 644 gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
|++|+|+||.||+++.++.++|+|||++..+.
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.2e-12 Score=145.87 Aligned_cols=242 Identities=24% Similarity=0.210 Sum_probs=176.9
Q ss_pred CCeeEeeEEee--eCcEEEEEEEE----CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCce
Q 003971 524 SELTVGTRVGI--GFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRL 596 (782)
Q Consensus 524 s~y~i~~~LG~--G~fG~VYkg~~----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l 596 (782)
..+.+.+.+|. |.+|.||.+.. .+..+|+|.-+........-..=.+|+....+++ |+|.++.+..+...+.+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34556778999 99999998855 5778898873332222222223345666666675 99999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHH----HHHHHHhccccccCCCcccEEEcCC-CeEEEEecCcc
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR----GLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLS 671 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~----gL~yLHs~gIIHrDIKPeNILLd~~-g~VKLaDFGLA 671 (782)
++-+|++. .+|..+.+ .....++...++.++.+... ||.++|+.+++|-|+||.||+...+ ...+++|||+.
T Consensus 194 fiqtE~~~-~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeeecccc-chhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 99999997 56666554 23345788888999999999 9999999999999999999999999 88999999999
Q ss_pred ccccCCCCCCCCC-----CCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhcCC-CC
Q 003971 672 RIITDSPMRDSSS-----AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV--LPERVVYAVANEGS-RL 743 (782)
Q Consensus 672 ~~l~~~~~~~~~~-----~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~--~~~evl~~i~~~~~-~~ 743 (782)
..+.+........ .|...|++||+.++. ++...|+|++|.+..+..++..+.... ..-... ...+ ..
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~----r~~~ip~ 345 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL----RQGYIPL 345 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccc----ccccCch
Confidence 9887765433322 678899999998776 788999999999999998886644221 110000 1111 00
Q ss_pred C---CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 E---IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ~---ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+ -....+...+..++. +|..|+++..+..+
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 0 112245567777887 89999998877653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.5e-11 Score=119.35 Aligned_cols=128 Identities=15% Similarity=0.082 Sum_probs=96.7
Q ss_pred eeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCcee-eEeccccCCCceEEEEEEecccc
Q 003971 529 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKPPRLSMITEYMELGS 607 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIV-kL~g~~~d~~~l~LV~Ey~~gGs 607 (782)
.+.|+.|.++.||++...+..|++|+...... ....+..|+.+++.+.+.+++ +++.+.. ...++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 35688999999999999999999999754321 123456899999988655543 4554433 23589999999988
Q ss_pred hhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccc-----cccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 608 LYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI-----VHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 608 L~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gI-----IHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
+.... .....++.+++++|+.||..++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76431 0112456789999999999885 9999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=5e-11 Score=138.16 Aligned_cols=145 Identities=19% Similarity=0.218 Sum_probs=94.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE-C-CeEEEEEEeecccc---------------------------C-h----HHHH--
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW-N-GTDVAIKVFLEQDL---------------------------T-A----ENME-- 566 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~-~-g~~VAVKil~~~~~---------------------------~-~----~~~e-- 566 (782)
+.+|.. +.||.|++|.||+|+. + |+.||||+...... . . +..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455665 7899999999999987 4 89999999864310 0 0 0011
Q ss_pred ----HHHHHHHHHHhCC----CCceeeEecccc-CCCceEEEEEEecccchhhHHHhhccc---ccchHHHHHHHHHHHH
Q 003971 567 ----DFCNEISILSRLR----HPNVILFLGACT-KPPRLSMITEYMELGSLYHLIHLSGQK---KKLSWRRKLKMLRDIC 634 (782)
Q Consensus 567 ----~f~~EI~iLk~L~----HPNIVkL~g~~~-d~~~l~LV~Ey~~gGsL~dlL~~~~~~---~~Ls~~~~l~Ia~QIa 634 (782)
+|.+|+..+.+++ +.+.+.+-.++. .....++||||+.|+.+.++......+ ..+....+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 2344444444442 333333222221 133467999999999998753211111 1344454555555554
Q ss_pred HHHHHHHhccccccCCCcccEEEcCCC----eEEEEecCcccccc
Q 003971 635 RGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRIIT 675 (782)
Q Consensus 635 ~gL~yLHs~gIIHrDIKPeNILLd~~g----~VKLaDFGLA~~l~ 675 (782)
..|++|+|+||.||+++.++ +++++|||++..+.
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 58999999999999999888 99999999987664
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.6e-10 Score=130.71 Aligned_cols=163 Identities=21% Similarity=0.232 Sum_probs=122.6
Q ss_pred CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHH
Q 003971 546 NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRR 625 (782)
Q Consensus 546 ~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~ 625 (782)
.+.++.|..+..... ...+...+-+.-|+.++||||++++..+...+.+|+|+|-+. .|...++. +....
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 566777777654433 334556677888999999999999999999999999999986 56666652 23556
Q ss_pred HHHHHHHHHHHHHHHH-hccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCch
Q 003971 626 KLKMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 704 (782)
Q Consensus 626 ~l~Ia~QIa~gL~yLH-s~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~k 704 (782)
+...+.||+.||.||| +.+++|++|....|+|+..|..||++|-++...............--.|..|+.+.... -.
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cc
Confidence 6677899999999998 57899999999999999999999999998765433221111111222466666554332 34
Q ss_pred hHHHHHHHHHHHHHhC
Q 003971 705 CDIFSLGVIMWELCTL 720 (782)
Q Consensus 705 sDVWSLGvILyELLTG 720 (782)
.|.|-|||+++|++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 6999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.4e-10 Score=118.64 Aligned_cols=138 Identities=17% Similarity=0.098 Sum_probs=98.5
Q ss_pred eEEeeeCcEEEEEEEEC--------CeEEEEEEeecccc-----------C---------hHHHHHHH----HHHHHHHh
Q 003971 530 TRVGIGFFGEVFRGIWN--------GTDVAIKVFLEQDL-----------T---------AENMEDFC----NEISILSR 577 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~--------g~~VAVKil~~~~~-----------~---------~~~~e~f~----~EI~iLk~ 577 (782)
..||.|--+.||.|... +..+|||++..... . ....+.+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999753 37899998743210 0 01122333 79999998
Q ss_pred CCC--CceeeEeccccCCCceEEEEEEecccchh-hHHHhhcccccchHHHHHHHHHHHHHHHHHH-HhccccccCCCcc
Q 003971 578 LRH--PNVILFLGACTKPPRLSMITEYMELGSLY-HLIHLSGQKKKLSWRRKLKMLRDICRGLMCI-HRMKIVHRDLKSA 653 (782)
Q Consensus 578 L~H--PNIVkL~g~~~d~~~l~LV~Ey~~gGsL~-dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yL-Hs~gIIHrDIKPe 653 (782)
+.. -++...+++ ..-++||||+.++.+. ..+. ...++..+...++.+++.+|.+| |+.||||+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 853 344455543 3468999999875442 2222 12345556677889999999999 8999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccC
Q 003971 654 NCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 654 NILLd~~g~VKLaDFGLA~~l~~ 676 (782)
|||++ ++.++|+|||.+.....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCCC
Confidence 99997 46899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.2e-11 Score=139.01 Aligned_cols=245 Identities=22% Similarity=0.193 Sum_probs=176.9
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE---CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCce
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRL 596 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~---~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l 596 (782)
....+|..+..||.|.|+.|+.... .+..|++|.+.........-..-..|+-+...+. |.+++.++..|....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788999999999999998754 4678999987655443332223345666666664 99999999989888889
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC-CeEEEEecCcccccc
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIIT 675 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~-g~VKLaDFGLA~~l~ 675 (782)
|+-.|||.++++..... -...+++..++++..|++.++.++|++.++|+|+||+||++..+ +..++.|||....+.
T Consensus 342 ~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred cCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 99999999998876553 33467888899999999999999999999999999999999876 788999999987532
Q ss_pred CCCCCCCCCCCCCcc-cCccccccCCCCchhHHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHhcCCCCCCCC--hHHH
Q 003971 676 DSPMRDSSSAGTPEW-MAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE--GPLG 751 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y-~APEvl~~~~~s~ksDVWSLGvILyELLTGk~-PF~~~~~~evl~~i~~~~~~~~ip~--~~L~ 751 (782)
-. .......+..| .+++......+..+.|+|+||..+.+.+++.. +..+..-.. +..+..+..+. ..+.
T Consensus 419 ~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~-----i~~~~~p~~~~~~~~~q 491 (524)
T KOG0601|consen 419 FS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT-----IRSGDTPNLPGLKLQLQ 491 (524)
T ss_pred ee--cccccccccccccchhhccccccccccccccccccccccccCcccCccccccee-----eecccccCCCchHHhhh
Confidence 21 11112223334 36666777888999999999999999999875 433322111 12222333333 2344
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~L~ 775 (782)
.+.+.+.. ++..||.+.++..+..
T Consensus 492 ~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 492 VLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred hhhhhhcCCccccchhhhhhcccch
Confidence 55555666 8888899988876544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.5e-11 Score=127.63 Aligned_cols=202 Identities=25% Similarity=0.315 Sum_probs=141.9
Q ss_pred HHHhCCCCceeeEeccccCCC-----ceEEEEEEecccchhhHHHhhcc-cccchHHHHHHHHHHHHHHHHHHHhcc--c
Q 003971 574 ILSRLRHPNVILFLGACTKPP-----RLSMITEYMELGSLYHLIHLSGQ-KKKLSWRRKLKMLRDICRGLMCIHRMK--I 645 (782)
Q Consensus 574 iLk~L~HPNIVkL~g~~~d~~-----~l~LV~Ey~~gGsL~dlL~~~~~-~~~Ls~~~~l~Ia~QIa~gL~yLHs~g--I 645 (782)
.|-.+-|.|||+++.|+.+.+ ...++.||+..|++..+|++..+ ...+......+|+.||+.||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 344567999999999986543 47899999999999999986543 356788888999999999999999874 9
Q ss_pred cccCCCcccEEEcCCCeEEEEecCcccccc--CCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCC
Q 003971 646 VHRDLKSANCLVNKHWTVKICDFGLSRIIT--DSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN 721 (782)
Q Consensus 646 IHrDIKPeNILLd~~g~VKLaDFGLA~~l~--~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk 721 (782)
+|+++..+.|++..+|-+|+.--....... .... ....-.+-++|.+||.=.....+-++|||+||...++|..+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 999999999999999988875221111100 0000 011223567999999877667788999999999999998876
Q ss_pred CC-CCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 722 RP-WEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 722 ~P-F~~~~~~evl~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
.- -........-..+.+ .......+--+.++..|+. .|..||++.+++-|..-+
T Consensus 280 iq~tnseS~~~~ee~ia~--~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIAN--VIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred eccCCCcceeehhhhhhh--heeeccCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 53 222221111111111 1111222234568899999 999999999999875544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.1e-11 Score=145.63 Aligned_cols=247 Identities=20% Similarity=0.246 Sum_probs=184.7
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccc-cChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQD-LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~-~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
+....+.+.+.+-+-.|.++.++.+.-. |...+.|+..... +...+.+....+-.++-..++|-++.....+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 4456778888888999999999977542 3334444432222 112223444445555555667888877766666677
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.+++++|+.++.|...++. .+..+.+..+.++..+..+++|||...++|+|++|.|+|...+++.+++|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999999999883 3467777788888999999999999999999999999999999999999998432211
Q ss_pred C------C---------------C----------CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 003971 676 D------S---------------P----------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 724 (782)
Q Consensus 676 ~------~---------------~----------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF 724 (782)
. . . .......||+.|.+||.+.+......+|+|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 0 0012346899999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCC----ChHHHHHHHHhhh-CCCCCCCHH
Q 003971 725 EGVLPERVVYAVANEGSRLEIP----EGPLGRLIADCWA-EPQERPSCE 768 (782)
Q Consensus 725 ~~~~~~evl~~i~~~~~~~~ip----~~~L~~LI~~CL~-DP~kRPSa~ 768 (782)
....+..+...+.+.....+.- ....++++...+. +|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999998887776544333221 2347788888887 888886654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.2e-09 Score=110.36 Aligned_cols=132 Identities=21% Similarity=0.279 Sum_probs=102.3
Q ss_pred EEeeeCcEEEEEEEECCeEEEEEEeeccccChHH------HHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEec
Q 003971 531 RVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN------MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 604 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~------~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 604 (782)
.+++|+-+.+|.+.+.|..+++|.-..+...... .+.-.+|+.++.+++--.|..-+=+..+.+...++|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 5789999999999888888888876554433222 2456689999998875444433334456667789999999
Q ss_pred ccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 605 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 605 gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++..++ +.++||||+..
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888622 245777888888999999999999999999998764 99999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.8e-09 Score=108.53 Aligned_cols=139 Identities=19% Similarity=0.224 Sum_probs=103.7
Q ss_pred eEEeeeCcEEEEEEEECC-eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC--ceeeEeccccCC---CceEEEEEEe
Q 003971 530 TRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP--NVILFLGACTKP---PRLSMITEYM 603 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~g-~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HP--NIVkL~g~~~d~---~~l~LV~Ey~ 603 (782)
+.|+.|.++.||++...+ +.+++|+....... .....+.+|+++++.+.+. ++.+++.+.... +..+++|||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999997754 89999997543321 1235678999999999753 456677766553 2578999999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR----------------------------------------- 642 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs----------------------------------------- 642 (782)
+|.++.+.+.. ..++..+...++.+++++|.+||+
T Consensus 83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99988765421 245666666777777777777773
Q ss_pred ---------------ccccccCCCcccEEEcC--CCeEEEEecCcccc
Q 003971 643 ---------------MKIVHRDLKSANCLVNK--HWTVKICDFGLSRI 673 (782)
Q Consensus 643 ---------------~gIIHrDIKPeNILLd~--~g~VKLaDFGLA~~ 673 (782)
..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 67789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.3e-09 Score=106.98 Aligned_cols=146 Identities=18% Similarity=0.167 Sum_probs=108.0
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHH------HHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 528 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN------MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 528 i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~------~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
....|-+|+-+.|+++.+.|+.+.||.-..+...... .+...+|+.+|.++.--.|.--.-++.+...-.++||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4567889999999999999999999976544433222 3467789999998875454433334555566688999
Q ss_pred Eecc-cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC---eEEEEecCccccc
Q 003971 602 YMEL-GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSRII 674 (782)
Q Consensus 602 y~~g-GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g---~VKLaDFGLA~~l 674 (782)
|++| .++.+++..... ..........++.+|-+.+.-||.++|||+||.++||+|..++ .+.|+|||++..-
T Consensus 91 ~~~g~~~vk~~i~~~~~-~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTME-DESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHcc-CcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9987 466677754332 2233334478899999999999999999999999999996554 4689999998543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.3e-08 Score=110.79 Aligned_cols=246 Identities=17% Similarity=0.231 Sum_probs=159.6
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceee--------EeccccCCCceEE
Q 003971 528 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVIL--------FLGACTKPPRLSM 598 (782)
Q Consensus 528 i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVk--------L~g~~~d~~~l~L 598 (782)
.+..||+|+-+.+|-.-.-+.. +-|++........ .+-+..|... .||-+-. ++|. .....+.+
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa~~-----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGf 87 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPAAQ-----AQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGF 87 (637)
T ss_pred CCccccCCccceeeecchhhch-hheeecCCCchHH-----HHHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEE
Confidence 4677999999999954332223 3488765432211 1223444444 3553322 2221 11223667
Q ss_pred EEEEecccchh-hHHH---hhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 599 ITEYMELGSLY-HLIH---LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 599 V~Ey~~gGsL~-dlL~---~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
+|..+.+..-- .++. +...-....|...++.++.++.+.+.||..|.+-+|+.++|+|+++++.|.|.|-......
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence 77777764322 2221 1112345789999999999999999999999999999999999999999999986544333
Q ss_pred cCCCCCCCCCCCCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhC-CCCCCCCC-------hHHH--HHHHH--
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTL-NRPWEGVL-------PERV--VYAVA-- 737 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTG-k~PF~~~~-------~~ev--l~~i~-- 737 (782)
.........+|...|++||.-. +-..+...|.|.||+++|+++.| +.||.+.. +.+. .....
T Consensus 168 -~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y 246 (637)
T COG4248 168 -ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY 246 (637)
T ss_pred -cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence 3333445667999999999765 23446779999999999999887 78997542 2221 00000
Q ss_pred ----hcCCCC---CCC----ChHHHHHHHHhhh---CCCCCCCHHHHHHHHHhhhhcc
Q 003971 738 ----NEGSRL---EIP----EGPLGRLIADCWA---EPQERPSCEEILSRLLDCEYSL 781 (782)
Q Consensus 738 ----~~~~~~---~ip----~~~L~~LI~~CL~---DP~kRPSa~EIL~~L~di~~sL 781 (782)
..+.++ .+| ...++.|..+|+. ++.-||+++..+..|..+..+|
T Consensus 247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 011111 111 2357889999997 4668999999998887776554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.8e-08 Score=105.31 Aligned_cols=142 Identities=15% Similarity=0.045 Sum_probs=98.6
Q ss_pred EEeeeCcEEEEEEEECCeEEEEEEeeccccCh---------HHHHHHHHHHHHHHhCCCCce--eeEeccccC-----CC
Q 003971 531 RVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA---------ENMEDFCNEISILSRLRHPNV--ILFLGACTK-----PP 594 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~---------~~~e~f~~EI~iLk~L~HPNI--VkL~g~~~d-----~~ 594 (782)
.+-......|+++...|+.|.||......... .....+.+|...+.+|..-+| ...+++... ..
T Consensus 29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 34444444577888889999999764333110 001147789988888743222 222333321 23
Q ss_pred ceEEEEEEeccc-chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC-------CCeEEEE
Q 003971 595 RLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-------HWTVKIC 666 (782)
Q Consensus 595 ~l~LV~Ey~~gG-sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~-------~g~VKLa 666 (782)
..++|+|++++. +|.+++... .....+......++.+++..+..||..||+|+|+++.|||++. ++.+.|+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~-~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADW-ATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 478999999986 788887421 1234456677889999999999999999999999999999975 4689999
Q ss_pred ecCcccc
Q 003971 667 DFGLSRI 673 (782)
Q Consensus 667 DFGLA~~ 673 (782)
||+.+..
T Consensus 188 Dl~r~~~ 194 (268)
T PRK15123 188 DLHRAQI 194 (268)
T ss_pred ECCcccc
Confidence 9998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.7e-08 Score=98.39 Aligned_cols=127 Identities=28% Similarity=0.307 Sum_probs=83.5
Q ss_pred EEEEEEE-CCeEEEEEEeeccccC------------------------hHHHHHHHHHHHHHHhCCCC--ceeeEecccc
Q 003971 539 EVFRGIW-NGTDVAIKVFLEQDLT------------------------AENMEDFCNEISILSRLRHP--NVILFLGACT 591 (782)
Q Consensus 539 ~VYkg~~-~g~~VAVKil~~~~~~------------------------~~~~e~f~~EI~iLk~L~HP--NIVkL~g~~~ 591 (782)
.||.|.. +|..+|||+....... ........+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899987 7889999987532110 01134567899999999755 345555442
Q ss_pred CCCceEEEEEEec--ccchhhHHHhhcccccchHHHHHHHHHHHHHHHHH-HHhccccccCCCcccEEEcCCCeEEEEec
Q 003971 592 KPPRLSMITEYME--LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC-IHRMKIVHRDLKSANCLVNKHWTVKICDF 668 (782)
Q Consensus 592 d~~~l~LV~Ey~~--gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~y-LHs~gIIHrDIKPeNILLd~~g~VKLaDF 668 (782)
.-++||||++ |..+..+... .++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 2489999999 6666554431 11234456677788886655 579999999999999999988 9999999
Q ss_pred Ccccccc
Q 003971 669 GLSRIIT 675 (782)
Q Consensus 669 GLA~~l~ 675 (782)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.72 E-value=5e-07 Score=102.58 Aligned_cols=214 Identities=16% Similarity=0.232 Sum_probs=149.6
Q ss_pred CcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC----CCceEEEEEEecc-cch
Q 003971 536 FFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPRLSMITEYMEL-GSL 608 (782)
Q Consensus 536 ~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d----~~~l~LV~Ey~~g-GsL 608 (782)
.-.+.|++.. +|..|++|+++....... .....-+++++++.|+|||+|.++|.. +..+++||+|.++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3467889865 799999999843332111 122356889999999999999999863 3468999999986 456
Q ss_pred hhHHHh------------hcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 609 YHLIHL------------SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 609 ~dlL~~------------~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
.++.-. ...+...++..+|.++.|+..||.++|+.|+..+-|.+.+||++.+.+++|...|....+..
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 544311 01234578899999999999999999999999999999999999998999998888766543
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCC-CCCCCChHHH-HHHHHhcCCCCCCCChHHHHHH
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERV-VYAVANEGSRLEIPEGPLGRLI 754 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~-PF~~~~~~ev-l~~i~~~~~~~~ip~~~L~~LI 754 (782)
+. . |.+.. -.+-|.=.||.+++.|.||.. -+........ +..+.. .....+++++
T Consensus 446 d~------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~------~yS~D~rn~v 502 (655)
T KOG3741|consen 446 DP------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITT------TYSTDLRNVV 502 (655)
T ss_pred CC------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhh------hhhHHHHHHH
Confidence 32 0 11111 235688899999999999954 3443333333 222211 1223467777
Q ss_pred HHhhh-CCCCCCCHHHHHHHHH
Q 003971 755 ADCWA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~L~ 775 (782)
.-+.. ++++ -++.+++.++-
T Consensus 503 ~yl~s~~~~~-ksI~~llp~~~ 523 (655)
T KOG3741|consen 503 EYLESLNFRE-KSIQDLLPMIG 523 (655)
T ss_pred HHHHhcCccc-ccHHHHHHHHH
Confidence 77776 6665 67777776643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.6e-07 Score=94.68 Aligned_cols=106 Identities=24% Similarity=0.234 Sum_probs=79.8
Q ss_pred HHHHHHHHHHHhCCCCc--eeeEeccccCC----CceEEEEEEeccc-chhhHHHhhcccccchHHHHHHHHHHHHHHHH
Q 003971 566 EDFCNEISILSRLRHPN--VILFLGACTKP----PRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638 (782)
Q Consensus 566 e~f~~EI~iLk~L~HPN--IVkL~g~~~d~----~~l~LV~Ey~~gG-sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~ 638 (782)
..+.+|...+..|..-+ ..+.+++.... ...++|+|++++. +|.+++... ..++......++.+++..++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHHH
Confidence 45677888777774322 23333333321 2358999999974 788888632 22667778899999999999
Q ss_pred HHHhccccccCCCcccEEEcCCC---eEEEEecCccccc
Q 003971 639 CIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSRII 674 (782)
Q Consensus 639 yLHs~gIIHrDIKPeNILLd~~g---~VKLaDFGLA~~l 674 (782)
-||.+||+|+|+++.|||++.++ .+.|+||+-++..
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.3e-06 Score=93.23 Aligned_cols=137 Identities=26% Similarity=0.288 Sum_probs=99.5
Q ss_pred eEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccC--------------------hHHHHHHHHHHHHHHhCCCC--ce
Q 003971 527 TVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLT--------------------AENMEDFCNEISILSRLRHP--NV 583 (782)
Q Consensus 527 ~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~--------------------~~~~e~f~~EI~iLk~L~HP--NI 583 (782)
.++++||-|--+.||.|.. +|.++|||.-...... .-......+|.++|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4578999999999999987 6999999974321100 01134566888999988644 45
Q ss_pred eeEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeE
Q 003971 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 663 (782)
Q Consensus 584 VkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~V 663 (782)
.+-++ .+...+||||++|-.|...- ++......++..|+.-+.-+-..||||+|+.+=||+++++|.+
T Consensus 174 P~P~~----~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 174 PKPIA----WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCccc----cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence 55444 34568999999997776432 1334444566666666666668999999999999999999999
Q ss_pred EEEecCcccccc
Q 003971 664 KICDFGLSRIIT 675 (782)
Q Consensus 664 KLaDFGLA~~l~ 675 (782)
.++||-.+....
T Consensus 242 ~vIDwPQ~v~~~ 253 (304)
T COG0478 242 VVIDWPQAVPIS 253 (304)
T ss_pred EEEeCcccccCC
Confidence 999998775543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1e-07 Score=111.01 Aligned_cols=141 Identities=21% Similarity=0.275 Sum_probs=96.9
Q ss_pred HHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-CC--------CCCCCCCcccCccccccCC
Q 003971 631 RDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RD--------SSSAGTPEWMAPELIRNEP 700 (782)
Q Consensus 631 ~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~-~~--------~~~~GT~~Y~APEvl~~~~ 700 (782)
.+++.|+.|+|+ .++||++|.|++|.++.++..||+.|+++........ .. ....-...|.|||++....
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 345599999996 6899999999999999999999999998865543111 00 0112345799999999988
Q ss_pred CCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhc------CCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHH
Q 003971 701 FTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANE------GSRLEIPEGPLGRLIADCWA-EPQERPSCEEILS 772 (782)
Q Consensus 701 ~s~ksDVWSLGvILyELLTG-k~PF~~~~~~evl~~i~~~------~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~ 772 (782)
.+.++|+||+||++|.+..| +.-+............... +....+| .++.+-+.+++. ++..||++..++.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p-~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLP-SELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCc-HHHHHHHHHHhcCCcccCcchhhhhc
Confidence 89999999999999999954 4444433222211111111 1111223 346666777777 9999997776653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.6e-06 Score=86.53 Aligned_cols=139 Identities=15% Similarity=0.068 Sum_probs=100.6
Q ss_pred eeeCcEEEEEEEECCeEEEEEEeecc---ccC-hHHHHHHHHHHHHHHhCCCCc--eeeEecccc---C--CCceEEEEE
Q 003971 533 GIGFFGEVFRGIWNGTDVAIKVFLEQ---DLT-AENMEDFCNEISILSRLRHPN--VILFLGACT---K--PPRLSMITE 601 (782)
Q Consensus 533 G~G~fG~VYkg~~~g~~VAVKil~~~---~~~-~~~~e~f~~EI~iLk~L~HPN--IVkL~g~~~---d--~~~l~LV~E 601 (782)
|.||-+-|++....|..+-+|.-... .+. +.-...|.+|...|..|..-+ +.+.. ++. . ...-+||+|
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEE
Confidence 56888999998888888888874311 111 223468999999999985322 33333 221 1 123688999
Q ss_pred Eecc-cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe--EEEEecCcccc
Q 003971 602 YMEL-GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--VKICDFGLSRI 673 (782)
Q Consensus 602 y~~g-GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~--VKLaDFGLA~~ 673 (782)
-+.| -+|.+++.. ..-.+.+..+...++.+|+..++-||+.|+.|+|+.+.|||++.++. ++++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~-~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQ-HAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhc-CCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7764 467777642 12335677888899999999999999999999999999999986666 99999976654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.31 E-value=8.4e-06 Score=85.07 Aligned_cols=138 Identities=16% Similarity=0.154 Sum_probs=93.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHH-HH------HHHHHHHHHHhCC---CCceeeEecccc--
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN-ME------DFCNEISILSRLR---HPNVILFLGACT-- 591 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~-~e------~f~~EI~iLk~L~---HPNIVkL~g~~~-- 591 (782)
.+|.+.+.+-......|.+-..+|+.+.+|.........+. .. ...+++..+..++ ...+..++.+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk 110 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK 110 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence 67888888888888888888889999999997654432211 11 1223444444443 222333222221
Q ss_pred ---CCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEec
Q 003971 592 ---KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 668 (782)
Q Consensus 592 ---d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDF 668 (782)
-....+++|||++|..|.++.. +++ .+...+.+++..||+.|++|+|.+|.|++++++ .++++||
T Consensus 111 ~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 111 IFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 2234578999999988877543 222 244567788999999999999999999999866 4999999
Q ss_pred Ccccc
Q 003971 669 GLSRI 673 (782)
Q Consensus 669 GLA~~ 673 (782)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 86643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.3e-05 Score=77.72 Aligned_cols=141 Identities=18% Similarity=0.150 Sum_probs=83.3
Q ss_pred eeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC--ceeeEeccc---cCCCceEEEEEEe
Q 003971 529 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP--NVILFLGAC---TKPPRLSMITEYM 603 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HP--NIVkL~g~~---~d~~~l~LV~Ey~ 603 (782)
++.|+.|..+.||+....+..+++|+.... .....+..|..+++.+... .+.+++.++ ......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467999999999999987789999996433 3346777888888888533 244555533 2233478999999
Q ss_pred cccchhh----------------HHH---hhc-ccccchH-H--------HHHHH------------HHHHHH-HHHHHH
Q 003971 604 ELGSLYH----------------LIH---LSG-QKKKLSW-R--------RKLKM------------LRDICR-GLMCIH 641 (782)
Q Consensus 604 ~gGsL~d----------------lL~---~~~-~~~~Ls~-~--------~~l~I------------a~QIa~-gL~yLH 641 (782)
+|..+.. .+. ... ....+.. . ..... ...+.. .++.++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987776 111 010 0000000 0 00000 111222 333343
Q ss_pred h-------ccccccCCCcccEEEc-CCCeEEEEecCcccc
Q 003971 642 R-------MKIVHRDLKSANCLVN-KHWTVKICDFGLSRI 673 (782)
Q Consensus 642 s-------~gIIHrDIKPeNILLd-~~g~VKLaDFGLA~~ 673 (782)
. ..++|+|+.+.|||++ +++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 4599999999999999 667778999987743
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=8.2e-06 Score=94.76 Aligned_cols=142 Identities=20% Similarity=0.244 Sum_probs=89.6
Q ss_pred eEEeeeCcEEEEEEEE-CCeEEEEEEeecccc---------------------------Ch-HHH----------HHHHH
Q 003971 530 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDL---------------------------TA-ENM----------EDFCN 570 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~---------------------------~~-~~~----------e~f~~ 570 (782)
+.|+.++-|.||+|+. +|+.||||+....-. .. ..+ -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999987 599999999643210 00 001 12444
Q ss_pred HHHHHHhCC-----CCceeeEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHH-HHHHHhcc
Q 003971 571 EISILSRLR-----HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG-LMCIHRMK 644 (782)
Q Consensus 571 EI~iLk~L~-----HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~g-L~yLHs~g 644 (782)
|...+.+++ .++|.--.=+++-...-.++|||++|-.+.+...... ..++.+.+. ..++++ +..+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia---~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELA---ELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHH---HHHHHHHHHHHHhcC
Confidence 555555542 2333211112233345689999999999988753211 233322222 222222 22233479
Q ss_pred ccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 645 IIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++|.|.+|.||+++.+|++.+.|||+...+..
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999877643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.8e-05 Score=81.19 Aligned_cols=135 Identities=16% Similarity=0.139 Sum_probs=81.9
Q ss_pred eEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCc--eeeEeccccCCCceEEEEEEecccc
Q 003971 530 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGACTKPPRLSMITEYMELGS 607 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN--IVkL~g~~~d~~~l~LV~Ey~~gGs 607 (782)
..||.|..+.||+. .+..+++|...... . .....+|.++++.+..-+ +.+.+++....+...++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 46899999999984 35567888875422 2 244678999998886333 3566666667777889999999863
Q ss_pred -hhhHH---------------------HhhcccccchHHHHH-HHHH----------HHHH-HHHHHHh----ccccccC
Q 003971 608 -LYHLI---------------------HLSGQKKKLSWRRKL-KMLR----------DICR-GLMCIHR----MKIVHRD 649 (782)
Q Consensus 608 -L~dlL---------------------~~~~~~~~Ls~~~~l-~Ia~----------QIa~-gL~yLHs----~gIIHrD 649 (782)
+...+ |... .......... .+.. .+.. ...+|.. ..++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 11111 1000 0011111100 0100 0111 1222221 2478999
Q ss_pred CCcccEEEcCCCeEEEEecCccc
Q 003971 650 LKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 650 IKPeNILLd~~g~VKLaDFGLA~ 672 (782)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.92 E-value=6.4e-05 Score=78.18 Aligned_cols=137 Identities=18% Similarity=0.080 Sum_probs=82.9
Q ss_pred EEeeeCc-EEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEEEEEecccch
Q 003971 531 RVGIGFF-GEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMELGSL 608 (782)
Q Consensus 531 ~LG~G~f-G~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL 608 (782)
.|-.|.+ +.||+....+..+.||+..... ...+.+|+++++.+. +--+.+++++....+..++||++++|.++
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3445555 7899987777788888864332 234567888888874 33355677776666678999999998776
Q ss_pred hhHH-------------------Hhhcc-cccchHH--HHHHHHH--------------------HHHHHHHHHH-----
Q 003971 609 YHLI-------------------HLSGQ-KKKLSWR--RKLKMLR--------------------DICRGLMCIH----- 641 (782)
Q Consensus 609 ~dlL-------------------~~~~~-~~~Ls~~--~~l~Ia~--------------------QIa~gL~yLH----- 641 (782)
.... +.... ...+... ....... .+...+..|-
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 5331 10000 0011000 0000000 0111122221
Q ss_pred --hccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 642 --RMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 642 --s~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2348999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.92 E-value=5.4e-05 Score=80.22 Aligned_cols=138 Identities=17% Similarity=0.148 Sum_probs=91.3
Q ss_pred eEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHH----------------------HHHHHHHHHHHhCC--CCcee
Q 003971 530 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENM----------------------EDFCNEISILSRLR--HPNVI 584 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~----------------------e~f~~EI~iLk~L~--HPNIV 584 (782)
..|.+|--+.||+|.. ++..+|||++......-... .-..+|...|+++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 3677888889999975 68999999986543221111 12234566666653 22222
Q ss_pred eEeccccCCCceEEEEEEecccch-hhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCe
Q 003971 585 LFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWT 662 (782)
Q Consensus 585 kL~g~~~d~~~l~LV~Ey~~gGsL-~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~ 662 (782)
+-+.+. .-.++|||+..... .-.|+ ...+.......+..++++.+.-|-. .++||+||..=|||+. ++.
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 333322 24789999975411 11111 1223333677788889999988876 8999999999999999 779
Q ss_pred EEEEecCccccccC
Q 003971 663 VKICDFGLSRIITD 676 (782)
Q Consensus 663 VKLaDFGLA~~l~~ 676 (782)
+.|+|||.|....+
T Consensus 205 p~iID~~QaV~~~h 218 (268)
T COG1718 205 PYIIDVSQAVTIDH 218 (268)
T ss_pred EEEEECccccccCC
Confidence 99999999876643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00021 Score=73.93 Aligned_cols=127 Identities=23% Similarity=0.350 Sum_probs=92.2
Q ss_pred CCeeEeeEEeeeCc-EEEEEEEECCeEEEEEEeec---ccc-------Ch---------HHHHHHHHHHHHHHhCC---C
Q 003971 524 SELTVGTRVGIGFF-GEVFRGIWNGTDVAIKVFLE---QDL-------TA---------ENMEDFCNEISILSRLR---H 580 (782)
Q Consensus 524 s~y~i~~~LG~G~f-G~VYkg~~~g~~VAVKil~~---~~~-------~~---------~~~e~f~~EI~iLk~L~---H 580 (782)
.+++.++.||.|.- |.||++...|+.||+|++.. ... .. ....-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78899999999999 99999999999999999321 110 00 12346888988877775 4
Q ss_pred Cce--eeEeccccCC------------------CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHH
Q 003971 581 PNV--ILFLGACTKP------------------PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640 (782)
Q Consensus 581 PNI--VkL~g~~~d~------------------~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yL 640 (782)
.++ |+++|+..-. ....||.||++... .++ ..-+.++.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHHH
Confidence 566 8999886211 12467778776533 122 23355677888899
Q ss_pred HhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 641 HRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 641 Hs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
|..||+-+|+++.|.. .=+|+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999986 3478999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=4.9e-06 Score=96.61 Aligned_cols=181 Identities=22% Similarity=0.183 Sum_probs=133.1
Q ss_pred eeEEeeeCcEEEEEEEECCeE-EEEEEeeccccChHHHHHHHHHHHHHHhCCCCc-eeeEeccccCCCceEEEEEEeccc
Q 003971 529 GTRVGIGFFGEVFRGIWNGTD-VAIKVFLEQDLTAENMEDFCNEISILSRLRHPN-VILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~g~~-VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN-IVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
.+-+++|+++++|+.+...+. ...+.+... ....-++++|.+++||| .+..++-++.+...++.++++.++
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 345679999999987654332 223433211 34456899999999999 777777777788899999999877
Q ss_pred -chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003971 607 -SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685 (782)
Q Consensus 607 -sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~ 685 (782)
+...... .....+...+...+.+.-+++++|||+.-=+|+| ||+..+ +..+..||+....+.... ...+..
T Consensus 320 rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~ 391 (829)
T KOG0576|consen 320 RSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAI 391 (829)
T ss_pred ccccccCC--hhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-ccccCC
Confidence 3222211 1122344555566777888999999988778998 777765 689999999988776542 345778
Q ss_pred CCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 003971 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 724 (782)
Q Consensus 686 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF 724 (782)
+|+.++|||+.....+..+.|+|++|+-..++--|-.|-
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 999999999999999999999999998777777666553
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00013 Score=73.94 Aligned_cols=130 Identities=22% Similarity=0.212 Sum_probs=92.6
Q ss_pred eEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceee-EeccccCCCceEEEEEEecc
Q 003971 527 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL-FLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 527 ~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVk-L~g~~~d~~~l~LV~Ey~~g 605 (782)
.+.+.||+|.+|.||+|.+.|..+|+|+-.... ....+..|+++|..++-.++.. +|.+-.+ ++.|||+.|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 345679999999999999999999999854332 2356788999999998666643 3333222 445999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCC-cccEEEcCCCeEEEEecCccccc
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLK-SANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIK-PeNILLd~~g~VKLaDFGLA~~l 674 (782)
-.|...... .+ .+-+..+++.-.-|-..||-|+.|. |...+|..++.+.|+||.-|...
T Consensus 97 ~~L~~~~~~------~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 97 RPLGKLEIG------GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cchhhhhhc------cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 888765431 02 2234456666666778899999994 66555556669999999988743
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0003 Score=86.54 Aligned_cols=79 Identities=19% Similarity=0.172 Sum_probs=56.8
Q ss_pred eeEEeeeCcEEEEEEEECC----eEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCce--eeEeccccCC---CceEE
Q 003971 529 GTRVGIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNV--ILFLGACTKP---PRLSM 598 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~g----~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNI--VkL~g~~~d~---~~l~L 598 (782)
.++|+.|.++.+|+....+ ..+++|+....... .....+.+|+.+|+.+. |.+| .+++.+|.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4778999999999987643 46778875432221 12346789999999995 6665 7778877664 45789
Q ss_pred EEEEecccch
Q 003971 599 ITEYMELGSL 608 (782)
Q Consensus 599 V~Ey~~gGsL 608 (782)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999998653
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00012 Score=74.62 Aligned_cols=101 Identities=23% Similarity=0.276 Sum_probs=81.0
Q ss_pred HHHHHHHhCCC-CceeeEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh---ccc
Q 003971 570 NEISILSRLRH-PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR---MKI 645 (782)
Q Consensus 570 ~EI~iLk~L~H-PNIVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs---~gI 645 (782)
+|.-+++.+++ +++.+++|+|.+ +++.||...+++.........-...+|.++.+|+.++++.+.+|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57888898976 699999999954 7899999977665321000011246899999999999999999997 458
Q ss_pred cccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 646 VHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 646 IHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.-.|++++|+-++++|++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 88999999999999999999999877554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00022 Score=83.19 Aligned_cols=140 Identities=23% Similarity=0.241 Sum_probs=90.0
Q ss_pred eEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHH------------------------------------HHHHHHHH
Q 003971 530 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAEN------------------------------------MEDFCNEI 572 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~------------------------------------~e~f~~EI 572 (782)
+.||.-+.|.||+|+. +|+.||||+-+.. +.... .-+|.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5799999999999976 7899999985322 11100 11455666
Q ss_pred HHHHhC----CCCc------eeeEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh
Q 003971 573 SILSRL----RHPN------VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642 (782)
Q Consensus 573 ~iLk~L----~HPN------IVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs 642 (782)
+...++ .|-+ |.++|-.+ .....|+|||++|..+.++.... ...++...+...+.++..- -+=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~~l~~~~~~--qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAID--KRGISPHDILNKLVEAYLE--QIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHH--HcCCCHHHHHHHHHHHHHH--HHHh
Confidence 554443 3444 33443322 23478999999999888765321 2234444433333332221 2224
Q ss_pred ccccccCCCcccEEEcC----CCeEEEEecCccccccC
Q 003971 643 MKIVHRDLKSANCLVNK----HWTVKICDFGLSRIITD 676 (782)
Q Consensus 643 ~gIIHrDIKPeNILLd~----~g~VKLaDFGLA~~l~~ 676 (782)
.|++|+|=+|.||+++. ++.+.+-|||+...+.+
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 58999999999999984 67899999999877654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00028 Score=87.06 Aligned_cols=196 Identities=19% Similarity=0.235 Sum_probs=136.0
Q ss_pred HHHHHHHHHHHhCCCCceeeEeccccCCCc----eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHH
Q 003971 566 EDFCNEISILSRLRHPNVILFLGACTKPPR----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 641 (782)
Q Consensus 566 e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~----l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLH 641 (782)
....-|...+.+..|+|++.++.+-.+... ..+..+++...++...+. .-...+....+.+..++..||.|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHH
Confidence 334456677888899999999888654432 345567888888887776 4457888999999999999999999
Q ss_pred hccccccCCCcc---cEEEcCCCeEEEE--ecCccccccCCCCCCCCCCCCCcccCccccccCCCCc--hhHHHHHHHHH
Q 003971 642 RMKIVHRDLKSA---NCLVNKHWTVKIC--DFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTE--KCDIFSLGVIM 714 (782)
Q Consensus 642 s~gIIHrDIKPe---NILLd~~g~VKLa--DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~--ksDVWSLGvIL 714 (782)
+....|.-+... +...+..+.+.+. ||+.+..+.+.... .....+..+.++|......++. ..|+|.+|..+
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc-hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 986655555444 4444556677776 99888877654332 2333455678888887665554 47999999999
Q ss_pred HHHHhCCCCCC-CCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003971 715 WELCTLNRPWE-GVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRL 774 (782)
Q Consensus 715 yELLTGk~PF~-~~~~~evl~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 774 (782)
..+..|..+-. .......+... . .....+....|+. ++++|+++.+++.+.
T Consensus 383 ~~~~~~~~i~~~~~~~~~~l~~~--------~-~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVPVSLLDVL--------S-TSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcCcccccccchhhhhccc--------c-chhhhhhhhhhcchhhhhccchhhhhhch
Confidence 99998876421 11111111110 0 1146777888998 999999999998763
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00091 Score=69.55 Aligned_cols=73 Identities=21% Similarity=0.153 Sum_probs=45.1
Q ss_pred eEEeeeCcE-EEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC---ceeeEeccccCC---CceEEEEEE
Q 003971 530 TRVGIGFFG-EVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP---NVILFLGACTKP---PRLSMITEY 602 (782)
Q Consensus 530 ~~LG~G~fG-~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HP---NIVkL~g~~~d~---~~l~LV~Ey 602 (782)
+.|+.|+.. .||+. +..+++|+..... ....+.+|.+++..+... -+.+.++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457777776 58875 3457788754321 234678899999887531 233444433332 234889999
Q ss_pred ecccchh
Q 003971 603 MELGSLY 609 (782)
Q Consensus 603 ~~gGsL~ 609 (782)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0021 Score=66.38 Aligned_cols=133 Identities=16% Similarity=0.181 Sum_probs=91.1
Q ss_pred eEEeeeCcEEEEEEEECCeEEEEEEeeccc--------------cChHHHHHHHHHHHHHHhCC------CCceeeEecc
Q 003971 530 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQD--------------LTAENMEDFCNEISILSRLR------HPNVILFLGA 589 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~g~~VAVKil~~~~--------------~~~~~~e~f~~EI~iLk~L~------HPNIVkL~g~ 589 (782)
..||+|+.=.||.--. .....||+..... .......++.+|+.....+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 4699999999996433 3345678876554 11122456777777766665 7899999999
Q ss_pred ccCCCceEEEEEEecc------cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC---
Q 003971 590 CTKPPRLSMITEYMEL------GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH--- 660 (782)
Q Consensus 590 ~~d~~~l~LV~Ey~~g------GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~--- 660 (782)
.+++-...+|+|.+.. -+|.+++. ...++. . +...+-+-..||-..+|+.+|++|.||++...
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999998763 24556653 334444 2 33334445568889999999999999999533
Q ss_pred C-eEEEEe-cCcc
Q 003971 661 W-TVKICD-FGLS 671 (782)
Q Consensus 661 g-~VKLaD-FGLA 671 (782)
. .+.|+| ||-.
T Consensus 158 ~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 158 EFRLVLIDGLGEK 170 (199)
T ss_pred ceEEEEEeCCCCc
Confidence 2 567776 4433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0028 Score=65.34 Aligned_cols=73 Identities=15% Similarity=0.131 Sum_probs=46.8
Q ss_pred eeEEeeeCcEEEEEEEEC---CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCc-eeeEeccccCCCceEEEEEEec
Q 003971 529 GTRVGIGFFGEVFRGIWN---GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN-VILFLGACTKPPRLSMITEYME 604 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~---g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN-IVkL~g~~~d~~~l~LV~Ey~~ 604 (782)
.+.|..|-...+|+.... +..|++|+....... .....+|+.+++.+...+ ..++++.+. + .++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeC
Confidence 356778888999998764 578899976532211 112236888888885333 334444332 1 47999999
Q ss_pred ccch
Q 003971 605 LGSL 608 (782)
Q Consensus 605 gGsL 608 (782)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00059 Score=57.05 Aligned_cols=60 Identities=23% Similarity=0.225 Sum_probs=47.7
Q ss_pred ccccccchhhHHHHHHhhhcCCccccccccCCCCcccc---ccccCcceEEEEeCCeeeeeec
Q 003971 187 IRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMEC---VDSYKHMSVIVVLNSVELLVDL 246 (782)
Q Consensus 187 i~~g~~r~ra~lfkvlad~~~l~~~~~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 246 (782)
-+.|.|.+.|.||+.|.-.+|+|||++.|........- .....|.|+.|-++.+=+.+|-
T Consensus 4 ~~~G~C~~~a~l~~~llr~~GIpar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~~~~W~~~D~ 66 (68)
T smart00460 4 TKYGTCGEFAALFVALLRSLGIPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYLEGGWVPVDP 66 (68)
T ss_pred ccceeeHHHHHHHHHHHHHCCCCeEEEeeeecCCCCCcccccCCCcEEEEEEEECCCeEEEeC
Confidence 46899999999999999999999999999763222111 3457899999999877777773
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0037 Score=66.81 Aligned_cols=140 Identities=16% Similarity=0.195 Sum_probs=84.1
Q ss_pred eeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCc--eeeEeccc------cCCCceEEEE
Q 003971 529 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGAC------TKPPRLSMIT 600 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN--IVkL~g~~------~d~~~l~LV~ 600 (782)
.+.|..|....+|+....+..+++|+... .. .+.+..|+.++..+.+.+ +.+++... ..++..++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 45677788889999877777899998753 11 244566788877775332 34444321 2234568999
Q ss_pred EEecccchhh----HH----------Hhhccc--------ccchHHHHH----------HHHHHHHHHHHHHHh------
Q 003971 601 EYMELGSLYH----LI----------HLSGQK--------KKLSWRRKL----------KMLRDICRGLMCIHR------ 642 (782)
Q Consensus 601 Ey~~gGsL~d----lL----------~~~~~~--------~~Ls~~~~l----------~Ia~QIa~gL~yLHs------ 642 (782)
+|++|..+.. .. |..... ....+.... .....+..++.++..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999866532 11 110000 001111100 011123344455543
Q ss_pred -ccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 643 -MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 643 -~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
.+++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4699999999999999987778999988743
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0013 Score=69.24 Aligned_cols=135 Identities=16% Similarity=0.088 Sum_probs=77.3
Q ss_pred EeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCce-eeEeccccCCCceEEEEEEecccchhh
Q 003971 532 VGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSMITEYMELGSLYH 610 (782)
Q Consensus 532 LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~~~l~LV~Ey~~gGsL~d 610 (782)
+..|-.+.+|+...++..+++|+........ .-...+|..+++.+...++ .+++..+. -++|+||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 4567788999988888889999854322110 0124578888888864323 23333322 368999999876542
Q ss_pred H-----------------HHhhcc-cccchHH-HHHHHHHHH---------HHHHHHHHh--------ccccccCCCccc
Q 003971 611 L-----------------IHLSGQ-KKKLSWR-RKLKMLRDI---------CRGLMCIHR--------MKIVHRDLKSAN 654 (782)
Q Consensus 611 l-----------------L~~~~~-~~~Ls~~-~~l~Ia~QI---------a~gL~yLHs--------~gIIHrDIKPeN 654 (782)
. +|.... ...++.. .+..+..++ ...+..+-. ..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 111110 1111211 111221111 111222221 248999999999
Q ss_pred EEEcCCCeEEEEecCcccc
Q 003971 655 CLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 655 ILLd~~g~VKLaDFGLA~~ 673 (782)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999988743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.005 Score=66.98 Aligned_cols=78 Identities=13% Similarity=-0.067 Sum_probs=56.0
Q ss_pred eEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCC---CceeeEeccccC---CCceEEEE
Q 003971 527 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH---PNVILFLGACTK---PPRLSMIT 600 (782)
Q Consensus 527 ~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H---PNIVkL~g~~~d---~~~l~LV~ 600 (782)
.-.+.||.|..+.||+....+..+.+|..+ .... ...|..|...|+.+.- -.+.+++++|.. .+..++||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~-~~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGNPMPLMAR-SFST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcCCCCEEEEEec-cccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 345679999999999987655567778743 2111 2467889999988853 356777776654 35689999
Q ss_pred EEecccch
Q 003971 601 EYMELGSL 608 (782)
Q Consensus 601 Ey~~gGsL 608 (782)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0071 Score=65.52 Aligned_cols=143 Identities=15% Similarity=0.164 Sum_probs=83.1
Q ss_pred eeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCc--eeeEeccc------cCCCceE
Q 003971 526 LTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGAC------TKPPRLS 597 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN--IVkL~g~~------~d~~~l~ 597 (782)
....+.++.|....+|+...++..+++|+..... . .+....|++++..|...+ +.+++... ...+..+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ceeccccCCccccceEEEEeCCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 3345667788888999987766678899865421 1 234456677777764222 33443321 1234578
Q ss_pred EEEEEecccchhh--------------HHHhhccc--c-------cchHHHHH------------HHHHHHHHHHHHHHh
Q 003971 598 MITEYMELGSLYH--------------LIHLSGQK--K-------KLSWRRKL------------KMLRDICRGLMCIHR 642 (782)
Q Consensus 598 LV~Ey~~gGsL~d--------------lL~~~~~~--~-------~Ls~~~~l------------~Ia~QIa~gL~yLHs 642 (782)
++++|++|..+.. .+|..... . .-.|.... .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 9999999854321 01111110 0 00111100 011123344555542
Q ss_pred -------ccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 643 -------MKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 643 -------~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 579999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.00018 Score=90.27 Aligned_cols=161 Identities=16% Similarity=0.098 Sum_probs=120.3
Q ss_pred HHHHHHHHHHHHhCCCCceeeEeccccC--CCceEEEEEEecccchhhHHHhhcc-cccchHHHHHHHHHHHHHHHHHHH
Q 003971 565 MEDFCNEISILSRLRHPNVILFLGACTK--PPRLSMITEYMELGSLYHLIHLSGQ-KKKLSWRRKLKMLRDICRGLMCIH 641 (782)
Q Consensus 565 ~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~l~LV~Ey~~gGsL~dlL~~~~~-~~~Ls~~~~l~Ia~QIa~gL~yLH 641 (782)
.+-...|...++...|++++....-... ....|..++|+.+|.+++.+-.+-+ ...+....+.....+.+.+..-+|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 3445556666777789998876654432 3346889999999999998864322 234444445545555466777777
Q ss_pred hc-----cccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHH
Q 003971 642 RM-----KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWE 716 (782)
Q Consensus 642 s~-----gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyE 716 (782)
+. -.+|+++|+.|.+|..+.++|++++|+.+...+.........+++.|+.|+....-.++.++|+|..|+.+|+
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 53 1799999999999999999999999999854443333345678889999999888888989999999999999
Q ss_pred HHhCCCCCC
Q 003971 717 LCTLNRPWE 725 (782)
Q Consensus 717 LLTGk~PF~ 725 (782)
...|..+|.
T Consensus 1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred HhcccHHHH
Confidence 998887763
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.018 Score=62.51 Aligned_cols=139 Identities=20% Similarity=0.261 Sum_probs=75.4
Q ss_pred eEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-----CCceeeEe-c--cccCCCceEEEEE
Q 003971 530 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----HPNVILFL-G--ACTKPPRLSMITE 601 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-----HPNIVkL~-g--~~~d~~~l~LV~E 601 (782)
+.|+.|....+|+...++..+++|++. .... +....|+.++..|. .|.++.-. | +....+..+++++
T Consensus 28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~--~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQGEYVLTLFE--RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCCCcEEEEEec--cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 457778888999987766689999875 2222 23334555555553 33333211 0 1122445789999
Q ss_pred Eecccchhh-----H---------HHhhccc--------ccchH-HHHHH------------HHHH-HHHHHHHHH----
Q 003971 602 YMELGSLYH-----L---------IHLSGQK--------KKLSW-RRKLK------------MLRD-ICRGLMCIH---- 641 (782)
Q Consensus 602 y~~gGsL~d-----l---------L~~~~~~--------~~Ls~-~~~l~------------Ia~Q-Ia~gL~yLH---- 641 (782)
|++|..+.. . +|..... ..+.+ ..... .+.+ +...++.+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999864311 1 1111000 01111 11110 1111 111223332
Q ss_pred ---hccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 642 ---RMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 642 ---s~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
..+++|+|+++.|||++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 23799999999999998765568999998753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.00079 Score=73.89 Aligned_cols=138 Identities=14% Similarity=0.173 Sum_probs=94.4
Q ss_pred CeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChH--------------------HHHHHHHHHHHHHhCC-CCc
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAE--------------------NMEDFCNEISILSRLR-HPN 582 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~--------------------~~e~f~~EI~iLk~L~-HPN 582 (782)
-+.++++||-|.-+-||.+-+ +|++.++|+-......-. ..-...+|...|+.|. |-.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 456789999999999999977 599999986321111000 0123456777888775 222
Q ss_pred -eeeEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC
Q 003971 583 -VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 661 (782)
Q Consensus 583 -IVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g 661 (782)
+.+.+ +.+..++|||++.|-.|...-+. .+.. .+...+..-+--|-..|+||+|..-=||++++++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeec------CChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 22333 34556899999998888754431 1222 2334445555677889999999999999999999
Q ss_pred eEEEEecCcccccc
Q 003971 662 TVKICDFGLSRIIT 675 (782)
Q Consensus 662 ~VKLaDFGLA~~l~ 675 (782)
.++++||-......
T Consensus 240 ~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 240 KIVVIDFPQMVSTS 253 (465)
T ss_pred CEEEeechHhhccC
Confidence 99999998765443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.011 Score=63.67 Aligned_cols=73 Identities=18% Similarity=0.272 Sum_probs=46.4
Q ss_pred eEEeeeCcEEEEEEEEC--------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCce-eeEeccccCCCceEEEE
Q 003971 530 TRVGIGFFGEVFRGIWN--------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSMIT 600 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~--------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~~~l~LV~ 600 (782)
+.|..|-...||+.... ++.+++|+...... ......+|..++..+...++ .++++++.. .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 45666777899988764 47899999654321 12344578888888753333 344554432 3579
Q ss_pred EEecccchh
Q 003971 601 EYMELGSLY 609 (782)
Q Consensus 601 Ey~~gGsL~ 609 (782)
+|++|..+.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.041 Score=59.07 Aligned_cols=29 Identities=24% Similarity=0.328 Sum_probs=25.3
Q ss_pred ccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 643 ~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 578999998763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.059 Score=61.37 Aligned_cols=77 Identities=17% Similarity=0.034 Sum_probs=52.1
Q ss_pred eeEEeeeCcEEEEEEEEC-C-eEEEEEEeecccc---C--hHHHHHHHHHHHHHHhCC---CCceeeEeccccCCCceEE
Q 003971 529 GTRVGIGFFGEVFRGIWN-G-TDVAIKVFLEQDL---T--AENMEDFCNEISILSRLR---HPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~-g-~~VAVKil~~~~~---~--~~~~e~f~~EI~iLk~L~---HPNIVkL~g~~~d~~~l~L 598 (782)
.+.||.|.+..||++... | +.++||.-..... . +-..+.+..|.+.|+.+. -.++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 367999999999999874 4 4899997431100 0 123456778888888763 2456677765 3355789
Q ss_pred EEEEecccc
Q 003971 599 ITEYMELGS 607 (782)
Q Consensus 599 V~Ey~~gGs 607 (782)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.0045 Score=56.52 Aligned_cols=102 Identities=22% Similarity=0.277 Sum_probs=58.2
Q ss_pred HHHHHHHHhcCCCChHHHHHHHHHHHHhhhCCC-CCCChhhhhHHHHHHHHhhcceeEeccccccccchhhHHHHHHhhh
Q 003971 127 KQLIVALVKGLNSNPAAMIKKIAGLVADFYKRP-SVESPAKAALEETSHMFETRGVQLLGQIRHGSCRPRAILFKVLADT 205 (782)
Q Consensus 127 ~~l~~~~~~~~~~~~~~~~~~~a~~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~g~i~~g~~r~ra~lfkvlad~ 205 (782)
|+|...++.+.. ++.+.++.|...|.+.+.-- ......... -...|+ -+.|.|..-|.||..|+-.
T Consensus 1 ~~la~~i~~~~~-~~~~~~~~i~~~v~~~~~y~~~~~~~~~~~---~~~~l~---------~~~G~C~~~a~l~~allr~ 67 (113)
T PF01841_consen 1 RALAREITANSK-TPLEKAKAIYDWVRSNIRYDDPNYSPGPRD---ASEVLR---------SGRGDCEDYASLFVALLRA 67 (113)
T ss_dssp --------TTSH-CHHCCCCCCCCCCCCCCCEC-TCCCCCCTT---HHHHHH---------CEEESHHHHHHHHHHHHHH
T ss_pred CCcccccCCCCC-CHHHHHHHHHHHHHhCcEEeCCCCCCCCCC---HHHHHH---------cCCCccHHHHHHHHHHHhh
Confidence 355566665555 56666666666666555433 011111110 112222 3459999999999999999
Q ss_pred cCCccccccccCCC----CccccccccCcceEEEEeCCee
Q 003971 206 VGLESRLMVGLPND----GTMECVDSYKHMSVIVVLNSVE 241 (782)
Q Consensus 206 ~~l~~~~~~g~~~~----~~~~~~~~~~~~~~~~~~~~~~ 241 (782)
.|+|||+|.|...+ +...-.+...|.|+-|.+.+..
T Consensus 68 ~Gipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~~~~~ 107 (113)
T PF01841_consen 68 LGIPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYLPGGG 107 (113)
T ss_dssp HT--EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEETTTE
T ss_pred CCCceEEEEEEcCCccccccccCCCCCCEEEEEEEEcCCc
Confidence 99999999998832 2233455667999999994433
|
e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.03 Score=62.84 Aligned_cols=139 Identities=17% Similarity=0.187 Sum_probs=92.5
Q ss_pred eEEeeeCcEEEEEEEE-CCeEEEEEEeeccccC----------------------hHH-H-HHHHHHHHHHHhCCCCcee
Q 003971 530 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLT----------------------AEN-M-EDFCNEISILSRLRHPNVI 584 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~----------------------~~~-~-e~f~~EI~iLk~L~HPNIV 584 (782)
..|..|--+.||.+.. +|..+|||+++..-+. +.. + .-..+|+..|++++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4688899999999976 7889999987543211 000 1 1233577778887654432
Q ss_pred eEeccccCCCceEEEEEEecccch-hhHHHhhcccccchHHHHHHHHHHHHHHHHHHH-hccccccCCCcccEEEcCCCe
Q 003971 585 LFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHWT 662 (782)
Q Consensus 585 kL~g~~~d~~~l~LV~Ey~~gGsL-~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLH-s~gIIHrDIKPeNILLd~~g~ 662 (782)
----... ....|||+|+....- .-.| +...++...+..+-.|++.-|.-|- ..++||.||.-=|+|+.+ |.
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw~aPkL----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~ 302 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGWAAPKL----KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GK 302 (520)
T ss_pred CCCceee--ecceEeeeeccCCCCcCccc----ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CE
Confidence 1111011 124789999963221 1222 2345677778888888888888774 578999999999999855 68
Q ss_pred EEEEecCcccccc
Q 003971 663 VKICDFGLSRIIT 675 (782)
Q Consensus 663 VKLaDFGLA~~l~ 675 (782)
+.|+|.+.+....
T Consensus 303 lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 303 LYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEccccccCC
Confidence 9999999876543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.07 Score=59.02 Aligned_cols=146 Identities=14% Similarity=0.156 Sum_probs=83.3
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCC--CceeeEeccccCCC--ceEEEEEEe
Q 003971 528 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH--PNVILFLGACTKPP--RLSMITEYM 603 (782)
Q Consensus 528 i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H--PNIVkL~g~~~d~~--~l~LV~Ey~ 603 (782)
+.+.+-.|....+|.....++.++++ ...............+|..+++.+.- --+-..++.|.++. ..+.||+|+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 33444344444566666668888888 33222233344566678888887742 23345566676665 679999999
Q ss_pred cccchhhHHHhhc-----------------------------ccccchHHHHHHHHH--------------HHHHHHHHH
Q 003971 604 ELGSLYHLIHLSG-----------------------------QKKKLSWRRKLKMLR--------------DICRGLMCI 640 (782)
Q Consensus 604 ~gGsL~dlL~~~~-----------------------------~~~~Ls~~~~l~Ia~--------------QIa~gL~yL 640 (782)
.|..+.+.+.... ........++..+.. ....-..||
T Consensus 108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 9843322211000 000000011111111 112223455
Q ss_pred Hhc--------cccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 641 HRM--------KIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 641 Hs~--------gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
+.+ .++|+|+++.|++++.++.+=|.||+++..-
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 432 3799999999999999988999999998654
|
|
| >COG5279 CYK3 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.0097 Score=68.10 Aligned_cols=60 Identities=23% Similarity=0.286 Sum_probs=51.5
Q ss_pred cccccchhhHHHHHHhhhcCCccccccccC-CCCccccccccCcceEEEEeCCeeeeeecc
Q 003971 188 RHGSCRPRAILFKVLADTVGLESRLMVGLP-NDGTMECVDSYKHMSVIVVLNSVELLVDLM 247 (782)
Q Consensus 188 ~~g~~r~ra~lfkvlad~~~l~~~~~~g~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (782)
..+.|-.=|.|||.||-..||||-+|.|+- +.....=--+++|-|++|.+++-=|+||-.
T Consensus 208 heavCtgYa~lfK~lcn~lgIp~~iIegf~k~~~~~~~~~~iNHaWN~VkiD~~yy~VDtT 268 (521)
T COG5279 208 HEAVCTGYAELFKELCNALGIPCEIIEGFLKSPIYYTRDININHAWNIVKIDNEYYLVDTT 268 (521)
T ss_pred cccccchHHHHHHHHHHhcCCceEEEeecccccccccCCccccceeeEEEECCeEEEEeee
Confidence 458899999999999999999999999994 443444455899999999999988999975
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.11 Score=57.69 Aligned_cols=142 Identities=20% Similarity=0.316 Sum_probs=80.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCcee-eEeccccCCCce
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKPPRL 596 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIV-kL~g~~~d~~~l 596 (782)
+.+.+ +.|-.|-...+|++... ++.|++|+..... .. .-.-.+|..+++.+..-++. ++++.+...
T Consensus 37 ~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g--- 109 (344)
T PLN02236 37 EALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--EL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG--- 109 (344)
T ss_pred CcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ce-eechHHHHHHHHHHHHcCCCCceEEEECCc---
Confidence 34444 45555888899998642 3578999875432 11 11225688888888643332 445554332
Q ss_pred EEEEEEecccchhhH-----------------HHhhc---ccccchHHHHHHHHHHH-----------------HHHHHH
Q 003971 597 SMITEYMELGSLYHL-----------------IHLSG---QKKKLSWRRKLKMLRDI-----------------CRGLMC 639 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dl-----------------L~~~~---~~~~Ls~~~~l~Ia~QI-----------------a~gL~y 639 (782)
.|.+|+++.++... +|... ......+.++..++.++ ...+..
T Consensus 110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 188 (344)
T PLN02236 110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL 188 (344)
T ss_pred -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence 57999987666411 11111 00011233333333221 111222
Q ss_pred HH--------hccccccCCCcccEEEcC-CCeEEEEecCcccc
Q 003971 640 IH--------RMKIVHRDLKSANCLVNK-HWTVKICDFGLSRI 673 (782)
Q Consensus 640 LH--------s~gIIHrDIKPeNILLd~-~g~VKLaDFGLA~~ 673 (782)
|. ...++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 21 235899999999999986 46899999988753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.12 Score=55.79 Aligned_cols=30 Identities=20% Similarity=0.432 Sum_probs=25.0
Q ss_pred cccccCCCcccEEEcCCCe-EEEEecCcccc
Q 003971 644 KIVHRDLKSANCLVNKHWT-VKICDFGLSRI 673 (782)
Q Consensus 644 gIIHrDIKPeNILLd~~g~-VKLaDFGLA~~ 673 (782)
.++|+|+++.|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 46999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.13 Score=56.07 Aligned_cols=74 Identities=22% Similarity=0.153 Sum_probs=47.2
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC---CCceeeEeccccCCCceEEEEEEec
Q 003971 528 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR---HPNVILFLGACTKPPRLSMITEYME 604 (782)
Q Consensus 528 i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~---HPNIVkL~g~~~d~~~l~LV~Ey~~ 604 (782)
-.+.++-|....+|+...+++.+.||+-... ....|..|..-|+.|. --.+.+.+++....+.-++++||++
T Consensus 21 ~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLDTDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp EEEEE--SSSSEEEEEETTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeEecCCCChhheEEEECCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 4567888999999998888999999996522 1245778888888884 3346677777666666799999998
Q ss_pred cc
Q 003971 605 LG 606 (782)
Q Consensus 605 gG 606 (782)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.19 Score=57.43 Aligned_cols=75 Identities=17% Similarity=0.001 Sum_probs=51.1
Q ss_pred eeEEeeeCcEEEEEEEECCeEEEEEEeecccc--Ch---HHHHHHHHHHHHHHhCC---CCceeeEeccccCCCceEEEE
Q 003971 529 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL--TA---ENMEDFCNEISILSRLR---HPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~--~~---~~~e~f~~EI~iLk~L~---HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.+.||.|....||+....+..++||.-..... .. .....-..|...|+.+. ..++.+++.++.+. .+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEEE
Confidence 57899999999999987777799997531111 00 12334445677776654 24777888887744 57889
Q ss_pred EEecc
Q 003971 601 EYMEL 605 (782)
Q Consensus 601 Ey~~g 605 (782)
||+++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.17 Score=55.85 Aligned_cols=142 Identities=18% Similarity=0.276 Sum_probs=78.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECC-----eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCce-eeEeccccCCCceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~g-----~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~~~l~ 597 (782)
+++++ +.|..|-...+|+....+ ..|++|+...... ..-.-.+|..+++.+..-++ .++++++. .+
T Consensus 15 ~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 15 SDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred CceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 34444 445448888899886543 3788998754321 11223468888888864444 34555542 22
Q ss_pred EEEEEecccchhh-------HH----------Hhhc-c-cc-cchHHHHHHHHHHH----------------------HH
Q 003971 598 MITEYMELGSLYH-------LI----------HLSG-Q-KK-KLSWRRKLKMLRDI----------------------CR 635 (782)
Q Consensus 598 LV~Ey~~gGsL~d-------lL----------~~~~-~-~~-~Ls~~~~l~Ia~QI----------------------a~ 635 (782)
+|.+|+++.++.. .+ |... . .. .--+..+..+..++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 4889987765521 01 1100 0 00 11223333333222 11
Q ss_pred HHHHHH----hc----cccccCCCcccEEEcC-CCeEEEEecCcccc
Q 003971 636 GLMCIH----RM----KIVHRDLKSANCLVNK-HWTVKICDFGLSRI 673 (782)
Q Consensus 636 gL~yLH----s~----gIIHrDIKPeNILLd~-~g~VKLaDFGLA~~ 673 (782)
-+..+. .. -+.|.|+.+.|||+++ ++.++++||..|..
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 122221 11 3799999999999975 57899999998743
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.38 Score=52.28 Aligned_cols=30 Identities=17% Similarity=0.219 Sum_probs=27.2
Q ss_pred cccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 644 gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
+++|+|+.+.|||++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999998999999987743
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.5 Score=52.65 Aligned_cols=137 Identities=19% Similarity=0.244 Sum_probs=81.0
Q ss_pred EEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCc------eeeEecc----ccCCCceEEEE
Q 003971 531 RVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN------VILFLGA----CTKPPRLSMIT 600 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN------IVkL~g~----~~d~~~l~LV~ 600 (782)
.|.. .-..||+....+..+++|+.... ... .++..|+..+..|.-.+ +..+-|- .......+-++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRYILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred cccc-ccCceEEEEecCCCeEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 3444 55678998887666799997654 333 45566788888774221 2222222 12223678899
Q ss_pred EEecccchhh-H--------------HHhhccc---------ccchHHH----H---------HHHHHHHHHHHHHHHh-
Q 003971 601 EYMELGSLYH-L--------------IHLSGQK---------KKLSWRR----K---------LKMLRDICRGLMCIHR- 642 (782)
Q Consensus 601 Ey~~gGsL~d-l--------------L~~~~~~---------~~Ls~~~----~---------l~Ia~QIa~gL~yLHs- 642 (782)
+|++|..+.. . ++..... ....|.. . .....++...+..+..
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999877762 1 1111110 1122220 0 1122344445555543
Q ss_pred -------cc--ccccCCCcccEEEcCCCe-EEEEecCccc
Q 003971 643 -------MK--IVHRDLKSANCLVNKHWT-VKICDFGLSR 672 (782)
Q Consensus 643 -------~g--IIHrDIKPeNILLd~~g~-VKLaDFGLA~ 672 (782)
.+ +||+|+.|.||+++.+.. +-++||+.+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 24 999999999999998874 8899999774
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.03 E-value=0.38 Score=54.21 Aligned_cols=73 Identities=19% Similarity=0.048 Sum_probs=45.9
Q ss_pred EEeeeCcEEEEEEEECC--eEEEEEEeeccc-----cChHHHHHHHHHHHHHHhCC--CC-ceeeEeccccCCCceEEEE
Q 003971 531 RVGIGFFGEVFRGIWNG--TDVAIKVFLEQD-----LTAENMEDFCNEISILSRLR--HP-NVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 531 ~LG~G~fG~VYkg~~~g--~~VAVKil~~~~-----~~~~~~e~f~~EI~iLk~L~--HP-NIVkL~g~~~d~~~l~LV~ 600 (782)
.||.|....||++...+ +.++||.-.... .-+-......-|...|+... -| .+.++|.+ +.....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 47999999999998753 578998632110 00122345557888887764 34 44455543 444567899
Q ss_pred EEecc
Q 003971 601 EYMEL 605 (782)
Q Consensus 601 Ey~~g 605 (782)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.96 E-value=1.2 Score=49.06 Aligned_cols=70 Identities=13% Similarity=0.056 Sum_probs=40.7
Q ss_pred eCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCc--eeeEe---c--cccCCCceEEEEEEeccc
Q 003971 535 GFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFL---G--ACTKPPRLSMITEYMELG 606 (782)
Q Consensus 535 G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN--IVkL~---g--~~~d~~~l~LV~Ey~~gG 606 (782)
+.-..||+... +++.+++|+....... ..++..|++.+..|.... ++... | ....++..+.++++++|.
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~---~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWS---DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCC---HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence 45567898876 5678999987533322 345556777777663211 22211 1 111234567899999875
Q ss_pred c
Q 003971 607 S 607 (782)
Q Consensus 607 s 607 (782)
.
T Consensus 113 ~ 113 (325)
T PRK11768 113 A 113 (325)
T ss_pred C
Confidence 4
|
|
| >COG1305 Transglutaminase-like enzymes, putative cysteine proteases [Amino acid transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.82 E-value=0.5 Score=50.23 Aligned_cols=107 Identities=19% Similarity=0.235 Sum_probs=71.8
Q ss_pred HHHHHHHHHhcCCCChHHHHHHHHHHHHhhhCCCCCCChhhhhHHHHHHHHhhcceeEeccccccccchhhHHHHHHhhh
Q 003971 126 LKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRGVQLLGQIRHGSCRPRAILFKVLADT 205 (782)
Q Consensus 126 l~~l~~~~~~~~~~~~~~~~~~~a~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~i~~g~~r~ra~lfkvlad~ 205 (782)
+.+|...+..+.. ++.+.+..|...|.+.+--..-..+.... ....|+. | .|.|+|-|.||=+|+=.
T Consensus 144 ~~~la~~~~~~~~-~~~~~~~~~~~~~~~~~~y~~~~~~~~~~---~~~~l~~------~---~G~C~d~a~l~val~Ra 210 (319)
T COG1305 144 VAELAARETGGAT-TPREKAAALFDYVNSKIRYSPGPTPVTGS---ASDALRL------G---RGVCRDFAHLLVALLRA 210 (319)
T ss_pred HHHHHHHhhcccC-CHHHHHHHHHHHHhhcceeecCCCCCCCC---HHHHHHh------C---CcccccHHHHHHHHHHH
Confidence 6777777666666 78888888888886332211011111100 0122222 2 99999999999999999
Q ss_pred cCCccccccccCCCCc---c---ccccccCcceEEEEeCCe-eeeee
Q 003971 206 VGLESRLMVGLPNDGT---M---ECVDSYKHMSVIVVLNSV-ELLVD 245 (782)
Q Consensus 206 ~~l~~~~~~g~~~~~~---~---~~~~~~~~~~~~~~~~~~-~~~~~ 245 (782)
.|+|+|.|.|+..+.. . .......|-|+-|-++.. -+-+|
T Consensus 211 ~GIpAR~V~Gy~~~~~~~~~~~~~~~~~~~Haw~ev~~~~~gW~~~D 257 (319)
T COG1305 211 AGIPARYVSGYLGAEVEPLSGRPLVRNDDAHAWAEVYLPGRGWVPLD 257 (319)
T ss_pred cCCcceeeeccccCCCCcccccccccCcccceeeeeecCCCccEeec
Confidence 9999999999973332 1 234556799999999985 66666
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.33 E-value=0.96 Score=46.20 Aligned_cols=31 Identities=35% Similarity=0.544 Sum_probs=21.8
Q ss_pred ccccccCCCcccEEE-cCCCeEEEEecCcccc
Q 003971 643 MKIVHRDLKSANCLV-NKHWTVKICDFGLSRI 673 (782)
Q Consensus 643 ~gIIHrDIKPeNILL-d~~g~VKLaDFGLA~~ 673 (782)
..+.|+|+.+.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8889999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.26 E-value=0.42 Score=54.56 Aligned_cols=75 Identities=16% Similarity=0.037 Sum_probs=48.9
Q ss_pred eeEEeeeCcEEEEEEEEC--CeEEEEEEeeccc-c---ChHHHHHHHHHHHHHHhCC--CC-ceeeEeccccCCCceEEE
Q 003971 529 GTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQD-L---TAENMEDFCNEISILSRLR--HP-NVILFLGACTKPPRLSMI 599 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~-~---~~~~~e~f~~EI~iLk~L~--HP-NIVkL~g~~~d~~~l~LV 599 (782)
.+.||.|.-.-||++... ++.++||.-.... . -+-..+...-|.+.|+.+. .| ++.++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 577999999999999874 6678998532110 1 0122456677888888764 34 45555543 44456788
Q ss_pred EEEecc
Q 003971 600 TEYMEL 605 (782)
Q Consensus 600 ~Ey~~g 605 (782)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888864
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.79 E-value=1.7 Score=49.38 Aligned_cols=78 Identities=17% Similarity=0.154 Sum_probs=45.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECC---eE-----EEEEEeeccccChHHHHHHHHHHHHHHhCCCCce-eeEeccccCCC
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWNG---TD-----VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPP 594 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~g---~~-----VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~~ 594 (782)
+++.+ +.|..|-...+|++...+ .. |.+++.... . ...-.-.+|+.+++.+...++ .++++.+..
T Consensus 51 ~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~--~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~-- 124 (383)
T PTZ00384 51 EFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY--N-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD-- 124 (383)
T ss_pred ccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC--C-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC--
Confidence 34444 456558889999986532 22 344432111 1 111122468899998875554 455555532
Q ss_pred ceEEEEEEecccchh
Q 003971 595 RLSMITEYMELGSLY 609 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~ 609 (782)
++++||++|.+|.
T Consensus 125 --g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 --FTIQEWVEGNTMG 137 (383)
T ss_pred --EEEEEEeccccCC
Confidence 6999999987764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.42 E-value=1.9 Score=54.82 Aligned_cols=31 Identities=26% Similarity=0.420 Sum_probs=26.1
Q ss_pred ccccccCCCcccEEEcCCC--eEE-EEecCcccc
Q 003971 643 MKIVHRDLKSANCLVNKHW--TVK-ICDFGLSRI 673 (782)
Q Consensus 643 ~gIIHrDIKPeNILLd~~g--~VK-LaDFGLA~~ 673 (782)
.++||+|+.+.|||++.++ ++. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999998775 565 999998753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 782 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-71 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-71 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-40 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-39 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-39 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-39 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-37 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-37 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-37 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-37 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-37 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-37 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-37 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-37 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-37 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-37 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-37 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-37 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-37 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-37 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-37 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-36 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-36 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-36 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-36 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-36 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-36 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-36 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-36 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-36 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-36 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-36 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-36 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-36 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-36 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-36 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-36 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-36 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-36 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-36 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-36 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-36 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-36 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-35 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-35 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-35 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-35 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-35 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-35 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-35 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-34 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-34 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-34 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-34 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-33 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-33 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-33 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-33 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-33 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-33 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-33 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-33 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-33 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-33 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-32 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-32 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-32 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-32 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-32 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-32 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-32 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-32 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-32 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-32 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-32 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-32 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-32 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-32 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-32 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-32 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-32 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-32 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-32 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-32 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-32 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-32 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-32 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-32 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-31 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-31 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-31 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-31 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-31 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-31 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-31 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-31 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-31 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-31 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-31 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-31 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-31 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-31 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-31 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-31 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-31 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-30 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-30 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-30 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-30 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-30 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-30 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-30 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-30 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-30 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-30 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-30 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-30 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-29 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-29 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-29 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-29 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-29 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-29 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-29 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-29 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-29 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-29 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-29 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-29 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-29 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-29 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-29 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-29 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-29 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-29 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-29 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-29 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-29 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-29 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-28 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-28 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-28 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-28 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-28 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-28 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-28 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-28 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-28 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-28 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-28 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-28 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-28 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-28 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-28 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-28 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-28 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-28 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-28 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-28 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-28 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-28 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-28 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-27 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-27 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-27 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-27 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-27 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-27 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-27 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-27 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-27 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-27 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-27 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-27 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-27 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-27 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-27 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-26 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-26 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-26 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-26 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-26 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-26 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-26 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-26 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-26 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-26 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-26 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-26 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-26 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-26 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-26 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-26 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-25 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-25 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-25 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-25 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-25 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-25 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-25 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-25 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-25 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-25 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-25 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-25 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-25 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-25 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-25 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-25 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-25 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-25 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-24 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-24 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-24 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-24 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-24 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-24 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-24 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-24 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-24 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-24 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-24 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-24 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-24 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-24 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-24 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-24 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-24 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-23 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-23 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-23 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-23 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-23 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-23 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-23 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-23 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-23 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-23 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-23 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-23 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-23 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-23 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-23 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-23 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-23 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-23 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-23 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-23 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-23 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-23 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-23 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-23 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-23 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-23 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-23 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-23 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-22 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-22 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-22 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-22 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-22 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-22 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-22 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-22 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-22 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-22 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-22 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-22 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-22 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-22 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-22 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-22 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-22 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-22 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-22 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-21 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-21 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-21 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-21 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-21 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-21 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-21 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-21 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-21 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-21 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-21 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-21 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-21 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-21 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-21 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-21 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-21 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-21 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-21 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-20 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-20 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-20 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-20 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-20 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-20 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-20 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-20 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-20 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-20 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-20 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-20 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-20 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-20 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-20 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-20 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-20 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-20 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-20 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-20 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-20 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-19 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-19 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-19 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-19 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-19 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-19 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-19 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-18 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-18 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-18 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-18 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-18 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-18 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-18 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-18 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-17 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-17 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-17 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-17 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-17 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-17 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-17 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-17 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-17 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-17 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-17 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-17 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-17 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-17 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-17 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-17 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-17 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-17 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-17 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-17 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-17 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-17 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-17 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-17 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-17 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-17 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-17 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-17 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-16 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-16 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-16 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-16 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-16 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-16 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-16 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-14 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 420 bits (1082), Expect = e-142
Identities = 125/289 (43%), Positives = 187/289 (64%), Gaps = 6/289 (2%)
Query: 492 NSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVA 551
+ + + + + + ++ +I + +L + ++G G FG V R W+G+DVA
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVA 64
Query: 552 IKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHL 611
+K+ +EQD AE + +F E++I+ RLRHPN++LF+GA T+PP LS++TEY+ GSLY L
Sbjct: 65 VKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRL 124
Query: 612 IHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFG 669
+H SG +++L RR+L M D+ +G+ +H IVHR+LKS N LV+K +TVK+CDFG
Sbjct: 125 LHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFG 184
Query: 670 LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 729
LSR+ + + S+AGTPEWMAPE++R+EP EK D++S GVI+WEL TL +PW + P
Sbjct: 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244
Query: 730 ERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
+VV AV + RLEIP + +I CW EP +RPS I+ L
Sbjct: 245 AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 381 bits (980), Expect = e-128
Identities = 94/273 (34%), Positives = 142/273 (52%), Gaps = 23/273 (8%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLE--QDLTAENMEDFCNEISILS 576
IDF+ELT+ +GIG FG+V+R W G +VA+K + ++ +E+ E + +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 577 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
L+HPN+I G C K P L ++ E+ G L ++ K++ + I RG
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARG 117
Query: 637 LMCIHRMK---IVHRDLKSANCLVNK--------HWTVKICDFGLSRIITDSPMRDSSSA 685
+ +H I+HRDLKS+N L+ + + +KI DFGL+R + S+A
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAA 175
Query: 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI 745
G WMAPE+IR F++ D++S GV++WEL T P+ G+ V Y VA L I
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235
Query: 746 PEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
P P +L+ DCW +P RPS IL +L
Sbjct: 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-127
Identities = 76/269 (28%), Positives = 128/269 (47%), Gaps = 17/269 (6%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILS 576
+ IDF +L T++ GE+++G W G D+ +KV +D + DF E L
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 577 RLRHPNVILFLGACTKPP--RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
HPNV+ LGAC PP ++IT +M GSLY+++H G + + +K D+
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMA 121
Query: 635 RGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMA 692
RG+ +H ++ I L S + ++++ T +I + + P W+A
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS-----FQSPGRMYAPAWVA 176
Query: 693 PELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG- 748
PE ++ +P D++S V++WEL T P+ + + VA EG R IP G
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236
Query: 749 --PLGRLIADCW-AEPQERPSCEEILSRL 774
+ +L+ C +P +RP + I+ L
Sbjct: 237 SPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 373 bits (959), Expect = e-124
Identities = 81/290 (27%), Positives = 145/290 (50%), Gaps = 24/290 (8%)
Query: 504 ESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE 563
P ++ + +EW+I F +L +G +G G FG+V+ G W+G +VAI++ + +
Sbjct: 13 SFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNED 71
Query: 564 NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSW 623
++ F E+ + RH NV+LF+GAC PP L++IT + +LY ++ K L
Sbjct: 72 QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR--DAKIVLDV 129
Query: 624 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD-- 681
+ ++ ++I +G+ +H I+H+DLKS N + + V I DFGL I
Sbjct: 130 NKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE 188
Query: 682 ---SSSAGTPEWMAPELIRN---------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 729
G +APE+IR PF++ D+F+LG I +EL P++
Sbjct: 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248
Query: 730 ERVVYAVANEGSRLEIPEG----PLGRLIADCWA-EPQERPSCEEILSRL 774
E +++ + G + + + + ++ CWA E +ERP+ +++ L
Sbjct: 249 EAIIWQMGT-GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 371 bits (955), Expect = e-123
Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 21/279 (7%)
Query: 515 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISI 574
+ S+L G +G G FG+ + T + + E F E+ +
Sbjct: 1 SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKV 60
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
+ L HPNV+ F+G K RL+ ITEY++ G+L +I + W +++ +DI
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIA 118
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS------------ 682
G+ +H M I+HRDL S NCLV ++ V + DFGL+R++ D +
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 683 --SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NE 739
+ G P WMAPE+I + EK D+FS G+++ E+ LP + + +
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238
Query: 740 GSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 774
P + C +P++RPS ++ L
Sbjct: 239 FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 370 bits (953), Expect = e-123
Identities = 87/273 (31%), Positives = 154/273 (56%), Gaps = 17/273 (6%)
Query: 515 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISI 574
A ++W I ++TVG R+G G FG V++G W+G DVA+K+ T + ++ F NE+ +
Sbjct: 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
L + RH N++LF+G T P L+++T++ E SLYH +H + K ++ + + R
Sbjct: 74 LRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTA 130
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSSSAGTPEWMA 692
RG+ +H I+HRDLKS N +++ TVKI DFGL+ + +G+ WMA
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 693 PELIRNE---PFTEKCDIFSLGVIMWELCTLNRPWEGVLP-ERVVYAVANEGSRLEIPEG 748
PE+IR + P++ + D+++ G++++EL T P+ + ++++ V ++ +
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250
Query: 749 P------LGRLIADCWA-EPQERPSCEEILSRL 774
+ RL+A+C + ERPS IL+ +
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-119
Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 29/287 (10%)
Query: 510 NKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-----TA 562
+ +E+ ++G G FG V +G + + VAIK + D
Sbjct: 5 GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 563 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 622
E ++F E+ I+S L HPN++ G PP M+ E++ G LYH + + +
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLL--DKAHPIK 120
Query: 623 WRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLV-----NKHWTVKICDFGLSRIIT 675
W KL+++ DI G+ + IVHRDL+S N + N K+ DFGLS+
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV 180
Query: 676 DSPMRDSSSAGTPEWMAPELI--RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--R 731
S G +WMAPE I E +TEK D +S +I++ + T P++ +
Sbjct: 181 HSVS---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 732 VVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
+ + EG R IPE L +I CW+ +P++RP I+ L
Sbjct: 238 FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 355 bits (912), Expect = e-117
Identities = 87/270 (32%), Positives = 139/270 (51%), Gaps = 18/270 (6%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH 580
ID+ E+ V VG G FG V + W DVAIK + + F E+ LSR+ H
Sbjct: 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES----ERKAFIVELRQLSRVNH 60
Query: 581 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
PN++ GAC P + ++ EY E GSLY+++H + + + +G+ +
Sbjct: 61 PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 641 HRMK---IVHRDLKSANCLVNKHWTV-KICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
H M+ ++HRDLK N L+ TV KICDFG + I ++ G+ WMAPE+
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT---NNKGSAAWMAPEVF 175
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGV-LPERVVYAVANEGSRLEIPEG---PLGR 752
++EKCD+FS G+I+WE+ T +P++ + P + + G+R + + P+
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235
Query: 753 LIADCWA-EPQERPSCEEILSRLLDCEYSL 781
L+ CW+ +P +RPS EEI+ +
Sbjct: 236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-102
Identities = 78/307 (25%), Positives = 124/307 (40%), Gaps = 53/307 (17%)
Query: 514 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEIS 573
L ++ + ++G G +GEV+ G W G VA+KVF + + E EI
Sbjct: 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE---TEIY 83
Query: 574 ILSRLRHPNVILFLGACTKP----PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM 629
+RH N++ F+ A K +L +IT+Y E GSLY + L + LK+
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKL 139
Query: 630 LRDICRGLMCIH--------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681
GL +H + I HRDLKS N LV K+ T I D GL+
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 682 ----SSSAGTPEWMAPELI------RNEPFTEKCDIFSLGVIMWELCT----------LN 721
++ GT +M PE++ + D++S G+I+WE+
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
Query: 722 RPWEGVLP-----ERVVYAVANEGSRLEIPEGP--------LGRLIADCW-AEPQERPSC 767
P+ ++P E + V + R P +G+L+ +CW P R +
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
Query: 768 EEILSRL 774
+ L
Sbjct: 320 LRVKKTL 326
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-102
Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 53/300 (17%)
Query: 525 ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
++T+ VG G +GEV+RG W G +VA+K+F +D + E E+ LRH N++
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE---TELYNTVMLRHENIL 65
Query: 585 LFLGACTK----PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
F+ + +L +IT Y E+GSLY + L L+++ I GL +
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHL 121
Query: 641 H--------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP----MRDSSSAGTP 688
H + I HRDLKS N LV K+ I D GL+ + + S + ++ GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 689 EWMAPELIRNEP------FTEKCDIFSLGVIMWELCT----------LNRPWEGVLP--- 729
+MAPE++ ++ DI++ G+++WE+ P+ V+P
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241
Query: 730 --ERVVYAVANEGSRLEIPE--------GPLGRLIADCW-AEPQERPSCEEILSRLLDCE 778
E + V + R IP L +L+ +CW P R + I L +
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = 1e-96
Identities = 75/307 (24%), Positives = 130/307 (42%), Gaps = 53/307 (17%)
Query: 514 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEIS 573
L + + +G G FGEV+RG W G +VA+K+F ++ + E EI
Sbjct: 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIY 88
Query: 574 ILSRLRHPNVILFLGACTK----PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM 629
LRH N++ F+ A K +L ++++Y E GSL+ ++ + ++ +K+
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKL 144
Query: 630 LRDICRGLMCIH--------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681
GL +H + I HRDLKS N LV K+ T I D GL+ +
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204
Query: 682 ----SSSAGTPEWMAPELIRNE------PFTEKCDIFSLGVIMWELCTLNR--------- 722
+ GT +MAPE++ + ++ DI+++G++ WE+
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264
Query: 723 -PWEGVLP-----ERVVYAVANEGSRLEIPEG--------PLGRLIADCW-AEPQERPSC 767
P+ ++P E + V + R IP + +++ +CW A R +
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 768 EEILSRL 774
I L
Sbjct: 325 LRIKKTL 331
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 7e-92
Identities = 78/320 (24%), Positives = 127/320 (39%), Gaps = 68/320 (21%)
Query: 514 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEIS 573
A E ++D L + +G G +G V++G + VA+KVF + ++F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKN 57
Query: 574 I--LSRLRHPNVILFLGACTKPP-----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 626
I + + H N+ F+ + ++ EY GSL + W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSS 113
Query: 627 LKMLRDICRGLMCIH---------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677
++ + RGL +H + I HRDL S N LV T I DFGLS +T +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 678 PMRDSSS--------AGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWEL---CT 719
+ GT +MAPE++ E ++ D+++LG+I WE+ CT
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 720 LNRPWEGVLPERVVYA---------------VANEGSRLEIPEG---------PLGRLIA 755
P E V ++ + V+ E R + PE L I
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 756 DCW-AEPQERPSCEEILSRL 774
DCW + + R + + R+
Sbjct: 294 DCWDQDAEARLTAQXAEERM 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 2e-87
Identities = 67/305 (21%), Positives = 117/305 (38%), Gaps = 53/305 (17%)
Query: 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISIL 575
E L + G FG V++ VA+K+F QD + E+ L
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSL 72
Query: 576 SRLRHPNVILFLGACTKPPRLSM----ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 631
++H N++ F+GA + + + IT + E GSL + +SW +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----ANVVSWNELCHIAE 128
Query: 632 DICRGLMCIH----------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681
+ RGL +H + I HRD+KS N L+ + T I DFGL+
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 682 SSS--AGTPEWMAPELIRNEP-----FTEKCDIFSLGVIMWELCTLNRPWEGVLP----- 729
+ GT +MAPE++ + D++++G+++WEL + +G +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 730 -----------ERVVYAVANEGSRLEIPE--------GPLGRLIADCWAE-PQERPSCEE 769
E + V ++ R + + L I +CW + R S
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 770 ILSRL 774
+ R+
Sbjct: 309 VGERI 313
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 2e-73
Identities = 80/274 (29%), Positives = 131/274 (47%), Gaps = 16/274 (5%)
Query: 514 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDF 568
+ ++ I ++ + +G GFFGEV+ G++ +VA+K ++D T +N E F
Sbjct: 2 MGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKT-CKKDCTLDNKEKF 60
Query: 569 CNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 628
+E I+ L HP+++ +G + P +I E G L +L K L +
Sbjct: 61 MSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGEL--GHYLERNKNSLKVLTLVL 117
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 688
IC+ + + + VHRD+ N LV VK+ DFGLSR I D +S P
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 177
Query: 689 -EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP 746
+WM+PE I FT D++ V MWE+ + +P+ + + V+ + +G RL P
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-EKGDRLPKP 236
Query: 747 EG---PLGRLIADCWA-EPQERPSCEEILSRLLD 776
+ L L+ CW +P +RP E++ L D
Sbjct: 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 6e-73
Identities = 90/270 (33%), Positives = 140/270 (51%), Gaps = 13/270 (4%)
Query: 514 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEI 572
L Y W ID +LT +G G FG V G W G DVAIK+ +++ +E ++F E
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSE--DEFIEEA 70
Query: 573 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 632
++ L H ++ G CTK + +ITEYM G L L +L + + ++ L+M +D
Sbjct: 71 KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKD 128
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWM 691
+C + + + +HRDL + NCLVN VK+ DFGLSR + D S + P W
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 692 APELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG-- 748
PE++ F+ K DI++ GV+MWE+ +L P+E + +G RL P
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLAS 247
Query: 749 -PLGRLIADCW-AEPQERPSCEEILSRLLD 776
+ ++ CW + ERP+ + +LS +LD
Sbjct: 248 EKVYTIMYSCWHEKADERPTFKILLSNILD 277
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 1e-72
Identities = 82/270 (30%), Positives = 134/270 (49%), Gaps = 13/270 (4%)
Query: 514 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLTAENMEDFCNE 571
+ ++W ++ +L +G ++G G FGEVF G T VA+K + L + F E
Sbjct: 104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS-CRETLPPDLKAKFLQE 162
Query: 572 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 631
IL + HPN++ +G CT+ + ++ E ++ G L L + +L + L+M+
Sbjct: 163 ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF--LTFLRTEGARLRVKTLLQMVG 220
Query: 632 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT-P-E 689
D G+ + +HRDL + NCLV + +KI DFG+SR D S P +
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG 748
W APE + ++ + D++S G+++WE +L P+ + ++ V G RL PE
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK-GGRLPCPEL 339
Query: 749 ---PLGRLIADCWA-EPQERPSCEEILSRL 774
+ RL+ CWA EP +RPS I L
Sbjct: 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 4e-72
Identities = 81/265 (30%), Positives = 143/265 (53%), Gaps = 13/265 (4%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSR 577
+ E+T+ +G G FG V G W G DVA+K+ +++ +E ++F E + +
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKM-IKEGSMSE--DEFFQEAQTMMK 59
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
L HP ++ F G C+K + ++TEY+ G L L +L K L + L+M D+C G+
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCL--LNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 696
+ + +HRDL + NCLV++ VK+ DFG++R + D S P +W APE+
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF 177
Query: 697 RNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGR 752
++ K D+++ G++MWE+ +L P++ VV V ++G RL P + +
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-SQGHRLYRPHLASDTIYQ 236
Query: 753 LIADCW-AEPQERPSCEEILSRLLD 776
++ CW P++RP+ +++LS +
Sbjct: 237 IMYSCWHELPEKRPTFQQLLSSIEP 261
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 5e-72
Identities = 81/275 (29%), Positives = 127/275 (46%), Gaps = 16/275 (5%)
Query: 514 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDF 568
+ ++ I + +G +G G FG+V +GI+ VAIK + + E F
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKF 63
Query: 569 CNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 628
E + + HP+++ +G T+ P +I E LG L L +K L +
Sbjct: 64 LQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGEL--RSFLQVRKYSLDLASLIL 120
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 688
+ L + + VHRD+ + N LV+ + VK+ DFGLSR + DS +S P
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180
Query: 689 -EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP 746
+WMAPE I FT D++ GV MWE+ +P++GV V+ + G RL +P
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMP 239
Query: 747 EG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 777
L L+ CWA +P RP E+ ++L
Sbjct: 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 9e-72
Identities = 84/267 (31%), Positives = 146/267 (54%), Gaps = 13/267 (4%)
Query: 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLTAENMEDFCNEIS 573
Y++W ++ +++T+ ++G G +GEV+ G+W VA+K L++D E+F E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEV--EEFLKEAA 61
Query: 574 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 633
++ ++HPN++ LG CT+ P +ITE+M G+L + ++++S L M I
Sbjct: 62 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQI 120
Query: 634 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMA 692
+ + + +HRDL + NCLV ++ VK+ DFGLSR++T + A P +W A
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 693 PELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG--- 748
PE + F+ K D+++ GV++WE+ T P+ G+ +V + + R+E PEG
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPE 239
Query: 749 PLGRLIADCW-AEPQERPSCEEILSRL 774
+ L+ CW P +RPS EI
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-71
Identities = 83/266 (31%), Positives = 138/266 (51%), Gaps = 13/266 (4%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILS 576
+W ID SELT +G G FG V G W VAIK + + +E EDF E ++
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSE--EDFIEEAEVMM 58
Query: 577 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
+L HP ++ G C + + ++TE+ME G L +L Q+ + L M D+C G
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL--SDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPEL 695
+ + ++HRDL + NCLV ++ +K+ DFG++R + D S+ P +W +PE+
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 751
++ K D++S GV+MWE+ + P+E VV + + G RL P +
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTHVY 235
Query: 752 RLIADCW-AEPQERPSCEEILSRLLD 776
+++ CW P++RP+ +L +L +
Sbjct: 236 QIMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 2e-71
Identities = 95/294 (32%), Positives = 141/294 (47%), Gaps = 20/294 (6%)
Query: 500 NKVLESPMFQNKPLLAYEE--WNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVA 551
+ + P A + I S +T +G G FGEV++G+ VA
Sbjct: 18 ENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVA 77
Query: 552 IKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHL 611
IK L+ T + DF E I+ + H N+I G +K + +ITEYME G+L
Sbjct: 78 IKT-LKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL--D 134
Query: 612 IHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671
L + + S + + MLR I G+ + M VHRDL + N LVN + K+ DFGLS
Sbjct: 135 KFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
Query: 672 RIITDSPMRDSSSAGT--P-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGV 727
R++ D P +++G P W APE I FT D++S G++MWE+ T RP+ +
Sbjct: 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254
Query: 728 LPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 777
V+ A+ N+G RL P + +L+ CW E RP +I+S L
Sbjct: 255 SNHEVMKAI-NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 2e-70
Identities = 81/279 (29%), Positives = 141/279 (50%), Gaps = 20/279 (7%)
Query: 513 LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEI 572
W ++ EL + +G G FG+V G + G VA+K ++ D TA+ F E
Sbjct: 10 EFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQ---AFLAEA 65
Query: 573 SILSRLRHPNVILFLGACTK-PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 631
S++++LRH N++ LG + L ++TEYM GSL + S + L LK
Sbjct: 66 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSL 124
Query: 632 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EW 690
D+C + + VHRDL + N LV++ K+ DFGL++ + + + P +W
Sbjct: 125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKW 180
Query: 691 MAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG- 748
APE +R + F+ K D++S G+++WE+ + R P+ + + VV V +G +++ P+G
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGC 239
Query: 749 --PLGRLIADCW-AEPQERPSCEEI---LSRLLDCEYSL 781
+ ++ +CW + RPS ++ L + E L
Sbjct: 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHELHL 278
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 4e-70
Identities = 93/289 (32%), Positives = 138/289 (47%), Gaps = 19/289 (6%)
Query: 501 KVLESPMFQNKPLLAYEE--WNIDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIK 553
+ P +P A I+ S + + +G G GEV G VAIK
Sbjct: 24 QFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK 83
Query: 554 VFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH 613
L+ T DF +E SI+ + HPN+I G T+ ++TEYME GSL
Sbjct: 84 A-LKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL--DTF 140
Query: 614 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673
L + + + + MLR + G+ + + VHRDL + N LV+ + K+ DFGLSR+
Sbjct: 141 LRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 674 ITDSPMRDSSSAGT--P-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLP 729
+ D P ++ G P W APE I F+ D++S GV+MWE+ RP+ +
Sbjct: 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260
Query: 730 ERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
V+ +V EG RL P G L +L+ DCW + +RP +I+S L
Sbjct: 261 RDVISSV-EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 4e-70
Identities = 79/275 (28%), Positives = 125/275 (45%), Gaps = 17/275 (6%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLT-AENMEDFCN 570
I +L + ++G G FG V RG W+ VA+K L+ E M+DF
Sbjct: 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 571 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 630
E++ + L H N+I G PP + M+TE LGSL L L + +
Sbjct: 71 EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSL--LDRLRKHQGHFLLGTLSRYA 127
Query: 631 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT--P 688
+ G+ + + +HRDL + N L+ VKI DFGL R + + P
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 689 -EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP 746
W APE ++ F+ D + GV +WE+ T PW G+ ++++ + EG RL P
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 247
Query: 747 EG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 777
E + ++ CWA +P++RP+ + LL+
Sbjct: 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 4e-70
Identities = 85/282 (30%), Positives = 149/282 (52%), Gaps = 15/282 (5%)
Query: 504 ESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLT 561
+ Y++W ++ +++T+ ++G G +GEV+ G+W VA+K L++D
Sbjct: 200 RNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTM 258
Query: 562 AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHL-SGQKKK 620
E+F E +++ ++HPN++ LG CT+ P +ITE+M G+L L +L +++
Sbjct: 259 EV--EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL--LDYLRECNRQE 314
Query: 621 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680
+S L M I + + + +HR+L + NCLV ++ VK+ DFGLSR++T
Sbjct: 315 VSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374
Query: 681 DSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVAN 738
+ A P +W APE + F+ K D+++ GV++WE+ T P+ G+ +V +
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-E 433
Query: 739 EGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLD 776
+ R+E PEG + L+ CW P +RPS EI
Sbjct: 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 5e-70
Identities = 98/299 (32%), Positives = 147/299 (49%), Gaps = 21/299 (7%)
Query: 489 YMANSEFVSTWNKVLESPMFQNKP---LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW 545
Y +++ + L + +KP LA + W I L + ++G G FGEV+ G W
Sbjct: 149 YSKHADGLCH---RLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 205
Query: 546 NG-TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 604
NG T VAIK + E F E ++ +LRH ++ ++ P ++TEYM
Sbjct: 206 NGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMS 261
Query: 605 LGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 663
GSL L L K L + + M I G+ + RM VHRDL++AN LV ++
Sbjct: 262 KGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 319
Query: 664 KICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-N 721
K+ DFGL+R+I D+ A P +W APE FT K D++S G+++ EL T
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379
Query: 722 RPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLD 776
P+ G++ V+ V G R+ P L L+ CW EP+ERP+ E + + L D
Sbjct: 380 VPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 5e-70
Identities = 91/268 (33%), Positives = 143/268 (53%), Gaps = 15/268 (5%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISIL 575
+EW + L + R+G G FGEV+ G +NG T VA+K L+Q + + F E +++
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSP--DAFLAEANLM 62
Query: 576 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDIC 634
+L+H ++ T+ P +ITEYME GSL + L + KL+ + L M I
Sbjct: 63 KQLQHQRLVRLYAVVTQEPIY-IITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAP 693
G+ I +HRDL++AN LV+ + KI DFGL+R+I D+ A P +W AP
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 694 ELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---P 749
E I FT K D++S G+++ E+ T R P+ G+ V+ + G R+ P+
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDNCPEE 238
Query: 750 LGRLIADCW-AEPQERPSCEEILSRLLD 776
L +L+ CW P++RP+ + + S L D
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 6e-70
Identities = 96/304 (31%), Positives = 143/304 (47%), Gaps = 19/304 (6%)
Query: 489 YMANSEFVSTWNKVLESPMFQNKPLLAYEE--WNIDFSELTVGTRVGIGFFGEVFRGIWN 546
+ N + P P E +D + +++ VG G FGEV G
Sbjct: 8 HFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 547 G-----TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601
VAIK L+ T + DF E SI+ + HPN+I G TK + ++TE
Sbjct: 68 LPSKKEISVAIKT-LKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126
Query: 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 661
YME GSL L + + + + MLR I G+ + M VHRDL + N L+N +
Sbjct: 127 YMENGSL--DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL 184
Query: 662 TVKICDFGLSRIITDSPMRDSSSAGT--P-EWMAPELIRNEPFTEKCDIFSLGVIMWELC 718
K+ DFGL R++ D P ++ G P W +PE I FT D++S G+++WE+
Sbjct: 185 VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 719 TL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSR 773
+ RP+ + + V+ AV +EG RL P L +L+ DCW + RP E+I+S
Sbjct: 245 SYGERPYWEMSNQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 774 LLDC 777
L
Sbjct: 304 LDKL 307
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 7e-70
Identities = 70/267 (26%), Positives = 128/267 (47%), Gaps = 18/267 (6%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISI 574
+ +E +G G FG V++G+W VAIK L + + + ++ +E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEAYV 70
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
++ + +P+V LG C + +IT+ M G L L ++ K + + L I
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIA 127
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EWMA 692
+G+ + ++VHRDL + N LV VKI DFGL++++ + + P +WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 693 PELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG--- 748
E I + +T + D++S GV +WEL T ++P++G+ + + +G RL P
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTI 246
Query: 749 PLGRLIADCWA-EPQERPSCEEILSRL 774
+ ++ CW + RP E++
Sbjct: 247 DVYMIMRKCWMIDADSRPKFRELIIEF 273
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 1e-69
Identities = 76/278 (27%), Positives = 133/278 (47%), Gaps = 18/278 (6%)
Query: 517 EEWNIDFSELTVG-TRVGIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDFCNE 571
++ + L + +G G FG V +G++ DVAIKV L+Q + E+ E
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMRE 60
Query: 572 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 631
I+ +L +P ++ +G C L ++ E G L L G+++++ ++L
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPL--HKFLVGKREEIPVSNVAELLH 117
Query: 632 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT--P- 688
+ G+ + VHRDL + N L+ KI DFGLS+ + ++ + P
Sbjct: 118 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 177
Query: 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPE 747
+W APE I F+ + D++S GV MWE + +P++ + V+ + +G R+E P
Sbjct: 178 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPP 236
Query: 748 G---PLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 781
L L++DCW + ++RP + R+ C YSL
Sbjct: 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 6e-69
Identities = 88/279 (31%), Positives = 137/279 (49%), Gaps = 15/279 (5%)
Query: 506 PMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAEN 564
+ + + W I L + ++G G FGEV+ +N T VA+K + +
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMS 226
Query: 565 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHL-SGQKKKLSW 623
+E F E +++ L+H ++ TK P + +ITE+M GSL L L S + K
Sbjct: 227 VEAFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSL--LDFLKSDEGSKQPL 283
Query: 624 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 683
+ + I G+ I + +HRDL++AN LV+ KI DFGL+R+I D+
Sbjct: 284 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343
Query: 684 SAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGS 741
A P +W APE I FT K D++S G+++ E+ T P+ G+ V+ A+ G
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGY 402
Query: 742 RLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLD 776
R+ PE L ++ CW P+ERP+ E I S L D
Sbjct: 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 2e-68
Identities = 85/331 (25%), Positives = 137/331 (41%), Gaps = 24/331 (7%)
Query: 458 RDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYE 517
+ + S+P + S + + P +
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMP--------STR 383
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNEI 572
++ I + +G +G G FG+V +GI+ VAIK + + E F E
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQEA 442
Query: 573 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 632
+ + HP+++ +G T+ P +I E LG L L +K L +
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQ 499
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWM 691
+ L + + VHRD+ + N LV+ + VK+ DFGLSR + DS +S P +WM
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 692 APELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG-- 748
APE I FT D++ GV MWE+ +P++GV V+ + G RL +P
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCP 618
Query: 749 -PLGRLIADCWA-EPQERPSCEEILSRLLDC 777
L L+ CWA +P RP E+ ++L
Sbjct: 619 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 3e-68
Identities = 79/281 (28%), Positives = 143/281 (50%), Gaps = 19/281 (6%)
Query: 502 VLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLT 561
+ + W ++ EL + +G G FG+V G + G VA+K ++ D T
Sbjct: 171 KVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDAT 229
Query: 562 AENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLSMITEYMELGSLYHLIHL-SGQKK 619
A+ F E S++++LRH N++ LG + L ++TEYM GSL + +L S +
Sbjct: 230 AQ---AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL--VDYLRSRGRS 284
Query: 620 KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679
L LK D+C + + VHRDL + N LV++ K+ DFGL++ + +
Sbjct: 285 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342
Query: 680 RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVA 737
+ P +W APE +R + F+ K D++S G+++WE+ + R P+ + + VV V
Sbjct: 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV- 399
Query: 738 NEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 774
+G +++ P+G + ++ +CW + RP+ ++ +L
Sbjct: 400 EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 4e-68
Identities = 95/284 (33%), Positives = 141/284 (49%), Gaps = 16/284 (5%)
Query: 503 LESPMFQNKP---LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQ 558
L + +KP LA + W I L + ++G G FGEV+ G WNG T VAIK
Sbjct: 243 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP- 301
Query: 559 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK 618
+ E F E ++ +LRH ++ ++ P ++TEYM GSL +
Sbjct: 302 --GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLK-GETG 357
Query: 619 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678
K L + + M I G+ + RM VHRDL++AN LV ++ K+ DFGL+R+I D+
Sbjct: 358 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
Query: 679 MRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAV 736
A P +W APE FT K D++S G+++ EL T P+ G++ V+ V
Sbjct: 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
Query: 737 ANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLD 776
G R+ P L L+ CW EP+ERP+ E + + L D
Sbjct: 478 -ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 5e-68
Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 18/281 (6%)
Query: 514 LAYEEWNIDFSELTVGTRV-GIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDF 568
+ +E +D LT+ + G G FG V +G + VA+K+ + ++
Sbjct: 6 IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 65
Query: 569 CNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 628
E +++ +L +P ++ +G C ++ E ELG L + Q + + + ++
Sbjct: 66 LAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQ---QNRHVKDKNIIE 121
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT- 687
++ + G+ + VHRDL + N L+ KI DFGLS+ + +
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 688 -P-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLE 744
P +W APE I F+ K D++S GV+MWE + +P+ G+ V + +G R+
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGERMG 240
Query: 745 IPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 781
P G + L+ CW + + RP + RL + Y +
Sbjct: 241 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 6e-68
Identities = 61/284 (21%), Positives = 117/284 (41%), Gaps = 40/284 (14%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNG---------TDVAIKVFLEQDLTAENMEDFC 569
I +L +G G F ++F+G+ T+V +KV E F
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFF 60
Query: 570 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM 629
S++S+L H +++L G C ++ E+++ GSL +L K ++ KL++
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSL--DTYLKKNKNCINILWKLEV 118
Query: 630 LRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--------VKICDFGLSRIITDS---- 677
+ + + + ++H ++ + N L+ + +K+ D G+S +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 678 -PMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVY 734
+ W+ PE I N + D +S G +WE+C+ ++P + +R +
Sbjct: 179 ERIP---------WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229
Query: 735 AVANEGSRLEIPEG-PLGRLIADCWA-EPQERPSCEEILSRLLD 776
+ +L P+ L LI +C EP RPS I+ L
Sbjct: 230 FY-EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNS 272
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 2e-67
Identities = 83/290 (28%), Positives = 126/290 (43%), Gaps = 30/290 (10%)
Query: 515 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMED 567
+I ++ + +G G FG+VF VA+K + L A D
Sbjct: 6 GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--D 63
Query: 568 FCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIHL 614
F E +L+ L+H +++ F G C L M+ EYM+ G L
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 615 SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674
K +L + L + I G++ + VHRDL + NCLV + VKI DFG+SR +
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 183
Query: 675 TDSPM-RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPER 731
+ R P WM PE I FT + D++S GVI+WE+ T +PW +
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243
Query: 732 VVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 777
V+ + +G LE P + ++ CW EPQ+R + +EI L
Sbjct: 244 VIECI-TQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 6e-67
Identities = 73/291 (25%), Positives = 129/291 (44%), Gaps = 36/291 (12%)
Query: 515 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDF 568
+ + L ++G G FG V ++ VA+K L+ T E++ DF
Sbjct: 1 GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHS-TEEHLRDF 58
Query: 569 CNEISILSRLRHPNVILFLGACTKPPRLS--MITEYMELGSLYHLIHLSGQKKKLSWRRK 626
EI IL L+H N++ + G C R + +I EY+ GSL +L K+++ +
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL--RDYLQKHKERIDHIKL 116
Query: 627 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSS 684
L+ IC+G+ + + +HRDL + N LV VKI DFGL++++ +
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 685 AGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR----------------PWEGV 727
+P W APE + F+ D++S GV+++EL T +
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236
Query: 728 LPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
+ ++ + RL P+G + ++ +CW +RPS ++ R+
Sbjct: 237 IVFHLIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-66
Identities = 73/269 (27%), Positives = 126/269 (46%), Gaps = 18/269 (6%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEI 572
+EL +G G FG V +G+W V IKV +E ++ + + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV-IEDKSGRQSFQAVTDHM 66
Query: 573 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 632
+ L H +++ LG C L ++T+Y+ LGSL L H+ + L + L
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSL--LDHVRQHRGALGPQLLLNWGVQ 123
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EW 690
I +G+ + +VHR+L + N L+ V++ DFG++ ++ D S A TP +W
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 691 MAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG- 748
MA E I +T + D++S GV +WEL T P+ G+ V + +G RL P+
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-EKGERLAQPQIC 242
Query: 749 --PLGRLIADCWA-EPQERPSCEEILSRL 774
+ ++ CW + RP+ +E+ +
Sbjct: 243 TIDVYMVMVKCWMIDENIRPTFKELANEF 271
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 1e-66
Identities = 78/307 (25%), Positives = 135/307 (43%), Gaps = 39/307 (12%)
Query: 502 VLESPMFQNKPLLAY---EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAI 552
E+ FQ A+ + + L ++G G FG V ++ VA+
Sbjct: 16 TTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAV 75
Query: 553 KVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR--LSMITEYMELGSLYH 610
K L+ T E++ DF EI IL L+H N++ + G C R L +I EY+ GSL
Sbjct: 76 KK-LQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL-- 131
Query: 611 LIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 670
+L K+++ + L+ IC+G+ + + +HRDL + N LV VKI DFGL
Sbjct: 132 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191
Query: 671 SRIITDSPM--RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR----- 722
++++ + +P W APE + F+ D++S GV+++EL T
Sbjct: 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251
Query: 723 -----------PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSC 767
++ ++ + RL P+G + ++ +CW +RPS
Sbjct: 252 PAEFMRMIGNDKQGQMIVFHLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 310
Query: 768 EEILSRL 774
++ R+
Sbjct: 311 RDLALRV 317
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-66
Identities = 86/292 (29%), Positives = 145/292 (49%), Gaps = 23/292 (7%)
Query: 507 MFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQD 559
F + +EW + ++T+ +G G FG V+ G+ G T VAIK + +
Sbjct: 8 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEA 66
Query: 560 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY-------HLI 612
+ +F NE S++ +V+ LG ++ +I E M G L +
Sbjct: 67 ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAM 126
Query: 613 HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672
+ S + ++M +I G+ ++ K VHRDL + NC+V + +TVKI DFG++R
Sbjct: 127 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 673 IITDSPM-RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLP 729
I ++ R P WM+PE +++ FT D++S GV++WE+ TL +P++G+
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246
Query: 730 ERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 777
E+V+ V EG L+ P+ L L+ CW P+ RPS EI+S + +
Sbjct: 247 EQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-66
Identities = 79/296 (26%), Positives = 127/296 (42%), Gaps = 34/296 (11%)
Query: 509 QNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTA 562
+ KP + + + L +G G FG+V + G VA+K L+ +
Sbjct: 6 EKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGG 64
Query: 563 ENMEDFCNEISILSRLRHPNVILFLGACTKPPR--LSMITEYMELGSLYHLIHLSGQKKK 620
++ D EI IL L H N++ + G CT+ + +I E++ GSL +L K K
Sbjct: 65 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL--KEYLPKNKNK 122
Query: 621 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 679
++ +++LK IC+G+ + + VHRDL + N LV VKI DFGL++ I
Sbjct: 123 INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 182
Query: 680 -RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL---------------NR 722
+P W APE + F D++S GV + EL T
Sbjct: 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242
Query: 723 PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
+ R+V + EG RL P + +L+ CW +P R S + ++
Sbjct: 243 THGQMTVTRLVNTL-KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 2e-66
Identities = 83/292 (28%), Positives = 122/292 (41%), Gaps = 47/292 (16%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 571
I S + +G FG+V++G G VAIK L+ E+F +E
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT-LKDKAEGPLREEFRHE 62
Query: 572 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIHLSGQK 618
+ +RL+HPNV+ LG TK LSMI Y G L K
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 619 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS- 677
L + ++ I G+ + +VH+DL + N LV VKI D GL R + +
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 678 ----------PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEG 726
P+R WMAPE I F+ DI+S GV++WE+ + +P+ G
Sbjct: 183 YYKLLGNSLLPIR---------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 233
Query: 727 VLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 774
+ VV + L P+ + L+ +CW P RP ++I SRL
Sbjct: 234 YSNQDVVEMI-RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 3e-66
Identities = 85/333 (25%), Positives = 143/333 (42%), Gaps = 51/333 (15%)
Query: 480 GSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGE 539
G+ GSS + ++E+P + + +I ++ + +G G FG+
Sbjct: 1 GAMGSGSSLSPTEGKGSGLQGHIIENPQYFSDA----CVHHIKRRDIVLKWELGEGAFGK 56
Query: 540 VFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 592
VF + VA+K ++ + +DF E +L+ L+H +++ F G CT+
Sbjct: 57 VFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIVRFFGVCTE 114
Query: 593 PPRLSMITEYMELGSL------------YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
L M+ EYM G L L + L + + G++ +
Sbjct: 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL 174
Query: 641 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-----------PMRDSSSAGTPE 689
+ VHRDL + NCLV + VKI DFG+SR I + P+R
Sbjct: 175 AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR--------- 225
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG 748
WM PE I FT + D++S GV++WE+ T +PW + + + +G LE P
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI-TQGRELERPRA 284
Query: 749 ---PLGRLIADCW-AEPQERPSCEEILSRLLDC 777
+ ++ CW EPQ+R S +++ +RL
Sbjct: 285 CPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 4e-66
Identities = 70/267 (26%), Positives = 128/267 (47%), Gaps = 18/267 (6%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISI 574
+ +E +G G FG V++G+W VAIK L + + + ++ +E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEAYV 70
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
++ + +P+V LG C + +IT+ M G L L ++ K + + L I
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIA 127
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EWMA 692
+G+ + ++VHRDL + N LV VKI DFGL++++ + + P +WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 693 PELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG--- 748
E I + +T + D++S GV +WEL T ++P++G+ + + +G RL P
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTI 246
Query: 749 PLGRLIADCWA-EPQERPSCEEILSRL 774
+ ++ CW + RP E++
Sbjct: 247 DVYMIMVKCWMIDADSRPKFRELIIEF 273
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-65
Identities = 76/275 (27%), Positives = 131/275 (47%), Gaps = 21/275 (7%)
Query: 517 EEWNI--DFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFC 569
++ I + +G G FG V+ G + AIK L + + +E F
Sbjct: 12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS-LSRITEMQQVEAFL 70
Query: 570 NEISILSRLRHPNVILFLGACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 628
E ++ L HPNV+ +G P ++ YM G L L + ++ + + +
Sbjct: 71 REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL--LQFIRSPQRNPTVKDLIS 128
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRDSSSA 685
+ RG+ + K VHRDL + NC++++ +TVK+ DFGL+R I D ++ A
Sbjct: 129 FGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 686 GTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRL 743
P +W A E ++ FT K D++S GV++WEL T P+ + P + + + +G RL
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-AQGRRL 247
Query: 744 EIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 774
PE L +++ CW A+P RP+ ++ +
Sbjct: 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-65
Identities = 81/281 (28%), Positives = 131/281 (46%), Gaps = 21/281 (7%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNE 571
E+ ID + L +G +G G FG V G VA+K + + +E+F +E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 572 ISILSRLRHPNVILFLGACTK-----PPRLSMITEYMELGSLYHLI---HLSGQKKKLSW 623
+ + HPNVI LG C + P+ +I +M+ G L+ + L K +
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 624 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDS 682
+ LK + DI G+ + +HRDL + NC++ TV + DFGLS+ I R
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 683 SSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEG 740
A P +W+A E + + +T K D+++ GV MWE+ T P+ GV + + G
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL-LHG 265
Query: 741 SRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 777
RL+ PE L ++ CW +P +RP+ + +L
Sbjct: 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-65
Identities = 80/282 (28%), Positives = 129/282 (45%), Gaps = 23/282 (8%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 569
+ + +T+ +G G FGEV+ G +G VA+K L + + ++ DF
Sbjct: 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFL 81
Query: 570 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY----HLIHLSGQKKKLSWRR 625
E I+S+ H N++ +G + ++ E M G L Q L+
Sbjct: 82 MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 626 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSR-IITDSPMRD 681
L + RDI G + +HRD+ + NCL+ KI DFG++R I S R
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 682 SSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANE 739
A P +WM PE FT K D +S GV++WE+ +L P+ + V+ V
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-TS 260
Query: 740 GSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 777
G R++ P+ P+ R++ CW +P++RP+ IL R+ C
Sbjct: 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 7e-65
Identities = 78/277 (28%), Positives = 132/277 (47%), Gaps = 21/277 (7%)
Query: 515 AYEEWNIDFSE--LTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMED 567
A + I S + +G G FG V+ G A+K L + +
Sbjct: 14 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ 72
Query: 568 FCNEISILSRLRHPNVILFLGACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 626
F E I+ HPNV+ LG C + ++ YM+ G L + + + + +
Sbjct: 73 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL 130
Query: 627 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRDSS 683
+ + +G+ + K VHRDL + NC++++ +TVK+ DFGL+R + D + + +
Sbjct: 131 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190
Query: 684 SAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGS 741
A P +WMA E ++ + FT K D++S GV++WEL T P+ V + + +G
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGR 249
Query: 742 RLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 774
RL PE PL ++ CW + + RPS E++SR+
Sbjct: 250 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 9e-65
Identities = 73/294 (24%), Positives = 134/294 (45%), Gaps = 22/294 (7%)
Query: 502 VLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFL 556
+L+S ++ E+ I + T+G +G G FG V VA+K+
Sbjct: 1 MLDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK 60
Query: 557 EQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PPRLSMITEYMELGSLYH 610
+ + ++E+F E + + HP+V +G + P +I +M+ G L+
Sbjct: 61 ADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHA 120
Query: 611 LI---HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICD 667
+ + L + ++ + DI G+ + +HRDL + NC++ + TV + D
Sbjct: 121 FLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180
Query: 668 FGLSRIITDSPM-RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPW 724
FGLSR I R ++ P +W+A E + + +T D+++ GV MWE+ T P+
Sbjct: 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
Query: 725 EGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 774
G+ + + G+RL+ P + L+ CW A+P++RPS + L
Sbjct: 241 AGIENAEIYNYL-IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-64
Identities = 82/287 (28%), Positives = 134/287 (46%), Gaps = 27/287 (9%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 569
E+W + L G +G G FG+V G VA+K+ L+ A+ E
Sbjct: 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM-LKSTAHADEKEALM 97
Query: 570 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-----------YHLIHLSGQ 617
+E+ I+S L +H N++ LGACT + +ITEY G L +
Sbjct: 98 SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 618 KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITD 676
S R L + +G+ + +HRD+ + N L+ KI DFGL+R I+ D
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 677 SPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVY 734
S +A P +WMAPE I + +T + D++S G+++WE+ +L P+ G+L Y
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277
Query: 735 AVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 777
+ +G ++ P + ++ CW EP RP+ ++I S L +
Sbjct: 278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-64
Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 36/288 (12%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCN 570
+ L +G G FG+V ++ VA+K L+ D ++ +
Sbjct: 24 DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA-LKADAGPQHRSGWKQ 82
Query: 571 EISILSRLRHPNVILFLGACTKPPR--LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 628
EI IL L H ++I + G C L ++ EY+ LGSL + + + + L
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLL 138
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAG 686
+ IC G+ +H +HRDL + N L++ VKI DFGL++ + + R
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 687 TP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL---------------NRPWEGVLPE 730
+P W APE ++ F D++S GV ++EL T +
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258
Query: 731 RVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
R+ + G RL P+ + L+ +CW E RP+ E ++ L
Sbjct: 259 RLTELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-64
Identities = 83/290 (28%), Positives = 131/290 (45%), Gaps = 31/290 (10%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 569
+W + L+ G +G G FG+V G VA+K+ L+ E
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALM 74
Query: 570 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL---------------YHLIH 613
+E+ +LS L H N++ LGACT +ITEY G L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 614 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR- 672
+ + L L + +G+ + +HRDL + N L+ KICDFGL+R
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 673 IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPE 730
I DS +A P +WMAPE I N +T + D++S G+ +WEL +L P+ G+ +
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 731 RVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLD 776
Y + EG R+ PE + ++ CW A+P +RP+ ++I+ +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 4e-64
Identities = 90/305 (29%), Positives = 146/305 (47%), Gaps = 32/305 (10%)
Query: 504 ESPMFQNKPLLAYE--EWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKV 554
E P+ ++ L Y+ +W L +G +G G FG+V G VA+K+
Sbjct: 5 ELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM 64
Query: 555 FLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR-LSMITEYMELGSL---- 608
L++ T +E+ IL + H NV+ LGACTKP L +I E+ + G+L
Sbjct: 65 -LKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 609 ---------YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK 659
Y + K L+ + + +G+ + K +HRDL + N L+++
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183
Query: 660 HWTVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWEL 717
VKICDFGL+R I D A P +WMAPE I + +T + D++S GV++WE+
Sbjct: 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 718 CTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILS 772
+L P+ GV + EG+R+ P+ + + + DCW EP +RP+ E++
Sbjct: 244 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 773 RLLDC 777
L +
Sbjct: 304 HLGNL 308
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 4e-64
Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 23/282 (8%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 569
+ + +T+ +G G FGEV+ G +G VA+K L + + ++ DF
Sbjct: 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFL 122
Query: 570 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY----HLIHLSGQKKKLSWRR 625
E I+S+ H N++ +G + ++ E M G L Q L+
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 626 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSR-IITDSPMRD 681
L + RDI G + +HRD+ + NCL+ KI DFG++R I R
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 682 SSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANE 739
A P +WM PE FT K D +S GV++WE+ +L P+ + V+ V
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-TS 301
Query: 740 GSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 777
G R++ P+ P+ R++ CW +P++RP+ IL R+ C
Sbjct: 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 5e-64
Identities = 88/339 (25%), Positives = 149/339 (43%), Gaps = 27/339 (7%)
Query: 458 RDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMA----NSEFVSTWNKVLESPMFQNKPL 513
R + + SP G E +S Y N F ++ + +
Sbjct: 17 RRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELV 76
Query: 514 LAYEEWNIDFSE--LTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENME 566
A + I S + +G G FG V+ G A+K L + +
Sbjct: 77 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVS 135
Query: 567 DFCNEISILSRLRHPNVILFLGACTK--PPRLSMITEYMELGSLYHLIHLSGQKKKLSWR 624
F E I+ HPNV+ LG C + L ++ YM+ G L + + + + +
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRN--FIRNETHNPTVK 192
Query: 625 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRD 681
+ + +G+ + K VHRDL + NC++++ +TVK+ DFGL+R + D + +
Sbjct: 193 DLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 252
Query: 682 SSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANE 739
+ A P +WMA E ++ + FT K D++S GV++WEL T P+ V + + +
Sbjct: 253 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQ 311
Query: 740 GSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 774
G RL PE PL ++ CW + + RPS E++SR+
Sbjct: 312 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 350
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-63
Identities = 85/293 (29%), Positives = 140/293 (47%), Gaps = 37/293 (12%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 569
+W L +G +G G FG+V + T VA+K+ L+++ + + D
Sbjct: 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-LKENASPSELRDLL 74
Query: 570 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL--------------------- 608
+E ++L ++ HP+VI GAC++ L +I EY + GSL
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 609 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 668
++ L+ + I +G+ + MK+VHRDL + N LV + +KI DF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 669 GLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWE 725
GLSR + + S P +WMA E + + +T + D++S GV++WE+ TL P+
Sbjct: 195 GLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 726 GVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 774
G+ PER+ + G R+E P+ + RL+ CW EP +RP +I L
Sbjct: 255 GIPPERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-63
Identities = 91/325 (28%), Positives = 144/325 (44%), Gaps = 58/325 (17%)
Query: 500 NKVLESPMFQNKPLLA---YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TD 549
+++ +PM+Q PLL + + +G G FG VF+ G T
Sbjct: 20 DRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTM 79
Query: 550 VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL- 608
VA+K+ L+++ +A+ DF E ++++ +PN++ LG C + ++ EYM G L
Sbjct: 80 VAVKM-LKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 609 --------------------YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648
S LS +L + R + G+ + K VHR
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198
Query: 649 DLKSANCLVNKHWTVKICDFGLSRIITDS-----------PMRDSSSAGTPEWMAPELIR 697
DL + NCLV ++ VKI DFGLSR I + P+R WM PE I
Sbjct: 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR---------WMPPESIF 249
Query: 698 NEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 753
+T + D+++ GV++WE+ + +P+ G+ E V+Y V +G+ L PE L L
Sbjct: 250 YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV-RDGNILACPENCPLELYNL 308
Query: 754 IADCW-AEPQERPSCEEILSRLLDC 777
+ CW P +RPS I L
Sbjct: 309 MRLCWSKLPADRPSFCSIHRILQRM 333
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 7e-63
Identities = 83/288 (28%), Positives = 148/288 (51%), Gaps = 32/288 (11%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG---------TDVAIKVFLEQDLTAENMED 567
+W +LT+G +G G FG+V G VA+K+ L+ D T +++ D
Sbjct: 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSD 86
Query: 568 FCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIH 613
+E+ ++ + +H N+I LGACT+ L +I EY G+L Y
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 614 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR- 672
+++++++ + + RG+ + K +HRDL + N LV ++ +KI DFGL+R
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 673 IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPE 730
I + +++ P +WMAPE + + +T + D++S GV+MWE+ TL P+ G+ E
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 731 RVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 774
+ + EG R++ P L ++ DCW A P +RP+ ++++ L
Sbjct: 267 ELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-62
Identities = 90/391 (23%), Positives = 165/391 (42%), Gaps = 28/391 (7%)
Query: 414 RGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSP 473
+ + + L + L I + A N S + A +LP+ P
Sbjct: 215 QDKAGKYCIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHP 274
Query: 474 HE--YGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAY--------EEWNIDF 523
+ + S GY +++ +K PM + + ++ +
Sbjct: 275 STLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKR 334
Query: 524 SELTVG-TRVGIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDFCNEISILSRL 578
L + +G G FG V +G++ DVAIKV L+Q + E+ E I+ +L
Sbjct: 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQIMHQL 393
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
+P ++ +G C + ++ E G L L G+++++ ++L + G+
Sbjct: 394 DNPYIVRLIGVCQAEALM-LVMEMAGGGPL--HKFLVGKREEIPVSNVAELLHQVSMGMK 450
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT--P-EWMAPEL 695
+ VHR+L + N L+ KI DFGLS+ + ++ + P +W APE
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 751
I F+ + D++S GV MWE + +P++ + V+ + +G R+E P L
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPPECPPELY 569
Query: 752 RLIADCWA-EPQERPSCEEILSRLLDCEYSL 781
L++DCW + ++RP + R+ C YSL
Sbjct: 570 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 1e-62
Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 36/296 (12%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 569
+W L G +G G FG+V G VA+K+ L++ + E
Sbjct: 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALM 96
Query: 570 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------------- 608
+E+ ++++L H N++ LGACT + +I EY G L
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 609 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 668
+ L++ L + +G+ + VHRDL + N LV VKICDF
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 669 GLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWE 725
GL+R I++DS +A P +WMAPE + +T K D++S G+++WE+ +L P+
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276
Query: 726 GVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 777
G+ + Y + G +++ P + ++ CW + ++RPS + S L
Sbjct: 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-62
Identities = 80/282 (28%), Positives = 131/282 (46%), Gaps = 28/282 (9%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDFCNEI 572
+D++++ +G G FG+V + D AIK +++ + ++ DF E+
Sbjct: 18 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGEL 76
Query: 573 SILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIHLSGQK 618
+L +L HPN+I LGAC L + EY G+L +
Sbjct: 77 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 619 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678
LS ++ L D+ RG+ + + + +HRDL + N LV +++ KI DFGLSR
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEV 194
Query: 679 MRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAV 736
+ P WMA E + +T D++S GV++WE+ +L P+ G+ + +
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
Query: 737 ANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 774
+G RLE P + L+ CW +P ERPS +IL L
Sbjct: 255 -PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-62
Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 33/287 (11%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCN 570
+ + L +++G G FG V ++ VA+K L+ + DF
Sbjct: 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ-LQHSGP-DQQRDFQR 73
Query: 571 EISILSRLRHPNVILFLGACTKPPRLS--MITEYMELGSLYHLIHLSGQKKKLSWRRKLK 628
EI IL L ++ + G P R S ++ EY+ G L L + +L R L
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL--RDFLQRHRARLDASRLLL 131
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAG 686
IC+G+ + + VHRDL + N LV VKI DFGL++++
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 687 TP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERV------------ 732
+P W APE + + F+ + D++S GV+++EL T ++
Sbjct: 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
Query: 733 -VYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
+ + EG RL P + L+ CWA PQ+RPS + +L
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-62
Identities = 85/291 (29%), Positives = 145/291 (49%), Gaps = 32/291 (10%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG---------TDVAIKVFLEQDLTAENMED 567
W + L +G +G G FG+V G T VA+K+ L+ D T +++ D
Sbjct: 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSD 120
Query: 568 FCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIH 613
+E+ ++ + +H N+I LGACT+ L +I EY G+L Y
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 614 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673
+++LS + + + RG+ + K +HRDL + N LV + +KI DFGL+R
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 674 I-TDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPE 730
I + +++ P +WMAPE + + +T + D++S GV++WE+ TL P+ GV E
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
Query: 731 RVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 777
+ + EG R++ P L ++ DCW A P +RP+ ++++ L
Sbjct: 301 ELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 1e-61
Identities = 83/288 (28%), Positives = 148/288 (51%), Gaps = 32/288 (11%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG---------TDVAIKVFLEQDLTAENMED 567
+W +LT+G +G G FG+V G VA+K+ L+ D T +++ D
Sbjct: 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSD 132
Query: 568 FCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIH 613
+E+ ++ + +H N+I LGACT+ L +I EY G+L Y
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 614 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR- 672
+++++++ + + RG+ + K +HRDL + N LV ++ +KI DFGL+R
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 673 IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPE 730
I + +++ P +WMAPE + + +T + D++S GV+MWE+ TL P+ G+ E
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312
Query: 731 RVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 774
+ + EG R++ P L ++ DCW A P +RP+ ++++ L
Sbjct: 313 ELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-59
Identities = 75/280 (26%), Positives = 131/280 (46%), Gaps = 14/280 (5%)
Query: 505 SPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRG--IWNGTDVAIK-VFLEQDLT 561
P FQ + L + + + ++G G F EV+R + +G VA+K V + +
Sbjct: 13 VPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD 72
Query: 562 AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK- 620
A+ D EI +L +L HPNVI + + + L+++ E + G L +I ++K+
Sbjct: 73 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL 132
Query: 621 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680
+ R K +C L +H +++HRD+K AN + VK+ D GL R +
Sbjct: 133 IPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 192
Query: 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 740
S GTP +M+PE I + K DI+SLG +++E+ L P+ G +Y++ +
Sbjct: 193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKI 250
Query: 741 SRLEIPEGPLGR-------LIADCWA-EPQERPSCEEILS 772
+ + P P L+ C +P++RP +
Sbjct: 251 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-59
Identities = 66/257 (25%), Positives = 114/257 (44%), Gaps = 20/257 (7%)
Query: 529 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 586
+G G F V++G+ +VA ++ LT + F E +L L+HPN++ F
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 587 LGA----CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
+ + ++TE M G+L + + K + + R I +GL +H
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 643 MK--IVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 699
I+HRDLK N + +VKI D GL+ + S + + GTPE+MAPE+ +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEMYEEK 205
Query: 700 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGR-LIA 755
+ E D+++ G+ M E+ T P+ +Y G + + P + +I
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264
Query: 756 DCWA-EPQERPSCEEIL 771
C ER S +++L
Sbjct: 265 GCIRQNKDERYSIKDLL 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 5e-59
Identities = 70/263 (26%), Positives = 133/263 (50%), Gaps = 11/263 (4%)
Query: 520 NIDFSEL---TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISI 574
N+ F + ++G G FG+ +G IK ++++ E+ E+++
Sbjct: 17 NLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAV 76
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
L+ ++HPN++ + + + L ++ +Y E G L+ I+ + + L IC
Sbjct: 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQIC 135
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694
L +H KI+HRD+KS N + K TV++ DFG++R++ + + GTP +++PE
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 751
+ N+P+ K DI++LG +++ELCTL +E + +V + GS + L
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI-ISGSFPPVSLHYSYDLR 254
Query: 752 RLIADCWA-EPQERPSCEEILSR 773
L++ + P++RPS IL +
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEK 277
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 7e-56
Identities = 72/261 (27%), Positives = 119/261 (45%), Gaps = 15/261 (5%)
Query: 527 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
V +G G +G R +G + K +T + +E+++L L+HPN++
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 68
Query: 585 LFLGA--CTKPPRLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMCIH 641
+ L ++ EY E G L +I ++++ L L+++ + L H
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 642 RMK-----IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
R ++HRDLK AN ++ VK+ DFGL+RI+ + GTP +M+PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 753
+ EK DI+SLG +++ELC L P+ + + + EG IP L +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDELNEI 247
Query: 754 IADCWA-EPQERPSCEEILSR 773
I + RPS EEIL
Sbjct: 248 ITRMLNLKDYHRPSVEEILEN 268
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 6e-53
Identities = 65/268 (24%), Positives = 115/268 (42%), Gaps = 36/268 (13%)
Query: 527 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+G G FG+VF+ +G IK E E E+ L++L H N++
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIK---RVKYNNEKAE---REVKALAKLDHVNIV 67
Query: 585 LFLGA----------------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 628
+ G +K L + E+ + G+L I + +KL L+
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALE 126
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 688
+ I +G+ IH K+++RDLK +N + VKI DFGL + + R + S GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-TRSKGTL 185
Query: 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG 748
+M+PE I ++ + ++ D+++LG+I+ EL + + I +
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE------TSKFFTDLRDGIISDI 239
Query: 749 ---PLGRLIADCWA-EPQERPSCEEILS 772
L+ + +P++RP+ EIL
Sbjct: 240 FDKKEKTLLQKLLSKKPEDRPNTSEILR 267
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-52
Identities = 66/329 (20%), Positives = 118/329 (35%), Gaps = 46/329 (13%)
Query: 462 NSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQ-NKPLLAYEEWN 520
+ + + + F ++ L+SP + ++P +++
Sbjct: 4 HHHHSSGVDLGTENLYFQSMHQLQPRR----VSFRGEASETLQSPGYDPSRPESFFQQ-- 57
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 578
F L+ +G G +GEVF+ +G A+K + ++ E+ ++
Sbjct: 58 -SFQRLSR---LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 579 -RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
+HP + A + L + TE SL H L + LRD L
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQ--HCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 697
+H +VH D+K AN + K+ DFGL + + G P +MAPEL+
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGDPRYMAPELL- 228
Query: 698 NEPFTEKCDIFSLGVIMWELCTLNRPW----------EGVLPERVVYAVANEGSRLEIPE 747
+ D+FSLG+ + E+ +G LP E
Sbjct: 229 QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP-------------EFTA 275
Query: 748 G---PLGRLIADCWA-EPQERPSCEEILS 772
G L ++ +P+ R + E +L+
Sbjct: 276 GLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-52
Identities = 64/273 (23%), Positives = 113/273 (41%), Gaps = 28/273 (10%)
Query: 527 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
++G G F V G+ +G A+K L + ++ E+ E + HPN++
Sbjct: 32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNIL 89
Query: 585 LFLGACTKPP----RLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMC 639
+ C + ++ + + G+L++ I L + L+ + L +L ICRGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA---------GTPEW 690
IH HRDLK N L+ + D G + T +
Sbjct: 150 IHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 691 MAPELI---RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE 747
APEL + E+ D++SLG +++ + P++ V + A+A + +L IP+
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-QLSIPQ 268
Query: 748 GP-----LGRLIADCWAE-PQERPSCEEILSRL 774
P L +L+ P +RP +LS+L
Sbjct: 269 SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-51
Identities = 89/271 (32%), Positives = 145/271 (53%), Gaps = 17/271 (6%)
Query: 510 NKPLLAYEEWNIDFSEL-TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENME 566
L + D EL T ++G G FGEVF+GI N T VAIK+ ++ + + +E
Sbjct: 7 QSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIE 65
Query: 567 DFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 626
D EI++LS+ P V + G+ K +L +I EY+ GS L+ + L +
Sbjct: 66 DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQI 121
Query: 627 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 686
+LR+I +GL +H K +HRD+K+AN L+++H VK+ DFG++ +TD+ ++ ++ G
Sbjct: 122 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 181
Query: 687 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEI 745
TP WMAPE+I+ + K DI+SLG+ EL P + P +V++ + L
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL-- 239
Query: 746 PEGPLGRLIADCWA-----EPQERPSCEEIL 771
EG + + + EP RP+ +E+L
Sbjct: 240 -EGNYSKPLKEFVEACLNKEPSFRPTAKELL 269
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-51
Identities = 61/268 (22%), Positives = 125/268 (46%), Gaps = 28/268 (10%)
Query: 527 TVGTRVGIGFFGEVFRGI-WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--V 583
++ ++G G +VF+ + AIK ++ + ++ + NEI+ L++L+ + +
Sbjct: 31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
I + M+ E L + +KK + + +++ + IH+
Sbjct: 91 IRLYDYEITDQYIYMVMECGN-IDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRII---TDSPMRDSSSAGTPEWMAPELIRNEP 700
IVH DLK AN L+ +K+ DFG++ + T S ++D S GT +M PE I++
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMS 204
Query: 701 -----------FTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG 748
+ K D++SLG I++ + P++ ++ ++A+ + +E P+
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 749 P---LGRLIADCWA-EPQERPSCEEILS 772
P L ++ C +P++R S E+L+
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 6e-51
Identities = 61/268 (22%), Positives = 125/268 (46%), Gaps = 28/268 (10%)
Query: 527 TVGTRVGIGFFGEVFRGI-WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--V 583
++ ++G G +VF+ + AIK ++ + ++ + NEI+ L++L+ + +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
I + M+ E L + +KK + + +++ + IH+
Sbjct: 72 IRLYDYEITDQYIYMVMECGN-IDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRII---TDSPMRDSSSAGTPEWMAPELIRNEP 700
IVH DLK AN L+ +K+ DFG++ + T S ++D S GT +M PE I++
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMS 185
Query: 701 -----------FTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG 748
+ K D++SLG I++ + P++ ++ ++A+ + +E P+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 749 P---LGRLIADCWA-EPQERPSCEEILS 772
P L ++ C +P++R S E+L+
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 6e-50
Identities = 82/317 (25%), Positives = 125/317 (39%), Gaps = 25/317 (7%)
Query: 468 SLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELT 527
S+ S + S S A + + + E + K E+ + +T
Sbjct: 4 SVSSGQAHSLA--SLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 528 VGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 585
RVG G FGEV R G A+K + L +E E+ + L P ++
Sbjct: 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVE----ELVACAGLSSPRIVP 114
Query: 586 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
GA + P +++ E +E GSL LI G L R L L GL +H +I
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 646 VHRDLKSANCLVNKH-WTVKICDFGLSRIITD-----SPMRDSSSAGTPEWMAPELIRNE 699
+H D+K+ N L++ +CDFG + + S + GT MAPE++ +
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 700 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG-SRLEIPEG--PLGR-LIA 755
P K DI+S +M + PW + +A+E EIP PL I
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQ 291
Query: 756 DCWA-EPQERPSCEEIL 771
+ EP R S E+
Sbjct: 292 EGLRKEPVHRASAMELR 308
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 2e-49
Identities = 60/268 (22%), Positives = 124/268 (46%), Gaps = 28/268 (10%)
Query: 527 TVGTRVGIGFFGEVFRGI-WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--V 583
++ ++G G +VF+ + AIK ++ + ++ + NEI+ L++L+ + +
Sbjct: 59 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
I + M+ E L + +KK + + +++ + IH+
Sbjct: 119 IRLYDYEITDQYIYMVMECGN-IDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRII---TDSPMRDSSSAGTPEWMAPELIRNEP 700
IVH DLK AN L+ +K+ DFG++ + T S ++D S G +M PE I++
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD-SQVGAVNYMPPEAIKDMS 232
Query: 701 -----------FTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG 748
+ K D++SLG I++ + P++ ++ ++A+ + +E P+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 749 P---LGRLIADCWA-EPQERPSCEEILS 772
P L ++ C +P++R S E+L+
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-49
Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 30/280 (10%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISIL 575
W+I+ + + +G G V VAIK LE+ +M++ EI +
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAM 67
Query: 576 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK------M 629
S+ HPN++ + + L ++ + + GS+ +I K L +
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIK-HIVAKGEHKSGVLDESTIATI 126
Query: 630 LRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS----- 684
LR++ GL +H+ +HRD+K+ N L+ + +V+I DFG+S + +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 685 AGTPEWMAPELI-RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-R 742
GTP WMAPE++ + + K DI+S G+ EL T P+ P +V+
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 743 LEIPEGPLGR----------LIADCWA-EPQERPSCEEIL 771
LE +I+ C +P++RP+ E+L
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-49
Identities = 71/251 (28%), Positives = 124/251 (49%), Gaps = 15/251 (5%)
Query: 530 TRVGIGFFGEVFRG--IWNGTDVAIKVF-LEQDLTAENMEDFCNEISILSRLRHPNVILF 586
++G G +G V++ G VAIK +E DL ++ EISI+ + P+V+ +
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSPHVVKY 89
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
G+ K L ++ EY GS+ +I L K L+ +L+ +GL +H M+ +
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 706
HRD+K+ N L+N K+ DFG++ +TD+ + ++ GTP WMAPE+I+ + D
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVAD 207
Query: 707 IFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA-EP 761
I+SLG+ E+ P+ + P R ++ + PE + C P
Sbjct: 208 IWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSP 267
Query: 762 QERPSCEEILS 772
++R + ++L
Sbjct: 268 EQRATATQLLQ 278
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 9e-49
Identities = 57/277 (20%), Positives = 99/277 (35%), Gaps = 34/277 (12%)
Query: 527 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+G G FG VF + + + AIK + E E+ L++L HP ++
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 585 LFLGAC------------TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 632
+ A + L + + +L ++ ++ L +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS------------PMR 680
I + +H ++HRDLK +N VK+ DFGL + R
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 740
+ GT +M+PE I ++ K DIFSLG+I++EL P+ +
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNL 243
Query: 741 SRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSR 773
+ ++ D + P ERP I+
Sbjct: 244 KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 55/273 (20%), Positives = 101/273 (36%), Gaps = 36/273 (13%)
Query: 527 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNV 583
++G G FG VF+ + +G AIK + + + ++ E+ + L +H +V
Sbjct: 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMCIHR 642
+ + A + + + EY GSL I + + +L + RGL IH
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 643 MKIVHRDLKSANCLVNKH-------------------WTVKICDFGLSRIITDSPMRDSS 683
M +VH D+K +N +++ KI D G I+
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QV 189
Query: 684 SAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 742
G ++A E+++ N K DIF+L + + + +G
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEIRQGRL 245
Query: 743 LEIPEG---PLGRLIADCWA-EPQERPSCEEIL 771
IP+ L+ +P+ RPS ++
Sbjct: 246 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 72/264 (27%), Positives = 127/264 (48%), Gaps = 12/264 (4%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISIL 575
E++ ++ E +G G +G V+ G N +AIK E+D + + EI++
Sbjct: 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALH 73
Query: 576 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
L+H N++ +LG+ ++ + + E + GSL L+ K + + + I
Sbjct: 74 KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE 133
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694
GL +H +IVHRD+K N L+N + +KI DFG S+ + + GT ++MAPE
Sbjct: 134 GLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE 193
Query: 695 LIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG--P 749
+I P + + DI+SLG + E+ T P+ + P+ ++ V EIPE
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253
Query: 750 LGR-LIADCWA-EPQERPSCEEIL 771
+ I C+ +P +R ++L
Sbjct: 254 EAKAFILKCFEPDPDKRACANDLL 277
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-48
Identities = 71/276 (25%), Positives = 127/276 (46%), Gaps = 19/276 (6%)
Query: 511 KPLLAYEEWNIDFSEL-TVGTRVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENME 566
+ ++D +E+ + +G G FG+V++ T A KV + + E +E
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELE 61
Query: 567 DFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 626
D+ EI IL+ HP ++ LGA +L ++ E+ G++ ++ + L+ +
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL--DRGLTEPQI 119
Query: 627 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 686
+ R + L +H +I+HRDLK+ N L+ +++ DFG+S + + S G
Sbjct: 120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG 179
Query: 687 TPEWMAPELIRNEPFTE-----KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 741
TP WMAPE++ E + K DI+SLG+ + E+ + P + P RV+ +A
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP 239
Query: 742 -RLEIPEG---PLGRLIADCWA-EPQERPSCEEILS 772
L P + P+ RPS ++L
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-48
Identities = 70/249 (28%), Positives = 124/249 (49%), Gaps = 15/249 (6%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSRLRHPNVILFL 587
++G G G V+ + T VAI+ L+Q E NEI ++ ++PN++ +L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYL 83
Query: 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 647
+ L ++ EY+ GSL ++ + + + + R+ + L +H +++H
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 648 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 707
RD+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K DI
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 708 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA-EPQ 762
+SLG++ E+ P+ P R +Y +A G+ L+ PE + C + +
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVE 259
Query: 763 ERPSCEEIL 771
+R S +E+L
Sbjct: 260 KRGSAKELL 268
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-47
Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 34/266 (12%)
Query: 531 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 587
VG G +G+V++G G AIKV D+T + E+ EI++L + H N+ +
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKV---MDVTGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 588 GA------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK------MLRDICR 635
GA +L ++ E+ GS+ LI K + LK + R+I R
Sbjct: 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-------KNTKGNTLKEEWIAYICREILR 140
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
GL +H+ K++HRD+K N L+ ++ VK+ DFG+S + + R ++ GTP WMAPE+
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 200
Query: 696 IRNEPFTE-----KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE-- 747
I + + K D++SLG+ E+ P + P R ++ + + RL+ +
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 260
Query: 748 GPLGRLIADCWA-EPQERPSCEEILS 772
I C +RP+ E+++
Sbjct: 261 KKFQSFIESCLVKNHSQRPATEQLMK 286
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-47
Identities = 60/249 (24%), Positives = 116/249 (46%), Gaps = 15/249 (6%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSRLRHPNVILFL 587
++G G G V + VA+K+ L + + E NE+ I+ +H NV+
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMY 108
Query: 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 647
+ L ++ E+++ G+L ++ + +L+ + + + + L +H ++H
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQGVIH 164
Query: 648 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 707
RD+KS + L+ VK+ DFG I+ + S GTP WMAPE+I + + DI
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDI 224
Query: 708 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA-EPQ 762
+SLG+++ E+ P+ P + + + + +L+ L + +PQ
Sbjct: 225 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQ 284
Query: 763 ERPSCEEIL 771
ER + +E+L
Sbjct: 285 ERATAQELL 293
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-46
Identities = 72/252 (28%), Positives = 111/252 (44%), Gaps = 17/252 (6%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSRLRHPNVILFL 587
+G G FG V+ VAIK + E +D E+ L +LRHPN I +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 647
G + ++ EY GS L+ + KK L + +GL +H ++H
Sbjct: 121 GCYLREHTAWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 648 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE---PFTEK 704
RD+K+ N L+++ VK+ DFG + I+ +S GTP WMAPE+I + K
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 705 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE--GPLGRLIADCWA-E 760
D++SLG+ EL P + +Y +A S L+ + C
Sbjct: 234 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 293
Query: 761 PQERPSCEEILS 772
PQ+RP+ E +L
Sbjct: 294 PQDRPTSEVLLK 305
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-46
Identities = 70/287 (24%), Positives = 116/287 (40%), Gaps = 47/287 (16%)
Query: 524 SELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP 581
S+ +G G FG+V R + AIK T E + +E+ +L+ L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQ 62
Query: 582 NVILFLGA-------------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 628
V+ + A K L + EY E G+LY LIH + +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWR 120
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD------- 681
+ R I L IH I+HRDLK N +++ VKI DFGL++ + S
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 682 -------SSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVV 733
+S+ GT ++A E++ EK D++SLG+I +E+ G+ ++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNIL 238
Query: 734 YAVANEGSRLEIPEG-------PLGRLIADC-WAEPQERPSCEEILS 772
+ + +E P ++I +P +RP +L+
Sbjct: 239 KKLRS--VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-45
Identities = 77/282 (27%), Positives = 118/282 (41%), Gaps = 41/282 (14%)
Query: 526 LTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPN 582
L V + G F V+ + + +G + A+K L + E+ + +L HPN
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI--IQEVCFMKKLSGHPN 87
Query: 583 VILFLGACTKPPRLSMITEY-----MEL--GSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
++ F A + S + EL G L + + LS LK+ CR
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 636 GLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-------- 685
+ +HR K I+HRDLK N L++ T+K+CDFG + I+ P S+
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 686 ----GTPEWMAPELI---RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN 738
TP + PE+I N P EK DI++LG I++ LC P+E R+V
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG--- 264
Query: 739 EGSRLEIPEGP-----LGRLIADCWAE-PQERPSCEEILSRL 774
+ IP LI P+ER S E++ +L
Sbjct: 265 ---KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 18/216 (8%)
Query: 527 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+ +G G VFRG G AIKVF ++ E +L +L H N++
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 585 LFLGA--CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
T +I E+ GSLY ++ L L +LRD+ G+ +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 643 MKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR- 697
IVHR++K N + + K+ DFG +R + D S GT E++ P++
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-VSLYGTEEYLHPDMYER 189
Query: 698 -------NEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
+ + D++S+GV + T + P+
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-44
Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 13/231 (5%)
Query: 527 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+ R+G G FG V R I G VAIK Q+L+ +N E +C EI I+ +L HPNV+
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 585 -LF-----LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
L + EY E G L ++ L +L DI L
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 639 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
+H +I+HRDLK N ++ + KI D G ++ + + GT +++APEL
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF-VGTLQYLAPEL 194
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 746
+ + +T D +S G + +E T RP+ + E S I
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-42
Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 18/216 (8%)
Query: 527 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+ +G G VFRG G AIKVF ++ E +L +L H N++
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 585 LFLGA--CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
T +I E+ GSLY ++ L L +LRD+ G+ +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 643 MKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR- 697
IVHR++K N + + K+ DFG +R + D S GT E++ P++
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-VSLYGTEEYLHPDMYER 189
Query: 698 -------NEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
+ + D++S+GV + T + P+
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 63/281 (22%), Positives = 122/281 (43%), Gaps = 15/281 (5%)
Query: 504 ESPMFQNKPLLAYEEWNIDFS--ELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQD 559
E + + L ++ + + + +G G G VF+ +G +A K+ + +
Sbjct: 11 EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL-IHLE 69
Query: 560 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-- 617
+ E+ +L P ++ F GA +S+ E+M+ GSL ++ +G+
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP 129
Query: 618 KKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676
++ L K+ + +GL + + KI+HRD+K +N LVN +K+CDFG+S + D
Sbjct: 130 EQILG-----KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184
Query: 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV 736
S M + S GT +M+PE ++ ++ + DI+S+G+ + E+ P + +
Sbjct: 185 S-MAN-SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 737 ANEGSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDC 777
+ P R + + LLD
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY 283
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-42
Identities = 48/277 (17%), Positives = 101/277 (36%), Gaps = 35/277 (12%)
Query: 509 QNKPLLAYEEWNIDFSELTVGTRVGIGF--FGEVFRGI--WNGTDVAIKVFLEQDLTAEN 564
+N + + + T +G GF V G V ++ + + E
Sbjct: 10 ENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM 69
Query: 565 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWR 624
+ E+ + HPN++ + L ++T +M GS LI +
Sbjct: 70 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-------CTHFM 122
Query: 625 RKLK------MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678
+ +L+ + + L IH M VHR +K+++ L++ V + + +
Sbjct: 123 DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182
Query: 679 MR-------DSSSAGTPEWMAPELIR--NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 729
R S W++PE+++ + + K DI+S+G+ EL + P++ +
Sbjct: 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242
Query: 730 ERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQERPS 766
+++ E G + L+ +E
Sbjct: 243 TQMLL---------EKLNGTVPCLLDTSTIPAEELTM 270
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 70/227 (30%), Positives = 115/227 (50%), Gaps = 17/227 (7%)
Query: 523 FSELTVGTR-------VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMEDFCNEISI 574
+L T +G G FG+V++G + +G VA+K + E+F EI
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI--EEFETEIET 88
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSG---QKKKLSWRRKLKMLR 631
LS RHP+++ +G C + + +I +YME G+L HL G +SW ++L++
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR--HLYGSDLPTMSMSWEQRLEICI 146
Query: 632 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS--AGTPE 689
RGL +H I+HRD+KS N L+++++ KI DFG+S+ T+ S+ GT
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLG 206
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV 736
++ PE TEK D++S GV+++E+ LP +V
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-41
Identities = 68/261 (26%), Positives = 106/261 (40%), Gaps = 31/261 (11%)
Query: 533 GIGFFGE-VFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGAC 590
G G G V+RG+++ DVA+K L + + + E+ +L HPNVI +
Sbjct: 33 GHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHPNVIRYFCTE 87
Query: 591 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 650
+ E +L + + +L+ GL +H + IVHRDL
Sbjct: 88 KDRQFQYIAIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDL 144
Query: 651 KSANCLV-----NKHWTVKICDFGLSRIITD---SPMRDSSSAGTPEWMAPELIR---NE 699
K N L+ + I DFGL + + S R S GT W+APE++ E
Sbjct: 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE 204
Query: 700 PFTEKCDIFSLGVIMWE-LCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR------ 752
T DIFS G + + + + P+ L +R + S L+
Sbjct: 205 NPTYTVDIFSAGCVFYYVISEGSHPFGKSL-QRQANILLGACS-LDCLHPEKHEDVIARE 262
Query: 753 LIADCWA-EPQERPSCEEILS 772
LI A +PQ+RPS + +L
Sbjct: 263 LIEKMIAMDPQKRPSAKHVLK 283
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 522 DFSEL-TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL 578
FS+ V +G G F V R + T + A K+ + L+A + + E I +L
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
+HPN++ + + ++ + + G L+ I ++ S ++ I +
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIA 119
Query: 639 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPE 694
H IVHR+LK N L+ K VK+ DFGL+ + D AGTP +++PE
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPE 177
Query: 695 LIRNEPFTEKCDIFSLGVIM 714
+++ +P+++ DI++ GVI+
Sbjct: 178 VLKKDPYSKPVDIWACGVIL 197
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-41
Identities = 58/273 (21%), Positives = 115/273 (42%), Gaps = 21/273 (7%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISI 574
+ W+ +L +G G +G V + + +G +A+K + + + + ++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR-IRSTVDEKEQKQLLMDLDV 73
Query: 575 LSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL--KMLR 631
+ R P ++ F GA + + E M S ++ K+
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 632 DICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 690
+ L + +KI+HRD+K +N L+++ +K+CDFG+S + DS + + AG +
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPY 191
Query: 691 MAPELI----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGS-RLE 744
MAPE I + + + D++SLG+ ++EL T P+ + V +L
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251
Query: 745 IPEG-----PLGRLIADC-WAEPQERPSCEEIL 771
E + C + +RP +E+L
Sbjct: 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-41
Identities = 48/250 (19%), Positives = 89/250 (35%), Gaps = 25/250 (10%)
Query: 541 FRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600
++ + + + + M+ +I + N + L + L +
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 660
+ +L ++ + L + I + +H ++HRDLK +N
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 200
Query: 661 WTVKICDFGLSRIITDSPMRDSSSA------------GTPEWMAPELIRNEPFTEKCDIF 708
VK+ DFGL + + GT +M+PE I ++ K DIF
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIF 260
Query: 709 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP------LGRLIADCWA-EP 761
SLG+I++EL ERV + + L+ P ++ D + P
Sbjct: 261 SLGLILFELLYSFSTQM----ERV--RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSP 314
Query: 762 QERPSCEEIL 771
ERP +I+
Sbjct: 315 TERPEATDII 324
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 523 FSELTVGTR-------VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMEDFCNEISI 574
EL V + +G G FG+V++G + +GT VA+K E+ ++ F E+ +
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ-FQTEVEM 80
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDI 633
+S H N++ G C P ++ YM GS+ L + L W ++ ++
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 634 CRGLMCIH---RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPE 689
RGL +H KI+HRD+K+AN L+++ + + DFGL++++ +++ GT
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCT 719
+APE + +EK D+F GV++ EL T
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 18/216 (8%)
Query: 518 EWNI-DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEIS 573
+W + DF +G +G G FG V+ R + +A+KV + L +E E+
Sbjct: 5 QWALEDF---EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 574 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 633
I S LRHPN++ G R+ +I EY LG++Y + + K +R + ++
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITEL 118
Query: 634 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAP 693
L H +++HRD+K N L+ +KI DFG S S R + GT +++ P
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPP 176
Query: 694 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 729
E+I EK D++SLGV+ +E G P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLV------GKPP 206
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 76/353 (21%), Positives = 134/353 (37%), Gaps = 82/353 (23%)
Query: 506 PMFQNKPLLAYE--EWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFL 556
P+ ++ L Y+ +W L +G +G G FG+V G VA+K+ L
Sbjct: 2 PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-L 60
Query: 557 EQDLTAENMEDFCNEIS---------------------------ILSRLRHPNVILFLGA 589
++ T +E+ I+ + N+ +L +
Sbjct: 61 KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
Query: 590 CTK--PPRLSMITEYMELGSLYHLIHLS-------------------------------- 615
P + + + I +
Sbjct: 121 KRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180
Query: 616 ----GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671
K L+ + + +G+ + K +HRDL + N L+++ VKICDFGL+
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 672 R-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVL 728
R I D A P +WMAPE I + +T + D++S GV++WE+ +L P+ GV
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
Query: 729 PERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 777
+ EG+R+ P+ + + + DCW EP +RP+ E++ L +
Sbjct: 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 523 FSELTVGTR-------------VGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENM---E 566
F EL T +G G FG V++G N T VA+K L + +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK-LAAMVDITTEELKQ 75
Query: 567 DFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 626
F EI ++++ +H N++ LG + L ++ YM GSL + LSW +
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 627 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-- 684
K+ + G+ +H +HRD+KSAN L+++ +T KI DFGL+R S +
Sbjct: 136 CKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR---ASEKFAQTVMT 192
Query: 685 ---AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 719
GT +MAPE +R E T K DI+S GV++ E+ T
Sbjct: 193 SRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIIT 229
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-39
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 522 DFSEL-TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL 578
FS+ V +G G F V R + T + A K+ + L+A + + E I +L
Sbjct: 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
+HPN++ + + ++ + + G L+ I ++ S ++ I +
Sbjct: 86 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIA 142
Query: 639 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPE 694
H IVHR+LK N L+ K VK+ DFGL+ + D AGTP +++PE
Sbjct: 143 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPE 200
Query: 695 LIRNEPFTEKCDIFSLGVIM 714
+++ +P+++ DI++ GVI+
Sbjct: 201 VLKKDPYSKPVDIWACGVIL 220
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEISI 574
++ ID ++ G +G G FG V+ R N +A+KV + L E +E EI I
Sbjct: 10 KFTIDDFDI--GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI 67
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
S LRHPN++ R+ ++ E+ G LY + + + +R + ++
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ---KHGRFDEQRSATFMEELA 124
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694
L H K++HRD+K N L+ +KI DFG S + S R + GT +++ PE
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRR-TMCGTLDYLPPE 182
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 729
+I + EK D++ GV+ +E G+ P
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLV------GMPP 211
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 522 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF----LEQDLTAENMEDFCNEISI 574
+ +G +G G F V + G + A K L + E+ E++I
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
L +RHPN+I + +I E + G L+ + +K+ L+ + L+ I
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---EKESLTEDEATQFLKQIL 118
Query: 635 RGLMCIHRMKIVHRDLKSANCL-VNKHW---TVKICDFGLSRII-TDSPMRDSSSAGTPE 689
G+ +H +I H DLK N + ++K+ +K+ DFG++ I + ++ GTPE
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI--FGTPE 176
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIM 714
++APE++ EP + D++S+GVI
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-38
Identities = 66/298 (22%), Positives = 114/298 (38%), Gaps = 51/298 (17%)
Query: 517 EEWNIDFSELTVGTRV-GIGFFGEV-FRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISI 574
+ L V ++ G G G V F+G + G VA+K L + + EI +
Sbjct: 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML-----IDFCDIALMEIKL 61
Query: 575 LSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLI----HLSGQKKKLSWRRKLKM 629
L+ HPNVI + + T L + E +L L+ K + +
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 630 LRDICRGLMCIHRMKIVHRDLKSANCLV-------------NKHWTVKICDFGLSRIITD 676
LR I G+ +H +KI+HRDLK N LV ++ + I DFGL + +
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 677 SPMRDSSS----AGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWELCTLNRP-- 723
++ +GT W APEL+ T DIFS+G + + + + +
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 724 WEGVLPERVVYAVANEGSRLEIPEGP---------LGRLIADCWAEPQERPSCEEILS 772
+ E + ++ + ++I +P +RP+ ++L
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMID---HDPLKRPTAMKVLR 295
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 63/270 (23%), Positives = 119/270 (44%), Gaps = 23/270 (8%)
Query: 520 NIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISI-LS 576
+ +L +G G +G V + +G +A+K + + ++ + ++ I +
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISMR 61
Query: 577 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
+ P + F GA + + + E M+ + + + + K+ I +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 637 LMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
L +H ++ ++HRD+K +N L+N VK+CDFG+S + D + AG +MAPE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMAPER 180
Query: 696 IRNE----PFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEGPL 750
I E ++ K DI+SLG+ M EL L P++ P + + V E P+ P
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE----PSPQLPA 236
Query: 751 GR-------LIADC-WAEPQERPSCEEILS 772
+ + C +ERP+ E++
Sbjct: 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 522 DFSEL-TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL 578
F+E + +G G FGEV + T + A+KV + ++ E+ +L +L
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
HPN++ ++ E G L+ I ++K+ S ++++ + G+
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGIT 135
Query: 639 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPE 694
+H+ IVHRDLK N L+ K +KI DFGLS ++ M+D GT ++APE
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPE 193
Query: 695 LIRNEPFTEKCDIFSLGVIM 714
++R + EKCD++S GVI+
Sbjct: 194 VLR-GTYDEKCDVWSAGVIL 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 47/193 (24%), Positives = 90/193 (46%), Gaps = 12/193 (6%)
Query: 527 TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+G G F EVF T A+K + + NEI++L +++H N++
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHENIV 69
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
++ + + G L+ I ++ + + +++ + + +H
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 645 IVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPF 701
IVHRDLK N L ++ + I DFGLS++ + M + GTP ++APE++ +P+
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA--CGTPGYVAPEVLAQKPY 184
Query: 702 TEKCDIFSLGVIM 714
++ D +S+GVI
Sbjct: 185 SKAVDCWSIGVIT 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 522 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF----LEQDLTAENMEDFCNEISI 574
+ +G +G G F V + G + A K + E+ E+SI
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
L ++ H NVI + +I E + G L+ + QK+ LS ++ I
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQIL 125
Query: 635 RGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPE 689
G+ +H KI H DLK N ++ +K+ DFGL+ I D ++ GTPE
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI--FGTPE 183
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIM 714
++APE++ EP + D++S+GVI
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-38
Identities = 50/199 (25%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 522 DFSEL-TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL 578
F+E + +G G F V R + + A + + L+A + + E I L
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
+HPN++ + ++ +I + + G L+ I ++ S ++ I ++
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVL 124
Query: 639 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
H+M +VHR+LK N L+ K VK+ DFGL+ + AGTP +++PE+
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 696 IRNEPFTEKCDIFSLGVIM 714
+R +P+ + D+++ GVI+
Sbjct: 185 LRKDPYGKPVDLWACGVIL 203
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-38
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 522 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF----LEQDLTAENMEDFCNEISI 574
+ + G +G G F V + G A K + + ED E+SI
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
L ++HPNVI + +I E + G L+ + +K+ L+ + L+ I
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQIL 124
Query: 635 RGLMCIHRMKIVHRDLKSANCL-VNKHW---TVKICDFGLSRIIT-DSPMRDSSSAGTPE 689
G+ +H ++I H DLK N + ++++ +KI DFGL+ I + ++ GTPE
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--FGTPE 182
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIM 714
++APE++ EP + D++S+GVI
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 58/270 (21%), Positives = 115/270 (42%), Gaps = 20/270 (7%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISI 574
+ + + ++L +G G G+V++ G +A+K + + E + ++ +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ-MRRSGNKEENKRILMDLDV 76
Query: 575 LSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 633
+ + P ++ G + + E M + + G + R KM I
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG---PIPERILGKMTVAI 133
Query: 634 CRGLMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMA 692
+ L + + ++HRD+K +N L+++ +K+CDFG+S + D SAG +MA
Sbjct: 134 VKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMA 192
Query: 693 PELI-----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGS-RLEI 745
PE I + + D++SLG+ + EL T P++ + V+ V E L
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG 252
Query: 746 PEG---PLGRLIADC-WAEPQERPSCEEIL 771
G + DC + ++RP ++L
Sbjct: 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 68/262 (25%), Positives = 107/262 (40%), Gaps = 32/262 (12%)
Query: 528 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMED-FCNEISILSRLRHPNVI 584
G +G G F + F A K+ + L + + EISI L H +V+
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
F G + ++ E SL L ++K L+ LR I G +HR +
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 704
++HRDLK N +N+ VKI DFGL+ + R GTP ++APE++ + + +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 705 CDIFSLGVIMWELCTLNRPWEGVLP----------ERVVYAVANEGSRLEIPE---GPLG 751
D++S+G IM+ L G P R+ IP+
Sbjct: 196 VDVWSIGCIMYTLLV------GKPPFETSCLKETYLRIKKN------EYSIPKHINPVAA 243
Query: 752 RLIADC-WAEPQERPSCEEILS 772
LI +P RP+ E+L+
Sbjct: 244 SLIQKMLQTDPTARPTINELLN 265
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 56/272 (20%), Positives = 102/272 (37%), Gaps = 31/272 (11%)
Query: 533 GIGFFGEVFRGIWNGTDVAIKVF---------------LEQDLTAENMEDFCNEISILSR 577
G F ++ + A+K + ++ +DF NE+ I++
Sbjct: 40 NQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSG-----QKKKLSWRRKLKMLRD 632
+++ + G T + +I EYME S+ + + +++
Sbjct: 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKS 159
Query: 633 ICRGLMCIHRMK-IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM 691
+ IH K I HRD+K +N L++K+ VK+ DFG S + D ++ S GT E+M
Sbjct: 160 VLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--GSRGTYEFM 217
Query: 692 APELIRNEPFT--EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP 749
PE NE K DI+SLG+ ++ + P+ + ++ +E P
Sbjct: 218 PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK-NIEYPLDR 276
Query: 750 LGRLIADCWAEPQER-----PSCEEILSRLLD 776
L + + L L
Sbjct: 277 NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLR 308
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 53/189 (28%), Positives = 92/189 (48%), Gaps = 10/189 (5%)
Query: 533 GIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH-PNVILFLGA 589
G G F V + I G + A K ++ + + +EI++L + P VI
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97
Query: 590 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 649
+ +I EY G ++ L L + +S +++++ I G+ +H+ IVH D
Sbjct: 98 YENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLD 156
Query: 650 LKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPELIRNEPFTEKC 705
LK N L+ +KI DFG+SR I +R+ GTPE++APE++ +P T
Sbjct: 157 LKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI--MGTPEYLAPEILNYDPITTAT 214
Query: 706 DIFSLGVIM 714
D++++G+I
Sbjct: 215 DMWNIGIIA 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-37
Identities = 65/266 (24%), Positives = 120/266 (45%), Gaps = 23/266 (8%)
Query: 522 DFSEL-TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRL 578
SE+ ++G G +GEV T AIK+ + ++ + E+++L L
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
HPN++ ++ E + G L+ I + K + +++ + G+
Sbjct: 94 DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVT 150
Query: 639 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
+H+ IVHRDLK N L+ K +KI DFGLS + + + GT ++APE+
Sbjct: 151 YLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-KMKERLGTAYYIAPEV 209
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP------ 749
+R + + EKCD++S+GVI++ L P+ G + ++ V + PE
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268
Query: 750 ---LGRLIADCWAEPQERPSCEEILS 772
+ +++ + Q R S ++ L
Sbjct: 269 KDLIKQMLQ---FDSQRRISAQQALE 291
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-37
Identities = 67/275 (24%), Positives = 112/275 (40%), Gaps = 41/275 (14%)
Query: 522 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 578
F+E + +G G FGEV + + A+KV + ++ E+ +L +L
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
HPN++ ++ E G L+ I ++K+ S ++++ + G+
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGIT 135
Query: 639 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRII-TDSPMRDSSSAGTPEWMAPE 694
+H+ IVHRDLK N L+ K +KI DFGLS ++ M+D GT ++APE
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPE 193
Query: 695 LIRNEPFTEKCDIFSLGVIMWE-LCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRL 753
++R + EKCD++S GVI++ L G P Y + G
Sbjct: 194 VLR-GTYDEKCDVWSAGVILYILLS-------GTPP---FYGKNEYDILKRVETGKY-AF 241
Query: 754 IADCWAE----------------PQERPSCEEILS 772
W P R + + L
Sbjct: 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-37
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 522 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF----LEQDLTAENMEDFCNEISI 574
+ +G +G G F V + G + A K E+ E+SI
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
L ++ HPN+I + +I E + G L+ + QK+ LS ++ I
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQIL 125
Query: 635 RGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPE 689
G+ +H KI H DLK N ++ +K+ DFGL+ I D ++ GTPE
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI--FGTPE 183
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIM 714
++APE++ EP + D++S+GVI
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 48/194 (24%), Positives = 88/194 (45%), Gaps = 14/194 (7%)
Query: 527 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
T+ +G G +GEV + A K + + E+++ F EI I+ L HPN+I
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNII 69
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
+ ++ E G L+ + K+ ++++D+ + H++
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 645 IVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPELIRNEP 700
+ HRDLK N L + +K+ DFGL+ MR GTP +++P+++
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVLEG-L 183
Query: 701 FTEKCDIFSLGVIM 714
+ +CD +S GV+M
Sbjct: 184 YGPECDEWSAGVMM 197
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 68/257 (26%), Positives = 108/257 (42%), Gaps = 22/257 (8%)
Query: 528 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMED-FCNEISILSRLRHPNVI 584
G +G G F + F A K+ + L + + EISI L H +V+
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
F G + ++ E SL L ++K L+ LR I G +HR +
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 704
++HRDLK N +N+ VKI DFGL+ + R GTP ++APE++ + + +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 705 CDIFSLGVIMWELCTLNRPWEGVLP-----ERVVYAVANEGSRLEIPE---GPLGRLIAD 756
D++S+G IM+ L G P + Y + IP+ LI
Sbjct: 222 VDVWSIGCIMYTLLV------GKPPFETSCLKETYLRIKKN-EYSIPKHINPVAASLIQK 274
Query: 757 C-WAEPQERPSCEEILS 772
+P RP+ E+L+
Sbjct: 275 MLQTDPTARPTINELLN 291
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 59/269 (21%), Positives = 113/269 (42%), Gaps = 29/269 (10%)
Query: 528 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAEN--MEDFCNEISILSRLRHPNV 583
+ ++G G V+ VAIK + + ++ F E+ S+L H N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKA-IFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 584 --ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 641
++ + L M EY+E +L I LS + I G+ H
Sbjct: 74 VSMIDVDEEDDCYYLVM--EYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAH 128
Query: 642 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-GTPEWMAPELIRNEP 700
M+IVHRD+K N L++ + T+KI DFG+++ ++++ + ++ GT ++ +PE + E
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 701 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP----------L 750
E DI+S+G++++E+ P+ G + + +P L
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD----SVPNVTTDVRKDIPQSL 244
Query: 751 GRLIADCWA-EPQERP-SCEEILSRLLDC 777
+I + R + +E+ L
Sbjct: 245 SNVILRATEKDKANRYKTIQEMKDDLSSV 273
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 15/194 (7%)
Query: 527 TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
V + +G G V+R GT A+KV + + EI +L RL HPN+I
Sbjct: 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNII 111
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
P +S++ E + G L+ I +K S R ++ I + +H
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 645 IVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPELIRNEP 700
IVHRDLK N L +KI DFGLS+I+ M+ GTP + APE++R
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV--CGTPGYCAPEILRGCA 226
Query: 701 FTEKCDIFSLGVIM 714
+ + D++S+G+I
Sbjct: 227 YGPEVDMWSVGIIT 240
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 527 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
++G G FG+V +G + IK + +D + ME EI +L L HPN+I
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKT-INKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
+ ++ E E G L I + K LS ++++ + L H
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 644 KIVHRDLKSANCLV---NKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPELIRNE 699
+VH+DLK N L + H +KI DFGL+ + D + +AGT +MAPE+ +
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMAPEVFK-R 200
Query: 700 PFTEKCDIFSLGVIM 714
T KCDI+S GV+M
Sbjct: 201 DVTFKCDIWSAGVVM 215
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 5/193 (2%)
Query: 528 VGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEISILSRLRHPNVI 584
VG +G G F V+ I G +VAIK+ ++ + M NE+ I +L+HP+++
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
+ ++ E G + + + K S + I G++ +H
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQIITGMLYLHSHG 132
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 704
I+HRDL +N L+ ++ +KI DFGL+ + + + GTP +++PE+ +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192
Query: 705 CDIFSLGVIMWEL 717
D++SLG + + L
Sbjct: 193 SDVWSLGCMFYTL 205
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 64/305 (20%), Positives = 108/305 (35%), Gaps = 62/305 (20%)
Query: 527 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHP 581
+ +G G +G V I AIK+ + + +++E E+ ++ +L HP
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 582 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL-------------- 627
N+ + ++ E G L +++ +
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 628 -----------------------KMLRDICRGLMCIHRMKIVHRDLKSANCLV--NKHWT 662
++R I L +H I HRD+K N L NK +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208
Query: 663 VKICDFGLSRIITDSPMRD----SSSAGTPEWMAPELIR--NEPFTEKCDIFSLGVIMWE 716
+K+ DFGLS+ + ++ AGTP ++APE++ NE + KCD +S GV++
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 717 LCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP---------LGRLIADCWAEPQERPSC 767
L P+ GV + V N+ E P L L+ ER
Sbjct: 269 LLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLN---RNVDERFDA 325
Query: 768 EEILS 772
L
Sbjct: 326 MRALQ 330
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-36
Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 13/279 (4%)
Query: 443 HDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKV 502
H SG NL M + S +E S + S+ S
Sbjct: 6 HHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVD 65
Query: 503 LESP--MFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQ 558
+ +P F ++ + A + F ++ +G G FG+V + T +A K+ +
Sbjct: 66 IPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR 125
Query: 559 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK 618
+ ++ E+ NEIS++++L H N+I A + ++ EY++ G L+ I +
Sbjct: 126 GM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--IDES 181
Query: 619 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--VKICDFGLSRIIT- 675
L+ + ++ IC G+ +H+M I+H DLK N L +KI DFGL+R
Sbjct: 182 YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 676 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIM 714
++ + GTPE++APE++ + + D++S+GVI
Sbjct: 242 REKLKVN--FGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 47/199 (23%), Positives = 86/199 (43%), Gaps = 13/199 (6%)
Query: 522 DFSEL-TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL 578
+ E + +G G FG V R + + K + + EISIL+
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIA 58
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
RH N++ + L MI E++ ++ I+ S + L+ R + + +C L
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQ 116
Query: 639 CIHRMKIVHRDLKSAN--CLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPEL 695
+H I H D++ N + T+KI +FG +R + R PE+ APE+
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEV 174
Query: 696 IRNEPFTEKCDIFSLGVIM 714
+++ + D++SLG ++
Sbjct: 175 HQHDVVSTATDMWSLGTLV 193
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 527 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF------LEQDLTAENMEDFCNEISILSRL 578
+ +G G GEV VAI++ + A+ + EI IL +L
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
HP +I ++ E ME G L+ + K+L + +
Sbjct: 198 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQ 253
Query: 639 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPE 694
+H I+HRDLK N L+ + +KI DFG S+I+ + S MR GTP ++APE
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPE 311
Query: 695 LIRN---EPFTEKCDIFSLGVIM 714
++ + + D +SLGVI+
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-35
Identities = 71/268 (26%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 522 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDL-TAENMEDFCNEISILSR 577
FS+ +G G FGEV G + A+KV ++ + + E E+ +L +
Sbjct: 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
L HPN++ ++ E G L+ I +K+ S +++R + G+
Sbjct: 83 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGI 139
Query: 638 MCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDS-PMRDSSSAGTPEWMAP 693
+H+ KIVHRDLK N L+ +K ++I DFGLS S M+D GT ++AP
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAP 197
Query: 694 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP---- 749
E++ + EKCD++S GVI++ L + P+ G ++ V E+P+
Sbjct: 198 EVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256
Query: 750 -----LGRLIADCWAEPQERPSCEEILS 772
+ +++ P R S + L
Sbjct: 257 SAKDLIRKMLT---YVPSMRISARDALD 281
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 49/210 (23%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 522 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF------LEQDLTAENMEDFCNEI 572
+F + +G G V R + G + A+K+ L + E E E
Sbjct: 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET 150
Query: 573 SILSRLR-HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 631
IL ++ HP++I + + + ++ + M G L+ + +K LS + ++R
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMR 207
Query: 632 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEW 690
+ + +H IVHRDLK N L++ + +++ DFG S + +R+ GTP +
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGTPGY 265
Query: 691 MAPELIR------NEPFTEKCDIFSLGVIM 714
+APE+++ + + ++ D+++ GVI+
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 522 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF-------LEQDLTAENMEDFCNE 571
F E +G G V R I + A+K+ + E E E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 572 ISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 630
+ IL ++ HPN+I ++ + M+ G L+ + +K LS + K++
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIM 130
Query: 631 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD-SPMRDSSSAGTPE 689
R + + +H++ IVHRDLK N L++ +K+ DFG S + +R+ GTP
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPS 188
Query: 690 WMAPELIR------NEPFTEKCDIFSLGVIM 714
++APE+I + + ++ D++S GVIM
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 527 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF------LEQDLTAENMEDFCNEISILSRL 578
+ +G G GEV VAIK+ + A+ + EI IL +L
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
HP +I ++ E ME G L+ + K+L + +
Sbjct: 73 NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQ 128
Query: 639 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPE 694
+H I+HRDLK N L+ + +KI DFG S+I+ + S MR GTP ++APE
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPE 186
Query: 695 LIRN---EPFTEKCDIFSLGVIM 714
++ + + D +SLGVI+
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 56/193 (29%), Positives = 90/193 (46%), Gaps = 11/193 (5%)
Query: 527 TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+ +G G FG V R + T K + NEISI+++L HP +I
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLI 111
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
A + +I E++ G L+ I + + K+S + +R C GL +H
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 645 IVHRDLKSAN--CLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPELIRNEPF 701
IVH D+K N C K +VKI DFGL+ + D ++ + T E+ APE++ EP
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPV 227
Query: 702 TEKCDIFSLGVIM 714
D++++GV+
Sbjct: 228 GFYTDMWAIGVLG 240
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-35
Identities = 57/251 (22%), Positives = 99/251 (39%), Gaps = 15/251 (5%)
Query: 470 PSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSEL-TV 528
G E+G + +P+ + + +
Sbjct: 105 DERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD---HVLDHYDI 161
Query: 529 GTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 586
+G G FG V R T + A K + + E EI +S LRHP ++
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
A + MI E+M G L+ + + + K+S ++ +R +C+GL +H V
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 647 HRDLKSAN--CLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPELIRNEPFTE 703
H DLK N + +K+ DFGL+ + ++ + GT E+ APE+ +P
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGY 335
Query: 704 KCDIFSLGVIM 714
D++S+GV+
Sbjct: 336 YTDMWSVGVLS 346
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 10/213 (4%)
Query: 512 PLLAYEEWNIDFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAE---NM 565
+L + ++ F ++ + +G G F V R I G A+K+ T+ +
Sbjct: 11 GILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 566 EDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK-KKLSWR 624
ED E SI L+HP+++ L + L M+ E+M+ L I S
Sbjct: 71 EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 625 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRD 681
+R I L H I+HRD+K L+ VK+ FG++ + +S +
Sbjct: 131 VASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190
Query: 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIM 714
GTP +MAPE+++ EP+ + D++ GVI+
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 43/291 (14%), Positives = 92/291 (31%), Gaps = 44/291 (15%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFC 569
E+ + + V +G G F +V+ + +KV + +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT-- 115
Query: 570 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ--KKKLSWRRKL 627
+ L + F A ++ E G+L + I+L +K + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 628 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT-----------VKICDFGLSRIITD 676
+ + +H +I+H D+K N ++ + + + D G S +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 677 SP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 734
P ++ T + E++ N+P+ + D F + ++ + G +
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF------GTYMK---- 285
Query: 735 AVANEGSRLEIPEGPLGRLIADCWAE---------PQERPSCEEILSRLLD 776
V NEG + D W E ++L + L
Sbjct: 286 -VKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 14/188 (7%)
Query: 533 GIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGA 589
G G F + + + A+K+ ++ + EI+ L HPN++
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKIISKRME-----ANTQKEITALKLCEGHPNIVKLHEV 74
Query: 590 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 649
++ E + G L+ I +KK S ++R + + +H + +VHRD
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIK---KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 650 LKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 706
LK N L N + +KI DFG +R+ + T + APEL+ + E CD
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCD 191
Query: 707 IFSLGVIM 714
++SLGVI+
Sbjct: 192 LWSLGVIL 199
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 72/279 (25%), Positives = 114/279 (40%), Gaps = 49/279 (17%)
Query: 527 TVGTRVGIGFFGEVFRGIWNGTD--VAIKV-----------FLEQDLTAENMEDFCNEIS 573
++G G +GEV AIKV + + E+ NEIS
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 574 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 633
+L L HPN+I ++TE+ E G L+ I + K +++ I
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQI 155
Query: 634 CRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRII-TDSPMRDSSSAGTPE 689
G+ +H+ IVHRD+K N L+ N +KI DFGLS D +RD GT
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--RLGTAY 213
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP 749
++APE+++ + + EKCD++S GVIM+ L G P ++ ++ +G
Sbjct: 214 YIAPEVLK-KKYNEKCDVWSCGVIMYILLC------GYPP---FGGQNDQDIIKKVEKGK 263
Query: 750 LGRLIADCWAE----------------PQERPSCEEILS 772
+ W +R + EE L+
Sbjct: 264 Y-YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 5e-33
Identities = 35/292 (11%), Positives = 71/292 (24%), Gaps = 48/292 (16%)
Query: 526 LTVGTRVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSRLRHPN 582
L + + +G VF A+KVF + + + +E +RL +
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 583 V-----------------------ILFLGACTKPPRLSMITEYMEL--GSLYHLIHL--- 614
L ++ M L L
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183
Query: 615 -SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673
+ + + R + +VH N + + + D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 674 ITDSPMRDSSSAGTPEWMAPELI--RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-- 729
+ R +S+ + E + FT + + LG+ ++ + L P+ V P
Sbjct: 244 VGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 730 -ERVVYAVANEGSRLEIPEGPLGRLIADCWA--------EPQERPSCEEILS 772
+ G L + + R E +
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-33
Identities = 41/288 (14%), Positives = 82/288 (28%), Gaps = 43/288 (14%)
Query: 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVF-LEQDLTAENMEDFCNEISILSRLR--- 579
L GT +G G + V + + ++ E+ L LR
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 580 ----------------------HPNVILFLGACTKPPRLS----MITEYMELGSLY-HLI 612
+I LS L + L+
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 613 HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672
S K L +L++ + R L +H +VH L+ + ++++ V + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 673 IITDSPMRDSSSA-GTPEWMAPELIRNEP-----FTEKCDIFSLGVIMWELCTLNRPWEG 726
S + PE A ++ T D ++LG+ ++ + + P
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 727 VLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSR 773
+ IP+ P+ L+ ++R + +
Sbjct: 320 DAALGGSEWIFRS--CKNIPQ-PVRALLEGFLRYPKEDRLLPLQAMET 364
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 68/271 (25%), Positives = 126/271 (46%), Gaps = 28/271 (10%)
Query: 528 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAEN--MEDFCNEISILSRLRHPNV 583
+G +G G EV + + DVA+KV L DL + F E + L HP +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKV-LRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 584 I------LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
+ P + M EY++ +L ++H + ++ +R ++++ D C+ L
Sbjct: 75 VAVYDTGEAETPAGPLPYIVM--EYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQAL 129
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS--PMRDSSSA-GTPEWMAPE 694
H+ I+HRD+K AN +++ VK+ DFG++R I DS + +++ GT ++++PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE------GSRLEIPEG 748
R + + D++SLG +++E+ T P+ G P V Y E +
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA- 248
Query: 749 PLGRLIADCWA-EPQERP-SCEEILSRLLDC 777
L ++ A P+ R + E+ + L+
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRV 279
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 533 GIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGA 589
G G V I + A+K+ +Q E+ +L + + H NV+ +
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 590 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 649
+ R ++ E M GS+ IH +++ + +++D+ L +H I HRD
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 650 LKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSS-------AGTPEWMAPELIR-- 697
LK N L N+ VKICDF L I + S G+ E+MAPE++
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 698 ---NEPFTEKCDIFSLGVIM 714
+ ++CD++SLGVI+
Sbjct: 197 SEEASIYDKRCDLWSLGVIL 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-32
Identities = 58/260 (22%), Positives = 99/260 (38%), Gaps = 27/260 (10%)
Query: 528 VGTRVGIGFFGEVFRG---IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
V + G G ++ NG V +K L AE E L+ + HP+++
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKG-LVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 585 LFLGACTKPPRLSMITEY--MEL---GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
R Y ME SL +KL + L +I L
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSY 197
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 699
+H + +V+ DLK N ++ + +K+ D G I GTP + APE++R
Sbjct: 198 LHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTG 252
Query: 700 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA 759
P T DI+++G + L G + + + L+ + GRL+
Sbjct: 253 P-TVATDIYTVGRTLAALTLDLPTRNGRYVD----GLPEDDPVLKTYD-SYGRLLRRAID 306
Query: 760 -EPQERP-SCEEILSRLLDC 777
+P++R + EE+ ++L
Sbjct: 307 PDPRQRFTTAEEMSAQLTGV 326
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 53/195 (27%), Positives = 91/195 (46%), Gaps = 16/195 (8%)
Query: 527 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNV 583
V +G+G + R I + A+K+ ++ D EI IL R +HPN+
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQHPNI 78
Query: 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
I + ++TE M+ G L I ++K S R +L I + + +H
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 644 KIVHRDLKSANCLVNKH----WTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 699
+VHRDLK +N L +++ICDFG ++ + + T ++APE++ +
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195
Query: 700 PFTEKCDIFSLGVIM 714
+ CDI+SLGV++
Sbjct: 196 GYDAACDIWSLGVLL 210
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 20/192 (10%)
Query: 533 GIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGA 589
G+G G+V G A+K+ + E+ + P+++ L
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIVCILDV 90
Query: 590 C----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
L +I E ME G L+ I G + + R +++RDI + +H I
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFLHSHNI 149
Query: 646 VHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 702
HRD+K N L K +K+ DFG ++ T + ++ TP ++APE++ E +
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP--CYTPYYVAPEVLGPEKYD 207
Query: 703 EKCDIFSLGVIM 714
+ CD++SLGVIM
Sbjct: 208 KSCDMWSLGVIM 219
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 68/255 (26%), Positives = 114/255 (44%), Gaps = 29/255 (11%)
Query: 533 GIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 590
G G F +V I G +VAIK+ + L +++ E+ I+ L HPN++
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 591 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 650
L +I EY G ++ + ++ + R I + H+ +IVHRDL
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDL 140
Query: 651 KSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT-EKCDIFS 709
K+ N L++ +KI DFG S T + G P + APEL + + + + D++S
Sbjct: 141 KAENLLLDADMNIKIADFGFSNEFTVGGKL-DAFCGAPPYAAPELFQGKKYDGPEVDVWS 199
Query: 710 LGVIMWELCTLNRPWEG----VLPERVVYAVANEGSRLEIPEGPLGRLIADCW------- 758
LGVI++ L + + P++G L ERV+ + IP + DC
Sbjct: 200 LGVILYTLVSGSLPFDGQNLKELRERVLRG------KYRIPFY----MSTDCENLLKRFL 249
Query: 759 -AEPQERPSCEEILS 772
P +R + E+I+
Sbjct: 250 VLNPIKRGTLEQIMK 264
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 64/270 (23%), Positives = 111/270 (41%), Gaps = 31/270 (11%)
Query: 527 TVGTRVGIGFFGEVFRGIWNGTD------VAIKVFLEQDLTAENM--EDFCNEISILSRL 578
+ VG G G+V+ D VA+K+ + + L+++ + E RL
Sbjct: 37 RLRRLVGRGGMGDVYEA----EDTVRERIVALKL-MSETLSSDPVFRTRMQREARTAGRL 91
Query: 579 RHPNV--ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
+ P+V I G + M + L ++ G L+ R + ++R I
Sbjct: 92 QEPHVVPIHDFGEIDGQLYVDM--RLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSA 146
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-GTPEWMAPEL 695
L H HRD+K N LV+ + DFG++ TD + + GT +MAPE
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE------GSRLEIPEGP 749
T + DI++L +++E T + P++G V+ A N+ R IP
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQGD-QLSVMGAHINQAIPRPSTVRPGIPVA- 264
Query: 750 LGRLIADCWA-EPQER-PSCEEILSRLLDC 777
+IA A P++R +C ++ +
Sbjct: 265 FDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 66/287 (22%), Positives = 115/287 (40%), Gaps = 61/287 (21%)
Query: 527 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVF-----------------------LEQDLT 561
T+ +G G +G V + T A+KV +
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 562 AENMEDFC-NEISILSRLRHPNVI-LF--LGACTKPPRLSMITEYMELGSLYHLIHLSGQ 617
+ EI+IL +L HPNV+ L L + L M+ E + G + +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVP----T 130
Query: 618 KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677
K LS + +D+ +G+ +H KI+HRD+K +N LV + +KI DFG+S S
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 678 PMRDSSSAGTPEWMAPELIRNEPFT---EKCDIFSLGVIMWELCTLNRPWEGVLP----- 729
S++ GTP +MAPE + + D++++GV ++ G P
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF------GQCPFMDER 244
Query: 730 ERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLD 776
+++ LE P+ +P +++++R+LD
Sbjct: 245 IMCLHSKIKSQ-ALEFPD------------QPDIAEDLKDLITRMLD 278
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 56/249 (22%), Positives = 100/249 (40%), Gaps = 22/249 (8%)
Query: 533 GIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 590
G G +GEV VA+K+ ++ + E+ EI I L H NV+ F G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 591 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 650
+ + EY G L+ I + + + G++ +H + I HRD+
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131
Query: 651 KSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFT-EKCDI 707
K N L+++ +KI DFGL+ + + + GT ++APEL++ F E D+
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 708 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQERPSC 767
+S G+++ + PW+ Y+ E P + +
Sbjct: 192 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID-------------SAP 238
Query: 768 EEILSRLLD 776
+L ++L
Sbjct: 239 LALLHKILV 247
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 48/256 (18%), Positives = 104/256 (40%), Gaps = 30/256 (11%)
Query: 470 PSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVG 529
P+ P + + + + ++ + +N + Y+
Sbjct: 17 PAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYK---------VTS 67
Query: 530 TRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 586
+G+G G+V + A+K+ ++ E+ + R + P+++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRI 120
Query: 587 LGAC----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
+ L ++ E ++ G L+ I G + + R ++++ I + +H
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS 179
Query: 643 MKIVHRDLKSANCLV---NKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPELIRN 698
+ I HRD+K N L + +K+ DFG ++ T + + TP ++APE++
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLGP 237
Query: 699 EPFTEKCDIFSLGVIM 714
E + + CD++SLGVIM
Sbjct: 238 EKYDKSCDMWSLGVIM 253
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 43/293 (14%), Positives = 85/293 (29%), Gaps = 52/293 (17%)
Query: 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVF-LEQDLTAENMEDFCNEISILSRLR-- 579
L GT +G G + V + + ++ E+ L LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 580 -----------------------HPNVILFLGACTKPPRLS----MITEYMELGSLY-HL 611
+I LS L + L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 612 IHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671
+ S K L +L++ + R L +H +VH L+ + ++++ V + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 672 RIITDSPMRDSSSAGTPEWMAPELI-----------RNEPFTEKCDIFSLGVIMWELCTL 720
S+ + + PEL R T D ++LG++++ +
Sbjct: 254 VRDG----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 721 NRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILS 772
+ P + S IP+ P+ L+ ++R + +
Sbjct: 310 DLPITKDAALGGSEWIFR--SCKNIPQ-PVRALLEGFLRYPKEDRLLPLQAME 359
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 56/249 (22%), Positives = 100/249 (40%), Gaps = 22/249 (8%)
Query: 533 GIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 590
G G +GEV VA+K+ ++ + E+ EI I L H NV+ F G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 591 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 650
+ + EY G L+ I + + + G++ +H + I HRD+
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131
Query: 651 KSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFT-EKCDI 707
K N L+++ +KI DFGL+ + + + GT ++APEL++ F E D+
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 708 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQERPSC 767
+S G+++ + PW+ Y+ E P + +
Sbjct: 192 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID-------------SAP 238
Query: 768 EEILSRLLD 776
+L ++L
Sbjct: 239 LALLHKILV 247
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 527 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCN-EISILSRLRHPNV 583
+G +G+G FG+V G G VA+K+ Q + + ++ EI L RHP++
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
I + P M+ EY+ G L+ I + ++ ++ + I + HR
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT- 702
+VHRDLK N L++ H KI DFGLS +++D +S G+P + APE+I +
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-TSCGSPNYAAPEVISGRLYAG 189
Query: 703 EKCDIFSLGVIMWELCTLNRPWEGVLP 729
+ DI+S GVI++ L G LP
Sbjct: 190 PEVDIWSCGVILYALLC------GTLP 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDF-CNEISILSRL 578
DF + +G G F V R + + AIK+ ++ + EN + E ++SRL
Sbjct: 31 DFKFGKI---LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD------ 632
HP + +L Y + G L ++ RK+ +
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK--YI----------RKIGSFDETCTRFY 135
Query: 633 ---ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD--SPMRDSSSAGT 687
I L +H I+HRDLK N L+N+ ++I DFG +++++ R +S GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 688 PEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 719
++++PEL+ + + D+++LG I+++L
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 46/201 (22%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 527 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCN------EISILSRL 578
+ + +G G FG V+ +V +K ++ + + + EI+ILSR+
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGS-LYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
H N+I L ++ E G L+ I + +L + R + +
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAV 143
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 697
+ I+HRD+K N ++ + +T+K+ DFG + + + + GT E+ APE++
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY-TFCGTIEYCAPEVLM 202
Query: 698 NEPFT-EKCDIFSLGVIMWEL 717
P+ + +++SLGV ++ L
Sbjct: 203 GNPYRGPELEMWSLGVTLYTL 223
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 58/261 (22%), Positives = 107/261 (40%), Gaps = 28/261 (10%)
Query: 527 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCN----EISILSRLRH 580
VG +G G FG V+ G + + VAIK + ++ E+ +L ++
Sbjct: 46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 581 --PNVILFLGACTKPPRLSMITEYME-LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
VI L +P +I E E + L+ I ++ L + +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAV 162
Query: 638 MCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
H ++HRD+K N L++ +K+ DFG ++ D+ D GT + PE I
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD--FDGTRVYSPPEWI 220
Query: 697 RNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP---LGR 752
R + ++SLG++++++ + P+E E ++ ++ +
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRG------QVFFRQRVSSECQH 272
Query: 753 LIADC-WAEPQERPSCEEILS 772
LI C P +RP+ EEI +
Sbjct: 273 LIRWCLALRPSDRPTFEEIQN 293
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 527 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+G G FG R VA+K EN++ EI LRHPN++
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIV 79
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
F P L++I EY G LY I + S + + G+ H M+
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERI---CNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 645 IVHRDLKSANCLVNKHWT--VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 702
I HRDLK N L++ +KICDFG S+ S+ GTP ++APE++ + +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRQEYD 195
Query: 703 -EKCDIFSLGVIMWELCTLNRPWEGVLP 729
+ D++S GV ++ + G P
Sbjct: 196 GKIADVWSCGVTLYVMLV------GAYP 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 9/210 (4%)
Query: 522 DFSELTVGTRVGIGFFGEVFRGIWNGTDV--AIKVFLEQDLTAENMEDFC--NEISILSR 577
F + V +G G FGEVF T A K L + + E IL++
Sbjct: 186 WFLDFRV---LGRGGFGEVFACQMKATGKLYACKK-LNKKRLKKRKGYQGAMVEKKILAK 241
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICRG 636
+ ++ A L ++ M G + YH+ ++ R + I G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
L +H+ I++RDLK N L++ V+I D GL+ + + AGTP +MAPEL+
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
E + D F+LGV ++E+ P+
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 528 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCN-EISILSRLRHPNVI 584
+ +G G FG+V VA+K Q L +M EIS L LRHP++I
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
T P + M+ EY G L+ I +KK+++ + + I + HR K
Sbjct: 73 KLYDVITTPTDIVMVIEYAG-GELFDYI---VEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT-E 703
IVHRDLK N L++ + VKI DFGLS I+TD +S G+P + APE+I + +
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK-TSCGSPNYAAPEVINGKLYAGP 187
Query: 704 KCDIFSLGVIMWELCTLNRPWEGVLP 729
+ D++S G++++ + G LP
Sbjct: 188 EVDVWSCGIVLYVMLV------GRLP 207
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 65/263 (24%), Positives = 107/263 (40%), Gaps = 30/263 (11%)
Query: 527 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFL-EQDLTAENMEDFCN---EISILSRLR- 579
+G +G G FG VF G + + VAIKV + L + D E+++L ++
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 580 ---HPNVILFLGACTKPPRLSMITEYMELGS-LYHLIHLSGQKKKLSWRRKLKMLRDICR 635
HP VI L ++ E L+ I +K L +
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT---EKGPLGEGPSRCFFGQVVA 150
Query: 636 GLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694
+ H +VHRD+K N L++ + K+ DFG ++ D P D GT + PE
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD--FDGTRVYSPPE 208
Query: 695 LIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP---L 750
I + ++SLG++++++ + P+E + ++ + L P
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERD--QEIL------EAELHFPAHVSPDC 260
Query: 751 GRLIADC-WAEPQERPSCEEILS 772
LI C +P RPS EEIL
Sbjct: 261 CALIRRCLAPKPSSRPSLEEILL 283
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 62/194 (31%), Positives = 101/194 (52%), Gaps = 8/194 (4%)
Query: 528 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCN-EISILSRLRHPNVI 584
+G +G+G FG+V G G VA+K+ Q + + ++ EI L RHP++I
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
+ P + M+ EY+ G L+ I + +L + ++ + I G+ HR
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT-E 703
+VHRDLK N L++ H KI DFGLS +++D +S G+P + APE+I +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-TSCGSPNYAAPEVISGRLYAGP 195
Query: 704 KCDIFSLGVIMWEL 717
+ DI+S GVI++ L
Sbjct: 196 EVDIWSSGVILYAL 209
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 28/207 (13%)
Query: 531 RVGIGFFGEVFRG--IWNGTDVAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 582
++G G +G VF+ VA+K V L+ D +A EI +L L+H N
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA------LREICLLKELKHKN 62
Query: 583 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
++ +L+++ E+ + L + L + +GL H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF--LFQLLKGLGFCHS 119
Query: 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APE-LI 696
++HRDLK N L+N++ +K+ +FGL+R P+R + E W P+ L
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVR----CYSAEVVTLWYRPPDVLF 174
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRP 723
+ ++ D++S G I EL RP
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-27
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 10/209 (4%)
Query: 522 DFSELTVGTRVGIGFFGEVFRGIWNGTDV--AIKVFLEQDLTAENMEDFC--NEISILSR 577
F + V +G G FGEV T A K LE+ + + NE IL +
Sbjct: 185 TFRQYRV---LGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEK 240
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
+ V+ A L ++ M G L I+ G + R + +IC GL
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGL 299
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 697
+HR +IV+RDLK N L++ H ++I D GL+ + + GT +MAPE+++
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVK 358
Query: 698 NEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
NE +T D ++LG +++E+ P++
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQ 387
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 528 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLT-AENMEDFCN-EISILSRLRHPNV 583
+G +G G +G+V A+K+ ++ L N E EI +L RLRH NV
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 584 I-LF--LGACTKPPRLSMITEYMELGS--LYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
I L L K ++ M+ EY G + + +K+ + + GL
Sbjct: 69 IQLVDVLYNEEKQ-KMYMVMEYCVCGMQEMLDSV----PEKRFPVCQAHGYFCQLIDGLE 123
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELI 696
+H IVH+D+K N L+ T+KI G++ + D +S G+P + PE+
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 697 RN-EPFT-EKCDIFSLGVIMWELCTLNRPWEGVLP 729
+ F+ K DI+S GV ++ + T G+ P
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITT------GLYP 212
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-26
Identities = 56/263 (21%), Positives = 109/263 (41%), Gaps = 25/263 (9%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 578
DF L V +G G FGEV + A+K+ + ++ F E +L
Sbjct: 75 DFEILKV---IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
+ A L ++ +Y G L LS + +L L ++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT--LLSKFEDRLPEEMARFYLAEMVIAID 189
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR 697
+H++ VHRD+K N L++ + +++ DFG +++ D ++ S + GTP++++PE+++
Sbjct: 190 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 698 NEPFTEK-----CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR 752
+ CD +SLGV M+E+ P+ + N R + P
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV--- 306
Query: 753 LIADCWAEPQERPSCEEILSRLL 775
+ ++++ RL+
Sbjct: 307 --------TDVSENAKDLIRRLI 321
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 28/203 (13%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQD-----LTAENMEDFCNEISILSRLRHPN 582
++G G +G VF+ T VAIK F +D A EI +L +L+HPN
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA------LREIRMLKQLKHPN 63
Query: 583 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
++ L + RL ++ EY + ++ H + + + + + + H+
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSI--TWQTLQAVNFCHK 120
Query: 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APE-LI 696
+HRD+K N L+ KH +K+CDFG +R++T P E W +PE L+
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSD----YYDDEVATRWYRSPELLV 175
Query: 697 RNEPFTEKCDIFSLGVIMWELCT 719
+ + D++++G + EL +
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLS 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 36/213 (16%)
Query: 531 RVGIGFFGEVFRG--IWNGTDVAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 582
++G G FGEVF+ G VA+K V +E + +TA EI IL L+H N
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA------LREIKILQLLKHEN 77
Query: 583 VILFLGACT--------KPPRLSMITEYME--LGSLYHLIHLSGQKKKLSWRRKLKMLRD 632
V+ + C + ++ ++ E L L LS K + ++++
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL-----LSNVLVKFTLSEIKRVMQM 132
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE--- 689
+ GL IHR KI+HRD+K+AN L+ + +K+ DFGL+R + T
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF-SLAKNSQPNRYTNRVVT 191
Query: 690 -WM-APELIRNEP-FTEKCDIFSLGVIMWELCT 719
W PEL+ E + D++ G IM E+ T
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 56/236 (23%), Positives = 106/236 (44%), Gaps = 15/236 (6%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 578
D+ + V +G G FGEV R A+K+ + ++ + F E I++
Sbjct: 70 DYEVVKV---IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
P V+ A L M+ EYM G L +L+ + + ++ L
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWARFYTAEVVLALD 182
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR 697
IH M +HRD+K N L++K +K+ DFG ++ + +R ++ GTP++++PE+++
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 698 NEPFTEK----CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP 749
++ CD +S+GV ++E+ + P+ + N + L P+
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 55/243 (22%), Positives = 102/243 (41%), Gaps = 24/243 (9%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 578
DF L V +G G F EV + G A+K+ + D+ + F E +L
Sbjct: 62 DFEILKV---IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR----DIC 634
+ A L ++ EY G L LS +++ +M R +I
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLT--LLSKFGERIP----AEMARFYLAEIV 172
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAP 693
+ +HR+ VHRD+K N L+++ +++ DFG ++ D +R + GTP++++P
Sbjct: 173 MAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 694 ELIRNE-------PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 746
E+++ + +CD ++LGV +E+ P+ + + L +P
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292
Query: 747 EGP 749
Sbjct: 293 LVD 295
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 28/203 (13%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQD-----LTAENMEDFCNEISILSRLRHPN 582
VG G +G V + T VAIK F D A EI +L +LRH N
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA------MREIKLLKQLRHEN 85
Query: 583 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
++ L C K R ++ E+++ ++ + L L ++ K L I G+ H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHS 142
Query: 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APE-LI 696
I+HRD+K N LV++ VK+CDFG +R + +P E W APE L+
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGE----VYDDEVATRWYRAPELLV 197
Query: 697 RNEPFTEKCDIFSLGVIMWELCT 719
+ + + D++++G ++ E+
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFM 220
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 531 RVGIGFFGEVFRG--IWNGTDVAIK-VFLEQD----LTAENMEDFCNEISILSRLRHPNV 583
++G G + V++G G VA+K V L+ + TA EIS++ L+H N+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA------IREISLMKELKHENI 65
Query: 584 ILFLGACTKPPRLSMITEYME--LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 641
+ +L+++ E+M+ L + + L + +GL H
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 642 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APELI 696
KI+HRDLK N L+NK +K+ DFGL+R P+ + E W AP+++
Sbjct: 126 ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVN----TFSSEVVTLWYRAPDVL 180
Query: 697 RNEPF-TEKCDIFSLGVIMWELCTLNRP 723
+ DI+S G I+ E+ T +P
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMIT-GKP 207
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 39/225 (17%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIK---VFLEQDLTAENMEDFCN-- 570
+NI S+ + + +G G +G V G VAIK F F
Sbjct: 6 VYNIS-SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPL------FALRT 56
Query: 571 --EISILSRLRHPNVILFLGACTKPPRLSM-----ITEYMELGSLYHLIHLSGQKKKLSW 623
EI IL +H N+I + I E M+ L+ +I S Q LS
Sbjct: 57 LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI--STQM--LSD 111
Query: 624 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 683
+ R + +H ++HRDLK +N L+N + +K+CDFGL+RII +S +S
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 684 SAGTPEWM----------APELIRN-EPFTEKCDIFSLGVIMWEL 717
G M APE++ ++ D++S G I+ EL
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 582
++G G +G V++ N A+K + LE++ T EISIL L+H N
Sbjct: 9 KIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTT------IREISILKELKHSN 61
Query: 583 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
++ RL ++ E+++ L L+ + + + L + G+ H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF--LLQLLNGIAYCHD 118
Query: 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APELIR 697
+++HRDLK N L+N+ +KI DFGL+R P+R T E W AP+++
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVR----KYTHEIVTLWYRAPDVLM 173
Query: 698 NEPF-TEKCDIFSLGVIMWELCTLNRP 723
+ DI+S+G I E+ P
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVN-GTP 199
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 73/303 (24%), Positives = 114/303 (37%), Gaps = 56/303 (18%)
Query: 472 SPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTR 531
S HE + G+ ++ S+ K S + +W I +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIP-DRYEIRHL 60
Query: 532 VGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCN----EISILSRLRHP 581
+G G +G V VAIK VF +DL C EI+IL+RL H
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLI------DCKRILREIAILNRLNHD 112
Query: 582 NVILFLGACTKPPRLS-----MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
+V+ L ++ E + L + L+ +L ++ G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR-TPVY--LTELHIKTLLYNLLVG 168
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM----- 691
+ +H I+HRDLK ANCLVN+ +VK+CDFGL+R + +S +P
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 692 ----------------------APELIRNEP-FTEKCDIFSLGVIMWELCTLNRPWEGVL 728
APELI + +TE D++S+G I EL + +
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 729 PER 731
+R
Sbjct: 289 ADR 291
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 29/203 (14%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 582
+VG G +G V++ + VA+K + L+ + TA EIS+L L HPN
Sbjct: 28 KVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTA------IREISLLKELHHPN 80
Query: 583 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
++ + L+++ E+ME L ++ + + S + L + RG+ H+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIY--LYQLLRGVAHCHQ 137
Query: 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APE-LI 696
+I+HRDLK N L+N +K+ DFGL+R P+R T E W AP+ L+
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSY----THEVVTLWYRAPDVLM 192
Query: 697 RNEPFTEKCDIFSLGVIMWELCT 719
++ ++ DI+S+G I E+ T
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMIT 215
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 41/208 (19%)
Query: 531 RVGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCN----EISILSRLRH 580
+G G G V +VAIK F Q+ T E+ ++ + H
Sbjct: 32 PIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQT------HAKRAYRELVLMKCVNH 83
Query: 581 PNVILFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
N+I L T L ++ E M+ +L +I + +L R +L +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI-----QMELDHERMSYLLYQML 137
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM--- 691
G+ +H I+HRDLK +N +V T+KI DFGL+R +S TP +
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTPYVVTRY 191
Query: 692 --APELIRNEPFTEKCDIFSLGVIMWEL 717
APE+I + E DI+S+G IM E+
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEM 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 47/241 (19%)
Query: 504 ESPMFQNKPLLAYEEWNIDFSELTVGTR------VGIGFFGEVFRGI--WNGTDVAIK-- 553
M ++K + + S TV R +G G G V +VAIK
Sbjct: 36 HYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL 95
Query: 554 --VFLEQDLTAENMEDFCN----EISILSRLRHPNVILFLGACTKPPRLS------MITE 601
F Q+ T E+ ++ + H N+I L T L ++ E
Sbjct: 96 SRPF--QNQT------HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147
Query: 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 661
M+ +L +I + +L R +L + G+ +H I+HRDLK +N +V
Sbjct: 148 LMD-ANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
Query: 662 TVKICDFGLSRIITDSPMRDSSSAGTPEWM-----APELIRNEPFTEKCDIFSLGVIMWE 716
T+KI DFGL+R S M TP + APE+I + E DI+S+G IM E
Sbjct: 202 TLKILDFGLARTAGTSFMM------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
Query: 717 L 717
+
Sbjct: 256 M 256
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 522 DFSELTVGTRVGIGFFGEVF---RGIWNGTDV--AIKVFLEQDLTAENMEDFCNEISILS 576
F L V +G G FG+VF + + A+KV + L + E IL
Sbjct: 25 QFELLKV---LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 577 RLRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
+ HP I+ L T +L +I +++ G L+ LS ++ + L ++
Sbjct: 82 EVNHP-FIVKLHYAFQT-EGKLYLILDFLRGGDLFT--RLS-KEVMFTEEDVKFYLAELA 136
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694
L +H + I++RDLK N L+++ +K+ DFGLS+ D + S GT E+MAPE
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
++ T+ D +S GV+M+E+ T P++G
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQD----LTAENMEDFCNEISILSRLRHPNV 583
++G G + V++G TD VA+K + LE + TA E+S+L L+H N+
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA------IREVSLLKDLKHANI 62
Query: 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
+ L+++ EY++ L + G + + L + RGL HR
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCHRQ 119
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APELIRN 698
K++HRDLK N L+N+ +K+ DFGL+R + P + E W P+++
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTY----DNEVVTLWYRPPDILLG 174
Query: 699 EP-FTEKCDIFSLGVIMWELCTLNRP 723
++ + D++ +G I +E+ T RP
Sbjct: 175 STDYSTQIDMWGVGCIFYEMAT-GRP 199
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 36/210 (17%)
Query: 532 VGIGFFGEVFRGI-WNGTDVAIKVFLEQDLTAENMEDFCN---------EISILSRLRHP 581
+ G +G V G+ G VAIK + + EI +L+ HP
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 582 NVILFLGACTKPPRLS-----MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
N++ + ++TE M L +IH Q+ +S + + I G
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH--DQRIVISPQHIQYFMYHILLG 146
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-------RDSSSAGTPE 689
L +H +VHRDL N L+ + + ICDF L+R T R
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR--------- 197
Query: 690 WM-APELIRN-EPFTEKCDIFSLGVIMWEL 717
W APEL+ + FT+ D++S G +M E+
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 34/210 (16%)
Query: 532 VGIGFFGEVFRGIW--NGTDVAIK-VFLEQDLTAENMEDFCN-EISILSRLRHPNVILFL 587
+G G FG V++ +G VAIK V ++ F N E+ I+ +L H N++ L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIV-RL 112
Query: 588 GACTKPPR-------LSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMC 639
L+++ +Y+ ++Y + H S K+ L + + R L
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 640 IHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIIT-DSPMRD--SSSAGTPEWM-APE 694
IH I HRD+K N L++ +K+CDFG ++ + P S + APE
Sbjct: 172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS-----RYYRAPE 226
Query: 695 LI-RNEPFTEKCDIFSLGVIMWELCTLNRP 723
LI +T D++S G ++ EL L +P
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELL-LGQP 255
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 51/220 (23%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 578
F L +G G FG+V + A+K +Q N + + E+ I+ L
Sbjct: 16 HFEILRA---IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICR-- 635
HP ++ + + M+ + + G L YHL ++ + + +
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL------------QQNVHFKEETVKLF 120
Query: 636 ------GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 689
L + +I+HRD+K N L+++H V I DF ++ ++ + ++ AGT
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKP 179
Query: 690 WMAPELIRNEPF---TEKCDIFSLGVIMWELCTLNRPWEG 726
+MAPE+ + + D +SLGV +EL RP+
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 578
F + +G G FG V + +G A+K+ +Q + +E NE IL +
Sbjct: 42 QFDRIKT---LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR--- 635
P ++ + L M+ EY+ G ++ HL RR + R
Sbjct: 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HL---------RRIGRFSEPHARFYA 147
Query: 636 -----GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 690
+H + +++RDLK N L+++ +++ DFG ++ + R + GTPE
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEA 204
Query: 691 MAPELIRNEPFTEKCDIFSLGVIMWELCT 719
+APE+I ++ + + D ++LGV+++E+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 522 DFSELTVGTRVGIGFFGEVF---RGIWNGTDV--AIKVFLEQDLTAENMEDFC--NEISI 574
F L V +G G +G+VF + T A+KV + + + E +I
Sbjct: 18 CFELLRV---LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74
Query: 575 LSRLRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 632
L ++HP I+ L T +L +I EY+ G L+ L ++ L +
Sbjct: 75 LEEVKHP-FIVDLIYAFQT-GGKLYLILEYLSGGELFM--QLE-REGIFMEDTACFYLAE 129
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMA 692
I L +H+ I++RDLK N ++N VK+ DFGL + + GT E+MA
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189
Query: 693 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
PE++ D +SLG +M+++ T P+ G
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 577
DFS + +G G FGEV+ R G A+K L++ + NE +LS
Sbjct: 190 DFSVHRI---IGRGGFGEVYGCRKADTGKMYAMKC-LDKKRIKMKQGETLALNERIMLSL 245
Query: 578 L---RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
+ P ++ A P +LS I + M G L++ HLS Q S +I
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHY--HLS-QHGVFSEADMRFYAAEII 302
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694
GL +H +V+RDLK AN L+++H V+I D GL+ + + +S GT +MAPE
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPE 360
Query: 695 LI-RNEPFTEKCDIFSLGVIMWELCT 719
++ + + D FSLG ++++L
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLR 386
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-24
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 528 VGTRVGIGFFGEVFRG----IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 583
G +VG G +G V++ + D A+K ++ C EI++L L+HPNV
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA----CREIALLRELKHPNV 80
Query: 584 ILFLGACT--KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL------KMLRDICR 635
I ++ ++ +Y E L+H+I K +L +L I
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 636 GLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITDSPMRDSSSAGTPE-- 689
G+ +H ++HRDLK AN LV + VKI D G +R+ SP++ + P
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLK-PLADLDPVVV 197
Query: 690 --WM-APELIRNEPF-TEKCDIFSLGVIMWELCTLNRP 723
W APEL+ T+ DI+++G I EL T P
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EP 234
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 532 VGIGFFGEVFRGIWNGTD-VAIK-VFLEQDLTAENMEDFCN-EISILSRLRHPNVILFLG 588
+G G FG VF+ +D VAIK V + + F N E+ I+ ++HPNV+ L
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQD--------KRFKNRELQIMRIVKHPNVVD-LK 98
Query: 589 ACTKPP-------RLSMITEYMELGSLYHLI-HLSGQKKKLSWRR-KLKMLRDICRGLMC 639
A L+++ EY+ ++Y H + K+ + KL M + + R L
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRSLAY 156
Query: 640 IHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APELI- 696
IH + I HRD+K N L++ +K+ DFG ++I+ + S + APELI
Sbjct: 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRYYRAPELIF 214
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRP 723
+T DI+S G +M EL +P
Sbjct: 215 GATNYTTNIDIWSTGCVMAELM-QGQP 240
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 8e-24
Identities = 62/254 (24%), Positives = 98/254 (38%), Gaps = 51/254 (20%)
Query: 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFC 569
+ ++ + +G G +G V+ +VAIK +F +DL C
Sbjct: 19 IKNVHVP-DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLI------DC 69
Query: 570 N----EISILSRLRHPNVILFLGACTKPPRLS-----MITEYMELGSLYHLIHLSGQKKK 620
EI+IL+RL+ +I L ++ E + L L +
Sbjct: 70 KRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFK-TPIF-- 125
Query: 621 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680
L+ +L ++ G IH I+HRDLK ANCL+N+ +VK+CDFGL+R I
Sbjct: 126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 681 DSSSAGTPEWM----------------------APELIRNEP-FTEKCDIFSLGVIMWEL 717
+ + APELI + +T+ DI+S G I EL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 718 CTLNRPWEGVLPER 731
+ + R
Sbjct: 246 LNMLQSHINDPTNR 259
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 73/238 (30%), Positives = 99/238 (41%), Gaps = 44/238 (18%)
Query: 506 PMFQNKPLLAYEEWNIDFSELTVGTR------VGIGFFGEVFRGI--WNGTDVAIK---V 554
M F VG R +G G +G V N VAIK
Sbjct: 6 HMAAAAAAGPEMVRGQVF---DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP 62
Query: 555 FLEQDLTAENMEDFCN----EISILSRLRHPNVILFLGACTKPPRLSM-----ITEYMEL 605
F + T +C EI IL R RH N+I P M + + ME
Sbjct: 63 F--EHQT------YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 665
LY L+ + LS L I RGL IH ++HRDLK +N L+N +KI
Sbjct: 115 -DLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKI 169
Query: 666 CDFGLSRIITDSPMRDSSSAGTPE----WM-APELIRN-EPFTEKCDIFSLGVIMWEL 717
CDFGL+R+ P D + T W APE++ N + +T+ DI+S+G I+ E+
Sbjct: 170 CDFGLARVA--DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 50/230 (21%)
Query: 516 YEEWNIDFSELTVGTR------VGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAE 563
+ + +++ + + VG G +G V I +G VAIK F Q
Sbjct: 10 FYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEI-- 65
Query: 564 NMEDFCN----EISILSRLRHPNVILFLGACTKPPRLS------MITEYMELGSLYHLIH 613
F E+ +L ++H NVI L T L ++ +M+ L ++
Sbjct: 66 ----FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM- 119
Query: 614 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673
K S + ++ + +GL IH +VHRDLK N VN+ +KI DFGL+R
Sbjct: 120 ----GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR- 174
Query: 674 ITDSPMRDSSSAGTPEWM-----APELIRN-EPFTEKCDIFSLGVIMWEL 717
D+ M T + APE+I + + + DI+S+G IM E+
Sbjct: 175 HADAEM-------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 578
DF L +G G FG V R NG A+KV ++ + +E +E +LS +
Sbjct: 7 DFQILRT---LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 579 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD------ 632
HP +I G ++ MI +Y+E G L+ L RK + +
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFS--LL----------RKSQRFPNPVAKFY 111
Query: 633 ---ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 689
+C L +H I++RDLK N L++K+ +KI DFG ++ + D + GTP+
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPD 168
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCT 719
++APE++ +P+ + D +S G++++E+
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 531 RVGIGFFGEVFRG--IWNGTDVAIK-VFLEQDLTAENMEDFCN----EISILSRLR---H 580
+G+G +G V++ +G VA+K V + E+++L RL H
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNG--GGGGGGLPISTVREVALLRRLEAFEH 73
Query: 581 PNV-----ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
PNV + + +++++ E+++ L + + + K ++R R
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DLMRQFLR 131
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM 691
GL +H IVHRDLK N LV TVK+ DFGL+RI M TP W
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMA-----LTPVVVTLWY 185
Query: 692 -APELIRNEPFTEKCDIFSLGVIMWELCT 719
APE++ + D++S+G I E+
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 531 RVGIGFFGEVFRGI---WNGTDVAIK-VFLEQD-----LTAENMEDFCNEISILSRLR-- 579
+G G +G+VF+ G VA+K V ++ L+ E+++L L
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST------IREVAVLRHLETF 71
Query: 580 -HPNV-----ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 633
HPNV + + + +L+++ E+++ L + + + K M+ +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK-DMMFQL 129
Query: 634 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE---- 689
RGL +H ++VHRDLK N LV +K+ DFGL+RI M T
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMA-----LTSVVVTL 183
Query: 690 WM-APELIRNEPFTEKCDIFSLGVIMWELCTLNRP 723
W APE++ + D++S+G I E+ +P
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 39/198 (19%), Positives = 76/198 (38%), Gaps = 40/198 (20%)
Query: 527 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNV 583
+G+G G+V + A+K+ ++ E+ + R + P++
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHI 73
Query: 584 ILFLGAC----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
+ + L ++ E ++ G L+ I + + R ++++ I +
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 640 IHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
+H + I HRD+K N L + +K+ DFG A E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------AKETT 171
Query: 697 RNEPFTEKCDIFSLGVIM 714
E + + CD++SLGVIM
Sbjct: 172 G-EKYDKSCDMWSLGVIM 188
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 66/204 (32%), Positives = 91/204 (44%), Gaps = 33/204 (16%)
Query: 531 RVGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCN----EISILSRLRH 580
VG G +G V + G VAIK F Q F E+ +L +RH
Sbjct: 32 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSEL------FAKRAYRELRLLKHMRH 83
Query: 581 PNVILFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
NVI L T L ++ +M L L+ +KL R ++ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMK----HEKLGEDRIQFLVYQML 138
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694
+GL IH I+HRDLK N VN+ +KI DFGL+R DS M T + APE
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGYVV--TRWYRAPE 195
Query: 695 LIRN-EPFTEKCDIFSLGVIMWEL 717
+I N +T+ DI+S+G IM E+
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEM 219
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCN----EISILSRLRHPNV 583
+G G F V++ T+ VAIK + L +E + EI +L L HPN+
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHR--SEAKDGINRTALREIKLLQELSHPNI 74
Query: 584 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
I L A +S++ ++ME L +I + S + + +GL +H+
Sbjct: 75 IGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAY--MLMTLQGLEYLHQH 131
Query: 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APELIRN 698
I+HRDLK N L++++ +K+ DFGL++ P R T + W APEL+
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAY----THQVVTRWYRAPELLFG 186
Query: 699 EPF-TEKCDIFSLGVIMWELCTLNRP 723
D++++G I+ EL P
Sbjct: 187 ARMYGVGVDMWAVGCILAELLL-RVP 211
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 577
DF L + +G G FG+V R G A+K+ L +++ E E +L
Sbjct: 6 DFDYLKL---LGKGTFGKVILVREKATGRYYAMKI-LRKEVIIAKDEVAHTVTESRVLQN 61
Query: 578 LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
RHP + L T RL + EY G L+ HLS +++ + R +I
Sbjct: 62 TRHP-FLTALKYAFQT-HDRLCFVMEYANGGELFF--HLS-RERVFTEERARFYGAEIVS 116
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
L +H +V+RD+K N +++K +KI DFGL + + GTPE++APE+
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
+ + + D + LGV+M+E+ P+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 49/220 (22%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 516 YEEWNIDFSEL---TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCN 570
YE +++ + ++G G + EVF I N V +K+ L +
Sbjct: 25 YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI-----LKPVKKKKIKR 79
Query: 571 EISILSRLR-HPNVILFLGACTKPP---RLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 626
EI IL LR PN+I K P +++ E++ L + L+
Sbjct: 80 EIKILENLRGGPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDI 132
Query: 627 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRD-SSS 684
+ +I + L H M I+HRD+K N +++ +H +++ D+GL+ P ++ +
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVR 190
Query: 685 AGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRP 723
+ + PEL+ + + + D++SLG ++ + P
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 532 VGIGFFGEVFRGIW--NGTDVAIK-VFLEQDLTAENMEDFCN----EISILSRLRHPNVI 584
G G FG V G G VAIK V QD F N + L+ L HPN++
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVI--QDPR------FRNRELQIMQDLAVLHHPNIV 82
Query: 585 LFLGACTKPPR--------LSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICR 635
L + L+++ EY+ +L+ + ++ L + R
Sbjct: 83 Q-LQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 636 GLMCIHR--MKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDSPMRDSSSAGTPEWM- 691
+ C+H + + HRD+K N LVN+ T+K+CDFG ++ + SP + + +
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPNVAYICSRYYR 198
Query: 692 APELIRN-EPFTEKCDIFSLGVIMWELCTLNRP 723
APELI + +T DI+S+G I E+ L P
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMM-LGEP 230
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-22
Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 39/232 (16%)
Query: 509 QNKPLLAYEEWNIDFSELTVGTR------VGIGFFGEVFRGI--WNGTDVAIK----VFL 556
++ + ++ + V R VG G +G V G VA+K F
Sbjct: 8 HSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF- 66
Query: 557 EQDLTAENMEDFCN----EISILSRLRHPNVILFLGACTKPPRLS------MITEYMELG 606
Q + E+ +L ++H NVI L T L ++T M
Sbjct: 67 -QSII------HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-A 118
Query: 607 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKIC 666
L +++ +KL+ ++ I RGL IH I+HRDLK +N VN+ +KI
Sbjct: 119 DLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174
Query: 667 DFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWEL 717
DFGL+R T M + T + APE++ N + + DI+S+G IM EL
Sbjct: 175 DFGLAR-HTADEMTGYVA--TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 7e-22
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 12/210 (5%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 577
+F L + +G G FG+V + G A+K+ L++++ E E +L
Sbjct: 149 EFEYLKL---LGKGTFGKVILVKEKATGRYYAMKI-LKKEVIVAKDEVAHTLTENRVLQN 204
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
RHP + + RL + EY G L+ HLS +++ S R +I L
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFF--HLS-RERVFSEDRARFYGAEIVSAL 261
Query: 638 MCIHRMK-IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
+H K +V+RDLK N +++K +KI DFGL + + GTPE++APE++
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
+ + D + LGV+M+E+ P+
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-22
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 34/208 (16%)
Query: 531 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 582
++G G +GEV++ I T+ VAIK + LE + TA E+S+L L+H N
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA------IREVSLLKELQHRN 94
Query: 583 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 642
+I RL +I EY E L + + +S R L + G+ H
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 643 MKIVHRDLKSANCLVNKHWT-----VKICDFGLSRIITDSPMRDSSSAGTPE----WM-A 692
+ +HRDLK N L++ +KI DFGL+R P+R T E W
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQF----THEIITLWYRP 205
Query: 693 PELIRNEP-FTEKCDIFSLGVIMWELCT 719
PE++ ++ DI+S+ I E+
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLM 233
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-22
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 577
DF + +G G FG+VF AIK L++D+ + + C E +LS
Sbjct: 18 DFILHKM---LGKGSFGKVFLAEFKKTNQFFAIKA-LKKDVVLMDDDVECTMVEKRVLSL 73
Query: 578 -LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
HP + + T L + EY+ G L + I K R +I
Sbjct: 74 AWEHP-FLTHMFCTFQT-KENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEII 128
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694
GL +H IV+RDLK N L++K +KI DFG+ + + ++ GTP+++APE
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
++ + + D +S GV+++E+ P+ G
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 1e-21
Identities = 75/341 (21%), Positives = 140/341 (41%), Gaps = 22/341 (6%)
Query: 401 MNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQ 460
++ L E E F +D L ++ L + ++ G S + +
Sbjct: 211 QKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKA 270
Query: 461 MNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWN 520
L EY + GS G + + + K +++
Sbjct: 271 GVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFD 330
Query: 521 I----------DFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDF 568
DF+ L V +G G FG+V GTD A+K+ L++D+ ++ +
Sbjct: 331 NNGNRDRMKLTDFNFLMV---LGKGSFGKVMLSERKGTDELYAVKI-LKKDVVIQDDDVE 386
Query: 569 C--NEISILSRLRHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRR 625
C E +L+ P + L +C + RL + EY+ G L + H+ Q +
Sbjct: 387 CTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY--HIQ-QVGRFKEPH 443
Query: 626 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 685
+ +I GL + I++RDLK N +++ +KI DFG+ + + +
Sbjct: 444 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC 503
Query: 686 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
GTP+++APE+I +P+ + D ++ GV+++E+ P+EG
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 522 DFSELTVGTRVGIGFFGEVF---RGIWNGTDV--AIKVFLEQDLTAENMEDFC---NEIS 573
+F L V +G G +G+VF + + T A+KV L++ + + E
Sbjct: 55 NFELLKV---LGTGAYGKVFLVRKISGHDTGKLYAMKV-LKKATIVQKAKTTEHTRTERQ 110
Query: 574 ILSRLRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 631
+L +R ++ L T +L +I +Y+ G L+ HLS Q+++ + +
Sbjct: 111 VLEHIRQSPFLVTLHYAFQT-ETKLHLILDYINGGELFT--HLS-QRERFTEHEVQIYVG 166
Query: 632 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEW 690
+I L +H++ I++RD+K N L++ + V + DFGLS + D R GT E+
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 691 MAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEG 726
MAP+++R + D +SLGV+M+EL T P+
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 54/216 (25%), Positives = 83/216 (38%), Gaps = 44/216 (20%)
Query: 531 RVGIGFFGEVFRGI--WNGTDVAIK--VFLEQDLTAENMEDFCN----EISILSRLRHPN 582
+G G G VF + VAIK V D EI I+ RL H N
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQ------SVKHALREIKIIRRLDHDN 69
Query: 583 VILFLGACTKPPRLS--------------MITEYMELGSLYHLIHLSGQKKKLSWRRKLK 628
++ ++ EYME L +++ + L
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE----QGPLLEEHARL 124
Query: 629 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDSPMRDSSSAGT 687
+ + RGL IH ++HRDLK AN +N +KI DFGL+RI+ P +
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM--DPHYSHKGHLS 182
Query: 688 PE----WM-APELIRN-EPFTEKCDIFSLGVIMWEL 717
W +P L+ + +T+ D+++ G I E+
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 58/211 (27%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 577
+F + V +G G FG+V R G A+KV L++D+ ++ + C E ILS
Sbjct: 24 NFEFIRV---LGKGSFGKVMLARVKETGDLYAVKV-LKKDVILQDDDVECTMTEKRILSL 79
Query: 578 LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
R+ + L C T P RL + E++ G L H+ + ++ R +I
Sbjct: 80 ARNHPFLTQLFCCFQT-PDRLFFVMEFVNGGDLMF--HIQ-KSRRFDEARARFYAAEIIS 135
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
LM +H I++RDLK N L++ K+ DFG+ + + + ++ GTP+++APE+
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
++ + D +++GV+++E+ + P+E
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 14/220 (6%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 577
DF L V +G G + +V R A+KV ++++L ++ + E + +
Sbjct: 10 DFDLLRV---IGRGSYAKVLLVRLKKTDRIYAMKV-VKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 578 LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
+ ++ L +C T RL + EY+ G L H+ +++KL +I
Sbjct: 66 ASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMF--HMQ-RQRKLPEEHARFYSAEISL 121
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
L +H I++RDLK N L++ +K+ D+G+ + S+ GTP ++APE+
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 181
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA 735
+R E + D ++LGV+M+E+ P++ V
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 7e-21
Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 14/211 (6%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 577
DF+ L V +G G FG+V A+K+ L++D+ ++ + C E +L+
Sbjct: 21 DFNFLMV---LGKGSFGKVMLSERKGTDELYAVKI-LKKDVVIQDDDVECTMVEKRVLAL 76
Query: 578 LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
P + L +C T RL + EY+ G L + H+ Q + + +I
Sbjct: 77 PGKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMY--HIQ-QVGRFKEPHAVFYAAEIAI 132
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
GL + I++RDLK N +++ +KI DFG+ + + + GTP+++APE+
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI 192
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
I +P+ + D ++ GV+++E+ P+EG
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 8e-21
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 14/220 (6%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 577
DF L V +G G + +V R A++V ++++L ++ + E + +
Sbjct: 53 DFDLLRV---IGRGSYAKVLLVRLKKTDRIYAMRV-VKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 578 LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
+ ++ L +C T RL + EY+ G L H+ +++KL +I
Sbjct: 109 ASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMF--HMQ-RQRKLPEEHARFYSAEISL 164
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
L +H I++RDLK N L++ +K+ D+G+ + S+ GTP ++APE+
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 224
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA 735
+R E + D ++LGV+M+E+ P++ V
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 54/238 (22%), Positives = 91/238 (38%), Gaps = 58/238 (24%)
Query: 532 VGIGFFGEVFRGIWN--GTDVAIK-VFLEQDLTAENMEDFCN-EISILSRLRHPNVI--- 584
+G G FG V G A+K V + + N E+ I+ L H N+I
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YKNRELDIMKVLDHVNIIKLV 66
Query: 585 -----------------------------LFLGACTKPPR------LSMITEYMELGSLY 609
+ + L++I EY+ +L+
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 610 HLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICD 667
++ + + + + R + IH + I HRD+K N LVN K T+K+CD
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 668 FGLSRIITDSPMRDSSSAGTPEWM-APELIRN-EPFTEKCDIFSLGVIMWELCTLNRP 723
FG ++ + P S + + APEL+ +T D++S+G + EL L +P
Sbjct: 186 FGSAKKL--IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI-LGKP 240
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 57/239 (23%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCN- 570
+ ++ + + ++G G +G V++ I G VA+K F Q+ T
Sbjct: 4 DRHVL-RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNST------DAQR 54
Query: 571 ---EISILSRLR-HPNVILFLGACTKPPRLS---MITEYMELGSLYHLIH---LSGQKKK 620
EI IL+ L H N++ L + ++ +YME L+ +I L K+
Sbjct: 55 TFREIMILTELSGHENIVNLLNVL-RADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQ 112
Query: 621 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680
++ + + + +H ++HRD+K +N L+N VK+ DFGLSR +
Sbjct: 113 Y-------VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 681 DSSSAGTPEWM---------------------APELIRN-EPFTEKCDIFSLGVIMWEL 717
++ + APE++ +T+ D++SLG I+ E+
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-20
Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 16/212 (7%)
Query: 522 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 577
DF L V +G G FG+V R A+KV L++ + E+ +E ++L +
Sbjct: 39 DFHFLKV---IGKGSFGKVLLARHKAEEVFYAVKV-LQKKAILKKKEEKHIMSERNVLLK 94
Query: 578 -LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
++HP ++ L T +L + +Y+ G L++ HL +++ R +I
Sbjct: 95 NVKHP-FLVGLHFSFQT-ADKLYFVLDYINGGELFY--HLQ-RERCFLEPRARFYAAEIA 149
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694
L +H + IV+RDLK N L++ + + DFGL + + S+ GTPE++APE
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
++ +P+ D + LG +++E+ P+
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 30/261 (11%), Positives = 70/261 (26%), Gaps = 46/261 (17%)
Query: 528 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENM-EDFCNEISILSRLRHPNVI 584
+ G + ++ VA+ Q + +++ ++ + LSR+ P V
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
L ++ E++ GSL + S ++ ++ + HR
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVAD-----TSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 704
+ + V+ V + M +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPAT--------------------MPDA-------NPQ 182
Query: 705 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------RLEIPEGP--LGRLIAD 756
DI +G ++ L P + + + + P + + A
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242
Query: 757 CWA-EPQERPSCEEILSRLLD 776
+ R + L L+
Sbjct: 243 SVQGDGGIRSAST--LLNLMQ 261
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 57/209 (27%), Positives = 82/209 (39%), Gaps = 40/209 (19%)
Query: 532 VGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCN----EISILSRLRH----- 580
+G G FG+V + VA+K+ N + F EI IL LR
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKM-------VRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 581 -PNVILFLGA-------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 632
NVI L C M E + + +LY LI + + S K
Sbjct: 158 TMNVIHMLENFTFRNHIC-------MTFELLSM-NLYELIK-KNKFQGFSLPLVRKFAHS 208
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVN--KHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 690
I + L +H+ +I+H DLK N L+ +K+ DFG S S +
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR---FY 265
Query: 691 MAPELIRNEPFTEKCDIFSLGVIMWELCT 719
APE+I + D++SLG I+ EL T
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.9 bits (183), Expect = 1e-14
Identities = 38/198 (19%), Positives = 58/198 (29%), Gaps = 50/198 (25%)
Query: 524 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENME------DFCNEISILSR 577
+L ++G G FGEVF+ I + T VAIK+ + N + EI I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 578 L---------RHPNVILFLGAC------------------------------TKPPRLSM 598
L R I K +L +
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDLKSANCLV 657
+ E+ G + K S +L + L ++ HRDL N L+
Sbjct: 140 VLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 658 NKHWTVKICDFGLSRIIT 675
K K+ + T
Sbjct: 196 KKTSLKKLHYTLNGKSST 213
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 47/219 (21%), Positives = 85/219 (38%), Gaps = 48/219 (21%)
Query: 533 GIGFFGEVFRG--IWNGTDVAIKV------FLEQDLTAENMEDFCNEISILSRLR----- 579
G G F V+ + N T VA+K+ + E EI +L R+
Sbjct: 28 GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---------EIKLLQRVNDADNT 78
Query: 580 ------HPNVILFL------GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 627
+++ L G + M+ E + +L LI + +
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVH--VVMVFEVLGE-NLLALIKKYEHRG-IPLIYVK 134
Query: 628 KMLRDICRGLMCIHRM-KIVHRDLKSANCLVN------KHWTVKICDFGLSRIITDSPMR 680
++ + + GL +HR I+H D+K N L+ +KI D G + +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---H 191
Query: 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 719
++S T E+ +PE++ P+ DI+S +++EL T
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 32/210 (15%)
Query: 528 VGTRVGIGFFGEVFRGIW--NGTDVAIKV------FLEQDLTAENMEDFCNEISILSRLR 579
+ + +G G FG+V + VAIK+ FL Q E+ +L +
Sbjct: 58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI---------EVRLLELMN 108
Query: 580 HP------NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 633
++ L ++ E + +LY L+ + + +S K + +
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQM 166
Query: 634 CRGLMCIH--RMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 689
C L+ + + I+H DLK N L+ K +KI DFG S + +
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQYIQSRF 223
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCT 719
+ +PE++ P+ D++SLG I+ E+ T
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 61/227 (26%), Positives = 93/227 (40%), Gaps = 46/227 (20%)
Query: 528 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH----P 581
VG ++G G FGE+ G ++ VAIK LE + E +L P
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQ--LHLEYRFYKQLGSGDGIP 68
Query: 582 NVILFLGACTKPPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLK---MLRD--ICR 635
V F G C K +M+ E LG SL L L + S LK M+ I R
Sbjct: 69 QVYYF-GPCGK--YNAMVLEL--LGPSLEDLFDLCD--RTFS----LKTVLMIAIQLISR 117
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWT-----VKICDFGLSRIITDS------PMRDSSS 684
+ +H +++RD+K N L+ + + I DF L++ D P R+ S
Sbjct: 118 -MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS 176
Query: 685 -AGTPEWMAPELIRNEPFTE---KCDIFSLGVIMWELCTLNRPWEGV 727
GT +M+ I E + D+ +LG + + PW+G+
Sbjct: 177 LTGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 51/236 (21%), Positives = 80/236 (33%), Gaps = 78/236 (33%)
Query: 533 GIGFFGEVFRGI---WNGTDVAIKV------FLEQDLTAENMEDFCNEISILSRLRHP-- 581
G G FG+V I G VA+K+ + E + EI +L L
Sbjct: 23 GEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---------EIQVLEHLNTTDP 73
Query: 582 ----NVILFLGA-------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 630
+ L C ++ E + L S Y I +G KM
Sbjct: 74 NSTFRCVQMLEWFEHHGHIC-------IVFELLGL-STYDFIKENG-FLPFRLDHIRKMA 124
Query: 631 RDICRGLMCIHRMKIVHRDLKSANCLVN-------------------KHWTVKICDFG-- 669
IC+ + +H K+ H DLK N L + +K+ DFG
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 670 ------LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 719
S +++ R APE+I +++ CD++S+G I+ E
Sbjct: 185 TYDDEHHSTLVSTRHYR-----------APEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 40/235 (17%), Positives = 78/235 (33%), Gaps = 74/235 (31%)
Query: 532 VGIGFFGEVFR---GIWNGTDVAIKVFLEQDLTAENMEDFCN----EISILSRLRHP--- 581
+G G FG+V + VA+K+ N+ + EI++L +++
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKII-------RNVGKYREAARLEINVLKKIKEKDKE 79
Query: 582 ---NVILFLGA-------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 631
+L C + E + + + + + M
Sbjct: 80 NKFLCVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLK-ENNFQPYPLPHVRHMAY 130
Query: 632 DICRGLMCIHRMKIVHRDLKSANCLVN-------------------KHWTVKICDFG--- 669
+C L +H ++ H DLK N L K+ ++++ DFG
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 670 -----LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 719
+ I+ R PE+I + + CD++S+G I++E
Sbjct: 191 FDHEHHTTIVATRHYR-----------PPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 49/240 (20%), Positives = 77/240 (32%), Gaps = 82/240 (34%)
Query: 533 GIGFFGEVFRGI--WNGTDVAIKV------FLEQDLTAENMEDFCNEISILSRLRH---- 580
G G FG V N A+KV + E IL ++++
Sbjct: 44 GDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---------EADILKKIQNDDIN 94
Query: 581 -PNVILFLGA-------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 632
N++ + G C +I E + SLY +I + +
Sbjct: 95 NNNIVKYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRNN-YNGFHIEDIKLYCIE 145
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVN-------------------------KHWTVKICD 667
I + L + +M + H DLK N L++ K +K+ D
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 668 FG--------LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 719
FG II R APE+I N + D++S G ++ EL T
Sbjct: 206 FGCATFKSDYHGSIINTRQYR-----------APEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 54/231 (23%)
Query: 528 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMED----FCNEISILSRLRH- 580
VG R+G G FG +F G + N VAIK E +E L
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF--------EPRRSDAPQLRDEYRTYKLLAGC 65
Query: 581 ---PNVILFLGACTKPPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLK---MLRD- 632
PNV F G ++ + LG SL L+ L G +K S +K M
Sbjct: 66 TGIPNVYYF-GQEGL--HNVLVIDL--LGPSLEDLLDLCG--RKFS----VKTVAMAAKQ 114
Query: 633 -ICRGLMCIHRMKIVHRDLKSANCLVNKHWT-----VKICDFGLSRIITDS------PMR 680
+ R + IH +V+RD+K N L+ + + + + DFG+ + D P R
Sbjct: 115 MLAR-VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 681 DSSS-AGTPEWMAPELIRNEPFTEKC---DIFSLGVIMWELCTLNRPWEGV 727
+ + +GT +M+ I E+ D+ +LG + + PW+G+
Sbjct: 174 EKKNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 42/224 (18%)
Query: 528 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMED----FCNEISILSRLRH- 580
+G ++G G FG+++ G I G +VAIK+ E ++ E I ++
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHIESKIYKMMQGG 64
Query: 581 ---PNVILFLGACTKPPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
P + GA M+ E LG SL L + +K S + L + +
Sbjct: 65 VGIPTIRWC-GAEGD--YNVMVMEL--LGPSLEDLFNFCS--RKFSLKTVLLLADQMISR 117
Query: 637 LMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDS------PMRDSSS-AG 686
+ IH +HRD+K N L+ K V I DFGL++ D+ P R++ + G
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
Query: 687 TPEWMAPELIRNEPFTEKC---DIFSLGVIMWELCTLNRPWEGV 727
T + + I E+ D+ SLG ++ + PW+G+
Sbjct: 178 TARYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 48/239 (20%), Positives = 76/239 (31%), Gaps = 46/239 (19%)
Query: 528 VGTRVGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 586
VG +G G FG ++ + + V + + E+ R P I
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQK 98
Query: 587 LGACTKPPRLSM------------ITEY----ME-LG-SLYHLIHLSGQKKKLSWRRKLK 628
K L + Y M+ G L + + K+ S K
Sbjct: 99 WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA--KRFS----RK 152
Query: 629 ---MLRD--ICRGLMCIHRMKIVHRDLKSANCLVN--KHWTVKICDFGLSRIITDS---- 677
L + L IH + VH D+K++N L+N V + D+GL+
Sbjct: 153 TVLQLSLRILDI-LEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 678 --PMRDSSS-AGTPEWMAPELIRNEPFTEKC---DIFSLGVIMWELCTLNRPWEGVLPE 730
GT E+ + I D+ LG M + T + PWE L +
Sbjct: 212 AYAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 42/224 (18%)
Query: 528 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMED----FCNEISILSRLRH- 580
+G ++G G FGE++ G I +VAIK+ EN++ E I L+
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKIYRILQGG 62
Query: 581 ---PNVILFLGACTKPPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
PNV F G ++ + LG SL L + +KLS + L + +
Sbjct: 63 TGIPNVRWF-GVEGD--YNVLVMDL--LGPSLEDLFNF--CSRKLSLKTVLMLADQMINR 115
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLSRIITDS------PMRDSSS-AG 686
+ +H +HRD+K N L+ V I DFGL++ D+ P R++ + G
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 687 TPEWMAPELIRNEPFTEKC---DIFSLGVIMWELCTLNRPWEGV 727
T + + + E+ D+ SLG ++ + PW+G+
Sbjct: 176 TARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 50/263 (19%), Positives = 84/263 (31%), Gaps = 86/263 (32%)
Query: 528 VGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----H 580
V ++G G F V+ I VA+KV E +EI +L +R
Sbjct: 41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRNSDPND 97
Query: 581 PN---VILFLGA-----------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 626
PN V+ L C M+ E + L I S + L
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHIC-------MVFEVLGH-HLLKWIIKSNYQG-LPLPCV 148
Query: 627 LKMLRDICRGLMCIHR-MKIVHRDLKSANCLVN--------------------------- 658
K+++ + +GL +H +I+H D+K N L++
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 659 ----------------------KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
+ VKI D G + + D T ++ + E++
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ---TRQYRSLEVL 265
Query: 697 RNEPFTEKCDIFSLGVIMWELCT 719
+ DI+S + +EL T
Sbjct: 266 IGSGYNTPADIWSTACMAFELAT 288
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 39/249 (15%), Positives = 74/249 (29%), Gaps = 66/249 (26%)
Query: 528 VGTRVGIGFFGEVFRGI----------WNGTDVAIKVFLEQDLTAENME-DFCNEISILS 576
+ + G ++ ++K+ + + NE +
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL--------DAKDGRLFNEQNFFQ 97
Query: 577 RLRHPNVILFLGACTKPPRLSMITEY-------------ME-LG-SLYHLIHLSGQKKKL 621
R P + P L++ T + LG SL + +S K L
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP-KHVL 156
Query: 622 SWRRKLK---MLRD--ICRGLMCIHRMKIVHRDLKSANCLV--NKHWTVKICDFGLSRII 674
S + + + L +H + VH ++ + N V V + +G +
Sbjct: 157 S----ERSVLQVACRLLDA-LEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
Query: 675 TDS----PMRDSSSA---GTPEWMA------PELIRNEPFTEKCDIFSLGVIMWELCTLN 721
S + S + G E+++ R + D+ SLG M +
Sbjct: 212 CPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR------RSDLQSLGYCMLKWLYGF 265
Query: 722 RPWEGVLPE 730
PW LP
Sbjct: 266 LPWTNCLPN 274
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 51/245 (20%), Positives = 78/245 (31%), Gaps = 57/245 (23%)
Query: 528 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 585
+G ++G G FG ++ A V + EN F +E+ R+ + I
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHV--VKVEYQENGPLF-SELKFYQRVAKKDCIK 97
Query: 586 FLGACTKPPRLSMITEY----------------ME-LG-SLYHLIHLSGQKKKLSWRRKL 627
+ L + Y ME LG L + +G
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG---TFK----K 150
Query: 628 K---MLRD--ICRGLMCIHRMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDS--- 677
L + L IH + VH D+K+AN L+ V + D+GLS +
Sbjct: 151 STVLQLGIRMLDV-LEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 678 ---PMRDSSS-AGTPEWMA------PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV 727
GT E+ + L R + D+ LG M PWE
Sbjct: 210 KQYQENPRKGHNGTIEFTSLDAHKGVALSR------RSDVEILGYCMLRWLCGKLPWEQN 263
Query: 728 LPERV 732
L + V
Sbjct: 264 LKDPV 268
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 44.4 bits (104), Expect = 4e-05
Identities = 20/90 (22%), Positives = 32/90 (35%), Gaps = 18/90 (20%)
Query: 334 ASLDRKLSEP-NIATTFWRRSRRKVIAEQRTASSRSEGASTSEARRIRRRSISITPEIGD 392
A DR EP +I WR +RK + E AS E +A++ ++ +
Sbjct: 75 AQADRLTQEPESIRK--WREEQRKRLQELDAASKVMEQEWREKAKK----------DLEE 122
Query: 393 DIVRAVRAMNETLKQNR-----LLQERGED 417
R + + NR Q+ D
Sbjct: 123 WNQRQSEQVEKNKINNRIADKAFYQQPDAD 152
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 782 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.35 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.16 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.0 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.95 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.94 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.71 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.35 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.28 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.05 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 96.95 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.93 | |
| 3kd4_A | 506 | Putative protease; structural genomics, joint cent | 96.91 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.78 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.76 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.65 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.56 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.41 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.23 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.01 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.53 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 95.49 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.47 | |
| 3maz_A | 125 | Signal-transducing adaptor protein 1; modular doma | 95.28 | |
| 1aot_F | 106 | FYN protein-tyrosine kinase; SH2 domain, signal tr | 95.0 | |
| 1blj_A | 114 | P55 BLK protein tyrosine kinase; signal transducti | 94.19 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.85 | |
| 1lkk_A | 105 | Human P56 tyrosine kinase; complex (tyrosine kinas | 93.57 | |
| 2el8_A | 118 | Signal-transducing adaptor protein 2; SH2 domain, | 92.95 | |
| 2f4m_A | 295 | Peptide N-glycanase; glycoproteins, ubiquitin-depe | 91.98 | |
| 1rja_A | 100 | Tyrosine-protein kinase 6; human protein tyrosine | 91.94 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.86 | |
| 2dly_A | 121 | FYN-related kinase; BRK family kinase, structural | 90.82 | |
| 1nrv_A | 105 | Growth factor receptor-bound protein 10; dimer, si | 90.26 | |
| 4d8k_A | 175 | Tyrosine-protein kinase LCK; protein kinases, SH2 | 90.24 | |
| 3pqz_A | 117 | Growth factor receptor-bound protein 7; SH2, binds | 89.01 | |
| 2aug_A | 126 | Growth factor receptor-bound protein 14; phosphory | 88.83 | |
| 3ov1_A | 117 | Growth factor receptor-bound protein 2; GRB2 SH2 d | 87.03 | |
| 1d4t_A | 104 | T cell signal transduction molecule SAP; SH2 domai | 85.7 | |
| 2ekx_A | 110 | Cytoplasmic tyrosine-protein kinase BMX; SH2 domai | 85.54 | |
| 1i3z_A | 103 | EWS/FLI1 activated transcript 2; SH2 domain phosph | 85.51 | |
| 2dx0_A | 138 | Phospholipase C, gamma 2; phosphoric diester hydro | 85.38 | |
| 2cia_A | 102 | Cytoplasmic protein NCK2; SH2-domain, SH3 domain, | 85.13 | |
| 1ka6_A | 128 | SH2 domain protein 1A; SH2 domain, protein-peptide | 84.26 | |
| 3tkz_A | 109 | Tyrosine-protein phosphatase non-receptor type 11; | 84.06 | |
| 2gsb_A | 119 | RAS GTPase-activating protein 1; GAP, RAS P21 prot | 83.85 | |
| 1jyr_A | 96 | Growth factor receptor-bound protein 2; receptor b | 83.68 | |
| 2hdv_A | 111 | SH2-B PH domain containing signaling mediator 1 ga | 83.3 | |
| 2ge9_A | 125 | Tyrosine-protein kinase BTK; SH2 domain, structure | 81.28 | |
| 2ysx_A | 119 | Signaling inositol polyphosphate phosphatase SHIP | 81.19 | |
| 1r1p_A | 100 | GRB2-related adaptor protein 2; SH2, GADS, phospho | 81.1 | |
| 2eo3_A | 111 | CRK-like protein; phosphorylation, repeat, SH2 dom | 81.05 | |
| 2eo6_A | 141 | B-cell linker protein; SH2, cytoplasmic adapter pr | 80.94 | |
| 3us4_A | 98 | Megakaryocyte-associated tyrosine-protein kinase; | 80.6 | |
| 2dm0_A | 125 | Tyrosine-protein kinase TXK; TEC family kinase, st | 80.07 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=456.40 Aligned_cols=262 Identities=35% Similarity=0.620 Sum_probs=222.5
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
...|+++.++|.+.++||+|+||+||+|.+++ .||||+++.........+.|.+|+.+|++++|||||+++++|.+ +.
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 35689999999999999999999999998766 58999998766677778899999999999999999999999865 56
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+++|||||++|+|.++++. ....+++.+++.|+.||+.||+|||+++||||||||+||||++++++||+|||+|+...
T Consensus 106 ~~iVmEy~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp CEEEEECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEEEEEcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 8999999999999999963 34579999999999999999999999999999999999999999999999999998764
Q ss_pred CCC--CCCCCCCCCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----CC
Q 003971 676 DSP--MRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IP 746 (782)
Q Consensus 676 ~~~--~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~----ip 746 (782)
... ......+||+.|||||++.+ .+|+.++|||||||+||||+||+.||.+.+....+..+...+...+ ++
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 263 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY 263 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence 322 22345789999999999964 4699999999999999999999999998877666666655543322 22
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003971 747 ---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 781 (782)
Q Consensus 747 ---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~sL 781 (782)
+..+.+|+.+||+ ||.+|||+.+|+++|+.++-++
T Consensus 264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 2368999999999 9999999999999999887654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=461.76 Aligned_cols=249 Identities=27% Similarity=0.513 Sum_probs=217.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|+++++||+|+||+||+|.+ +|+.||||++.+........+.|.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 47899999999999999999988 5889999999887777777889999999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
|||+||+|.+++... ....+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+......
T Consensus 103 Ey~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp ECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred eCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 999999999999632 3456899999999999999999999999999999999999999999999999999876433222
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHh
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADC 757 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~C 757 (782)
....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..+++..+...... .++ +..+.+||.+|
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~ 260 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQL 260 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHH
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHH
Confidence 33568999999999999999999999999999999999999999999999888888775543 232 34699999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. ||.+|||+.|+++|
T Consensus 261 L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 261 FKRNPRDRPSVNSILEK 277 (350)
T ss_dssp TCSSGGGSCCHHHHHTS
T ss_pred ccCChhHCcCHHHHhcC
Confidence 99 99999999999975
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=447.38 Aligned_cols=259 Identities=31% Similarity=0.561 Sum_probs=218.9
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 590 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~ 590 (782)
.+.+..++|.+.++||+|+||+||+|.+. ++.||||++... .....++|.+|+++|++++|||||+++|+|
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34567789999999999999999999863 678999998643 345568899999999999999999999999
Q ss_pred cCCCceEEEEEEecccchhhHHHhhcc------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc
Q 003971 591 TKPPRLSMITEYMELGSLYHLIHLSGQ------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN 658 (782)
Q Consensus 591 ~d~~~l~LV~Ey~~gGsL~dlL~~~~~------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd 658 (782)
.+.+.+|+|||||++|+|.++++.... ...+++.+++.|+.||+.||+|||+++||||||||+||||+
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 999999999999999999999974321 24689999999999999999999999999999999999999
Q ss_pred CCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 003971 659 KHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYA 735 (782)
Q Consensus 659 ~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~ 735 (782)
+++.+||+|||+++....... .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....+++..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999987644322 2235679999999999999999999999999999999999 8999999998888777
Q ss_pred HHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 736 VANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 736 i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+.. +.+++.|. ..+.+|+.+||+ ||.+|||+.||+++|+.+..
T Consensus 273 i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 273 ITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 654 44555553 469999999999 99999999999999998743
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=445.89 Aligned_cols=257 Identities=32% Similarity=0.499 Sum_probs=222.4
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 591 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 591 (782)
.++..+++++.++||+|+||+||+|.+ +++.||||++.... .....++|.+|+.++++++|||||+++|+|.
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 346678899999999999999999986 35789999986543 2334578999999999999999999999999
Q ss_pred CCCceEEEEEEecccchhhHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc
Q 003971 592 KPPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN 658 (782)
Q Consensus 592 d~~~l~LV~Ey~~gGsL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd 658 (782)
+++.+++|||||++|+|.+++..... ...+++.+++.|+.||+.||+|||+++||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 99999999999999999999964321 24689999999999999999999999999999999999999
Q ss_pred CCCeEEEEecCccccccCCC--CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 003971 659 KHWTVKICDFGLSRIITDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYA 735 (782)
Q Consensus 659 ~~g~VKLaDFGLA~~l~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~ 735 (782)
+++++||+|||+++...... ......+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..++...
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999998764332 22345689999999999999999999999999999999998 8999999998888777
Q ss_pred HHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 736 VANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 736 i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
+.. +.+++.|+ ..+.+|+.+||. ||.+||||.+|+++|+.+
T Consensus 260 i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 654 44555554 368999999999 999999999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=445.43 Aligned_cols=257 Identities=30% Similarity=0.568 Sum_probs=222.2
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 592 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 592 (782)
.+..++|.+.++||+|+||+||+|.+ +++.||||++... .....++|.+|+++|++++|||||+++|+|.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 46678999999999999999999976 3678999998643 34556889999999999999999999999999
Q ss_pred CCceEEEEEEecccchhhHHHhhc----------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSG----------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 662 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~----------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~ 662 (782)
++.+|+|||||++|+|.++++..+ ....+++.+++.++.||+.||+|||+++||||||||+||||++++.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 999999999999999999997432 2357999999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 003971 663 VKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANE 739 (782)
Q Consensus 663 VKLaDFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~ 739 (782)
+||+|||+|+........ .....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~- 245 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ- 245 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH-
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence 999999999876443222 223468999999999999999999999999999999998 8999999998888877765
Q ss_pred CCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 740 GSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 740 ~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+.+++.|. ..+.+|+.+||+ ||.+|||+.+|++.|+++..
T Consensus 246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 44455553 469999999999 99999999999999998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=449.35 Aligned_cols=244 Identities=25% Similarity=0.397 Sum_probs=217.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
+.|++.++||+|+||+||+|.+ +|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5699999999999999999988 58899999997654332 3568899999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
||+||+|.+++.. ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.......
T Consensus 152 y~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 227 (346)
T 4fih_A 152 FLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227 (346)
T ss_dssp CCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred CCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence 9999999999862 469999999999999999999999999999999999999999999999999999876655555
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChHHHHHHHHh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGPLGRLIADC 757 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~-~~ip---~~~L~~LI~~C 757 (782)
.+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+...... ...+ ...+.+||.+|
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999999988888777654321 1111 34689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. ||.+|||+.|+++|
T Consensus 308 L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 308 LVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCSSTTTSCCHHHHTTC
T ss_pred cCCChhHCcCHHHHhcC
Confidence 99 99999999999976
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=450.19 Aligned_cols=263 Identities=32% Similarity=0.574 Sum_probs=226.9
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEECC-------eEEEEEEeeccccChHHHHHHHHHHHHHHhCCC-CceeeEe
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRH-PNVILFL 587 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g-------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H-PNIVkL~ 587 (782)
..+|+++.++|+++++||+|+||+||+|.+.+ +.||||++.... .....+.|.+|+.+|.+++| ||||+++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 35799999999999999999999999998743 579999987543 34446789999999999965 8999999
Q ss_pred ccccCC-CceEEEEEEecccchhhHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcc
Q 003971 588 GACTKP-PRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 653 (782)
Q Consensus 588 g~~~d~-~~l~LV~Ey~~gGsL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPe 653 (782)
|+|.+. ..+++|||||++|+|.++++.... ...+++..++.++.||+.||+|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 998764 568999999999999999974321 345899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 003971 654 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 730 (782)
Q Consensus 654 NILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~ 730 (782)
||||++++.+||+|||+|+.+..... .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654322 2235679999999999999999999999999999999998 89999988766
Q ss_pred HHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 731 RVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 731 evl~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
..+...+..+.++..|+ ..+.+|+.+||+ ||.+|||+.+|+++|+++..
T Consensus 295 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 66666667777777764 369999999999 99999999999999998743
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=444.69 Aligned_cols=246 Identities=22% Similarity=0.347 Sum_probs=218.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
.++|++++.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+++|+.++|||||++++++.+++.+|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999988 588999999976543 223457899999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC-
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 678 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~- 678 (782)
|||++||+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.+....
T Consensus 111 mEy~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999997 34579999999999999999999999999999999999999999999999999999875332
Q ss_pred -CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHH
Q 003971 679 -MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIAD 756 (782)
Q Consensus 679 -~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~ 756 (782)
....+.+||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+..++...+.......+ .-...+.+||.+
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 234577999999999999999999999999999999999999999999999888888877554322 123468999999
Q ss_pred hhh-CCCCCCCHHHHH
Q 003971 757 CWA-EPQERPSCEEIL 771 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL 771 (782)
||. ||.+|||+.|++
T Consensus 268 lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 268 LLVLDATKRLGCEEME 283 (311)
T ss_dssp HSCSSGGGSTTSGGGT
T ss_pred HccCCHhHCcChHHHc
Confidence 999 999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=433.86 Aligned_cols=242 Identities=27% Similarity=0.475 Sum_probs=208.6
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC----CCceEEE
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPRLSMI 599 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d----~~~l~LV 599 (782)
|++.++||+|+||+||+|.+ ++..||+|++..........+.|.+|+.+|+.++|||||+++++|.+ ...+|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 46788999999999999988 47789999998777777777899999999999999999999999864 3568999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--ccccCCCcccEEEc-CCCeEEEEecCccccccC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVN-KHWTVKICDFGLSRIITD 676 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g--IIHrDIKPeNILLd-~~g~VKLaDFGLA~~l~~ 676 (782)
||||+||+|.+++. ....+++..++.++.||+.||+|||++| ||||||||+||||+ .++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999997 3457999999999999999999999998 99999999999997 479999999999986543
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CC---ChHHHH
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IP---EGPLGR 752 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip---~~~L~~ 752 (782)
. ...+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+......+...+..+..+. .+ ...+.+
T Consensus 185 ~--~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (290)
T 3fpq_A 185 S--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp T--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred C--ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence 2 3346789999999999875 599999999999999999999999987766555555555443332 22 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003971 753 LIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
|+.+||. ||.+|||+.|+++|
T Consensus 262 li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 262 IIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999 99999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-52 Score=444.59 Aligned_cols=250 Identities=25% Similarity=0.354 Sum_probs=212.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
.+.++|++++.||+|+||+||+|.+ .++.||||++.+..........+.+|+.+|+.++|||||++++++.+++.
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 3457899999999999999999976 36789999997665444344568899999999999999999999999999
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+|+||||++||+|.+++. ..+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 101 ~~ivmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999999997 34579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHH
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLI 754 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI 754 (782)
.......+.+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+..++...+.......+ .-+..+.+|+
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 257 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 257 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 554455678999999999999999999999999999999999999999999999988888876543322 1234699999
Q ss_pred HHhhh-CCCCCCC-----HHHHHHH
Q 003971 755 ADCWA-EPQERPS-----CEEILSR 773 (782)
Q Consensus 755 ~~CL~-DP~kRPS-----a~EIL~~ 773 (782)
.+||. ||.+||| ++|+++|
T Consensus 258 ~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 258 RMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHcccCHHHCCCCCcCCHHHHHcC
Confidence 99999 9999998 5788764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=442.24 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=215.1
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
....+.|.+.++||+|+||+||+|.+ +|+.||||++..+... .+|+.+++.++|||||+++++|.+++.+|
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34567899999999999999999988 5889999999765432 36999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC-eEEEEecCccccccC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITD 676 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g-~VKLaDFGLA~~l~~ 676 (782)
+|||||+||+|.++++. .+.+++.+++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+..
T Consensus 127 ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp EEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred EEEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 99999999999999973 45799999999999999999999999999999999999999987 699999999987754
Q ss_pred CCC-----CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC---C
Q 003971 677 SPM-----RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP---E 747 (782)
Q Consensus 677 ~~~-----~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip---~ 747 (782)
... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+...+...+....... .++ +
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s 283 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA 283 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC
Confidence 321 2234689999999999999999999999999999999999999999887777777776654332 233 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 748 GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 748 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
..+.+||.+||. ||.+|||+.||+++|....
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 468999999999 9999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=451.41 Aligned_cols=244 Identities=25% Similarity=0.397 Sum_probs=217.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
+.|++.++||+|+||+||+|.+ +|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+.+.+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 5799999999999999999988 58899999997654332 3568899999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
||+||+|.+++.. ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.......
T Consensus 229 y~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 229 FLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp CCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred CCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 9999999999862 469999999999999999999999999999999999999999999999999999876655555
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChHHHHHHHHh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGPLGRLIADC 757 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~-~~ip---~~~L~~LI~~C 757 (782)
.+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+...... ...+ ...+.+||.+|
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999999988888877654321 1111 34699999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. ||.+|||+.|+++|
T Consensus 385 L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 385 LVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCSSTTTSCCHHHHTTC
T ss_pred cCCChhHCcCHHHHhcC
Confidence 99 99999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=426.98 Aligned_cols=246 Identities=30% Similarity=0.460 Sum_probs=200.7
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
..+|++.+.||+|+||+||+|.+ +|+.||||++.+.... ....+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 36899999999999999999987 5899999999766543 33356799999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+ +|+|.+++. ..+.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp EECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 9999 679998886 34679999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHh
Q 003971 680 RDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADC 757 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~C 757 (782)
...+.+||+.|+|||++.+..| +.++|||||||++|+|+||+.||.+.+...+...+.......+ .-+..+.+|+.+|
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 246 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 3346789999999999998876 5799999999999999999999999988888887776544322 2245689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. ||.+|||+.|+++|
T Consensus 247 L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQD 263 (275)
T ss_dssp SCSSGGGSCCHHHHHHC
T ss_pred ccCChhHCcCHHHHHcC
Confidence 99 99999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=419.92 Aligned_cols=249 Identities=29% Similarity=0.477 Sum_probs=201.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC----ceEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP----RLSMI 599 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~----~l~LV 599 (782)
.+|.+.++||+|+||+||+|.++|+.||||++.... .....+..|+..+..++|||||+++++|.+++ .+|+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 468899999999999999999999999999986432 11122334566667889999999999997654 57999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc--------cccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM--------KIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~--------gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
|||+++|+|.++++. ..+++..+..++.|++.||+|||++ +||||||||+||||+.++++||+|||++
T Consensus 80 ~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999963 3689999999999999999999987 8999999999999999999999999999
Q ss_pred ccccCCCC----CCCCCCCCCcccCccccccC------CCCchhHHHHHHHHHHHHHhCCCCCC----------CC----
Q 003971 672 RIITDSPM----RDSSSAGTPEWMAPELIRNE------PFTEKCDIFSLGVIMWELCTLNRPWE----------GV---- 727 (782)
Q Consensus 672 ~~l~~~~~----~~~~~~GT~~Y~APEvl~~~------~~s~ksDVWSLGvILyELLTGk~PF~----------~~---- 727 (782)
+....... .....+||+.|+|||++.+. .++.++|||||||+||||+||..||. +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 87654322 12346899999999999764 36789999999999999999976542 22
Q ss_pred -ChHHHHHHHHhcCCCCCCCCh--------HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 728 -LPERVVYAVANEGSRLEIPEG--------PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 728 -~~~evl~~i~~~~~~~~ip~~--------~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
........+.....++.+|.. .+.+|+.+||. ||.+|||+.+|++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 233444445556666666642 47789999999 99999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=419.25 Aligned_cols=245 Identities=24% Similarity=0.349 Sum_probs=191.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC-------
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------- 594 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------- 594 (782)
++|++++.||+|+||+||+|.+ +|+.||||++.... .....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4699999999999999999987 58899999987554 3344578999999999999999999999986543
Q ss_pred -----ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecC
Q 003971 595 -----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 669 (782)
Q Consensus 595 -----~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFG 669 (782)
.+|++||||++|+|.+++.........++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 379999999999999999754444456677889999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC------------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Q 003971 670 LSRIITDSPM------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAV 736 (782)
Q Consensus 670 LA~~l~~~~~------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~e-vl~~i 736 (782)
+|+.+..... ...+.+||+.|||||++.+..|+.++|||||||++|||++ ||.+..... ....+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~ 240 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence 9987654321 1234689999999999999999999999999999999996 886543222 22222
Q ss_pred HhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 737 ANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 737 ~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. ....++.. .....+|+.+||+ ||.+|||+.|++++
T Consensus 241 ~-~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 241 R-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp H-TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred h-cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2 22222111 1246789999999 99999999999984
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=424.61 Aligned_cols=246 Identities=25% Similarity=0.344 Sum_probs=211.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC------CCc
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PPR 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d------~~~ 595 (782)
++|.+++.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999988 58999999997766666667889999999999999999999998653 467
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+|+|||||. |+|.+++. ..+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999996 67988886 45689999999999999999999999999999999999999999999999999998764
Q ss_pred CC----CCCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------
Q 003971 676 DS----PMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE------ 744 (782)
Q Consensus 676 ~~----~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~------ 744 (782)
.. .....+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+....+..+......+.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 32 2233467999999999998775 569999999999999999999999999998888877754322211
Q ss_pred ------------------C--------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 ------------------I--------PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 ------------------i--------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. -+..+.+||.+||. ||.+|||+.|+|+|
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 12357789999999 99999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=422.94 Aligned_cols=355 Identities=27% Similarity=0.461 Sum_probs=275.6
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccccccccccccCCCCCCCccC
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 477 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~~~~s~~~~slPssp~~~~ 477 (782)
.+.|+|.++++.|+..++.+|+|++|.|+ ..++.|.+++...+...++..+||.+.+.....- .+. +. ..+
T Consensus 74 ~g~i~r~~ae~~L~~~~~~~G~FLvR~s~----~~~g~y~lsv~~~~~~~~~~v~H~~I~~~~~g~~-~i~-~~--~~F- 144 (454)
T 1qcf_A 74 FKGISRKDAERQLLAPGNMLGSFMIRDSE----TTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGF-YIS-PR--STF- 144 (454)
T ss_dssp ETTCCHHHHHHHHHSTTCCTTCEEEEECS----SSTTSEEEEEEEEETTTEEEEEEEEEEECTTSCE-ESS-SS--SCB-
T ss_pred ccccchhhhhhhhhcCCCCCceEEEEECc----CCCCeEEEEEEecccCCCCceEEEEEEEcCCCcE-EEe-Cc--ccc-
Confidence 56788999999999999999999999998 5677888888776655667788888776321100 000 00 000
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhh-------hccCCcccCC--CccccccccccCCCeeEeeEEeeeCcEEEEEEEE-CC
Q 003971 478 SHGSERGGSSGYMANSEFVSTWNK-------VLESPMFQNK--PLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NG 547 (782)
Q Consensus 478 s~~S~~~~ss~~~~~s~~~s~~~~-------~l~sp~~~~~--p~~~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g 547 (782)
..-.+....+.+ .+..+..... .....+.|.+..++|.+.+.||+|+||+||+|.+ ++
T Consensus 145 ------------~sl~eLv~~y~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~ 212 (454)
T 1qcf_A 145 ------------STLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKH 212 (454)
T ss_dssp ------------SSHHHHHHHHTSSCTTSSSCCCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTT
T ss_pred ------------CCHHHHHHHHHhccCCccccccccccccCccccccccceeechHHeEEEEEcccCCceEEEEEEECCc
Confidence 000011111000 0001111111 1223567899999999999999999999999988 47
Q ss_pred eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHH
Q 003971 548 TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 627 (782)
Q Consensus 548 ~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l 627 (782)
..||||++..... ..+.|.+|+.+|+.++||||+++++++. ...+++||||+.+|+|.+++... ....+++..++
T Consensus 213 ~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~ 287 (454)
T 1qcf_A 213 TKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLI 287 (454)
T ss_dssp EEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH-HHHTCCHHHHH
T ss_pred cEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc-cCCCCCHHHHH
Confidence 8899999875443 3578999999999999999999999987 55789999999999999999732 23467889999
Q ss_pred HHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC-CCCCCCCCcccCccccccCCCCchhH
Q 003971 628 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR-DSSSAGTPEWMAPELIRNEPFTEKCD 706 (782)
Q Consensus 628 ~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksD 706 (782)
.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....+|+.|+|||++....++.++|
T Consensus 288 ~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 367 (454)
T 1qcf_A 288 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367 (454)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHH
Confidence 99999999999999999999999999999999999999999999876432211 22345678999999999999999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 707 IFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 707 VWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
||||||++|||+| |+.||.+....++...+.. +.+.+.| +..+.+|+.+||. ||.+|||+.+|++.|+++..
T Consensus 368 vwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 368 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 9999999999999 9999999988887776654 4444444 3469999999999 99999999999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=421.06 Aligned_cols=355 Identities=28% Similarity=0.487 Sum_probs=270.8
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccccccccccccCCCCCCCccC
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 477 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~~~~s~~~~slPssp~~~~ 477 (782)
.+.|.|.++++.|+..++.+|+|++|.|+ ..++.|.+++...+...+++.+||.+.+..... .-+.. ...+.
T Consensus 69 ~g~~~r~~ae~~L~~~~~~~G~FLvR~s~----~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~---~~~~~-~~~F~ 140 (452)
T 1fmk_A 69 FGKITRRESERLLLNAENPRGTFLVRESE----TTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGG---FYITS-RTQFN 140 (452)
T ss_dssp EETCCHHHHHHHHTCTTSCTTEEEEEECS----SSTTCEEEEEEEEETTTEEEEEEEEEEECTTSC---EESST-TSEES
T ss_pred cCCccHHHHHHHhccCCCCCceEEEEeCC----CCCCceEEEEEeeccCCCCcEEEEEEEEcCCCC---EEEec-CcccC
Confidence 46789999999999999999999999998 567788888887665566788999887642110 00000 00000
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhhh-------ccCCccc---CCCccccccccccCCCeeEeeEEeeeCcEEEEEEEEC-
Q 003971 478 SHGSERGGSSGYMANSEFVSTWNKV-------LESPMFQ---NKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN- 546 (782)
Q Consensus 478 s~~S~~~~ss~~~~~s~~~s~~~~~-------l~sp~~~---~~p~~~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~- 546 (782)
+-...+..+... +..+... .........|++..++|++.++||+|+||.||+|.++
T Consensus 141 -------------Sl~~Li~~y~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~ 207 (452)
T 1fmk_A 141 -------------SLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG 207 (452)
T ss_dssp -------------SHHHHHHHHTTCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETT
T ss_pred -------------CHHHHHHHhhhccccchhhccccccccccccCCCCccccccChhHceeeeeecCCCCeEEEEEEECC
Confidence 000111110000 0000000 1112235678999999999999999999999999985
Q ss_pred CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHH
Q 003971 547 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 626 (782)
Q Consensus 547 g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~ 626 (782)
+..||||++...... .+.|.+|+.+|+.++||||+++++++.+ +.+++||||+++|+|.+++... ....+++..+
T Consensus 208 ~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~-~~~~~~~~~~ 282 (452)
T 1fmk_A 208 TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQL 282 (452)
T ss_dssp TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH-HHTTCCHHHH
T ss_pred CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc-CCCCCCHHHH
Confidence 467999998765433 4679999999999999999999999877 6789999999999999999632 2346899999
Q ss_pred HHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC-CCCCCCCCcccCccccccCCCCchh
Q 003971 627 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR-DSSSAGTPEWMAPELIRNEPFTEKC 705 (782)
Q Consensus 627 l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ks 705 (782)
+.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....+++.|+|||++.+..++.++
T Consensus 283 ~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s 362 (452)
T 1fmk_A 283 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362 (452)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccc
Confidence 999999999999999999999999999999999999999999999876543222 2234577899999999999999999
Q ss_pred HHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 706 DIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 706 DVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
|||||||++|||++ |+.||.+....+....+.. +.+.+.|. ..+.+|+.+||. ||.+|||+.+|++.|+++..
T Consensus 363 DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred cHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 99999999999999 8999999988877776654 44444443 468999999999 99999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=392.18 Aligned_cols=265 Identities=47% Similarity=0.898 Sum_probs=224.4
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 515 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 515 ~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
....+.+...+|.+.+.||+|+||+||+|.++|+.||||++..........+.|.+|+.++++++||||+++++++.+..
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 45667788899999999999999999999999999999999877777777789999999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--ccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g--IIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
.+++||||+++|+|.+++........+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999975433445999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hH
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GP 749 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~---~~ 749 (782)
.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+........++. ..
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (309)
T 3p86_A 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred cccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence 765443344567899999999999999999999999999999999999999999998888877766665555553 46
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+.+|+.+||. ||.+|||+.++++.|+.+..
T Consensus 268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 9999999999 99999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=405.06 Aligned_cols=345 Identities=24% Similarity=0.442 Sum_probs=259.5
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccccccccccccCCCCCCCccC
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 477 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~~~~s~~~~slPssp~~~~ 477 (782)
.+.|.|.++++.|+ .+|+|++|.|++ .. .+.+++.. .++.+||.+.+... ....
T Consensus 17 hg~i~r~~a~~lL~----~~G~flvR~s~~----~~-~~~lsv~~-----~~~~~h~~i~~~~~----~~~~-------- 70 (377)
T 3cbl_A 17 HGAIPRAEVAELLV----HSGDFLVRESQG----KQ-EYVLSVLW-----DGLPRHFIIQSLDN----LYRL-------- 70 (377)
T ss_dssp CTTCCHHHHHHHCC----STTEEEEEECC------C-CEEEEC----------CCEEEC----C----CCCC--------
T ss_pred CCCCCHHHHHHHHh----cCCCEEEEEeCC----CC-cEEEEEEE-----CCCccchhhccccc----eEEe--------
Confidence 46788999999887 479999999973 22 67777764 24677887765311 0000
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhhhcc----CCcccCCCccccccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEE
Q 003971 478 SHGSERGGSSGYMANSEFVSTWNKVLE----SPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVA 551 (782)
Q Consensus 478 s~~S~~~~ss~~~~~s~~~s~~~~~l~----sp~~~~~p~~~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VA 551 (782)
....+.+-...+..+..... ............+.|.++.++|.+.+.||+|+||.||+|.+ +++.||
T Consensus 71 -------~~~~F~sl~~LI~~y~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va 143 (377)
T 3cbl_A 71 -------EGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVA 143 (377)
T ss_dssp -----------CCSHHHHHHHHHHHTCCC-----CCCCEECCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEE
T ss_pred -------cceeccchHHHHHHHhhccCCcccccCcccccCccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEE
Confidence 00011111122222111100 00011112234567889999999999999999999999998 588999
Q ss_pred EEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHH
Q 003971 552 IKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 631 (782)
Q Consensus 552 VKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~ 631 (782)
||++... ......+.|.+|+.+++.++||||+++++++.+...+++||||+++|+|.+++.. ....+++..++.++.
T Consensus 144 vK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~ 220 (377)
T 3cbl_A 144 VKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVG 220 (377)
T ss_dssp EEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHH
T ss_pred EEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHH
Confidence 9998643 3344556789999999999999999999999999999999999999999999873 234689999999999
Q ss_pred HHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhHHHH
Q 003971 632 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFS 709 (782)
Q Consensus 632 QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWS 709 (782)
||+.||+|||++||+||||||+|||++.++.+||+|||+++......... ....+++.|+|||++.+..++.++||||
T Consensus 221 qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 300 (377)
T 3cbl_A 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300 (377)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHH
T ss_pred HHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHH
Confidence 99999999999999999999999999999999999999998754332111 1223567899999999888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 710 LGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 710 LGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
|||++|||++ |..||.+.........+. .+.+.+.| +..+.+|+.+||. ||.+|||+.+|++.|+++..
T Consensus 301 lG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 301 FGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp HHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 9999999998 999999988877665554 34444444 3469999999999 99999999999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=424.97 Aligned_cols=246 Identities=25% Similarity=0.412 Sum_probs=217.6
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|.+++.||+|+||+||+|.+ +|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 36899999999999999999988 58899999987543 334577889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC--CeEEEEecCccccccCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH--WTVKICDFGLSRIITDSP 678 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~--g~VKLaDFGLA~~l~~~~ 678 (782)
|||+||+|.+++.. ....+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 234 E~~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 234 EFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp ECCCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred eecCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999998852 34579999999999999999999999999999999999999854 899999999999875432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~L 753 (782)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+.........+ ...+.+|
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 3345689999999999999999999999999999999999999999999999888887655443221 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
|.+||. ||.+|||+.|+++|
T Consensus 391 i~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999 99999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=424.32 Aligned_cols=355 Identities=28% Similarity=0.473 Sum_probs=275.7
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccccccccccccCCCCCCCccC
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 477 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~~~~s~~~~slPssp~~~~ 477 (782)
.+.|.|.++++.|+..++.+|+|++|.|+ ..++.|.+++...+...++..+||.+.+..... ..+.. ...
T Consensus 152 ~g~i~r~~ae~~L~~~~~~~G~FLvR~S~----~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~-~~i~~---~~~-- 221 (535)
T 2h8h_A 152 FGKITRRESERLLLNAENPRGTFLVRESE----TTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGG-FYITS---RTQ-- 221 (535)
T ss_dssp CCSCCHHHHHHHHTCTTCCTTEEEEEECS----SSTTCEEEEEEEEETTTEEEEEEEEEBC-CCSC-EEEET---TEE--
T ss_pred ccccCHHHHHHHhccCCCCCCeEEEEecC----CCCCcEEEEEEeeccCCCCceEEEEEEEcCCCc-EEeec---ccc--
Confidence 46789999999999999999999999998 457788888887666667788999887642110 00000 000
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhhhc-------cCCccc---CCCccccccccccCCCeeEeeEEeeeCcEEEEEEEEC-
Q 003971 478 SHGSERGGSSGYMANSEFVSTWNKVL-------ESPMFQ---NKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN- 546 (782)
Q Consensus 478 s~~S~~~~ss~~~~~s~~~s~~~~~l-------~sp~~~---~~p~~~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~- 546 (782)
+..-.+.+..+.... ..+... ....+..+.|++..++|++.++||+|+||.||+|.++
T Consensus 222 -----------F~SL~eLv~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~ 290 (535)
T 2h8h_A 222 -----------FNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG 290 (535)
T ss_dssp -----------ESSHHHHHHHHHHCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETT
T ss_pred -----------ccChHHhheeeccccCccccccccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECC
Confidence 000111111111100 000000 1112235778999999999999999999999999985
Q ss_pred CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHH
Q 003971 547 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 626 (782)
Q Consensus 547 g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~ 626 (782)
+..||||++...... .+.|.+|+.+|+.++||||+++++++.+ ..+++||||+.+|+|.+++... ....+++.++
T Consensus 291 ~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~ 365 (535)
T 2h8h_A 291 TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQL 365 (535)
T ss_dssp TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH-HHTTCCHHHH
T ss_pred CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc-CCCCCCHHHH
Confidence 467999999765433 4679999999999999999999999877 6789999999999999999632 2346899999
Q ss_pred HHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-CCCCCCCCCcccCccccccCCCCchh
Q 003971 627 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKC 705 (782)
Q Consensus 627 l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ks 705 (782)
+.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....... ......++..|+|||++.+..++.++
T Consensus 366 ~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s 445 (535)
T 2h8h_A 366 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445 (535)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchh
Confidence 99999999999999999999999999999999999999999999987643211 12234577899999999999999999
Q ss_pred HHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 706 DIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 706 DVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
|||||||+||||++ |+.||.+....++...+.. +.+...+ ...+.+||.+||. ||.+||++.+|++.|+++..
T Consensus 446 DvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 99999999999999 8999999988877776654 4444444 3469999999999 99999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=400.56 Aligned_cols=240 Identities=23% Similarity=0.333 Sum_probs=196.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~ 597 (782)
++|++.++||+|+||+||+|.+ .++.||||++.... ....+.+|+++|+.+ +|||||+++++|.+.+.+|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 5799999999999999999976 26789999986543 235678999999998 6999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC-CeEEEEecCccccccC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITD 676 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~-g~VKLaDFGLA~~l~~ 676 (782)
+||||+++|+|.+++. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...+
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999999884 48999999999999999999999999999999999999876 8999999999986543
Q ss_pred CCC----------------------------CCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCC-
Q 003971 677 SPM----------------------------RDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEG- 726 (782)
Q Consensus 677 ~~~----------------------------~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~- 726 (782)
... .....+||+.|+|||++.+. .|+.++||||+||++|||+||+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 211 12346899999999999875 489999999999999999999999954
Q ss_pred CChHHHHHHHHhcCC---------------------------------------C----------------CCCCChHHH
Q 003971 727 VLPERVVYAVANEGS---------------------------------------R----------------LEIPEGPLG 751 (782)
Q Consensus 727 ~~~~evl~~i~~~~~---------------------------------------~----------------~~ip~~~L~ 751 (782)
.+....+..+..... . ....+....
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 344343333321000 0 001123577
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+|+.+||. ||.+|||++|+|+|
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHCcCChhHCcCHHHHhcC
Confidence 89999999 99999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=405.63 Aligned_cols=344 Identities=23% Similarity=0.440 Sum_probs=261.6
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccccccccccccCCCCCCCccC
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 477 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~~~~s~~~~slPssp~~~~ 477 (782)
.+.|.|.++++.|.. ..+|+|++|.|+ ...+.+.+++.. ++..+||.+..... ...+... ..+.
T Consensus 84 hg~i~r~~ae~~L~~--~~~G~FlvR~S~----~~~g~~~Lsv~~-----~~~v~H~~I~~~~~----~~~i~~~-~~F~ 147 (450)
T 1k9a_A 84 HGKITREQAERLLYP--PETGLFLVREST----NYPGDYTLCVSC-----EGKVEHYRIMYHAS----KLSIDEE-VYFE 147 (450)
T ss_dssp CTTCCHHHHHHHTCS--CCTTEEEEEECS----SSTTSEEEEEEC-----SSSEEEEEEEEETT----EEESSSS-SCBS
T ss_pred ccCcCHHHhhhhhcc--CCCceEEEEecC----CCCCceEEEEEe-----CCeeeEEEEEecCC----ceEeccc-cccc
Confidence 567899999999964 345999999998 445667777743 45677777633211 1111000 0000
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhhhc-------cCCcccCCC-----ccccccccccCCCeeEeeEEeeeCcEEEEEEEE
Q 003971 478 SHGSERGGSSGYMANSEFVSTWNKVL-------ESPMFQNKP-----LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW 545 (782)
Q Consensus 478 s~~S~~~~ss~~~~~s~~~s~~~~~l-------~sp~~~~~p-----~~~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~ 545 (782)
.-..+...+.... ..+.....+ .+....|.+..++|++.+.||+|+||.||+|.+
T Consensus 148 -------------sl~eLv~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~ 214 (450)
T 1k9a_A 148 -------------NLMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY 214 (450)
T ss_dssp -------------SHHHHHHHHHHCCTTSSSCCCEECCCTTCEEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEE
T ss_pred -------------cHHHHHhhhcccccchhhhccccccccCcccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEe
Confidence 0111111111000 000000000 012456889999999999999999999999999
Q ss_pred CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC-ceEEEEEEecccchhhHHHhhcccccchHH
Q 003971 546 NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWR 624 (782)
Q Consensus 546 ~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~-~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~ 624 (782)
+++.||||++.... ..+.|.+|+.+|++++||||+++++++.+.. .+++||||+++|+|.+++... ....+++.
T Consensus 215 ~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~-~~~~~~~~ 289 (450)
T 1k9a_A 215 RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGD 289 (450)
T ss_dssp TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH-CTTTCCHH
T ss_pred cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc-CCCCCCHH
Confidence 99999999987543 3467999999999999999999999986654 799999999999999999743 23347899
Q ss_pred HHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCch
Q 003971 625 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 704 (782)
Q Consensus 625 ~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~k 704 (782)
.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....+++.|+|||++.+..++.+
T Consensus 290 ~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 366 (450)
T 1k9a_A 290 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTK 366 (450)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSCCCHH
T ss_pred HHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcCCCCCcH
Confidence 99999999999999999999999999999999999999999999999865332 223467889999999999999999
Q ss_pred hHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 705 CDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 705 sDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+|||||||++|||++ |+.||.+....+....+. .+.++..|. ..+.+||.+||. ||.+|||+.++++.|+++..
T Consensus 367 sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 999999999999998 999999887777666554 344555553 469999999999 99999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=411.58 Aligned_cols=348 Identities=27% Similarity=0.551 Sum_probs=264.5
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccccccccccccCCCCCCCccC
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 477 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~~~~s~~~~slPssp~~~~ 477 (782)
.+.|.|.+++..|.. +.+|+|++|.|+ ...+.+.+++.. +++.+||.+.+..... .-.... ..+
T Consensus 109 hg~i~r~~ae~ll~~--~~~G~fLvR~s~----~~~~~~~lsv~~-----~~~v~h~~I~~~~~g~---~~~~~~-~~F- 172 (495)
T 1opk_A 109 HGPVSRNAAEYLLSS--GINGSFLVRESE----SSPGQRSISLRY-----EGRVYHYRINTASDGK---LYVSSE-SRF- 172 (495)
T ss_dssp EEECCHHHHHHHGGG--CCTTEEEEEECS----SSTTCEEEEEEE-----TTEEEEEECEECTTSC---EESSTT-SCB-
T ss_pred ccCCCHHHHHHHhhC--CCCceEEEEeCC----CCCCceEEEEee-----CCeEEEEEEEecCCCc---eEeccC-ccc-
Confidence 356778888866643 678999999998 445677777764 3467788776531110 000000 000
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhhhcc-------CCcc-cCCC-----ccccccccccCCCeeEeeEEeeeCcEEEEEEE
Q 003971 478 SHGSERGGSSGYMANSEFVSTWNKVLE-------SPMF-QNKP-----LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGI 544 (782)
Q Consensus 478 s~~S~~~~ss~~~~~s~~~s~~~~~l~-------sp~~-~~~p-----~~~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~ 544 (782)
..-.+.+..+..... .+.. ...+ ...+..|++..++|.+.++||+|+||.||+|.
T Consensus 173 ------------~sl~eLv~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~ 240 (495)
T 1opk_A 173 ------------NTLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGV 240 (495)
T ss_dssp ------------SSHHHHHHHHTTCCTTSSSCCCEECCCCSCCCCSSSCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEE
T ss_pred ------------hhHHHHhhhhcccccccchhccccccccccccccccCccccccccCHHHceeeeEecCCCCeEEEEEE
Confidence 000011110000000 0000 0000 11356788999999999999999999999999
Q ss_pred EC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecccchhhHHHhhcccccch
Q 003971 545 WN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 622 (782)
Q Consensus 545 ~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls 622 (782)
+. +..||||++..... ..+.|.+|+.+|+.++||||++++++|.+...+++||||+++|+|.+++... ....++
T Consensus 241 ~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~~~~ 316 (495)
T 1opk_A 241 WKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVS 316 (495)
T ss_dssp EGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS-CTTTSC
T ss_pred EcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc-CcCCCC
Confidence 84 78999999875443 2578999999999999999999999999999999999999999999999743 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC-CCCCCCCCcccCccccccCCC
Q 003971 623 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR-DSSSAGTPEWMAPELIRNEPF 701 (782)
Q Consensus 623 ~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~-~~~~~GT~~Y~APEvl~~~~~ 701 (782)
+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....+++.|+|||++.+..+
T Consensus 317 ~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 396 (495)
T 1opk_A 317 AVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396 (495)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCC
Confidence 9999999999999999999999999999999999999999999999999876543222 234456789999999999999
Q ss_pred CchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003971 702 TEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLD 776 (782)
Q Consensus 702 s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~d 776 (782)
+.++|||||||++|||++ |..||.+.....+...+ ..+.+...+. ..+.+|+.+||. ||.+|||+.+|++.|++
T Consensus 397 ~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 475 (495)
T 1opk_A 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475 (495)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 999999999999999999 89999988877665554 4444544443 469999999999 99999999999999998
Q ss_pred hh
Q 003971 777 CE 778 (782)
Q Consensus 777 i~ 778 (782)
+.
T Consensus 476 ~~ 477 (495)
T 1opk_A 476 MF 477 (495)
T ss_dssp SC
T ss_pred HH
Confidence 64
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=423.10 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=205.7
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHH---HHHHHHhCCCCceeeEeccccCCC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCN---EISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~---EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
+..++|.+++.||+|+||+||+|.+ +|+.||||++.+..... .....+.+ ++.+++.++|||||+++++|.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 4467999999999999999999988 58899999997654321 11223334 456667778999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+|+||||++||+|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus 266 ~lylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999999973 457999999999999999999999999999999999999999999999999999887
Q ss_pred cCCCCCCCCCCCCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCC-CCCChH
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGV---LPERVVYAVANEGSRL-EIPEGP 749 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTGk~PF~~~---~~~evl~~i~~~~~~~-~ip~~~ 749 (782)
... ...+.+||+.|||||++. +..|+.++|||||||++|||++|+.||.+. ....+...+....... ..-...
T Consensus 343 ~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 343 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420 (689)
T ss_dssp SSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred CCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence 543 335679999999999996 457999999999999999999999999754 2333444444333222 112346
Q ss_pred HHHHHHHhhh-CCCCCCC-----HHHHHHH
Q 003971 750 LGRLIADCWA-EPQERPS-----CEEILSR 773 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPS-----a~EIL~~ 773 (782)
+.+||.+||. ||.+|++ +.||++|
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 9999999999 9999998 7888875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=382.87 Aligned_cols=248 Identities=25% Similarity=0.444 Sum_probs=222.2
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
...+|++.+.||+|+||.||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 457899999999999999999987 688999999987776777778899999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp ECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred EECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 999999999999863 3578999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCCcccCccccccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHHh
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIADC 757 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-p~~~L~~LI~~C 757 (782)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+.......+. ....+.+|+.+|
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 248 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRF 248 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 34567899999999999988775 8999999999999999999999999988888887776554432 245689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. ||.+|||+.++++|
T Consensus 249 L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 249 LVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCSSTTTSCCHHHHTTC
T ss_pred CCCChhHCcCHHHHhcC
Confidence 99 99999999999876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=415.69 Aligned_cols=260 Identities=26% Similarity=0.514 Sum_probs=218.2
Q ss_pred ccccccCCCeeEee-EEeeeCcEEEEEEEE----CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 003971 517 EEWNIDFSELTVGT-RVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 591 (782)
Q Consensus 517 ~e~~i~~s~y~i~~-~LG~G~fG~VYkg~~----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 591 (782)
.++.++...+.+.. +||+|+||+||+|.+ .++.||||++..........+.|.+|+.+|+.++|||||+++++|.
T Consensus 361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 440 (635)
T 4fl3_A 361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE 440 (635)
T ss_dssp SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34555556666644 899999999999965 3578999999776655556788999999999999999999999996
Q ss_pred CCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 592 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 592 d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
. +.+++||||+.+|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus 441 ~-~~~~lv~E~~~~g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla 516 (635)
T 4fl3_A 441 A-ESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 516 (635)
T ss_dssp S-SSEEEEEECCTTEEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred c-CCEEEEEEccCCCCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence 5 45899999999999999996 3457899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC---CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 003971 672 RIITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP- 746 (782)
Q Consensus 672 ~~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip- 746 (782)
+.+..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....++...+.. +.+...+
T Consensus 517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~ 595 (635)
T 4fl3_A 517 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPA 595 (635)
T ss_dssp HHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCT
T ss_pred cccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 87654321 1223457789999999999999999999999999999998 9999999988877766654 4444444
Q ss_pred --ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003971 747 --EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 781 (782)
Q Consensus 747 --~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~sL 781 (782)
+..+.+||..||. ||.+||++.+|++.|+++.+++
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 3469999999999 9999999999999999987765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=361.97 Aligned_cols=254 Identities=29% Similarity=0.562 Sum_probs=225.4
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC--Cce
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRL 596 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l 596 (782)
+.+..++|.+.+.||+|+||.||+|.++++.||||++..........+.|.+|+.+++.++||||+++++++.+. ...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 456778999999999999999999999999999999987776667778899999999999999999999999887 778
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--ccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g--IIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
+++|||+++|+|.+++... ....+++..++.++.||+.||+|||++| |+||||||+|||++.++.++|+|||++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEEEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred EeeecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999999732 2336899999999999999999999999 999999999999999999999999987653
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCC---chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---h
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFT---EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---G 748 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s---~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~---~ 748 (782)
.. ....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.........+......+.++. .
T Consensus 164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence 22 346789999999999876544 489999999999999999999999998888888877776666553 4
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
.+.+++..||. ||.+|||+.++++.|+++.
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 69999999999 9999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=385.09 Aligned_cols=261 Identities=29% Similarity=0.582 Sum_probs=223.2
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeE
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 586 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL 586 (782)
..|.+..++|.+++.||+|+||.||+|.+. +..||||++... ......+.+.+|+.+++.+ +||||+++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 346677789999999999999999999762 356999998654 3445567899999999999 89999999
Q ss_pred eccccCCCceEEEEEEecccchhhHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcc
Q 003971 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 653 (782)
Q Consensus 587 ~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPe 653 (782)
+++|.+.+.+|+||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 9999999999999999999999999974321 235889999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 003971 654 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 730 (782)
Q Consensus 654 NILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~ 730 (782)
|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999987654322 2234567889999999999999999999999999999999 99999988877
Q ss_pred HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 731 RVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 731 evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+....+.. +.+...+ ...+.+|+.+||. ||.+||++.+++++|+++..
T Consensus 313 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 313 ELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp GHHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 76665544 4444444 3469999999999 99999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=360.71 Aligned_cols=252 Identities=37% Similarity=0.688 Sum_probs=210.2
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccC--hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLT--AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~--~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
+++.++|++.+.||+|+||.||+|.+.++.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 467789999999999999999999999999999998654322 233578899999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc---ccccCCCcccEEEcC--------CCeEEEE
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK---IVHRDLKSANCLVNK--------HWTVKIC 666 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g---IIHrDIKPeNILLd~--------~g~VKLa 666 (782)
+||||+++++|.+++. ...+++..++.++.|++.||+|||++| |+||||||+|||++. ++.+||+
T Consensus 83 lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999999884 457899999999999999999999999 999999999999986 7789999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003971 667 DFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 746 (782)
Q Consensus 667 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip 746 (782)
|||++....... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.........+.........+
T Consensus 159 Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 159 DFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp CCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred cCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 999998765432 235679999999999999999999999999999999999999999998888887777766555554
Q ss_pred C---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 747 E---GPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 747 ~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
. ..+.+++.+||. ||.+|||+.+++++|+++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 3 469999999999 999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=410.75 Aligned_cols=259 Identities=27% Similarity=0.526 Sum_probs=216.6
Q ss_pred ccccccCCCeeEee-EEeeeCcEEEEEEEE----CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 003971 517 EEWNIDFSELTVGT-RVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 591 (782)
Q Consensus 517 ~e~~i~~s~y~i~~-~LG~G~fG~VYkg~~----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 591 (782)
..+.+...++.+.+ .||+|+||.||+|.+ ++..||||++.... .....+.|.+|+.+|+.++|||||+++++|.
T Consensus 328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 406 (613)
T 2ozo_A 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406 (613)
T ss_dssp CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence 34566777888777 899999999999976 35579999987543 2334678999999999999999999999997
Q ss_pred CCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 592 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 592 d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
. +.+++||||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus 407 ~-~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 407 A-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp S-SSEEEEEECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred c-CCeEEEEEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 6 569999999999999999862 3456899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC---CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 003971 672 RIITDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE 747 (782)
Q Consensus 672 ~~l~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~ 747 (782)
+.+...... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....++...+.. +.+...|.
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~ 562 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPP 562 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT-TCCCCCCT
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 876433211 122346689999999999999999999999999999998 9999999888877766554 44555543
Q ss_pred ---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 748 ---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 748 ---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
..+.+||..||. ||.+||++.+|++.|+++..+
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 469999999999 999999999999999988654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=361.33 Aligned_cols=256 Identities=31% Similarity=0.630 Sum_probs=222.9
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
.|.+..++|++.+.||+|+||.||+|.+ +++.||+|++....... +.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 5778889999999999999999999988 78889999997654433 5688999999999999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEEECCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEEEEeCCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999999999863 345689999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHH
Q 003971 677 SPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLG 751 (782)
Q Consensus 677 ~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~ 751 (782)
... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+.... ....+ +..+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHVY 237 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCTTSCHHHH
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-cCCCCCcCCHHHH
Confidence 211 2234567889999999999999999999999999999999 999999998888777766542 22222 45799
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 752 RLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+++..||. ||.+||++.+++++|+++..
T Consensus 238 ~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 99999999 99999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=380.99 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=218.9
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
+..++|.+.+.||+|+||+||++.+ +|+.||||++.+... .....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 3457899999999999999999987 588999999975432 2234567889999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 82 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999998873 457899999999999999999999999999999999999999999999999999875444
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIAD 756 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~ 756 (782)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+ .-...+.+|+.+
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 4445577899999999999999999999999999999999999999999888888777766543322 224579999999
Q ss_pred hhh-CCCCCC-----CHHHHHHH
Q 003971 757 CWA-EPQERP-----SCEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRP-----Sa~EIL~~ 773 (782)
||. ||.+|| ++.++++|
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HhhcCHHHhcCCCCCCHHHHHcC
Confidence 999 999999 89999876
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=370.90 Aligned_cols=245 Identities=28% Similarity=0.466 Sum_probs=215.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
..+|++.+.||+|+||+||+|.+ +++.||||++....... .+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 36799999999999999999986 68899999987554332 467889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+.+|+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 97 e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp ECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred ECCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 99999999999863 35899999999999999999999999999999999999999999999999999887655555
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC---ChHHHHHHHH
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP---EGPLGRLIAD 756 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip---~~~L~~LI~~ 756 (782)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+....... ..+ +..+.+|+.+
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 252 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHH
Confidence 566789999999999999999999999999999999999999999988877777665544322 222 3358999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003971 757 CWA-EPQERPSCEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~ 773 (782)
||. ||.+|||+.+++++
T Consensus 253 ~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 253 CLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HSCSSTTTSCCHHHHTTC
T ss_pred HccCChhHCcCHHHHhhC
Confidence 999 99999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=375.81 Aligned_cols=265 Identities=31% Similarity=0.563 Sum_probs=223.0
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeE
Q 003971 515 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 586 (782)
Q Consensus 515 ~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL 586 (782)
....|++..++|.+++.||+|+||.||+|.+ +++.||||++.... .....+.+.+|+.+++++ +||||+++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 3567888899999999999999999999974 34789999986543 344567899999999999 79999999
Q ss_pred eccccCCCc-eEEEEEEecccchhhHHHhhcc------------------------------------------------
Q 003971 587 LGACTKPPR-LSMITEYMELGSLYHLIHLSGQ------------------------------------------------ 617 (782)
Q Consensus 587 ~g~~~d~~~-l~LV~Ey~~gGsL~dlL~~~~~------------------------------------------------ 617 (782)
+++|.+.+. +++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999887654 8999999999999999974321
Q ss_pred ---------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC--C
Q 003971 618 ---------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--R 680 (782)
Q Consensus 618 ---------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~--~ 680 (782)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence 11289999999999999999999999999999999999999999999999999987643321 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHH
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIAD 756 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~ 756 (782)
.....||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.............+.....+ ...+.+++..
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 331 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 234568889999999999999999999999999999998 999998877655555555555555444 3469999999
Q ss_pred hhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 757 CWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
||. ||.+|||+.+++++|+.+...
T Consensus 332 ~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HccCChhhCCCHHHHHHHHHHHHHH
Confidence 999 999999999999999987653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=361.06 Aligned_cols=259 Identities=31% Similarity=0.601 Sum_probs=221.1
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
...|.+..++|++.+.||+|+||.||++.+. +..||||++....... +.+.+|+.+++.++||||+++++++.+..
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 4567888899999999999999999999884 5689999997654433 56889999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CeEEEEeccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 99999999999999999863 2456999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC-CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC--CCCCChHH
Q 003971 675 TDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR--LEIPEGPL 750 (782)
Q Consensus 675 ~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~--~~ip~~~L 750 (782)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+...... +...+..+
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 250 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 250 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHH
Confidence 43211 1234557788999999999899999999999999999998 99999999888777776654222 22234579
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 751 GRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 751 ~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.+|+..||. ||.+|||+.+++++|+++..
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 999999999 99999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=357.35 Aligned_cols=257 Identities=28% Similarity=0.579 Sum_probs=221.5
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
.+++..++|++.+.||+|+||.||+|.+. +..||+|++...... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 35677789999999999999999999884 568999998765443 35688999999999999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEEEEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 9999999999999998743 34689999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC--CCCChHHHH
Q 003971 677 SPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL--EIPEGPLGR 752 (782)
Q Consensus 677 ~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~--~ip~~~L~~ 752 (782)
... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+....... ...+..+.+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence 322 1234556778999999999889999999999999999999 999999988887777665543221 222457999
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 753 LIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
++..||. ||.+|||+.+++++|+.+..
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 9999999 99999999999999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=370.05 Aligned_cols=262 Identities=31% Similarity=0.540 Sum_probs=223.2
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEECC-------eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecc
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g-------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~ 589 (782)
..+.+..++|.+.+.||+|+||.||+|.+.+ +.||||++.... .....+.|.+|+.+++.++||||++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3466778899999999999999999998753 789999987543 34456789999999999999999999999
Q ss_pred ccCCCceEEEEEEecccchhhHHHhhcc---------------------cccchHHHHHHHHHHHHHHHHHHHhcccccc
Q 003971 590 CTKPPRLSMITEYMELGSLYHLIHLSGQ---------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648 (782)
Q Consensus 590 ~~d~~~l~LV~Ey~~gGsL~dlL~~~~~---------------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHr 648 (782)
+.+.+.+++||||+++|+|.+++..... ...+++..++.++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 9999999999999999999999974321 2578999999999999999999999999999
Q ss_pred CCCcccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 003971 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWE 725 (782)
Q Consensus 649 DIKPeNILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~ 725 (782)
||||+|||++.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987643221 2234568899999999999899999999999999999999 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 726 GVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 726 ~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
+.........+.... ....+ +..+.+|+.+||. ||.+||++.+++++|+++...
T Consensus 279 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 279 GMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCChHHHHHHHhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 998887777665543 33333 3469999999999 999999999999999987654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=382.19 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=212.2
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCce
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 596 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l 596 (782)
+..++|.+.+.||+|+||+||+|.+ +++.||||++.+... .....+.+.+|+.+++.+ +||||+++++++.+...+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4568999999999999999999987 478999999975432 233456788999999988 699999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
|+||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++....
T Consensus 100 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999999873 45799999999999999999999999999999999999999999999999999986544
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHH
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIA 755 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-p~~~L~~LI~ 755 (782)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+.......+. ....+.+|+.
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 256 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILK 256 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 444455778999999999999988999999999999999999999999999998888888775543322 2456899999
Q ss_pred Hhhh-CCCCCCCH------HHHHHH
Q 003971 756 DCWA-EPQERPSC------EEILSR 773 (782)
Q Consensus 756 ~CL~-DP~kRPSa------~EIL~~ 773 (782)
+||. ||.+||++ .++++|
T Consensus 257 ~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 257 SFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHhhhCHHHccCCcccCCHHHHhhC
Confidence 9999 99999998 778764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=363.09 Aligned_cols=263 Identities=32% Similarity=0.596 Sum_probs=224.6
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEe
Q 003971 515 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 587 (782)
Q Consensus 515 ~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~ 587 (782)
....|.+..++|.+.+.||+|+||.||+|.+ .++.||||++.... .....+.+.+|+.+++.++||||++++
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 3456788889999999999999999999976 24789999986443 455568899999999999999999999
Q ss_pred ccccCCCceEEEEEEecccchhhHHHhhcc---------------------cccchHHHHHHHHHHHHHHHHHHHhcccc
Q 003971 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQ---------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIV 646 (782)
Q Consensus 588 g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~---------------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gII 646 (782)
+++.+.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||++||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 172 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 999999999999999999999999975322 23589999999999999999999999999
Q ss_pred ccCCCcccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCC
Q 003971 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRP 723 (782)
Q Consensus 647 HrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~P 723 (782)
||||||+|||++.++.+||+|||++........ ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654322 2234567889999999999999999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 724 WEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 724 F~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
|.+.........+.. +.....+ +..+.+|+.+||. ||.+||++.+++++|+++..
T Consensus 253 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 253 YPGIPPERLFNLLKT-GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp STTCCGGGHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHhhc-CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 998887776655544 3333333 3469999999999 99999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=363.73 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=207.6
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh------------------------HHHHHHHHHHHHH
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA------------------------ENMEDFCNEISIL 575 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~------------------------~~~e~f~~EI~iL 575 (782)
..++|.+.+.||+|+||.||+|.+ +++.||||++....... ...+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 357899999999999999999987 58899999987654211 1235788999999
Q ss_pred HhCCCCceeeEeccccC--CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcc
Q 003971 576 SRLRHPNVILFLGACTK--PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 653 (782)
Q Consensus 576 k~L~HPNIVkL~g~~~d--~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPe 653 (782)
+.++||||+++++++.+ ...+++||||+++++|.+++. ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 99999999999999876 567999999999999988653 457999999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 003971 654 NCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLPE 730 (782)
Q Consensus 654 NILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~---~s~ksDVWSLGvILyELLTGk~PF~~~~~~ 730 (782)
|||++.++.+||+|||++..............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 99999999999999999988765443445678999999999998765 378899999999999999999999988877
Q ss_pred HHHHHHHhcCCCCCC---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 731 RVVYAVANEGSRLEI---PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 731 evl~~i~~~~~~~~i---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.....+.......+. -...+.+|+.+||. ||.+||++.++++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 776666554433322 23469999999999 99999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=376.79 Aligned_cols=246 Identities=24% Similarity=0.398 Sum_probs=218.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|.+.+.||+|+||.||+|.+ +|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 5799999999999999999988 48899999998777666677889999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC---CeEEEEecCccccccCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH---WTVKICDFGLSRIITDSP 678 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~---g~VKLaDFGLA~~l~~~~ 678 (782)
|+.+|+|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 109 ~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 109 LVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred cCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 999999998886 34578999999999999999999999999999999999999765 459999999998775432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~L 753 (782)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+.+ +..+.+|
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 186 -AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264 (362)
T ss_dssp -SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred -ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 3345789999999999999999999999999999999999999999998888887777655444332 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. ||.+||++.+++++
T Consensus 265 i~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 265 IDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999 99999999999876
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=362.16 Aligned_cols=247 Identities=22% Similarity=0.299 Sum_probs=208.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|++.++||+|+||+||+|.+ +++.||||++............+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999988 57899999998776666666888999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+.+ ++.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9986 44444432 34679999999999999999999999999999999999999999999999999998876544445
Q ss_pred CCCCCCCcccCccccccCC-CCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhcCCCCC---------------
Q 003971 682 SSSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELCTLNRP-WEGVLPERVVYAVANEGSRLE--------------- 744 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~-~s~ksDVWSLGvILyELLTGk~P-F~~~~~~evl~~i~~~~~~~~--------------- 744 (782)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.........+......+.
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 5678999999999997765 89999999999999999998887 566666666655543211110
Q ss_pred ---------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 ---------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 ---------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..+..+.+|+.+||. ||.+|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 012357899999999 99999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=388.86 Aligned_cols=247 Identities=24% Similarity=0.381 Sum_probs=220.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|.+.+.||+|+||+||+|.+ +|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 5799999999999999999987 68999999998777666667889999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc---CCCeEEEEecCccccccCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd---~~g~VKLaDFGLA~~l~~~~ 678 (782)
|+.+|+|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 91 ~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 91 LVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred eCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999999887 345799999999999999999999999999999999999998 46789999999998876554
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~L 753 (782)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.......+.+ +..+.+|
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 247 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 44456789999999999999999999999999999999999999999999888888887765544332 3469999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. ||.+|||+.++++|
T Consensus 248 i~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 248 INKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHcCCChhHCCCHHHHhcC
Confidence 999999 99999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=365.29 Aligned_cols=256 Identities=30% Similarity=0.558 Sum_probs=213.2
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
.+..++|.+++.||+|+||+||+|.+ +++.||+|++.. ......+.|.+|+.+++.++||||+++++++.+....+
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 34568999999999999999999988 488999998854 34556688999999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEEECCTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEecCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 99999999999999973 2457899999999999999999999999999999999999999999999999999876443
Q ss_pred CCCC--------------CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHh
Q 003971 678 PMRD--------------SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER-----VVYAVAN 738 (782)
Q Consensus 678 ~~~~--------------~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~e-----vl~~i~~ 738 (782)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2211 15679999999999999999999999999999999999999986532211 1111111
Q ss_pred cCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 739 EGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 739 ~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
......+ +..+.+|+.+||. ||.+|||+.++++.|+++...
T Consensus 242 ~~~~~~~-~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 242 RYCPPNC-PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HTCCTTC-CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCCCC-CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1112222 3458999999999 999999999999999988643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=360.50 Aligned_cols=264 Identities=28% Similarity=0.520 Sum_probs=224.9
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEe
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 587 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 587 (782)
...|++..++|.+.+.||+|+||.||+|.+ .++.||||++.... .....+.+.+|+.+++.+ +||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 456888889999999999999999999975 35789999987543 334467899999999999 899999999
Q ss_pred ccccCCCceEEEEEEecccchhhHHHhhcc---------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCc
Q 003971 588 GACTKPPRLSMITEYMELGSLYHLIHLSGQ---------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 652 (782)
Q Consensus 588 g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~---------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKP 652 (782)
+++.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999999999999974321 12589999999999999999999999999999999
Q ss_pred ccEEEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 003971 653 ANCLVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLP 729 (782)
Q Consensus 653 eNILLd~~g~VKLaDFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~ 729 (782)
+|||++.++.+||+|||++......... .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+...
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999999999999876543221 224457789999999999999999999999999999999 9999988776
Q ss_pred HHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 730 ERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 730 ~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
................+ +..+.+|+.+||. ||.+|||+.+++++|+++..+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 66566555555444433 3469999999999 999999999999999987643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=371.47 Aligned_cols=263 Identities=28% Similarity=0.514 Sum_probs=220.2
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEec
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 588 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g 588 (782)
.+|++..++|.+.+.||+|+||.||+|.+ .+..||||++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 35788889999999999999999999986 35579999986443 233457889999999999 8999999999
Q ss_pred cccCCCceEEEEEEecccchhhHHHhhcc--------------------cccchHHHHHHHHHHHHHHHHHHHhcccccc
Q 003971 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQ--------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648 (782)
Q Consensus 589 ~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~--------------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHr 648 (782)
++...+.+++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999999999999974321 1347999999999999999999999999999
Q ss_pred CCCcccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 003971 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWE 725 (782)
Q Consensus 649 DIKPeNILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~ 725 (782)
||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999987643322 1224457889999999999999999999999999999998 999998
Q ss_pred CCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 726 GVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 726 ~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
+.............+.....+ +..+.+|+..||. ||.+|||+.+++++|+.+...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 887666666666665555444 3479999999999 999999999999999987543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=375.76 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=216.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH----HHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE----NMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~----~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
+.|.+++.||+|+||+||+|.+ +|+.||+|++........ ..+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 5799999999999999999988 588999999976553221 3467899999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC----eEEEEecCcccc
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRI 673 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g----~VKLaDFGLA~~ 673 (782)
+||||+++|+|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 92 lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 92 LILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999986 456799999999999999999999999999999999999998776 799999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCCh
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEG 748 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-----ip~~ 748 (782)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+........ ....
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 247 (361)
T 2yab_A 169 IEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247 (361)
T ss_dssp CCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 7543 233467899999999999999999999999999999999999999999988888887766543332 1234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+.+||.+||. ||.+|||+.++++|
T Consensus 248 ~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 248 LAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 68999999999 99999999999965
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=352.02 Aligned_cols=256 Identities=31% Similarity=0.634 Sum_probs=222.0
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
+|.++.++|.+.+.||+|+||.||++.+ ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 4677889999999999999999999988 6788999999765443 36788999999999999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
+++|||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp EEEECCCTTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEEEeCCCCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999999999863 235689999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHH
Q 003971 677 SPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLG 751 (782)
Q Consensus 677 ~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~ 751 (782)
... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...........+.... ....+ +..+.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~ 235 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHVY 235 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCTTSCHHHH
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-cCCCCccCcHHHH
Confidence 211 1234567889999999998899999999999999999999 899999988887777665532 22222 45799
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 752 RLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+++.+||. ||.+||++.+++++|+++..
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999 99999999999999998854
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=365.83 Aligned_cols=264 Identities=25% Similarity=0.451 Sum_probs=206.6
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC--Ce---EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN--GT---DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 590 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~--g~---~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~ 590 (782)
.+.+.+..++|.+.+.||+|+||.||+|.+. +. .||||++..........+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 3456677789999999999999999999763 22 799999976655556678899999999999999999999999
Q ss_pred cCCCce------EEEEEEecccchhhHHHhhccc---ccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC
Q 003971 591 TKPPRL------SMITEYMELGSLYHLIHLSGQK---KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 661 (782)
Q Consensus 591 ~d~~~l------~LV~Ey~~gGsL~dlL~~~~~~---~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g 661 (782)
...... +++|||+.+|+|.+++...... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 876654 9999999999999998643221 2589999999999999999999999999999999999999999
Q ss_pred eEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 003971 662 TVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVAN 738 (782)
Q Consensus 662 ~VKLaDFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~ 738 (782)
.+||+|||+++........ .....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+.........+..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 9999999999876443221 223457789999999999999999999999999999999 8999999888777777665
Q ss_pred cCCCCCCC--ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 739 EGSRLEIP--EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 739 ~~~~~~ip--~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.......+ ...+.+|+.+||. ||.+|||+.++++.|+++..
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 44322221 3469999999999 99999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=366.58 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=206.3
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
-.++|++.++||+|+||+||+|.+ +|+.||+|++............+.+|+.+++.++||||+++++++.+...+++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 347899999999999999999988 6889999998765554445678899999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++ +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 99985 77777652 3456899999999999999999999999999999999999999999999999999887554444
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---C-----------
Q 003971 681 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---I----------- 745 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~---i----------- 745 (782)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+. .
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 456789999999999876 5689999999999999999999999988776665555543111110 0
Q ss_pred -----------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 -----------------PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 -----------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
-...+.+|+.+||. ||.+|||+.|+++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 01357789999999 99999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=361.15 Aligned_cols=247 Identities=22% Similarity=0.317 Sum_probs=205.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
++|++.+.||+|+||+||+|.+ .++.||+|++..........+.+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 6899999999999999999988 488999999876554443446788999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+++ +|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 986 88888763 235789999999999999999999999999999999999999999999999999987654433344
Q ss_pred CCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------------
Q 003971 683 SSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------ 743 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~------------------ 743 (782)
...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 5678999999999876 458999999999999999999999999988777766654321100
Q ss_pred ------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..-+..+.+|+.+||. ||.+|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0012357899999999 99999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=359.07 Aligned_cols=260 Identities=33% Similarity=0.661 Sum_probs=208.7
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 515 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 515 ~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
..+.+++...+|++.++||+|+||.||+|.+.+ .+|||++..........+.|.+|+.+++.++||||+++++++ ...
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 345677888999999999999999999998766 499999987766677778899999999999999999999965 455
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
..++||||+.+++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred ccEEEEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 68999999999999998853 3457899999999999999999999999999999999999999999999999999765
Q ss_pred cCC--CCCCCCCCCCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC--
Q 003971 675 TDS--PMRDSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP-- 746 (782)
Q Consensus 675 ~~~--~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip-- 746 (782)
... ........||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.............+... ..+
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc
Confidence 432 12223467999999999986 6678999999999999999999999998876666555555443322 211
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 747 ----EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 747 ----~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
+..+.+|+.+||. ||.+||++.++++.|+++.
T Consensus 251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 2469999999999 9999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=368.27 Aligned_cols=256 Identities=32% Similarity=0.541 Sum_probs=218.4
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
++...+|.+.+.||+|+||.||+|.+ .+..||||++.... .....+.|.+|+.+++.++||||+++++++.+..
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45567899999999999999999987 24569999986543 4455678999999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
..++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred ccEEEeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999863 3457899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC---CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003971 675 TDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 747 (782)
Q Consensus 675 ~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~ 747 (782)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+... .....+ +
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCCCCCCcC
Confidence 54321 1223456788999999999999999999999999999999 99999999888877776554 333333 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 748 GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 748 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
..+.+|+..||. ||.+||++.+|++.|+.+..
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 469999999999 99999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=368.19 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=206.1
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeecccc--ChHHHHHHHHHHHHHHhCCCCceeeEeccccC
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRLRHPNVILFLGACTK 592 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~--~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 592 (782)
.+..++|.+.+.||+|+||.||++.+ +++.||+|++..... .......+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 34557899999999999999999986 578999999876543 22334668899999999999999999999999
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
.+.+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred CCEEEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999999873 3568999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHH
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLG 751 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~ 751 (782)
............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ .-...+.
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 654443344567899999999999999999999999999999999999999999988888777766443222 2245799
Q ss_pred HHHHHhhh-CCCCCC-----CHHHHHHH
Q 003971 752 RLIADCWA-EPQERP-----SCEEILSR 773 (782)
Q Consensus 752 ~LI~~CL~-DP~kRP-----Sa~EIL~~ 773 (782)
+|+.+||. ||.+|| ++.++++|
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 99999999 999999 78888875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=371.47 Aligned_cols=261 Identities=30% Similarity=0.558 Sum_probs=224.3
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeE
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 586 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL 586 (782)
..|++..++|.+++.||+|+||.||+|.+. +..||||++... ......+.+.+|+.+++.+ +||||+++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 456778899999999999999999999863 257999998654 3445568899999999999 89999999
Q ss_pred eccccCCCceEEEEEEecccchhhHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcc
Q 003971 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 653 (782)
Q Consensus 587 ~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPe 653 (782)
++++.+.+.+++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 9999999999999999999999999974321 245899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 003971 654 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 730 (782)
Q Consensus 654 NILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~ 730 (782)
|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654322 2234567889999999999999999999999999999999 99999998887
Q ss_pred HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 731 RVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 731 evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.....+.. +.....+ ...+.+|+.+||. ||.+||++.+++++|+.+..
T Consensus 301 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 301 ELFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp HHHHHHHT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHc-CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 77666554 3333333 3469999999999 99999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=369.68 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=212.0
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC--
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-- 594 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~-- 594 (782)
.++.+...+|++.+.||+|+||+||+|.+.++.||||++.... .....+..|+.+++.++||||+++++++.+..
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 4567788999999999999999999999999999999986442 23345667999999999999999999997754
Q ss_pred --ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc----------cccccCCCcccEEEcCCCe
Q 003971 595 --RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM----------KIVHRDLKSANCLVNKHWT 662 (782)
Q Consensus 595 --~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~----------gIIHrDIKPeNILLd~~g~ 662 (782)
.+++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. ||+||||||+|||++.++.
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred CceEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 37999999999999999963 3589999999999999999999999 9999999999999999999
Q ss_pred EEEEecCccccccCCCC--CCCCCCCCCcccCccccccC-----CCCchhHHHHHHHHHHHHHhCCCCCCCC--------
Q 003971 663 VKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNE-----PFTEKCDIFSLGVIMWELCTLNRPWEGV-------- 727 (782)
Q Consensus 663 VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~-----~~s~ksDVWSLGvILyELLTGk~PF~~~-------- 727 (782)
+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999999987654322 22346799999999999863 4567899999999999999999999653
Q ss_pred --------ChHHHHHHHHhcCCCCCCCC--------hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 728 --------LPERVVYAVANEGSRLEIPE--------GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 728 --------~~~evl~~i~~~~~~~~ip~--------~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
........+......+.++. ..+.+|+.+||. ||.+|||+.++++.|+++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 22233333333333443332 138899999999 99999999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=352.94 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=218.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|.+.+.||+|+||.||+|.+ +++.||+|++..........+.+.+|+.+++.++||||+++++++.+....+++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 37899999999999999999987 4889999999877777677788999999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe---EEEEecCccccccCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLSRIITDS 677 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~---VKLaDFGLA~~l~~~ 677 (782)
||+.+++|.+.+.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999999988863 356899999999999999999999999999999999999976655 999999999876543
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGR 752 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~ 752 (782)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.........+ +..+.+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 162 E-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp C-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred c-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 2 3345679999999999999999999999999999999999999999998888888777655444332 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003971 753 LIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
|+.+||. ||.+|||+.+++++
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHcccChhhCCCHHHHhcC
Confidence 9999999 99999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=359.71 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=205.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|++.+.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 36899999999999999999988 4889999998776665556678899999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++++|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 82 e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9999999998876 4457899999999999999999999999999999999999999999999999999887654444
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------------------
Q 003971 681 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------------ 741 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~------------------ 741 (782)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 456689999999999876 6789999999999999999999999998887776655432110
Q ss_pred -CCC-------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 -RLE-------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 -~~~-------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
... -.+..+.+|+.+||. ||.+|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 012347889999999 99999999999976
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=368.90 Aligned_cols=246 Identities=24% Similarity=0.440 Sum_probs=216.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
..++|.+.+.||+|+||+||++.+ +|+.||+|++.+.... ....+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 457899999999999999999987 5889999998754321 2335678899999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
||||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999999999999997 3457899999999999999999999999999999999999999999999999999876442
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHh
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADC 757 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~C 757 (782)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+ .-...+.+|+.+|
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l 237 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 237 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 3467899999999999999999999999999999999999999999988888888776543322 2245799999999
Q ss_pred hh-CCCCCC-----CHHHHHHH
Q 003971 758 WA-EPQERP-----SCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRP-----Sa~EIL~~ 773 (782)
|. ||.+|| +++++++|
T Consensus 238 L~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 238 ITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTS
T ss_pred hccCHHHcCCCcCCCHHHHhcC
Confidence 99 999999 89999865
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=369.84 Aligned_cols=249 Identities=22% Similarity=0.362 Sum_probs=211.1
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~ 597 (782)
..++|.+.+.||+|+||.||++.+ +++.||||++.+... .....+.+.+|+.+++.+ +||||+++++++.+...+|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 457899999999999999999988 488999999976654 344567788999999988 8999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 87 lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999998873 357899999999999999999999999999999999999999999999999999875444
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhcCCCCC-CCC
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV---------LPERVVYAVANEGSRLE-IPE 747 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~---------~~~evl~~i~~~~~~~~-ip~ 747 (782)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ .-.
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s 243 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSC
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCC
Confidence 34455778999999999999999999999999999999999999999752 23333444444332221 123
Q ss_pred hHHHHHHHHhhh-CCCCCCCH------HHHHHH
Q 003971 748 GPLGRLIADCWA-EPQERPSC------EEILSR 773 (782)
Q Consensus 748 ~~L~~LI~~CL~-DP~kRPSa------~EIL~~ 773 (782)
..+.+|+.+||. ||.+||++ .++++|
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 468999999999 99999995 677654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=358.19 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=213.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
.++|++.+.||+|+||.||++.+ .++.||+|++..... .....+.|.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 36899999999999999999987 588999999865443 345567899999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 999999999999873 35789999999999999999999999999999999999999999999999999987654322
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---C---CChHHHH
Q 003971 680 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---I---PEGPLGR 752 (782)
Q Consensus 680 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~---i---p~~~L~~ 752 (782)
......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.................. . -+..+.+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence 22346799999999999999999999999999999999999999999888776666554432211 1 1346899
Q ss_pred HHHHhhh-CCCCCC-CHHHHHHHHHhhh
Q 003971 753 LIADCWA-EPQERP-SCEEILSRLLDCE 778 (782)
Q Consensus 753 LI~~CL~-DP~kRP-Sa~EIL~~L~di~ 778 (782)
++.+||. ||.+|| ++.++++.|+.+.
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 9999999 999998 9999999998763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=374.49 Aligned_cols=250 Identities=20% Similarity=0.335 Sum_probs=216.1
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeecccc-ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCce
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 596 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l 596 (782)
+..++|.+.+.||+|+||+||+|.+. ++.||||++.+... .....+.+..|..++..+ +||||+++++++.+.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 45689999999999999999999984 67899999876432 123356788999999988 799999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++....
T Consensus 97 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999999873 35689999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHH
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIA 755 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~ 755 (782)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+.......+ .-+..+.+|+.
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 253 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 253 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 44445678899999999999999999999999999999999999999999998888888776543322 12346899999
Q ss_pred Hhhh-CCCCCCC-----HHHHHHH
Q 003971 756 DCWA-EPQERPS-----CEEILSR 773 (782)
Q Consensus 756 ~CL~-DP~kRPS-----a~EIL~~ 773 (782)
+||. ||.+||+ +.+|++|
T Consensus 254 ~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 254 GLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999 9999995 5777765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=376.35 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=215.8
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCC
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPP 594 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~ 594 (782)
..+..++|.+.+.||+|+||+||+|.+ +|+.||||++.+... .....+.+..|..++..+ +||||+++++++.+..
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 345678999999999999999999988 588999999975432 122356778899999877 8999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++..
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999999873 357899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHH
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRL 753 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~L 753 (782)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+ .-+..+.+|
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 248 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 4433345577899999999999999999999999999999999999999999988888877766543322 224579999
Q ss_pred HHHhhh-CCCCCCCHH-HHHHH
Q 003971 754 IADCWA-EPQERPSCE-EILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~-EIL~~ 773 (782)
+.+||. ||.+||++. +|++|
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHhcCCHhHcCCChHHHHcC
Confidence 999999 999999997 77643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.55 Aligned_cols=246 Identities=26% Similarity=0.418 Sum_probs=214.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh----HHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~----~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
+.|.+.+.||+|+||.||++.+ +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+...++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5699999999999999999988 48899999987654322 13577899999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC----eEEEEecCcccc
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRI 673 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g----~VKLaDFGLA~~ 673 (782)
+||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999986 446799999999999999999999999999999999999998887 899999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCCh
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEG 748 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-----ip~~ 748 (782)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+........ ..+.
T Consensus 168 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 168 IDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp CCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence 75432 33456899999999999999999999999999999999999999999888887777665443322 1234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+.+|+.+||. ||.+|||+.++++|
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 68899999999 99999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=363.28 Aligned_cols=262 Identities=29% Similarity=0.560 Sum_probs=223.3
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEECC-------eEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEec
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 588 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g-------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g 588 (782)
+.|++..++|.+.+.||+|+||.||+|.+.+ ..||+|++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4688889999999999999999999998742 379999986543 344567899999999999 8999999999
Q ss_pred cccCCCceEEEEEEecccchhhHHHhhcc-----------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE
Q 003971 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQ-----------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV 657 (782)
Q Consensus 589 ~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~-----------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL 657 (782)
++.+.+.+++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 99999999999999999999999874321 3457999999999999999999999999999999999999
Q ss_pred cCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 003971 658 NKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVY 734 (782)
Q Consensus 658 d~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~ 734 (782)
+.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 9999999999999986643321 1234457789999999999999999999999999999998 899998877666666
Q ss_pred HHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 735 AVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 735 ~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.+.........+ +..+.+|+..||. ||.+|||+.+++++|+++..
T Consensus 278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 666555544433 4569999999999 99999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=361.52 Aligned_cols=263 Identities=31% Similarity=0.562 Sum_probs=223.9
Q ss_pred ccccccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceee
Q 003971 513 LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 585 (782)
Q Consensus 513 ~~~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVk 585 (782)
....++|++..++|.+.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEee
Confidence 3445778888899999999999999999999754 5789999986443 3344567999999999999999999
Q ss_pred EeccccCCCceEEEEEEecccchhhHHHhhcc-------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc
Q 003971 586 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN 658 (782)
Q Consensus 586 L~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~-------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd 658 (782)
+++++.+....++||||+++|+|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 172 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc
Confidence 99999999999999999999999999874321 14568999999999999999999999999999999999999
Q ss_pred CCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 003971 659 KHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYA 735 (782)
Q Consensus 659 ~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~ 735 (782)
.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 999999999999986643321 1223457889999999999999999999999999999999 8899999888877776
Q ss_pred HHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 736 VANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 736 i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
+..... ...+ +..+.+|+.+||. ||.+|||+.+++++|++.
T Consensus 253 ~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 253 VMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 655433 2222 3469999999999 999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=354.99 Aligned_cols=258 Identities=30% Similarity=0.536 Sum_probs=207.6
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 591 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 591 (782)
.++++..++|.+.+.||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 456677789999999999999999999873 4569999976432 3445678999999999999999999999985
Q ss_pred CCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 592 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 592 d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
+ +..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 87 ~-~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 87 E-NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp S-SSCEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred c-CccEEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccc
Confidence 4 568999999999999999863 2346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003971 672 RIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP--- 746 (782)
Q Consensus 672 ~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip--- 746 (782)
........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.... ....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~ 242 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNC 242 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTC
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCCCCCCC
Confidence 87654322 2234457789999999999999999999999999999996 899999888777776665433 33333
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 747 EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 747 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+..+.+++.+||. ||.+||++.+++++|+++..
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 3469999999999 99999999999999998743
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=370.03 Aligned_cols=249 Identities=26% Similarity=0.377 Sum_probs=210.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc---ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~---~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
++|.+.+.||+|+||+||+|.+ +++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5799999999999999999987 588999999864321 11135778999999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe---EEEEecCccccc
Q 003971 599 ITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLSRII 674 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~---VKLaDFGLA~~l 674 (782)
||||+++++|.+.+.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 999999999987775332 3346899999999999999999999999999999999999986654 999999999887
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCChH
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEGP 749 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-----ip~~~ 749 (782)
..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ......+........ .....
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~ 262 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISES 262 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHH
Confidence 665444556789999999999999999999999999999999999999998853 444555544333221 12346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+|+.+||. ||.+|||+.++++|
T Consensus 263 ~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 263 AKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 8999999999 99999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=356.67 Aligned_cols=258 Identities=28% Similarity=0.505 Sum_probs=209.0
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC-
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK- 592 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d- 592 (782)
++..++|++.+.||+|+||+||+|.+ +++.||||++... .....+.|.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 34557899999999999999999984 5789999998643 34556789999999999999999999998854
Q ss_pred -CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 593 -PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 593 -~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
...+++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 35689999999999999999732 346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC---CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---------------HH
Q 003971 672 RIITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER---------------VV 733 (782)
Q Consensus 672 ~~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~e---------------vl 733 (782)
........ ......+++.|+|||.+.+..++.++|||||||++|+|+||..||....... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 87654321 1234457778999999999999999999999999999999999986532211 11
Q ss_pred HHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003971 734 YAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 781 (782)
Q Consensus 734 ~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~sL 781 (782)
........+...+ +..+.+|+..||. ||.+|||+.++++.|+++...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 2222333344443 3469999999999 9999999999999999986543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=356.32 Aligned_cols=247 Identities=32% Similarity=0.585 Sum_probs=204.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHh--CCCCceeeEeccccC----CCce
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR--LRHPNVILFLGACTK----PPRL 596 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~--L~HPNIVkL~g~~~d----~~~l 596 (782)
.++|++.+.||+|+||+||+|.++++.||||++... ....+..|.+++.. ++||||+++++++.. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 468999999999999999999999999999998543 23566677887777 789999999998644 3458
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHH--------hccccccCCCcccEEEcCCCeEEEEec
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH--------RMKIVHRDLKSANCLVNKHWTVKICDF 668 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLH--------s~gIIHrDIKPeNILLd~~g~VKLaDF 668 (782)
++||||+++|+|.++++ ...+++..++.++.||+.||+||| +.||+||||||+|||++.++.+||+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 99999999999999985 346899999999999999999999 999999999999999999999999999
Q ss_pred CccccccCCCCC----CCCCCCCCcccCccccccC------CCCchhHHHHHHHHHHHHHhC----------CCCCCCC-
Q 003971 669 GLSRIITDSPMR----DSSSAGTPEWMAPELIRNE------PFTEKCDIFSLGVIMWELCTL----------NRPWEGV- 727 (782)
Q Consensus 669 GLA~~l~~~~~~----~~~~~GT~~Y~APEvl~~~------~~s~ksDVWSLGvILyELLTG----------k~PF~~~- 727 (782)
|+++........ .....||+.|+|||++.+. .++.++|||||||++|||++| +.||...
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 999876543222 2345899999999999876 455799999999999999999 8888543
Q ss_pred ----ChHHHHHHHHhcCCCCCCCC--------hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 728 ----LPERVVYAVANEGSRLEIPE--------GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 728 ----~~~evl~~i~~~~~~~~ip~--------~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
...............+.++. ..+.+|+.+||. ||.+|||+.++++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 301 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence 22233333333444444443 248899999999 9999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=356.97 Aligned_cols=253 Identities=23% Similarity=0.430 Sum_probs=209.2
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC--C-------eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWN--G-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 591 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~--g-------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 591 (782)
+..++|.+.+.||+|+||.||+|.+. + ..||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 45678999999999999999999763 2 569999986443 334578999999999999999999999999
Q ss_pred CCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe--------E
Q 003971 592 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--------V 663 (782)
Q Consensus 592 d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~--------V 663 (782)
+.+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999973 2345899999999999999999999999999999999999998877 9
Q ss_pred EEEecCccccccCCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhcCC
Q 003971 664 KICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGS 741 (782)
Q Consensus 664 KLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk-~PF~~~~~~evl~~i~~~~~ 741 (782)
||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|. .||.................
T Consensus 161 kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (289)
T 4fvq_A 161 KLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236 (289)
T ss_dssp EECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred eeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC
Confidence 99999998765332 23457889999999987 67999999999999999999965 45666555554444333322
Q ss_pred CCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003971 742 RLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 781 (782)
Q Consensus 742 ~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~sL 781 (782)
.+......+.+|+.+||. ||.+|||+.+++++|+++..+-
T Consensus 237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 222234569999999999 9999999999999999986653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=366.09 Aligned_cols=245 Identities=21% Similarity=0.313 Sum_probs=215.0
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|.+.+.||+|+||.||+|.+ +++.||+|++... ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 37899999999999999999988 5889999998643 234567889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC--CCeEEEEecCccccccCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK--HWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~--~g~VKLaDFGLA~~l~~~~ 678 (782)
||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 81 EFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999998862 3347899999999999999999999999999999999999987 7899999999998775432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-----p~~~L~~L 753 (782)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+......... .+..+.+|
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 223457899999999999988999999999999999999999999999988888887765544321 23468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. ||.+|||+.++++|
T Consensus 238 i~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 238 VDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999 99999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.39 Aligned_cols=259 Identities=25% Similarity=0.509 Sum_probs=216.7
Q ss_pred ccccccCCCeeEee-EEeeeCcEEEEEEEE----CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 003971 517 EEWNIDFSELTVGT-RVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 591 (782)
Q Consensus 517 ~e~~i~~s~y~i~~-~LG~G~fG~VYkg~~----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 591 (782)
.++.++.++|.+.+ .||+|+||.||+|.+ .++.||||++..........+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 45667778999998 999999999999965 367899999976655555568899999999999999999999999
Q ss_pred CCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 592 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 592 d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
..+..++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 55678999999999999999973 456899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC---CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 003971 672 RIITDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP- 746 (782)
Q Consensus 672 ~~l~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip- 746 (782)
......... .....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+.........+.. +..+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 243 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPA 243 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCT
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 876543221 123456789999999998889999999999999999999 9999999888776665544 3334443
Q ss_pred --ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 747 --EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 747 --~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
+..+.+++.+||. ||.+||++.++++.|+++-.+
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 3469999999999 999999999999999988654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=349.05 Aligned_cols=259 Identities=32% Similarity=0.559 Sum_probs=220.8
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
.++|++..++|++.+.||+|+||.||+|.++ +..||||++...... .+.+.+|+.+++.++||||+++++++.. +
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 3578888999999999999999999999884 568999998654433 4678899999999999999999999875 4
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
..++||||+++++|.+++... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CcEEEEecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 589999999999999998632 2236899999999999999999999999999999999999999999999999999877
Q ss_pred cCCCCC-CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003971 675 TDSPMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 749 (782)
Q Consensus 675 ~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~ 749 (782)
...... .....+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+....+....+... .....+ +..
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEE 238 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHH
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-cCCCCcccccHH
Confidence 543222 234557889999999998889999999999999999999 89999998887777666543 333333 347
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
+.+|+..||. ||.+|||+.++++.|+++...
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 9999999999 999999999999999987543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=357.32 Aligned_cols=263 Identities=31% Similarity=0.566 Sum_probs=220.0
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEe
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 587 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 587 (782)
..+|.+..++|.+.+.||+|+||.||+|.+ +++.||||++.... .....+.+.+|+.+++.+ +||||++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 356778889999999999999999999975 35789999986543 344557899999999999 699999999
Q ss_pred ccccCCC-ceEEEEEEecccchhhHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcc
Q 003971 588 GACTKPP-RLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 653 (782)
Q Consensus 588 g~~~d~~-~l~LV~Ey~~gGsL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPe 653 (782)
+++...+ .++++|||+++++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 9987754 48999999999999999974322 123899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 003971 654 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 730 (782)
Q Consensus 654 NILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~ 730 (782)
|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 99999999999999999987644322 1234457889999999999999999999999999999998 99999887655
Q ss_pred HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 731 RVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 731 evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.........+.....+ ...+.+++..||. ||.+|||+.+++++|+++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 5554444444444443 3469999999999 99999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=371.33 Aligned_cols=259 Identities=29% Similarity=0.511 Sum_probs=219.2
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 591 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 591 (782)
.++..++|.+.+.||+|+||+||+|.+ .++.||||++... ........+.+|+.+++.++||||+++++++.
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 455668999999999999999999984 3568999998643 33445578999999999999999999999999
Q ss_pred CCCceEEEEEEecccchhhHHHhhcc----cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC---eEE
Q 003971 592 KPPRLSMITEYMELGSLYHLIHLSGQ----KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVK 664 (782)
Q Consensus 592 d~~~l~LV~Ey~~gGsL~dlL~~~~~----~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g---~VK 664 (782)
+....++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999999975431 24689999999999999999999999999999999999998554 599
Q ss_pred EEecCccccccCCC--CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003971 665 ICDFGLSRIITDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 741 (782)
Q Consensus 665 LaDFGLA~~l~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~ 741 (782)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~- 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG- 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 99999998653221 12234567899999999999999999999999999999998 999999998888777766543
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 742 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 742 ~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
....+ +..+.+|+.+||. ||.+||++.+|+++|+.+..
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 33322 3469999999999 99999999999999988754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=383.79 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=208.6
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
.+..++|.+.+.||+|+||.||+|.+ +|+.||||++..... .......+.+|+.+++.++||||++++++|.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34557899999999999999999987 588999999875432 233456788999999999999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++...
T Consensus 224 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999998863 4578999999999999999999998 999999999999999999999999999998755
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHH
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLI 754 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI 754 (782)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.......+ .-...+.+|+
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 444445567899999999999999999999999999999999999999999988888887776554332 2245699999
Q ss_pred HHhhh-CCCCCC-----CHHHHHHH
Q 003971 755 ADCWA-EPQERP-----SCEEILSR 773 (782)
Q Consensus 755 ~~CL~-DP~kRP-----Sa~EIL~~ 773 (782)
.+||. ||.+|| ++.++++|
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhC
Confidence 99999 999999 99999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=351.25 Aligned_cols=258 Identities=28% Similarity=0.532 Sum_probs=219.9
Q ss_pred cccccCCCeeEee-EEeeeCcEEEEEEEE----CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC
Q 003971 518 EWNIDFSELTVGT-RVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 592 (782)
Q Consensus 518 e~~i~~s~y~i~~-~LG~G~fG~VYkg~~----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 592 (782)
++.+..++|.+.. .||+|+||.||+|.+ .+..||||++.... .....+.+.+|+.+++.++||||+++++++ .
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 4566778888887 999999999999975 47789999987543 345568899999999999999999999999 4
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
.+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCcEEEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence 4569999999999999998862 34568999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC---CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003971 673 IITDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP-- 746 (782)
Q Consensus 673 ~l~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip-- 746 (782)
........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+.. +..+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~ 237 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPE 237 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-TCCCCCCTT
T ss_pred eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc-CCcCCCCCC
Confidence 76543221 223457889999999998889999999999999999998 9999998888777666554 3333333
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 747 -EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 747 -~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
+..+.+++..||. ||.+||++.+++++|+++..+
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 3479999999999 999999999999999988654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=376.14 Aligned_cols=251 Identities=21% Similarity=0.364 Sum_probs=209.3
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCc
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 595 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~ 595 (782)
.+..++|.+.+.||+|+||+||+|.+ +++.||||++.+.... ....+.+..|+.++..+ +||||+++++++.+...
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 34567899999999999999999987 5789999999765443 23345678899999887 89999999999999999
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+|+||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++...
T Consensus 128 ~~lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999998873 4579999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhcCCCCC-C
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV---------LPERVVYAVANEGSRLE-I 745 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~---------~~~evl~~i~~~~~~~~-i 745 (782)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ .
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 4444556789999999999999999999999999999999999999999643 22223344443332221 1
Q ss_pred CChHHHHHHHHhhh-CCCCCCCH------HHHHHH
Q 003971 746 PEGPLGRLIADCWA-EPQERPSC------EEILSR 773 (782)
Q Consensus 746 p~~~L~~LI~~CL~-DP~kRPSa------~EIL~~ 773 (782)
-...+.+|+.+||. ||.+||++ .+|++|
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 23468999999999 99999985 677665
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=371.10 Aligned_cols=247 Identities=21% Similarity=0.356 Sum_probs=216.8
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
...++|.+.+.||+|+||.||++.+ +|+.||||++.+... .....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 3457899999999999999999988 588999999865432 2234577889999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999999973 346899999999999999999999999999999999999999999999999999876542
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIAD 756 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~ 756 (782)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......+ .-+..+.+|+.+
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 271 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 2456899999999999999999999999999999999999999999988888887776543322 124579999999
Q ss_pred hhh-CCCCCCC-----HHHHHHH
Q 003971 757 CWA-EPQERPS-----CEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPS-----a~EIL~~ 773 (782)
||. ||.+||+ +.+|++|
T Consensus 272 lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 272 LLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HhhcCHHhccCCccCCHHHHHhC
Confidence 999 9999998 8888865
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=360.08 Aligned_cols=261 Identities=28% Similarity=0.571 Sum_probs=222.0
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeE
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 586 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL 586 (782)
..|.+..++|.+++.||+|+||.||+|.+. +..||||++.... .....+.+.+|+.+++.+ +||||+++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 456778899999999999999999999863 5679999986543 345567899999999999 89999999
Q ss_pred eccccCCCceEEEEEEecccchhhHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcc
Q 003971 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 653 (782)
Q Consensus 587 ~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPe 653 (782)
++++.+.+.+++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 9999999999999999999999999974321 234899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 003971 654 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 730 (782)
Q Consensus 654 NILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~ 730 (782)
|||++.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999987654322 1234567889999999998889999999999999999999 99999998887
Q ss_pred HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 731 RVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 731 evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+....+... .....+ ...+.+++..||. ||.+||++.+++++|+++..
T Consensus 267 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 267 ELFKLLKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcC-CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 776665543 333333 3469999999999 99999999999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=364.94 Aligned_cols=247 Identities=23% Similarity=0.371 Sum_probs=204.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|++.+.||+|+||+||+|.+ +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 47899999999999999999987 5889999998654432 22467889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC--C
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS--P 678 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~--~ 678 (782)
||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+... .
T Consensus 85 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999999886 4557999999999999999999999999999999999999999999999999999865422 1
Q ss_pred CCCCCCCCCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHhcCCCCCC---CChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA-VANEGSRLEI---PEGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~-i~~~~~~~~i---p~~~L~~L 753 (782)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........... +......... ....+.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 22346789999999999988765 7799999999999999999999987655433322 2222222211 23468899
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. ||.+|||+.|++++
T Consensus 242 i~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHccCChhhCcCHHHHhhC
Confidence 999999 99999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=359.46 Aligned_cols=243 Identities=25% Similarity=0.390 Sum_probs=211.9
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
.|...+.||+|+||.||+|.+ +|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 377788999999999999987 589999999875443 2346788999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+++++|.+++. ...+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus 124 ~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 124 LQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 99999999885 34689999999999999999999999999999999999999999999999999987765433445
Q ss_pred CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----CChHHHHHHHHhh
Q 003971 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI----PEGPLGRLIADCW 758 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i----p~~~L~~LI~~CL 758 (782)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......... .+..+.+++.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 678999999999999999999999999999999999999999988887777666543322111 1346899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003971 759 A-EPQERPSCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRPSa~EIL~~ 773 (782)
. ||.+|||+.+++++
T Consensus 280 ~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 280 VRDPQERATAQELLDH 295 (321)
T ss_dssp CSSTTTSCCHHHHHTS
T ss_pred cCChhhCcCHHHHhcC
Confidence 9 99999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=354.24 Aligned_cols=258 Identities=31% Similarity=0.654 Sum_probs=223.0
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
++.|++..++|++.+.||+|+||.||+|.+. +..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4678888999999999999999999999884 8899999986433 3457889999999999999999999999999
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
...++||||+++++|.+++... ....+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++..
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred CCEEEEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 9999999999999999999743 345689999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCC-CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---Ch
Q 003971 674 ITDSPMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EG 748 (782)
Q Consensus 674 l~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~ 748 (782)
....... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+.. ......+ +.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 239 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DYRMERPEGCPE 239 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-TCCCCCCTTCCH
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-cCCCCCCCCCCH
Confidence 6543221 233456788999999999999999999999999999999 9999998877766665544 3333333 34
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
.+.+|+..||. ||.+|||+.++++.|+++.
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 69999999999 9999999999999998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=374.45 Aligned_cols=252 Identities=20% Similarity=0.339 Sum_probs=208.3
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHH-HHhCCCCceeeEeccccCCCce
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISI-LSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~i-Lk~L~HPNIVkL~g~~~d~~~l 596 (782)
...++|.+.+.||+|+||+||++.+ +++.||||++.+.... ......+..|..+ ++.++||||+++++++.+.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 3457899999999999999999988 4778999999776543 2334567777776 5778999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 115 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999999873 45789999999999999999999999999999999999999999999999999987554
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHH
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIA 755 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~ 755 (782)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+........ .-...+.+|+.
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 271 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 271 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Confidence 44445577899999999999999999999999999999999999999999998888888876543322 12346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHH
Q 003971 756 DCWA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 756 ~CL~-DP~kRPSa~EIL~~L~ 775 (782)
+||. ||.+||++.+.+..+.
T Consensus 272 ~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 272 GLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp HHTCSSGGGSTTTTTTHHHHH
T ss_pred HHcccCHHhCCCCCCCHHHHh
Confidence 9999 9999999854444443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=370.15 Aligned_cols=252 Identities=19% Similarity=0.294 Sum_probs=211.0
Q ss_pred ccCCCeeEeeEEeee--CcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 521 IDFSELTVGTRVGIG--FFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 521 i~~s~y~i~~~LG~G--~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
....+|++.++||+| +||.||+|.+ +|+.||||++..........+.+.+|+.+++.++|||||++++++.+.+.+
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 355789999999999 9999999998 488999999987776666778899999999999999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999999999998743 235689999999999999999999999999999999999999999999999999865432
Q ss_pred CC-------CCCCCCCCCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----
Q 003971 677 SP-------MRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR----- 742 (782)
Q Consensus 677 ~~-------~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~----- 742 (782)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 11 11234578999999999987 67899999999999999999999999876555444333221110
Q ss_pred ------------------------------------------CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 ------------------------------------------LEIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 ------------------------------------------~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...-...+.+|+.+||. ||.+|||+.++++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00012358889999999 99999999999976
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=356.29 Aligned_cols=265 Identities=29% Similarity=0.515 Sum_probs=214.2
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 590 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~ 590 (782)
...+.+..++|.+.+.||+|+||.||+|.+. +..||||++..........+.+.+|+.+++.++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3556677789999999999999999999762 34799999977666666678899999999999999999999998
Q ss_pred cCCC-----ceEEEEEEecccchhhHHHhh---cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe
Q 003971 591 TKPP-----RLSMITEYMELGSLYHLIHLS---GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 662 (782)
Q Consensus 591 ~d~~-----~l~LV~Ey~~gGsL~dlL~~~---~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~ 662 (782)
.+.. ..+++|||+.+++|.+++... .....+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 7754 359999999999999988532 23457999999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 003971 663 VKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANE 739 (782)
Q Consensus 663 VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~ 739 (782)
+||+|||++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 265 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence 99999999987644321 1234457889999999999999999999999999999999 88999988877777666553
Q ss_pred CCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003971 740 GSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 781 (782)
Q Consensus 740 ~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~sL 781 (782)
. ....+ ...+.+++.+||. ||.+||++.+++++|+++..++
T Consensus 266 ~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 266 H-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp C-CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred C-CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 3 33333 3469999999999 9999999999999999986654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=351.95 Aligned_cols=249 Identities=27% Similarity=0.459 Sum_probs=212.1
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
....++|.+.+.||+|+||.||+|.+ ++..||||++....... .....+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 34568999999999999999999988 46689999986543221 2246788999999999999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999998873 35689999999999999999999999999999999999999999999999999866543
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHH
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIA 755 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip~~~L~~LI~ 755 (782)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+....... ......+.+|+.
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 2 2345679999999999999999999999999999999999999999988887777766544332 223456999999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003971 756 DCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 756 ~CL~-DP~kRPSa~EIL~~ 773 (782)
+||. ||.+||++.++++|
T Consensus 240 ~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 240 RLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHCCSSGGGSCCHHHHHHC
T ss_pred HHhccChhhCCCHHHHhhC
Confidence 9999 99999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=351.75 Aligned_cols=255 Identities=28% Similarity=0.563 Sum_probs=211.2
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC-Cc
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-PR 595 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-~~ 595 (782)
..|.+..++|++.+.||+|+||.||++.++|+.||||++.... ..+.+.+|+.+++.++||||+++++++.+. +.
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 4577788999999999999999999999999999999986432 346789999999999999999999986554 57
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+++||||+++++|.+++... ....+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred eEEEEecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 89999999999999998633 22347899999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHH
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLG 751 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~ 751 (782)
.. .....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||...........+.. +.....+ +..+.
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~ 244 (278)
T 1byg_A 169 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVY 244 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCCTTCCHHHH
T ss_pred cc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCcccCCHHHH
Confidence 32 224467889999999999999999999999999999998 9999998877666655433 3333333 34699
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 752 RLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
+++..||. ||.+||++.++++.|+++...
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 245 EVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 99999999 999999999999999988653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=362.87 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=199.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC-------
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------- 594 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------- 594 (782)
++|.+.+.||+|+||.||+|.+ +|+.||||++.... .....+.+.+|+.+++.++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 5799999999999999999988 58899999997554 2334578999999999999999999999885443
Q ss_pred --------------------------------------------------ceEEEEEEecccchhhHHHhhcccccchHH
Q 003971 595 --------------------------------------------------RLSMITEYMELGSLYHLIHLSGQKKKLSWR 624 (782)
Q Consensus 595 --------------------------------------------------~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~ 624 (782)
.++++|||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999999999865555567778
Q ss_pred HHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC------------CCCCCCCCCCcccC
Q 003971 625 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP------------MRDSSSAGTPEWMA 692 (782)
Q Consensus 625 ~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~------------~~~~~~~GT~~Y~A 692 (782)
.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .......||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 899999999999999999999999999999999999999999999998775432 12234679999999
Q ss_pred ccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHH
Q 003971 693 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCE 768 (782)
Q Consensus 693 PEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~ 768 (782)
||++.+..++.++|||||||++|+|++|..|+... ......... ...+... ...+.+|+.+||. ||.+||++.
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 321 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRN-LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT 321 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHT-TCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhc-cCCCcccccCChhHHHHHHHHccCCCCcCCCHH
Confidence 99999999999999999999999999987764321 111222211 2111111 2357889999999 999999999
Q ss_pred HHHHH
Q 003971 769 EILSR 773 (782)
Q Consensus 769 EIL~~ 773 (782)
+++++
T Consensus 322 ~~l~~ 326 (332)
T 3qd2_B 322 DIIEN 326 (332)
T ss_dssp HHHHS
T ss_pred HHhhc
Confidence 99975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=356.71 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=210.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC--ceEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP--RLSM 598 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~--~l~L 598 (782)
.++|.+.+.||+|+||+||+|.+. ++.||||++...... ...+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 467999999999999999999884 889999998754432 23567889999999999999999999987655 7899
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE----cCCCeEEEEecCccccc
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRII 674 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL----d~~g~VKLaDFGLA~~l 674 (782)
||||+++++|.+++........+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999999999855444459999999999999999999999999999999999999 78889999999999877
Q ss_pred cCCCCCCCCCCCCCcccCccccc--------cCCCCchhHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCC
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIR--------NEPFTEKCDIFSLGVIMWELCTLNRPWEGV----LPERVVYAVANEGSR 742 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~--------~~~~s~ksDVWSLGvILyELLTGk~PF~~~----~~~evl~~i~~~~~~ 742 (782)
.... ......||+.|+|||++. +..++.++|||||||++|||++|+.||... ........+......
T Consensus 167 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~ 245 (319)
T 4euu_A 167 EDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (319)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred CCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence 5543 334567999999999986 567899999999999999999999999643 234444444443221
Q ss_pred C-----------------CCC---------ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 743 L-----------------EIP---------EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 743 ~-----------------~ip---------~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
. .++ ...+.+++.+||. ||.+|||+.|++++..+-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1 111 1247889999999 999999999999998875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=350.44 Aligned_cols=250 Identities=33% Similarity=0.605 Sum_probs=209.8
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHH-----HHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-----MEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~-----~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
+..++|.+.+.||+|+||.||+|.+ +++.||||++......... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 4458899999999999999999988 6889999998655432221 16789999999999999999999999776
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--ccccCCCcccEEEcCCCe-----EEEE
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWT-----VKIC 666 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g--IIHrDIKPeNILLd~~g~-----VKLa 666 (782)
. ++||||+++++|.+.+.. ....+++..++.++.|++.||+|||++| |+||||||+|||++.++. +||+
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred C--eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 5 799999999999988862 3457899999999999999999999999 999999999999987776 9999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCcccc--ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhcCCC
Q 003971 667 DFGLSRIITDSPMRDSSSAGTPEWMAPELI--RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV--VYAVANEGSR 742 (782)
Q Consensus 667 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl--~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~ev--l~~i~~~~~~ 742 (782)
|||+++.... ......||+.|+|||++ ....++.++|||||||++|+|++|+.||........ ...+......
T Consensus 172 Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 4f0f_A 172 DFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248 (287)
T ss_dssp CCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred CCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence 9999975543 23456799999999998 445678999999999999999999999986654333 4444455555
Q ss_pred CCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 743 LEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 743 ~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
+.++. ..+.+|+.+||. ||.+|||+.++++.|+++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 55543 369999999999 999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=361.64 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=196.6
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|++.+.||+|+||.||+|.+ +|+.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 46899999999999999999987 588999999875542 223467889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhc---ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 601 EYMELGSLYHLIHLSG---QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~---~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
||++ ++|.+++.... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 9998 58888886432 1245899999999999999999999999999999999999999999999999999877544
Q ss_pred CCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------
Q 003971 678 PMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------- 743 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~------------- 743 (782)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 334456789999999999876 468999999999999999999999999988877776664321110
Q ss_pred ----------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ----------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ----------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+..+.+|+.+||. ||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0112368899999999 99999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=355.54 Aligned_cols=249 Identities=35% Similarity=0.665 Sum_probs=204.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++.++|.+.+.||+|+||+||++.+.++.||||++... ...+.|.+|+.++++++||||+++++++.+ ..++||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 46688999999999999999999999999999998532 335789999999999999999999999874 479999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh---ccccccCCCcccEEEcCCCe-EEEEecCccccccC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR---MKIVHRDLKSANCLVNKHWT-VKICDFGLSRIITD 676 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs---~gIIHrDIKPeNILLd~~g~-VKLaDFGLA~~l~~ 676 (782)
||+++++|.+++........+++..++.++.|++.||+|||+ +||+||||||+|||++.++. +||+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999999999744333457899999999999999999999 89999999999999988876 79999999976543
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCCCCC---ChHHH
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP--ERVVYAVANEGSRLEIP---EGPLG 751 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~--~evl~~i~~~~~~~~ip---~~~L~ 751 (782)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........ .+..+..+ +..+.
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 234 (307)
T 2eva_A 159 H---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTRPPLIKNLPKPIE 234 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TTCCCCCBTTCCHHHH
T ss_pred c---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cCCCCCcccccCHHHH
Confidence 2 2345699999999999999999999999999999999999999986432 22333332 23333332 34699
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 752 RLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+|+.+||. ||.+|||+.+++++|+++..
T Consensus 235 ~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 99999999 99999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=362.41 Aligned_cols=250 Identities=23% Similarity=0.390 Sum_probs=207.3
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCC--CceeeEeccccCCCc
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH--PNVILFLGACTKPPR 595 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H--PNIVkL~g~~~d~~~ 595 (782)
..+...+|.+.+.||+|+||.||++.+ +++.||||++..........+.+.+|+.+++.++| |||+++++++.+...
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 455668899999999999999999987 67889999998776666677889999999999986 999999999999999
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+++||| +.+++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 84 ~~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEEC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEEEEe-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999999 56789999987 345789999999999999999999999999999999999997 5789999999998765
Q ss_pred CCCC--CCCCCCCCCcccCcccccc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCC
Q 003971 676 DSPM--RDSSSAGTPEWMAPELIRN-----------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGS 741 (782)
Q Consensus 676 ~~~~--~~~~~~GT~~Y~APEvl~~-----------~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~-evl~~i~~~~~ 741 (782)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+.....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 4322 2235679999999999865 67899999999999999999999999875443 34444444343
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 ~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
....+ ...+.+|+.+||. ||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 33333 3569999999999 99999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=372.47 Aligned_cols=255 Identities=34% Similarity=0.587 Sum_probs=206.8
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
++...+|.+.+.||+|+||.||+|.+. +..||||++.... .....+.|.+|+.+++.++||||+++++++.+..
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 445678999999999999999999763 6679999986543 4455678999999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+++||||+++|+|.+++.. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred ceEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999999973 3457899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC---CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003971 675 TDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 747 (782)
Q Consensus 675 ~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~ 747 (782)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+.. +.+...+ +
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~ 276 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCP 276 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT-TEECCCCTTCB
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccc
Confidence 543221 122345778999999999999999999999999999998 9999999888777766544 3333333 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 748 GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 748 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
..+.+|+..||. ||.+||++.+|++.|+++.
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 469999999999 9999999999999998874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=351.22 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=211.0
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 592 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 592 (782)
..+....|++.+.||+|+||.||+|.+ +++.||||++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 344556799999999999999999984 58899999986543 23345788999999999999999999999987
Q ss_pred C--CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCc
Q 003971 593 P--PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 670 (782)
Q Consensus 593 ~--~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGL 670 (782)
. ..+++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence 6 668999999999999999863 235689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC---CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC--------------CChHHHH
Q 003971 671 SRIITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG--------------VLPERVV 733 (782)
Q Consensus 671 A~~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~--------------~~~~evl 733 (782)
+........ ......||..|+|||++.+..++.++|||||||++|+|++|..|+.. .......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 987754431 23356688899999999999999999999999999999999987532 2222333
Q ss_pred HHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 734 YAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 734 ~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
............+. ..+.+|+.+||. ||.+|||+.++++.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 33334444444443 469999999999 9999999999999998763
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=348.28 Aligned_cols=252 Identities=17% Similarity=0.227 Sum_probs=211.3
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~L 598 (782)
..++|.+.+.||+|+||.||+|.+ +++.||||++..... .+.+.+|+.+++.+ +|+||+++++++.+....++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 457899999999999999999986 689999999865432 24577899999999 79999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe-----EEEEecCcccc
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT-----VKICDFGLSRI 673 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~-----VKLaDFGLA~~ 673 (782)
||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 84 v~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99999 99999999732 346899999999999999999999999999999999999987776 99999999987
Q ss_pred ccCCCC-------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCC
Q 003971 674 ITDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV---LPERVVYAVANEGSRL 743 (782)
Q Consensus 674 l~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~---~~~evl~~i~~~~~~~ 743 (782)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. ........+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 754322 124567999999999999999999999999999999999999999874 3333333333222111
Q ss_pred C------CCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 744 E------IPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 744 ~------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
. --+..+.+|+..||. ||.+||++.+|++.|+++...
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 1 113469999999999 999999999999999987654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=351.79 Aligned_cols=252 Identities=28% Similarity=0.464 Sum_probs=214.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccc--cCCCceEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC--TKPPRLSM 598 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~--~d~~~l~L 598 (782)
.++|++.+.||+|+||.||++.+ +++.||+|++..........+.+.+|+.+++.++||||+++++++ .....+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999988 588999999987766666778899999999999999999999987 44677999
Q ss_pred EEEEecccchhhHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcc-----ccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 599 ITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMK-----IVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g-----IIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.| |+|+||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999987432 2345899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGP 749 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~ 749 (782)
.............||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.... ...++ +..
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-cccCCcccCHH
Confidence 76543222223468999999999999999999999999999999999999999988877766665543 33333 357
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L~ 775 (782)
+.+++.+||. ||.+||++.++++++.
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 9999999999 9999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=360.72 Aligned_cols=248 Identities=19% Similarity=0.253 Sum_probs=209.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV 599 (782)
..+|.+.+.||+|+||+||+|.+ +++.||||++...... +.+.+|+.+++.+ +||||+++++++......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 37899999999999999999986 6899999998654332 3578999999999 899999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe-----EEEEecCccccc
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT-----VKICDFGLSRII 674 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~-----VKLaDFGLA~~l 674 (782)
|||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.+
T Consensus 84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 9999 89999998743 457999999999999999999999999999999999999998887 999999999876
Q ss_pred cCCCCC-------CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCC
Q 003971 675 TDSPMR-------DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL---PERVVYAVANEGSRLE 744 (782)
Q Consensus 675 ~~~~~~-------~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~---~~evl~~i~~~~~~~~ 744 (782)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+....+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 543221 245689999999999999999999999999999999999999998743 3333333322111111
Q ss_pred -------CCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 745 -------IPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 745 -------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.| .+.+|+..||. ||.+||++.+|++.|+++..
T Consensus 241 ~~~~~~~~p--~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 241 IEVLCENFP--EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHHTTTCH--HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHhccCh--HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 22 79999999999 99999999999999987643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=359.60 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=213.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc---ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~---~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
++|.+.+.||+|+||.||+|.+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 6799999999999999999987 577899999865432 33456789999999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhh-------------------------------------cccccchHHHHHHHHHHHHHHHHHHH
Q 003971 599 ITEYMELGSLYHLIHLS-------------------------------------GQKKKLSWRRKLKMLRDICRGLMCIH 641 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~-------------------------------------~~~~~Ls~~~~l~Ia~QIa~gL~yLH 641 (782)
||||+++|+|.+++... .....+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999988411 01234578889999999999999999
Q ss_pred hccccccCCCcccEEEcCCC--eEEEEecCccccccCCC----CCCCCCCCCCcccCcccccc--CCCCchhHHHHHHHH
Q 003971 642 RMKIVHRDLKSANCLVNKHW--TVKICDFGLSRIITDSP----MRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVI 713 (782)
Q Consensus 642 s~gIIHrDIKPeNILLd~~g--~VKLaDFGLA~~l~~~~----~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvI 713 (782)
++||+||||||+|||++.++ .+||+|||++..+.... .......||+.|+|||++.+ ..++.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 99999999999999998776 89999999998654321 12345679999999999875 678999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhhh
Q 003971 714 MWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWA-EPQERPSCEEILSR--LLDCE 778 (782)
Q Consensus 714 LyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~LI~~CL~-DP~kRPSa~EIL~~--L~di~ 778 (782)
+|+|++|+.||.+.........+.........+ ...+.+|+.+||. ||.+||++.+++++ ++++.
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 999999999999999888888887766555443 3468999999999 99999999999986 55544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=360.46 Aligned_cols=252 Identities=27% Similarity=0.548 Sum_probs=206.8
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCe----EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
..++|++.+.||+|+||+||+|.+ +++ .||+|.+.... .....+.|.+|+.+++.++||||++++++|.+..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 447899999999999999999987 344 35777765332 2334578999999999999999999999998765
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.+++++|+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred eEEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 7899999999999999873 34578999999999999999999999999999999999999999999999999998775
Q ss_pred CCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003971 676 DSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 749 (782)
Q Consensus 676 ~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~ 749 (782)
.... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+.. +.....+ ...
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc-CCCCCCCccCCHH
Confidence 4322 2234457889999999999999999999999999999999 9999998887766555544 3333333 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
+.+|+.+||. ||.+||++.+++++|+.+.
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 8999999999 9999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=364.04 Aligned_cols=248 Identities=23% Similarity=0.293 Sum_probs=199.8
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
..++|.+.++||+|+||+||+|.+ +++.||||++..........+.+.+|+.+++.++||||+++++++.+...+++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 346899999999999999999987 688999999976655555567788999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE-----cCCCeEEEEecCccccc
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV-----NKHWTVKICDFGLSRII 674 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL-----d~~g~VKLaDFGLA~~l 674 (782)
|||+.+ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||++...
T Consensus 112 ~e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 112 FEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999985 8988886 34568999999999999999999999999999999999999 45566999999999877
Q ss_pred cCCCCCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--------
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-------- 745 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-------- 745 (782)
...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......+..
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 5444444566789999999999874 5899999999999999999999999998887777766542211110
Q ss_pred -----------------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 -----------------------PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 -----------------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
....+.+|+.+||. ||.+|||+.++++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 12457899999999 99999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=348.85 Aligned_cols=257 Identities=30% Similarity=0.526 Sum_probs=214.2
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 592 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 592 (782)
.+.+..++|.+.+.||+|+||.||+|.+. +..||+|++.... .....+.|.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 45667789999999999999999999762 2359999986543 34456889999999999999999999999876
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
+ ..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred C-CCEEEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 4 57899999999999999863 23468999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003971 673 IITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 747 (782)
Q Consensus 673 ~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~ 747 (782)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+.... ....+ +
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 240 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKPDLCP 240 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-CCCCCTTCC
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-CCCCCCCCC
Confidence 7654322 2234567889999999999999999999999999999998 999998877766665554433 23222 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 748 GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 748 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
..+.+++.+||. ||.+||++.+++++|+++..
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 241 PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 469999999999 99999999999999998743
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.70 Aligned_cols=254 Identities=29% Similarity=0.540 Sum_probs=211.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CC---eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce-EE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NG---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL-SM 598 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g---~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l-~L 598 (782)
.|.+.+.||+|+||+||+|.+ ++ ..+|+|++... ......+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 566789999999999999976 22 36999998643 3345568899999999999999999999999876665 99
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
++||+.+++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999863 34678999999999999999999999999999999999999999999999999998654321
Q ss_pred ----CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003971 679 ----MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIP---EGPL 750 (782)
Q Consensus 679 ----~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~-PF~~~~~~evl~~i~~~~~~~~ip---~~~L 750 (782)
.......+|+.|+|||.+.+..++.++|||||||++|+|++|.. ||...........+.. ......+ +..+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-GRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT-TCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc-CCCCCCCccchHHH
Confidence 22234568889999999999999999999999999999999655 5666666555554443 3333333 3469
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhhhccC
Q 003971 751 GRLIADCWA-EPQERPSCEEILSRLLDCEYSLC 782 (782)
Q Consensus 751 ~~LI~~CL~-DP~kRPSa~EIL~~L~di~~sL~ 782 (782)
.+++..||. ||.+|||+.++++.|+++...++
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 999999999 99999999999999999876654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=382.69 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=217.1
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
..+.+..++|.+.+.||+|+||+||+|.+ +++.||+|++.+... .....+.+.+|+.+++.++|||||+++++|.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 45566778999999999999999999988 578999999865322 111234578999999999999999999999999
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
..+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 999999999999999998862 3589999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CCCCCCCCCcccCccccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003971 674 ITDSPM-RDSSSAGTPEWMAPELIRNEP----FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-- 746 (782)
Q Consensus 674 l~~~~~-~~~~~~GT~~Y~APEvl~~~~----~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-- 746 (782)
...... .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+.........|
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence 654332 234678999999999998765 7889999999999999999999999999888888877643222222
Q ss_pred ---ChHHHHHHHHhhh-CCCC--CCCHHHHHHH
Q 003971 747 ---EGPLGRLIADCWA-EPQE--RPSCEEILSR 773 (782)
Q Consensus 747 ---~~~L~~LI~~CL~-DP~k--RPSa~EIL~~ 773 (782)
...+.+||.+||. +|.+ ||++.+|++|
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 3469999999999 8888 9999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.80 Aligned_cols=257 Identities=34% Similarity=0.552 Sum_probs=213.6
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEEC------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 592 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~~------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 592 (782)
.++..++|.+.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 3567789999999999999999999763 2359999986543 34456789999999999999999999999999
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
....++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCCcEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999999863 34578999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC---CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003971 673 IITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP-- 746 (782)
Q Consensus 673 ~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip-- 746 (782)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+... .+...+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~ 274 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPMD 274 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTT
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-CcCCCccc
Confidence 7654321 1223456789999999999999999999999999999999 99999998887777666543 333333
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 747 -EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 747 -~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+..+.+|+.+||. ||.+||++.+++++|+++..
T Consensus 275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 275 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3469999999999 99999999999999988743
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.30 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=205.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc----
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPR---- 595 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~---- 595 (782)
.++|++.+.||+|+||.||++.+ +++.||||++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 37899999999999999999987 688999999976543 33446788999999999999999999999876544
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.|+||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 4999999999999999973 3578999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC---CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CC
Q 003971 676 DSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PE 747 (782)
Q Consensus 676 ~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-----p~ 747 (782)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+................+.. .+
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence 4321 223456999999999999999999999999999999999999999999888877777665443321 23
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHH-HHHh
Q 003971 748 GPLGRLIADCWA-EPQERPSCEEILS-RLLD 776 (782)
Q Consensus 748 ~~L~~LI~~CL~-DP~kRPSa~EIL~-~L~d 776 (782)
..+.+|+.+||. ||.+||+..+++. .|..
T Consensus 248 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 468999999999 9999997666554 4443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=350.83 Aligned_cols=257 Identities=28% Similarity=0.494 Sum_probs=203.5
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccc-cChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD-LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~-~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
...+|++.+.||+|+||.||+|.+ +|+.||||++.... ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 446899999999999999999987 68899999987543 344556789999999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 599 ITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+|||+.+++|.+++.... ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 999999999999886422 3456899999999999999999999999999999999999999999999999999876554
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCC----ChHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--PERVVYAVANEGSRLEIP----EGPLG 751 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~--~~evl~~i~~~~~~~~ip----~~~L~ 751 (782)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.. .......+.... .+..+ +..+.
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 268 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-YPPLPSDHYSEELR 268 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC-SCCCCTTTSCHHHH
T ss_pred CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc-CCCCcccccCHHHH
Confidence 333345679999999999999999999999999999999999999997542 333333333332 22222 34699
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 752 RLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+|+.+||. ||.+||++.++++.|+++..
T Consensus 269 ~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 269 QLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 99999999 99999999999999998854
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=369.43 Aligned_cols=246 Identities=23% Similarity=0.325 Sum_probs=198.7
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCC--ceE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPP--RLS 597 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~--~l~ 597 (782)
.++|.+.+.||+|+||.||+|.+ +|+.||||++..........+.+.+|+.+++.+. ||||+++++++...+ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 36899999999999999999987 5889999998766555666788899999999997 999999999986543 689
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+||||+. ++|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 9999998 588888852 46899999999999999999999999999999999999999999999999999865321
Q ss_pred ---------------------CCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 003971 678 ---------------------PMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA 735 (782)
Q Consensus 678 ---------------------~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~ 735 (782)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 112234689999999999876 6789999999999999999999999999888777766
Q ss_pred HHhcCCCCC------------------------------------------------CCChHHHHHHHHhhh-CCCCCCC
Q 003971 736 VANEGSRLE------------------------------------------------IPEGPLGRLIADCWA-EPQERPS 766 (782)
Q Consensus 736 i~~~~~~~~------------------------------------------------ip~~~L~~LI~~CL~-DP~kRPS 766 (782)
+......+. .....+.+|+.+||. ||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 653211111 112357899999999 9999999
Q ss_pred HHHHHHH
Q 003971 767 CEEILSR 773 (782)
Q Consensus 767 a~EIL~~ 773 (782)
+.|+++|
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.41 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=214.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH----HHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE----NMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~----~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
++|.+.+.||+|+||.||+|.+ +|+.||+|++........ ..+.+.+|+.+++.++||||+++++++.+...++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 5799999999999999999988 588999999876543221 3577899999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC----eEEEEecCcccc
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRI 673 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g----~VKLaDFGLA~~ 673 (782)
+||||+++++|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 92 LILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999997 346789999999999999999999999999999999999999887 899999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCCh
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEG 748 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-----ip~~ 748 (782)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+........ ..+.
T Consensus 169 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (321)
T 2a2a_A 169 IEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247 (321)
T ss_dssp CCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred cCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence 75432 33456799999999999999999999999999999999999999999888887777665433221 1234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+.+|+.+||. ||.+|||+.+++++
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 68999999999 99999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=349.47 Aligned_cols=249 Identities=27% Similarity=0.365 Sum_probs=217.0
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
...+|.+.+.||+|+||.||++.+ .++.+|+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 346899999999999999999988 478899999876543 34456788999999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
+|||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999998863 3578999999999999999999999999999999999999999999999999998775444
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHHh
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIADC 757 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip~~~L~~LI~~C 757 (782)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+....... ...+..+.+++.+|
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 249 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 249 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHH
Confidence 44456779999999999999889999999999999999999999999988777766665543322 12235689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. ||.+||++.+++++
T Consensus 250 l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 250 LQTDPTARPTINELLND 266 (294)
T ss_dssp TCSSGGGSCCGGGGGGS
T ss_pred cccChhhCcCHHHHhhC
Confidence 99 99999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=371.94 Aligned_cols=251 Identities=21% Similarity=0.330 Sum_probs=211.0
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
...+..++|.+.+.||+|+||.||++.+ +++.||+|++..... .......+.+|+.+++.++|||||+++++|.+..
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 4556778999999999999999999987 477899999865432 2233577889999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+|+||||+.+|+|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++...
T Consensus 89 ~~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEEECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999999987 4557999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCC-CCCC
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGV---LPERVVYAVANEGSRL-EIPE 747 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTGk~PF~~~---~~~evl~~i~~~~~~~-~ip~ 747 (782)
... ......+||+.|+|||++.. ..++.++|||||||++|+|++|+.||... ........+....... ..-.
T Consensus 166 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s 244 (384)
T 4fr4_A 166 PRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244 (384)
T ss_dssp CTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC
T ss_pred cCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC
Confidence 543 23457789999999999864 45899999999999999999999999743 3334444433322221 1223
Q ss_pred hHHHHHHHHhhh-CCCCCCC-HHHHHH
Q 003971 748 GPLGRLIADCWA-EPQERPS-CEEILS 772 (782)
Q Consensus 748 ~~L~~LI~~CL~-DP~kRPS-a~EIL~ 772 (782)
..+.+|+.+||. ||.+||+ +.++++
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 569999999999 9999998 777765
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.69 Aligned_cols=243 Identities=22% Similarity=0.373 Sum_probs=211.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|++.+.||+|+||.||+|.+. +..+|+|++...... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999884 668999998755432 35678999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE---cCCCeEEEEecCccccccCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL---d~~g~VKLaDFGLA~~l~~~~ 678 (782)
|+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999998863 4568999999999999999999999999999999999999 788999999999998765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-----p~~~L~~L 753 (782)
......||+.|+|||++.+. ++.++|||||||++|+|++|+.||...........+......... -+..+.+|
T Consensus 164 -~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (277)
T 3f3z_A 164 -MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241 (277)
T ss_dssp -CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHH
T ss_pred -chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHH
Confidence 33466799999999998765 899999999999999999999999998888887777665443321 23468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. ||.+||++.+++++
T Consensus 242 i~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 242 IRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999 99999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=359.28 Aligned_cols=253 Identities=26% Similarity=0.513 Sum_probs=209.2
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeE----EEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTD----VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~----VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
+..++|++.+.||+|+||+||+|.+ +++. ||+|.+..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-S 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-S
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-C
Confidence 3457899999999999999999987 3443 77787654322 2223567789999999999999999999864 5
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
..++|+||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred ccEEEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 68999999999999999863 2457899999999999999999999999999999999999999999999999999887
Q ss_pred cCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---Ch
Q 003971 675 TDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EG 748 (782)
Q Consensus 675 ~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~ 748 (782)
..... ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+.. +.....+ ..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 244 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK-GERLAQPQICTI 244 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT-TCBCCCCTTBCT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCCCcCcH
Confidence 54322 2234568889999999999999999999999999999999 9999998877766665544 3333333 33
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
.+.+|+.+||. ||.+||++.+++++|+.+.
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 58899999999 9999999999999998864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.06 Aligned_cols=256 Identities=27% Similarity=0.491 Sum_probs=211.0
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccc-cCCCce
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC-TKPPRL 596 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~-~d~~~l 596 (782)
..+|.+.+.||+|+||.||+|.+. +..+|+|.+... ......+.+.+|+.++++++||||+++++++ ...+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 356899999999999999999862 235888987643 3345567899999999999999999999985 455678
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
+++|||+++|+|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999999963 345689999999999999999999999999999999999999999999999999987644
Q ss_pred CCC----CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC--CCCChH
Q 003971 677 SPM----RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL--EIPEGP 749 (782)
Q Consensus 677 ~~~----~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~--~ip~~~ 749 (782)
... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+....... ..-+..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 260 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence 221 2234567889999999999999999999999999999999 566777776666655555433222 112456
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 781 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~sL 781 (782)
+.+++.+||. ||.+||++.++++.|+.+...+
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 9999999999 9999999999999999987654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=374.78 Aligned_cols=246 Identities=27% Similarity=0.374 Sum_probs=187.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC-----CCce
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-----PPRL 596 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-----~~~l 596 (782)
++|.+++.||+|+||+||+|.+ +++.||||++..........+.+.+|+.+|+.++||||+++++++.. ...+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 7899999999999999999987 58899999997665566667889999999999999999999999843 3569
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
|+||||+. ++|.+++. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 133 ~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 99999985 68888886 456799999999999999999999999999999999999999999999999999987642
Q ss_pred CC---------------------------CCCCCCCCCCcccCcccc-ccCCCCchhHHHHHHHHHHHHHh---------
Q 003971 677 SP---------------------------MRDSSSAGTPEWMAPELI-RNEPFTEKCDIFSLGVIMWELCT--------- 719 (782)
Q Consensus 677 ~~---------------------------~~~~~~~GT~~Y~APEvl-~~~~~s~ksDVWSLGvILyELLT--------- 719 (782)
.. ......+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 21 112345789999999976 56679999999999999999999
Q ss_pred --CCCCCCCCCh--------------------HHHHHHHHhcCCC--------------------------------CCC
Q 003971 720 --LNRPWEGVLP--------------------ERVVYAVANEGSR--------------------------------LEI 745 (782)
Q Consensus 720 --Gk~PF~~~~~--------------------~evl~~i~~~~~~--------------------------------~~i 745 (782)
|+.+|.+... ...+..+...... ...
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 6667765431 1111111110000 001
Q ss_pred CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
....+.+|+.+||. ||.+|||+.|+++|
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 13458899999999 99999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=361.63 Aligned_cols=264 Identities=26% Similarity=0.430 Sum_probs=213.2
Q ss_pred ccccccccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 003971 513 LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 591 (782)
Q Consensus 513 ~~~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 591 (782)
.++..++....++|.+.+.||+|+||.||+|.+ +++.||||++....... ....+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 345677888889999999999999999999976 58899999986543221 2236889999999999999999999999
Q ss_pred CCCceEEEEEEecccchhhHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhc---cccccCCCcccEEEcCCCeEEEEe
Q 003971 592 KPPRLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRM---KIVHRDLKSANCLVNKHWTVKICD 667 (782)
Q Consensus 592 d~~~l~LV~Ey~~gGsL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~gL~yLHs~---gIIHrDIKPeNILLd~~g~VKLaD 667 (782)
+....++||||+.+|+|.+++.... ....+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999997432 234589999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCCC-CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHh----
Q 003971 668 FGLSRIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV----LPERVVYAVAN---- 738 (782)
Q Consensus 668 FGLA~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~----~~~evl~~i~~---- 738 (782)
||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||... ...........
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 999987653322 233456999999999999888999999999999999999999999521 10011111111
Q ss_pred cCCCC---------CCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 739 EGSRL---------EIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 739 ~~~~~---------~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
..... ..+. ..+.+++..||. ||.+|||+.+++++|+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 11100 1111 248889999999 999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=353.94 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=207.9
Q ss_pred eeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccc--cChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEe
Q 003971 526 LTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQD--LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 603 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~--~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 603 (782)
|..++.||+|+||.||+|.++++.||||++.... ......+.+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 3345899999999999999999999999986543 22344678999999999999999999999999999999999999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC--CC
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RD 681 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~--~~ 681 (782)
++++|.+++........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 9999999997555556799999999999999999999999999999999999999999999999999987643221 12
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHhcC---------CCCCCCC-
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV----VYAVANEG---------SRLEIPE- 747 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~ev----l~~i~~~~---------~~~~ip~- 747 (782)
....||+.|+|||.+.+. ++.++|||||||++|+|++|..||........ ...+.... .....+.
T Consensus 193 ~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST 271 (307)
T ss_dssp SSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHH
T ss_pred cccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchH
Confidence 345799999999988764 78999999999999999999999976543221 11111111 0111111
Q ss_pred --hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 748 --GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 748 --~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
..+.+++.+||. ||.+||++.+++++|+++..
T Consensus 272 ~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 272 SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 247889999999 99999999999999998764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=357.50 Aligned_cols=249 Identities=27% Similarity=0.362 Sum_probs=217.6
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
...+|.+.+.||+|+||.||++.+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 346899999999999999999988 477899999876543 34556788999999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
+|||+.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999998863 3578999999999999999999999999999999999999999999999999998775444
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHh
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADC 757 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~C 757 (782)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+........ .....+.+|+.+|
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 275 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence 444567899999999999999999999999999999999999999998887777666655433222 2245689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. ||.+||++.+++++
T Consensus 276 l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 276 LQTDPTARPTINELLND 292 (335)
T ss_dssp TCSSGGGSCCGGGGGGS
T ss_pred ccCChhHCcCHHHHhcC
Confidence 99 99999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=379.24 Aligned_cols=256 Identities=20% Similarity=0.323 Sum_probs=217.8
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccC
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTK 592 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 592 (782)
..++.+..++|.+.+.||+|+||+||++.+ +|+.||||++.+... .....+.+.+|+.++..++||||++++++|.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 345667788999999999999999999988 588999999875432 12234568899999999999999999999999
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
.+.+|+||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 99999999999999999999732 3478999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CCCCCCCCCcccCccccc-------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 003971 673 IITDSPM-RDSSSAGTPEWMAPELIR-------NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE 744 (782)
Q Consensus 673 ~l~~~~~-~~~~~~GT~~Y~APEvl~-------~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ 744 (782)
....... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+....+........
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence 7754332 233568999999999987 35689999999999999999999999999988888877765322222
Q ss_pred C------CChHHHHHHHHhhhCCCCC---CCHHHHHHH
Q 003971 745 I------PEGPLGRLIADCWAEPQER---PSCEEILSR 773 (782)
Q Consensus 745 i------p~~~L~~LI~~CL~DP~kR---PSa~EIL~~ 773 (782)
. -+..+.+||.+||.+|.+| |+++++++|
T Consensus 291 ~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 291 LPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTS
T ss_pred CCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcC
Confidence 2 2346899999999988888 699999876
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=359.66 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=208.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
..++|++.+.||+|+||.||+|.+. |+.||||++..........+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4578999999999999999999884 88999999977666666667788999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 103 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999999988765 345789999999999999999999999999999999999999999999999999987655444
Q ss_pred CCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------------
Q 003971 680 RDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR---------------- 742 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~---------------- 742 (782)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 44567899999999999875 7899999999999999999999999988877766655421110
Q ss_pred ----CC------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 ----LE------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 ----~~------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+. .-+..+.+|+.+||. ||.+|||+.+++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 013458899999999 99999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=381.97 Aligned_cols=255 Identities=20% Similarity=0.330 Sum_probs=217.0
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
..+.+..++|.+.++||+|+||+||+|.+ .++.||||++.+.... ....+.+.+|+.++..++||||++++++|.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 44566778999999999999999999988 4789999998653321 11223488999999999999999999999999
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
..+|+||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 999999999999999999973 246799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CCCCCCCCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 003971 674 ITDSPM-RDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP- 746 (782)
Q Consensus 674 l~~~~~-~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip- 746 (782)
...... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+....+........+|
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence 654332 234568999999999987 5668999999999999999999999999999888888876543222222
Q ss_pred -----ChHHHHHHHHhhh-CCCC--CCCHHHHHHH
Q 003971 747 -----EGPLGRLIADCWA-EPQE--RPSCEEILSR 773 (782)
Q Consensus 747 -----~~~L~~LI~~CL~-DP~k--RPSa~EIL~~ 773 (782)
...+.+||.+||. +|.+ ||+++++++|
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 3468999999998 7777 9999999976
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=357.23 Aligned_cols=250 Identities=22% Similarity=0.284 Sum_probs=210.8
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-----CCceeeEec
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----HPNVILFLG 588 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-----HPNIVkL~g 588 (782)
+.+..+-.++|.+.++||+|+||+||+|.+ +++.||||++... ......+..|+.+++.++ ||||+++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 344455568999999999999999999998 6889999998632 334567788999999996 999999999
Q ss_pred cccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC---------
Q 003971 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK--------- 659 (782)
Q Consensus 589 ~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~--------- 659 (782)
++...+..++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence 999999999999999 89999998743 3346899999999999999999999999999999999999975
Q ss_pred ----------------CCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCC
Q 003971 660 ----------------HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 723 (782)
Q Consensus 660 ----------------~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~P 723 (782)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 789999999999875432 2456899999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCC------------------------CC-----------------------ChHHHHHHHH
Q 003971 724 WEGVLPERVVYAVANEGSRLE------------------------IP-----------------------EGPLGRLIAD 756 (782)
Q Consensus 724 F~~~~~~evl~~i~~~~~~~~------------------------ip-----------------------~~~L~~LI~~ 756 (782)
|.+.........+.......+ .| ...+.+|+.+
T Consensus 259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 998887776665543221111 00 1346689999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003971 757 CWA-EPQERPSCEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~ 773 (782)
||. ||.+|||+.++++|
T Consensus 339 ~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 339 ILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HCCSSGGGSCCHHHHTTS
T ss_pred HhcCChhhCCCHHHHhcC
Confidence 999 99999999999865
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.39 Aligned_cols=246 Identities=27% Similarity=0.458 Sum_probs=209.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC----CCc
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPR 595 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d----~~~ 595 (782)
....|.+.+.||+|+||.||+|.+ ++..||+|++..........+.+.+|+.+++.++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 445689999999999999999988 57789999998777777777889999999999999999999998754 456
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--ccccCCCcccEEEc-CCCeEEEEecCccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVN-KHWTVKICDFGLSR 672 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g--IIHrDIKPeNILLd-~~g~VKLaDFGLA~ 672 (782)
+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.| |+|+||||+|||++ .++.+||+|||++.
T Consensus 104 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 8999999999999999973 357899999999999999999999999 99999999999997 78999999999997
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-C---CCh
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-I---PEG 748 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-i---p~~ 748 (782)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...............+..+. . ...
T Consensus 181 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 181 LKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp GCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 65433 2335679999999998875 489999999999999999999999988666555555444433222 1 234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+.+|+.+||. ||.+|||+.+++++
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhC
Confidence 69999999999 99999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=376.95 Aligned_cols=245 Identities=26% Similarity=0.474 Sum_probs=214.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|.+.++||+|+||+||+|.+ +++.||||++............+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 6799999999999999999988 58899999987554433445788999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc---CCCeEEEEecCccccccCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd---~~g~VKLaDFGLA~~l~~~~ 678 (782)
|+.+|+|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 102 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 102 LYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 9999999988863 35789999999999999999999999999999999999995 55689999999998765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~L 753 (782)
.....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.........+.........+ +..+.+|
T Consensus 179 -~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 179 -KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp ----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred -ccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 33466899999999999864 9999999999999999999999999999988888887766555443 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. ||.+|||+.++++|
T Consensus 257 i~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999 99999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=367.31 Aligned_cols=257 Identities=20% Similarity=0.217 Sum_probs=203.2
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHH---------HHHHHHHHHHHHhCCCCcee
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAEN---------MEDFCNEISILSRLRHPNVI 584 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~---------~e~f~~EI~iLk~L~HPNIV 584 (782)
+...+|.+.+.||+|+||.||+|.+. ++.||||++......... ...+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 45678999999999999999999873 468999998654321110 12344566677788899999
Q ss_pred eEeccccCC----CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc--
Q 003971 585 LFLGACTKP----PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-- 658 (782)
Q Consensus 585 kL~g~~~d~----~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd-- 658 (782)
++++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence 999998764 4489999999 9999999873 346799999999999999999999999999999999999999
Q ss_pred CCCeEEEEecCccccccCCCC-------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 003971 659 KHWTVKICDFGLSRIITDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER 731 (782)
Q Consensus 659 ~~g~VKLaDFGLA~~l~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~e 731 (782)
.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 889999999999987643211 1134569999999999999999999999999999999999999998543222
Q ss_pred HHHHHHhcCC------------CCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 732 VVYAVANEGS------------RLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 732 vl~~i~~~~~------------~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
.......... ...-.+..+.+++..||. ||.+||++.+|++.|+++...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 2211111110 001224569999999999 999999999999999987554
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=360.71 Aligned_cols=261 Identities=29% Similarity=0.501 Sum_probs=213.1
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
..++....++|.+.+.||+|+||.||+|.+ +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 344555678999999999999999999987 588999998765432 34578999999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999999886322 123689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCC--CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcCCC---
Q 003971 674 ITDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV------VYAVANEGSR--- 742 (782)
Q Consensus 674 l~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~ev------l~~i~~~~~~--- 742 (782)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+... .......+..
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 54321 122345689999999999988999999999999999999999999975433221 1111111110
Q ss_pred ------CCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 743 ------LEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 743 ------~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
..++. ..+.+++.+||. ||.+|||+.+++++|+.+.
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111 247889999999 9999999999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=346.58 Aligned_cols=248 Identities=24% Similarity=0.420 Sum_probs=214.4
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
+..++|.+.+.||+|+||.||+|.+ +++.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 4557899999999999999999988 4778999998654321 122467889999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
++|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999999873 346899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIAD 756 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip~~~L~~LI~~ 756 (782)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||...........+....... ..-+..+.+++.+
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence 2345679999999999999999999999999999999999999999888877777666543322 1224579999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003971 757 CWA-EPQERPSCEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~ 773 (782)
||. ||.+||++.+++++
T Consensus 246 ~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 246 LLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HSCSSGGGSCCHHHHHTC
T ss_pred HhhcCHhhCCCHHHHhhC
Confidence 999 99999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=350.92 Aligned_cols=250 Identities=23% Similarity=0.397 Sum_probs=187.2
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
..++|.+.+.||+|+||.||+|.+ +|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346899999999999999999987 6889999998654321 1224678899999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
+|||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999862 33578999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCCChHHHHHHHHh
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIPEGPLGRLIADC 757 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~-~~ip~~~L~~LI~~C 757 (782)
.......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+...... +...+..+.+|+.+|
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHH
Confidence 3334567999999999999988999999999999999999999999876654444333222211 112245689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. ||.+||++.+++++
T Consensus 247 l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 247 LRRNPADRLSLSSVLDH 263 (278)
T ss_dssp SCSSGGGSCCHHHHTTS
T ss_pred cccCHhhCCCHHHHhcC
Confidence 99 99999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.61 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=207.1
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccC
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK 592 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d 592 (782)
..++.....+|.+.+.||+|+||.||+|.+ +++.||||++...... .+.+.+|+.+++.+ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 344555678999999999999999999998 6889999998654332 36788999999999 79999999999876
Q ss_pred ------CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEE
Q 003971 593 ------PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKIC 666 (782)
Q Consensus 593 ------~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLa 666 (782)
...+++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence 46789999999999999998743 34578999999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 003971 667 DFGLSRIITDSPMRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 741 (782)
Q Consensus 667 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~ 741 (782)
|||++..............||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 251 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence 9999987654333334567999999999987 56789999999999999999999999998888777666655433
Q ss_pred CCCC---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 RLEI---PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 ~~~i---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.... -+..+.+|+.+||. ||.+||++.+++++
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 252 PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 2222 23579999999999 99999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.39 Aligned_cols=246 Identities=24% Similarity=0.423 Sum_probs=210.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH----HHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE----NMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~----~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
++|.+.+.||+|+||.||++.+ +++.||+|++........ ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4699999999999999999988 488999999876543221 3578899999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC----eEEEEecCcccc
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRI 673 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g----~VKLaDFGLA~~ 673 (782)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999999863 45789999999999999999999999999999999999998877 899999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCCh
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEG 748 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-----ip~~ 748 (782)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.........+........ ..+.
T Consensus 162 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 162 IEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp CC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred ccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 65432 23456799999999999999999999999999999999999999999888777776655433221 1234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+.+|+.+||. ||.+||++.+++++
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 68999999999 99999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.80 Aligned_cols=244 Identities=34% Similarity=0.597 Sum_probs=215.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
+.|.+.+.||+|+||.||+|.+ +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 5699999999999999999987 5889999998765433 345789999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+++++|.+++. ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..........
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 999999999885 3568999999999999999999999999999999999999999999999999998876554444
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 758 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~~CL 758 (782)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.... ...++ +..+.+|+.+||
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCCSSCCHHHHHHHHHHC
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-CCCCccccCHHHHHHHHHHc
Confidence 56789999999999999999999999999999999999999999888877666654432 23222 346999999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003971 759 A-EPQERPSCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRPSa~EIL~~ 773 (782)
. ||.+|||+.+++++
T Consensus 256 ~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSGGGSCCHHHHTTC
T ss_pred CCChhhCcCHHHHhhC
Confidence 9 99999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=377.64 Aligned_cols=244 Identities=25% Similarity=0.326 Sum_probs=202.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC------
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 594 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------ 594 (782)
.++|.+++.||+|+||+||+|.+ +++.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999987 5889999999876556666788999999999999999999999986553
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+|+||||+.++ |.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 469999999865 555543 24889999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---------- 744 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~---------- 744 (782)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+....+..+......+.
T Consensus 215 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 215 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp --C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred CCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 543 233567899999999999999999999999999999999999999999887777666654211110
Q ss_pred -------------------CC--------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 -------------------IP--------------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 -------------------ip--------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+ ...+.+|+.+||. ||.+|||+.|+++|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 1247889999999 99999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=352.65 Aligned_cols=259 Identities=29% Similarity=0.462 Sum_probs=194.1
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccc---
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGAC--- 590 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~--- 590 (782)
+.+++...+|++.++||+|+||.||+|.+ +++.||||++... .....+.+.+|+.+++.+. ||||+++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 45566677999999999999999999998 6889999998544 3444578899999999996 99999999988
Q ss_pred -----cCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--ccccCCCcccEEEcCCCeE
Q 003971 591 -----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTV 663 (782)
Q Consensus 591 -----~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g--IIHrDIKPeNILLd~~g~V 663 (782)
.....+++++||+. |+|.+++........+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 34445899999996 689888875445667999999999999999999999999 9999999999999999999
Q ss_pred EEEecCccccccCCCCC------------CCCCCCCCcccCcccc---ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 003971 664 KICDFGLSRIITDSPMR------------DSSSAGTPEWMAPELI---RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL 728 (782)
Q Consensus 664 KLaDFGLA~~l~~~~~~------------~~~~~GT~~Y~APEvl---~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~ 728 (782)
||+|||++......... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+..
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99999999876543211 1145689999999998 56678999999999999999999999998765
Q ss_pred hHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 729 PERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 729 ~~evl~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.......... ..........+.+|+.+||. ||.+||++.+++++|+++..
T Consensus 258 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 258 KLRIVNGKYS-IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------CC-CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhcCccc-CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4433322111 11111123468999999999 99999999999999998754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=345.93 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=195.5
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
+++..++|++.+.||+|+||+||++.+ +|+.||||++..........+.+..+...++.++||||+++++++.+.+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 456678999999999999999999988 789999999876544444444455555668888999999999999999999
Q ss_pred EEEEEEecccchhhHHHh-hcccccchHHHHHHHHHHHHHHHHHHHhc-cccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 597 SMITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~-~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~-gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
++||||+++ +|.+++.. ......+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999985 87776653 22456799999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCcccc----ccCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCC---
Q 003971 675 TDSPMRDSSSAGTPEWMAPELI----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGV-LPERVVYAVANEGSRLEIP--- 746 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl----~~~~~s~ksDVWSLGvILyELLTGk~PF~~~-~~~evl~~i~~~~~~~~ip--- 746 (782)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||... ..................+
T Consensus 161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T 3fme_A 161 VDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred cccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence 5432 22345799999999996 5667899999999999999999999999864 4444444444433222221
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+..+.+|+.+||. ||.+|||+.+++++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 240 SAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 3468999999999 99999999999984
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=362.08 Aligned_cols=246 Identities=27% Similarity=0.377 Sum_probs=197.4
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
...++|.+.+.||+|+||+||++.+ +++.||||++....... +.+.+|+.+++.++||||+++++++.+...+++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 3567899999999999999999988 58899999987544322 567899999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe--EEEEecCccccccC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--VKICDFGLSRIITD 676 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~--VKLaDFGLA~~l~~ 676 (782)
||||+.+|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 94 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 94 IMEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999999998863 357999999999999999999999999999999999999987765 99999999975433
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCCCC---CCh
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPFTEK-CDIFSLGVIMWELCTLNRPWEGVLP----ERVVYAVANEGSRLEI---PEG 748 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~s~k-sDVWSLGvILyELLTGk~PF~~~~~----~evl~~i~~~~~~~~i---p~~ 748 (782)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+... ......+.......+. ...
T Consensus 171 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 171 H-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred c-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 2 22345679999999999988887665 8999999999999999999986533 3444444443332222 134
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+.+|+.+||. ||.+|||+.++++|
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhC
Confidence 68999999999 99999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=346.53 Aligned_cols=247 Identities=28% Similarity=0.438 Sum_probs=206.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|.+.++||+|+||.||++.+ ++..+|+|++...... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 6799999999999999999987 5789999998765432 235788999999999999999999999999999999999
Q ss_pred EecccchhhHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE---cCCCeEEEEecCccccccCC
Q 003971 602 YMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 602 y~~gGsL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL---d~~g~VKLaDFGLA~~l~~~ 677 (782)
|+++++|.+.+... .....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999999888533 234679999999999999999999999999999999999999 45688999999999876543
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChHHHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGPLGRL 753 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip----~~~L~~L 753 (782)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.................... ...+.+|
T Consensus 181 ~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (285)
T 3is5_A 181 E-HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258 (285)
T ss_dssp -------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHH
T ss_pred c-cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHH
Confidence 2 2345679999999999864 58999999999999999999999999988877776665544333221 3468899
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. ||.+|||+.+++++
T Consensus 259 i~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 259 LKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999 99999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=359.38 Aligned_cols=243 Identities=30% Similarity=0.465 Sum_probs=210.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
..|.+.+.||+|+||.||+|.+ +++.||||++...... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999986 6889999998765432 344578999999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+. |+|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 9998 577777753 2457899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003971 681 DSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 754 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI 754 (782)
....||+.|+|||++. ...++.++|||||||++|||++|+.||.+.........+.........+ +..+.+|+
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 3567999999999984 5678999999999999999999999999988877777766554333222 34689999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003971 755 ADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+||. ||.+|||+.+++++
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTC
T ss_pred HHHcccChhhCcCHHHHhhC
Confidence 99999 99999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=365.21 Aligned_cols=249 Identities=23% Similarity=0.379 Sum_probs=207.4
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC--CCceeeEeccccCCCce
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR--HPNVILFLGACTKPPRL 596 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~--HPNIVkL~g~~~d~~~l 596 (782)
.+...+|.+.+.||+|+||+||++.+ +++.||||++..........+.+.+|+.+++.++ ||||+++++++...+.+
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34456799999999999999999987 5788999999877666667789999999999996 59999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
|+||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+..
T Consensus 132 ~lv~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEe-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99999 567899999873 34788999999999999999999999999999999999995 57999999999987643
Q ss_pred CCC--CCCCCCCCCcccCcccccc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCC
Q 003971 677 SPM--RDSSSAGTPEWMAPELIRN-----------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-ERVVYAVANEGSR 742 (782)
Q Consensus 677 ~~~--~~~~~~GT~~Y~APEvl~~-----------~~~s~ksDVWSLGvILyELLTGk~PF~~~~~-~evl~~i~~~~~~ 742 (782)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+..+......
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence 321 2345689999999999865 4689999999999999999999999987643 3445555544444
Q ss_pred CCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 LEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 ~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+ ...+.+|+.+||. ||.+||++.+++++
T Consensus 287 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 3333 4579999999999 99999999999976
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=355.71 Aligned_cols=242 Identities=23% Similarity=0.267 Sum_probs=197.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|++.++||+|+||+||+|.+ +|+.||||++............+..|+..+..+ +||||++++++|.+...+++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6799999999999999999988 588999999876655555556667777766665 8999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 212 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-A 212 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-C
Confidence 999 56888877633 4569999999999999999999999999999999999999999999999999998765432 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CCChHHHHHHHHh
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---IPEGPLGRLIADC 757 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~---ip~~~L~~LI~~C 757 (782)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||.+... ...+........ ..+..+.+|+.+|
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~ 288 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMM 288 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHH
Confidence 345679999999999886 689999999999999999999776654322 222222211111 1234689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. ||.+|||+.+++++
T Consensus 289 L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 289 LEPDPKLRATAEALLAL 305 (311)
T ss_dssp SCSSTTTSCCHHHHHTS
T ss_pred cCCChhhCcCHHHHHhC
Confidence 99 99999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=346.82 Aligned_cols=256 Identities=30% Similarity=0.561 Sum_probs=209.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC---Ce--EEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWN---GT--DVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~---g~--~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
+..++|++.+.||+|+||.||+|.++ ++ .||||++..... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 44578999999999999999999752 22 689999865543 2345678999999999999999999999998765
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.++++||+++++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+|||++.++.+||+|||++...
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred -ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999988732 356899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC---CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003971 675 TDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 747 (782)
Q Consensus 675 ~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~ 747 (782)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+.........+ +
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 54322 1234567889999999998889999999999999999999 999999999888888777665554443 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 748 GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 748 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
..+.+++.+||. ||.+||++.+++++|++...
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 469999999999 99999999999999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=342.35 Aligned_cols=250 Identities=26% Similarity=0.466 Sum_probs=206.1
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
.+..++|.+.+.||+|+||.||+|.+ +|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+....
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 34557999999999999999999988 5889999998654321 22356788999999999999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999999873 34689999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCCCCCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHH
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLI 754 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI 754 (782)
.. ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...........+.......+ .-+..+.+++
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 242 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHH
Confidence 32 2235678999999999988765 6899999999999999999999998887777766655432221 1245799999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003971 755 ADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+||. ||.+|||+.+++++
T Consensus 243 ~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 243 MHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHTCSSGGGSCCHHHHHHS
T ss_pred HHHccCChhhCCCHHHHHhC
Confidence 99999 99999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=368.37 Aligned_cols=246 Identities=29% Similarity=0.435 Sum_probs=205.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
..+|.+.+.||+|+||+||+|.+ +++.||||++....... .....+.+|+.+++.++||||+++++++.+...+++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999998 68899999986543221 1235788999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+ +|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 9999 6788888863 4579999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCCCCCCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCChHHHHHHHHh
Q 003971 680 RDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEGPLGRLIADC 757 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~-~~~ip~~~L~~LI~~C 757 (782)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........+..... .+...+..+.+|+.+|
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 242 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRM 242 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTT
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHH
Confidence 3346789999999999988776 7899999999999999999999987544332222111111 1111234689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. ||.+|||+.+++++
T Consensus 243 L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 243 IVADPMQRITIQEIRRD 259 (336)
T ss_dssp SCSSGGGSCCHHHHTTC
T ss_pred cCCChhHCcCHHHHHhC
Confidence 99 99999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=360.98 Aligned_cols=243 Identities=26% Similarity=0.365 Sum_probs=192.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|.+.+.||+|+||.||+|.+ .++.||||++.... ..+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 36799999999999999999998 46789999987542 2356789999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC---CCeEEEEecCccccccCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLSRIITDS 677 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~---~g~VKLaDFGLA~~l~~~ 677 (782)
||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 128 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 128 ELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999999886 3456899999999999999999999999999999999999975 889999999999876543
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCC-----CChHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVANEGSRLEI-----PEGPLG 751 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~e-vl~~i~~~~~~~~i-----p~~~L~ 751 (782)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... ....+......... ....+.
T Consensus 205 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 283 (349)
T 2w4o_A 205 V-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred c-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence 2 2345679999999999999999999999999999999999999998776555 44444443332221 134689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+|+.+||. ||.+|||+.+++++
T Consensus 284 ~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 284 DLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999 99999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.51 Aligned_cols=252 Identities=30% Similarity=0.487 Sum_probs=198.8
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHH--HhCCCCceeeEeccc-----
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISIL--SRLRHPNVILFLGAC----- 590 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iL--k~L~HPNIVkL~g~~----- 590 (782)
+..+..++|++.+.||+|+||.||+|.++++.||||++.... ...+..|.+++ ..++||||+++++.+
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 345678999999999999999999999999999999986432 23445555554 458999999999743
Q ss_pred cCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc---------cccccCCCcccEEEcCCC
Q 003971 591 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM---------KIVHRDLKSANCLVNKHW 661 (782)
Q Consensus 591 ~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~---------gIIHrDIKPeNILLd~~g 661 (782)
.....+++||||+++|+|.+++.. ...++..++.++.||+.||+|||+. ||+||||||+|||++.++
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred CCCceEEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 334467999999999999999963 2458889999999999999999999 999999999999999999
Q ss_pred eEEEEecCccccccCCC--------CCCCCCCCCCcccCcccccc-------CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 003971 662 TVKICDFGLSRIITDSP--------MRDSSSAGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWELCTLNRPWEG 726 (782)
Q Consensus 662 ~VKLaDFGLA~~l~~~~--------~~~~~~~GT~~Y~APEvl~~-------~~~s~ksDVWSLGvILyELLTGk~PF~~ 726 (782)
.+||+|||+++.+.... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 99999999998764321 11234579999999999986 3566789999999999999999776532
Q ss_pred C------------------ChHHHHHHHHhcCCCCCCCCh---------HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 727 V------------------LPERVVYAVANEGSRLEIPEG---------PLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 727 ~------------------~~~evl~~i~~~~~~~~ip~~---------~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
. ........+.....++.++.. .+.+|+.+||. ||.+|||+.++++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1 111222223334444444432 58999999999 9999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.13 Aligned_cols=253 Identities=27% Similarity=0.550 Sum_probs=206.3
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeE----EEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTD----VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~----VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
+...+|++.+.||+|+||.||+|.+ +++. ||+|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 3457899999999999999999987 4444 5677664332 2334578999999999999999999999998765
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+++++|+.+|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred -ceEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 8899999999999999873 3456899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---Ch
Q 003971 675 TDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EG 748 (782)
Q Consensus 675 ~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~ 748 (782)
..... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+.. ......+ ..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 246 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQPPICTI 246 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCCCTTBCH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCCccCCH
Confidence 43322 2234557889999999999999999999999999999999 9999998887776665544 3333333 34
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
.+.+|+.+||. ||.+||++.++++.|+.+.
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 69999999999 9999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=361.07 Aligned_cols=241 Identities=25% Similarity=0.419 Sum_probs=206.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|.+.+.||+|+||+||++.+ +++.||||++...... +.+|++++.++ +||||+++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 5799999999999999999988 5889999999765432 34688888887 7999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC----CeEEEEecCccccccC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH----WTVKICDFGLSRIITD 676 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~----g~VKLaDFGLA~~l~~ 676 (782)
||+.+|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||+..+ +.+||+|||+++....
T Consensus 96 E~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 9999999999886 34579999999999999999999999999999999999998533 3599999999988765
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHhcCCCCCC-----CCh
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG---VLPERVVYAVANEGSRLEI-----PEG 748 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~---~~~~evl~~i~~~~~~~~i-----p~~ 748 (782)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+ ....++...+......... -..
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 252 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCH
Confidence 54445567899999999999988899999999999999999999999975 3555666666554433221 234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+.+|+.+||. ||.+||++.++++|
T Consensus 253 ~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 68999999999 99999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=342.82 Aligned_cols=242 Identities=23% Similarity=0.324 Sum_probs=204.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++............+.+|+..+..+ +||||+++++++.+.+.+++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999988 588999999987655555678889999999999 8999999999999999999999
Q ss_pred EEecccchhhHHHhhcc-cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC-------------------
Q 003971 601 EYMELGSLYHLIHLSGQ-KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH------------------- 660 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~-~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~------------------- 660 (782)
||+++++|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 99999999999974322 2568999999999999999999999999999999999999844
Q ss_pred CeEEEEecCccccccCCCCCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 003971 661 WTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 739 (782)
Q Consensus 661 g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~ 739 (782)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|..|+..... ...+ ..
T Consensus 171 ~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~-~~ 242 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEI-RQ 242 (289)
T ss_dssp CCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHH-HT
T ss_pred eEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHH-Hc
Confidence 47999999999876543 245699999999999776 567899999999999999999987755432 2222 22
Q ss_pred CCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 740 GSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 740 ~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+..+.++ +..+.+|+.+||. ||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 3333333 3579999999999 99999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=352.03 Aligned_cols=255 Identities=28% Similarity=0.459 Sum_probs=211.9
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc--C
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT--K 592 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~--d 592 (782)
++.++|++.+.||+|+||.||++.+ .++.||||++... .....+.+.+|+.+++.++||||+++++++. +
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 3457899999999999999999984 5788999998654 3445577999999999999999999999876 4
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
...+++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CceEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 56689999999999999999732 3468999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC---CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--------------HHHHH
Q 003971 673 IITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--------------RVVYA 735 (782)
Q Consensus 673 ~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~--------------evl~~ 735 (782)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 7654321 223456888999999999998999999999999999999999998643322 22233
Q ss_pred HHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 736 VANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 736 i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
....+.....+ +..+.+|+.+||. ||.+|||+.+++++|+.+..
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 33344444433 3469999999999 99999999999999998743
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=359.28 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=199.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
+++|.+.+.||+|+||+||+|.+ +++.||||++...... .....+.+|+.+++.++||||+++++++.+...+++||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 36899999999999999999988 5889999998644321 11224557999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+. |+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 80 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 80 EYLD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp ECCS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cccc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 9998 488887763 3456899999999999999999999999999999999999999999999999999876544444
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---C-----------
Q 003971 681 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---I----------- 745 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~---i----------- 745 (782)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+. .
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 456678999999999876 5689999999999999999999999999888777766654221110 0
Q ss_pred -----------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 -----------------PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 -----------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+..+.+|+.+||. ||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 12357899999999 99999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=365.85 Aligned_cols=246 Identities=25% Similarity=0.383 Sum_probs=213.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|.+.+.||+|+||.||+|.+ +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 36899999999999999999988 57899999986543 233467889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC--CCeEEEEecCccccccCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK--HWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~--~g~VKLaDFGLA~~l~~~~ 678 (782)
||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 128 E~~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 128 EFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp ECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999998862 2347899999999999999999999999999999999999974 5789999999998775432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-----p~~~L~~L 753 (782)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+......... .+..+.+|
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 284 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 223457999999999999999999999999999999999999999998888877777665433221 13468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. ||.+|||+.+++++
T Consensus 285 i~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 285 IKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCChhHCcCHHHHhhC
Confidence 999999 99999999999976
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=377.83 Aligned_cols=249 Identities=27% Similarity=0.482 Sum_probs=217.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
+...+|.+++.||+|+||.||+|.+ +|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3457899999999999999999988 5889999998754322 123567889999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+||||+++|+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 93 lv~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 93 MVMEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999999986 4567999999999999999999999999999999999999999999999999999887543
Q ss_pred CCCCCCCCCCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIA 755 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~ 755 (782)
. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........+.......+ .-...+.+|+.
T Consensus 170 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 248 (476)
T 2y94_A 170 E-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLK 248 (476)
T ss_dssp C-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred c-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHH
Confidence 2 3356789999999999988765 6899999999999999999999999888777777765443322 22456999999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003971 756 DCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 756 ~CL~-DP~kRPSa~EIL~~ 773 (782)
+||. ||.+|||+.++++|
T Consensus 249 ~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 249 HMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHTCSSTTTSCCHHHHHTC
T ss_pred HHcCCCchhCcCHHHHHhC
Confidence 9999 99999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=374.85 Aligned_cols=245 Identities=25% Similarity=0.443 Sum_probs=209.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|.+++.||+|+||+||+|.+ ++..||||++............+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4799999999999999999988 57899999997665444445788999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC---CCeEEEEecCccccccCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~---~g~VKLaDFGLA~~l~~~~ 678 (782)
|+.+|+|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 117 ~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 117 CYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 9999999988863 357899999999999999999999999999999999999975 4569999999998775432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~L 753 (782)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+.........+ +..+.+|
T Consensus 194 -~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 194 -KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp -CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred -cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 3346789999999999874 58999999999999999999999999999988888887765544332 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. ||.+|||+.++++|
T Consensus 272 i~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHCCCChhhCccHHHHhcC
Confidence 999999 99999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=356.36 Aligned_cols=249 Identities=23% Similarity=0.252 Sum_probs=203.8
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh---HHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA---ENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~---~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
...+|.+.+.||+|+||.||+|.+ +|+.||||++....... .....+.+|+.+++.++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 347899999999999999999987 48899999986543221 1124678999999999999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++||||+.+ +|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 999999986 78777752 345688999999999999999999999999999999999999999999999999988765
Q ss_pred CCCCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----------
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----------- 744 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~----------- 744 (782)
.........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......+..+......+.
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 44445567899999999998754 589999999999999999999999999888777776654221110
Q ss_pred ------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 ------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 ------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.....+.+|+.+||. ||.+|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 012468899999999 99999999999976
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=351.41 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=203.9
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC---hHHHHHHHHHHHHHHhCC---CCceeeEeccccCC
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT---AENMEDFCNEISILSRLR---HPNVILFLGACTKP 593 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~---~~~~e~f~~EI~iLk~L~---HPNIVkL~g~~~d~ 593 (782)
..++|++.+.||+|+||+||+|.+ +++.||||++...... ......+.+|+.+++.++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999986 6889999998644321 111245667777777664 99999999998765
Q ss_pred C-----ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEec
Q 003971 594 P-----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 668 (782)
Q Consensus 594 ~-----~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDF 668 (782)
. .++++|||+. ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 4 4799999998 5999888632 2344899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----
Q 003971 669 GLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---- 744 (782)
Q Consensus 669 GLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~---- 744 (782)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......+.
T Consensus 165 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 165 GLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp SCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9998765432 23456799999999999999999999999999999999999999999988887777654211110
Q ss_pred ------------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 ------------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 ------------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.-...+.+|+.+||. ||.+|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 012357899999999 99999999999976
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=375.10 Aligned_cols=245 Identities=28% Similarity=0.472 Sum_probs=216.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
++|.+.+.||+|+||.||+|.+ +|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 6799999999999999999988 5889999999765432 334678999999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE---cCCCeEEEEecCccccccCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL---d~~g~VKLaDFGLA~~l~~~ 677 (782)
||+.+|+|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 106 e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 106 EVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp CCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 9999999999886 44679999999999999999999999999999999999999 56789999999999877543
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGR 752 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~ 752 (782)
. .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+.........+ +..+.+
T Consensus 183 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 183 K-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260 (484)
T ss_dssp C-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred c-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence 2 2234579999999999876 58999999999999999999999999999988888887766555443 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003971 753 LIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
|+.+||. ||.+|||+.++++|
T Consensus 261 li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHCCCChhHCcCHHHHhhC
Confidence 9999999 99999999999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=362.88 Aligned_cols=257 Identities=19% Similarity=0.209 Sum_probs=201.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeeccccChH---------HHHHHHHHHHHHHhCCCCceeeE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAE---------NMEDFCNEISILSRLRHPNVILF 586 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~~~~---------~~e~f~~EI~iLk~L~HPNIVkL 586 (782)
+..++|.+.+.||+|+||.||+|.+ .+..+|||++........ ....+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 3457899999999999999999988 457899999875532111 12346788899999999999999
Q ss_pred eccccC----CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC-
Q 003971 587 LGACTK----PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW- 661 (782)
Q Consensus 587 ~g~~~d----~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g- 661 (782)
++++.. ...+|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence 999877 67899999999 9999999863 34899999999999999999999999999999999999999887
Q ss_pred -eEEEEecCccccccCCCC-------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC--ChHH
Q 003971 662 -TVKICDFGLSRIITDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV--LPER 731 (782)
Q Consensus 662 -~VKLaDFGLA~~l~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~--~~~e 731 (782)
.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+. ....
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999987643211 113567999999999999999999999999999999999999999652 2222
Q ss_pred HHHHHHh--cCCCC--------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003971 732 VVYAVAN--EGSRL--------EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 781 (782)
Q Consensus 732 vl~~i~~--~~~~~--------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~sL 781 (782)
....... ..... ...+..+.+++.+||. ||.+||++.+|++.|++....+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 2111111 11100 0123469999999999 9999999999999999876554
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=352.09 Aligned_cols=258 Identities=29% Similarity=0.526 Sum_probs=213.8
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 592 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 592 (782)
++..++|.+.+.||+|+||.||+|.+ .+..||||++... ........+.+|+.+++.++||||+++++++.+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 35567899999999999999999973 4668999998643 234456789999999999999999999999999
Q ss_pred CCceEEEEEEecccchhhHHHhhcc----cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC---CCeEEE
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQ----KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKI 665 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~----~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~---~g~VKL 665 (782)
....++||||+++++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||++. +..+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999999974321 145899999999999999999999999999999999999984 456999
Q ss_pred EecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC
Q 003971 666 CDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR 742 (782)
Q Consensus 666 aDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~ 742 (782)
+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|+| |..||...........+.... .
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~ 263 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-R 263 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-C
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-C
Confidence 99999986543322 1223457889999999999999999999999999999998 999999888877766665443 3
Q ss_pred CCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 743 LEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 743 ~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
...+ +..+.+|+.+||. ||.+||++.+++++|..+..
T Consensus 264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 3222 3469999999999 99999999999999987743
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=362.89 Aligned_cols=243 Identities=27% Similarity=0.401 Sum_probs=206.4
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEe
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 603 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 603 (782)
|...+.||+|+||.||+|.+ +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.+++||||+
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 33467899999999999987 58899999987643 234578999999999999999999999999999999999999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE--cCCCeEEEEecCccccccCCCCCC
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL--d~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...... ..
T Consensus 169 ~~~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~ 245 (373)
T 2x4f_A 169 DGGELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KL 245 (373)
T ss_dssp TTCEEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BC
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cc
Confidence 99999988863 34568999999999999999999999999999999999999 567899999999998775432 33
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHHHHH
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRLIAD 756 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-----p~~~L~~LI~~ 756 (782)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..+......... -...+.+|+.+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 4567999999999999999999999999999999999999999999888888887765543321 13468999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003971 757 CWA-EPQERPSCEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~ 773 (782)
||. ||.+||++.+++++
T Consensus 326 ~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 326 LLIKEKSWRISASEALKH 343 (373)
T ss_dssp TSCSSGGGSCCHHHHHHS
T ss_pred HcCCChhhCCCHHHHhcC
Confidence 999 99999999999984
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=340.06 Aligned_cols=246 Identities=23% Similarity=0.358 Sum_probs=206.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|++.+.||+|+||.||+|.+ +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 5799999999999999999988 5889999998755432 345788999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC--C
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--M 679 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~--~ 679 (782)
|+++++|.+++. ....+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999999999885 44578999999999999999999999999999999999999999999999999998654321 1
Q ss_pred CCCCCCCCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCCCCCC---CChHHHHHH
Q 003971 680 RDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERV-VYAVANEGSRLEI---PEGPLGRLI 754 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTGk~PF~~~~~~ev-l~~i~~~~~~~~i---p~~~L~~LI 754 (782)
......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ...+......... .+..+.+|+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 2345679999999999987765 7799999999999999999999987654322 2233322222111 234689999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003971 755 ADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+||. ||.+|||+.+++++
T Consensus 243 ~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHCCCCchhCCCHHHHhcC
Confidence 99999 99999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=347.42 Aligned_cols=243 Identities=24% Similarity=0.402 Sum_probs=209.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|.+.+.||+|+||.||++.+ +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+...++++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 5799999999999999999987 588999999875432 223568899999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE---cCCCeEEEEecCccccccCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL---d~~g~VKLaDFGLA~~l~~~~ 678 (782)
|+++++|.+++.. ...+++..++.++.|++.||.|||++||+|+||||+|||+ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 9999999998863 3468999999999999999999999999999999999999 78899999999999765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~L 753 (782)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.........+ +..+.+|
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 241 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence 1223468999999999999999999999999999999999999999988888777776654433221 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. ||.+||++.+++++
T Consensus 242 i~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 242 ICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999 99999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=356.53 Aligned_cols=261 Identities=30% Similarity=0.561 Sum_probs=216.5
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 515 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 515 ~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
...+|.+..++|.+.+.||+|+||.||+|.+.+ .+|+|++..........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 346788899999999999999999999999876 4999998765544444466788999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+++++||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred ceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 99999999999999999862 334689999999999999999999999999999999999998 679999999998765
Q ss_pred cCC-----CCCCCCCCCCCcccCcccccc---------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 003971 675 TDS-----PMRDSSSAGTPEWMAPELIRN---------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 740 (782)
Q Consensus 675 ~~~-----~~~~~~~~GT~~Y~APEvl~~---------~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~ 740 (782)
... ........||+.|+|||++.. ..++.++|||||||++|+|++|+.||...........+....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 321 112234568999999999864 457899999999999999999999999988887777665543
Q ss_pred CCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 741 SRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 741 ~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.....+ +..+.+|+..||. ||.+|||+.++++.|+++..
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 322221 3469999999999 99999999999999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=357.83 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=206.8
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC-------
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------- 592 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d------- 592 (782)
..++|.+.+.||+|+||.||+|.+ +|+.||||++............+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 347899999999999999999988 58899999987665544445678899999999999999999999876
Q ss_pred -CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 593 -PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 593 -~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
.+.+++||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 3468999999986 66666642 3356899999999999999999999999999999999999999999999999999
Q ss_pred ccccCC----CCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--
Q 003971 672 RIITDS----PMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-- 744 (782)
Q Consensus 672 ~~l~~~----~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-- 744 (782)
..+... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+........
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 876422 122345678999999999876 4589999999999999999999999999888777666654221111
Q ss_pred C-C------------------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 I-P------------------------------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 i-p------------------------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. + +..+.+|+.+||. ||.+|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 0 2347789999999 99999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=348.86 Aligned_cols=254 Identities=22% Similarity=0.279 Sum_probs=204.0
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 598 (782)
.+++|.+.+.||+|+||.||++.+ +++.||||++..... .....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 357899999999999999999987 588999999865543 23345788999999999999999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~ 678 (782)
++||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999999873 3568999999999999999999999999999999999999999999999999998765432
Q ss_pred C-CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CC---CChHHHHH
Q 003971 679 M-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EI---PEGPLGRL 753 (782)
Q Consensus 679 ~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~i---p~~~L~~L 753 (782)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......+ .. -+..+.+|
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 1 2235579999999999999999999999999999999999999999877654444333322211 11 13469999
Q ss_pred HHHhhh-CCCCCC-CHHHHHHHHHhhh
Q 003971 754 IADCWA-EPQERP-SCEEILSRLLDCE 778 (782)
Q Consensus 754 I~~CL~-DP~kRP-Sa~EIL~~L~di~ 778 (782)
+.+||. ||.+|| +++++++.|++..
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred HHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 999999 999999 9999999998763
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.81 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=206.7
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
++.....+|.....||+|+||.||+|.+ +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 3445556666677899999999999987 57899999987553 2335778999999999999999999999999999
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC-CCeEEEEecCccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRII 674 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~-~g~VKLaDFGLA~~l 674 (782)
.++||||+++++|.+++........+++..++.++.||+.||+|||++||+|+||||+|||++. ++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 9999999999999999975444456778999999999999999999999999999999999987 899999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCC---Ch
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVANEGSRLEIP---EG 748 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~--~s~ksDVWSLGvILyELLTGk~PF~~~~~~e-vl~~i~~~~~~~~ip---~~ 748 (782)
...........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ...........+.++ +.
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence 54333344667999999999997653 8899999999999999999999997654332 222222223333333 34
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+.+|+.+||. ||.+||++.+++++
T Consensus 254 ~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 68999999999 99999999999865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=347.53 Aligned_cols=248 Identities=31% Similarity=0.561 Sum_probs=201.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhC--CCCceeeEeccccCC----CceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL--RHPNVILFLGACTKP----PRLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L--~HPNIVkL~g~~~d~----~~l~ 597 (782)
++|++.+.||+|+||.||+|.++++.||||++.... ...+..|.+++..+ +||||+++++++... ..++
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 689999999999999999999999999999985432 24455666666555 899999999998776 6799
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc--------cccccCCCcccEEEcCCCeEEEEecC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM--------KIVHRDLKSANCLVNKHWTVKICDFG 669 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~--------gIIHrDIKPeNILLd~~g~VKLaDFG 669 (782)
+||||+++|+|.+++.. ..+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||
T Consensus 112 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 99999999999999962 3689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCC----CCCCCCCCcccCccccccCCCCch------hHHHHHHHHHHHHHhC----------CCCCCCCC-
Q 003971 670 LSRIITDSPMR----DSSSAGTPEWMAPELIRNEPFTEK------CDIFSLGVIMWELCTL----------NRPWEGVL- 728 (782)
Q Consensus 670 LA~~l~~~~~~----~~~~~GT~~Y~APEvl~~~~~s~k------sDVWSLGvILyELLTG----------k~PF~~~~- 728 (782)
++..+...... .....||+.|+|||++.+..+..+ +|||||||++|||+|| +.||....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 99776443221 235679999999999987766554 9999999999999999 77775432
Q ss_pred ----hHHHHHHHHhcCCCCCCCC--------hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 729 ----PERVVYAVANEGSRLEIPE--------GPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 729 ----~~evl~~i~~~~~~~~ip~--------~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
.......+......+..+. ..+.+|+.+||. ||.+|||+.+++++|+.+..+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 2223333333333444442 248899999999 999999999999999988653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=341.25 Aligned_cols=246 Identities=26% Similarity=0.420 Sum_probs=207.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC---------
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--------- 592 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--------- 592 (782)
.+|.+.+.||+|+||.||+|.+ +++.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 5799999999999999999988 48899999987543 346689999999999999999998754
Q ss_pred -------CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEE
Q 003971 593 -------PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 665 (782)
Q Consensus 593 -------~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKL 665 (782)
...++++|||+++++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 34589999999999999999743 3457899999999999999999999999999999999999999999999
Q ss_pred EecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 003971 666 CDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI 745 (782)
Q Consensus 666 aDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i 745 (782)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||... ......+ ........
T Consensus 164 ~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~-~~~~~~~~ 239 (284)
T 2a19_B 164 GDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDL-RDGIISDI 239 (284)
T ss_dssp CCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHH-HTTCCCTT
T ss_pred Ccchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHh-hccccccc
Confidence 9999998775532 234567999999999999999999999999999999999999987532 1222222 22333334
Q ss_pred CChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 746 PEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 746 p~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
.+..+.+++.+||. ||.+||++.+++++|..++.+
T Consensus 240 ~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 240 FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 45579999999999 999999999999999988764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=349.14 Aligned_cols=247 Identities=29% Similarity=0.533 Sum_probs=208.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHh--CCCCceeeEeccccCCC----ceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR--LRHPNVILFLGACTKPP----RLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~--L~HPNIVkL~g~~~d~~----~l~ 597 (782)
++|.+.+.||+|+||.||+|.++++.||||++... ....+.+|++++.. ++||||+++++++.... .++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 67999999999999999999999999999998533 24667889999988 78999999999998775 799
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHH--------hccccccCCCcccEEEcCCCeEEEEecC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH--------RMKIVHRDLKSANCLVNKHWTVKICDFG 669 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLH--------s~gIIHrDIKPeNILLd~~g~VKLaDFG 669 (782)
+||||+++|+|.+++.. ..+++..++.++.|++.||+||| +.||+||||||+|||++.++.+||+|||
T Consensus 117 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 99999999999999963 36899999999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCCC----CCCCCCCCCcccCccccccCC------CCchhHHHHHHHHHHHHHhC----------CCCCCCC--
Q 003971 670 LSRIITDSPM----RDSSSAGTPEWMAPELIRNEP------FTEKCDIFSLGVIMWELCTL----------NRPWEGV-- 727 (782)
Q Consensus 670 LA~~l~~~~~----~~~~~~GT~~Y~APEvl~~~~------~s~ksDVWSLGvILyELLTG----------k~PF~~~-- 727 (782)
++........ ......||+.|+|||++.+.. ++.++|||||||++|+|+|| +.||...
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 9987654332 224567999999999998752 33789999999999999999 7898754
Q ss_pred ---ChHHHHHHHHhcCCCCCCCC--------hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 728 ---LPERVVYAVANEGSRLEIPE--------GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 728 ---~~~evl~~i~~~~~~~~ip~--------~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
........+.....++.++. ..+.+|+.+||. ||.+|||+.+++++|+++..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 23344444444445555553 258899999999 99999999999999998854
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=345.54 Aligned_cols=246 Identities=28% Similarity=0.511 Sum_probs=207.9
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
..++|.+.+.||+|+||.||+|.+. |+.||||++..... .+.+.+|+.+++.++||||+++++++.+...+++|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 3478999999999999999999884 88999999875432 35788999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++........
T Consensus 103 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 103 MEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred eecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999999863 345789999999999999999999999999999999999999999999999999987765433
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CC---CChHHHHHHH
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EI---PEGPLGRLIA 755 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~i---p~~~L~~LI~ 755 (782)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+....... .. .+..+.+|+.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence 4456679999999999999999999999999999999999999999888776666554432211 11 2346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003971 756 DCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 756 ~CL~-DP~kRPSa~EIL~~ 773 (782)
+||. ||.+||++.+++++
T Consensus 261 ~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 261 QCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHTCSCTTTSCCHHHHTTS
T ss_pred HHccCChhhCcCHHHHHhC
Confidence 9999 99999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.32 Aligned_cols=236 Identities=22% Similarity=0.367 Sum_probs=180.6
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEEEEEeccc
Q 003971 530 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
+.||+|+||+||+|.+ +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....|+||||+++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 6799999999999988 4889999998643 2456778999999997 999999999999999999999999999
Q ss_pred chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC---eEEEEecCccccccCCCCCCCC
Q 003971 607 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSRIITDSPMRDSS 683 (782)
Q Consensus 607 sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g---~VKLaDFGLA~~l~~~~~~~~~ 683 (782)
+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...........
T Consensus 92 ~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 168 (325)
T 3kn6_A 92 ELFERIK---KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168 (325)
T ss_dssp BHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccc
Confidence 9999987 346799999999999999999999999999999999999997765 8999999999876554444456
Q ss_pred CCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCC-----CChHHH
Q 003971 684 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-------ERVVYAVANEGSRLEI-----PEGPLG 751 (782)
Q Consensus 684 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~-------~evl~~i~~~~~~~~i-----p~~~L~ 751 (782)
.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... .+....+......... ....+.
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 248 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAK 248 (325)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHH
T ss_pred cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHH
Confidence 7899999999999999999999999999999999999999976433 3444444333322221 134689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+|+..||. ||.+|||+.+++++
T Consensus 249 ~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 249 DLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHCCCChhHCCCHHHHhcC
Confidence 99999999 99999999998865
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=373.50 Aligned_cols=246 Identities=28% Similarity=0.455 Sum_probs=211.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-----------HHHHHHHHHHHHHHhCCCCceeeEecc
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-----------ENMEDFCNEISILSRLRHPNVILFLGA 589 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-----------~~~e~f~~EI~iLk~L~HPNIVkL~g~ 589 (782)
.++|.++++||+|+||+||+|.+ .++.||||++....... ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 36899999999999999999988 47889999987654321 235678999999999999999999999
Q ss_pred ccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC---eEEEE
Q 003971 590 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKIC 666 (782)
Q Consensus 590 ~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g---~VKLa 666 (782)
+.+...+|+||||+++|+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999999998863 35799999999999999999999999999999999999998776 69999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-
Q 003971 667 DFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI- 745 (782)
Q Consensus 667 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i- 745 (782)
|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+.........
T Consensus 192 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 192 DFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp CCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred ECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 99999877543 23356789999999999875 5899999999999999999999999999998888888776544332
Q ss_pred ----CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 ----PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 ----p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+..+.+|+.+||. ||.+|||+.+++++
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 23468999999999 99999999999976
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=359.41 Aligned_cols=242 Identities=27% Similarity=0.333 Sum_probs=202.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC------c
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------R 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------~ 595 (782)
++|.+.+.||+|+||.||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 7899999999999999999987 5889999998765555556678999999999999999999999987653 4
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 69999999 7899998863 468999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 743 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~----------- 743 (782)
.. .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+......+
T Consensus 180 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 180 SE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp SS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred cc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 32 345688999999999877 679999999999999999999999999888777666554321111
Q ss_pred ---------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ---------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ---------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
......+.+|+.+||. ||.+|||+.++++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0113458899999999 99999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=352.44 Aligned_cols=256 Identities=31% Similarity=0.574 Sum_probs=211.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEE--EEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCc
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDV--AIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 595 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~V--AVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~ 595 (782)
+..++|.+.+.||+|+||.||+|.+ ++..+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 3457899999999999999999976 56654 889886432 233456789999999999 89999999999999999
Q ss_pred eEEEEEEecccchhhHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe
Q 003971 596 LSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 662 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~ 662 (782)
+++||||+++++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 999999999999999987432 2246899999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003971 663 VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 741 (782)
Q Consensus 663 VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~ 741 (782)
+||+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+.. +.
T Consensus 181 ~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-~~ 258 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GY 258 (327)
T ss_dssp EEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-TC
T ss_pred EEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc-CC
Confidence 999999999754321 12234567889999999998889999999999999999998 9999999888776665543 33
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 742 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 742 ~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
....+ +..+.+|+.+||. ||.+||++.+++++|.++..
T Consensus 259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 33333 3469999999999 99999999999999998743
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=357.72 Aligned_cols=244 Identities=25% Similarity=0.320 Sum_probs=199.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC------
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 594 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------ 594 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47899999999999999999987 5889999999766555666788999999999999999999999987665
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+|+||||+.+ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 68999999985 6777764 35889999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 743 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~----------- 743 (782)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 178 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 178 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred ccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 433 22345689999999999999999999999999999999999999999988877766665432111
Q ss_pred ---------C--------------CC---------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ---------E--------------IP---------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ---------~--------------ip---------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. .+ ...+.+|+.+||. ||.+|||+.++++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 01 1247889999999 99999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=341.22 Aligned_cols=247 Identities=25% Similarity=0.420 Sum_probs=213.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc---C----hHHHHHHHHHHHHHHhCC-CCceeeEeccccC
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---T----AENMEDFCNEISILSRLR-HPNVILFLGACTK 592 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~---~----~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d 592 (782)
.++|.+.+.||+|+||.||+|.+ +++.||||++..... . ....+.+.+|+.+++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 47899999999999999999988 578999999875531 1 123467889999999996 9999999999999
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
....++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 9999999999999999999873 3578999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccc------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIR------NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 746 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~------~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip 746 (782)
...... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+.........+
T Consensus 173 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 173 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred hcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 765432 334567999999999985 4568899999999999999999999999988887777776655444333
Q ss_pred -----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 -----EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 -----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+..+.+|+.+||. ||.+||++.+++++
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 2469999999999 99999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=347.28 Aligned_cols=247 Identities=28% Similarity=0.487 Sum_probs=205.6
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|++.+.||+|+||.||+|.+. ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 368999999999999999999984 8899999986543 233578899999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.........
T Consensus 96 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 96 EFCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp ECCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred EeCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 99999999998863 2356899999999999999999999999999999999999999999999999997654222112
Q ss_pred CCCCCCCCcccCcccc-----ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-C---ChHHH
Q 003971 681 DSSSAGTPEWMAPELI-----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-P---EGPLG 751 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl-----~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-p---~~~L~ 751 (782)
.....||+.|+|||++ .+..++.++|||||||++|+|++|+.||...........+......... + +..+.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHH
Confidence 2346789999999998 4667899999999999999999999999998887777766654432221 1 34689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+|+..||. ||.+|||+.+++++
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHcccChhhCCCHHHHhcC
Confidence 99999999 99999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=350.64 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=210.3
Q ss_pred CCeeEe-eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEE
Q 003971 524 SELTVG-TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 524 s~y~i~-~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV 599 (782)
..|.+. +.||+|+||.||+|.+ +++.||||++............+.+|+.+++.+. ||||+++++++.+...+++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 457776 8899999999999988 4889999999776555555678999999999995 69999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC---CCeEEEEecCccccccC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLSRIITD 676 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~---~g~VKLaDFGLA~~l~~ 676 (782)
|||+.+|+|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 999999999998852 23467899999999999999999999999999999999999987 78999999999987654
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHH
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLG 751 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~ 751 (782)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.........+ ...+.
T Consensus 187 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 265 (327)
T 3lm5_A 187 AC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLAT 265 (327)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred cc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHH
Confidence 32 2345679999999999999999999999999999999999999999988888777766544333221 34689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+|+.+||. ||.+|||+.+++++
T Consensus 266 ~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 266 DFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHcCCChhhCcCHHHHhCC
Confidence 99999999 99999999999976
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=349.07 Aligned_cols=251 Identities=27% Similarity=0.481 Sum_probs=208.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC--Cc
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PR 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~ 595 (782)
..|+++++||+|+||+||++.+ +++.||||++... ......+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 3459999999999999998865 5788999998754 3345567899999999999999999999999774 56
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+++||||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 8999999999999999862 348999999999999999999999999999999999999999999999999998775
Q ss_pred CCCC---CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--------------HHHHHHHh
Q 003971 676 DSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--------------RVVYAVAN 738 (782)
Q Consensus 676 ~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~--------------evl~~i~~ 738 (782)
.... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 4321 123456888999999999988999999999999999999999999754321 11222333
Q ss_pred cCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 739 EGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 739 ~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.......+ +..+.+|+..||. ||.+|||+.++++.|+.+..
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 34444433 3469999999999 99999999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=355.01 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=208.7
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
++..++|.+.+.||+|+||.||++.+. ++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 345578999999999999999999984 8899999987543 4455678999999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc-cccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~-gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 108 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999999973 34689999999999999999999996 999999999999999999999999999976543
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--------------------
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV-------------------- 736 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i-------------------- 736 (782)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp H--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred c--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 2 223567999999999999999999999999999999999999999877655432211
Q ss_pred ---------------------HhcCCCCCCC----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 737 ---------------------ANEGSRLEIP----EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 737 ---------------------~~~~~~~~ip----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
......+..+ +..+.+|+.+||. ||.+|||+.++++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0111122222 3368899999999 99999999999976
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=390.39 Aligned_cols=252 Identities=20% Similarity=0.344 Sum_probs=217.4
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCC
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPP 594 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~ 594 (782)
..+..++|.+.+.||+|+||+||+|.+ +++.||||++.+... .....+.+..|+.++..+ +||||+++++++.+.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 345678999999999999999999988 477899999975432 223356788999999988 6999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+|+||||+++|+|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+++..
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999999973 357999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHH
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRL 753 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-p~~~L~~L 753 (782)
..........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++...+.......+. -...+.+|
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 572 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 572 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHH
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 54444556789999999999999999999999999999999999999999999998888888765433321 23469999
Q ss_pred HHHhhh-CCCCCCCH-----HHHHHH
Q 003971 754 IADCWA-EPQERPSC-----EEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa-----~EIL~~ 773 (782)
|..||. ||.+||++ .+|++|
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 999999 99999997 777754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=338.91 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=204.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccc-cCCCceEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC-TKPPRLSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~-~d~~~l~LV 599 (782)
.++|++.+.||+|+||.||+|.+ +++.||||++...... +.+.+|+.+++.++|++++..+..+ ......+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 37899999999999999999986 6899999998655432 3578999999999988866666555 556778999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE---cCCCeEEEEecCccccccC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL---d~~g~VKLaDFGLA~~l~~ 676 (782)
|||+ +++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 84 ~e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 84 MELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 9999 8999999863 23578999999999999999999999999999999999999 4888999999999987654
Q ss_pred CCC-------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCC---
Q 003971 677 SPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP---ERVVYAVANEGSRL--- 743 (782)
Q Consensus 677 ~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~---~evl~~i~~~~~~~--- 743 (782)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ......+.......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 322 12456799999999999999999999999999999999999999986432 12222222211111
Q ss_pred ---CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 744 ---EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 744 ---~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
..-+..+.+|+..||. ||.+||++.++++.|+++..
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 1123569999999999 99999999999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=341.83 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=200.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccc-cCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC-TKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~-~d~~~l~LV~ 600 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++...... ..+.+|+.+++.++|++++..+..+ ......+++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 6899999999999999999986 6889999987554332 3577899999999988777666655 5667789999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE---cCCCeEEEEecCccccccCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL---d~~g~VKLaDFGLA~~l~~~ 677 (782)
||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 999 8999999863 24568999999999999999999999999999999999999 78899999999999876543
Q ss_pred CC-------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCCC---
Q 003971 678 PM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---RVVYAVANEGSRLE--- 744 (782)
Q Consensus 678 ~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~---evl~~i~~~~~~~~--- 744 (782)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... .....+........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 22 223567999999999999999999999999999999999999999764321 12222211111111
Q ss_pred ---CCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 745 ---IPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 745 ---ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
--+..+.+|+..||. ||.+||++.++++.|+++..
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 114569999999999 99999999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=361.74 Aligned_cols=246 Identities=27% Similarity=0.354 Sum_probs=197.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC-----Cce
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PRL 596 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-----~~l 596 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++..........+.+.+|+.+|+.++||||+++++++... ..+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 7899999999999999999987 578999999976655566678899999999999999999999998766 569
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
|+||||+. ++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99999987 59998886 456799999999999999999999999999999999999999999999999999987643
Q ss_pred CCC----------------------CCCCCCCCCcccCcccc-ccCCCCchhHHHHHHHHHHHHHhCCC-----------
Q 003971 677 SPM----------------------RDSSSAGTPEWMAPELI-RNEPFTEKCDIFSLGVIMWELCTLNR----------- 722 (782)
Q Consensus 677 ~~~----------------------~~~~~~GT~~Y~APEvl-~~~~~s~ksDVWSLGvILyELLTGk~----------- 722 (782)
... .....+||+.|+|||++ ....++.++|||||||++|||++|..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 321 12567899999999986 56679999999999999999998543
Q ss_pred CCCCCCh-----------------HHHHHHHHh------------------------cCCCCC--------CCChHHHHH
Q 003971 723 PWEGVLP-----------------ERVVYAVAN------------------------EGSRLE--------IPEGPLGRL 753 (782)
Q Consensus 723 PF~~~~~-----------------~evl~~i~~------------------------~~~~~~--------ip~~~L~~L 753 (782)
+|.+... ...+..+.. ...... -.+..+.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 3433321 111111111 001111 113458899
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. ||.+|||+.|+++|
T Consensus 342 l~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHhcCCcccCCCHHHHhcC
Confidence 999999 99999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=361.34 Aligned_cols=254 Identities=29% Similarity=0.538 Sum_probs=202.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--C-C--eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC-CCceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--N-G--TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~-g--~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-~~~l~ 597 (782)
..|.+.+.||+|+||+||+|.+ + + ..||+|.+.... .....+.|.+|+.+++.++||||++++++|.. .+..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 4578899999999999999976 2 2 358999876432 34456889999999999999999999998654 56789
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 168 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999999963 3456889999999999999999999999999999999999999999999999999876433
Q ss_pred CC----CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003971 678 PM----RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 749 (782)
Q Consensus 678 ~~----~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip---~~~ 749 (782)
.. ......+|+.|+|||++.+..++.++|||||||++|||+| |..||.+....+....+... .+...| +..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~-~~~~~p~~~~~~ 324 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT-CCCCCCTTCCHH
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHH
Confidence 21 1233457789999999999999999999999999999999 67788877666555555443 333333 357
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 781 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~sL 781 (782)
+.+++.+||. ||.+||++.+++++|+++...+
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999999 9999999999999999886543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=357.56 Aligned_cols=256 Identities=16% Similarity=0.182 Sum_probs=210.0
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEE-------ECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC---CCcee
Q 003971 515 AYEEWNIDFSELTVGTRVGIGFFGEVFRGI-------WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR---HPNVI 584 (782)
Q Consensus 515 ~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~-------~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~---HPNIV 584 (782)
...++++..++|.+.+.||+|+||+||+|. ..++.||||++.... ..++..|+.+++.++ |+||+
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv 130 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFM 130 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBC
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhh
Confidence 345677788999999999999999999993 268899999986432 356788899988887 99999
Q ss_pred eEeccccCCCceEEEEEEecccchhhHHHhhc--ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC---
Q 003971 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSG--QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK--- 659 (782)
Q Consensus 585 kL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~--~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~--- 659 (782)
++++++...+..|+||||+++|+|.+++.... ....+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 131 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp CEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGT
T ss_pred hhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccccc
Confidence 99999999999999999999999999997432 2457999999999999999999999999999999999999998
Q ss_pred --------CCeEEEEecCccccccC--CCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 003971 660 --------HWTVKICDFGLSRIITD--SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 729 (782)
Q Consensus 660 --------~g~VKLaDFGLA~~l~~--~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~ 729 (782)
++.+||+|||+++.+.. ........+||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999976532 22234567899999999999999999999999999999999999999964322
Q ss_pred HHHHHHHHhcCCCCCCC-ChHHHHHHHHhhh-CCCCC-CCHHHHHHHHHhhhh
Q 003971 730 ERVVYAVANEGSRLEIP-EGPLGRLIADCWA-EPQER-PSCEEILSRLLDCEY 779 (782)
Q Consensus 730 ~evl~~i~~~~~~~~ip-~~~L~~LI~~CL~-DP~kR-PSa~EIL~~L~di~~ 779 (782)
.... ........+ ...+.+++..|+. +|.+| |++.++.+.|+++..
T Consensus 291 ~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 291 GECK----PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp TEEE----ECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred Ccee----echhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 1100 001111112 3468899999999 88888 688888888887643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=345.91 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=197.8
Q ss_pred CCeeEe-eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEE
Q 003971 524 SELTVG-TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 524 s~y~i~-~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV 599 (782)
+.|.+. +.||+|+||.||+|.+ +++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+.+.+++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 568885 7899999999999986 688999999875532 2346788999999985 799999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe---EEEEecCccccccC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLSRIITD 676 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~---VKLaDFGLA~~l~~ 676 (782)
|||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999873 357899999999999999999999999999999999999988776 99999999976532
Q ss_pred CC-------CCCCCCCCCCcccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------------
Q 003971 677 SP-------MRDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP--------------- 729 (782)
Q Consensus 677 ~~-------~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvILyELLTGk~PF~~~~~--------------- 729 (782)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 11 11224569999999999875 4578899999999999999999999976542
Q ss_pred HHHHHHHHhcCCCCC-----CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 730 ERVVYAVANEGSRLE-----IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 730 ~evl~~i~~~~~~~~-----ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
......+.......+ .-+..+.+|+.+||. ||.+|||+.+++++
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 223334433332221 113468999999999 99999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=377.38 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=214.3
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
.+..++|.+.+.||+|+||+||+|.+ +|+.||||++.+.... ....+.+.+|+.+++.++||||+++++++.+...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 34567899999999999999999988 5889999999755432 22356788999999999999999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcc-cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 597 SMITEYMELGSLYHLIHLSGQ-KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~-~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
|+||||++||+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999998864322 4579999999999999999999999999999999999999999999999999998876
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCCC-CCCChHH
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV----LPERVVYAVANEGSRL-EIPEGPL 750 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~----~~~evl~~i~~~~~~~-~ip~~~L 750 (782)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+. ....+...+....... ..-+..+
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~ 420 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHH
Confidence 5444445568999999999999999999999999999999999999999865 3445555555433222 1224569
Q ss_pred HHHHHHhhh-CCCCCCCH-----HHHHHH
Q 003971 751 GRLIADCWA-EPQERPSC-----EEILSR 773 (782)
Q Consensus 751 ~~LI~~CL~-DP~kRPSa-----~EIL~~ 773 (782)
.+|+.+||. ||.+||++ .+|++|
T Consensus 421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp HHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred HHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 999999999 99999965 677654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=361.12 Aligned_cols=242 Identities=21% Similarity=0.358 Sum_probs=193.0
Q ss_pred CCCeeEe-eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHH-hCCCCceeeEeccccC----CC
Q 003971 523 FSELTVG-TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILS-RLRHPNVILFLGACTK----PP 594 (782)
Q Consensus 523 ~s~y~i~-~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk-~L~HPNIVkL~g~~~d----~~ 594 (782)
.++|.+. +.||+|+||+||++.+ +++.||||++... ..+.+|+.++. ..+||||++++++|.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 4678876 6899999999999988 5889999998532 35668888874 4589999999998865 56
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC---CCeEEEEecCcc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLS 671 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~---~g~VKLaDFGLA 671 (782)
.+|+||||+++|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 789999999999999999732 2346999999999999999999999999999999999999987 789999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhcCCCCCC--
Q 003971 672 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER----VVYAVANEGSRLEI-- 745 (782)
Q Consensus 672 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~e----vl~~i~~~~~~~~i-- 745 (782)
+...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... ....+.........
T Consensus 212 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 212 KETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp EECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred cccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 8765332 2346789999999999999999999999999999999999999997654321 23333333333222
Q ss_pred ---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 ---PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 ---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
-...+.+||.+||. ||.+|||+.++++|
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 13468999999999 99999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.14 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=205.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC--hHHHHHHHHHHHHHHhCCCCceeeEeccc--cCCCce
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT--AENMEDFCNEISILSRLRHPNVILFLGAC--TKPPRL 596 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~--~~~~e~f~~EI~iLk~L~HPNIVkL~g~~--~d~~~l 596 (782)
..+|.+.+.||+|+||.||++.+ +++.||+|++...... ....+.+.+|+.+++.++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36899999999999999999987 5789999998654321 23457899999999999999999999998 455679
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++||||+.++ |.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 9999999976 66666532 345789999999999999999999999999999999999999999999999999987643
Q ss_pred CC--CCCCCCCCCCcccCccccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHH
Q 003971 677 SP--MRDSSSAGTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLG 751 (782)
Q Consensus 677 ~~--~~~~~~~GT~~Y~APEvl~~~~--~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~ 751 (782)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........+........ .-...+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence 21 1223567999999999998654 37899999999999999999999999888777776665433221 1234699
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+|+.+||. ||.+||++.+++++
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHccCChhhCCCHHHHhcC
Confidence 99999999 99999999999976
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=364.21 Aligned_cols=246 Identities=25% Similarity=0.362 Sum_probs=195.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC------hHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT------AENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~------~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
.++|.+.+.||+|+||+||+|.+ +++.||||++...... ......+.+|+.+|++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 36899999999999999999987 5789999999765421 1122357899999999999999999999865 4
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC---eEEEEecCcc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLS 671 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g---~VKLaDFGLA 671 (782)
.+|+||||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 213 ~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred ceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 5899999999999998886 456799999999999999999999999999999999999997544 5999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---
Q 003971 672 RIITDSPMRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--- 745 (782)
Q Consensus 672 ~~l~~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i--- 745 (782)
+...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...............+.....
T Consensus 290 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 290 KILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp TSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred eecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 8765432 3346789999999999853 56889999999999999999999999866443333333333322222
Q ss_pred ---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 ---PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 ---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
....+.+|+.+||. ||.+||++.++++|
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 13468999999999 99999999999976
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.35 Aligned_cols=241 Identities=22% Similarity=0.389 Sum_probs=204.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH------HHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE------NMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~------~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++........ ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 5799999999999999999987 688999999976543221 23467789999999999999999999999999
Q ss_pred eEEEEEEeccc-chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 596 LSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 596 l~LV~Ey~~gG-sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
+++||||+.+| +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999777 9999886 4557999999999999999999999999999999999999999999999999999877
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHH
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRL 753 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~~~L~~L 753 (782)
.... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... .......+...+..+.+|
T Consensus 181 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~l~~l 254 (335)
T 3dls_A 181 ERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----VEAAIHPPYLVSKELMSL 254 (335)
T ss_dssp CTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----TTTCCCCSSCCCHHHHHH
T ss_pred CCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----HhhccCCCcccCHHHHHH
Confidence 5432 2345679999999999988876 88999999999999999999999764321 011111122234579999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+..||. ||.+|||+.+++++
T Consensus 255 i~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 255 VSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999 99999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.45 Aligned_cols=255 Identities=25% Similarity=0.441 Sum_probs=192.4
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
.|.+..++|.+.+.||+|+||.||+|.+ +++.||||++..... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 4667789999999999999999999976 688999999865432 2335678899999999999999999999999999
Q ss_pred eEEEEEEecccchhhHHHhh-----cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCc
Q 003971 596 LSMITEYMELGSLYHLIHLS-----GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 670 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~-----~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGL 670 (782)
.++||||+++++|.+++... .....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999999988632 1235689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC-----CCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 003971 671 SRIITDSP-----MRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE 744 (782)
Q Consensus 671 A~~l~~~~-----~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ 744 (782)
+....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 98764321 11234579999999999876 5689999999999999999999999988776665554443222110
Q ss_pred -----------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 -----------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 -----------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.....+.+|+.+||. ||.+||++.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 112368899999999 99999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=366.51 Aligned_cols=248 Identities=15% Similarity=0.134 Sum_probs=194.7
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHH---HHHHhCCCCceeeEec---
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEI---SILSRLRHPNVILFLG--- 588 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI---~iLk~L~HPNIVkL~g--- 588 (782)
++....++|.+.+.||+|+||+||+|.+ +|+.||||++..... .....+.|.+|+ .+++.++|||||++++
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 3444567899999999999999999985 588999999975532 334567899999 4555568999999984
Q ss_pred ----cccCCC-----------------ceEEEEEEecccchhhHHHhhc----ccccchHHHHHHHHHHHHHHHHHHHhc
Q 003971 589 ----ACTKPP-----------------RLSMITEYMELGSLYHLIHLSG----QKKKLSWRRKLKMLRDICRGLMCIHRM 643 (782)
Q Consensus 589 ----~~~d~~-----------------~l~LV~Ey~~gGsL~dlL~~~~----~~~~Ls~~~~l~Ia~QIa~gL~yLHs~ 643 (782)
++.+.+ ..|++|||+ +|+|.+++.... ....+++..++.++.||+.||+|||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 444332 378999999 679999987432 123456688999999999999999999
Q ss_pred cccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccC-----------CCCchhHHHHHHH
Q 003971 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-----------PFTEKCDIFSLGV 712 (782)
Q Consensus 644 gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-----------~~s~ksDVWSLGv 712 (782)
||+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||||||
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999999986433 2345677 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 713 IMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 713 ILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
++|||++|+.||.+.........+... ...-+..+.+|+.+||. ||.+||++.+++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIFRS---CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGGSS---CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccchhhhhhh---ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999999999776543332222211 11224569999999999 99999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=352.89 Aligned_cols=246 Identities=22% Similarity=0.408 Sum_probs=211.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc--Ch----HHHHHHHHHHHHHHhC-CCCceeeEeccccCCC
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL--TA----ENMEDFCNEISILSRL-RHPNVILFLGACTKPP 594 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~--~~----~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~ 594 (782)
.+|.+.+.||+|+||.||+|.+ +|+.||||++..... .. ...+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999988 488999999865432 11 2245788999999999 7999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
..++||||+++++|.+++. ....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+
T Consensus 174 ~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 9999999999999999986 3357899999999999999999999999999999999999999999999999999877
Q ss_pred cCCCCCCCCCCCCCcccCcccccc------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRN------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-- 746 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~------~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-- 746 (782)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.........+
T Consensus 251 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 251 EPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 5432 3346789999999999863 358889999999999999999999999888877777666554433221
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 ---EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+..+.+|+.+||. ||.+||++.+++++
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3358999999999 99999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.39 Aligned_cols=255 Identities=23% Similarity=0.387 Sum_probs=208.6
Q ss_pred cccccccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC--CCceeeEeccc
Q 003971 514 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR--HPNVILFLGAC 590 (782)
Q Consensus 514 ~~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~--HPNIVkL~g~~ 590 (782)
+..+.+.+...+|.+.+.||+|+||.||++.+ +++.||||++..........+.+.+|+.+++.++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 34566777788999999999999999999987 5788999999877666667788999999999997 59999999999
Q ss_pred cCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCc
Q 003971 591 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 670 (782)
Q Consensus 591 ~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGL 670 (782)
.+...++++|| +.+++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||+
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred ecCCEEEEEEe-cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccc
Confidence 99999999999 66789999987 3457899999999999999999999999999999999999965 8999999999
Q ss_pred cccccCCCC--CCCCCCCCCcccCcccccc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHH
Q 003971 671 SRIITDSPM--RDSSSAGTPEWMAPELIRN-----------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-ERVVYAV 736 (782)
Q Consensus 671 A~~l~~~~~--~~~~~~GT~~Y~APEvl~~-----------~~~s~ksDVWSLGvILyELLTGk~PF~~~~~-~evl~~i 736 (782)
+........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 987644321 1234579999999999875 4688999999999999999999999987643 3344444
Q ss_pred HhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 737 ANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 737 ~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.........+ +..+.+|+.+||. ||.+||++.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 4444333333 4579999999999 99999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=353.67 Aligned_cols=250 Identities=17% Similarity=0.197 Sum_probs=203.3
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC----------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceee------
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIWN----------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL------ 585 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~~----------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVk------ 585 (782)
..++|.+.+.||+|+||.||+|.+. ++.||||++... +.+.+|+.+++.++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 3578999999999999999999873 678999998643 35778999999999999998
Q ss_pred ---------EeccccC-CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccE
Q 003971 586 ---------FLGACTK-PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANC 655 (782)
Q Consensus 586 ---------L~g~~~d-~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNI 655 (782)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 4445544 67789999999 99999999732 246799999999999999999999999999999999999
Q ss_pred EEcCCC--eEEEEecCccccccCCCC-------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 003971 656 LVNKHW--TVKICDFGLSRIITDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726 (782)
Q Consensus 656 LLd~~g--~VKLaDFGLA~~l~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~ 726 (782)
|++.++ .+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 999999999987643211 12345799999999999999999999999999999999999999987
Q ss_pred CC--hHHHHHHHH---hcCCCCC-------CCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 727 VL--PERVVYAVA---NEGSRLE-------IPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 727 ~~--~~evl~~i~---~~~~~~~-------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
.. ......... ....... ..+..+.+|+..||. ||.+||++.++++.|+++...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 53 222222221 1111110 124579999999999 999999999999999988643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=351.49 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=206.4
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
..|++. ++|.+.+.||+|+||.||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 114 (371)
T 4exu_A 36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 114 (371)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence 345544 7899999999999999999987 5889999999776656666788999999999999999999999998776
Q ss_pred ce------EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEec
Q 003971 595 RL------SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 668 (782)
Q Consensus 595 ~l------~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDF 668 (782)
.. ++||||+. ++|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 115 SLRNFYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp SSTTCCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECST
T ss_pred CcccceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEec
Confidence 55 99999998 57777663 34899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----
Q 003971 669 GLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---- 743 (782)
Q Consensus 669 GLA~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~---- 743 (782)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 189 g~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 189 GLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp TCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CcccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 999866432 345678999999999887 678999999999999999999999999988777666654321111
Q ss_pred ----------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ----------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ----------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
......+.+|+.+||. ||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0113468899999999 99999999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.20 Aligned_cols=245 Identities=26% Similarity=0.470 Sum_probs=212.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++..........+.+.+|+.+++.++||||+++++++.+...+++++|
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 6799999999999999999988 58899999997665544556789999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC---CeEEEEecCccccccCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH---WTVKICDFGLSRIITDSP 678 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~---g~VKLaDFGLA~~l~~~~ 678 (782)
|+.+++|.+.+.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.+||+|||++.......
T Consensus 102 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 102 LYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred ccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 9999999988863 3468999999999999999999999999999999999999754 479999999998765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~L 753 (782)
......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||.+.........+.........+ +..+.++
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 179 -KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp -SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred -ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 22344588899999998765 8999999999999999999999999988888777776655444332 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. ||.+|||+.+++++
T Consensus 257 i~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 257 IRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHcccChhhCcCHHHHhcC
Confidence 999999 99999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=359.47 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=204.6
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeecccc--ChHHHHHHHHHHHHHHhC-CCCceeeEecccc
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRL-RHPNVILFLGACT 591 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~--~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~ 591 (782)
.+..++|.+.+.||+|+||.||++.+ +++.||||++..... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 44567999999999999999999987 688999999865432 112234567899999999 6999999999999
Q ss_pred CCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 592 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 592 d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
....+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eCceEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999999873 347899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC-CCCCCCCCCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCCC-
Q 003971 672 RIITDSP-MRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGV----LPERVVYAVANEGSRL- 743 (782)
Q Consensus 672 ~~l~~~~-~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTGk~PF~~~----~~~evl~~i~~~~~~~- 743 (782)
+.+.... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ........+.......
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 286 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 286 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC
Confidence 8654321 12234579999999999985 35789999999999999999999999643 2333333333322211
Q ss_pred CCCChHHHHHHHHhhh-CCCCCC-----CHHHHHHHH
Q 003971 744 EIPEGPLGRLIADCWA-EPQERP-----SCEEILSRL 774 (782)
Q Consensus 744 ~ip~~~L~~LI~~CL~-DP~kRP-----Sa~EIL~~L 774 (782)
..-...+.+|+.+||. ||.+|| ++.+++++.
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1123468999999999 999999 999999763
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=351.39 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=212.1
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChH---------------HHHHHHHHHHHHHhCCCCceee
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE---------------NMEDFCNEISILSRLRHPNVIL 585 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~---------------~~e~f~~EI~iLk~L~HPNIVk 585 (782)
....+|.+.+.||+|+||.||+|.++++.||||++........ ..+.+.+|+.+++.++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 4457999999999999999999999999999999865432211 1278899999999999999999
Q ss_pred EeccccCCCceEEEEEEecccchhhH------HHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEc
Q 003971 586 FLGACTKPPRLSMITEYMELGSLYHL------IHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVN 658 (782)
Q Consensus 586 L~g~~~d~~~l~LV~Ey~~gGsL~dl------L~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd 658 (782)
+++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ .||+|+||||+|||++
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 99999999999999999999999998 541 125679999999999999999999999 9999999999999999
Q ss_pred CCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccC-CCCc-hhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH
Q 003971 659 KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTE-KCDIFSLGVIMWELCTLNRPWEGVLP-ERVVYA 735 (782)
Q Consensus 659 ~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~-ksDVWSLGvILyELLTGk~PF~~~~~-~evl~~ 735 (782)
.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|+.||..... ......
T Consensus 187 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp TTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred CCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 9999999999999876543 33456799999999999887 6666 99999999999999999999988776 555555
Q ss_pred HHhcCCCCC--------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 736 VANEGSRLE--------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 736 i~~~~~~~~--------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.......+ ..+..+.+|+.+||. ||.+||++.+++++
T Consensus 265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 543322222 123468999999999 99999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.18 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=205.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE---CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC---CCCceeeEecccc----
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RHPNVILFLGACT---- 591 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~---~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L---~HPNIVkL~g~~~---- 591 (782)
..++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 347899999999999999999987 478899999875543332234566777777766 8999999999986
Q ss_pred -CCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCc
Q 003971 592 -KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 670 (782)
Q Consensus 592 -d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGL 670 (782)
....+++||||+. |+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5567899999998 5999888643 234589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Q 003971 671 SRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------- 743 (782)
Q Consensus 671 A~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~------- 743 (782)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 167 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 167 ARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred cccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 98664321 2345679999999999999999999999999999999999999999988877766665321100
Q ss_pred ---------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ---------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ---------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..-+..+.+|+.+||. ||.+||++.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0012357899999999 99999999999965
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=356.60 Aligned_cols=242 Identities=26% Similarity=0.344 Sum_probs=190.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC------Cc
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------PR 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------~~ 595 (782)
++|.+.+.||+|+||.||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 7899999999999999999987 588999999876555555678899999999999999999999998654 56
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+|+++||+ +++|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 89999999 689998885 2468999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 743 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~----------- 743 (782)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+......+
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 184 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred cc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 32 345689999999999877 678999999999999999999999999988777666554321111
Q ss_pred -------------CC--------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 -------------EI--------PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 -------------~i--------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.. ....+.+|+.+||. ||.+|||+.++++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00 12357899999999 99999999999976
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=359.43 Aligned_cols=254 Identities=23% Similarity=0.372 Sum_probs=210.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC--ceEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP--RLSM 598 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~--~l~L 598 (782)
..+|.+.+.||+|+||+||+|.+. |+.||||++..... ....+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 468999999999999999999884 88999999875433 223567889999999999999999999987655 6899
Q ss_pred EEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE----cCCCeEEEEecCccccc
Q 003971 599 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRII 674 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL----d~~g~VKLaDFGLA~~l 674 (782)
||||+++|+|.+++........+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999999999754444459999999999999999999999999999999999999 78889999999999876
Q ss_pred cCCCCCCCCCCCCCcccCcccccc--------CCCCchhHHHHHHHHHHHHHhCCCCCCC----CChHHHHHHHHhcCCC
Q 003971 675 TDSPMRDSSSAGTPEWMAPELIRN--------EPFTEKCDIFSLGVIMWELCTLNRPWEG----VLPERVVYAVANEGSR 742 (782)
Q Consensus 675 ~~~~~~~~~~~GT~~Y~APEvl~~--------~~~s~ksDVWSLGvILyELLTGk~PF~~----~~~~evl~~i~~~~~~ 742 (782)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. .........+......
T Consensus 167 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 167 EDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (396)
T ss_dssp CCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred cCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence 5432 3345679999999999865 4578899999999999999999999964 2344555555543321
Q ss_pred C-----------------CCC---------ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 743 L-----------------EIP---------EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 743 ~-----------------~ip---------~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
. .++ ...+.+++..||. ||.+||++.++++.+.++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 1 011 1247789999999 9999999999999998864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.91 Aligned_cols=239 Identities=20% Similarity=0.308 Sum_probs=198.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccC--CCceE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTK--PPRLS 597 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d--~~~l~ 597 (782)
.++|++.+.||+|+||.||+|.+ +++.||||++.... .+.+.+|+.+++.++ ||||+++++++.+ ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 47899999999999999999987 68899999986332 367889999999997 9999999999987 56789
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC-eEEEEecCccccccC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITD 676 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g-~VKLaDFGLA~~l~~ 676 (782)
++|||+.+++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 110 lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999998874 478999999999999999999999999999999999999776 899999999987654
Q ss_pred CCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHh-------------cCC
Q 003971 677 SPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGV-LPERVVYAVAN-------------EGS 741 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~-~~~evl~~i~~-------------~~~ 741 (782)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... .....+..+.. ...
T Consensus 184 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 184 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 32 3345689999999999877 67899999999999999999999999533 33222222211 000
Q ss_pred CC-------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 RL-------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 ~~-------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.. ..-...+.+|+.+||. ||.+|||+.++++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0023468999999999 99999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.33 Aligned_cols=250 Identities=23% Similarity=0.290 Sum_probs=206.6
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE---CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC------ceeeEeccccCC
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP------NVILFLGACTKP 593 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~---~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HP------NIVkL~g~~~d~ 593 (782)
.++|++.+.||+|+||.||+|.+ +++.||||++... ....+.+.+|+.+++.++|+ +|+++++++.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 47899999999999999999987 5789999998643 33457788999999988765 499999999999
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC--------------
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-------------- 659 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~-------------- 659 (782)
+.+++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred CcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 9999999999 78999888633 2346889999999999999999999999999999999999987
Q ss_pred -----CCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 003971 660 -----HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 734 (782)
Q Consensus 660 -----~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~ 734 (782)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+......
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred cccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 668999999999875432 245689999999999999999999999999999999999999999887766554
Q ss_pred HHHhcCCCCC------------------------------------------CC---ChHHHHHHHHhhh-CCCCCCCHH
Q 003971 735 AVANEGSRLE------------------------------------------IP---EGPLGRLIADCWA-EPQERPSCE 768 (782)
Q Consensus 735 ~i~~~~~~~~------------------------------------------ip---~~~L~~LI~~CL~-DP~kRPSa~ 768 (782)
.+.......+ .+ ...+.+|+.+||. ||.+|||+.
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 4432111000 00 1247799999999 999999999
Q ss_pred HHHHH--HHhhhhc
Q 003971 769 EILSR--LLDCEYS 780 (782)
Q Consensus 769 EIL~~--L~di~~s 780 (782)
|++++ ++.+..+
T Consensus 325 ell~hp~f~~~~~~ 338 (339)
T 1z57_A 325 EALKHPFFDLLKKS 338 (339)
T ss_dssp HHTTSGGGGGGGC-
T ss_pred HHhcCHHHHHHhcc
Confidence 99976 5555443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=351.79 Aligned_cols=252 Identities=27% Similarity=0.353 Sum_probs=200.1
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeecccc---------ChHHHHHHHHHHHHHHhCCCCceeeEe
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDL---------TAENMEDFCNEISILSRLRHPNVILFL 587 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~---------~~~~~e~f~~EI~iLk~L~HPNIVkL~ 587 (782)
++....++|.+.+.||+|+||.||+|.+ +|+.||||++..... .....+.+.+|+.+++.++||||++++
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 3444568999999999999999999977 688999999855332 122347899999999999999999999
Q ss_pred cccc-----CCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe
Q 003971 588 GACT-----KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 662 (782)
Q Consensus 588 g~~~-----d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~ 662 (782)
+++. ....+|+||||+. |+|.+.+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIH--DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND 172 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC
Confidence 9983 3446899999998 57777775 23457899999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 003971 663 VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 741 (782)
Q Consensus 663 VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~ 741 (782)
+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 173 ~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 173 ITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp EEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999999997654332 2345678999999999877 6789999999999999999999999999887777666543221
Q ss_pred CCC----------------------C-----------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 RLE----------------------I-----------PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 ~~~----------------------i-----------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+. . ....+.+|+.+||. ||.+|||+.++++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111 0 12358899999999 99999999999976
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.84 Aligned_cols=257 Identities=28% Similarity=0.507 Sum_probs=211.0
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
.+...+|++.+.||+|+||.||++.+ +++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 34557899999999999999999984 5889999998653 334567899999999999999999999998765
Q ss_pred C--ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 594 P--RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 594 ~--~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
+ .+++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CCCceEEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 4 68999999999999999973 2346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC---CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH------------H---HH
Q 003971 672 RIITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE------------R---VV 733 (782)
Q Consensus 672 ~~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~------------e---vl 733 (782)
........ ......++..|+|||.+.+..++.++|||||||++|+|+||..||...... . .+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 87754322 123456778899999999888999999999999999999999988643111 0 11
Q ss_pred HHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 734 YAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 734 ~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
............+ +..+.+|+.+||. ||.+||++.++++.|+++.-.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 2222333333333 3469999999999 999999999999999987643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=344.57 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=207.4
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc---
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT--- 591 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~--- 591 (782)
+.+.+..++|.+.+.||+|+||.||++.+ +++.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 44556778999999999999999999986 6889999998653 3445678999999999999999999999986
Q ss_pred -CCCceEEEEEEecccchhhHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecC
Q 003971 592 -KPPRLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 669 (782)
Q Consensus 592 -d~~~l~LV~Ey~~gGsL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFG 669 (782)
.....++|+||+.+|+|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence 3456899999999999999887432 34678999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCC---------CCCCCCCCcccCccccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHH
Q 003971 670 LSRIITDSPMR---------DSSSAGTPEWMAPELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLP--ERVVYA 735 (782)
Q Consensus 670 LA~~l~~~~~~---------~~~~~GT~~Y~APEvl~~~~---~s~ksDVWSLGvILyELLTGk~PF~~~~~--~evl~~ 735 (782)
++......... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... ......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 98765321000 01234789999999987654 68899999999999999999999953211 111112
Q ss_pred HHhcCCCCCC---CChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 736 VANEGSRLEI---PEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 736 i~~~~~~~~i---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+ ......+. .+..+.+|+.+||. ||.+||++.+++++|+++..
T Consensus 260 ~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 V-QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp H-HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred h-hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 2 22222221 23469999999999 99999999999999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=353.32 Aligned_cols=246 Identities=24% Similarity=0.311 Sum_probs=200.8
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC-----
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----- 592 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d----- 592 (782)
+....+|.+++.||+|+||+||+|.+ +|+.||||++...... +.+|+.+++.++||||++++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 44567899999999999999999987 6889999998654322 2369999999999999999999833
Q ss_pred ---------------------------------CCceEEEEEEecccchhhHHHh-hcccccchHHHHHHHHHHHHHHHH
Q 003971 593 ---------------------------------PPRLSMITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLM 638 (782)
Q Consensus 593 ---------------------------------~~~l~LV~Ey~~gGsL~dlL~~-~~~~~~Ls~~~~l~Ia~QIa~gL~ 638 (782)
...+++||||+++ +|.+.+.. ......+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3348899999984 77766642 224567999999999999999999
Q ss_pred HHHhccccccCCCcccEEEc-CCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHH
Q 003971 639 CIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWE 716 (782)
Q Consensus 639 yLHs~gIIHrDIKPeNILLd-~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyE 716 (782)
|||++||+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 99999999999999999998 68999999999998765432 33456789999999998765 48999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHhcCCCC------------------------------CCCChHHHHHHHHhhh-CCCCCC
Q 003971 717 LCTLNRPWEGVLPERVVYAVANEGSRL------------------------------EIPEGPLGRLIADCWA-EPQERP 765 (782)
Q Consensus 717 LLTGk~PF~~~~~~evl~~i~~~~~~~------------------------------~ip~~~L~~LI~~CL~-DP~kRP 765 (782)
|++|+.||.+......+..+......+ ...+..+.+|+.+||. ||.+||
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 999999999988887777665421111 0012358899999999 999999
Q ss_pred CHHHHHHH
Q 003971 766 SCEEILSR 773 (782)
Q Consensus 766 Sa~EIL~~ 773 (782)
|+.|+++|
T Consensus 315 t~~e~l~h 322 (383)
T 3eb0_A 315 NPYEAMAH 322 (383)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999965
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=343.31 Aligned_cols=245 Identities=25% Similarity=0.328 Sum_probs=202.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC-----Cc
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PR 595 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-----~~ 595 (782)
.++|.+.+.||+|+||.||+|.+. |+.||||++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 478999999999999999999884 8899999986432 344457788999999999999999999987654 67
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
.++++||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 899999998 588888752 468999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC----------CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-
Q 003971 676 DSPM----------RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL- 743 (782)
Q Consensus 676 ~~~~----------~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~- 743 (782)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 3211 1123578999999998764 678999999999999999999999999887766555443211110
Q ss_pred --------------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 --------------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 --------------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..-+..+.+|+.+||. ||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0112357899999999 99999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=347.51 Aligned_cols=245 Identities=26% Similarity=0.369 Sum_probs=197.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC------hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT------AENMEDFCNEISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~------~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999988 5789999998654321 122346889999999999999999999987665
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe---EEEEecCccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLSR 672 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~---VKLaDFGLA~ 672 (782)
.|+||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 899999999999999886 4567899999999999999999999999999999999999987654 9999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI---- 745 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i---- 745 (782)
...... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...............+.....
T Consensus 166 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 166 ILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp ECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred eccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 764321 112346899999999974 567899999999999999999999999765443222222222222211
Q ss_pred --CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 --PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 --p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
-...+.+|+.+||. ||.+||++.+++++
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 13468999999999 99999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=339.46 Aligned_cols=252 Identities=24% Similarity=0.402 Sum_probs=190.9
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
..+....++|.+.+.||+|+||.||+|.+ +|+.||||++..........+.+..+..+++.++||||+++++++.+.+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 45667788999999999999999999988 5889999999766544443444555556788889999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc-cccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~-gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
.+++||||+ ++.+..+... ....+++..++.++.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++..
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred cEEEEEecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999999 4555555442 245789999999999999999999995 999999999999999999999999999977
Q ss_pred ccCCCCCCCCCCCCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCC-
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGV-LPERVVYAVANEGSRLEIP- 746 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTGk~PF~~~-~~~evl~~i~~~~~~~~ip- 746 (782)
..... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||... ........+.... ....+
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 252 (318)
T 2dyl_A 175 LVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PPLLPG 252 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-CCCCCS
T ss_pred ccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-CCCCCc
Confidence 64432 223567999999999984 456889999999999999999999999874 4444444444432 22222
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 ----EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+..+.+|+.+||. ||.+||++.+++++
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3469999999999 99999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=336.89 Aligned_cols=244 Identities=25% Similarity=0.336 Sum_probs=197.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc---------
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT--------- 591 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~--------- 591 (782)
.++|.+.+.||+|+||.||+|.+. ++.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 378999999999999999999884 889999998654 3455678999999999999999999998863
Q ss_pred -----CCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc-CCCeEEE
Q 003971 592 -----KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKI 665 (782)
Q Consensus 592 -----d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd-~~g~VKL 665 (782)
+...+++||||+. |+|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999998 59998885 35689999999999999999999999999999999999997 5679999
Q ss_pred EecCccccccCCCC---CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 003971 666 CDFGLSRIITDSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 741 (782)
Q Consensus 666 aDFGLA~~l~~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~ 741 (782)
+|||++........ ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999987643211 1223457899999998865 6789999999999999999999999998887766665543321
Q ss_pred CC-------------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 RL-------------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 ~~-------------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.. ..-+..+.+|+.+||. ||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 10 0113468899999999 99999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=347.88 Aligned_cols=244 Identities=28% Similarity=0.373 Sum_probs=203.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC-----Cce
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PRL 596 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-----~~l 596 (782)
.+|++.+.||+|+||.||+|.+ +++.||||++.... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 6899999999999999999987 58899999986433 344457889999999999999999999998654 368
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
|+++||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 99999998 488888852 4689999999999999999999999999999999999999999999999999987643
Q ss_pred CCC---CCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Q 003971 677 SPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------- 743 (782)
Q Consensus 677 ~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~--------- 743 (782)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 211 1245689999999998654 558999999999999999999999999887666655554211111
Q ss_pred -----------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 -----------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 -----------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+..+.+|+.+||. ||.+|||+.++++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0113458899999999 99999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=344.69 Aligned_cols=241 Identities=26% Similarity=0.345 Sum_probs=202.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc------
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR------ 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~------ 595 (782)
.+|.+.+.||+|+||.||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 6899999999999999999987 58899999997665555667789999999999999999999999987654
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
++++|||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999998 58887763 248999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------- 741 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~------------- 741 (782)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 178 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 178 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred CC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 32 235678999999999877 6789999999999999999999999998887666555443110
Q ss_pred -------------CCC------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 -------------RLE------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 -------------~~~------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
... .....+.+|+.+||. ||.+|||+.++++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 113468999999999 99999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=358.83 Aligned_cols=243 Identities=24% Similarity=0.274 Sum_probs=205.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC------CCCceeeEeccccCCC
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL------RHPNVILFLGACTKPP 594 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L------~HPNIVkL~g~~~d~~ 594 (782)
..+|.+.+.||+|+||.||+|.+ .++.||||++... ......+.+|+.+++.+ +|+||+++++++....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 36799999999999999999987 4789999998643 33346777888888887 5779999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe--EEEEecCccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--VKICDFGLSR 672 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~--VKLaDFGLA~ 672 (782)
.++++|||+. ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||+++
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred eEEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999999997 5888888643 3345899999999999999999999999999999999999999887 9999999997
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--------
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-------- 744 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-------- 744 (782)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+......+.
T Consensus 251 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~ 327 (429)
T 3kvw_A 251 YEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327 (429)
T ss_dssp ETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred ecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence 65432 3456899999999999999999999999999999999999999999888777665543211000
Q ss_pred ----------------------------------------------------CCChHHHHHHHHhhh-CCCCCCCHHHHH
Q 003971 745 ----------------------------------------------------IPEGPLGRLIADCWA-EPQERPSCEEIL 771 (782)
Q Consensus 745 ----------------------------------------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL 771 (782)
..+..+.+|+.+||. ||.+|||+.|++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence 012347899999999 999999999999
Q ss_pred HH
Q 003971 772 SR 773 (782)
Q Consensus 772 ~~ 773 (782)
+|
T Consensus 408 ~H 409 (429)
T 3kvw_A 408 RH 409 (429)
T ss_dssp TS
T ss_pred CC
Confidence 75
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=354.83 Aligned_cols=243 Identities=25% Similarity=0.299 Sum_probs=199.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC------ce
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------RL 596 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------~l 596 (782)
.+|.+.+.||+|+||+||+|.+ .+..+|+|++...... ..+|+.+++.++||||++++++|.... .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 5799999999999999999988 5566899887543321 226999999999999999999985433 38
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc-CCCeEEEEecCcccccc
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIIT 675 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd-~~g~VKLaDFGLA~~l~ 675 (782)
++||||++++.+..+.........+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 89999999865555444333456899999999999999999999999999999999999999 79999999999998764
Q ss_pred CCCCCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 743 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~----------- 743 (782)
... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......+..+......+
T Consensus 194 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 272 (394)
T 4e7w_A 194 AGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272 (394)
T ss_dssp TTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred CCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 432 23456789999999998764 58999999999999999999999999988777766655421110
Q ss_pred -------C------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 -------E------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 -------~------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. ..+..+.+|+.+||. ||.+|||+.++++|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 012368899999999 99999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=375.23 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=211.6
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
+..++|.+.+.||+|+||.||+|.+ +|+.||||++.+.... ......+.+|+.+|+.++||||+++++++.+...+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4567899999999999999999988 5889999999754321 223467889999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+||||++||+|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999999999988632 2345899999999999999999999999999999999999999999999999999877543
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCC-CCCChHHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL----PERVVYAVANEGSRL-EIPEGPLGR 752 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~----~~evl~~i~~~~~~~-~ip~~~L~~ 752 (782)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ...+...+....... ..-...+.+
T Consensus 340 ~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~d 418 (576)
T 2acx_A 340 Q-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARS 418 (576)
T ss_dssp C-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred c-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHH
Confidence 2 2345689999999999999899999999999999999999999998753 333444443322211 112356999
Q ss_pred HHHHhhh-CCCCCC-----CHHHHHHH
Q 003971 753 LIADCWA-EPQERP-----SCEEILSR 773 (782)
Q Consensus 753 LI~~CL~-DP~kRP-----Sa~EIL~~ 773 (782)
|+.+||. ||.+|| ++.++++|
T Consensus 419 LI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 419 LCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 9999999 999999 78999876
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=356.69 Aligned_cols=242 Identities=23% Similarity=0.305 Sum_probs=196.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC------CCc
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PPR 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d------~~~ 595 (782)
.+|.+.+.||+|+||+||+|.+ +|+.||||++..... .+.+|+++|+.++|||||+++++|.. ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4699999999999999999998 588999999864422 22369999999999999999998743 223
Q ss_pred eEEEEEEecccchhhHHH-hhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC-CeEEEEecCcccc
Q 003971 596 LSMITEYMELGSLYHLIH-LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRI 673 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~-~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~-g~VKLaDFGLA~~ 673 (782)
+++||||+++ +|.+.+. .......+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 6789999986 5555443 22345679999999999999999999999999999999999999954 6789999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR---------- 742 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~---------- 742 (782)
+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......+..+......
T Consensus 207 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 207 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp CCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred cccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 64432 23456889999999998764 7999999999999999999999999998877666655432110
Q ss_pred -----CCC---------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 -----LEI---------------PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 -----~~i---------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..+ .+..+.+|+.+||. ||.+||++.|+++|
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 001 12468899999999 99999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=346.59 Aligned_cols=250 Identities=23% Similarity=0.281 Sum_probs=193.2
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc--
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR-- 595 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~-- 595 (782)
....++|.+.+.||+|+||.||+|.+ +|+.||||++...... ...+.+++..+..++||||++++++|.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34567999999999999999999988 4889999998654322 2356678888899999999999999855332
Q ss_pred -----eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHH--hccccccCCCcccEEEcC-CCeEEEEe
Q 003971 596 -----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH--RMKIVHRDLKSANCLVNK-HWTVKICD 667 (782)
Q Consensus 596 -----l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLH--s~gIIHrDIKPeNILLd~-~g~VKLaD 667 (782)
+++||||++++.+..+.........+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 7899999997544444333345667899999999999999999999 999999999999999996 89999999
Q ss_pred cCccccccCCCCCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--
Q 003971 668 FGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-- 744 (782)
Q Consensus 668 FGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-- 744 (782)
||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......+.
T Consensus 176 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 176 FGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp CTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 99998775432 23456789999999998664 489999999999999999999999999888777766654211110
Q ss_pred ----------------------------C---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 ----------------------------I---PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 ----------------------------i---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. ....+.+|+.+||. ||.+|||+.++++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 11358899999999 99999999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=343.13 Aligned_cols=255 Identities=22% Similarity=0.365 Sum_probs=185.8
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHH-HHHhCCCCceeeEeccccC
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEIS-ILSRLRHPNVILFLGACTK 592 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~-iLk~L~HPNIVkL~g~~~d 592 (782)
...|.+..++|.+.+.||+|+||.||+|.+. |+.||||++..... ......+..|+. +++.++||||+++++++.+
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 3567888899999999999999999999884 89999999876543 333456666766 6777899999999999999
Q ss_pred CCceEEEEEEecccchhhHHHhh--cccccchHHHHHHHHHHHHHHHHHHHhc-cccccCCCcccEEEcCCCeEEEEecC
Q 003971 593 PPRLSMITEYMELGSLYHLIHLS--GQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFG 669 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~--~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~-gIIHrDIKPeNILLd~~g~VKLaDFG 669 (782)
.+..++||||+.+ +|.+++... .....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999986 777766531 1246789999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCcccCcccc----ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 003971 670 LSRIITDSPMRDSSSAGTPEWMAPELI----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI 745 (782)
Q Consensus 670 LA~~l~~~~~~~~~~~GT~~Y~APEvl----~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i 745 (782)
++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.............+..+.+
T Consensus 172 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 172 ISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp SSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred Cceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 998765432 22345799999999998 4567899999999999999999999999875432111111111222222
Q ss_pred C-------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 P-------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 p-------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+ ...+.+|+..||. ||.+||++.+++++
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 1 3468999999999 99999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.62 Aligned_cols=242 Identities=27% Similarity=0.440 Sum_probs=192.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC---------
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--------- 592 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--------- 592 (782)
++|.+.+.||+|+||.||+|.+ +++.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 5799999999999999999987 5889999998542 3456788999999999999999999998754
Q ss_pred ----CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEec
Q 003971 593 ----PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 668 (782)
Q Consensus 593 ----~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDF 668 (782)
...+++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 3568999999999999999973 3456788999999999999999999999999999999999999999999999
Q ss_pred CccccccCCC--------------CCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHH
Q 003971 669 GLSRIITDSP--------------MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERV 732 (782)
Q Consensus 669 GLA~~l~~~~--------------~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~-~~ev 732 (782)
|++....... .......||+.|+|||++.+. .++.++|||||||++|+|++ ||.... ....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9998764321 112345689999999999864 68999999999999999998 665432 2233
Q ss_pred HHHHHhcCCC--CCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 733 VYAVANEGSR--LEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 733 l~~i~~~~~~--~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
...+...... ...+ ...+.+|+.+||. ||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 3333322111 1122 2348999999999 99999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=348.05 Aligned_cols=243 Identities=21% Similarity=0.291 Sum_probs=196.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC--------CCceeeEecccc-
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR--------HPNVILFLGACT- 591 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~--------HPNIVkL~g~~~- 591 (782)
..+|.+.++||+|+||+||+|.+ +++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 47899999999999999999987 5889999998643 344577889999999985 788999999987
Q ss_pred ---CCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc-cccccCCCcccEEEcCCC------
Q 003971 592 ---KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHW------ 661 (782)
Q Consensus 592 ---d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~-gIIHrDIKPeNILLd~~g------ 661 (782)
....+++||||+. ++|.+.+... ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 113 SGVNGTHICMVFEVLG-HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EETTEEEEEEEECCCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred cCCCCceEEEEEeccC-ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 5667999999995 4555555422 335689999999999999999999998 999999999999999775
Q ss_pred -------------------------------------------eEEEEecCccccccCCCCCCCCCCCCCcccCcccccc
Q 003971 662 -------------------------------------------TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 698 (782)
Q Consensus 662 -------------------------------------------~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~ 698 (782)
.+||+|||++...... .....||+.|+|||++.+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHT
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcC
Confidence 7999999999876432 345689999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCCCC-----------------------------
Q 003971 699 EPFTEKCDIFSLGVIMWELCTLNRPWEGVL------PERVVYAVANEGSRL----------------------------- 743 (782)
Q Consensus 699 ~~~s~ksDVWSLGvILyELLTGk~PF~~~~------~~evl~~i~~~~~~~----------------------------- 743 (782)
..++.++|||||||++|+|++|+.||.... .......+.......
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 999999999999999999999999997654 222222221100000
Q ss_pred -----------CCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 -----------EIPE---GPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 -----------~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..+. ..+.+|+.+||. ||.+|||+.++++|
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0111 247789999999 99999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=353.46 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=181.9
Q ss_pred CeeE-eeEEeeeCcEEEEEEEEC----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccc--cCCCceE
Q 003971 525 ELTV-GTRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC--TKPPRLS 597 (782)
Q Consensus 525 ~y~i-~~~LG~G~fG~VYkg~~~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~--~d~~~l~ 597 (782)
.|.+ +++||+|+||+||+|.+. ++.||||++...... ..+.+|+.+|+.++||||+++++++ .....++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 4555 568999999999999863 678999998654433 4678999999999999999999999 4567899
Q ss_pred EEEEEecccchhhHHHhhc------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE----cCCCeEEEEe
Q 003971 598 MITEYMELGSLYHLIHLSG------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICD 667 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL----d~~g~VKLaD 667 (782)
+||||+.+ +|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999975 7777765322 12258999999999999999999999999999999999999 6788999999
Q ss_pred cCccccccCCC---CCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 003971 668 FGLSRIITDSP---MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---------RVVY 734 (782)
Q Consensus 668 FGLA~~l~~~~---~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~---------evl~ 734 (782)
||+++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.... ..+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 99998765321 123456899999999999874 5899999999999999999999999765432 2333
Q ss_pred HHHhcCCCCC---------------------------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 735 AVANEGSRLE---------------------------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 735 ~i~~~~~~~~---------------------------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+......+. .+...+.+|+.+||. ||.+|||+.|+++|
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 3322111110 013457789999999 99999999999976
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=355.07 Aligned_cols=247 Identities=15% Similarity=0.109 Sum_probs=181.7
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhC--CCCceeeEeccc-----
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL--RHPNVILFLGAC----- 590 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L--~HPNIVkL~g~~----- 590 (782)
....+|.+.+.||+|+||+||+|.+ +|+.||||++..... .....+.+.+|+.+++.+ +||||++++..+
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138 (371)
T ss_dssp CCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred CCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence 3345699999999999999999987 588999999987654 234456777885554444 699988865333
Q ss_pred --cCC-----------------CceEEEEEEecccchhhHHHhhcccccchHHHH------HHHHHHHHHHHHHHHhccc
Q 003971 591 --TKP-----------------PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK------LKMLRDICRGLMCIHRMKI 645 (782)
Q Consensus 591 --~d~-----------------~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~------l~Ia~QIa~gL~yLHs~gI 645 (782)
... ..+|+||||++ |+|.+++.... ..+++..+ +.++.||+.||+|||++||
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i 215 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKGL 215 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence 211 33799999999 89999997432 23344444 6777999999999999999
Q ss_pred cccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCC
Q 003971 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRP 723 (782)
Q Consensus 646 IHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTGk~P 723 (782)
+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999876432 114456799999999987 6799999999999999999999999
Q ss_pred CCCCChHHHH--HH---HHhcCCCCCCC-----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 724 WEGVLPERVV--YA---VANEGSRLEIP-----EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 724 F~~~~~~evl--~~---i~~~~~~~~ip-----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
|.+..+.... .. ..........+ +..+.+|+.+||. ||.+|||+.++++|
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9876432110 00 00001111111 3469999999999 99999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.84 Aligned_cols=243 Identities=19% Similarity=0.313 Sum_probs=200.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--C-eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCc------eeeEeccccCC
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWN--G-TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN------VILFLGACTKP 593 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~--g-~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN------IVkL~g~~~d~ 593 (782)
.++|.+.+.||+|+||+||+|.+. + +.||||++... ....+.+.+|+.+++.++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 478999999999999999999873 3 78999998643 334567889999999997665 99999999999
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE----------------
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---------------- 657 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL---------------- 657 (782)
..+++||||+ +++|.+.+... ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred CeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 9999999999 45666665432 23568999999999999999999999999999999999999
Q ss_pred ---cCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 003971 658 ---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 734 (782)
Q Consensus 658 ---d~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~ 734 (782)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 66789999999999875432 245689999999999999999999999999999999999999999887766554
Q ss_pred HHHhcCCCCC-----------------------------------------CC----ChHHHHHHHHhhh-CCCCCCCHH
Q 003971 735 AVANEGSRLE-----------------------------------------IP----EGPLGRLIADCWA-EPQERPSCE 768 (782)
Q Consensus 735 ~i~~~~~~~~-----------------------------------------ip----~~~L~~LI~~CL~-DP~kRPSa~ 768 (782)
.+.......+ .. ...+.+|+.+||. ||.+|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 4332111100 00 1247799999999 999999999
Q ss_pred HHHHH
Q 003971 769 EILSR 773 (782)
Q Consensus 769 EIL~~ 773 (782)
+++++
T Consensus 330 e~l~h 334 (355)
T 2eu9_A 330 EALLH 334 (355)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=369.78 Aligned_cols=257 Identities=30% Similarity=0.539 Sum_probs=215.9
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 591 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 591 (782)
..+.+..++|.+++.||+|+||.||+|.+. +..||||++... ......+.|.+|+.+++.++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 456677789999999999999999999873 456999987543 23445578999999999999999999999985
Q ss_pred CCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 592 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 592 d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
+ +.+++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred c-CceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCC
Confidence 4 568999999999999999863 2346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003971 672 RIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP--- 746 (782)
Q Consensus 672 ~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip--- 746 (782)
+....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.... +...+
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~ 617 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNC 617 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-CCCCCTTC
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCccc
Confidence 87654322 2234557789999999999999999999999999999997 999999998888777665543 33333
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 747 EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 747 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
+..+.+|+.+||. ||.+||++.++++.|+++.
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 3469999999999 9999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=333.91 Aligned_cols=241 Identities=25% Similarity=0.382 Sum_probs=193.5
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh----HHHHHHHHHHHHHHhC----CCCceeeEecccc
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRL----RHPNVILFLGACT 591 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~----~~~e~f~~EI~iLk~L----~HPNIVkL~g~~~ 591 (782)
-.++|++.+.||+|+||.||+|.+ +++.||||++....... .....+.+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 347899999999999999999987 68899999986554322 1234466799999998 8999999999999
Q ss_pred CCCceEEEEEE-ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc-CCCeEEEEecC
Q 003971 592 KPPRLSMITEY-MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFG 669 (782)
Q Consensus 592 d~~~l~LV~Ey-~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd-~~g~VKLaDFG 669 (782)
..+..++++|| +.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred cCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999999999 789999999873 34689999999999999999999999999999999999999 88999999999
Q ss_pred ccccccCCCCCCCCCCCCCcccCccccccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCC
Q 003971 670 LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE 747 (782)
Q Consensus 670 LA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~-~~~ip~ 747 (782)
++...... ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.... . +..... ......
T Consensus 186 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~~~~~~~~~~~~~ 257 (312)
T 2iwi_A 186 SGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E----ILEAELHFPAHVS 257 (312)
T ss_dssp SCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHTCCCCCTTSC
T ss_pred hhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H----HhhhccCCcccCC
Confidence 99877543 23456799999999999877664 58999999999999999999997632 1 112111 112224
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 748 GPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 748 ~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..+.+|+.+||. ||.+||++.+++++
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 569999999999 99999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=340.81 Aligned_cols=246 Identities=25% Similarity=0.385 Sum_probs=202.7
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh----HHHHHHHHHHHHHHhCC--CCceeeEec
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLR--HPNVILFLG 588 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~----~~~e~f~~EI~iLk~L~--HPNIVkL~g 588 (782)
.+...-.++|++.+.||+|+||.||+|.+ +++.||||++....... ...+.+.+|+.+++.++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34445568899999999999999999987 68899999997654322 12245678999999996 599999999
Q ss_pred cccCCCceEEEEEEecc-cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc-CCCeEEEE
Q 003971 589 ACTKPPRLSMITEYMEL-GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKIC 666 (782)
Q Consensus 589 ~~~d~~~l~LV~Ey~~g-GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd-~~g~VKLa 666 (782)
++.+.+..++++||+.+ ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ +++.+||+
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999999986 899998873 45789999999999999999999999999999999999999 78999999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCC
Q 003971 667 DFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG-SRLE 744 (782)
Q Consensus 667 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~-~~~~ 744 (782)
|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... +.... ....
T Consensus 193 Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~~~ 264 (320)
T 3a99_A 193 DFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 264 (320)
T ss_dssp CCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCCCCSS
T ss_pred eCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcccccccc
Confidence 99999877543 2345679999999999987765 6789999999999999999999976321 11211 1112
Q ss_pred CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
..+..+.+|+.+||. ||.+||++.+++++
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 224579999999999 99999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=342.45 Aligned_cols=244 Identities=21% Similarity=0.305 Sum_probs=203.8
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CC-----ceeeEeccccCC
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HP-----NVILFLGACTKP 593 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HP-----NIVkL~g~~~d~ 593 (782)
-.++|.+.+.||+|+||+||+|.+ +++.||||++... ......+..|+.+++.++ |+ +|+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 357999999999999999999987 5889999998643 334567788999988885 55 499999999999
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHH--hccccccCCCcccEEEc--CCCeEEEEecC
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH--RMKIVHRDLKSANCLVN--KHWTVKICDFG 669 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLH--s~gIIHrDIKPeNILLd--~~g~VKLaDFG 669 (782)
+.+++||||+.+ +|.+++... ....+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|||
T Consensus 129 ~~~~lv~e~~~~-~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 129 NHLCLVFEMLSY-NLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TEEEEEEECCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CceEEEEecCCC-CHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999999974 999888643 2346899999999999999999999 57999999999999995 47789999999
Q ss_pred ccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----
Q 003971 670 LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----- 744 (782)
Q Consensus 670 LA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~----- 744 (782)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+......+.
T Consensus 207 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 207 SSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred Cceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99877542 2456899999999999999999999999999999999999999999888777666553211100
Q ss_pred -----------CC-------------------------------------------------ChHHHHHHHHhhh-CCCC
Q 003971 745 -----------IP-------------------------------------------------EGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 745 -----------ip-------------------------------------------------~~~L~~LI~~CL~-DP~k 763 (782)
++ ...+.+|+.+||. ||.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 363 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence 00 0147899999999 9999
Q ss_pred CCCHHHHHHH
Q 003971 764 RPSCEEILSR 773 (782)
Q Consensus 764 RPSa~EIL~~ 773 (782)
|||+.|+++|
T Consensus 364 Rpta~e~L~h 373 (382)
T 2vx3_A 364 RIQPYYALQH 373 (382)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhcC
Confidence 9999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=339.03 Aligned_cols=245 Identities=20% Similarity=0.313 Sum_probs=196.4
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-----------CCceeeEe
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----------HPNVILFL 587 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-----------HPNIVkL~ 587 (782)
+...+|.+.+.||+|+||+||+|.+ +++.||||++... ....+.+.+|+.+++.++ ||||++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 3457899999999999999999987 6889999998643 234467889999999886 89999999
Q ss_pred ccccCCC----ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc-cccccCCCcccEEEc----
Q 003971 588 GACTKPP----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVN---- 658 (782)
Q Consensus 588 g~~~d~~----~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~-gIIHrDIKPeNILLd---- 658 (782)
+++.... .++++|||+ +++|.+++... ....+++..++.++.||+.||+|||++ ||+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 9987644 689999999 88999988743 244689999999999999999999998 999999999999994
Q ss_pred --CCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh------H
Q 003971 659 --KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP------E 730 (782)
Q Consensus 659 --~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~------~ 730 (782)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... .
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999876432 2356799999999999999999999999999999999999999986542 2
Q ss_pred HHHHHHHhcCC----------------------------------------CCCCC---ChHHHHHHHHhhh-CCCCCCC
Q 003971 731 RVVYAVANEGS----------------------------------------RLEIP---EGPLGRLIADCWA-EPQERPS 766 (782)
Q Consensus 731 evl~~i~~~~~----------------------------------------~~~ip---~~~L~~LI~~CL~-DP~kRPS 766 (782)
.....+..... ...++ ...+.+|+.+||. ||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 22222221000 00111 1247789999999 9999999
Q ss_pred HHHHHHH
Q 003971 767 CEEILSR 773 (782)
Q Consensus 767 a~EIL~~ 773 (782)
+.+++++
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=353.78 Aligned_cols=249 Identities=19% Similarity=0.274 Sum_probs=205.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCC-CceeeEeccccCCCceEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH-PNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H-PNIVkL~g~~~d~~~l~LV 599 (782)
.++|.++++||+|+||.||+|.+ +++.||||++...... ..+..|+.+++.++| ++|..+..++......++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 37899999999999999999987 5889999998655432 347789999999986 5666666667777889999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEE---cCCCeEEEEecCccccccC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILL---d~~g~VKLaDFGLA~~l~~ 676 (782)
|||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+..
T Consensus 82 me~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 9999 89999998732 4579999999999999999999999999999999999999 6889999999999987754
Q ss_pred CCCC-------CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCC---
Q 003971 677 SPMR-------DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP---ERVVYAVANEGSRL--- 743 (782)
Q Consensus 677 ~~~~-------~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~---~evl~~i~~~~~~~--- 743 (782)
.... .....||+.|+|||++.+..++.++|||||||+||||++|+.||.+... ...+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 3221 2256799999999999999999999999999999999999999987543 22333222211111
Q ss_pred ---CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 744 ---EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 744 ---~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
...+..+.+|+..||. ||.+||++.+|++.|+++.
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1123468999999999 9999999999999998874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=335.36 Aligned_cols=241 Identities=23% Similarity=0.367 Sum_probs=170.5
Q ss_pred CCeeEee-EEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC----CCce
Q 003971 524 SELTVGT-RVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPRL 596 (782)
Q Consensus 524 s~y~i~~-~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d----~~~l 596 (782)
++|.+.+ .||+|+||+||+|.+. ++.||||++... .. ........++.++||||+++++++.. ...+
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 6899865 6999999999999884 889999998643 11 11222334667799999999999865 4458
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC---CCeEEEEecCcccc
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLSRI 673 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~---~g~VKLaDFGLA~~ 673 (782)
++||||+++|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 9999999999999999732 2357999999999999999999999999999999999999976 45699999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhcCCCCC-----
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA----VANEGSRLE----- 744 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~----i~~~~~~~~----- 744 (782)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... +........
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (336)
T 3fhr_A 181 TTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS 258 (336)
T ss_dssp C------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTST
T ss_pred cccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhc
Confidence 6543 23456789999999999888899999999999999999999999977654433211 111111111
Q ss_pred CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.-...+.+|+.+||. ||.+|||+.+++++
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 259 EVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 113468999999999 99999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=341.43 Aligned_cols=244 Identities=26% Similarity=0.412 Sum_probs=185.5
Q ss_pred cCCC-eeEeeEEeeeCcEEEEEE-EECCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEE
Q 003971 522 DFSE-LTVGTRVGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSM 598 (782)
Q Consensus 522 ~~s~-y~i~~~LG~G~fG~VYkg-~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~L 598 (782)
...+ |.+.+.||+|+||+||.+ ..+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++.+...+|+
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 3444 555788999999999754 458999999998643 235678999999876 89999999999999999999
Q ss_pred EEEEecccchhhHHHhhcccc----cchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC-------------C
Q 003971 599 ITEYMELGSLYHLIHLSGQKK----KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-------------W 661 (782)
Q Consensus 599 V~Ey~~gGsL~dlL~~~~~~~----~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~-------------g 661 (782)
||||+. |+|.+++....... ..++..++.++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999996 69999987332111 11333467899999999999999999999999999999754 4
Q ss_pred eEEEEecCccccccCCCC----CCCCCCCCCcccCcccccc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 003971 662 TVKICDFGLSRIITDSPM----RDSSSAGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWELCT-LNRPWEGVLP 729 (782)
Q Consensus 662 ~VKLaDFGLA~~l~~~~~----~~~~~~GT~~Y~APEvl~~-------~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~ 729 (782)
.+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+...
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 899999999988754321 1234579999999999975 568999999999999999999 8999987654
Q ss_pred HHHHHHHHhcCCCCC-C---CC----hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 730 ERVVYAVANEGSRLE-I---PE----GPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 730 ~evl~~i~~~~~~~~-i---p~----~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.. ..+........ . .. ..+.+|+.+||. ||.+|||+.++++|
T Consensus 246 ~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 246 RE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 43 22333222221 1 11 358899999999 99999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=345.25 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=190.0
Q ss_pred ccccCCCeeEeeEEeeeCcEEE-EEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCce
Q 003971 519 WNIDFSELTVGTRVGIGFFGEV-FRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 596 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~V-Ykg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l 596 (782)
+.+...+|.+.+.||+|+||+| |++..+++.||||++..... ..+.+|+.+|+.+ +|||||++++++.+....
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 4455567999999999999985 55566899999999865432 2345799999999 799999999999999999
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC-----CCeEEEEecCcc
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-----HWTVKICDFGLS 671 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~-----~g~VKLaDFGLA 671 (782)
|+||||+. |+|.+++... ...+.+..++.++.||+.||+|||++||+||||||+|||++. ...+||+|||++
T Consensus 94 ~lv~E~~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEECCS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEECCC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99999997 5999888632 234455566789999999999999999999999999999953 236889999999
Q ss_pred ccccCCC---CCCCCCCCCCcccCccccc---cCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC
Q 003971 672 RIITDSP---MRDSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLE 744 (782)
Q Consensus 672 ~~l~~~~---~~~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ 744 (782)
+...... ......+||+.|+|||++. ...++.++|||||||++|||++ |..||....................
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence 8765332 1234567999999999997 4567889999999999999999 8899976655443332211111111
Q ss_pred CCC----hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 IPE----GPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 ip~----~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+. ..+.+|+.+||. ||.+|||+.++++|
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 111 237789999999 99999999999964
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=315.91 Aligned_cols=223 Identities=13% Similarity=0.058 Sum_probs=183.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.+|++.+.||+|+||.||+|.+. ++.||||++...... ....+.|.+|+.++..++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999984 899999999765443 455688999999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 680 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~ 680 (782)
||++|++|.+++.. . .....+..++.||+.||+|||++||+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999852 2 2445688899999999999999999999999999999999999997443
Q ss_pred CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHhcCCCC-----CCCChHHHH
Q 003971 681 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY---AVANEGSRL-----EIPEGPLGR 752 (782)
Q Consensus 681 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~---~i~~~~~~~-----~ip~~~L~~ 752 (782)
|++ +++.++|||||||++|+|+||+.||.+......+. ......... .--+..+.+
T Consensus 175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (286)
T 3uqc_A 175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238 (286)
T ss_dssp ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence 333 37899999999999999999999998765432110 000110000 011346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 753 LIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
|+.+||. ||.+| |+.++++.|++...
T Consensus 239 li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 239 VAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred HHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 9999999 99999 99999999998643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=325.91 Aligned_cols=238 Identities=21% Similarity=0.245 Sum_probs=187.2
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeecccc------ChHHHHHHHHHHHHHHhCC---------------
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL------TAENMEDFCNEISILSRLR--------------- 579 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~------~~~~~e~f~~EI~iLk~L~--------------- 579 (782)
+..++|.+.++||+|+||+||+|.++|+.||||++..... .....+.+.+|+.+++.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 3457899999999999999999999999999999976542 2233477889999999886
Q ss_pred -----------CCceeeEeccccC-------------CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHH
Q 003971 580 -----------HPNVILFLGACTK-------------PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635 (782)
Q Consensus 580 -----------HPNIVkL~g~~~d-------------~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~ 635 (782)
||||+++++++.+ ...+|+||||+++|++.+.+. ...+++..++.++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHH
Confidence 5555555555554 678999999999998776663 256899999999999999
Q ss_pred HHHHHH-hccccccCCCcccEEEcCCC--------------------eEEEEecCccccccCCCCCCCCCCCCCcccCcc
Q 003971 636 GLMCIH-RMKIVHRDLKSANCLVNKHW--------------------TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694 (782)
Q Consensus 636 gL~yLH-s~gIIHrDIKPeNILLd~~g--------------------~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APE 694 (782)
||+||| ++||+||||||+|||++.++ .+||+|||+++..... ..+||+.|+|||
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE 247 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence 999999 99999999999999999887 9999999999877542 347999999999
Q ss_pred ccccCCCCchhHHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCC-C-------ChHHHHHHHHhhh-CCCC
Q 003971 695 LIRNEPFTEKCDIFSLGVI-MWELCTLNRPWEGVLP-ERVVYAVANEGSRLEI-P-------EGPLGRLIADCWA-EPQE 763 (782)
Q Consensus 695 vl~~~~~s~ksDVWSLGvI-LyELLTGk~PF~~~~~-~evl~~i~~~~~~~~i-p-------~~~L~~LI~~CL~-DP~k 763 (782)
++.+.. +.++||||||++ .+++++|..||.+... ......+......... + +..+.+|+.+||. |
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 998776 899999998777 7788999999854321 1222233322111111 1 1248899999999 6
Q ss_pred CCCHHHHH-HH
Q 003971 764 RPSCEEIL-SR 773 (782)
Q Consensus 764 RPSa~EIL-~~ 773 (782)
|+.|++ +|
T Consensus 324 --sa~e~l~~H 332 (336)
T 2vuw_A 324 --SATDLLCQH 332 (336)
T ss_dssp --SHHHHHHHC
T ss_pred --CHHHHHhcC
Confidence 999998 54
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=312.53 Aligned_cols=221 Identities=22% Similarity=0.388 Sum_probs=177.6
Q ss_pred CCCeeEe-eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHH-HhCCCCceeeEeccccC----CC
Q 003971 523 FSELTVG-TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISIL-SRLRHPNVILFLGACTK----PP 594 (782)
Q Consensus 523 ~s~y~i~-~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iL-k~L~HPNIVkL~g~~~d----~~ 594 (782)
..+|.+. +.||+|+||.||++.+ +++.||||++... ..+.+|+.++ +.++||||+++++++.. ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3678887 7899999999999988 5889999998532 3566888887 66689999999999876 66
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC---CCeEEEEecCcc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLS 671 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~---~g~VKLaDFGLA 671 (782)
.+++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred eEEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 789999999999999999742 3347999999999999999999999999999999999999998 789999999998
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCC---
Q 003971 672 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS--RLEIP--- 746 (782)
Q Consensus 672 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~--~~~ip--- 746 (782)
..... ..++.++|||||||++|+|++|+.||.+............... ....+
T Consensus 168 ~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 168 KETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp EECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred ccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 65431 3467899999999999999999999987654432221111111 11111
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 ----EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+..+.+|+.+||. ||.+|||+.++++|
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 3468999999999 99999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=334.84 Aligned_cols=248 Identities=16% Similarity=0.120 Sum_probs=188.2
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCC-CceeeEe------
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRH-PNVILFL------ 587 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~H-PNIVkL~------ 587 (782)
++.....+|..++.||+|+||+||+|.+. |+.||||++..... .....+.|.+|+.+++.++| +|+....
T Consensus 72 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 72 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp SSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred cCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 34455667999999999999999999984 89999999873332 22335778999999999987 3221111
Q ss_pred ---------------ccccC-----CCceEEEEEEecccchhhHHHhh----cccccchHHHHHHHHHHHHHHHHHHHhc
Q 003971 588 ---------------GACTK-----PPRLSMITEYMELGSLYHLIHLS----GQKKKLSWRRKLKMLRDICRGLMCIHRM 643 (782)
Q Consensus 588 ---------------g~~~d-----~~~l~LV~Ey~~gGsL~dlL~~~----~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~ 643 (782)
.++.. ...++++|+++ +++|.+++... .....+++..++.++.||+.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11111 12345555554 67998888522 2345789999999999999999999999
Q ss_pred cccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCcccc----------ccCCCCchhHHHHHHHH
Q 003971 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI----------RNEPFTEKCDIFSLGVI 713 (782)
Q Consensus 644 gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl----------~~~~~s~ksDVWSLGvI 713 (782)
||+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||+
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999999999999999999999876433 345677 999999999 55568899999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 714 MWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 714 LyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+|||++|+.||.+.........+.... ..+ +..+.+|+.+||. ||.+||++.+++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~~~~~--~~~-~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWIFRSC--KNI-PQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGGGSSC--CCC-CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCcchhhhHHHHHhhc--ccC-CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999998765544333322211 122 3569999999999 99999998888754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=353.02 Aligned_cols=235 Identities=24% Similarity=0.340 Sum_probs=193.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE---CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCc---
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR--- 595 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~---~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~--- 595 (782)
-..+|++.+.||+|+||+||++.+ +++.||||++.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 347899999999999999999987 47899999986432 34456788999999999999999999999987665
Q ss_pred --eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 596 --LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 596 --l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
.|+||||++|++|.+++. ..+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred ceeEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 799999999999998764 268999999999999999999999999999999999999886 899999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChH
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGP 749 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip----~~~ 749 (782)
.... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+..... .....+ ...
T Consensus 231 ~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~~~~~~~~~~~~~ 296 (681)
T 2pzi_A 231 INSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------LPEDDPVLKTYDS 296 (681)
T ss_dssp TTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------CCTTCHHHHHCHH
T ss_pred cccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------ccccccccccCHH
Confidence 6543 4567999999999998764 899999999999999999998886531100 000001 235
Q ss_pred HHHHHHHhhh-CCCCCCC-HHHHHHHHHhh
Q 003971 750 LGRLIADCWA-EPQERPS-CEEILSRLLDC 777 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPS-a~EIL~~L~di 777 (782)
+.+|+.+||. ||.+||+ ++++.+.|..+
T Consensus 297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 8899999999 9999995 66666666654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=349.79 Aligned_cols=247 Identities=28% Similarity=0.360 Sum_probs=196.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC------CC
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PP 594 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d------~~ 594 (782)
..+|.+.+.||+|+||.||+|.+ +|+.||||++... ......+.+.+|+.+++.++||||+++++++.. ..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 36899999999999999999987 5889999998654 345556789999999999999999999998765 66
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe---EEEEecCcc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLS 671 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~---VKLaDFGLA 671 (782)
..++||||+++|+|.+++........+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 78999999999999999975444457899999999999999999999999999999999999987664 999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---------H-h---
Q 003971 672 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV---------A-N--- 738 (782)
Q Consensus 672 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i---------~-~--- 738 (782)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......... . .
T Consensus 172 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 172 KELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred ccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 8775432 334578999999999999999999999999999999999999999765332211000 0 0
Q ss_pred -cC----CCCCCC-------ChHHHHHHHHhhh-CCCCCCCHHHHH
Q 003971 739 -EG----SRLEIP-------EGPLGRLIADCWA-EPQERPSCEEIL 771 (782)
Q Consensus 739 -~~----~~~~ip-------~~~L~~LI~~CL~-DP~kRPSa~EIL 771 (782)
.. ...+.+ ...+.+|+..||. ||.+|||+.+++
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 00 000111 1358899999999 999999998844
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=297.50 Aligned_cols=186 Identities=16% Similarity=0.101 Sum_probs=133.8
Q ss_pred EEeeeCcEEEEEEE--ECCeEEEEEEeecccc--------ChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCceEEE
Q 003971 531 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDL--------TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 531 ~LG~G~fG~VYkg~--~~g~~VAVKil~~~~~--------~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV 599 (782)
.++.|++|.+..+. +-|+.||||++.+... ...+.++|.+|+++|+++ .|+||++++++++++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46667777666553 4689999999976531 123457899999999999 699999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||++|++|.+++. ..+.++.. +|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.......
T Consensus 321 MEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 99999999999997 34566654 4889999999999999999999999999999999999999999988765544
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCC
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 723 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~P 723 (782)
...+.+||+.|+|||++.+. +..++|+|++|+++++|.++..+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 44567899999999999875 56789999999999888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.9e-27 Score=267.50 Aligned_cols=185 Identities=16% Similarity=0.168 Sum_probs=148.2
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChH------HHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 528 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE------NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 528 i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~------~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
..+.||+|+||+||++...++.+++|+......... ..+.|.+|++++++++||||+++..++...+..|+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 356899999999999988999999998755443221 23568999999999999999955555556667899999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC-
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR- 680 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~- 680 (782)
|+++++|.+++.. ++.++.|++.||+|||++||+||||||+|||++. ++||+|||+++........
T Consensus 420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999862 5689999999999999999999999999999998 9999999999887542111
Q ss_pred ------CCCCCCCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 003971 681 ------DSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWE 725 (782)
Q Consensus 681 ------~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTGk~PF~ 725 (782)
....+||+.|+|||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 124679999999999987 568888999999999998888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=213.25 Aligned_cols=146 Identities=20% Similarity=0.183 Sum_probs=117.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccCh----------------HHHHHHHHHHHHHHhCCCCceeeE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTA----------------ENMEDFCNEISILSRLRHPNVILF 586 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~----------------~~~e~f~~EI~iLk~L~HPNIVkL 586 (782)
..|.+++.||+|+||.||+|.+ +|+.||||++....... .....+.+|+.+++.++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 3456679999999999999988 58899999986432211 13567899999999999 5 666
Q ss_pred eccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEE
Q 003971 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKIC 666 (782)
Q Consensus 587 ~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLa 666 (782)
.+++.. +..|+||||++|++|.+ +.. .....++.|++.||.|||++||+||||||+|||++ ++.+||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 665543 55799999999999998 421 12346999999999999999999999999999999 9999999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCccccc
Q 003971 667 DFGLSRIITDSPMRDSSSAGTPEWMAPELIR 697 (782)
Q Consensus 667 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~ 697 (782)
|||+++.. ..+.|||++.
T Consensus 235 DFG~a~~~-------------~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVEV-------------GEEGWREILE 252 (282)
T ss_dssp CCTTCEET-------------TSTTHHHHHH
T ss_pred ECCCCeEC-------------CCCCHHHHHH
Confidence 99999643 3468899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=8.2e-19 Score=182.06 Aligned_cols=138 Identities=17% Similarity=0.177 Sum_probs=106.4
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeE--EEEEEeeccccCh----------------------HHHHHHHHHHHHHHhC
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTD--VAIKVFLEQDLTA----------------------ENMEDFCNEISILSRL 578 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~--VAVKil~~~~~~~----------------------~~~e~f~~EI~iLk~L 578 (782)
-|.+.+.||+|+||.||+|.+ +|+. ||||++....... .....+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999987 8999 9999975432110 1123678999999999
Q ss_pred CCCce--eeEeccccCCCceEEEEEEecc-c----chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHH-hccccccCC
Q 003971 579 RHPNV--ILFLGACTKPPRLSMITEYMEL-G----SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDL 650 (782)
Q Consensus 579 ~HPNI--VkL~g~~~d~~~l~LV~Ey~~g-G----sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLH-s~gIIHrDI 650 (782)
+|++| ..++++ ...++||||+.+ | .|.++.. ..++..+..++.|++.||.||| +.||+||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR------ELKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG------GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh------ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 87754 333332 356899999953 4 4544432 1235567889999999999999 999999999
Q ss_pred CcccEEEcCCCeEEEEecCccccc
Q 003971 651 KSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 651 KPeNILLd~~g~VKLaDFGLA~~l 674 (782)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999988 8999999999765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.4e-16 Score=176.59 Aligned_cols=138 Identities=13% Similarity=0.203 Sum_probs=98.6
Q ss_pred CeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccC------------hHHHHH--------HHHHHHHHHhCCCCce
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLT------------AENMED--------FCNEISILSRLRHPNV 583 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~------------~~~~e~--------f~~EI~iLk~L~HPNI 583 (782)
=|.++++||+|+||.||+|.. +|+.||||++...... ...... ..+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 388999999999999999987 7899999997532110 000111 2245555555543332
Q ss_pred e--eEeccccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC
Q 003971 584 I--LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 661 (782)
Q Consensus 584 V--kL~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g 661 (782)
. ..+++ ...++||||++|++|..+.. ......++.||+.+|.|||+.|||||||||.|||+++++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence 1 11111 12379999999999876542 112356789999999999999999999999999998776
Q ss_pred ----------eEEEEecCcccccc
Q 003971 662 ----------TVKICDFGLSRIIT 675 (782)
Q Consensus 662 ----------~VKLaDFGLA~~l~ 675 (782)
.+.|+||+.+....
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETT
T ss_pred CcccccccccceEEEEeCCcccCC
Confidence 48999999886543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2e-11 Score=125.00 Aligned_cols=139 Identities=12% Similarity=0.022 Sum_probs=110.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
..|.+...++.|+.+.||++...++.+++|+....... ....+.+|+.+++.+. +..+.++++++.+.+..|+||||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 46888888888999999999888889999998643211 1235788999999985 66778899888888889999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR---------------------------------------- 642 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs---------------------------------------- 642 (782)
++|.+|.+.+. +......++.+++++|+.||+
T Consensus 92 i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999876531 112234678899999999998
Q ss_pred -------------------ccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 643 -------------------MKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 643 -------------------~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
..++|+|+++.|||++++..+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876666799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=2.3e-10 Score=115.47 Aligned_cols=135 Identities=16% Similarity=0.100 Sum_probs=96.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCc--eeeEeccccCCCceEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGACTKPPRLSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN--IVkL~g~~~d~~~l~LV 599 (782)
...|.+....+.|..+.||++.. +|+.+++|+..... ...+..|+.+++.+.+.+ +.+++++....+..+++
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 34555533334555699999865 46789999975431 235678999999886544 45688888777789999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc-----------------------------------
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK----------------------------------- 644 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g----------------------------------- 644 (782)
|||++|.+|. .. . .+ ...++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 94 LGEVPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EECCSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEecCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999998884 21 0 11 1245667777777777642
Q ss_pred -----------------------ccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 645 -----------------------IVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 645 -----------------------IIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
++|+|++|.|||+++++.+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998876677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=6.3e-10 Score=119.75 Aligned_cols=140 Identities=16% Similarity=0.218 Sum_probs=106.4
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEee--ccccChHHHHHHHHHHHHHHhCC--CCceeeEeccccCC---CceEEEE
Q 003971 528 VGTRVGIGFFGEVFRGIWNGTDVAIKVFL--EQDLTAENMEDFCNEISILSRLR--HPNVILFLGACTKP---PRLSMIT 600 (782)
Q Consensus 528 i~~~LG~G~fG~VYkg~~~g~~VAVKil~--~~~~~~~~~e~f~~EI~iLk~L~--HPNIVkL~g~~~d~---~~l~LV~ 600 (782)
..+.|+.|.++.||+....+..+++|+.. ..... .....+.+|+.+++.+. +..+.+++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35778999999999998878889999865 32211 12356778999999997 44577888888766 4589999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-------------------------------------- 642 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-------------------------------------- 642 (782)
||++|..+.+.. -..++..+...++.+++..|+.||+
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998875421 1246778888899999999999997
Q ss_pred --------------------ccccccCCCcccEEEcCCCe--EEEEecCcccc
Q 003971 643 --------------------MKIVHRDLKSANCLVNKHWT--VKICDFGLSRI 673 (782)
Q Consensus 643 --------------------~gIIHrDIKPeNILLd~~g~--VKLaDFGLA~~ 673 (782)
..++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999987653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=5.2e-09 Score=110.16 Aligned_cols=182 Identities=18% Similarity=0.121 Sum_probs=119.9
Q ss_pred eEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCc--eeeEeccccCCC---ceEEEEEEe
Q 003971 530 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPN--VILFLGACTKPP---RLSMITEYM 603 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPN--IVkL~g~~~d~~---~l~LV~Ey~ 603 (782)
+.++.|.+..||+.. ..+++|+... ......+.+|+.+|+.+. +.. +.+.+....... ..|+||+++
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 458999999999863 5688998542 233567889999998884 322 334444443333 358899999
Q ss_pred cccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 003971 604 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR----------------------------------------- 642 (782)
Q Consensus 604 ~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs----------------------------------------- 642 (782)
+|.++..... ..++..+...++.+++..|+.||+
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998875332 245667777788888888888885
Q ss_pred -----------------ccccccCCCcccEEEcC--CCeEEEEecCccccccCCCCCCCCCCCCCcccCccccc----c-
Q 003971 643 -----------------MKIVHRDLKSANCLVNK--HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR----N- 698 (782)
Q Consensus 643 -----------------~gIIHrDIKPeNILLd~--~g~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~----~- 698 (782)
..++|+|+++.||+++. ...+.|+||+.+...... ...........-..|+... .
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHc
Confidence 13799999999999998 566889999998654221 0000000000002232211 1
Q ss_pred CCC---------CchhHHHHHHHHHHHHHhCCCCC
Q 003971 699 EPF---------TEKCDIFSLGVIMWELCTLNRPW 724 (782)
Q Consensus 699 ~~~---------s~ksDVWSLGvILyELLTGk~PF 724 (782)
... ....+.|++|.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 12368999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=5.9e-06 Score=87.46 Aligned_cols=133 Identities=17% Similarity=0.107 Sum_probs=89.4
Q ss_pred eeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC---ceeeEecccc-CCCceEEEEEEec
Q 003971 529 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP---NVILFLGACT-KPPRLSMITEYME 604 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HP---NIVkL~g~~~-d~~~l~LV~Ey~~ 604 (782)
.+.++.|....||+. +..+++|+.. .......+..|+.+|+.+.+. .+.+.+.++. ..+..+++|+|++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 356888999999987 6788999842 223456788999999999742 2445555553 4455789999999
Q ss_pred ccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 003971 605 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR------------------------------------------ 642 (782)
Q Consensus 605 gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs------------------------------------------ 642 (782)
|.++....- ..++......++.++...|+.||+
T Consensus 97 G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 97 GQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp SEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred CeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 988865321 012333333344444444444442
Q ss_pred ------------------ccccccCCCcccEEEcC---CCe-EEEEecCcccc
Q 003971 643 ------------------MKIVHRDLKSANCLVNK---HWT-VKICDFGLSRI 673 (782)
Q Consensus 643 ------------------~gIIHrDIKPeNILLd~---~g~-VKLaDFGLA~~ 673 (782)
..++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 24699999999999987 455 48999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=1.3e-05 Score=81.92 Aligned_cols=131 Identities=15% Similarity=0.155 Sum_probs=90.8
Q ss_pred EEeeeCcE-EEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEEEEEeccc
Q 003971 531 RVGIGFFG-EVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 531 ~LG~G~fG-~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
.+..|..+ .||+... .+..+++|+-.. .....+..|...|+.+. +--+.+++.++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 45556555 6898765 356789998542 23466788999998885 323567778888888899999999998
Q ss_pred chhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 003971 607 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM------------------------------------------- 643 (782)
Q Consensus 607 sL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~------------------------------------------- 643 (782)
++.+..... ......+..+++..|..||..
T Consensus 106 ~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 106 TAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 877654311 111223444555555555531
Q ss_pred ---------------cccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 644 ---------------KIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 644 ---------------gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 268999999999999887777999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=1e-05 Score=86.46 Aligned_cols=83 Identities=12% Similarity=-0.031 Sum_probs=54.7
Q ss_pred eEeeEE-eeeCcEEEEEEEEC--------CeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCC-C--CceeeEeccccCC
Q 003971 527 TVGTRV-GIGFFGEVFRGIWN--------GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLR-H--PNVILFLGACTKP 593 (782)
Q Consensus 527 ~i~~~L-G~G~fG~VYkg~~~--------g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~-H--PNIVkL~g~~~d~ 593 (782)
...+.| +.|....+|+.... +..+++|+...... .......+..|+.+++.+. + -.+.+++.++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345678 88989999988654 67899998643220 0000134567888888774 2 2456677766554
Q ss_pred ---CceEEEEEEecccchh
Q 003971 594 ---PRLSMITEYMELGSLY 609 (782)
Q Consensus 594 ---~~l~LV~Ey~~gGsL~ 609 (782)
+..+++|||++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.95 E-value=4.9e-05 Score=79.72 Aligned_cols=137 Identities=13% Similarity=0.099 Sum_probs=78.2
Q ss_pred eEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-----CCceeeEe-c--cccCCCceEEEEE
Q 003971 530 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----HPNVILFL-G--ACTKPPRLSMITE 601 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-----HPNIVkL~-g--~~~d~~~l~LV~E 601 (782)
+.|+.|..+.||+....+..+++|+.... . ..+..|+.+++.|. .|.++... | +....+..+++++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666778999999887777999998642 2 23334555555543 34443311 1 1123456789999
Q ss_pred Eecccchh--------------hHHHhhcccc--c---------chHHH-------------------------------
Q 003971 602 YMELGSLY--------------HLIHLSGQKK--K---------LSWRR------------------------------- 625 (782)
Q Consensus 602 y~~gGsL~--------------dlL~~~~~~~--~---------Ls~~~------------------------------- 625 (782)
|++|..+. ..+|...... . ..|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 1112111100 0 01110
Q ss_pred HHHHHHHHHHHHHHHHh-------------ccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 626 KLKMLRDICRGLMCIHR-------------MKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 626 ~l~Ia~QIa~gL~yLHs-------------~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
...+..++..++.+|+. ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11112234445666652 469999999999999888899999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=7.9e-05 Score=81.09 Aligned_cols=76 Identities=17% Similarity=0.051 Sum_probs=48.3
Q ss_pred eeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc--Ch---HHHHHHHHHHHHHHhCCC--Cc-eeeEeccccCCCceEE
Q 003971 529 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL--TA---ENMEDFCNEISILSRLRH--PN-VILFLGACTKPPRLSM 598 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~--~~---~~~e~f~~EI~iLk~L~H--PN-IVkL~g~~~d~~~l~L 598 (782)
.+.||.|.++.||++.. .++.++||....... .. .....+..|.++++.+.. +. +.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 46799999999999954 567899998643211 00 112456778888887742 33 33555442 344689
Q ss_pred EEEEeccc
Q 003971 599 ITEYMELG 606 (782)
Q Consensus 599 V~Ey~~gG 606 (782)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00069 Score=71.06 Aligned_cols=143 Identities=14% Similarity=0.123 Sum_probs=80.3
Q ss_pred eEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCc--eeeEeccc------cCCCceEE
Q 003971 527 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGAC------TKPPRLSM 598 (782)
Q Consensus 527 ~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN--IVkL~g~~------~d~~~l~L 598 (782)
.-.+.|+.|....+|+....+..+++|+..... . .+.+..|+.+++.+...+ +.+++... ...+..++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~-~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred eEeeccCCCcccceEEEEeCCccEEEEEeCCCC-C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 345678889889999998766688999976421 1 134456777777664212 22333211 12345689
Q ss_pred EEEEecccchhh--------------HHHhhccc---------ccchHHHHHH------------HHHHHHHHHHHHHh-
Q 003971 599 ITEYMELGSLYH--------------LIHLSGQK---------KKLSWRRKLK------------MLRDICRGLMCIHR- 642 (782)
Q Consensus 599 V~Ey~~gGsL~d--------------lL~~~~~~---------~~Ls~~~~l~------------Ia~QIa~gL~yLHs- 642 (782)
+++|++|..+.. .++..... ....|..... +...+...+++++.
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 999999865421 11211000 0011221100 00113445555553
Q ss_pred ------ccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 643 ------MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 643 ------~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
.+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 4799999999999999876668999987753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.001 Score=71.16 Aligned_cols=76 Identities=17% Similarity=0.063 Sum_probs=60.3
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC---CCceeeEeccccCCCceEEEEEEec
Q 003971 528 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR---HPNVILFLGACTKPPRLSMITEYME 604 (782)
Q Consensus 528 i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~---HPNIVkL~g~~~d~~~l~LV~Ey~~ 604 (782)
-.+.|+.|.+..+|+....+..+++|+.... ....|..|...|+.|. ...+.+.+.++...+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3567999999999999878888999986532 2466888999888884 2567778877777778999999999
Q ss_pred ccch
Q 003971 605 LGSL 608 (782)
Q Consensus 605 gGsL 608 (782)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00088 Score=73.73 Aligned_cols=78 Identities=15% Similarity=0.128 Sum_probs=46.7
Q ss_pred HhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCC--CCcccCccccccC---CCCchhHHHHHHHHHH
Q 003971 641 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG--TPEWMAPELIRNE---PFTEKCDIFSLGVIMW 715 (782)
Q Consensus 641 Hs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~~~G--T~~Y~APEvl~~~---~~s~ksDVWSLGvILy 715 (782)
+...++|+|+++.|||++.++ ++|+||+.+..-... ........ ...|++|+..... ......++..+...+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 346799999999999998876 999999988654211 00000000 1235565544311 1122345557777777
Q ss_pred HHHhC
Q 003971 716 ELCTL 720 (782)
Q Consensus 716 ELLTG 720 (782)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0016 Score=68.13 Aligned_cols=135 Identities=18% Similarity=0.130 Sum_probs=74.3
Q ss_pred eeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCce-eeEeccccCCCceEEEEEEe-ccc
Q 003971 529 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSMITEYM-ELG 606 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~~~l~LV~Ey~-~gG 606 (782)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++ .++++++. +.-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCc
Confidence 577999999999998 66888987542111 1112357777776642222 35555443 3347899999 665
Q ss_pred chhhH--------H----------Hhhcc--cccch-HHHHHHHHHH--------------HHHHHHHHH--------hc
Q 003971 607 SLYHL--------I----------HLSGQ--KKKLS-WRRKLKMLRD--------------ICRGLMCIH--------RM 643 (782)
Q Consensus 607 sL~dl--------L----------~~~~~--~~~Ls-~~~~l~Ia~Q--------------Ia~gL~yLH--------s~ 643 (782)
++... . |.... ..... ...+..+... +...+..|. ..
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 55321 0 10000 00011 1111111111 111122221 12
Q ss_pred cccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 644 KIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 644 gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
.++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5667889999998754
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=96.95 E-value=1.5e-05 Score=89.96 Aligned_cols=146 Identities=8% Similarity=0.122 Sum_probs=61.4
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccccccccccccCCCCCCCccC
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 477 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~~~~s~~~~slPssp~~~~ 477 (782)
.+.|+|.+++..|.. .+|+|++|.|+ ...+.|.+++.. +++.+||.+.++ .. .+-
T Consensus 55 hg~i~r~~ae~lL~~---~~G~FLvR~S~----~~~g~~~Lsv~~-----~~~v~H~~I~~~---g~----------~~~ 109 (463)
T 3cxl_A 55 HGMISREAADQLLIV---AEGSYLIRESQ----RQPGTYTLALRF-----GSQTRNFRLYYD---GK----------HFV 109 (463)
T ss_dssp CCSCCHHHHHHHHTT---STTEEEEEECS----SSTTCEEEEEEC-----SSSEEEEECEES---SS----------EES
T ss_pred ccCCCHHHHHHHHcC---CCCeEEEeccC----CCCCCEEEEEEE-----CCEEEEEEEecC---Ce----------EEE
Confidence 467889999998853 68999999998 456778888875 457788887652 10 000
Q ss_pred CCCCCCCCCCCCCCCchhhh-----hhhhhccCCcccCCCccccccccccCCCeeEeeEEeeeCcEEEEEEEECC--eEE
Q 003971 478 SHGSERGGSSGYMANSEFVS-----TWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG--TDV 550 (782)
Q Consensus 478 s~~S~~~~ss~~~~~s~~~s-----~~~~~l~sp~~~~~p~~~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g--~~V 550 (782)
. ...+.+-.+.+. .+.....++.....+ +. .+.++|| ||.||+|.+.+ .+|
T Consensus 110 ---~----~~~F~sl~~Lv~dGl~~~~~~~~~~~~~l~~~--------i~----~l~~~lG---fG~v~~g~~~~~~~~V 167 (463)
T 3cxl_A 110 ---G----EKRFESIHDLVTDGLITLYIETKAAEYIAKMT--------IN----PIYEHVG---YTTLNREPAYKKHMPV 167 (463)
T ss_dssp ---S----SCCBSCHHHHHHHHHHHHHHHHHTHHHHHHTT--------SS----CSTTTSS---BCCC---------CCB
T ss_pred ---C----CCccCCHHHHHHHHHHhhhccCCCcchhhccc--------cc----cccccCC---chhhhcccccccCCch
Confidence 0 012222233333 222221111000000 11 3344566 99999998854 578
Q ss_pred EE------EEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 003971 551 AI------KVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 590 (782)
Q Consensus 551 AV------Kil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~ 590 (782)
|+ |.........+....|.+|..+++.++|||+++.+++.
T Consensus 168 av~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 168 LKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp GGGC-----------------------------------CBCCCEE
T ss_pred hhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 88 76655455555567789999999999999999988764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0062 Score=63.19 Aligned_cols=79 Identities=16% Similarity=0.098 Sum_probs=54.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC---ceeeEeccccCCCceEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP---NVILFLGACTKPPRLSMI 599 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HP---NIVkL~g~~~d~~~l~LV 599 (782)
.+..-.+.+|.|..+.||+... +|+.|.+|+....... ....|..|+..|+.|.-. -+.+.+++. .-+++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 4566678999999999999987 7899999986433221 123577899999888421 234444432 24789
Q ss_pred EEEecccch
Q 003971 600 TEYMELGSL 608 (782)
Q Consensus 600 ~Ey~~gGsL 608 (782)
|||+.++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987654
|
| >3kd4_A Putative protease; structural genomics, joint center for STR genomics, JCSG, protein structure initiative, PSI-2, hydrol; HET: MSE; 2.00A {Parabacteroides distasonis atcc 8503} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0022 Score=73.10 Aligned_cols=115 Identities=11% Similarity=0.144 Sum_probs=84.2
Q ss_pred cchhHHHHHHHHHHHHhcCCCChHHHHHHHHHHHHhhhCCCCCCChhhhhHH--HHHHHHhhcceeEeccccccccchhh
Q 003971 119 KDKKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALE--ETSHMFETRGVQLLGQIRHGSCRPRA 196 (782)
Q Consensus 119 ~d~~~~~l~~l~~~~~~~~~~~~~~~~~~~a~~v~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~g~i~~g~~r~ra 196 (782)
.++. +++++..+..+.. ++.+.++.|-..|.+++.--.+..+.. .|. ..+.-|++ +.|-|+-.|
T Consensus 226 ~~~~---i~~~a~~l~~~~~-~~~ek~~~iy~~V~~~i~y~~~~~~~~-g~~~~~a~~vl~~---------~~G~C~d~a 291 (506)
T 3kd4_A 226 QGYE---SKTFAQFLTDKSG-NEQEKVNIIRDHILNNLSTCPIPMAMT-GYTVRDIDTVLRS---------AYGTPLEIA 291 (506)
T ss_dssp CCHH---HHHHHHHHHSSCS-SHHHHHHHHHHHHHHHCEECCCCGGGG-TTCCCCHHHHHHH---------TEECHHHHH
T ss_pred CCHH---HHHHHHHHHhcCC-CHHHHHHHHHHHHHhccEecceecccC-CCCCCCHHHHHHh---------CCcchHHHH
Confidence 3555 8999999998887 999999999999999885221111110 000 01133333 369999999
Q ss_pred HHHHHHhhhcCCccccccccCC-CCcc-ccccccCcceEEEEeCCeeeeeecc
Q 003971 197 ILFKVLADTVGLESRLMVGLPN-DGTM-ECVDSYKHMSVIVVLNSVELLVDLM 247 (782)
Q Consensus 197 ~lfkvlad~~~l~~~~~~g~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (782)
+||.+|+-..|+|||+|.+... .|.. .-+.+.+|+++.|.++...|++|-=
T Consensus 292 ~Ll~AllRa~GIpA~~v~~~t~~~~~~~~~lp~~nh~i~~v~~~g~~y~lDat 344 (506)
T 3kd4_A 292 QLLNVMLNAAGIPSEVLAVYPGHLDTDACGLAAIQTLAVKATVDGKDQYLSAS 344 (506)
T ss_dssp HHHHHHHHHTTCCEEEEEEEETTSCGGGCCSTTCCEEEEEEEETTEEEEESSS
T ss_pred HHHHHHHHHCCCCcEEEEEEcCCCCCccCCCCCCCEEEEEEEECCEEEEEecC
Confidence 9999999999999999999863 3322 2344559999999999999999984
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0033 Score=66.41 Aligned_cols=32 Identities=31% Similarity=0.373 Sum_probs=27.7
Q ss_pred ccccccCCCcccEEEcCC----CeEEEEecCccccc
Q 003971 643 MKIVHRDLKSANCLVNKH----WTVKICDFGLSRII 674 (782)
Q Consensus 643 ~gIIHrDIKPeNILLd~~----g~VKLaDFGLA~~l 674 (782)
..++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999874 68999999988654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0039 Score=69.35 Aligned_cols=72 Identities=18% Similarity=0.281 Sum_probs=49.5
Q ss_pred eeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCce-eeEeccccCCCceEE
Q 003971 529 GTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSM 598 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~~~l~L 598 (782)
.+.|+.|....||++... +..+++|+..... . .+.+..|..+++.+...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 467888999999999764 4689999874321 1 1345579988888853333 566666543 38
Q ss_pred EEEEecccch
Q 003971 599 ITEYMELGSL 608 (782)
Q Consensus 599 V~Ey~~gGsL 608 (782)
|++|++|.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0037 Score=67.24 Aligned_cols=73 Identities=12% Similarity=0.170 Sum_probs=43.5
Q ss_pred eeEEeeeCcEEEEEEEECC----------eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCc-eeeEeccccCCCceE
Q 003971 529 GTRVGIGFFGEVFRGIWNG----------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN-VILFLGACTKPPRLS 597 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~g----------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN-IVkL~g~~~d~~~l~ 597 (782)
.+.|+.|....+|+....+ ..+++|+..... ........|..+++.+...+ +.++++.+. -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence 4567888889999997754 688889864321 11112346788888775333 335555442 37
Q ss_pred EEEEEecccch
Q 003971 598 MITEYMELGSL 608 (782)
Q Consensus 598 LV~Ey~~gGsL 608 (782)
++++|++|.++
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999998654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.56 E-value=0.027 Score=57.79 Aligned_cols=139 Identities=19% Similarity=0.156 Sum_probs=88.2
Q ss_pred ccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHH-hccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003971 605 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 683 (782)
Q Consensus 605 gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLH-s~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~~ 683 (782)
.-+|.++|.. .+.++++.++|.++.|.+.+|.-+- .+.-..+=+.|..|+|..+|.|.+.+ +.+.
T Consensus 32 ~vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 3478888873 4579999999999999999987762 11212333457899999999987753 1110
Q ss_pred CCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhhC---
Q 003971 684 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAE--- 760 (782)
Q Consensus 684 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~~~L~~LI~~CL~D--- 760 (782)
.....+.|||... ...+.+.=|||||+++|..+-...|=.. ...-...|.+||..|..+
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e----------------E~eLS~~LE~LL~~Mt~~~~d 159 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE----------------ERELSPPLEQLIDHMANTVEA 159 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE----------------EECCCHHHHHHHHHHTTCCC-
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc----------------chhhCHHHHHHHHHHHhcccc
Confidence 1123467888764 3457899999999999999875554210 011123466676666532
Q ss_pred -----------------------CCCCCCHHHHHHHHH
Q 003971 761 -----------------------PQERPSCEEILSRLL 775 (782)
Q Consensus 761 -----------------------P~kRPSa~EIL~~L~ 775 (782)
+..|+++.+|++.=.
T Consensus 160 ~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~ 197 (229)
T 2yle_A 160 DGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA 197 (229)
T ss_dssp -------------------CCSCCCCCCSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence 467899999987644
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.41 E-value=0.028 Score=58.87 Aligned_cols=138 Identities=12% Similarity=0.120 Sum_probs=78.2
Q ss_pred eEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCc--eeeEecc-----ccCCCceEEEEE
Q 003971 530 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGA-----CTKPPRLSMITE 601 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN--IVkL~g~-----~~d~~~l~LV~E 601 (782)
..|+ |....||+... +|+.+++|+....... ...+..|..+++.+.... +.+++.. ....+..+++++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 3566 88889998865 4668999998643222 245667888877774222 3444433 111344578999
Q ss_pred Eecccchhh----H----------HHhhcc------cccchHHHH----------------------HHHHHHHHHHHHH
Q 003971 602 YMELGSLYH----L----------IHLSGQ------KKKLSWRRK----------------------LKMLRDICRGLMC 639 (782)
Q Consensus 602 y~~gGsL~d----l----------L~~~~~------~~~Ls~~~~----------------------l~Ia~QIa~gL~y 639 (782)
|++|..+.. . ++.... ...++.... ...+.+++..++.
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 999865421 0 111110 011121110 0111122222222
Q ss_pred H----HhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 640 I----HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 640 L----Hs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
+ +...++|+|+++.|||++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 224589999999999998 4 899999988754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.014 Score=64.17 Aligned_cols=137 Identities=15% Similarity=0.204 Sum_probs=81.8
Q ss_pred eEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEE
Q 003971 530 TRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV 599 (782)
+.|..|-...+|++... ++.+++|+..... .....+.+|..+++.+. +.-..++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 56777888889998763 4689999863211 12355668999988875 2223566666654 389
Q ss_pred EEEecccchhhH-----------------HHhhcc--cccc--hHHHHHHHHHHHHH-------------------HHHH
Q 003971 600 TEYMELGSLYHL-----------------IHLSGQ--KKKL--SWRRKLKMLRDICR-------------------GLMC 639 (782)
Q Consensus 600 ~Ey~~gGsL~dl-----------------L~~~~~--~~~L--s~~~~l~Ia~QIa~-------------------gL~y 639 (782)
+||++|.+|..- +|.... .+.. -+.++.+++.++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998666411 011100 1111 24555556544422 2333
Q ss_pred HHh--------ccccccCCCcccEEEcCC----CeEEEEecCcccc
Q 003971 640 IHR--------MKIVHRDLKSANCLVNKH----WTVKICDFGLSRI 673 (782)
Q Consensus 640 LHs--------~gIIHrDIKPeNILLd~~----g~VKLaDFGLA~~ 673 (782)
|.. ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 259999999999999876 7899999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.01 E-value=0.062 Score=60.45 Aligned_cols=73 Identities=15% Similarity=0.032 Sum_probs=48.2
Q ss_pred eeEEeeeCcEEEEEEEECC--eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCce-eeEeccccCCCceEEEEEEecc
Q 003971 529 GTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~g--~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~~~l~LV~Ey~~g 605 (782)
.+.|+.|-...+|++...+ ..+++|+....... .-.-..|..+++.|...++ .++++++. + .+|+||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4678889999999998865 88999987432111 0111478889998875444 46777663 2 359999998
Q ss_pred cch
Q 003971 606 GSL 608 (782)
Q Consensus 606 GsL 608 (782)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 655
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.53 E-value=0.046 Score=58.44 Aligned_cols=32 Identities=22% Similarity=0.383 Sum_probs=28.0
Q ss_pred ccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 643 ~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998888999999877653
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=95.49 E-value=0.035 Score=59.08 Aligned_cols=123 Identities=17% Similarity=0.171 Sum_probs=86.5
Q ss_pred HHHHHHHHHhcCCCChHHHHHHHHHHHHhhhCCC-CCCChhhhhHHHHHHHHhhcceeEeccccccccchhhHHHHHHhh
Q 003971 126 LKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRP-SVESPAKAALEETSHMFETRGVQLLGQIRHGSCRPRAILFKVLAD 204 (782)
Q Consensus 126 l~~l~~~~~~~~~~~~~~~~~~~a~~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~g~i~~g~~r~ra~lfkvlad 204 (782)
++++...+..+.. ++.+.++.|...|.+.+.=- ......... ..-|+ -+.|.|+.-|.||-+|+-
T Consensus 128 i~~~A~~~~~~~~-~~~~~~~ai~~~v~~~~~Y~~~~~~~~~~a----~~~l~---------~~~G~C~d~A~l~val~R 193 (293)
T 3isr_A 128 LQKLAYKEFGKIE-NVYSKVLAITDWIYNNVEYISGSTNSQTSA----FDTIT---------ERAGVCRDFAHLGIALCR 193 (293)
T ss_dssp SHHHHHHHHTTCC-SHHHHHHHHHHHHHHHSEECTTSCCTTCCH----HHHHH---------HCEECHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCC-CHHHHHHHHHHHHHhhcEEeccCCCCCCCH----HHhhc---------CCcEehHHHHHHHHHHHH
Confidence 7888888876665 77789999999999876422 111111111 12222 368999999999999999
Q ss_pred hcCCccccccccCCCCccccccccCcceEEEEeCCeeeeeecccCCCccccCchhhhhhhcccccCCCCccC
Q 003971 205 TVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSVELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAE 276 (782)
Q Consensus 205 ~~~l~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (782)
..|||||+|.|+-.+.. ..-.|.|+-|-|+..=+.+|--. + .|. ..||--|.--|-++
T Consensus 194 a~GIPAR~VsGy~~~~~----~~~~HAW~Evyl~ggWv~~DpT~--~--~~~------~~~I~vA~GRD~~D 251 (293)
T 3isr_A 194 ALSIPARYFTGYAFKLN----PPDFHACFEAYIGGNWIIFDATR--L--VPL------NGLVKIATGRDAAD 251 (293)
T ss_dssp HTTCCEEEEEEEETTCS----SCCEEEEEEEEETTEEEEECTTC--C--SCG------GGEEEEEEESSGGG
T ss_pred HCCCCEEEEEEECCCCC----CCCeEEEEEEEECCcEEEEECCC--C--CCC------CCeEEEEECCCHHH
Confidence 99999999999874322 23359999999998777777542 2 222 45888777667665
|
| >3maz_A Signal-transducing adaptor protein 1; modular domain, phosphotyrosine, specificity, cytoplasm, phosphoprotein, SH2 domain, signaling protein; HET: PTR; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.28 E-value=0.0011 Score=62.22 Aligned_cols=54 Identities=7% Similarity=-0.005 Sum_probs=43.2
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
++.|+|+.||.. |..++.+|+|++|+|+ ..+ .|.++++.+++ ++..+||.+.+.
T Consensus 19 f~~isR~eAE~l-L~~~~~~GaFLVR~Se----~~~-~ySLSVR~~~~--~~~VKHYkI~~~ 72 (125)
T 3maz_A 19 FYTVSRKEATEM-LQKNPSLGNMILRPGS----DSR-NYSITIRQEID--IPRIKHYKVMSV 72 (125)
T ss_dssp BCCCCHHHHHHH-HHHCGGGCSEEEEECT----TSS-SEEEEEEECSS--SCEEEEEEEEEE
T ss_pred cCCCCHHHHHHH-HhccCCCCcEEEEeCC----CCC-CEEEEEEecCC--CCCEeeeEEEEe
Confidence 467899999964 5568889999999997 333 68888887644 789999999876
|
| >1aot_F FYN protein-tyrosine kinase; SH2 domain, signal transduction, peptide complex, complex (proto-oncogene/early protein); HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1aou_F* | Back alignment and structure |
|---|
Probab=95.00 E-value=0.0052 Score=55.07 Aligned_cols=57 Identities=14% Similarity=0.240 Sum_probs=47.3
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|.+++..|+..++.+|+|++|.|+ ...+.+.+++...++..+++.+|+.+.+.
T Consensus 10 g~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~~~LSv~~~~~~~~~~v~H~~I~~~ 66 (106)
T 1aot_F 10 GKLGRKDAERQLLSFGNPRGTFLIRESE----TTKGAYSLSIRDWDDMKGDHVKHYKIRKL 66 (106)
T ss_dssp BSCCHHHHHHHHHTTTCCTTEECCBCBS----SSSSBBCCEEECCBTTTBCCEEECCBEEE
T ss_pred CCCCHHHHHHHHhhCCCCCcEEEEEeCC----CCCCCEEEEEEecccCCCCcEEEEEEEEe
Confidence 4688999999999999999999999998 44678888888766556778889988764
|
| >1blj_A P55 BLK protein tyrosine kinase; signal transduction, transferase, phosphotransferase, phosphorylation; NMR {Mus musculus} SCOP: d.93.1.1 PDB: 1blk_A | Back alignment and structure |
|---|
Probab=94.19 E-value=0.013 Score=53.27 Aligned_cols=56 Identities=14% Similarity=0.171 Sum_probs=45.6
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|..++..|+..++.+|+|++|.|+ ...+.+.+++...+.. +++.+|+.+.+.
T Consensus 17 g~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~y~LSv~~~~~~-~~~v~H~~I~~~ 72 (114)
T 1blj_A 17 RTISRKDAERQLLAPMNKAGSFLIRESE----SNKGAFSLSVKDITTQ-GEVVKHYKIRSL 72 (114)
T ss_dssp CSCCHHHHHHHHSSTTCCTTCEEBCBCT----TCSSCEEEEECBCCTT-TCBCCCEEEEEE
T ss_pred CCCCHHHHHHHHhhCCCCCceEEEEeCC----CCCCCEEEEEEEecCC-CCcEEEEEEEEc
Confidence 5689999999999999999999999998 4456788888865433 677888888763
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.85 E-value=0.37 Score=53.62 Aligned_cols=73 Identities=12% Similarity=0.125 Sum_probs=46.9
Q ss_pred eeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCc-eeeEeccccCCCceEE
Q 003971 529 GTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN-VILFLGACTKPPRLSM 598 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN-IVkL~g~~~d~~~l~L 598 (782)
.+.|..|-...+|+.... +..|++|+...... ..-.-.+|..+++.+...+ ..++++.+. -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~---~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG---KFYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc---hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 466777888999999775 57899998643221 1112246788887774222 344554332 278
Q ss_pred EEEEecccch
Q 003971 599 ITEYMELGSL 608 (782)
Q Consensus 599 V~Ey~~gGsL 608 (782)
|++|++|.+|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998765
|
| >1lkk_A Human P56 tyrosine kinase; complex (tyrosine kinase/peptide); HET: PTR; 1.00A {Homo sapiens} SCOP: d.93.1.1 PDB: 1lcj_A* 1bhf_A* 1bhh_A 1lkl_A* 1bhh_B 1fbz_A* 1ijr_A* 1cwd_L* 1cwe_A* | Back alignment and structure |
|---|
Probab=93.57 E-value=0.0059 Score=54.57 Aligned_cols=57 Identities=11% Similarity=0.180 Sum_probs=46.1
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|.+|+..|+..++.+|+|++|.|+ ...+.+.+++...++..+++.+||.+.+.
T Consensus 9 g~isR~~Ae~lL~~~~~~~G~FLVR~S~----~~~g~~~LSv~~~~~~~~~~v~H~~I~~~ 65 (105)
T 1lkk_A 9 KNLSRKDAERQLLAPGNTHGSFLIRESE----STAGSFSLSVRDFDQNQGEVVKHYKIRNL 65 (105)
T ss_dssp TTCCHHHHHHHHTSTTCCTTCEEEEECS----SSTTCEEEEEEEEETTTEEEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCceEEEEECC----CCCCcEEEEEEEcccCCCCcEEEEEEEEC
Confidence 5689999999999999999999999998 34567888887655555677888887763
|
| >2el8_A Signal-transducing adaptor protein 2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.95 E-value=0.022 Score=52.43 Aligned_cols=55 Identities=9% Similarity=-0.066 Sum_probs=44.9
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
.+.|+|..|++.|++.+ .+|+|++|.|+ ..++.+.+++...+ ..+++.+||.+.+
T Consensus 25 hG~isR~eAe~lL~~~~-~~G~FLVR~S~----~~~g~y~LSv~~~~-~~~~~v~H~~I~~ 79 (118)
T 2el8_A 25 FLKVSRLEAQLLLERYP-ECGNLLLRPSG----DGADGVSVTTRQMH-NGTHVVRHYKVKR 79 (118)
T ss_dssp CCCCCHHHHHHHHHHSS-TTCSBEEEECC----SSSSSEEEEECCCB-TTBCCCEEECBCC
T ss_pred ecCCCHHHHHHHHhhCC-CCcEEEEeeCC----CCCCceEEEEEEec-CCCCcEEEEEEEE
Confidence 46789999999998887 99999999998 45778888888754 3357788998776
|
| >2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A* | Back alignment and structure |
|---|
Probab=91.98 E-value=0.1 Score=55.62 Aligned_cols=51 Identities=25% Similarity=0.293 Sum_probs=44.3
Q ss_pred cccccccchhhHHHHHHhhhcCCccccccccCCCCccccccccCcceEEEEeCC--eeeeeecc
Q 003971 186 QIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNS--VELLVDLM 247 (782)
Q Consensus 186 ~i~~g~~r~ra~lfkvlad~~~l~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 247 (782)
.-+.|.|++-|.||-+|+-.+|+|+|+|.|+ ..|.|+=|-+.. +=+-||-.
T Consensus 137 ~~r~G~C~d~A~lf~al~Ra~GIpAR~V~Gy-----------~~HaW~Evy~~g~~gWv~~Dpt 189 (295)
T 2f4m_A 137 ETRCGRCGEWANCFTLCCRALGFEARYVWDY-----------TDHVWTEVYSPSQQRWLHCDAC 189 (295)
T ss_dssp HHCEESHHHHHHHHHHHHHHTTCCEEEEEET-----------TTEEEEEEEETTTTEEEEEETT
T ss_pred HcCCEeeHHHHHHHHHHHHHCCCCEEEEcCC-----------CCEEEEEEEECCCCeEEEEeCC
Confidence 4589999999999999999999999999998 469999999986 55666644
|
| >1rja_A Tyrosine-protein kinase 6; human protein tyrosine kinase-6 (PTK6/BRK), SRC homology 2(S domain, solution structure, backbone dynamics, transferase; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=91.94 E-value=0.031 Score=49.61 Aligned_cols=51 Identities=14% Similarity=0.168 Sum_probs=42.0
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
+.|+|.+++..|...|..+|+|++|.|+ ...+.+.+++.. +++.+|+.+.+
T Consensus 7 g~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~ 57 (100)
T 1rja_A 7 GCISRSEAVRRLQAEGNATGAFLIRVSE----KPSADYVLSVRD-----TQAVRHYKIWR 57 (100)
T ss_dssp TTCCHHHHHHHHSSTTCSSCCEEEEECS----SSSSCEEEEECT-----TSSCEEEEEEE
T ss_pred CCCCHHHHHHHHhccCCCCCEEEEEeCC----CCCCCEEEEEEE-----CCEEEEEEEEE
Confidence 5689999999999999999999999998 345667888775 45778888776
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.86 E-value=0.51 Score=51.52 Aligned_cols=30 Identities=23% Similarity=0.378 Sum_probs=25.2
Q ss_pred cccccCCCcccEEE------cCCCeEEEEecCcccc
Q 003971 644 KIVHRDLKSANCLV------NKHWTVKICDFGLSRI 673 (782)
Q Consensus 644 gIIHrDIKPeNILL------d~~g~VKLaDFGLA~~ 673 (782)
.++|+|+.+.|||+ +++..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4566799999998754
|
| >2dly_A FYN-related kinase; BRK family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=90.82 E-value=0.033 Score=51.32 Aligned_cols=52 Identities=15% Similarity=0.225 Sum_probs=42.4
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
.+.|+|.+++..|+..++.+|+|++|.|+ ...+.+.+++.. +++.+||.+.+
T Consensus 20 hG~isR~eAe~lL~~~~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 71 (121)
T 2dly_A 20 FGAIKRADAEKQLLYSENQTGAFLIRESE----SQKGDFSLSVLD-----EGVVKHYRIRR 71 (121)
T ss_dssp CSSCCHHHHHHHHTSSSCCTTCEEEEECS----SSSSCEEEEEES-----SSCEEEEEEEE
T ss_pred ccCCCHHHHHHHHhcCCCCCCEEEEEcCC----CCCCceEEEEEE-----CCeEEEEEEEE
Confidence 35789999999999999999999999997 345667777765 35678888776
|
| >1nrv_A Growth factor receptor-bound protein 10; dimer, signaling protein; 1.65A {Homo sapiens} SCOP: d.93.1.1 PDB: 3m7f_A | Back alignment and structure |
|---|
Probab=90.26 E-value=0.032 Score=49.89 Aligned_cols=51 Identities=10% Similarity=0.016 Sum_probs=41.5
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
+.|+|.+|+..|...|+.+|+|++|.|+ ...+.+.+++.. +++.+|+.+.+
T Consensus 10 g~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~ 60 (105)
T 1nrv_A 10 GRISREESHRIIKQQGLVDGLFLLRDSQ----SNPKAFVLTLCH-----HQKIKNFQILP 60 (105)
T ss_dssp TTCCHHHHHHHHHHTTCCTTEEEEEECS----SCTTCEEEEEEE-----TTEEEEEEEEE
T ss_pred CCCCHHHHHHHHHhcCCCCceEEEEeCC----CCCCCEEEEEEe-----CCEEEEEEEEE
Confidence 5689999999999999999999999998 345677777764 35778887766
|
| >4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A* | Back alignment and structure |
|---|
Probab=90.24 E-value=0.031 Score=54.46 Aligned_cols=58 Identities=10% Similarity=0.178 Sum_probs=47.8
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
.+.|+|..++..|+..++.+|+|++|.|+ ...+.|.+++...+...+++.+||.+.+.
T Consensus 78 ~g~isr~~ae~lL~~~~~~~G~FLVR~S~----~~~g~y~LSv~~~~~~~~~~v~H~~I~~~ 135 (175)
T 4d8k_A 78 FKNLSRKDAERQLLAPGNTHGSFLIRESE----STAGSFSLSVRDFDQNQGEVVKHYKIRNL 135 (175)
T ss_dssp CSSCCHHHHHHHHHSTTCCTTCEEEEECS----SSTTCEEEEEEEECTTSCEEEEEEEEEEC
T ss_pred cCcccHHHHHHHHhcCCCCCCEEEEEECC----CCCCeEEEEEEeCcccCCCceEEEEEEEC
Confidence 35689999999999999999999999997 55677888887766666778899988653
|
| >3pqz_A Growth factor receptor-bound protein 7; SH2, binds phosphotyrosine, tyrosine kinases, cytoplasmic, P binding; 2.41A {Homo sapiens} PDB: 1mw4_A* 2l4k_A* 2qms_A | Back alignment and structure |
|---|
Probab=89.01 E-value=0.059 Score=49.00 Aligned_cols=52 Identities=12% Similarity=-0.028 Sum_probs=41.2
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
.+.|+|..+++.|...+..+|+|++|.|+ ...+.+.+++.. +++.+|+.+.+
T Consensus 18 hg~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 69 (117)
T 3pqz_A 18 HGRISREESQRLIGQQGLVDGLFLVRESQ----RNPQGFVLSLCH-----LQKVKHYLILP 69 (117)
T ss_dssp CCSCCHHHHHHHHHHTTCCTTEEEEEECC----C-CCCEEEEEEE-----TTEEEEEEEEE
T ss_pred cCCCCHHHHHHHHhcCCCCCCEEEEEecC----CCCCcEEEEEEe-----CCeeEEEEEEE
Confidence 35688999999999989999999999998 345667777765 46788888765
|
| >2aug_A Growth factor receptor-bound protein 14; phosphorylation, SH2 domain, signaling protein; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.83 E-value=0.047 Score=50.82 Aligned_cols=52 Identities=10% Similarity=0.115 Sum_probs=42.3
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
.+.|+|.+|++.|...++.+|+|++|.|+ ...+.|.+++.. +++.++|.+.+
T Consensus 30 hG~isR~eAe~lL~~~g~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 81 (126)
T 2aug_A 30 HHKISRDEAQRLIIQQGLVDGVFLVRDSQ----SNPKTFVLSMSH-----GQKIKHFQIIP 81 (126)
T ss_dssp ETTCCHHHHHHHHHTTTCCTTEEEEEECS----SSSCCEEEEEEE-----TTEEEEEEEEE
T ss_pred cCCCCHHHHHHHHhccCCCCCEEEEeecC----CCCCCEEEEEEc-----CCeEEEEEEEE
Confidence 46789999999999999999999999998 345677777765 35778887776
|
| >3ov1_A Growth factor receptor-bound protein 2; GRB2 SH2 domain, phosphotyrosine binding, signaling protein, signaling protein-antagonist complex; HET: PTR; 1.60A {Homo sapiens} SCOP: d.93.1.1 PDB: 3imj_A* 3in7_A* 3imd_A* 3kfj_A* 3n8m_A* 3in8_A* 3s8l_A* 3s8n_A* 3s8o_A* 2huy_A* 2h5k_A* 2huw_A* 2h46_E* 3c7i_A* 3n84_A* 1fhs_A 1bm2_A* 1bmb_A* 3ove_A* 1fyr_A* ... | Back alignment and structure |
|---|
Probab=87.03 E-value=0.068 Score=49.03 Aligned_cols=50 Identities=10% Similarity=0.167 Sum_probs=39.3
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
+.|+|..+++.|.. ++.+|+|++|.|+ ...+.|.+++.. +++.+++.+.+
T Consensus 11 G~isR~eAe~lL~~-~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 60 (117)
T 3ov1_A 11 GKIPRAKAEEMLSK-QRHDGAFLIRESE----SAPGDFSLSVKF-----GNDVQHFKVLR 60 (117)
T ss_dssp CSCCHHHHHHHHHT-CCSTTBEEEEECS----SSTTCEEEEEEE-----TTEEEEEECEE
T ss_pred CCCCHHHHHHHHhC-CCCCCcEEEEeCC----CCCCCEEEEEec-----CCceEEEEEEE
Confidence 46889999998777 8899999999997 445677777764 45778887765
|
| >1d4t_A T cell signal transduction molecule SAP; SH2 domain, tyrosine kinase, signal transduction, peptide recognition, signaling protein; 1.10A {Homo sapiens} SCOP: d.93.1.1 PDB: 1d1z_A 1d4w_A* 1m27_A* | Back alignment and structure |
|---|
Probab=85.70 E-value=0.072 Score=47.44 Aligned_cols=50 Identities=12% Similarity=0.095 Sum_probs=38.8
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
+.|+|..++..|...+ .+|+|++|.|+ ...+.+.+++.. +++.+|+.+.+
T Consensus 9 g~isR~~Ae~lL~~~~-~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~ 58 (104)
T 1d4t_A 9 GKISRETGEKLLLATG-LDGSYLLRDSE----SVPGVYCLCVLY-----HGYIYTYRVSQ 58 (104)
T ss_dssp CSCCHHHHHHHHHHHC-CTTEEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEE
T ss_pred cCCCHHHHHHHHHhcC-CCCEEEEeeCC----CCCCCEEEEEEE-----CCeEEEEEEEE
Confidence 4688999999887665 88999999997 345677777764 35778887775
|
| >2ekx_A Cytoplasmic tyrosine-protein kinase BMX; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.54 E-value=0.16 Score=45.74 Aligned_cols=55 Identities=13% Similarity=0.204 Sum_probs=41.4
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCC-CccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHD-EISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~~~~rs~~~~l~r~ 459 (782)
+.|+|..++..|... +.+|+|++|.|+ ..+.+.+++...+ ...+++.+||.+.+.
T Consensus 16 g~isR~~Ae~lL~~~-~~~G~FLVR~S~-----~~g~y~LSv~~~~~~~~~~~v~H~~I~~~ 71 (110)
T 2ekx_A 16 GNISRSQSEQLLRQK-GKEGAFMVRNSS-----QVGMYTVSLFSKAVNDKKGTVKHYHVHTN 71 (110)
T ss_dssp CSCCHHHHHHHHHHT-CCTTEEEEEECS-----STTCEEEEECCCCSSCSSCCCEEEECEEC
T ss_pred CCCCHHHHHHHHhcc-CCCceEEEEecC-----CCCCEEEEEEeccccCCCCcEEEEEEEEC
Confidence 568899999877665 488999999995 1577888887654 234567888888764
|
| >1i3z_A EWS/FLI1 activated transcript 2; SH2 domain phosphotyrosine signal transduction lymphocyte, signaling protein; HET: PTR; 2.15A {Mus musculus} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=85.51 E-value=0.095 Score=46.52 Aligned_cols=50 Identities=14% Similarity=0.078 Sum_probs=37.9
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
+.|+|.+++..|...+ .+|+|++|.|+ ...+.+.+++.. +++.+|+.+.+
T Consensus 8 g~isR~~Ae~lL~~~~-~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~ 57 (103)
T 1i3z_A 8 GCLTKRECEALLLKGG-VDGNFLIRDSE----SVPGALCLCVSF-----KKLVYSYRIFR 57 (103)
T ss_dssp SSCCHHHHHHHHHTTC-STTEEEEEECS----SSTTCEEEEEEC-----SSSEEEEEEEE
T ss_pred CCCCHHHHHHHHhhcC-CCceEEEEeCC----CCCCCEEEEEEE-----CCEEEEEEEEE
Confidence 4678999999876655 89999999997 334567777764 45778888775
|
| >2dx0_A Phospholipase C, gamma 2; phosphoric diester hydrolase, structural genomics, NPPSFA, national project on protein structural and functional analyses; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=85.38 E-value=0.11 Score=48.84 Aligned_cols=53 Identities=13% Similarity=0.150 Sum_probs=42.1
Q ss_pred HHHH-HHHHHhhhhhhh----cCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 398 VRAM-NETLKQNRLLQE----RGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 398 ~~~~-~~~~~~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
.+.| +|..|++.|... ++.+|+|++|.|+ ...+.|.+++.. +++.+||.+.+.
T Consensus 26 hG~i~sR~eAe~lL~~~c~~~g~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 83 (138)
T 2dx0_A 26 HKKVESRTSAEKLLQEYCAETGAKDGTFLVRESE----TFPNDYTLSFWR-----SGRVQHCRIRST 83 (138)
T ss_dssp CTTCCCHHHHHHHHHHHHTTTTCCTTCEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEEE
T ss_pred cCCCCCHHHHHHHHHhhccccCCCCCEEEEEeCC----CCCCCeEEEEEE-----CCeEEEEEEEEe
Confidence 4678 899999999876 8999999999998 345677787764 457888888764
|
| >2cia_A Cytoplasmic protein NCK2; SH2-domain, SH3 domain, phosphorylation, binding specificity; HET: PTR MPD; 1.45A {Homo sapiens} PDB: 1z3k_A 2ci9_A* 2ci8_A* | Back alignment and structure |
|---|
Probab=85.13 E-value=0.13 Score=45.80 Aligned_cols=49 Identities=8% Similarity=0.156 Sum_probs=37.6
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLS 457 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~ 457 (782)
+.|+|.+++..|++.+ .+|+|++|.|+ ...+.+.+++.. +++.+|+.+.
T Consensus 10 g~isR~~Ae~lL~~~~-~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~ 58 (102)
T 2cia_A 10 GNVTRHQAECALNERG-VEGDFLIRDSE----SSPSDFSVSLKA-----SGKNKHFKVQ 58 (102)
T ss_dssp CSCCHHHHHHHHHHHC-CTTEEEEEECS----SSTTCEEEEECC-----SSSCEEEEEE
T ss_pred CCCCHHHHHHHHhhCC-CCcEEEEEECC----CCCCCEEEEEEe-----CCeeEEEEEE
Confidence 4688999999876665 88999999998 335667888875 3467788766
|
| >1ka6_A SH2 domain protein 1A; SH2 domain, protein-peptide complex, immune system; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1ka7_A | Back alignment and structure |
|---|
Probab=84.26 E-value=0.14 Score=47.57 Aligned_cols=51 Identities=12% Similarity=0.093 Sum_probs=39.1
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|..++..|...+ .+|+|++|.|+ ...+.+.+++.. +++.+||.+.+.
T Consensus 9 G~isR~eAe~lL~~~~-~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 59 (128)
T 1ka6_A 9 GKISRETGEKLLLATG-LDGSYLLRDSE----SVPGVYCLCVLY-----HGYIYTYRVSQT 59 (128)
T ss_dssp CSCCHHHHHHHHHHHC-CTTCEEEEECS----SSTTCEEEEEES-----SSCEEEEEEEEC
T ss_pred CCCCHHHHHHHHhcCC-CCCEEEEeecC----CCCCCEEEEEEe-----CCEEEEEEEEEC
Confidence 4688999999877655 88999999998 345677787765 457788887753
|
| >3tkz_A Tyrosine-protein phosphatase non-receptor type 11; SH2 domain, protein protein interactions, PTR residues, HYDR peptide complex; HET: PTR; 1.80A {Homo sapiens} PDB: 3tl0_A* 1aya_A* 1ayb_A* 1ayc_A* 1ayd_A | Back alignment and structure |
|---|
Probab=84.06 E-value=0.11 Score=46.55 Aligned_cols=50 Identities=12% Similarity=0.145 Sum_probs=38.9
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
+.|+|..|+..|...+ .+|+|++|.|+ ...+.+.+++.. +++.+|+.+.+
T Consensus 12 g~isr~~Ae~lL~~~~-~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 61 (109)
T 3tkz_A 12 PNITGVEAENLLLTRG-VDGSFLARPSK----SNPGDFTLSVRR-----NGAVTHIKIQN 61 (109)
T ss_dssp TTCCHHHHHHHHHHHC-CTTEEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEE
T ss_pred cCCCHHHHHHHHhcCC-CCCEEEEEecC----CCCCCEEEEEEE-----CCEEEEEEEEe
Confidence 5688999998877665 89999999998 446677777764 56788887765
|
| >2gsb_A RAS GTPase-activating protein 1; GAP, RAS P21 protein activator, P120GAP, rasgap, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.85 E-value=0.16 Score=46.58 Aligned_cols=52 Identities=10% Similarity=0.077 Sum_probs=39.6
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
.+.|+|..++..|...+ .+|+|++|.|+ ...+.+.+++... ++.+||.+.+.
T Consensus 20 hG~isR~~Ae~lL~~~g-~~G~FLVR~S~----~~~g~y~LSv~~~-----~~v~H~~I~~~ 71 (119)
T 2gsb_A 20 HGKISKQEAYNLLMTVG-QVCSFLVRPSD----NTPGDYSLYFRTN-----ENIQRFKICPT 71 (119)
T ss_dssp CCSSCHHHHHHHHHHTC-CSSEEEEEECS----SSTTCEEEEEECS-----SCBCCCCEEEE
T ss_pred cCCCCHHHHHHHHhhcC-CCCeEEEEeCC----CCCCceEEEEEEC-----CEEEEEEEEEc
Confidence 35688999999887766 57999999998 3456777777652 47788887763
|
| >1jyr_A Growth factor receptor-bound protein 2; receptor binding, regulatory, inhibitor, signaling protein-I complex; HET: PTR; 1.55A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jyq_A* 1jyu_A 1qg1_E* 1x0n_A* 2aob_A* 2aoa_A* 3n7y_A* 1tze_E* 1zfp_E* 3mxc_A* 3mxy_A* 1cj1_A* | Back alignment and structure |
|---|
Probab=83.68 E-value=0.11 Score=45.67 Aligned_cols=50 Identities=12% Similarity=0.207 Sum_probs=38.3
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
+.|+|.+++..|...+ .+|+|++|.|+ ...+.+.+++.. +++.+|+.+.+
T Consensus 8 g~isR~~Ae~lL~~~~-~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~ 57 (96)
T 1jyr_A 8 GKIPRAKAEEMLSKQR-HDGAFLIRESE----SAPGDFSLSVKF-----GNDVQHFKVLR 57 (96)
T ss_dssp CSCCHHHHHHHHHTCC-STTBEEEEECS----SSTTCEEEEEEE-----TTEEEEEECEE
T ss_pred cCCCHHHHHHHHhcCC-CCcEEEEEecC----CCCCCEEEEEEe-----CCeEEEEEEEE
Confidence 4688999999887765 59999999998 345667777775 35678887765
|
| >2hdv_A SH2-B PH domain containing signaling mediator 1 gamma isoform; adapter protein, signaling protein; 2.00A {Mus musculus} PDB: 2hdx_A* 1rpy_A 1rqq_C* | Back alignment and structure |
|---|
Probab=83.30 E-value=0.13 Score=46.65 Aligned_cols=51 Identities=10% Similarity=0.124 Sum_probs=40.1
Q ss_pred HHHHHHHHhhhhhhhcC-CCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 399 RAMNETLKQNRLLQERG-EDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
+.|+|..++..|...++ .+|+|++|.|+ ...+.+.+++.. +++.+|+.+.+
T Consensus 14 G~isR~~Ae~lL~~~g~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 65 (111)
T 2hdv_A 14 GMLSRLKAAQLVLEGGTGSHGVFLVRQSE----TRRGECVLTFNF-----QGKAKHLRLSL 65 (111)
T ss_dssp EECCHHHHHHHHHTTGGGGTTEEEEEECS----SCTTEEEEEEEE-----TTEEEEEEEEE
T ss_pred CCCCHHHHHHHHHHcCCCCCCeEEEEecC----CCCCCEEEEEEe-----CCeEEEEEEEE
Confidence 45889999999998885 99999999998 344567777764 45678887765
|
| >2ge9_A Tyrosine-protein kinase BTK; SH2 domain, structure, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.28 E-value=0.21 Score=46.16 Aligned_cols=55 Identities=13% Similarity=0.125 Sum_probs=41.6
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCC-ccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDE-ISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~~~~rs~~~~l~r~ 459 (782)
+.|+|.+++..|...+ .+|+|++|.|+ ..+.+.+++...+. ..+++.++|.+.+.
T Consensus 16 G~isR~eAe~lL~~~g-~~G~FLVR~Ss-----~~g~y~LSv~~~~~~~~~~~v~H~~I~~~ 71 (125)
T 2ge9_A 16 KHMTRSQAEQLLKQEG-KEGGFIVRDSS-----KAGKYTVSVFAKSTGDPQGVIRHYVVCST 71 (125)
T ss_dssp TTCCHHHHHHHHHHHT-CTTEEEEEECS-----SSCCEEEEEEESSSSSTTCEEEEEECEEE
T ss_pred cCCCHHHHHHHHhhcC-CCceEEEEecC-----CCCCEEEEEEeccccCCCCeEEEEEEEEc
Confidence 5788999999877665 88999999994 25778888875442 23567888888764
|
| >2ysx_A Signaling inositol polyphosphate phosphatase SHIP II; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.19 E-value=0.17 Score=46.20 Aligned_cols=51 Identities=10% Similarity=0.082 Sum_probs=38.8
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|..++..|...+ .+|+|++|.|+ ...+.+.+++.. +++.+||.+.+.
T Consensus 15 G~isR~eAe~lL~~~~-~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 65 (119)
T 2ysx_A 15 GNITRSKAEELLSRTG-KDGSFLVRASE----SISRAYALCVLY-----RNCVYTYRILPN 65 (119)
T ss_dssp ESCCHHHHHHHHHHHC-CTTEEEEEECS----SCTTSEEEEEEC-----SSCEEEEEEEEC
T ss_pred CCCCHHHHHHHHhhcC-CCCEEEEEeCC----CCCCCEEEEEEE-----CCEEEEEEEEEc
Confidence 4688999999776544 89999999998 345677787775 356788887653
|
| >1r1p_A GRB2-related adaptor protein 2; SH2, GADS, phosphopeptide, peptide binding protein; HET: PTR; 1.80A {Mus musculus} SCOP: d.93.1.1 PDB: 1r1q_A* 1r1s_A* | Back alignment and structure |
|---|
Probab=81.10 E-value=0.24 Score=43.96 Aligned_cols=50 Identities=10% Similarity=0.153 Sum_probs=38.6
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|..++..|... .+|+|++|.|+ ...+.+.+++.. +++.+|+.+.+.
T Consensus 14 g~isR~~Ae~lL~~~--~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 63 (100)
T 1r1p_A 14 EGLSRHQAENLLMGK--DIGFFIIRASQ----SSPGDFSISVRH-----EDDVQHFKVMRD 63 (100)
T ss_dssp TTCCHHHHHHHHHTS--CTTBEEEEECS----SSTTCEEEEEEC-----SSSEEEEECEEC
T ss_pred cCCCHHHHHHHhcCC--CCCEEEEEecC----CCCCCEEEEEEE-----CCEEEEEEEEEc
Confidence 578999999999765 79999999998 345667777775 356788877653
|
| >2eo3_A CRK-like protein; phosphorylation, repeat, SH2 domain, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.05 E-value=0.17 Score=45.82 Aligned_cols=49 Identities=12% Similarity=0.119 Sum_probs=38.6
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
+.|+|.+|+..|. ++.+|+|++|.|+ ...+.+.+++.. +++.+|+.+.+
T Consensus 24 g~isR~~Ae~lL~--~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 72 (111)
T 2eo3_A 24 GPVSRQEAQTRLQ--GQRHGMFLVRDSS----TCPGDYVLSVSE-----NSRVSHYIINS 72 (111)
T ss_dssp ESCCHHHHHHHHS--SCCTTCEEEEECS----SSSSCEEEEEEE-----TTEEEEEEEEE
T ss_pred CCCCHHHHHHHhc--CCCCceEEEEeec----CCCCCEEEEEEe-----CCeEEEEEEEE
Confidence 5789999999885 7899999999998 335667777764 45678887766
|
| >2eo6_A B-cell linker protein; SH2, cytoplasmic adapter protein, B-cell adapter containing SH2 domain protein; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=80.94 E-value=0.21 Score=47.14 Aligned_cols=53 Identities=11% Similarity=0.016 Sum_probs=38.9
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
.+.|+|.+++..|++. +.+|+|++|.|+.. ...+.|.+++.. +++.+|+.+.+
T Consensus 27 hG~isR~eAe~lL~~~-~~~G~FLVR~S~~~--~~~g~y~LSv~~-----~~~v~H~~I~~ 79 (141)
T 2eo6_A 27 AGACDRKSAEEALHRS-NKDGSFLIRKSSGH--DSKQPYTLVAFF-----NKRVYNIPVRF 79 (141)
T ss_dssp EESCCHHHHHHHHHHH-CCTTCBCEEECSTT--CSSCSEEEEEEE-----TTEEEEEEECE
T ss_pred ecCCCHHHHHHHhhcc-CCCceEEEEECCCC--CCCCCEEEEEEE-----CCEEEEEEEEE
Confidence 3568999999987654 46999999999821 145677777765 35678887765
|
| >3us4_A Megakaryocyte-associated tyrosine-protein kinase; SH2 domain, signaling protein, structural genomics, joint CE structural genomics, JCSG; 1.50A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jwo_A | Back alignment and structure |
|---|
Probab=80.60 E-value=0.18 Score=44.34 Aligned_cols=50 Identities=12% Similarity=0.072 Sum_probs=37.9
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|..|+..|. +..+|+|++|.|+ ...+.+.+++.. +++.+|+.+.+.
T Consensus 10 g~isr~~Ae~lL~--~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 59 (98)
T 3us4_A 10 GKISGQEAVQQLQ--PPEDGLFLVRESA----RHPGDYVLCVSF-----GRDVIHYRVLHR 59 (98)
T ss_dssp CSCCHHHHHHHTC--SCCTTCEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEEE
T ss_pred CCCCHHHHHHHcc--CCCCcEEEEEeCC----CCCCcEEEEEEE-----CCceEEEEEEEe
Confidence 4688999999886 3589999999997 445667777765 456788877653
|
| >2dm0_A Tyrosine-protein kinase TXK; TEC family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.07 E-value=0.2 Score=46.19 Aligned_cols=56 Identities=11% Similarity=0.150 Sum_probs=41.9
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCC-CccCCCccccccccc
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHD-EISGGRSALYNLSRD 459 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~~~~rs~~~~l~r~ 459 (782)
.+.|+|.+++..|...+ .+|+|++|.|+ ..+.|.+++...+ ...+++.+||.+.+.
T Consensus 20 hG~isR~eAe~lL~~~~-~~G~FLVR~S~-----~~g~y~LSv~~~~~~~~~~~v~H~~I~~~ 76 (125)
T 2dm0_A 20 HRNITRNQAEHLLRQES-KEGAFIVRDSR-----HLGSYTISVFMGARRSTEAAIKHYQIKKN 76 (125)
T ss_dssp CCSCCHHHHHHHHHHHC-STTCBCEEEET-----TEEEEEEEEECCCSSSSSCCEEEEEEEEC
T ss_pred cCCCCHHHHHHHHhhcC-CCCEEEEEecC-----CCCCEEEEEEeccccCCCCcEEEEEEEEc
Confidence 35688999999776654 88999999994 1567888887654 334678889988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 782 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-78 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-71 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-70 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-68 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-68 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-66 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-65 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-65 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-64 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-63 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-62 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-61 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-59 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-59 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-58 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-56 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-55 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-53 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-52 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-51 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-51 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (641), Expect = 4e-78
Identities = 84/271 (30%), Positives = 148/271 (54%), Gaps = 17/271 (6%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILS 576
++W I ++TVG R+G G FG V++G W+G DVA+K+ T + ++ F NE+ +L
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 577 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
+ RH N++LF+G T P L+++T++ E SLYH +H + K + + + R +G
Sbjct: 60 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 116
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS--AGTPEWMAPE 694
+ +H I+HRDLKS N +++ TVKI DFGL+ + + +G+ WMAPE
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 695 LIRNE---PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-- 749
+IR + P++ + D+++ G++++EL T P+ + + + G
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 750 -----LGRLIADCWA-EPQERPSCEEILSRL 774
+ RL+A+C + ERP +IL+ +
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 2e-72
Identities = 73/261 (27%), Positives = 130/261 (49%), Gaps = 13/261 (4%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 578
W ++ EL + +G G FG+V G + G VA+K + F E S++++L
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQL 57
Query: 579 RHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
RH N++ LG + L ++TEYM GSL + G + L LK D+C +
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAM 116
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 697
+ VHRDL + N LV++ K+ DFGL++ + + + +W APE +R
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALR 173
Query: 698 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 754
+ F+ K D++S G+++WE+ + R +P + V +G +++ P+G + ++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 233
Query: 755 ADCWA-EPQERPSCEEILSRL 774
+CW + RPS ++ +L
Sbjct: 234 KNCWHLDAAMRPSFLQLREQL 254
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 8e-71
Identities = 82/264 (31%), Positives = 131/264 (49%), Gaps = 11/264 (4%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISIL 575
+EW + L + R+G G FGEV+ G +N T VA+K + + + F E +++
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLM 62
Query: 576 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
+L+H ++ T+ P +ITEYME GSL + KL+ + L M I
Sbjct: 63 KQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAE 120
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-PMRDSSSAGTPEWMAPE 694
G+ I +HRDL++AN LV+ + KI DFGL+R+I D+ + +W APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 751
I FT K D++S G+++ E+ T R + V G R+ P+ L
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240
Query: 752 RLIADCWA-EPQERPSCEEILSRL 774
+L+ CW P++RP+ + + S L
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 2e-70
Identities = 84/263 (31%), Positives = 133/263 (50%), Gaps = 13/263 (4%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 579
ID +LT +G G FG V G W DVAIK+ + + ++F E ++ L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLS 57
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
H ++ G CTK + +ITEYM G L + +L + + ++ L+M +D+C +
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEY 115
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPEWMAPELIRN 698
+ + +HRDL + NCLVN VK+ DFGLSR + D S W PE++
Sbjct: 116 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 699 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 754
F+ K DI++ GV+MWE+ +L + P+E +A +G RL P + ++
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIM 234
Query: 755 ADCWA-EPQERPSCEEILSRLLD 776
CW + ERP+ + +LS +LD
Sbjct: 235 YSCWHEKADERPTFKILLSNILD 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 2e-68
Identities = 87/267 (32%), Positives = 128/267 (47%), Gaps = 11/267 (4%)
Query: 514 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-VAIKVFLEQDLTAENMEDFCNEI 572
LA + W I L + ++G G FGEV+ G WNGT VAIK + E F E
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEA 63
Query: 573 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 632
++ +LRH ++ ++ P ++TEYM GSL + K + + M
Sbjct: 64 QVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQ 121
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPEWM 691
I G+ + RM VHRDL++AN LV ++ K+ DFGL+R+I D+ +W
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181
Query: 692 APELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG--- 748
APE FT K D++S G+++ EL T R + R V G R+ P
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241
Query: 749 PLGRLIADCWA-EPQERPSCEEILSRL 774
L L+ CW EP+ERP+ E + + L
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 224 bits (572), Expect = 4e-68
Identities = 80/266 (30%), Positives = 139/266 (52%), Gaps = 11/266 (4%)
Query: 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEIS 573
Y++W ++ +++T+ ++G G +GEV+ G+W VA+K +E+F E +
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAA 65
Query: 574 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 633
++ ++HPN++ LG CT+ P +ITE+M G+L + ++++S L M I
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQI 124
Query: 634 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-GTPEWMA 692
+ + + +HRDL + NCLV ++ VK+ DFGLSR++T + A +W A
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 693 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---P 749
PE + F+ K D+++ GV++WE+ T + VY + + R+E PEG
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244
Query: 750 LGRLIADCWA-EPQERPSCEEILSRL 774
+ L+ CW P +RPS EI
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 4e-68
Identities = 77/260 (29%), Positives = 127/260 (48%), Gaps = 11/260 (4%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 579
ID SELT +G G FG V G W N VAIK A + EDF E ++ +L
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLS 58
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
HP ++ G C + + ++ E+ME G L + Q+ + L M D+C G+
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAY 116
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPEWMAPELIRN 698
+ ++HRDL + NCLV ++ +K+ DFG++R + D S+ +W +PE+
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 699 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIA 755
++ K D++S GV+MWE+ + + V + G RL P + +++
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 236
Query: 756 DCWA-EPQERPSCEEILSRL 774
CW P++RP+ +L +L
Sbjct: 237 HCWKERPEDRPAFSRLLRQL 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 2e-66
Identities = 77/297 (25%), Positives = 135/297 (45%), Gaps = 37/297 (12%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFC 569
+W L G +G G FG+V G VA+K+ L++ + E
Sbjct: 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALM 88
Query: 570 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK---------- 618
+E+ ++++L H N++ LGACT + +I EY G L + + +K
Sbjct: 89 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 619 ----------KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 668
L++ L + +G+ + VHRDL + N LV VKICDF
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 669 GLSRIIT--DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWE 725
GL+R I + + ++ +WMAPE + +T K D++S G+++WE+ +L P+
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 726 GVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDCE 778
G+ + Y + G +++ P + ++ CWA + ++RPS + S L C+
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF-LGCQ 324
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 4e-66
Identities = 70/266 (26%), Positives = 124/266 (46%), Gaps = 17/266 (6%)
Query: 520 NIDFSEL-TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILS 576
+++ + + +G G FG+V++ T A KV + E +ED+ EI IL+
Sbjct: 7 DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILA 64
Query: 577 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
HPN++ L A L ++ E+ G++ ++ ++ L+ + + +
Sbjct: 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDA 122
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
L +H KI+HRDLK+ N L +K+ DFG+S T + R S GTP WMAPE++
Sbjct: 123 LNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 182
Query: 697 -----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPEG-- 748
++ P+ K D++SLG+ + E+ + P + P RV+ +A +E L P
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242
Query: 749 -PLGRLIADCWA-EPQERPSCEEILS 772
+ C R + ++L
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 7e-66
Identities = 70/261 (26%), Positives = 119/261 (45%), Gaps = 15/261 (5%)
Query: 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN 582
+ V +G G +G + +G + K +T + +E+++L L+HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 583 VILFLGACTKPP--RLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMC 639
++ + L ++ EY E G L +I ++++ L L+++ + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 640 IHR-----MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694
HR ++HRDLK AN ++ VK+ DFGL+RI+ + GTP +M+PE
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 751
+ + EK DI+SLG +++ELC L P+ + + + G IP L
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDELN 243
Query: 752 RLIADCWA-EPQERPSCEEIL 771
+I + RPS EEIL
Sbjct: 244 EIITRMLNLKDYHRPSVEEIL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 2e-65
Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 16/262 (6%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENM-EDFCNEISI 574
+W ++ + +G +G G FG V+ + +A+KV + L + E+ I
Sbjct: 2 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 59
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
S LRHPN++ G R+ +I EY LG++Y + + K +R + ++
Sbjct: 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELA 116
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694
L H +++HRD+K N L+ +KI DFG S S + GT +++ PE
Sbjct: 117 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPE 174
Query: 695 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 751
+I EK D++SLGV+ +E P+E + ++ P+
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGAR 232
Query: 752 RLIADCWA-EPQERPSCEEILS 772
LI+ P +RP E+L
Sbjct: 233 DLISRLLKHNPSQRPMLREVLE 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-65
Identities = 77/272 (28%), Positives = 126/272 (46%), Gaps = 17/272 (6%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLT-AENMEDFCNEISI 574
I +L + ++G G FG V RG W+ VA+K L+ E M+DF E++
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 575 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
+ L H N+I G PP + M+TE LGSL + + + +
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRYAVQVA 121
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT---DSPMRDSSSAGTPEWM 691
G+ + + +HRDL + N L+ VKI DFGL R + D + W
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 692 APELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG-- 748
APE ++ F+ D + GV +WE+ T + PW G+ ++++ + EG RL PE
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 749 -PLGRLIADCWA-EPQERPSCEEILSRLLDCE 778
+ ++ CWA +P++RP+ + LL+ +
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 6e-65
Identities = 66/267 (24%), Positives = 119/267 (44%), Gaps = 18/267 (6%)
Query: 521 IDFSELTVGTRV-GIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISIL 575
+D LT+ + G G FG V +G + VA+K+ + ++ E +++
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 576 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
+L +P ++ +G C + ++ E ELG L + Q + + + ++++ +
Sbjct: 63 QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSM 118
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS---AGTPEWMA 692
G+ + VHRDL + N L+ KI DFGLS+ + + +W A
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 693 PELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG--- 748
PE I F+ K D++S GV+MWE + + P+ G+ V + G R+ P G
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPR 237
Query: 749 PLGRLIADCWA-EPQERPSCEEILSRL 774
+ L+ CW + + RP + RL
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (548), Expect = 2e-64
Identities = 88/271 (32%), Positives = 132/271 (48%), Gaps = 19/271 (7%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEIS 573
ID S + + +G G FGEV G VAIK L+ T + DF +E S
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEAS 79
Query: 574 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 633
I+ + HPNVI G TK + +ITE+ME GSL + + + + + MLR I
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGI 137
Query: 634 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-----GTP 688
G+ + M VHRDL + N LVN + K+ DFGLSR + D + ++
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE 747
W APE I+ FT D++S G++MWE+ + P+ + + V+ A+ + RL P
Sbjct: 198 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPM 256
Query: 748 G---PLGRLIADCWA-EPQERPSCEEILSRL 774
L +L+ DCW + RP +I++ L
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 3e-64
Identities = 74/278 (26%), Positives = 132/278 (47%), Gaps = 18/278 (6%)
Query: 517 EEWNIDFSELTVG-TRVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNE 571
++ + L + +G G FG V +G++ DVAIKV L+Q + E+ E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMRE 59
Query: 572 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 631
I+ +L +P ++ +G C + ++ E G L+ + G+++++ ++L
Sbjct: 60 AQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLV--GKREEIPVSNVAELLH 116
Query: 632 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRDSSSAGTP 688
+ G+ + VHRDL + N L+ KI DFGLS+ + S+
Sbjct: 117 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 689 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE 747
+W APE I F+ + D++S GV MWE + + P++ + V+ + +G R+E P
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPP 235
Query: 748 G---PLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 781
L L++DCW + ++RP + R+ C YSL
Sbjct: 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 4e-63
Identities = 76/267 (28%), Positives = 119/267 (44%), Gaps = 14/267 (5%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEI 572
++ I + +G +G G FG+V +GI+ + VAIK + + E F E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEA 59
Query: 573 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 632
+ + HP+++ +G T+ P +I E LG L + +K L +
Sbjct: 60 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQ 116
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPEWM 691
+ L + + VHRD+ + N LV+ + VK+ DFGLSR + DS +S +WM
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 692 APELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG--- 748
APE I FT D++ GV MWE+ + V G RL +P
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236
Query: 749 PLGRLIADCWA-EPQERPSCEEILSRL 774
L L+ CWA +P RP E+ ++L
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 211 bits (538), Expect = 5e-63
Identities = 74/272 (27%), Positives = 116/272 (42%), Gaps = 18/272 (6%)
Query: 512 PLLAYEEWNIDFSEL-TVGTRVGIGFFGEVFRGIW--NGTDVAIKVF-LEQDLTAENMED 567
P +A + D +L + +G G FG V+ N VAIK + E +D
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 568 FCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 627
E+ L +LRHPN I + G + ++ EY + L KK L
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIA 118
Query: 628 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT 687
+ +GL +H ++HRD+K+ N L+++ VK+ DFG + I+ + +S GT
Sbjct: 119 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGT 174
Query: 688 PEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE 744
P WMAPE+I + K D++SLG+ EL P + +Y +A S
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
Query: 745 IPEG---PLGRLIADCWA-EPQERPSCEEILS 772
+ C PQ+RP+ E +L
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 7e-63
Identities = 88/269 (32%), Positives = 129/269 (47%), Gaps = 16/269 (5%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTD------VAIKVFLEQDLTAENMEDFCNEI 572
I S +T +G G FGEV++G+ + VAIK L+ T + DF E
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEA 60
Query: 573 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 632
I+ + H N+I G +K + +ITEYME G+L + + + S + + MLR
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRG 118
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA---GTPE 689
I G+ + M VHRDL + N LVN + K+ DFGLSR++ D P +++
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 690 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG- 748
W APE I FT D++S G++MWE+ T L V N+G RL P
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 238
Query: 749 --PLGRLIADCWA-EPQERPSCEEILSRL 774
+ +L+ CW E RP +I+S L
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-62
Identities = 70/253 (27%), Positives = 125/253 (49%), Gaps = 13/253 (5%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
T ++G G G V+ + G +VAI+ Q + E NEI ++ ++PN++
Sbjct: 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNPNIV 80
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
+L + L ++ EY+ GSL ++ + + + + R+ + L +H +
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 704
++HRD+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 705 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA- 759
DI+SLG++ E+ P+ P R +Y +A G+ L+ PE + C
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256
Query: 760 EPQERPSCEEILS 772
+ ++R S +E+L
Sbjct: 257 DVEKRGSAKELLQ 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 2e-62
Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 24/276 (8%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWNGT----DVAIKVFLEQDLTAENMEDFCNEISILS 576
+D++++ +G G FG+V + D AIK +++ + ++ DF E+ +L
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVLC 65
Query: 577 RL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH-------------LSGQKKKLS 622
+L HPN+I LGAC L + EY G+L + + LS
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 623 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682
++ L D+ RG+ + + + +HRDL + N LV +++ KI DFGLSR + ++ +
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVKKT 184
Query: 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 742
WMA E + +T D++S GV++WE+ +L + +Y +G R
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244
Query: 743 LEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
LE P + L+ CW +P ERPS +IL L
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (530), Expect = 7e-62
Identities = 85/294 (28%), Positives = 133/294 (45%), Gaps = 37/294 (12%)
Query: 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDF 568
+ + +G G FG VF+ T VA+K+ L+++ +A+ DF
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADF 63
Query: 569 CNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH--------------- 613
E ++++ +PN++ LG C + ++ EYM G L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 614 ------LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICD 667
S LS +L + R + G+ + K VHRDL + NCLV ++ VKI D
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 668 FGLSRII--TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PW 724
FGLSR I D D + A WM PE I +T + D+++ GV++WE+ + P+
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 725 EGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
G+ E V+Y V + G+ L PE L L+ CW+ P +RPS I L
Sbjct: 244 YGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 1e-61
Identities = 83/288 (28%), Positives = 140/288 (48%), Gaps = 23/288 (7%)
Query: 508 FQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDL 560
F + +EW + ++T+ +G G FG V+ G+ T VAIK + +
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAA 62
Query: 561 TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK-- 618
+ +F NE S++ +V+ LG ++ +I E M G L +
Sbjct: 63 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122
Query: 619 -----KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673
S + ++M +I G+ ++ K VHRDL + NC+V + +TVKI DFG++R
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182
Query: 674 ITDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPE 730
I ++ + WM+PE +++ FT D++S GV++WE+ TL P++G+ E
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242
Query: 731 RVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
+V+ V EG L+ P+ L L+ CW P+ RPS EI+S +
Sbjct: 243 QVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 3e-61
Identities = 76/288 (26%), Positives = 125/288 (43%), Gaps = 31/288 (10%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFC 569
+W + L+ G +G G FG+V VA+K+ L+ E
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALM 74
Query: 570 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH--------------- 613
+E+ +LS L H N++ LGACT +ITEY G L + +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 614 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673
+ + L L + +G+ + +HRDL + N L+ KICDFGL+R
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 674 ITDSPMRDSSS--AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW-EGVLPE 730
I + +WMAPE I N +T + D++S G+ +WEL +L G+ +
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 731 RVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
Y + EG R+ PE + ++ CW +P +RP+ ++I+ +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-61
Identities = 68/266 (25%), Positives = 116/266 (43%), Gaps = 20/266 (7%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRL 578
D L +G G F V++G+ T VA ++ LT + F E +L L
Sbjct: 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65
Query: 579 RHPNVILFLGACTKPPR----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
+HPN++ F + + + ++TE M G+L + + K + + R I
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQIL 122
Query: 635 RGLMCIHRMK--IVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM 691
+GL +H I+HRDLK N + +VKI D GL+ + S + + GTPE+M
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFM 180
Query: 692 APELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-- 749
APE+ + E D+++ G+ M E+ T P+ +Y G + +
Sbjct: 181 APEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 750 --LGRLIADCWA-EPQERPSCEEILS 772
+ +I C ER S +++L+
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 3e-61
Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 22/276 (7%)
Query: 513 LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMED 567
++ + F+E+ +G G FG V+ G D A+K L + +
Sbjct: 21 VIGPSSLIVHFNEV-----IGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ 74
Query: 568 FCNEISILSRLRHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 626
F E I+ HPNV+ LG C + ++ YM+ G L + I + + +
Sbjct: 75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDL 132
Query: 627 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM----RDS 682
+ + +G+ + K VHRDL + NC++++ +TVK+ DFGL+R + D +
Sbjct: 133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192
Query: 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 742
+ +WMA E ++ + FT K D++S GV++WEL T P + + +G R
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 252
Query: 743 LEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
L PE PL ++ CW + + RPS E++SR+
Sbjct: 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-60
Identities = 79/286 (27%), Positives = 139/286 (48%), Gaps = 30/286 (10%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---------VAIKVFLEQDLTAENMEDF 568
W + L +G +G G FG+V G D VA+K+ L+ D T +++ D
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDL 65
Query: 569 CNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH-------------L 614
+E+ ++ + +H N+I LGACT+ L +I EY G+L +
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 615 SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674
+++LS + + + RG+ + K +HRDL + N LV + +KI DFGL+R I
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 675 TDSPMRDSSSA--GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV 732
++ +WMAPE + + +T + D++S GV++WE+ TL +P
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 733 VYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
++ + EG R++ P L ++ DCW P +RP+ ++++ L
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 7e-60
Identities = 59/256 (23%), Positives = 106/256 (41%), Gaps = 14/256 (5%)
Query: 527 TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+ +G G +GEV + T+ VA+K+ ++ + E+ EI I L H NV+
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
F G + + EY G L+ I + + + G++ +H +
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSSSAGTPEWMAPELIRNEPF- 701
I HRD+K N L+++ +KI DFGL+ + + + GT ++APEL++ F
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 702 TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLG----RLIADC 757
E D++S G+++ + PW+ Y+ E P + L+
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 243
Query: 758 WA-EPQERPSCEEILS 772
P R + +I
Sbjct: 244 LVENPSARITIPDIKK 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-59
Identities = 62/250 (24%), Positives = 116/250 (46%), Gaps = 14/250 (5%)
Query: 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 579
DF +++ +G G G VF+ +G +A K+ + ++ E+ +L
Sbjct: 7 DFEKISE---LGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHECN 62
Query: 580 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
P ++ F GA +S+ E+M+ GSL ++ + ++ + K+ + +GL
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTY 119
Query: 640 IH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 698
+ + KI+HRD+K +N LVN +K+CDFG+S + DS +S GT +M+PE ++
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQG 177
Query: 699 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV--VYAVANEGSRLEIPEGPLGRLIAD 756
++ + DI+S+G+ + E+ P + + ++ EG E P P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 757 CWAEPQERPS 766
RP
Sbjct: 238 SSYGMDSRPP 247
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-59
Identities = 57/257 (22%), Positives = 105/257 (40%), Gaps = 14/257 (5%)
Query: 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHP 581
+ G +G G F V + AIK+ ++ + EN + E ++SRL HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 582 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 641
+ +L Y + G L I + +I L +H
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125
Query: 642 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT--DSPMRDSSSAGTPEWMAPELIRNE 699
I+HRDLK N L+N+ ++I DFG +++++ R +S GT ++++PEL+ +
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 700 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIAD 756
+ D+++LG I+++L P+ + + + PE L+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARDLVEK 243
Query: 757 CWA-EPQERPSCEEILS 772
+ +R CEE+
Sbjct: 244 LLVLDATKRLGCEEMEG 260
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 200 bits (509), Expect = 2e-58
Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 15/256 (5%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+ +G G FG V R G + A K + + E EI +S LRHP ++
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLV 86
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
A + MI E+M G L+ + + K+S ++ +R +C+GL +H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 645 IVHRDLKSANCLVNKHW--TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 702
VH DLK N + +K+ DFGL+ + ++ GT E+ APE+ +P
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVAEGKPVG 203
Query: 703 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LGRLIADC 757
D++S+GV+ + L + P+ G + + V + ++ I
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 263
Query: 758 WA-EPQERPSCEEILS 772
+P R + + L
Sbjct: 264 LLADPNTRMTIHQALE 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 7e-58
Identities = 68/265 (25%), Positives = 122/265 (46%), Gaps = 19/265 (7%)
Query: 522 DFSELTVGTRVGIGFFGEVFRGIWNGTD------VAIKVFLEQDLTAENMEDFCNEISIL 575
+F ++ V +G G FG V++G+W VAIK L + + + ++ +E ++
Sbjct: 10 EFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEAYVM 65
Query: 576 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
+ + +P+V LG C + +IT+ M G L + K + + L I +
Sbjct: 66 ASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAK 122
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSSSAGTPEWMAP 693
G+ + ++VHRDL + N LV VKI DFGL++++ + +WMA
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 694 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PL 750
E I + +T + D++S GV +WEL T +P + ++ +G RL P +
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242
Query: 751 GRLIADCWA-EPQERPSCEEILSRL 774
++ CW + RP E++
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 197 bits (503), Expect = 2e-57
Identities = 63/256 (24%), Positives = 107/256 (41%), Gaps = 15/256 (5%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+ +G G FG V R + G K + NEISI+++L HP +I
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLI 89
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
A + +I E++ G L+ I + K+S + +R C GL +H
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 645 IVHRDLKSANCLV--NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 702
IVH D+K N + K +VKI DFGL+ + + ++ T E+ APE++ EP
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDREPVG 206
Query: 703 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LGRLIADC 757
D++++GV+ + L + P+ G + V + I +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266
Query: 758 WA-EPQERPSCEEILS 772
EP++R + + L
Sbjct: 267 LQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (493), Expect = 1e-56
Identities = 63/257 (24%), Positives = 116/257 (45%), Gaps = 16/257 (6%)
Query: 527 TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+G G F EV T VAIK ++ L + NEI++L +++HPN++
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHPNIV 70
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
L +I + + G L+ I +K + R +++ + + +H +
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 645 IVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPF 701
IVHRDLK N L ++ + I DFGLS++ + S++ GTP ++APE++ +P+
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL-STACGTPGYVAPEVLAQKPY 186
Query: 702 TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LGRLIAD 756
++ D +S+GVI + L P+ ++ + + P I
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246
Query: 757 CWA-EPQERPSCEEILS 772
+P++R +CE+ L
Sbjct: 247 LMEKDPEKRFTCEQALQ 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 5e-56
Identities = 85/287 (29%), Positives = 137/287 (47%), Gaps = 30/287 (10%)
Query: 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFC 569
+W L +G +G G FG+V G D VA+K+ L++ T
Sbjct: 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRALM 64
Query: 570 NEISILSR-LRHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQ---------- 617
+E+ IL H NV+ LGACTKP L +I E+ + G+L +
Sbjct: 65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 618 ---KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674
K L+ + + +G+ + K +HRDL + N L+++ VKICDFGL+R I
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184
Query: 675 TDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPER 731
P +R + +WMAPE I + +T + D++S GV++WE+ +L P+ GV +
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244
Query: 732 VVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 774
EG+R+ P+ + + + DCW EP +RP+ E++ L
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 6e-56
Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 53/296 (17%)
Query: 525 ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+ + +G G FGEV+RG W G +VA+K+F ++ + E EI LRH N++
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENIL 60
Query: 585 LFLGACTKP----PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
F+ A K +L ++++Y E GSL+ ++ + ++ +K+ GL +
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHL 116
Query: 641 H--------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP----MRDSSSAGTP 688
H + I HRDLKS N LV K+ T I D GL+ + + + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 689 EWMAPELIRNE------PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY-------- 734
+MAPE++ + ++ DI+++G++ WE+ ++ Y
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 735 -------AVANEGSRLEIPEGP--------LGRLIADCWA-EPQERPSCEEILSRL 774
V + R IP + +++ +CW R + I L
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-55
Identities = 52/259 (20%), Positives = 105/259 (40%), Gaps = 16/259 (6%)
Query: 523 FSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRH 580
+ + + +G G FG V R + + K + + EISIL+ RH
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARH 60
Query: 581 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
N++ + L MI E++ ++ I+ S +L+ R + + +C L +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFL 118
Query: 641 HRMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 698
H I H D++ N + + T+KI +FG +R + PE+ APE+ ++
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-RLLFTAPEYYAPEVHQH 177
Query: 699 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LGRL 753
+ + D++SLG +++ L + P+ ++++ + N +
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 754 IADCWA-EPQERPSCEEIL 771
+ E + R + E L
Sbjct: 238 VDRLLVKERKSRMTASEAL 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 188 bits (478), Expect = 6e-55
Identities = 63/272 (23%), Positives = 116/272 (42%), Gaps = 26/272 (9%)
Query: 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVF-------LEQDLTAENMEDFCNEIS 573
+ +G G V R I + A+K+ + E E E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 574 ILSRLR-HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 632
IL ++ HPN+I ++ + M+ G L+ + +K LS + K++R
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRA 118
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMA 692
+ + +H++ IVHRDLK N L++ +K+ DFG S + GTP ++A
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYLA 177
Query: 693 PELIRNEP------FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 746
PE+I + ++ D++S GVIM+ L + P+ ++ + + + P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 747 EGP-----LGRLIADCWA-EPQERPSCEEILS 772
E + L++ +PQ+R + EE L+
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-53
Identities = 62/255 (24%), Positives = 111/255 (43%), Gaps = 13/255 (5%)
Query: 525 ELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSR-LRH 580
+ + +G G FG+VF + T+ AIK + L +++E E +LS H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 581 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
P + L + EY+ G L + I K R +I GL +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL 119
Query: 641 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 700
H IV+RDLK N L++K +KI DFG+ + + ++ GTP+++APE++ +
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 701 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADC 757
+ D +S GV+++E+ P+ G E + +++ + P L+
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKL 237
Query: 758 WA-EPQERPSCEEIL 771
+ EP++R +
Sbjct: 238 FVREPEKRLGVRGDI 252
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 183 bits (464), Expect = 7e-53
Identities = 64/266 (24%), Positives = 119/266 (44%), Gaps = 20/266 (7%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENM-EDFCNEISILSRLRHPNV 583
+G +G G EV DVA+KV + F E + L HP +
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 584 ILFLGAC----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 639
+ P ++ EY++ +L ++H + ++ +R ++++ D C+ L
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNF 126
Query: 640 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP---MRDSSSAGTPEWMAPELI 696
H+ I+HRD+K AN +++ VK+ DFG++R I DS + ++ GT ++++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LG 751
R + + D++SLG +++E+ T P+ G P V Y E L
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246
Query: 752 RLIADCWA-EPQERP-SCEEILSRLL 775
++ A P+ R + E+ + L+
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-52
Identities = 66/262 (25%), Positives = 113/262 (43%), Gaps = 20/262 (7%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN----MEDFCNEISILSRLRH 580
G +G G F V + G A K ++ + ED E+SIL ++H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 581 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
PNVI + +I E + G L+ + +K+ L+ + L+ I G+ +
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYL 129
Query: 641 HRMKIVHRDLKSANCLVNKHWT----VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 696
H ++I H DLK N ++ +KI DFGL+ I D + GTPE++APE++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKNIFGTPEFVAPEIV 188
Query: 697 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LG 751
EP + D++S+GVI + L + P+ G + + V+ E
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 752 RLIADCWA-EPQERPSCEEILS 772
I +P++R + ++ L
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 179 bits (455), Expect = 4e-51
Identities = 60/266 (22%), Positives = 122/266 (45%), Gaps = 22/266 (8%)
Query: 519 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISIL 575
+++ + + +G G FG V NG A+KV ++ + +E +E +L
Sbjct: 1 YSLQ--DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 58
Query: 576 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
S + HP +I G ++ MI +Y+E G L+ L+ + ++ ++C
Sbjct: 59 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCL 115
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
L +H I++RDLK N L++K+ +KI DFG ++ + D + GTP+++APE+
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEV 172
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGR 752
+ +P+ + D +S G++++E+ P+ + + N L P +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKD 230
Query: 753 LIADCWA-EPQER-----PSCEEILS 772
L++ + +R E++ +
Sbjct: 231 LLSRLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 7e-51
Identities = 60/264 (22%), Positives = 114/264 (43%), Gaps = 17/264 (6%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISILSR 577
+ ++ +G G FG+V G A+K+ ++ + A++ + E +L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 578 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 637
RHP + A RL + EY G L+ + +++ + R +I L
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSAL 118
Query: 638 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 697
+H +V+RD+K N +++K +KI DFGL + + GTPE++APE++
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 698 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 754
+ + D + LGV+M+E+ P+ ER+ + E + P L+
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLL 236
Query: 755 ADCWA-EPQERPSC-----EEILS 772
A +P++R +E++
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVME 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 8e-48
Identities = 54/261 (20%), Positives = 108/261 (41%), Gaps = 29/261 (11%)
Query: 532 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 588
+G+G G+V + A+K+ ++ E+ + R + P+++ +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 72
Query: 589 AC----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
L ++ E ++ G L+ I G + + R ++++ I + +H +
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 645 IVHRDLKSANCLVNKHW---TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPF 701
I HRD+K N L +K+ DFG ++ T ++ TP ++APE++ E +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKY 190
Query: 702 TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--GSRLEIPEGPLGR------- 752
+ CD++SLGVIM+ L P+ + + + E P
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 250
Query: 753 LIADCWA-EPQERPSCEEILS 772
LI + EP +R + E ++
Sbjct: 251 LIRNLLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 9e-48
Identities = 59/260 (22%), Positives = 107/260 (41%), Gaps = 26/260 (10%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLR- 579
VG +G G FG V+ GI + VAIK + ++ N E+ +L ++
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 580 -HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
VI L +P +I E E L ++ L + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQD--LFDFITERGALQEELARSFFWQVLEAVR 124
Query: 639 CIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 697
H ++HRD+K N L++ + +K+ DFG ++ D+ + GT + PE IR
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIR 182
Query: 698 NEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 753
+ ++SLG++++++ + P+E E ++ ++ + L
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRG------QVFFRQRVSSECQHL 234
Query: 754 IADCWA-EPQERPSCEEILS 772
I C A P +RP+ EEI +
Sbjct: 235 IRWCLALRPSDRPTFEEIQN 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (428), Expect = 5e-47
Identities = 64/263 (24%), Positives = 112/263 (42%), Gaps = 22/263 (8%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFC----NEISILSRLRH 580
+V +G G FGEV+ G A+K ++ + + E +S++S
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 581 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 640
P ++ A P +LS I + M G L++ + Q S +I GL +
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHM 123
Query: 641 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE-LIRNE 699
H +V+RDLK AN L+++H V+I D GL+ + + +S GT +MAPE L +
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGV 181
Query: 700 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIA 755
+ D FSLG ++++L + P+ + + +E+P+ L L+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 756 DCWA-EPQERPSC-----EEILS 772
+ R C +E+
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKE 264
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 161 bits (409), Expect = 2e-45
Identities = 55/279 (19%), Positives = 101/279 (36%), Gaps = 36/279 (12%)
Query: 527 TVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 585
++G G +G V++ N G A+K + EISIL L+H N++
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 586 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 645
RL ++ E+++ L + L L + G+ H ++
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 646 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEK 704
+HRDLK N L+N+ +KI DFGL+R + + T + AP+++ ++
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 705 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR------------ 752
DI+S+G I E+ + GV + + P
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 753 ------------------LIADCWA-EPQERPSCEEILS 772
L++ +P +R + ++ L
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 2e-44
Identities = 49/274 (17%), Positives = 96/274 (35%), Gaps = 30/274 (10%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+G ++G G FG+++ G G +VAIK+ + E I ++ I
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGI 65
Query: 585 LFLGAC-TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 643
+ C + M+ E + +K S + L + + + IH
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 644 KIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDSP-------MRDSSSAGTPEWMAP 693
+HRD+K N L+ K V I DFGL++ D+ + + GT + +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 694 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN-EGSRLEIPEGPLGR 752
+ + D+ SLG ++ + PW+G+ ++ P L +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 753 --------LIADCWA-EPQERPSCEEILSRLLDC 777
+ C + ++P + +
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 2e-44
Identities = 58/276 (21%), Positives = 101/276 (36%), Gaps = 39/276 (14%)
Query: 532 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAEN---MEDFCNEISILSRLRHPNVILF 586
+G G F V++ T+ VAIK + EI +L L HPN+I
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 587 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 646
L A +S++ ++ME + L+ + +GL +H+ I+
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 647 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKC 705
HRDLK N L++++ +K+ DFGL++ + T + APEL+ +
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 706 DIFSLGVIMWELCTLNRPWEGVLPERVVYAV------------------ANEGSRLEIPE 747
D++++G I+ EL G + + + + P
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 748 GPLGR-----------LIADCWA-EPQERPSCEEIL 771
PL LI + P R + + L
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 159 bits (402), Expect = 3e-44
Identities = 49/275 (17%), Positives = 93/275 (33%), Gaps = 30/275 (10%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
VG R+G G FG +F G N VAIK + + +E L I
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGI 63
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
+ + +++ + SL L+ L G +K S + + + + IH
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 645 IVHRDLKSANCLVNKHWT-----VKICDFGLSRIITDSP-------MRDSSSAGTPEWMA 692
+V+RD+K N L+ + + + + DFG+ + D + +GT +M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 693 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG------SRLEIP 746
+ + D+ +LG + + PW+G+ G E+
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 747 EG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 777
G + + P + +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 6e-44
Identities = 66/295 (22%), Positives = 120/295 (40%), Gaps = 52/295 (17%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
++G G FGEVF+ G VA+K L ++ EI IL L+H NV+
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 585 LFLGACTKPP--------RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 636
+ C + ++ ++ E L + K + ++++ + G
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNG 129
Query: 637 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS----PMRDSSSAGTPEWMA 692
L IHR KI+HRD+K+AN L+ + +K+ DFGL+R + + P R ++ T +
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 693 PELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN------------- 738
PEL+ E + D++ G IM E+ T + +G + + ++
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 739 ----EGSRLEIPEGPLGR----------------LIADCWA-EPQERPSCEEILS 772
+LE+ +G + LI +P +R ++ L+
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 57/280 (20%), Positives = 101/280 (36%), Gaps = 36/280 (12%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
++G G +G V++ G VA+K T EIS+L L HPN++
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
L +L ++ E++ + + L + +GL H +
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP-FTE 703
++HRDLK N L+N +K+ DFGL+R + T + APE++ ++
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 704 KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR----------- 752
DI+SLG I E+ T + G ++ + + P
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 753 -------------------LIADCWA-EPQERPSCEEILS 772
L++ +P +R S + L+
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (399), Expect = 3e-43
Identities = 62/309 (20%), Positives = 129/309 (41%), Gaps = 36/309 (11%)
Query: 478 SHGSERGGSSGYMANS--EFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIG 535
GSE+ ++A + +F+ W E+P L ++ +G G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKW----ETPSQNTAQLDQFD----------RIKTLGTG 52
Query: 536 FFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLGACTK 592
FG V +G A+K+ +Q + +E NE IL + P ++ +
Sbjct: 53 SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112
Query: 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 652
L M+ EY+ G ++ + + + S I +H + +++RDLK
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 653 ANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGV 712
N L+++ +++ DFG ++ + R + GTPE +APE+I ++ + + D ++LGV
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 713 IMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQER---- 764
+++E+ P+ P ++ + + ++ P L L+ + + +R
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNL 284
Query: 765 -PSCEEILS 772
+I +
Sbjct: 285 KNGVNDIKN 293
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 5e-43
Identities = 63/286 (22%), Positives = 108/286 (37%), Gaps = 43/286 (15%)
Query: 527 TVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RH 580
+G G +G+VF+ G VA+K Q E+++L L H
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 581 PNVILFLGACTKPP-----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 635
PNV+ CT +L+++ E+++ +L + + + M+ + R
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLR 127
Query: 636 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 695
GL +H ++VHRDLK N LV +K+ DFGL+RI + M +S T + APE+
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-QMALTSVVVTLWYRAPEV 186
Query: 696 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR--- 752
+ + D++S+G I E+ + G + + + + P
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 753 -------------------------LIADCWA-EPQERPSCEEILS 772
L+ C P +R S LS
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-42
Identities = 69/285 (24%), Positives = 107/285 (37%), Gaps = 40/285 (14%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
T + +G G +G V N VAIK + + EI IL R RH N+I
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
P M Y+ + ++ + + LS L I RGL IH
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 129
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIIT---DSPMRDSSSAGTPEWMAPELIRNE-P 700
++HRDLK +N L+N +KICDFGL+R+ D + T + APE++ N
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 701 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN---------------------E 739
+T+ DI+S+G I+ E+ + + G + +
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 740 GSRLEIPEGPLGR-----------LIADCWA-EPQERPSCEEILS 772
S + P R L+ P +R E+ L+
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 6e-42
Identities = 54/292 (18%), Positives = 99/292 (33%), Gaps = 49/292 (16%)
Query: 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 578
+ +++ V +G G FG V++ +G VAIK L+ + E+ I+ +L
Sbjct: 20 VSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKL 70
Query: 579 RHPNVILFLGACTKP------PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 632
H N++ L+++ +Y+ H S K+ L +
Sbjct: 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 633 ICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDSPMRDSSSAGTPEWM 691
+ R L IH I HRD+K N L++ +K+CDFG ++ + S
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190
Query: 692 APELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV--------------- 736
+ +T D++S G ++ EL + G + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 737 ---ANEGSRLEIPEGPLGR------------LIADCWA-EPQERPSCEEILS 772
E +I P + L + P R + E +
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 7e-41
Identities = 57/281 (20%), Positives = 99/281 (35%), Gaps = 38/281 (13%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
++G G +G VF+ VA+K D EI +L L+H N++
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
+L+++ E+ + + +G L + +GL H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCHSRN 121
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP-FTE 703
++HRDLK N L+N++ +K+ +FGL+R S+ T + P+++ ++
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 704 KCDIFSLGVIMWELCTLNRPW----------------EGVLPERVVYAVANEGSRLEIPE 747
D++S G I EL RP G E ++ P
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 748 GPLGR---------------LIADCWA-EPQERPSCEEILS 772
P L+ + P +R S EE L
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-40
Identities = 63/268 (23%), Positives = 117/268 (43%), Gaps = 25/268 (9%)
Query: 527 TVGTRVGIGFFGEVFRGI-----WNGTDVAIKVFLEQDLT--AENMEDFCNEISILSRLR 579
+ +G G +G+VF G A+KV + + A+ E E +L +R
Sbjct: 27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86
Query: 580 H-PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 638
P ++ A +L +I +Y+ G L+ + Q+++ + + +I L
Sbjct: 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALE 143
Query: 639 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS-SSAGTPEWMAPELIR 697
+H++ I++RD+K N L++ + V + DFGLS+ + GT E+MAP+++R
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 698 --NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----L 750
+ + D +SLGV+M+EL T P+ + ++ + E P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263
Query: 751 GRLIADCWA-EPQERPSC-----EEILS 772
LI +P++R C +EI
Sbjct: 264 KDLIQRLLMKDPKKRLGCGPRDADEIKE 291
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-37
Identities = 66/292 (22%), Positives = 111/292 (38%), Gaps = 41/292 (14%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISIL 575
W + + VG G +G V + G VAIK + + E+ +L
Sbjct: 13 AWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 576 SRLRHPNVILFLGACTKPPRLSMITE-YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 634
+RH NVI L T L T+ Y+ + + + + +KL R ++ +
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 131
Query: 635 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 694
+GL IH I+HRDLK N VN+ +KI DFGL+R + T + APE
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPE 188
Query: 695 LIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG------------- 740
+I N +T+ DI+S+G IM E+ T ++G + +
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 741 --------SRLEIPEGPLGRLIADCWAE------------PQERPSCEEILS 772
E+ + ++ + ++R + E L+
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-37
Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 3/202 (1%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+G G G V +VAIK + + E+ ++ + H N+I
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 585 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 644
L T L + + L + +L R +L + G+ +H
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 645 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 704
I+HRDLK +N +V T+KI DFGL+R S M + T + APE+I + E
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKEN 198
Query: 705 CDIFSLGVIMWELCTLNRPWEG 726
DI+S+G IM E+ + G
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPG 220
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 138 bits (347), Expect = 2e-36
Identities = 47/226 (20%), Positives = 95/226 (42%), Gaps = 22/226 (9%)
Query: 509 QNKPLLAYEEWNIDFS---ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE 563
+ + YE +++ + + ++G G + EVF I N V +K+ L
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI-----LKPV 71
Query: 564 NMEDFCNEISILSRLR-HPNVILFLGACTKPP--RLSMITEYMELGSLYHLIHLSGQKKK 620
+ EI IL LR PN+I P +++ E++ L +
Sbjct: 72 KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QT 125
Query: 621 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV-NKHWTVKICDFGLSRIITDSPM 679
L+ + +I + L H M I+HRD+K N ++ ++H +++ D+GL+
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-Q 184
Query: 680 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPW 724
+ + + PEL+ + + + D++SLG ++ + P+
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 7e-36
Identities = 64/296 (21%), Positives = 110/296 (37%), Gaps = 49/296 (16%)
Query: 518 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISIL 575
W + + VG G +G V G VA+K + + + E+ +L
Sbjct: 13 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 576 SRLRHPNVILFLGACTKPPRLS-----MITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 630
++H NVI L T L + ++ L +++ +KL+ ++
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLI 127
Query: 631 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 690
I RGL IH I+HRDLK +N VN+ +KI DFGL+R + T +
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWY 184
Query: 691 MAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG--------- 740
APE++ N + + DI+S+G IM EL T + G + +
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 741 ------------SRLEIPEGPLGR-----------LIADCWA-EPQERPSCEEILS 772
S ++P+ L+ + +R + + L+
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (270), Expect = 4e-26
Identities = 45/222 (20%), Positives = 84/222 (37%), Gaps = 28/222 (12%)
Query: 527 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 584
+ ++G G F V+ N T VA+K+ + E ED EI +L R+ +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNT 72
Query: 585 LFLGACTK-------------PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 631
P + ++ + LG + + + + ++ +
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 632 DICRGLM-CIHRMKIVHRDLKSANCLVN------KHWTVKICDFGLSRIITDSPMRDSSS 684
+ GL R I+H D+K N L+ +KI D G + + S
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN---S 189
Query: 685 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 726
T E+ +PE++ P+ DI+S +++EL T + +E
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.1 bits (215), Expect = 3e-20
Identities = 26/169 (15%), Positives = 51/169 (30%), Gaps = 33/169 (19%)
Query: 528 VGTRVGIGFFGEVFRGI-WNGTDVAIKVF----------------LEQDLTAENMEDFCN 570
+G +G G VF + +K + + + N
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 571 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 630
E L +L+ V +++ E ++ + + ++ ++L
Sbjct: 64 EFRALQKLQGLAVPKVYAWE----GNAVLMELID----------AKELYRVRVENPDEVL 109
Query: 631 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679
I + + IVH DL N LV++ + I DF S
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSV-EVGEEG 156
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 782 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.21 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.51 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.45 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.28 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.76 | |
| d1g83a2 | 104 | Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: | 94.71 | |
| d1qcfa2 | 103 | Hemopoetic cell kinase Hck {Human (Homo sapiens) [ | 94.35 | |
| d1lkka_ | 105 | p56-lck tyrosine kinase {Human (Homo sapiens) [Tax | 94.21 | |
| d1blja_ | 114 | P55 Blk protein tyrosine kinase {Mouse (Mus muscul | 94.0 | |
| d1o48a_ | 106 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 93.55 | |
| d1rjaa_ | 100 | Tyrosine-protein kinase 6 (Breast tumor kinase, Br | 92.73 | |
| d1nrva_ | 105 | Growth factor receptor-bound protein 10, GRB10 {Hu | 90.2 | |
| d1a81a1 | 129 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 89.88 | |
| d2qmsa1 | 113 | Growth factor receptor-bound protein 7 {Human (Hom | 88.85 | |
| d2oq1a1 | 130 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 88.66 | |
| d1i3za_ | 103 | Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus | 85.87 | |
| d1rpya_ | 86 | Adaptor protein Aps {Rat (Rattus norvegicus) [TaxI | 85.3 | |
| d1jyra_ | 96 | Growth factor receptor-bound protein 2 (GRB2) {Hum | 84.73 | |
| d1r1qa_ | 97 | GRB2-related adaptor protein 2 (MONA, GRID) {Mouse | 81.84 | |
| d2oq1a2 | 124 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 81.73 | |
| d1luia_ | 108 | Itk/tsk protein tyrosine kinase {Mouse (Mus muscul | 80.96 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=437.36 Aligned_cols=261 Identities=33% Similarity=0.640 Sum_probs=221.4
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
++|+++.++|.++++||+|+||+||+|++++ .||||++..........+.|.+|+.+|++++|||||++++++.+ +.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 4789999999999999999999999998766 59999998776666778899999999999999999999998765 568
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+|+....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEEEECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999999999863 345799999999999999999999999999999999999999999999999999987653
Q ss_pred CC--CCCCCCCCCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----CC-
Q 003971 677 SP--MRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IP- 746 (782)
Q Consensus 677 ~~--~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~----ip- 746 (782)
.. .......||+.|+|||++.+ .+|+.++|||||||++|||+||+.||.+.............+...+ ++
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 236 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccc
Confidence 22 22345689999999999864 3589999999999999999999999998877766666655544332 22
Q ss_pred --ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003971 747 --EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 781 (782)
Q Consensus 747 --~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~sL 781 (782)
+..+.+|+.+||. ||.+|||+.+|+++|+.+..++
T Consensus 237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 2469999999999 9999999999999999886543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-51 Score=431.20 Aligned_cols=260 Identities=30% Similarity=0.642 Sum_probs=224.6
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC
Q 003971 515 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 592 (782)
Q Consensus 515 ~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 592 (782)
.+++|+++.++|++.++||+|+||+||+|.+ +++.||||++..... ..++|.+|+.+|++++|||||+++++|.+
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 4678999999999999999999999999988 488999999865443 24679999999999999999999999999
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
.+.++++|||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred CCeeEEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccccee
Confidence 99999999999999999998632 35678999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC-CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---h
Q 003971 673 IITDSPMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---G 748 (782)
Q Consensus 673 ~l~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~---~ 748 (782)
........ .....||+.|+|||++.+..|+.++|||||||++|||++|..||...............+.++..|. .
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 243 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 243 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchH
Confidence 77544322 2334588999999999999999999999999999999998776554444444555556666666654 4
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
.+.+|+.+||. ||.+|||+.+|++.|+.+.
T Consensus 244 ~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 69999999999 9999999999999998763
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=422.46 Aligned_cols=258 Identities=33% Similarity=0.586 Sum_probs=220.8
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
.++|+++.++|++.++||+|+||+||+|.++ ++.||||++...... .+.|.+|+.++++++|||||++++++.+ +
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 4779999999999999999999999999985 678999998754433 3679999999999999999999998865 4
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+++||||+++|+|.+++... ....+++..++.++.||+.||.|||+++|+||||||+||||++++.+||+|||+|+.+
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CeEEEEEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence 579999999999999877532 2346899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCC-CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHhcCCCCCCCC---hH
Q 003971 675 TDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GP 749 (782)
Q Consensus 675 ~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~-PF~~~~~~evl~~i~~~~~~~~ip~---~~ 749 (782)
..... ......||+.|+|||++.+..++.++|||||||++|||+||.. ||......+....+. .+.++..|. ..
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEE 238 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHH
Confidence 54332 2345679999999999999999999999999999999999655 556666666655554 455555553 46
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 750 LGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 750 L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+.+|+.+||. ||.+|||+.+|++.|+++..
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 9999999999 99999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-51 Score=425.86 Aligned_cols=249 Identities=28% Similarity=0.470 Sum_probs=208.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC--CCceEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRLSMI 599 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~l~LV 599 (782)
++|++.+.||+|+||+||+|.+ +|+.||||++..........+.|.+|++++++++|||||++++++.+ ...+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6899999999999999999987 58899999998877777777889999999999999999999999864 4568999
Q ss_pred EEEecccchhhHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcc-----ccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 600 TEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMK-----IVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g-----IIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986432 3457999999999999999999999976 99999999999999999999999999998
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 750 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L 750 (782)
+..........+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+..++...+..... ..+| +..+
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~l 242 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-RRIPYRYSDEL 242 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCCTTSCHHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCcccCHHH
Confidence 76554445567899999999999999999999999999999999999999999988888777765443 3333 3479
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 751 GRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 751 ~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+|+.+||. ||.+|||+.|+++|
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCChhHCcCHHHHHhC
Confidence 999999999 99999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=418.60 Aligned_cols=253 Identities=31% Similarity=0.633 Sum_probs=209.4
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
++.++|+++++||+|+||+||+|.+ +++.||||++...... .++|.+|+.++++++|||||+++|+|.+++.+++|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 3567899999999999999999988 5778999998754433 36799999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+++|+|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~E~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EECCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEecCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999998863 346789999999999999999999999999999999999999999999999999987754432
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003971 680 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 754 (782)
Q Consensus 680 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG-k~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI 754 (782)
......||+.|+|||++.+..|+.++|||||||++|||+|+ +.||......+....+.. +.++..| +..+.+|+
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIM 235 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCCCTTSCHHHHHHH
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHH
Confidence 22346789999999999999999999999999999999995 566777777666666554 4444444 34699999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 755 ADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.+||+ ||.+|||+++|+++|+++..
T Consensus 236 ~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 99999 99999999999999998864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=423.74 Aligned_cols=246 Identities=27% Similarity=0.477 Sum_probs=217.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
.++|++++.||+|+||+||+|.+ +++.||+|++.+.... ....+.+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999988 4789999998754432 22356788999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 85 mEy~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 85 LEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred EeecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence 99999999999987 3457999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHHhh
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIADCW 758 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip~~~L~~LI~~CL 758 (782)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+....... ..-+..+.+|+.+||
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 239 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence 2345689999999999999999999999999999999999999999999888888776654332 222457999999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003971 759 A-EPQERPSCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRPSa~EIL~~ 773 (782)
. ||.+|||+.|+++|
T Consensus 240 ~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 240 KHNPSQRPMLREVLEH 255 (263)
T ss_dssp CSSGGGSCCHHHHHTC
T ss_pred cCCHhHCcCHHHHHcC
Confidence 9 99999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=425.37 Aligned_cols=244 Identities=28% Similarity=0.487 Sum_probs=217.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|++.++||+|+||+||+|.+ +|+.||||++....... .+.+.+|+.+++.++|||||++++++.+.+.+|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 5799999999999999999987 58999999987654432 4678999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|++||+|.+++. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.+.......
T Consensus 98 y~~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 98 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp CCTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred ecCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 999999998875 2468999999999999999999999999999999999999999999999999999876555555
Q ss_pred CCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChHHHHHHHHh
Q 003971 682 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGPLGRLIADC 757 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~-~~ip---~~~L~~LI~~C 757 (782)
...+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+.......+...... ...+ +..+.+|+.+|
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence 6778999999999999999999999999999999999999999998888877777655432 2232 34699999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003971 758 WA-EPQERPSCEEILSR 773 (782)
Q Consensus 758 L~-DP~kRPSa~EIL~~ 773 (782)
|. ||.+|||+.|+++|
T Consensus 254 L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQH 270 (293)
T ss_dssp TCSSTTTSCCHHHHTTC
T ss_pred ccCChhHCcCHHHHhcC
Confidence 99 99999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=421.12 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=206.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|+++++||+|+||+||+|.+ +|+.||||++...... ...+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 6899999999999999999988 5889999998765432 234678999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC--C
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--M 679 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~--~ 679 (782)
|+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+...... .
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999999986 45689999999999999999999999999999999999999999999999999998764322 2
Q ss_pred CCCCCCCCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChHHHHHH
Q 003971 680 RDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGPLGRLI 754 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip----~~~L~~LI 754 (782)
.....+||+.|+|||++.+..+ +.++|||||||++|||+||+.||.....................+ +..+.+|+
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 3356789999999999988876 578999999999999999999997665443333333322222211 34688999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003971 755 ADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+||. ||.+|||+.|+++|
T Consensus 241 ~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHcCCChhHCcCHHHHhcC
Confidence 99999 99999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=411.98 Aligned_cols=250 Identities=33% Similarity=0.621 Sum_probs=220.3
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
+.++|+++++||+|+||+||+|++ +++.||||++...... .++|.+|+.++++++|||||+++|+|.+++.+++||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 457899999999999999999998 4668999999866544 367999999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 679 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~- 679 (782)
||+.+|+|..++.. ....+++..++.++.|+++||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 79 Ey~~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 79 EYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp ECCTTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EccCCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999999988752 345788999999999999999999999999999999999999999999999999987654332
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHH
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIA 755 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~---~~L~~LI~ 755 (782)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+.. +.++..|. ..+.+|+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-CCCCCCcccccHHHHHHHH
Confidence 2234678999999999999999999999999999999998 7999999998887777654 44555553 46999999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHHhh
Q 003971 756 DCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 756 ~CL~-DP~kRPSa~EIL~~L~di 777 (782)
+||+ ||.+|||+.+|+++|.++
T Consensus 236 ~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 236 SCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHccCCHhHCcCHHHHHHHhhCC
Confidence 9999 999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=428.52 Aligned_cols=258 Identities=29% Similarity=0.536 Sum_probs=220.5
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEECC-------eEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEec
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 588 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~g-------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g 588 (782)
..|+++.++|.++++||+|+||+||+|.+.+ ..||+|++..... ......|.+|+.+|.++ +|||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 4588888999999999999999999998732 3689998865432 33346789999999998 8999999999
Q ss_pred cccCCCceEEEEEEecccchhhHHHhhcc--------------------cccchHHHHHHHHHHHHHHHHHHHhcccccc
Q 003971 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQ--------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648 (782)
Q Consensus 589 ~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~--------------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHr 648 (782)
+|.+.+.+|+||||+++|+|.++++.... ...+++..++.++.||+.||+|||++|||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 99999999999999999999999974321 2358999999999999999999999999999
Q ss_pred CCCcccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 003971 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWE 725 (782)
Q Consensus 649 DIKPeNILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~ 725 (782)
||||+|||++.++++||+|||+|+....... ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654322 1234568999999999999999999999999999999998 899999
Q ss_pred CCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003971 726 GVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLL 775 (782)
Q Consensus 726 ~~~~~evl~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~ 775 (782)
+......+..+...+.+++.|. ..+.+||.+||+ ||.+|||++||+++|.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 8887777777887777776664 469999999999 9999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-49 Score=419.08 Aligned_cols=255 Identities=35% Similarity=0.577 Sum_probs=209.6
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEEC--C---eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIWN--G---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~~--g---~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
+++.++|++.+.||+|+||+||+|.+. + ..||||.+.... .....+.|.+|+.+|++++|||||+++|+|.+.+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 355678999999999999999999873 2 258888875433 3455678999999999999999999999999999
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+++||||+++|+|.+++.. ..+.+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 99999999999999998863 3457899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC-----CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC-
Q 003971 675 TDSPMR-----DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE- 747 (782)
Q Consensus 675 ~~~~~~-----~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~- 747 (782)
...... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....++...+.. +.+++.|.
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~ 257 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPPPMD 257 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcc
Confidence 543211 122457899999999999999999999999999999998 8999999998887777654 44444443
Q ss_pred --hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 748 --GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 748 --~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
..+.+|+.+||. ||.+|||+.+|++.|+++.
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 469999999999 9999999999999998864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=422.91 Aligned_cols=246 Identities=27% Similarity=0.451 Sum_probs=213.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
+.|+++++||+|+||+||+|.+ +|+.||||++.... ....+.|.+|+++|+.++|||||++++++.+++.+|+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4689999999999999999988 57899999987543 3345788999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+++|+|.+++.. ....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 90 y~~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 90 FCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred cCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 9999999998763 24579999999999999999999999999999999999999999999999999998664332233
Q ss_pred CCCCCCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC---ChHHHH
Q 003971 682 SSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP---EGPLGR 752 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~ip---~~~L~~ 752 (782)
...+||+.|+|||++. +..|+.++|||||||++|||+||+.||.+.+..+.+..+....... ..+ +..+.+
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 4678999999999984 4568999999999999999999999999998888888777654322 222 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003971 753 LIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
|+.+||+ ||.+|||+.|+++|
T Consensus 248 li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999 99999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=414.49 Aligned_cols=257 Identities=28% Similarity=0.542 Sum_probs=220.3
Q ss_pred ccccCCCeeEeeE-EeeeCcEEEEEEEE----CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 519 WNIDFSELTVGTR-VGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 519 ~~i~~s~y~i~~~-LG~G~fG~VYkg~~----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
+.+..++|.+.+. ||+|+||+||+|.+ ++..||||++... ......+.|.+|+++|++++|||||+++++|.+
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 4556678888884 99999999999976 3457999998654 345557889999999999999999999999875
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
+.+|+||||+++|+|.+++. .....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CeEEEEEEeCCCCcHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence 45899999999999999875 2345799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC---CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC--
Q 003971 674 ITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE-- 747 (782)
Q Consensus 674 l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~-- 747 (782)
+..... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....++...+. .+.++++|.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~ 237 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPEC 237 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTC
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcC
Confidence 754322 2234578999999999999999999999999999999998 899999988877766554 455565554
Q ss_pred -hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 748 -GPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 748 -~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
..+.+|+..||. ||.+|||+.+|++.|+.+.++
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 469999999999 999999999999999987654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=410.21 Aligned_cols=255 Identities=34% Similarity=0.556 Sum_probs=209.9
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEECC------eEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~~g------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
+++.+.|++.+.||+|+||+||+|.+++ ..||||++.... .......|.+|+.++++++|||||+++|+|.+.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 4566889999999999999999997632 369999986543 344567899999999999999999999999999
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
+.++++|||+.++++.+++.. ....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CceEEEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999999987763 346799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC---CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhcCCCCCCCC--
Q 003971 674 ITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP-WEGVLPERVVYAVANEGSRLEIPE-- 747 (782)
Q Consensus 674 l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~P-F~~~~~~evl~~i~~~~~~~~ip~-- 747 (782)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|..| |......++.. .+..+.+++.|.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~-~i~~~~~~~~~~~~ 238 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK-AINDGFRLPTPMDC 238 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HHHTTCCCCCCTTC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH-HHhccCCCCCchhh
Confidence 654321 22345689999999999999999999999999999999997655 55555555544 445566666654
Q ss_pred -hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 748 -GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 748 -~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
..+.+|+.+||. ||.+|||+.+|++.|+.+.
T Consensus 239 ~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 469999999999 9999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=411.86 Aligned_cols=242 Identities=27% Similarity=0.477 Sum_probs=206.8
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC----CCceEEE
Q 003971 526 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPRLSMI 599 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d----~~~l~LV 599 (782)
|++.++||+|+||+||+|.+ +++.||+|++..........+.|.+|+++|++++|||||+++++|.+ ...+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 46778999999999999988 47789999998777666677889999999999999999999999854 3558999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--ccccCCCcccEEEc-CCCeEEEEecCccccccC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVN-KHWTVKICDFGLSRIITD 676 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~g--IIHrDIKPeNILLd-~~g~VKLaDFGLA~~l~~ 676 (782)
|||+++|+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+++....
T Consensus 91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999987 3457899999999999999999999998 99999999999996 578999999999986543
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CC---CChHHHH
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EI---PEGPLGR 752 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~-~i---p~~~L~~ 752 (782)
. .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+......+...+..+..+ .+ ....+.+
T Consensus 168 ~--~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (270)
T d1t4ha_ 168 S--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244 (270)
T ss_dssp T--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred C--ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence 2 3346789999999999876 59999999999999999999999998776555555544444332 22 2346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003971 753 LIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 753 LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
|+.+||. ||++|||+.|+++|
T Consensus 245 li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 245 IIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCCHhHCcCHHHHhCC
Confidence 9999999 99999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=421.11 Aligned_cols=248 Identities=21% Similarity=0.341 Sum_probs=214.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
.++|++++.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|++++++++|||||++++++.+++.+|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 36899999999999999999988 588999999875442 223457799999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCC-
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 678 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~- 678 (782)
|||+++|+|.+++. ..+.+++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||+|+.+....
T Consensus 87 mEy~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999999887 34579999999999999999999999999999999999999999999999999998775332
Q ss_pred -CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHH
Q 003971 679 -MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIAD 756 (782)
Q Consensus 679 -~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~ 756 (782)
......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+...+...+.......+ .-...+.+||.+
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 223456899999999999999999999999999999999999999999998888888776543321 123468999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003971 757 CWA-EPQERPSCEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPSa~EIL~~ 773 (782)
||. ||.+|||++|++++
T Consensus 244 ~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 244 LLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp TSCSSGGGSTTSGGGTCH
T ss_pred HccCCHhHCcCHHHHcCC
Confidence 999 99999999987543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=424.65 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=210.5
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 520 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 520 ~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
++..++|++.++||+|+||+||+|.+ +|+.||+|++.... .....+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34557899999999999999999998 58899999987653 3344578999999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
+||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+ +||+||||||+||||+.++++||+|||+|+...+
T Consensus 81 iVmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999999973 4579999999999999999999997 4899999999999999999999999999997654
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--------------------
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV-------------------- 736 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i-------------------- 736 (782)
. ...+.+||+.|+|||++.+.+|+.++|||||||++|||++|+.||.+.+........
T Consensus 158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 3 234678999999999999999999999999999999999999999765433221100
Q ss_pred ---------------------HhcCCCCCCC----ChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhhh
Q 003971 737 ---------------------ANEGSRLEIP----EGPLGRLIADCWA-EPQERPSCEEILSR--LLDCE 778 (782)
Q Consensus 737 ---------------------~~~~~~~~ip----~~~L~~LI~~CL~-DP~kRPSa~EIL~~--L~di~ 778 (782)
......+..+ ...+.+|+.+||. ||.+|||++|+++| +++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 0011111122 2358899999999 99999999999986 65543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=412.01 Aligned_cols=246 Identities=26% Similarity=0.531 Sum_probs=208.5
Q ss_pred eEEeeeCcEEEEEEEEC----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEEecc
Q 003971 530 TRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 605 (782)
Q Consensus 530 ~~LG~G~fG~VYkg~~~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 605 (782)
++||+|+||+||+|.+. ++.||||++..........+.|.+|+.+|++++|||||+++++|.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 47999999999999762 46799999976655555668899999999999999999999999654 57899999999
Q ss_pred cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCC---CC
Q 003971 606 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR---DS 682 (782)
Q Consensus 606 GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~---~~ 682 (782)
|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...... ..
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999987 4467999999999999999999999999999999999999999999999999999876543221 23
Q ss_pred CCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhh
Q 003971 683 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCW 758 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~---~~L~~LI~~CL 758 (782)
...||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....++...+. .+.+++.|. ..+.+|+.+||
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl 247 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCW 247 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHHHc
Confidence 4578999999999999999999999999999999998 899999998877666554 455566553 46999999999
Q ss_pred h-CCCCCCCHHHHHHHHHhhhhc
Q 003971 759 A-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 759 ~-DP~kRPSa~EIL~~L~di~~s 780 (782)
. ||.+|||+.+|++.|+++-++
T Consensus 248 ~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 248 TYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHhhCHHhh
Confidence 9 999999999999999887543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-49 Score=418.68 Aligned_cols=242 Identities=29% Similarity=0.428 Sum_probs=213.3
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
.|++.++||+|+||+||+|.+ +|+.||||++...... ....+.|.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 499999999999999999987 5889999999766543 3456789999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+.+|+|..++. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... .
T Consensus 96 ~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A 168 (309)
T ss_dssp CCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----B
T ss_pred ecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----C
Confidence 999999976664 346799999999999999999999999999999999999999999999999999987643 2
Q ss_pred CCCCCCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003971 682 SSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 755 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip---~~~L~~LI~ 755 (782)
...+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.........+.........+ +..+.+|+.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 45689999999999864 468999999999999999999999999998888888777655433332 346999999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003971 756 DCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 756 ~CL~-DP~kRPSa~EIL~~ 773 (782)
+||. ||.+|||+.++++|
T Consensus 249 ~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHTCSSGGGSCCHHHHTTC
T ss_pred HHCcCChhHCcCHHHHHhC
Confidence 9999 99999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=411.75 Aligned_cols=259 Identities=33% Similarity=0.592 Sum_probs=214.6
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC
Q 003971 515 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 593 (782)
Q Consensus 515 ~~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 593 (782)
..++|++++++|++++.||+|+||+||+|.+ +++.||||++...... .+.|.+|+.++++++|||||+++++|.+
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 4578999999999999999999999999988 4568999998655433 3679999999999999999999999865
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
+.+++||||+++|+|.+++... ....+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred CCeEEEEEecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhh
Confidence 4589999999999999888633 345699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhcCCCCCCCC---h
Q 003971 674 ITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP-WEGVLPERVVYAVANEGSRLEIPE---G 748 (782)
Q Consensus 674 l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~P-F~~~~~~evl~~i~~~~~~~~ip~---~ 748 (782)
...... ......||+.|+|||++.+..++.++|||||||++|||+||..| |.+....+.+..+. .+.+.+++. .
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 241 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPE 241 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCH
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCcccCH
Confidence 654322 22346799999999999999999999999999999999997655 55666666665554 344555543 4
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
.+.+|+.+||+ ||++||++.+|++.|+++..
T Consensus 242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 69999999999 99999999999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=421.84 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=220.7
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
+..++|.+++.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 4567899999999999999999987 588999999976543 2234578899999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+||||++||+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 82 iv~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999999987 3457899999999999999999999999999999999999999999999999999977655
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIAD 756 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-p~~~L~~LI~~ 756 (782)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...+...+.......+- -...+.+||.+
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 45556789999999999999999999999999999999999999999999998888777665433221 23468999999
Q ss_pred hhh-CCCCCCC-----HHHHHHH
Q 003971 757 CWA-EPQERPS-----CEEILSR 773 (782)
Q Consensus 757 CL~-DP~kRPS-----a~EIL~~ 773 (782)
||+ ||.+|++ ++++++|
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTS
T ss_pred hccCCchhhcccccccHHHHHcC
Confidence 999 9999995 8888875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-49 Score=418.87 Aligned_cols=245 Identities=25% Similarity=0.419 Sum_probs=200.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
+.|++.+.||+|+||+||+|.+ +|+.||||++....... ..+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5699999999999999999988 48899999997655432 24678899999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc---CCCeEEEEecCccccccCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd---~~g~VKLaDFGLA~~l~~~~ 678 (782)
|++||+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||+. +++.+||+|||+++......
T Consensus 88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999999997 456799999999999999999999999999999999999994 57899999999998765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~L 753 (782)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+.........+ +..+.+|
T Consensus 165 -~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 165 -VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred -eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHH
Confidence 3346789999999999999999999999999999999999999999999888888887765544332 2468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. ||.+|||+.|+++|
T Consensus 244 i~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 244 IRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCCHhHCcCHHHHhcC
Confidence 999999 99999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=405.80 Aligned_cols=256 Identities=31% Similarity=0.552 Sum_probs=209.7
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC
Q 003971 518 EWNIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 592 (782)
Q Consensus 518 e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 592 (782)
+|+++.++|.+++.||+|+||+||+|.+. +..||||.+... ......+.|.+|+.++++++|||||++++++.+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 47888899999999999999999999873 345888887533 234456789999999999999999999999964
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
+.+|+||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred -CeEEEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhe
Confidence 568999999999999988753 34578999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---
Q 003971 673 IITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE--- 747 (782)
Q Consensus 673 ~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~--- 747 (782)
.+..... ......||+.|+|||++.+..++.++|||||||++|||+| |..||.+....++...+.. +.++++|.
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~ 235 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPMPPNCP 235 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCCCTTCC
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCC
Confidence 7654322 2345578999999999999999999999999999999998 8999999988888777655 44444543
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 748 GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 748 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
..+.+||.+||. ||.+|||+.+|+++|+++.
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 469999999999 9999999999999998874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=409.99 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=216.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh----HHHHHHHHHHHHHHhCCCCceeeEeccccCCCceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~----~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 597 (782)
+.|.+++.||+|+||+||+|.+ +|+.||||++.+..... ...+.|.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5699999999999999999988 58899999997654322 23578999999999999999999999999999999
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC----eEEEEecCcccc
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRI 673 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g----~VKLaDFGLA~~ 673 (782)
+||||+++|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999999873 45799999999999999999999999999999999999998776 599999999988
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CCh
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEG 748 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-----p~~ 748 (782)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......... .+.
T Consensus 167 ~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 167 IDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp CTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 75432 345678999999999999999999999999999999999999999999998888887765443321 134
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 749 PLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.+.+||.+||. ||.+|||+.|+++|
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 68899999999 99999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=405.06 Aligned_cols=252 Identities=29% Similarity=0.576 Sum_probs=214.0
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC-CCceE
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLS 597 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-~~~l~ 597 (782)
|+++.++|++++.||+|+||.||+|.++|+.||||++.... ..+.|.+|+.++++++|||||+++|+|.+ .+.+|
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 78899999999999999999999999999999999986543 24678999999999999999999999865 46689
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 78 lv~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999999998632 2346899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHH
Q 003971 678 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRL 753 (782)
Q Consensus 678 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~---~~L~~L 753 (782)
.....+|+.|+|||++.+..++.++|||||||++|||+| |+.||......++...+ ..+.++++|. ..+.+|
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~l 232 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPAVYEV 232 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-TTTCCCCCCTTCCHHHHHH
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCccCCHHHHHH
Confidence 234578899999999999999999999999999999998 68889888877777665 4455666664 479999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 754 IADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
+.+||. ||.+|||+.+|+++|++++.
T Consensus 233 i~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 233 MKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 999999 99999999999999998875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.9e-48 Score=417.94 Aligned_cols=246 Identities=25% Similarity=0.414 Sum_probs=217.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
.++|.+++.||+|+||+||+|.+ +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999987 58999999986543 334578899999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc--CCCeEEEEecCccccccCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN--KHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd--~~g~VKLaDFGLA~~l~~~~ 678 (782)
||++||+|.+++.. ....+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+++.+....
T Consensus 103 E~~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 103 EFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EcCCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999998852 345799999999999999999999999999999999999996 46789999999998875432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip-----~~~L~~L 753 (782)
......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+.......... ...+.+|
T Consensus 181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 2345789999999999999999999999999999999999999999999988888887765544321 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
|.+||. ||.+|||+.|+++|
T Consensus 260 i~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999 99999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=405.58 Aligned_cols=263 Identities=32% Similarity=0.576 Sum_probs=214.5
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEe
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 587 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 587 (782)
..+|++..++|+++++||+|+||+||+|.+. ++.||||++.... .....+.+.+|+.++.++ +|+|||.++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 3578888899999999999999999999862 3679999986543 334457788888888777 689999999
Q ss_pred ccccCC-CceEEEEEEecccchhhHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhccccccCCCcc
Q 003971 588 GACTKP-PRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 653 (782)
Q Consensus 588 g~~~d~-~~l~LV~Ey~~gGsL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPe 653 (782)
+++... ..++++|||+++|+|.+++..... ...+++.+++.++.||+.||+|||++|||||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 987654 568999999999999999974321 235899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChH
Q 003971 654 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPE 730 (782)
Q Consensus 654 NILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk-~PF~~~~~~ 730 (782)
||||+.++++||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+||. .||.+....
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987644322 234567999999999999999999999999999999999975 588887766
Q ss_pred HHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 731 RVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 731 evl~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
..+......+.++..|. ..+.+|+.+||. ||.+|||+.+|+++|+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 66666667777776664 369999999999 99999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.7e-48 Score=412.14 Aligned_cols=245 Identities=24% Similarity=0.441 Sum_probs=217.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
.++|++++.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+.+++.++|||||++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46899999999999999999987 488999999875432 223457899999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+.||+|..++. ....+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 99999999998887 4557888999999999999999999999999999999999999999999999999887543
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhh
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCW 758 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL 758 (782)
....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+..+....+.......+ .-+..+.+++.+||
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 3467899999999999999999999999999999999999999999999888888876554332 22456999999999
Q ss_pred h-CCCCCC-----CHHHHHHH
Q 003971 759 A-EPQERP-----SCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRP-----Sa~EIL~~ 773 (782)
. ||.+|+ |++++++|
T Consensus 237 ~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTS
T ss_pred hhCHHhccccchhhHHHHHcC
Confidence 9 999996 89999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-47 Score=404.99 Aligned_cols=260 Identities=32% Similarity=0.556 Sum_probs=222.5
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEecc
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 589 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~ 589 (782)
.+|++..++|++.+.||+|+||+||+|++. ++.||||++... ......+.|.+|+.+|++++||||++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 357778889999999999999999999864 368999998654 344556789999999999999999999999
Q ss_pred ccCCCceEEEEEEecccchhhHHHhhc---------------------ccccchHHHHHHHHHHHHHHHHHHHhcccccc
Q 003971 590 CTKPPRLSMITEYMELGSLYHLIHLSG---------------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 648 (782)
Q Consensus 590 ~~d~~~l~LV~Ey~~gGsL~dlL~~~~---------------------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHr 648 (782)
|.+....+++|||+++|+|.+++.... ....+++..++.++.||+.||+|||+++||||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 999999999999999999999986321 12348899999999999999999999999999
Q ss_pred CCCcccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCC-CCCC
Q 003971 649 DLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWE 725 (782)
Q Consensus 649 DIKPeNILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk-~PF~ 725 (782)
||||+||||+.++.+||+|||+++.+..... ......||+.|+|||.+.+..|+.++|||||||++|||++|. .||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 9999999999999999999999987643322 223567899999999999999999999999999999999996 5888
Q ss_pred CCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 726 GVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 726 ~~~~~evl~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
+....+....+.. +.++.+|. ..+.+|+..||. ||.+||||.||++.|+++.
T Consensus 245 ~~~~~e~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 8888888777654 44555553 369999999999 9999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.6e-47 Score=397.73 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=212.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC----ce
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP----RL 596 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~----~l 596 (782)
++|++.+.||+|+||+||+|.+ +|+.||||++..... .....+.|.+|+.+++.++|||||++++++...+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 6799999999999999999987 589999999976554 3445678999999999999999999999987644 38
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
|+||||++|++|.+++. ..+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 87 ~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 99999999999998886 345799999999999999999999999999999999999999999999999999876543
Q ss_pred CC---CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CCh
Q 003971 677 SP---MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEG 748 (782)
Q Consensus 677 ~~---~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-----p~~ 748 (782)
.. ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+....+......+.. -+.
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 22 2334568999999999999999999999999999999999999999999988888887776554321 134
Q ss_pred HHHHHHHHhhh-CCCCCC-CHHHHHHHHHhhh
Q 003971 749 PLGRLIADCWA-EPQERP-SCEEILSRLLDCE 778 (782)
Q Consensus 749 ~L~~LI~~CL~-DP~kRP-Sa~EIL~~L~di~ 778 (782)
.+.+|+.+||. ||.+|| |++++++.|..+.
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 69999999999 999999 8999999988764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-47 Score=416.91 Aligned_cols=246 Identities=26% Similarity=0.387 Sum_probs=216.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
+++|++.+.||+|+||+||+|.+ +|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46799999999999999999987 58899999987543 233467889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc--CCCeEEEEecCccccccCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN--KHWTVKICDFGLSRIITDSP 678 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd--~~g~VKLaDFGLA~~l~~~~ 678 (782)
||++||+|.+.+.. ....+++.+++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+|+.+....
T Consensus 106 E~~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 106 EFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp ECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999999987752 345799999999999999999999999999999999999997 67899999999998875532
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-----p~~~L~~L 753 (782)
......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+......+..+......... -+..+.+|
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 234568999999999999999999999999999999999999999999998888888775544332 13468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
|.+||. ||.+|||+.|+++|
T Consensus 263 i~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999 99999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-48 Score=402.47 Aligned_cols=254 Identities=30% Similarity=0.553 Sum_probs=211.1
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP 594 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 594 (782)
++.++|++.+.||+|+||.||+|.++ ...||||++..... .....+.|.+|+.+|++++|||||+++|+|.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 34578999999999999999999762 23689999876543 33446789999999999999999999999976 4
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 674 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l 674 (782)
.+++||||+++|++.+.+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred chheeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 68999999999999988763 3457999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCC---CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---
Q 003971 675 TDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE--- 747 (782)
Q Consensus 675 ~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~--- 747 (782)
..... ......|++.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+....+...+.+++.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence 54322 1234567889999999999999999999999999999998 8999999999999998888887776654
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 748 GPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 748 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
..+.+|+..||. ||.+|||+.+|++.|++.
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 479999999999 999999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.2e-47 Score=397.57 Aligned_cols=247 Identities=25% Similarity=0.420 Sum_probs=217.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-------HHHHHHHHHHHHHHhCC-CCceeeEeccccC
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-------ENMEDFCNEISILSRLR-HPNVILFLGACTK 592 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-------~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d 592 (782)
+++|++.+.||+|+||+||+|++ +|+.||||++.+..... ...+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999988 68999999997665321 22356889999999997 9999999999999
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
++.+|+||||+++|+|.+++. ..+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999999997 34579999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCcccCcccccc------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRN------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 746 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~------~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip 746 (782)
...... .....+||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+.......+.........+
T Consensus 159 ~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 159 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred EccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 875532 3456789999999999853 457889999999999999999999999999888888887766544333
Q ss_pred -----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 -----EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 -----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+..+.+|+.+||. ||.+|||+.|+++|
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2368999999999 99999999999876
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-47 Score=413.11 Aligned_cols=245 Identities=21% Similarity=0.364 Sum_probs=216.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
.++|+++++||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.+...+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 46899999999999999999988 588999999875432 223457789999999999999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+.+|+|..++. ..+.+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+...
T Consensus 120 ~e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 99999999999886 3457999999999999999999999999999999999999999999999999999887542
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHHhh
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIADCW 758 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-p~~~L~~LI~~CL 758 (782)
....+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+.......+.......+. -+..+.+|+.+||
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 273 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHS
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHh
Confidence 34678999999999999999999999999999999999999999999988888887765543322 2346999999999
Q ss_pred h-CCCCCC-----CHHHHHHH
Q 003971 759 A-EPQERP-----SCEEILSR 773 (782)
Q Consensus 759 ~-DP~kRP-----Sa~EIL~~ 773 (782)
. ||.+|+ |++++++|
T Consensus 274 ~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 274 QVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTS
T ss_pred hhCHHhccccccccHHHHHcC
Confidence 9 999994 89999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=401.16 Aligned_cols=251 Identities=27% Similarity=0.545 Sum_probs=209.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--Ce----EEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCce
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIWN--GT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 596 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~~--g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 596 (782)
.++|+++++||+|+||+||+|.+. |+ .||+|.+.... .....+.|.+|+.++++++|||||+++|+|.++ ..
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 367999999999999999999873 33 58888875433 233467899999999999999999999999875 57
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccC
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 676 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~ 676 (782)
++++||+.+|+|.+.+.. ....+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+++....
T Consensus 86 ~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred eEEEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 888999999999988763 456799999999999999999999999999999999999999999999999999998754
Q ss_pred CCCC--CCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHH
Q 003971 677 SPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPL 750 (782)
Q Consensus 677 ~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~evl~~i~~~~~~~~ip~---~~L 750 (782)
.... .....||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+....++...+ ..+.+++.|. ..+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~p~~~~~~~ 242 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDV 242 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-HHTCCCCCCTTBCHHH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCcccCHHH
Confidence 3322 234568999999999999999999999999999999998 78899988777665544 4455555553 469
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 751 GRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 751 ~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
.+|+.+||. ||.+|||+.+|+++|..+.
T Consensus 243 ~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 999999999 9999999999999988763
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=407.92 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=215.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHH-hCCCCceeeEeccccCCCceEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILS-RLRHPNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk-~L~HPNIVkL~g~~~d~~~l~LV 599 (782)
++|.+++.||+|+||+||+|.+ +|+.||||++.+... .....+.+..|+.++. .++|||||++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999988 689999999975432 2233566778887765 68999999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 679 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~ 679 (782)
|||+++|+|.+++. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.......
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 99999999999997 345789999999999999999999999999999999999999999999999999987765555
Q ss_pred CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhh
Q 003971 680 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCW 758 (782)
Q Consensus 680 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~-ip~~~L~~LI~~CL 758 (782)
.....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+...+...+.......+ .-+..+.+|+.+||
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L 238 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 238 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHS
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhc
Confidence 55678899999999999999999999999999999999999999999999888887766543222 12457999999999
Q ss_pred h-CCCCCCCHH-HHHHH
Q 003971 759 A-EPQERPSCE-EILSR 773 (782)
Q Consensus 759 ~-DP~kRPSa~-EIL~~ 773 (782)
. ||.+||++. ++++|
T Consensus 239 ~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 239 VREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CSSGGGSBTTBSCGGGS
T ss_pred ccCCCCCcCHHHHHHhC
Confidence 9 999999995 77653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=398.57 Aligned_cols=261 Identities=29% Similarity=0.537 Sum_probs=225.9
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEec
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 588 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g 588 (782)
.+|++..++|.++++||+|+||.||+|.+ .++.||||++.... .......|.+|+.+++++ +|||||++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 46889999999999999999999999975 24689999987544 344567899999999999 6999999999
Q ss_pred cccCCCceEEEEEEecccchhhHHHhhc---------------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcc
Q 003971 589 ACTKPPRLSMITEYMELGSLYHLIHLSG---------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 653 (782)
Q Consensus 589 ~~~d~~~l~LV~Ey~~gGsL~dlL~~~~---------------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPe 653 (782)
+|.+...++++|||+++|+|.+++.... ....+++..++.++.||+.||+|||+++||||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999987432 2236899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 003971 654 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 730 (782)
Q Consensus 654 NILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~ 730 (782)
|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||+| |..||.+....
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987754322 2234678999999999999999999999999999999998 56667777777
Q ss_pred HHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 731 RVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 731 evl~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
..+..+...+.++..+. ..+.+||..||. ||.+|||+.+|++.|+..-
T Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 77777777777776653 469999999999 9999999999999998653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-47 Score=398.06 Aligned_cols=243 Identities=23% Similarity=0.248 Sum_probs=203.8
Q ss_pred EeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH---HHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 528 VGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE---NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 528 i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~---~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
.+++||+|+||+||+|.+ +|+.||||++........ ..+.+.+|+.+++.++|||||++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999987 588999999865443221 135688999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+.++.+..+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 99988776664 456789999999999999999999999999999999999999999999999999988766555556
Q ss_pred CCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------------
Q 003971 683 SSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------ 743 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~------------------ 743 (782)
..+||+.|+|||++.. ..|+.++|||||||++|||+||+.||.+....+.+..+......+
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 6789999999999865 468999999999999999999999999998888777665321110
Q ss_pred ---C--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 ---E--------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 ---~--------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. .....+.+|+.+||+ ||.+|||+.|+|+|
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 012358889999999 99999999999985
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=397.19 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=210.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|+++++||+|+||+||+|++ +|+.||||++..........+.+.+|+++|++++|||||++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999988 48899999997655444446789999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
|+.++.+..... .....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.........
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 998655544332 245679999999999999999999999999999999999999999999999999998876655555
Q ss_pred CCCCCCCcccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------------
Q 003971 682 SSSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---------------- 744 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~-~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~---------------- 744 (782)
....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+.......+......+.
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 6678999999999887665 57899999999999999999999999888777776643211100
Q ss_pred C--------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhh
Q 003971 745 I--------------PEGPLGRLIADCWA-EPQERPSCEEILSR--LLDC 777 (782)
Q Consensus 745 i--------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~--L~di 777 (782)
. -...+.+|+.+||. ||.+|||+.|+++| ++++
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0 01347889999999 99999999999987 5554
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=396.31 Aligned_cols=260 Identities=30% Similarity=0.570 Sum_probs=219.3
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeE
Q 003971 517 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 586 (782)
Q Consensus 517 ~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL 586 (782)
..|.++.++|.+++.||+|+||.||+|.+. +..||||++.... ......++.+|+..+.++ +|||||++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 348899999999999999999999999752 2469999986543 445567899999999888 79999999
Q ss_pred eccccCCCceEEEEEEecccchhhHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcc
Q 003971 587 LGACTKPPRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 653 (782)
Q Consensus 587 ~g~~~d~~~l~LV~Ey~~gGsL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPe 653 (782)
+++|.+++.+++||||+.+|+|.+++.... ....+++.+++.++.||+.||+|||+++||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 999999999999999999999999996432 1346899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 003971 654 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 730 (782)
Q Consensus 654 NILLd~~g~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-Gk~PF~~~~~~ 730 (782)
|||++.++.+||+|||+++....... ......||+.|+|||.+.++.|+.++|||||||++|||++ |+.||.+....
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999999999999987754322 2234678999999999999999999999999999999998 68899888887
Q ss_pred HHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 731 RVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 731 evl~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
.+...+ ..+.++..|. ..+.+|+.+||+ ||.+|||+.||++.|+++.
T Consensus 245 ~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 ELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 766554 4566666654 469999999999 9999999999999998874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=404.24 Aligned_cols=245 Identities=21% Similarity=0.314 Sum_probs=214.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 600 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 600 (782)
+++|.+++.||+|+||+||+|.+ +|+.||||++.... .....+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 57899999999999999999987 58899999997543 23356889999999999999999999999999999999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC--CeEEEEecCccccccCCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH--WTVKICDFGLSRIITDSP 678 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~--g~VKLaDFGLA~~l~~~~ 678 (782)
||++||+|.+++.. ....+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 81 E~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 81 EFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999999862 23479999999999999999999999999999999999999854 589999999998765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003971 679 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 753 (782)
Q Consensus 679 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-----p~~~L~~L 753 (782)
......+|+.|+|||.+.+..|+.++|||||||++|+|++|+.||.+.+.......+.......+. -+..+.+|
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHH
Confidence 234567899999999999999999999999999999999999999999998888888776544332 13468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003971 754 IADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 754 I~~CL~-DP~kRPSa~EIL~~ 773 (782)
+.+||. ||.+|||+.|+++|
T Consensus 238 i~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999 99999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=397.37 Aligned_cols=260 Identities=32% Similarity=0.577 Sum_probs=224.9
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEec
Q 003971 516 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 588 (782)
Q Consensus 516 ~~e~~i~~s~y~i~~~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g 588 (782)
.++|+++.++|.++++||+|+||+||+|.++ ++.||||++.... .......|.+|+.++++++|||||++++
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 4679999999999999999999999999764 4689999986543 4445678999999999999999999999
Q ss_pred cccCCCceEEEEEEecccchhhHHHhhc-------ccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC
Q 003971 589 ACTKPPRLSMITEYMELGSLYHLIHLSG-------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 661 (782)
Q Consensus 589 ~~~d~~~l~LV~Ey~~gGsL~dlL~~~~-------~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g 661 (782)
+|...+..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 9999999999999999999999886431 123468899999999999999999999999999999999999999
Q ss_pred eEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHh
Q 003971 662 TVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVAN 738 (782)
Q Consensus 662 ~VKLaDFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG-k~PF~~~~~~evl~~i~~ 738 (782)
++||+|||+++.+..... ......||+.|+|||.+.+..++.++|||||||++|||+|| +.||.+.+..+....+..
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999999999987644322 22345689999999999999999999999999999999998 478999888888777655
Q ss_pred cCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 739 EGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 739 ~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
+.+++.|. ..+.+|+.+||+ ||.+|||+.+|+++|++.
T Consensus 251 -~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 251 -GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred -CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 44555553 469999999999 999999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=397.63 Aligned_cols=255 Identities=32% Similarity=0.591 Sum_probs=213.3
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCe--EEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCceeeEeccccCCCc
Q 003971 521 IDFSELTVGTRVGIGFFGEVFRGIW--NGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 595 (782)
Q Consensus 521 i~~s~y~i~~~LG~G~fG~VYkg~~--~g~--~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~ 595 (782)
+++++|++.++||+|+||+||+|.+ +|. .||||.+.... .....+.|.+|+++|+++ +|||||+++++|.+.+.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 4668999999999999999999977 454 46677764332 233457899999999998 79999999999999999
Q ss_pred eEEEEEEecccchhhHHHhh-------------cccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCe
Q 003971 596 LSMITEYMELGSLYHLIHLS-------------GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 662 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~-------------~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~ 662 (782)
+++||||+++|+|.++++.. .....+++.+++.++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 99999999999999998643 22467899999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhcCC
Q 003971 663 VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGS 741 (782)
Q Consensus 663 VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk-~PF~~~~~~evl~~i~~~~~ 741 (782)
+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|. .||.+.+..++...+. .+.
T Consensus 166 ~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~-~~~ 243 (309)
T d1fvra_ 166 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 243 (309)
T ss_dssp EEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-GTC
T ss_pred eEEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-hcC
Confidence 999999999865432 2233567899999999999999999999999999999999975 5788888877776654 455
Q ss_pred CCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003971 742 RLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 778 (782)
Q Consensus 742 ~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~ 778 (782)
+++.|. ..+.+|+.+||. ||++|||+.+|+++|+++.
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 565553 469999999999 9999999999999998874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.6e-46 Score=405.35 Aligned_cols=247 Identities=25% Similarity=0.343 Sum_probs=203.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH-HHHHHHH---HHHHHHhCCCCceeeEeccccCCCc
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE-NMEDFCN---EISILSRLRHPNVILFLGACTKPPR 595 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~-~~e~f~~---EI~iLk~L~HPNIVkL~g~~~d~~~ 595 (782)
..++|.+.+.||+|+||+||+|.+ +|+.||||++.+...... ....+.+ |+.+++.++|||||++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 357899999999999999999988 588999999865433211 1233444 4667777789999999999999999
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+|+||||++||+|.+++. ....+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 82 ~~ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999987 34578999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-hcCCCCCCC---ChHH
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIP---EGPL 750 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~-~~~~~~~ip---~~~L 750 (782)
.. .....+||+.|+|||++.. ..|+.++|||||||++|||+||+.||.+........... .......+| +..+
T Consensus 159 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 159 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236 (364)
T ss_dssp SS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred CC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence 43 3346789999999999864 568999999999999999999999998754433222111 122223333 3469
Q ss_pred HHHHHHhhh-CCCCCCC-----HHHHHHH
Q 003971 751 GRLIADCWA-EPQERPS-----CEEILSR 773 (782)
Q Consensus 751 ~~LI~~CL~-DP~kRPS-----a~EIL~~ 773 (782)
.+||.+||. ||.+||| ++++++|
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 999999999 9999999 7888875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.1e-46 Score=388.22 Aligned_cols=247 Identities=21% Similarity=0.287 Sum_probs=207.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
++|.+.++||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+|++++|||||++++++.+.+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999988 578999999976655444467899999999999999999999999999999999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 682 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~~ 682 (782)
+.++.+..+.. ....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 99887777664 456899999999999999999999999999999999999999999999999999988766544455
Q ss_pred CCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----------------
Q 003971 683 SSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----------------- 744 (782)
Q Consensus 683 ~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~----------------- 744 (782)
...|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..+....+......+.
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 6679999999999875 4578999999999999999999999999888777766543111100
Q ss_pred -------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 -------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 -------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.....+.+|+.+||+ ||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 012357899999999 99999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=390.24 Aligned_cols=250 Identities=29% Similarity=0.524 Sum_probs=206.4
Q ss_pred EeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC-CCceEEEEE
Q 003971 528 VGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLSMITE 601 (782)
Q Consensus 528 i~~~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-~~~l~LV~E 601 (782)
..++||+|+||+||+|.+. ...||||++... ......+.|.+|+++|++++|||||+++|++.+ ++.+++|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 3678999999999999873 235899998643 345567889999999999999999999999865 467999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCC--
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-- 679 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~-- 679 (782)
|+++|+|.+++. .....+++..++.++.|++.||.|||+.+|+||||||+||||++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~--~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 110 YMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CCTTCBHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EeecCchhhhhc--cccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999886 3445678889999999999999999999999999999999999999999999999987654322
Q ss_pred --CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHH
Q 003971 680 --RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLI 754 (782)
Q Consensus 680 --~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~ip~---~~L~~LI 754 (782)
......||+.|+|||.+....++.++|||||||++|||+||+.||...............+.++..|. ..+.+|+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li 267 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVM 267 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHH
Confidence 22345689999999999999999999999999999999998887765443333333344455665553 4799999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003971 755 ADCWA-EPQERPSCEEILSRLLDCEYS 780 (782)
Q Consensus 755 ~~CL~-DP~kRPSa~EIL~~L~di~~s 780 (782)
.+||. ||.+||++.||+++|+.+..+
T Consensus 268 ~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 268 LKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 99999 999999999999999988643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=387.00 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=207.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC---CeEEEEEEeeccccChHHHHHHHHHHHHHHhC---CCCceeeEecccc-----C
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWN---GTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RHPNVILFLGACT-----K 592 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~---g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L---~HPNIVkL~g~~~-----d 592 (782)
++|+++++||+|+||+||+|.+. ++.||||++............+.+|+.+|+.+ +||||++++++|. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999873 56799999876544433334566788777666 7999999999984 3
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
...+++++||+.++.+..... .....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 356899999999887765543 345678999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Q 003971 673 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------- 743 (782)
Q Consensus 673 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~--------- 743 (782)
..... .......||+.|+|||++.+.+|+.++|||||||++|||++|+.||.+.+....+..+......+
T Consensus 165 ~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 65433 23456789999999999999999999999999999999999999999998888777665321110
Q ss_pred -------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhhh
Q 003971 744 -------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR--LLDCE 778 (782)
Q Consensus 744 -------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~--L~di~ 778 (782)
...+..+.+|+.+||. ||.+|||+.|+++| +++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 0012357889999999 99999999999986 55543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=396.67 Aligned_cols=242 Identities=22% Similarity=0.393 Sum_probs=198.4
Q ss_pred CCCeeEee-EEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHh-CCCCceeeEeccccC----CC
Q 003971 523 FSELTVGT-RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSR-LRHPNVILFLGACTK----PP 594 (782)
Q Consensus 523 ~s~y~i~~-~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~-L~HPNIVkL~g~~~d----~~ 594 (782)
.++|.+.. .||+|+||+||+|.+ +++.||||++... ..+.+|+.++.+ ++|||||+++++|.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 36898875 599999999999987 5889999998532 456789998755 589999999999865 45
Q ss_pred ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC---CCeEEEEecCcc
Q 003971 595 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLS 671 (782)
Q Consensus 595 ~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~---~g~VKLaDFGLA 671 (782)
.+|+|||||+||+|.+++... ....+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||++
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 689999999999999999732 2457999999999999999999999999999999999999975 567999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCC---
Q 003971 672 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS--RLEIP--- 746 (782)
Q Consensus 672 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~--~~~ip--- 746 (782)
+...... .....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.........+..... ....|
T Consensus 162 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 162 KETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp EECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred eeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 8775543 33567899999999999999999999999999999999999999987665544444333221 11222
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 747 ----EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 747 ----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+..+.+|+.+||. ||.+|||+.|+++|
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2358899999999 99999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=384.74 Aligned_cols=239 Identities=25% Similarity=0.413 Sum_probs=199.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh----HHHHHHHHHHHHHHhCC--CCceeeEeccccCCCc
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLR--HPNVILFLGACTKPPR 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~----~~~e~f~~EI~iLk~L~--HPNIVkL~g~~~d~~~ 595 (782)
++|++++.||+|+||+||+|.+ +|+.||||++.+..... .....+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999988 58899999987654321 11234678999999997 8999999999999999
Q ss_pred eEEEEEEecc-cchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC-CCeEEEEecCcccc
Q 003971 596 LSMITEYMEL-GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRI 673 (782)
Q Consensus 596 l~LV~Ey~~g-GsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~-~g~VKLaDFGLA~~ 673 (782)
.|+||||+.+ +++.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999976 57777776 3457999999999999999999999999999999999999985 57999999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCChHHH
Q 003971 674 ITDSPMRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEGPLG 751 (782)
Q Consensus 674 l~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~-~~~ip~~~L~ 751 (782)
.... .....+||+.|+|||++.+..+ +.++|||||||++|||+||+.||.+.. .+..... ....-+..+.
T Consensus 161 ~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 161 LKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQ 232 (273)
T ss_dssp CCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHH
T ss_pred cccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHH
Confidence 6443 3356789999999999987765 567999999999999999999997632 1222221 1122245799
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003971 752 RLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 752 ~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
+|+.+||. ||.+|||++|+++|
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHccCCHhHCcCHHHHhcC
Confidence 99999999 99999999999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=384.42 Aligned_cols=247 Identities=28% Similarity=0.487 Sum_probs=200.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHH--HHHHHHhCCCCceeeEeccccCCC----ceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCN--EISILSRLRHPNVILFLGACTKPP----RLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~--EI~iLk~L~HPNIVkL~g~~~d~~----~l~ 597 (782)
.+|.+.++||+|+||.||+|+++|+.||||++.... ...+.. |+..+..++|||||+++++|.+.. .++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 468899999999999999999999999999985432 233444 455556789999999999997653 589
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh--------ccccccCCCcccEEEcCCCeEEEEecC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR--------MKIVHRDLKSANCLVNKHWTVKICDFG 669 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs--------~gIIHrDIKPeNILLd~~g~VKLaDFG 669 (782)
+||||+++|+|.++++. ..+++.+++.++.|++.||+|||+ +||+||||||+||||+.++.+||+|||
T Consensus 78 lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 99999999999999973 368999999999999999999996 599999999999999999999999999
Q ss_pred ccccccCCCC----CCCCCCCCCcccCccccccCC------CCchhHHHHHHHHHHHHHhCCCCCCC-------------
Q 003971 670 LSRIITDSPM----RDSSSAGTPEWMAPELIRNEP------FTEKCDIFSLGVIMWELCTLNRPWEG------------- 726 (782)
Q Consensus 670 LA~~l~~~~~----~~~~~~GT~~Y~APEvl~~~~------~s~ksDVWSLGvILyELLTGk~PF~~------------- 726 (782)
+++....... ......||+.|+|||++.+.. ++.++|||||||+||||+||..||..
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9988754322 223568999999999987643 57789999999999999999876631
Q ss_pred --CChHHHHHHHHhcCCCCCCCCh--------HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003971 727 --VLPERVVYAVANEGSRLEIPEG--------PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 779 (782)
Q Consensus 727 --~~~~evl~~i~~~~~~~~ip~~--------~L~~LI~~CL~-DP~kRPSa~EIL~~L~di~~ 779 (782)
...............++.++.. .+.+|+.+||. ||.+|||+.||+++|+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 2333444444555555655532 37899999999 99999999999999998753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=379.52 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=202.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC--------
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-------- 592 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-------- 592 (782)
.++|+++++||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999987 58899999987665555556788999999999999999999998754
Q ss_pred CCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccc
Q 003971 593 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 672 (782)
Q Consensus 593 ~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~ 672 (782)
...+|++|||+.++.+..... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 346899999999877765543 45678899999999999999999999999999999999999999999999999998
Q ss_pred cccCCC----CCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--
Q 003971 673 IITDSP----MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-- 745 (782)
Q Consensus 673 ~l~~~~----~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~i-- 745 (782)
...... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+......+..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 664322 122346799999999998764 6899999999999999999999999988877776655432111100
Q ss_pred -------------------------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 746 -------------------------------PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 746 -------------------------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
....+.+|+.+||. ||++|||+.|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 01235679999999 99999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-44 Score=370.15 Aligned_cols=247 Identities=22% Similarity=0.283 Sum_probs=210.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCCceEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 601 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 601 (782)
++|+++++||+|+||+||+|++ +++.||||++..........+.+.+|+.+|+.++||||++++++|.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 6899999999999999999998 57889999997776666667899999999999999999999999999999999999
Q ss_pred EecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003971 602 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 681 (782)
Q Consensus 602 y~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~~~~~ 681 (782)
++.+++|..++. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++.........
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 999999988876 45678999999999999999999999999999999999999999999999999999876655444
Q ss_pred CCCCCCCcccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHhcCCCCC---------------
Q 003971 682 SSSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELCTLNRPW-EGVLPERVVYAVANEGSRLE--------------- 744 (782)
Q Consensus 682 ~~~~GT~~Y~APEvl~~~~-~s~ksDVWSLGvILyELLTGk~PF-~~~~~~evl~~i~~~~~~~~--------------- 744 (782)
....+++.|+|||++.... ++.++|||||||++|||++|+.|| .+.+..+....+......+.
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 5567888999999987664 689999999999999999999985 45555555544432111100
Q ss_pred ------------C---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 ------------I---PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 ------------i---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. -...+.+|+.+||. ||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 01257889999999 99999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=382.17 Aligned_cols=246 Identities=27% Similarity=0.351 Sum_probs=202.3
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC--
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-- 594 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~-- 594 (782)
|++ .++|+++++||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+|+.++|||||+++++|...+
T Consensus 14 ~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 14 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred eec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence 555 37899999999999999999987 4899999999876666666788999999999999999999999987654
Q ss_pred ----ceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCc
Q 003971 595 ----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 670 (782)
Q Consensus 595 ----~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGL 670 (782)
.+|+||||+ +.+|..+.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence 479999999 557777664 34699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------
Q 003971 671 SRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------ 743 (782)
Q Consensus 671 A~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~------ 743 (782)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..............+
T Consensus 168 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 168 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 9876542 346789999999999876 457899999999999999999999999887766655443211110
Q ss_pred --------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 --------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 --------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
......+.+|+.+||. ||.+|||+.|+|+|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0012357889999999 99999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=380.78 Aligned_cols=242 Identities=23% Similarity=0.274 Sum_probs=200.4
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC------CCce
Q 003971 525 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PPRL 596 (782)
Q Consensus 525 ~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d------~~~l 596 (782)
+|+.+++||+|+||+||+|++ +|+.||||++...... +.+|+.+|++++||||++++++|.. ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 689999999999999999998 5889999998755422 2379999999999999999999843 3347
Q ss_pred EEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCC-eEEEEecCcccccc
Q 003971 597 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIIT 675 (782)
Q Consensus 597 ~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g-~VKLaDFGLA~~l~ 675 (782)
|+||||++++.+..+.........+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 89999999876655554444566899999999999999999999999999999999999999775 89999999998775
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR------------ 742 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~------------ 742 (782)
... .....+||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........+..+......
T Consensus 175 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 175 RGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp TTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred CCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 433 3346789999999998765 56899999999999999999999999988877776665431100
Q ss_pred ------C------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 743 ------L------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 743 ------~------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. ......+.+|+.+||. ||.+|||+.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0012358899999999 99999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-43 Score=376.85 Aligned_cols=245 Identities=27% Similarity=0.352 Sum_probs=200.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCCC----ceE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP----RLS 597 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~----~l~ 597 (782)
++|+++++||+|+||+||+|.+ +|+.||||++.... .....+.+.+|+.+|+.++||||+++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 5799999999999999999987 58899999986543 3445678999999999999999999999986643 345
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCccccccCC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~~~ 677 (782)
++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 66677889999999862 36899999999999999999999999999999999999999999999999999876432
Q ss_pred C---CCCCCCCCCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 003971 678 P---MRDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------- 743 (782)
Q Consensus 678 ~---~~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~---------- 743 (782)
. ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+................+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 2 1234567999999999984 4567899999999999999999999999887665555443211110
Q ss_pred --------------CC--------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 --------------EI--------PEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 --------------~i--------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.. -+..+.+|+.+||. ||.+|||+.|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 12357899999999 99999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=374.12 Aligned_cols=247 Identities=25% Similarity=0.315 Sum_probs=205.7
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccCC---
Q 003971 519 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--- 593 (782)
Q Consensus 519 ~~i~~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--- 593 (782)
|++ .++|++.++||+|+||+||+|.+ +|+.||||++.+........+.+.+|+.+|+.++|||||++++++...
T Consensus 14 ~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 14 WEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92 (348)
T ss_dssp EEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred ccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence 554 37899999999999999999987 589999999987766666678899999999999999999999998543
Q ss_pred --CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcc
Q 003971 594 --PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 671 (782)
Q Consensus 594 --~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA 671 (782)
...+++++|+.+|+|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ccCceEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchh
Confidence 34577788889999999885 346999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------
Q 003971 672 RIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE------ 744 (782)
Q Consensus 672 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~~------ 744 (782)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 169 ~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 169 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp -CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 76543 33467899999999987665 468899999999999999999999998887776666543222110
Q ss_pred --------------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 745 --------------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 745 --------------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
-....+.+||.+||. ||.+|||+.|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 012357889999999 99999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-42 Score=360.63 Aligned_cols=247 Identities=19% Similarity=0.266 Sum_probs=194.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCce-eeEeccccCCCceEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSMIT 600 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~~~l~LV~ 600 (782)
++|+++++||+|+||+||+|.+ +|+.||||++...... +.+..|+++++.++|+|+ +.+.+++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 5799999999999999999987 4889999998754332 357789999999987665 45555567777889999
Q ss_pred EEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEc---CCCeEEEEecCccccccCC
Q 003971 601 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDS 677 (782)
Q Consensus 601 Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd---~~g~VKLaDFGLA~~l~~~ 677 (782)
||+.+ ++.+.+.. ....+++..++.++.|++.||+|||++|||||||||+|||++ .+..+||+|||+|+.+...
T Consensus 83 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 83 ELLGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp ECCCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEcCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99965 55554432 456799999999999999999999999999999999999985 4557999999999987543
Q ss_pred CC-------CCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hc---CCCC-
Q 003971 678 PM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA---NE---GSRL- 743 (782)
Q Consensus 678 ~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~---~~---~~~~- 743 (782)
.. ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...........+. .. ....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 21 2245679999999999999999999999999999999999999998765544333221 11 1101
Q ss_pred --CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 744 --EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 744 --~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
.--+..+.+++..||. ||.+||++.+|.+.|+++
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1113468999999999 999999999998888765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=373.24 Aligned_cols=243 Identities=25% Similarity=0.304 Sum_probs=194.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCceeeEeccccC------CCc
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PPR 595 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d------~~~ 595 (782)
++|+++++||+|+||+||+|.+ +|+.||||++............+.+|+.+++.++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999998 48999999998776666677889999999999999999999999854 367
Q ss_pred eEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccccc
Q 003971 596 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 675 (782)
Q Consensus 596 l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~l~ 675 (782)
+|+||||+.++.+.. +. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~~l~~~-~~-----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEEHHHH-HT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchHHHHh-hh-----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 899999998765543 32 358999999999999999999999999999999999999999999999999988765
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------
Q 003971 676 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------ 743 (782)
Q Consensus 676 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~~~~~------------ 743 (782)
.. ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+......+
T Consensus 171 ~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 171 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred cc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 43 23456789999999999999999999999999999999999999999887766655443211100
Q ss_pred -----------C-----------CC---------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 744 -----------E-----------IP---------EGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 744 -----------~-----------ip---------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
. .+ ...+.+|+.+||. ||++|||++|+|+|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 00 1136789999999 99999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.2e-42 Score=363.92 Aligned_cols=239 Identities=20% Similarity=0.313 Sum_probs=195.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccC--CCceE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTK--PPRLS 597 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d--~~~l~ 597 (782)
.++|+++++||+|+||+||+|++ +|+.||||++.... .+.+.+|+.+|+.++ ||||++++++|.. ...++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 36899999999999999999988 58999999986432 467889999999996 9999999999864 45699
Q ss_pred EEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCC-CeEEEEecCccccccC
Q 003971 598 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITD 676 (782)
Q Consensus 598 LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~-g~VKLaDFGLA~~l~~ 676 (782)
+||||+.+++|..+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 109 ~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999999998754 368999999999999999999999999999999999999865 4799999999987654
Q ss_pred CCCCCCCCCCCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHh------------c-CC
Q 003971 677 SPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVAN------------E-GS 741 (782)
Q Consensus 677 ~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTGk~PF~~~~~~e-vl~~i~~------------~-~~ 741 (782)
.. .....++|+.|+|||.+.+. .++.++||||+||++|+|++|+.||....... ....+.. . ..
T Consensus 183 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 183 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 32 34567899999999998765 47999999999999999999999997554322 2111110 0 00
Q ss_pred CC-------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003971 742 RL-------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 773 (782)
Q Consensus 742 ~~-------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 773 (782)
.. ..-...+.+||.+||. ||.+|||++|+|+|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0012357889999999 99999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=377.85 Aligned_cols=249 Identities=25% Similarity=0.395 Sum_probs=203.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeecccc--ChHHHHHHHHHHHHHHhCCC-CceeeEeccccCC
Q 003971 522 DFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRLRH-PNVILFLGACTKP 593 (782)
Q Consensus 522 ~~s~y~i~~~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~--~~~~~e~f~~EI~iLk~L~H-PNIVkL~g~~~d~ 593 (782)
..++|++++.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+.++++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 457899999999999999999976 378999999865432 12224567899999999976 8999999999999
Q ss_pred CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 594 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
..+++++||+.+|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CceeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999987 344678899999999999999999999999999999999999999999999999987
Q ss_pred ccCCC-CCCCCCCCCCcccCccccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCCC--
Q 003971 674 ITDSP-MRDSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--GSRLEIP-- 746 (782)
Q Consensus 674 l~~~~-~~~~~~~GT~~Y~APEvl~~~--~~s~ksDVWSLGvILyELLTGk~PF~~~~~~evl~~i~~~--~~~~~ip-- 746 (782)
+.... .......|++.|+|||.+.+. .++.++|||||||+||+|++|+.||.+.........+... ...+.+|
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 64322 223456799999999998754 4688999999999999999999999766444333333221 1122232
Q ss_pred -ChHHHHHHHHhhh-CCCCCC-----CHHHHHHH
Q 003971 747 -EGPLGRLIADCWA-EPQERP-----SCEEILSR 773 (782)
Q Consensus 747 -~~~L~~LI~~CL~-DP~kRP-----Sa~EIL~~ 773 (782)
+..+.+|+.+||. ||.+|| +++|+++|
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 3469999999999 999999 48899875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.1e-41 Score=355.30 Aligned_cols=247 Identities=18% Similarity=0.249 Sum_probs=203.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCC-CceeeEeccccCCCceEEE
Q 003971 523 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH-PNVILFLGACTKPPRLSMI 599 (782)
Q Consensus 523 ~s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H-PNIVkL~g~~~d~~~l~LV 599 (782)
..+|++++.||+|+||+||+|++ +|+.||||++...... ..+.+|+++++.++| +||+.+++++.+....++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 36899999999999999999987 5889999998654322 346788999999975 8999999999999999999
Q ss_pred EEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcC-----CCeEEEEecCccccc
Q 003971 600 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-----HWTVKICDFGLSRII 674 (782)
Q Consensus 600 ~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~-----~g~VKLaDFGLA~~l 674 (782)
|||+ +++|.+++.. ....+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.+
T Consensus 80 me~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 80 IDLL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9999 6799888863 3457899999999999999999999999999999999999964 578999999999876
Q ss_pred cCCC-------CCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCC--
Q 003971 675 TDSP-------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL---PERVVYAVANEGSR-- 742 (782)
Q Consensus 675 ~~~~-------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~---~~evl~~i~~~~~~-- 742 (782)
.... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.. .......+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 5431 12235679999999999999999999999999999999999999997543 22222222221111
Q ss_pred -----CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003971 743 -----LEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDC 777 (782)
Q Consensus 743 -----~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~di 777 (782)
..+ +..+.+++..||. +|.+||+++.+.+.|+++
T Consensus 237 ~~~l~~~~-p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 237 LRELCAGF-PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHHTTTS-CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hHHhcCCC-CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 112 2468999999999 999999999998888775
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.7e-37 Score=327.62 Aligned_cols=244 Identities=19% Similarity=0.298 Sum_probs=187.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-----------CCceeeEeccc
Q 003971 524 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----------HPNVILFLGAC 590 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-----------HPNIVkL~g~~ 590 (782)
.+|+++++||+|+||+||+|++ +|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4599999999999999999987 58999999986442 33467788999888875 57899999887
Q ss_pred cCC--CceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-ccccccCCCcccEEEcCCC------
Q 003971 591 TKP--PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHW------ 661 (782)
Q Consensus 591 ~d~--~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs-~gIIHrDIKPeNILLd~~g------ 661 (782)
... ...+++++++..+..............+++..++.++.||+.||+|||+ .||+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 543 4566777777665554444444566788999999999999999999998 8999999999999998655
Q ss_pred eEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH------HHHHH
Q 003971 662 TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE------RVVYA 735 (782)
Q Consensus 662 ~VKLaDFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTGk~PF~~~~~~------evl~~ 735 (782)
.++|+|||.+..... .....+||+.|+|||++....++.++||||+||++++|++|+.||...... .....
T Consensus 170 ~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 499999999987643 234678999999999999999999999999999999999999999644321 11111
Q ss_pred HHhc-C---------------------CCCC------------------CC---ChHHHHHHHHhhh-CCCCCCCHHHHH
Q 003971 736 VANE-G---------------------SRLE------------------IP---EGPLGRLIADCWA-EPQERPSCEEIL 771 (782)
Q Consensus 736 i~~~-~---------------------~~~~------------------ip---~~~L~~LI~~CL~-DP~kRPSa~EIL 771 (782)
.... + .... .+ ...+.+|+.+||. ||.+|||+.|+|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 1000 0 0000 00 1247789999999 999999999999
Q ss_pred HH
Q 003971 772 SR 773 (782)
Q Consensus 772 ~~ 773 (782)
+|
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 86
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=7.6e-23 Score=200.62 Aligned_cols=165 Identities=19% Similarity=0.171 Sum_probs=121.4
Q ss_pred eeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccC----------------hHHHHHHHHHHHHHHhCCCCceeeEec
Q 003971 526 LTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLT----------------AENMEDFCNEISILSRLRHPNVILFLG 588 (782)
Q Consensus 526 y~i~~~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~----------------~~~~e~f~~EI~iLk~L~HPNIVkL~g 588 (782)
+.++++||+|+||+||+|.+ +|+.||||++...... ......+..|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46889999999999999987 7899999987532110 111244567889999999999998886
Q ss_pred cccCCCceEEEEEEecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccccCCCcccEEEcCCCeEEEEec
Q 003971 589 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 668 (782)
Q Consensus 589 ~~~d~~~l~LV~Ey~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs~gIIHrDIKPeNILLd~~g~VKLaDF 668 (782)
+.. .+++|||+++..+.. ++......++.|++.+|+|||++||+||||||+|||++++ .++|+||
T Consensus 82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred ecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 532 379999999866543 2334456789999999999999999999999999999976 5899999
Q ss_pred CccccccCCCCCCCCCCCCCcccCc------cccccCCCCchhHHHHHHHHH
Q 003971 669 GLSRIITDSPMRDSSSAGTPEWMAP------ELIRNEPFTEKCDIFSLGVIM 714 (782)
Q Consensus 669 GLA~~l~~~~~~~~~~~GT~~Y~AP------Evl~~~~~s~ksDVWSLGvIL 714 (782)
|+|.....+.. ..|... +.+ .+.|+.++|+||+.--+
T Consensus 147 G~a~~~~~~~~--------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGW--------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTH--------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCc--------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99976543211 112211 111 24578889999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.21 E-value=1.4e-06 Score=86.32 Aligned_cols=140 Identities=12% Similarity=0.016 Sum_probs=89.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCceeeEeccccCCCceEEEEEE
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEY 602 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey 602 (782)
+.|+..+..+-++.+.||+...+++.++||+....... ....+..|...+..+. +--+.+++.++.+++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 45555554443445789998888888899987543321 1234667888887774 32345666777777888999999
Q ss_pred ecccchhhHHHhhcccccchHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 003971 603 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR---------------------------------------- 642 (782)
Q Consensus 603 ~~gGsL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~gL~yLHs---------------------------------------- 642 (782)
++|.++....... .....++.++++.++.||+
T Consensus 92 l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 92 ADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred ccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9998875433100 0011122233333333332
Q ss_pred -------------------ccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 643 -------------------MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 643 -------------------~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1369999999999999876667999987743
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.51 E-value=0.00012 Score=71.51 Aligned_cols=138 Identities=17% Similarity=0.107 Sum_probs=80.8
Q ss_pred EEeeeCc-EEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCC--CceeeEeccccCCCceEEEEEEeccc
Q 003971 531 RVGIGFF-GEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH--PNVILFLGACTKPPRLSMITEYMELG 606 (782)
Q Consensus 531 ~LG~G~f-G~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H--PNIVkL~g~~~d~~~l~LV~Ey~~gG 606 (782)
.+..|.. +.||+...+ +..+++|....... ..+..|+..++.+.. -.+.+++.++.+++..+++|++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3445554 678998774 55678887543321 245677888777643 23556777777778899999999987
Q ss_pred chhhHH--------------Hhhc----ccccc--hHHHHH-----HHH---------------HHHHHHHHHHHh----
Q 003971 607 SLYHLI--------------HLSG----QKKKL--SWRRKL-----KML---------------RDICRGLMCIHR---- 642 (782)
Q Consensus 607 sL~dlL--------------~~~~----~~~~L--s~~~~l-----~Ia---------------~QIa~gL~yLHs---- 642 (782)
++.... .... ....+ ...... .+. ......+..+..
T Consensus 92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence 663210 0000 00000 000000 000 011222333332
Q ss_pred ---ccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 643 ---MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 643 ---~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
..++|+|+.|.|||++++..+-|+||+.+..
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 2379999999999999876678999987743
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.95 E-value=0.00067 Score=71.89 Aligned_cols=78 Identities=17% Similarity=0.039 Sum_probs=47.5
Q ss_pred eeEEeeeCcEEEEEEEE--CCeEEEEEEeeccc-c----ChHHHHHHHHHHHHHHhCC-C--CceeeEeccccCCCceEE
Q 003971 529 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD-L----TAENMEDFCNEISILSRLR-H--PNVILFLGACTKPPRLSM 598 (782)
Q Consensus 529 ~~~LG~G~fG~VYkg~~--~g~~VAVKil~~~~-~----~~~~~e~f~~EI~iLk~L~-H--PNIVkL~g~~~d~~~l~L 598 (782)
.+.||.|....||++.. .++.++||.-.... . -.........|.+.|+.+. + ..+.+++.+. ....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 45689999999999965 46678888643210 0 0111233456888777663 2 3455666543 345688
Q ss_pred EEEEecccch
Q 003971 599 ITEYMELGSL 608 (782)
Q Consensus 599 V~Ey~~gGsL 608 (782)
+||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.45 E-value=0.0046 Score=63.24 Aligned_cols=71 Identities=11% Similarity=0.107 Sum_probs=44.0
Q ss_pred eCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCce-----eeEec--cccCCCceEEEEEEeccc
Q 003971 535 GFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-----ILFLG--ACTKPPRLSMITEYMELG 606 (782)
Q Consensus 535 G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-----VkL~g--~~~d~~~l~LV~Ey~~gG 606 (782)
+.-..||++.. +|+.|++|+....... .+++..|...+..|...+| +..-+ .+...+..+.++++++|.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 33468999976 7888999997654433 3556678888877742222 11111 112345578899998874
Q ss_pred ch
Q 003971 607 SL 608 (782)
Q Consensus 607 sL 608 (782)
.+
T Consensus 110 ~~ 111 (325)
T d1zyla1 110 QF 111 (325)
T ss_dssp EC
T ss_pred CC
Confidence 43
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.28 E-value=0.012 Score=59.18 Aligned_cols=31 Identities=19% Similarity=0.186 Sum_probs=27.4
Q ss_pred ccccccCCCcccEEEcCCCeEEEEecCcccc
Q 003971 643 MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 673 (782)
Q Consensus 643 ~gIIHrDIKPeNILLd~~g~VKLaDFGLA~~ 673 (782)
.|+||+|+.++||+++.+...-|.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887778999998753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.76 E-value=0.02 Score=59.87 Aligned_cols=77 Identities=18% Similarity=0.283 Sum_probs=51.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCce-eeEeccccCC
Q 003971 524 SELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKP 593 (782)
Q Consensus 524 s~y~i~~~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~ 593 (782)
+++.+ +.|+-|-.-.+|++... ...|.+++.... .. .....+|..+++.+.-.++ .++++++..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 44554 67888999999998753 245777776522 11 2344578888888853343 477777653
Q ss_pred CceEEEEEEecccchh
Q 003971 594 PRLSMITEYMELGSLY 609 (782)
Q Consensus 594 ~~l~LV~Ey~~gGsL~ 609 (782)
.+|+||++|.++.
T Consensus 117 ---g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPLS 129 (395)
T ss_dssp ---EEEECCCCEEECC
T ss_pred ---ceEEEEeccccCC
Confidence 6889999886553
|
| >d1g83a2 d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine kinase Fyn species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.71 E-value=0.0017 Score=56.24 Aligned_cols=57 Identities=14% Similarity=0.240 Sum_probs=47.9
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|+.|+..|+..++.+|+|++|.|+ ...+.+.+++...+...+++..|+.+.+.
T Consensus 11 g~i~R~eAe~~L~~~g~~~G~FLVR~S~----~~~g~~~Lsv~~~~~~~~~~v~h~~i~~~ 67 (104)
T d1g83a2 11 GKLGRKDAERQLLSFGNPRGTFLIRESE----TTKGAYSLSIRDWDDMKGDHVKHYKIRKL 67 (104)
T ss_dssp TTCCHHHHHHHHHSTTCCTTCEEEEECS----SSTTCEEEEEEEECSSSCEEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCCcEEEeccC----CCCCCeEEEEEEeecCcCCeEEEEEEEEc
Confidence 5689999999999999999999999997 55678888888777777777888876653
|
| >d1qcfa2 d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hemopoetic cell kinase Hck species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.35 E-value=0.0017 Score=56.12 Aligned_cols=57 Identities=12% Similarity=0.173 Sum_probs=45.8
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|..|+.+|+..++.||+|++|.|+ ...+.+.+++.......++...|+.+.+.
T Consensus 6 g~isR~eAe~~L~~~~~~~G~FLVR~S~----~~~g~~~Lsv~~~~~~~~~~v~H~~i~~~ 62 (103)
T d1qcfa2 6 KGISRKDAERQLLAPGNMLGSFMIRDSE----TTKGSYSLSVRDYDPRQGDTVKHYKIRTL 62 (103)
T ss_dssp TTCCHHHHHHHHHSTTCCTTCEEEEECS----SSTTSEEEEEEEEETTTEEEEEEEEEEEC
T ss_pred CCCCHHHHHHHHhhcCCCCCcEEEEccC----CCCCCeEEEEEecCCCcCceEEEEEEEEc
Confidence 5689999999999999999999999998 66677888876655555667777776553
|
| >d1lkka_ d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: p56-lck tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.21 E-value=0.0018 Score=56.11 Aligned_cols=56 Identities=11% Similarity=0.207 Sum_probs=45.3
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
+.|+|..|+.+|++.++.||+|++|.|+ ...+.+.+++...+...+.+..|+.+.+
T Consensus 9 g~isR~eAe~~L~~~~~~~GtFLVR~S~----~~~g~~~lsv~~~~~~~~~~v~h~~i~~ 64 (105)
T d1lkka_ 9 KNLSRKDAERQLLAPGNTHGSFLIRESE----STAGSFSLSVRDFDQNQGEVVKHYKIRN 64 (105)
T ss_dssp TTCCHHHHHHHHTSTTCCTTCEEEEECS----SSTTCEEEEEEEEETTTEEEEEEEEEEE
T ss_pred CCCCHHHHHHHHHhcCCCCCcEEEEccC----CCCCCEEEEEEEcccCCCccEEEEEEEE
Confidence 5789999999999999999999999997 5667788888766665556667776554
|
| >d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: P55 Blk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=94.00 E-value=0.0068 Score=53.17 Aligned_cols=57 Identities=14% Similarity=0.178 Sum_probs=44.4
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
++.|+|..|+++|++.++.||+|++|.|+ ..++.+.+++.... ..+...+|+.+.+.
T Consensus 16 ~g~isR~eAe~~L~~~~~~~G~FLVR~S~----~~~g~~~Lsv~~~~-~~~~~v~H~~i~~~ 72 (114)
T d1blja_ 16 FRTISRKDAERQLLAPMNKAGSFLIRESE----SNKGAFSLSVKDIT-TQGEVVKHYKIRSL 72 (114)
T ss_dssp CCSCCHHHHHHHHSSTTCCTTCEEBCBCT----TCSSCEEEEECBCC-TTTCBCCCEEEEEE
T ss_pred CCCCCHHHHHHHHHhcCCCCceEEEeccC----CCCCCeEEEEEeec-cCCCEEEEEEEEEc
Confidence 35789999999999999999999999997 66778888776432 23456677776653
|
| >d1o48a_ d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.55 E-value=0.0022 Score=55.70 Aligned_cols=57 Identities=14% Similarity=0.195 Sum_probs=45.7
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|+.|+..|++.++.||+|++|.|+ ...+.+.+++...+...+.+..++.+.+.
T Consensus 10 g~i~R~eAe~lL~~~~~~~G~FLVR~S~----~~~g~y~LSv~~~~~~~~~~i~h~~i~~~ 66 (106)
T d1o48a_ 10 GKITRRESERLLLNAENPRGTFLVRESE----TTKGAYCLSVSDFDNAKGLNVKHYKIRKL 66 (106)
T ss_dssp ESCCHHHHHHHHCCTTCCTTCEEEEECS----SSTTCEEEEEEEEETTTEEEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCCcEEEEccc----CCCCCEEEEEEecccCcccceEEEEEEEe
Confidence 4689999999999999999999999997 56777888887666665666667766553
|
| >d1rjaa_ d.93.1.1 (A:) Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.73 E-value=0.01 Score=50.95 Aligned_cols=52 Identities=13% Similarity=0.163 Sum_probs=42.5
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|..|+..|+..++.||+|++|.|+ ...+.+.+++.. +++.+|+.+.+.
T Consensus 7 g~isR~~Ae~~L~~~~~~~G~FLvR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 58 (100)
T d1rjaa_ 7 GCISRSEAVRRLQAEGNATGAFLIRVSE----KPSADYVLSVRD-----TQAVRHYKIWRR 58 (100)
T ss_dssp TTCCHHHHHHHHSSTTCSSCCEEEEECS----SSSSCEEEEECT-----TSSCEEEEEEEC
T ss_pred CCCCHHHHHHHHhccCCCCCeEEeecCC----CCCCCEEEEEEc-----CCCceEEEEEEC
Confidence 5689999999999999999999999997 556778888874 356788877653
|
| >d1nrva_ d.93.1.1 (A:) Growth factor receptor-bound protein 10, GRB10 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 10, GRB10 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.20 E-value=0.024 Score=48.79 Aligned_cols=52 Identities=10% Similarity=-0.005 Sum_probs=40.8
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|..|+..|...+..||+|++|.|+ ...+.+.+++.. ++...|+.+.+.
T Consensus 10 g~isR~~Ae~lL~~~g~~dG~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 61 (105)
T d1nrva_ 10 GRISREESHRIIKQQGLVDGLFLLRDSQ----SNPKAFVLTLCH-----HQKIKNFQILPC 61 (105)
T ss_dssp TTCCHHHHHHHHHHTTCCTTEEEEEECS----SCTTCEEEEEEE-----TTEEEEEEEEEC
T ss_pred CCCCHHHHHHHHhhcCCCCceEEEEeCC----CCCCCEEEEEEE-----CCceeEEEEEEe
Confidence 4689999999999999999999999997 445668887764 345677777654
|
| >d1a81a1 d.93.1.1 (A:9-137) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.88 E-value=0.016 Score=52.27 Aligned_cols=52 Identities=12% Similarity=0.173 Sum_probs=42.8
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|..|+..|+..+..||+|++|.|+ ...+.+.+++.. +++.+|+.+.+.
T Consensus 10 g~isR~~Ae~lL~~~g~~dG~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 61 (129)
T d1a81a1 10 GNITREEAEDYLVQGGMSDGLYLLRQSR----NYLGGFALSVAH-----GRKAHHYTIERE 61 (129)
T ss_dssp SSCCHHHHHHHHHHTTCCTTEEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCccEEEEccC----CCCcceEEEeee-----cccceEEEEEEc
Confidence 4689999999999999999999999997 456778888764 456788887764
|
| >d2qmsa1 d.93.1.1 (A:420-532) Growth factor receptor-bound protein 7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.85 E-value=0.043 Score=47.85 Aligned_cols=51 Identities=12% Similarity=-0.016 Sum_probs=40.6
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCcccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 458 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r 458 (782)
+.|+|..|+..|+..+..||+|++|.|+ ...+.+.+++.. +++..|+.+..
T Consensus 15 g~isR~~Ae~lL~~~g~~dG~FLvR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 65 (113)
T d2qmsa1 15 GRISREESQRLIGQQGLVDGLFLVRESQ----RNPQGFVLSLCH-----LQKVKHYLILP 65 (113)
T ss_dssp EEBCHHHHHHHHHHTTCCTTEEEEEECS----SCTTCEEEEEEE-----TTEEEEEEEEE
T ss_pred CCCCHHHHHHHHhccCCCCccEEEEecc----CCCCCEEEEEEe-----CCeEEEEEEEE
Confidence 4689999999999999999999999997 444667777753 45677777755
|
| >d2oq1a1 d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.66 E-value=0.035 Score=49.86 Aligned_cols=52 Identities=12% Similarity=0.024 Sum_probs=42.2
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|..|+..|+..|+.+|+|++|.|+ ...+.|.+++.. +++.+|+.+.+.
T Consensus 11 g~i~R~~Ae~~L~~~g~~~G~FLVR~S~----~~~g~yvLSv~~-----~~~v~H~~I~~~ 62 (130)
T d2oq1a1 11 GSISRAEAEEHLKLAGMADGLFLLRQCL----RSLGGYVLSLVH-----DVRFHHFPIERQ 62 (130)
T ss_dssp BSCCHHHHHHHHHHTTCCTTCEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCceEEEEecC----CCCccEEEEEee-----CCceEEEEEEEc
Confidence 4688999999999999999999999997 556678888764 456788887653
|
| >d1i3za_ d.93.1.1 (A:) Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Ews/fli1 activated transcript 2, Eat2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=85.87 E-value=0.047 Score=46.77 Aligned_cols=51 Identities=16% Similarity=0.144 Sum_probs=38.4
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|..||..|++. +.||+|++|+|+ ...+.+.+++.. +++.+|+.+.+.
T Consensus 8 g~isR~~AE~lL~~~-~~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 58 (103)
T d1i3za_ 8 GCLTKRECEALLLKG-GVDGNFLIRDSE----SVPGALCLCVSF-----KKLVYSYRIFRE 58 (103)
T ss_dssp SSCCHHHHHHHHHTT-CSTTEEEEEECS----SSTTCEEEEEEC-----SSSEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhC-CCCCeEEEEecC----CCCCCEEEEEEe-----CCeEEEEEeEEc
Confidence 458899999777554 589999999997 455778888775 346788887654
|
| >d1rpya_ d.93.1.1 (A:) Adaptor protein Aps {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Adaptor protein Aps species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=85.30 E-value=0.046 Score=45.17 Aligned_cols=52 Identities=10% Similarity=0.123 Sum_probs=38.6
Q ss_pred HHHHHHHHhhhhhhhc-CCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQER-GEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|..|+..|++.+ ..||+|++|.|+ ...+.+.+++.. .++.+++.+.+.
T Consensus 10 g~isR~~Ae~lL~~~~~~~dG~FLvR~S~----~~~g~~~Lsv~~-----~~~v~h~~I~~~ 62 (86)
T d1rpya_ 10 GTLSRVKAAQLVLAGGPRSHGLFVIRQSE----TRPGECVLTFNF-----QGKAKHLRLSLN 62 (86)
T ss_dssp TTCCHHHHHHHHHTTGGGGTTCEEEEECS----SSTTCEEEEEEE-----TTEEEEEEC---
T ss_pred CCCCHHHHHHHHHhCCCCCCceEEEEecC----CCCCcEEEEEEE-----CCceEEEEEEEc
Confidence 5789999999999887 489999999997 445667777764 345777776653
|
| >d1jyra_ d.93.1.1 (A:) Growth factor receptor-bound protein 2 (GRB2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 2 (GRB2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.73 E-value=0.048 Score=46.29 Aligned_cols=51 Identities=12% Similarity=0.196 Sum_probs=38.8
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|..|+..|++. +.+|+|++|.|+ ..++.+.+++.. .++.+|+.+.++
T Consensus 8 g~isR~~Ae~lL~~~-~~~G~FLvR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 58 (96)
T d1jyra_ 8 GKIPRAKAEEMLSKQ-RHDGAFLIRESE----SAPGDFSLSVKF-----GNDVQHFKVLRD 58 (96)
T ss_dssp CSCCHHHHHHHHHTC-CSTTBEEEEECS----SSTTCEEEEEEE-----TTEEEEEECEEC
T ss_pred CCCCHHHHHHHHhhC-CCCCeEEEEecC----CCCCCEEEEEEe-----CCceEEEEEEEC
Confidence 468999999888664 479999999997 556677887764 345778877664
|
| >d1r1qa_ d.93.1.1 (A:) GRB2-related adaptor protein 2 (MONA, GRID) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: GRB2-related adaptor protein 2 (MONA, GRID) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=81.84 E-value=0.13 Score=43.46 Aligned_cols=50 Identities=10% Similarity=0.137 Sum_probs=39.0
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
+.|+|..|+..|. +..+|+|++|.|+ ..++.+.+++.. .++.+|+.+.+.
T Consensus 11 g~isR~~Ae~lL~--~~~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 60 (97)
T d1r1qa_ 11 EGLSRHQAENLLM--GKDIGFFIIRASQ----SSPGDFSISVRH-----EDDVQHFKVMRD 60 (97)
T ss_dssp TTCCHHHHHHHHH--TSCTTCEEEEECS----SSTTCEEEEEEC-----SSSEEEEECEEC
T ss_pred CCCCHHHHHHHHh--cCCCCCEEEeecC----CCCCCEEEEEEe-----cCCeEEEEEEEc
Confidence 5789999998886 4689999999997 566778888764 345788877664
|
| >d2oq1a2 d.93.1.1 (A:135-258) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.73 E-value=0.062 Score=47.76 Aligned_cols=52 Identities=15% Similarity=0.171 Sum_probs=41.7
Q ss_pred HHHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCccCCCccccccccc
Q 003971 398 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 459 (782)
Q Consensus 398 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~rs~~~~l~r~ 459 (782)
.+.|+|..|+..|++.+..||+|++|.|+ . .+.|.+++.. +++.+||.+.+.
T Consensus 33 hg~isR~eAe~lL~~~~~~dGtFLVR~S~----~-~g~yvLSv~~-----~~~v~H~~I~~~ 84 (124)
T d2oq1a2 33 HSSLTREEAERKLYSGAQTDGKFLLRPRK----E-QGTYALSLIY-----GKTVYHYLISQD 84 (124)
T ss_dssp CSSCCHHHHHHHHHSSCCCTTEEEEEECS----S-TTEEEEEEEE-----TTEEEEEEEEEC
T ss_pred cCCCCHHHHHHHHhhcCCCCceEEeEecC----C-CCCEEEEeec-----CCceEEEEEEEC
Confidence 46789999999999999999999999996 2 4667777764 456788887653
|
| >d1luia_ d.93.1.1 (A:) Itk/tsk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Itk/tsk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=80.96 E-value=0.14 Score=43.97 Aligned_cols=54 Identities=13% Similarity=0.169 Sum_probs=38.5
Q ss_pred HHHHHHHHhhhhhhhcCCCCCCccCCCCCCCCCCCCCcccCCCCCCCcc-CCCcccccccc
Q 003971 399 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEIS-GGRSALYNLSR 458 (782)
Q Consensus 399 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~rs~~~~l~r 458 (782)
+.|+|..|+..|++.+ .||+|++|.|+ . .+.|.+++....... ++..+|+.+.+
T Consensus 11 g~isR~eAe~lL~~~~-~~G~FLVR~S~----~-~g~y~LSv~~~~~~~~~~~i~h~~I~~ 65 (108)
T d1luia_ 11 KSISRDKAEKLLLDTG-KEGAFMVRDSR----T-PGTYTVSVFTKAIISENPCIKHYHIKE 65 (108)
T ss_dssp TTCCHHHHHHHHHHHC-CTTEEEEEECC----T-TTCEEEEEECSCCTTTCSCEEEEECEE
T ss_pred CCCCHHHHHHHHHhcC-CCCeEEEEecC----C-CCCEEEEEEecCCcccCCceeEEEEEE
Confidence 5688999998887665 78999999986 3 467888877655443 34456666644
|